{"363287146456208eeaffc0ec62e4c8c8b15fd6da": [["INTRODUCTIONNeutrophils (PMN) are crucial for clearing microbial pathogens [1] .", [["PMN", "ANATOMY", 25, 28], ["PMN", "CELL", 25, 28], ["PMN", "CELL_TYPE", 25, 28], ["clearing microbial pathogens", "PROBLEM", 46, 74]]], ["Among many other proteins, PMNs produce matrix metalloproteinase (MMP)-8, a neutrophil collagenase, which is pivotal for initiation and consequent resolution of inflammation, presumably by altering chemotactic gradients [1] .", [["PMNs", "ANATOMY", 27, 31], ["inflammation", "DISEASE", 161, 173], ["PMNs", "CELL", 27, 31], ["matrix metalloproteinase (MMP)-8", "GENE_OR_GENE_PRODUCT", 40, 72], ["neutrophil collagenase", "GENE_OR_GENE_PRODUCT", 76, 98], ["PMNs", "CELL_TYPE", 27, 31], ["matrix metalloproteinase (MMP)-8", "PROTEIN", 40, 72], ["neutrophil collagenase", "PROTEIN", 76, 98], ["PMNs", "TEST", 27, 31], ["matrix metalloproteinase (MMP)", "TEST", 40, 70], ["a neutrophil collagenase", "TREATMENT", 74, 98], ["inflammation", "PROBLEM", 161, 173], ["altering chemotactic gradients", "PROBLEM", 189, 219], ["inflammation", "OBSERVATION", 161, 173], ["chemotactic gradients", "OBSERVATION", 198, 219]]], ["In general, a lack of MMP-8 has been associated with increased neutrophil counts at inflammatory sites [2, 3] .INTRODUCTIONMacrophage inflammatory protein (MIP)-1 \u03b1, also known as chemokine ligand 3 (CCL3), is a potent proinflammatory chemokine that is produced by macrophages in response to various stimuli including endotoxin.", [["neutrophil", "ANATOMY", 63, 73], ["macrophages", "ANATOMY", 265, 276], ["endotoxin", "CHEMICAL", 318, 327], ["MMP-8", "GENE_OR_GENE_PRODUCT", 22, 27], ["neutrophil", "CELL", 63, 73], ["INTRODUCTIONMacrophage inflammatory protein (MIP)-1 \u03b1", "GENE_OR_GENE_PRODUCT", 111, 164], ["chemokine ligand 3", "GENE_OR_GENE_PRODUCT", 180, 198], ["CCL3", "GENE_OR_GENE_PRODUCT", 200, 204], ["macrophages", "CELL", 265, 276], ["endotoxin", "SIMPLE_CHEMICAL", 318, 327], ["MMP-8", "PROTEIN", 22, 27], ["INTRODUCTIONMacrophage inflammatory protein (MIP)-1 \u03b1", "PROTEIN", 111, 164], ["chemokine ligand 3", "PROTEIN", 180, 198], ["CCL3", "PROTEIN", 200, 204], ["proinflammatory chemokine", "PROTEIN", 219, 244], ["macrophages", "CELL_TYPE", 265, 276], ["MMP", "TEST", 22, 25], ["increased neutrophil counts at inflammatory sites", "PROBLEM", 53, 102], ["INTRODUCTIONMacrophage inflammatory protein (MIP)", "TEST", 111, 160], ["chemokine ligand", "TEST", 180, 196], ["a potent proinflammatory chemokine", "PROBLEM", 210, 244], ["various stimuli", "TEST", 292, 307], ["endotoxin", "TREATMENT", 318, 327], ["increased", "OBSERVATION_MODIFIER", 53, 62], ["neutrophil counts", "OBSERVATION", 63, 80], ["inflammatory", "OBSERVATION_MODIFIER", 84, 96], ["potent", "OBSERVATION_MODIFIER", 212, 218], ["proinflammatory chemokine", "OBSERVATION", 219, 244], ["macrophages", "OBSERVATION", 265, 276]]], ["CCL3 propagates inflammation by further recruitment and activation of PMNs.", [["PMNs", "ANATOMY", 70, 74], ["inflammation", "DISEASE", 16, 28], ["CCL3", "GENE_OR_GENE_PRODUCT", 0, 4], ["PMNs", "CELL", 70, 74], ["CCL3", "PROTEIN", 0, 4], ["PMNs", "CELL_TYPE", 70, 74], ["CCL3 propagates inflammation", "PROBLEM", 0, 28], ["activation of PMNs", "TREATMENT", 56, 74], ["inflammation", "OBSERVATION", 16, 28], ["recruitment", "OBSERVATION_MODIFIER", 40, 51]]], ["Data from different experimental models, including a murine acute lung injury model, suggest that soluble as well as membrane bound MMP-8 degrades MIP-1\u03b1 and therefore mitigates inflammation, resulting in improved survival [4] .", [["lung", "ANATOMY", 66, 70], ["membrane", "ANATOMY", 117, 125], ["acute lung injury", "DISEASE", 60, 77], ["inflammation", "DISEASE", 178, 190], ["murine", "ORGANISM", 53, 59], ["lung", "ORGAN", 66, 70], ["membrane", "CELLULAR_COMPONENT", 117, 125], ["MMP-8", "GENE_OR_GENE_PRODUCT", 132, 137], ["MIP-1\u03b1", "GENE_OR_GENE_PRODUCT", 147, 153], ["membrane bound MMP-8", "PROTEIN", 117, 137], ["MIP-1\u03b1", "PROTEIN", 147, 153], ["murine", "SPECIES", 53, 59], ["a murine acute lung injury model", "PROBLEM", 51, 83], ["membrane bound MMP", "TEST", 117, 135], ["MIP", "TEST", 147, 150], ["inflammation", "PROBLEM", 178, 190], ["acute", "OBSERVATION_MODIFIER", 60, 65], ["lung", "ANATOMY", 66, 70], ["injury", "OBSERVATION", 71, 77], ["inflammation", "OBSERVATION", 178, 190]]], ["In turn, genetically deleting MIP 1-\u03b1 in MMP-8 knockout mice also reduced lung inflammation and mortality, thus suggesting an important role for an \"MMP-8/MIP-1\u03b1 axis\" in acute inflammation [4] .INTRODUCTIONHuman studies to date have largely reported associations between MMP-8 plasma levels or MMP-8 genotypes and clinical outcomes, without exploring underlying mechanisms [5] [6] [7] .", [["lung", "ANATOMY", 74, 78], ["lung inflammation", "DISEASE", 74, 91], ["inflammation", "DISEASE", 177, 189], ["MIP 1-\u03b1", "GENE_OR_GENE_PRODUCT", 30, 37], ["MMP-8", "GENE_OR_GENE_PRODUCT", 41, 46], ["mice", "ORGANISM", 56, 60], ["lung", "ORGAN", 74, 78], ["MMP-8", "GENE_OR_GENE_PRODUCT", 149, 154], ["MIP-1\u03b1", "GENE_OR_GENE_PRODUCT", 155, 161], ["MMP-8", "GENE_OR_GENE_PRODUCT", 272, 277], ["plasma", "ORGANISM_SUBSTANCE", 278, 284], ["MMP-8", "GENE_OR_GENE_PRODUCT", 295, 300], ["[5] [6] [7]", "SIMPLE_CHEMICAL", 374, 385], ["MIP 1", "PROTEIN", 30, 35], ["\u03b1", "DNA", 36, 37], ["MMP", "PROTEIN", 41, 44], ["MMP-8", "PROTEIN", 149, 154], ["MIP", "PROTEIN", 155, 158], ["MMP-8", "PROTEIN", 272, 277], ["MMP", "PROTEIN", 295, 298], ["mice", "SPECIES", 56, 60], ["mice", "SPECIES", 56, 60], ["MIP", "TEST", 30, 33], ["MMP", "TEST", 41, 44], ["reduced lung inflammation", "PROBLEM", 66, 91], ["an \"MMP", "TEST", 145, 152], ["MIP", "TEST", 155, 158], ["acute inflammation", "PROBLEM", 171, 189], [".INTRODUCTIONHuman studies", "TEST", 194, 220], ["MMP", "TEST", 272, 275], ["plasma levels", "TEST", 278, 291], ["MMP", "TEST", 295, 298], ["reduced", "OBSERVATION_MODIFIER", 66, 73], ["lung", "ANATOMY", 74, 78], ["inflammation", "OBSERVATION", 79, 91], ["acute", "OBSERVATION_MODIFIER", 171, 176], ["inflammation", "OBSERVATION", 177, 189]]], ["For example, preliminary analysis of the GenIMS study showed that the MMP-8 non-synonymous single-nucleotide polymorphism (SNP) rs1940475 was associated with 90-day mortality in patients with community-acquired pneumonia (CAP), and the presence of the A allele was associated with better survival [8] .", [["SNP", "CHEMICAL", 123, 126], ["pneumonia", "DISEASE", 211, 220], ["CAP", "DISEASE", 222, 225], ["MMP-8", "GENE_OR_GENE_PRODUCT", 70, 75], ["patients", "ORGANISM", 178, 186], ["A", "GENE_OR_GENE_PRODUCT", 252, 253], ["MMP", "PROTEIN", 70, 73], ["A allele", "DNA", 252, 260], ["patients", "SPECIES", 178, 186], ["preliminary analysis", "TEST", 13, 33], ["the GenIMS study", "TEST", 37, 53], ["the MMP", "TEST", 66, 73], ["non-synonymous single-nucleotide polymorphism (SNP)", "PROBLEM", 76, 127], ["community-acquired pneumonia", "PROBLEM", 192, 220], ["pneumonia", "OBSERVATION", 211, 220]]], ["The rs1940475 SNP causes a point mutation in the pro-domain of MMP-8.", [["SNP", "CHEMICAL", 14, 17], ["rs1940475", "GENE_OR_GENE_PRODUCT", 4, 13], ["MMP-8", "GENE_OR_GENE_PRODUCT", 63, 68], ["rs1940475 SNP", "DNA", 4, 17], ["MMP-8", "PROTEIN", 63, 68], ["a point mutation", "PROBLEM", 25, 41], ["MMP", "TEST", 63, 66]]], ["This results in an amino acid substitution of glutamic acid for lysine at position 87, thereby rendering it less amenable to activation, which results in functional suppression [9] .", [["amino acid", "CHEMICAL", 19, 29], ["glutamic acid", "CHEMICAL", 46, 59], ["lysine", "CHEMICAL", 64, 70], ["amino acid", "CHEMICAL", 19, 29], ["glutamic acid", "CHEMICAL", 46, 59], ["lysine", "CHEMICAL", 64, 70], ["amino acid", "AMINO_ACID", 19, 29], ["glutamic acid", "AMINO_ACID", 46, 59], ["lysine", "AMINO_ACID", 64, 70], ["position 87", "AMINO_ACID", 74, 85], ["an amino acid substitution", "TREATMENT", 16, 42], ["glutamic acid", "TREATMENT", 46, 59]]], ["As such, its ability to function as a negative feedback regulator in inflammation is impaired, leading to an over-recruitment of PMNs which may lead to tissue and organ damage.INTRODUCTIONTo better understand the role of MMP-8 in human inflammation, we investigated the influence of the rs1940475 SNP (K87E) on downstream chemokine and cytokine processing in human endotoxemia.", [["PMNs", "ANATOMY", 129, 133], ["tissue", "ANATOMY", 152, 158], ["organ", "ANATOMY", 163, 168], ["inflammation", "DISEASE", 69, 81], ["tissue and organ damage", "DISEASE", 152, 175], ["inflammation", "DISEASE", 236, 248], ["SNP", "CHEMICAL", 297, 300], ["endotoxemia", "DISEASE", 365, 376], ["PMNs", "CELL", 129, 133], ["tissue", "TISSUE", 152, 158], ["organ", "ORGAN", 163, 168], ["MMP-8", "GENE_OR_GENE_PRODUCT", 221, 226], ["human", "ORGANISM", 230, 235], ["rs1940475", "GENE_OR_GENE_PRODUCT", 287, 296], ["human", "ORGANISM", 359, 364], ["PMNs", "CELL_TYPE", 129, 133], ["MMP-8", "PROTEIN", 221, 226], ["rs1940475 SNP", "DNA", 287, 300], ["chemokine", "PROTEIN", 322, 331], ["cytokine", "PROTEIN", 336, 344], ["human", "SPECIES", 230, 235], ["human", "SPECIES", 359, 364], ["human", "SPECIES", 230, 235], ["human", "SPECIES", 359, 364], ["inflammation", "PROBLEM", 69, 81], ["PMNs", "PROBLEM", 129, 133], ["tissue and organ damage", "PROBLEM", 152, 175], ["MMP", "TEST", 221, 224], ["downstream chemokine and cytokine processing", "TREATMENT", 311, 355], ["human endotoxemia", "PROBLEM", 359, 376], ["organ", "ANATOMY", 163, 168], ["damage", "OBSERVATION", 169, 175], ["endotoxemia", "OBSERVATION", 365, 376]]], ["The human endotoxemia model is a well-established model, in which a defined inflammatory stimulus allows to study the pathogenesis and potential treatments for systemic inflammation [10] .", [["endotoxemia", "DISEASE", 10, 21], ["systemic inflammation", "DISEASE", 160, 181], ["human", "ORGANISM", 4, 9], ["human", "SPECIES", 4, 9], ["human", "SPECIES", 4, 9], ["The human endotoxemia model", "TEST", 0, 27], ["a defined inflammatory stimulus", "PROBLEM", 66, 97], ["systemic inflammation", "PROBLEM", 160, 181], ["endotoxemia", "OBSERVATION", 10, 21], ["inflammatory", "OBSERVATION", 76, 88]]], ["We hypothesized that subjects homozygous for the allele (A) would have lower peak MIP-1\u03b1 levels compared to subjects with mutated alleles (G).Study ParticipantsThe Medical University of Vienna Ethics Committee approved the study protocol, and all participants gave written informed consent prior to enrolment.", [["MIP-1\u03b1", "GENE_OR_GENE_PRODUCT", 82, 88], ["allele", "DNA", 49, 55], ["MIP", "PROTEIN", 82, 85], ["Participants", "SPECIES", 148, 160], ["participants", "SPECIES", 247, 259], ["lower peak MIP", "TEST", 71, 85], ["the study protocol", "TEST", 219, 237], ["enrolment", "TREATMENT", 299, 308]]], ["We obtained complete data and mRNA samples from 44 healthy Caucasian males.", [["samples", "ANATOMY", 35, 42], ["mRNA samples", "TEST", 30, 42]]], ["Determination of health status included a medical history, physical examination, laboratory testing, and virus and standard drug screening.", [["physical examination", "TEST", 59, 79], ["laboratory testing", "TEST", 81, 99], ["virus", "PROBLEM", 105, 110], ["standard drug screening", "TEST", 115, 138]]], ["Exclusion criteria were regular or recent intake of medications, including over-the-counter medications as well as clinically relevant abnormal findings detected in the screening examinations.Study ParticipantsThe experimental procedures of our LPS infusion studies have been described in detail elsewhere [11] .", [["LPS", "CHEMICAL", 245, 248], ["LPS", "SIMPLE_CHEMICAL", 245, 248], ["Participants", "SPECIES", 198, 210], ["medications", "TREATMENT", 52, 63], ["medications", "TREATMENT", 92, 103], ["clinically relevant abnormal findings", "PROBLEM", 115, 152], ["the screening examinations", "TEST", 165, 191], ["our LPS infusion studies", "TEST", 241, 265]]], ["Briefly, volunteers reported to the study ward at 8:00 a.m. after an overnight fast and received an intravenous bolus of 2 ng/kg LPS (National Reference Endotoxin, Escherichia coli, CC-RE-Lot 2; National Institutes of Health, Bethesda, MD, USA).", [["intravenous", "ANATOMY", 100, 111], ["LPS", "CHEMICAL", 129, 132], ["Endotoxin", "CHEMICAL", 153, 162], ["CC", "CHEMICAL", 182, 184], ["volunteers", "ORGANISM", 9, 19], ["intravenous", "IMMATERIAL_ANATOMICAL_ENTITY", 100, 111], ["LPS", "SIMPLE_CHEMICAL", 129, 132], ["Escherichia coli", "ORGANISM", 164, 180], ["Escherichia coli", "SPECIES", 164, 180], ["Escherichia coli", "SPECIES", 164, 180], ["an intravenous bolus", "TREATMENT", 97, 117], ["Endotoxin", "TEST", 153, 162], ["Escherichia coli", "TEST", 164, 180], ["CC", "TEST", 182, 184]]], ["Throughout the entire study period, participants were confined to bed rest, and vital parameters, i.e., electrocardiogram (ECG), heart rate, oxygen saturation, and blood pressure were continuously monitored.MMP-8 Genotype AnalysisBased on our preliminary findings in patients with CAP, [8] we selected the non-synonymous SNP 259A>G (rs1940475 in the National Center for Biotechnology Single Nucleotide Polymorphism database, http:// www.ncbi.nlm.nih.gov/SNP) for analysis.", [["heart", "ANATOMY", 129, 134], ["blood", "ANATOMY", 164, 169], ["oxygen", "CHEMICAL", 141, 147], ["CAP", "DISEASE", 281, 284], ["SNP", "CHEMICAL", 321, 324], ["oxygen", "CHEMICAL", 141, 147], ["participants", "ORGANISM", 36, 48], ["heart", "ORGAN", 129, 134], ["oxygen", "SIMPLE_CHEMICAL", 141, 147], ["blood", "ORGANISM_SUBSTANCE", 164, 169], ["MMP-8", "GENE_OR_GENE_PRODUCT", 207, 212], ["patients", "ORGANISM", 267, 275], ["MMP", "PROTEIN", 207, 210], ["rs1940475", "DNA", 333, 342], ["participants", "SPECIES", 36, 48], ["patients", "SPECIES", 267, 275], ["vital parameters", "TEST", 80, 96], ["electrocardiogram", "TEST", 104, 121], ["ECG", "TEST", 123, 126], ["heart rate", "TEST", 129, 139], ["oxygen saturation", "TEST", 141, 158], ["blood pressure", "TEST", 164, 178], ["MMP", "TEST", 207, 210], ["CAP", "TEST", 281, 284], ["the non-synonymous SNP", "TEST", 302, 324], ["Nucleotide Polymorphism database", "TEST", 391, 423], ["analysis", "TEST", 463, 471], ["heart", "ANATOMY", 129, 134], ["oxygen saturation", "OBSERVATION", 141, 158]]], ["All blood samples were immediately processed to avoid storageinduced changes in mRNA levels.", [["blood samples", "ANATOMY", 4, 17], ["blood samples", "ORGANISM_SUBSTANCE", 4, 17], ["All blood samples", "TEST", 0, 17], ["storageinduced changes in mRNA levels", "PROBLEM", 54, 91]]], ["After isolating total RNA with an RNeasy minikit (Qiagen, Valencia, CA, USA), mRNA was directly transcribed into cDNA, using a TaqMan reverse transcription reagents kit (Applied Biosystems, Foster City, CA, USA), and stored at \u221280\u00b0C until analysis.", [["mRNA", "RNA", 78, 82], ["cDNA", "DNA", 113, 117], ["isolating total RNA", "TREATMENT", 6, 25], ["an RNeasy minikit", "TREATMENT", 31, 48], ["a TaqMan reverse transcription reagents", "TREATMENT", 125, 164], ["analysis", "TEST", 239, 247], ["total RNA", "OBSERVATION", 16, 25]]], ["Consequently, cDNA samples were genotyped on an ABI 7700 Prism using a commercially available SNP assay (TaqMan MMP-8 assay, Applied Biosystems) and analyzed with Sequence Detection System software (Ver.", [["samples", "ANATOMY", 19, 26], ["SNP", "CHEMICAL", 94, 97], ["Ver", "CHEMICAL", 199, 202], ["cDNA samples", "DNA", 14, 26], ["MMP", "PROTEIN", 112, 115], ["cDNA samples", "TEST", 14, 26], ["an ABI", "TEST", 45, 51], ["SNP assay", "TEST", 94, 103], ["TaqMan MMP", "TEST", 105, 115]]], ["1.7, Applied Biosystems).Blood Sampling and AnalysisBlood samples were collected into ethylenediaminetetraacetic acid (EDTA) anti-coagulated tubes before LPS infusion and 2, 4, 6, and 24 h after LPS infusion.", [["Blood", "ANATOMY", 25, 30], ["Blood samples", "ANATOMY", 52, 65], ["ethylenediaminetetraacetic acid", "CHEMICAL", 86, 117], ["EDTA", "CHEMICAL", 119, 123], ["LPS", "CHEMICAL", 154, 157], ["LPS", "CHEMICAL", 195, 198], ["ethylenediaminetetraacetic acid", "CHEMICAL", 86, 117], ["EDTA", "CHEMICAL", 119, 123], ["Blood", "ORGANISM_SUBSTANCE", 25, 30], ["Blood samples", "ORGANISM_SUBSTANCE", 52, 65], ["ethylenediaminetetraacetic acid", "SIMPLE_CHEMICAL", 86, 117], ["EDTA", "SIMPLE_CHEMICAL", 119, 123], ["LPS", "SIMPLE_CHEMICAL", 154, 157], ["LPS", "SIMPLE_CHEMICAL", 195, 198], ["Blood Sampling", "TEST", 25, 39], ["Analysis", "TEST", 44, 52], ["Blood samples", "TEST", 52, 65], ["ethylenediaminetetraacetic acid (EDTA) anti-coagulated tubes", "TREATMENT", 86, 146], ["LPS infusion", "TREATMENT", 154, 166], ["LPS infusion", "TREATMENT", 195, 207]]], ["All samples were immediately centrifuged at 2,000\u00d7g at 4\u00b0C for 15 min and then stored at \u221280\u00b0C until batch analysis.Blood Sampling and AnalysisPlasma levels of tumor necrosis factor (TNF), interleukin (IL)-6, IL-8, and MIP-1\u03b1 were analyzed with high-sensitivity enzyme immunoassays (all R&D-Systems, Oxon, UK) [12] .", [["samples", "ANATOMY", 4, 11], ["Blood", "ANATOMY", 116, 121], ["tumor", "DISEASE", 160, 165], ["necrosis", "DISEASE", 166, 174], ["Blood", "ORGANISM_SUBSTANCE", 116, 121], ["tumor necrosis factor", "GENE_OR_GENE_PRODUCT", 160, 181], ["TNF", "GENE_OR_GENE_PRODUCT", 183, 186], ["interleukin (IL)-6", "GENE_OR_GENE_PRODUCT", 189, 207], ["IL-8", "GENE_OR_GENE_PRODUCT", 209, 213], ["MIP-1\u03b1", "GENE_OR_GENE_PRODUCT", 219, 225], ["tumor necrosis factor", "PROTEIN", 160, 181], ["TNF", "PROTEIN", 183, 186], ["interleukin (IL)-6, IL-8", "PROTEIN", 189, 213], ["MIP-1\u03b1", "PROTEIN", 219, 225], ["batch analysis", "TEST", 101, 115], ["Blood Sampling", "TEST", 116, 130], ["AnalysisPlasma levels", "TEST", 135, 156], ["tumor necrosis factor", "PROBLEM", 160, 181], ["TNF", "TEST", 183, 186], ["interleukin (IL)", "TEST", 189, 205], ["IL", "TEST", 209, 211], ["MIP", "TEST", 219, 222], ["enzyme immunoassays", "TEST", 262, 281], ["tumor necrosis", "OBSERVATION", 160, 174]]], ["Plasma concentrations of thrombin-anti-thrombin complexes (TAT) and fibrin split products (F1+2) were measured with immunoassays (Enzygnost TAT micro and Enzygnost F1+2 micro, both Dade Behring, Marburg, Germany) as described previously [13] [14] [15] .Blood Sampling and AnalysisDifferential blood counts were measured with an automatic cell counter (Sysmex, Milton Keynes, UK) [16] .Data AnalysisData are expressed as medians and inter-quartile ranges (IQR).", [["Blood", "ANATOMY", 253, 258], ["blood", "ANATOMY", 293, 298], ["cell", "ANATOMY", 338, 342], ["Plasma", "ORGANISM_SUBSTANCE", 0, 6], ["thrombin", "GENE_OR_GENE_PRODUCT", 25, 33], ["anti-thrombin complexes", "GENE_OR_GENE_PRODUCT", 34, 57], ["TAT", "GENE_OR_GENE_PRODUCT", 59, 62], ["fibrin", "GENE_OR_GENE_PRODUCT", 68, 74], ["[13] [14] [15]", "SIMPLE_CHEMICAL", 237, 251], ["Blood", "ORGANISM_SUBSTANCE", 253, 258], ["blood", "ORGANISM_SUBSTANCE", 293, 298], ["cell", "CELL", 338, 342], ["thrombin", "PROTEIN", 25, 33], ["anti-thrombin complexes", "PROTEIN", 34, 57], ["TAT", "PROTEIN", 59, 62], ["fibrin split products", "PROTEIN", 68, 89], ["Plasma concentrations", "TEST", 0, 21], ["thrombin", "TEST", 25, 33], ["anti-thrombin complexes", "TREATMENT", 34, 57], ["TAT", "TEST", 59, 62], ["fibrin split products", "TREATMENT", 68, 89], ["immunoassays", "TEST", 116, 128], ["Blood Sampling", "TEST", 253, 267], ["AnalysisDifferential blood counts", "TEST", 272, 305], ["thrombin", "OBSERVATION", 25, 33]]], ["We used the Kruskal-Wallis ANOVA for all statistical comparisons between groups, and the Mann-Whitney U test for individual comparisons.", [["individual comparisons", "TEST", 113, 135]]], ["Based on a study by Kumpf et al., [17] we estimated a sample size of 40 sufficient to demonstrate 40 % different peak MIP-1a levels between subjects homozygous for the A and G alleles, respectively.", [["MIP-1a", "GENE_OR_GENE_PRODUCT", 118, 124], ["A", "GENE_OR_GENE_PRODUCT", 168, 169], ["G", "GENE_OR_GENE_PRODUCT", 174, 175], ["MIP", "PROTEIN", 118, 121], ["a study", "TEST", 9, 16], ["a sample size", "TEST", 52, 65], ["different peak MIP", "TEST", 103, 121]]], ["A p value of <0.05 was considered statistically significant.", [["A p value", "TEST", 0, 9]]], ["All statistical calculations were performed with statistical software (Stata 12.1, College Station, TX, USA).MMP-8 Genotype Distribution and Subject CharacteristicsOf the 44 subjects genotyped, 9 (20.5 %) had the AA genotype, 9 (20.5 %) had the GG genotype, and the remaining 26 (59 %) had the AG genotype and thus were in Hardy-Weinberg equilibrium (p=0.23).", [["MMP-8", "GENE_OR_GENE_PRODUCT", 109, 114], ["MMP", "PROTEIN", 109, 112], ["All statistical calculations", "TEST", 0, 28], ["MMP", "TEST", 109, 112], ["the AA genotype", "TEST", 209, 224], ["the GG genotype", "TEST", 241, 256], ["the AG genotype", "PROBLEM", 290, 305]]], ["All participating subjects were healthy male nonsmokers, with a median age of 25.5 years (IQR, 23 to 30 years) and a median BMI of 23.4 kg/m2 (IQR, 21.8 to 24.2 kg/m 2 ), without any differences between different genotype carriers (Table 1) .Vital ParametersLPS infusion induced a transient increase in heart rate and a transient decrease in mean arterial blood pressure (MAP; all p<0.05 versus time), as previously described in this model [11] (Fig. 1) .", [["heart", "ANATOMY", 303, 308], ["arterial blood", "ANATOMY", 347, 361], ["ParametersLPS", "CHEMICAL", 248, 261], ["subjects", "ORGANISM", 18, 26], ["nonsmokers", "ORGANISM", 45, 55], ["heart", "ORGAN", 303, 308], ["arterial blood", "MULTI-TISSUE_STRUCTURE", 347, 361], ["Vital ParametersLPS infusion", "TREATMENT", 242, 270], ["a transient increase in heart rate", "PROBLEM", 279, 313], ["a transient decrease", "PROBLEM", 318, 338], ["mean arterial blood pressure", "TEST", 342, 370], ["MAP", "TEST", 372, 375], ["transient", "OBSERVATION_MODIFIER", 281, 290], ["increase", "OBSERVATION_MODIFIER", 291, 299], ["heart", "ANATOMY", 303, 308], ["transient", "OBSERVATION_MODIFIER", 320, 329], ["decrease", "OBSERVATION_MODIFIER", 330, 338], ["pressure", "OBSERVATION_MODIFIER", 362, 370]]], ["Peak IL-8 values were detectable 2 h after LPS infusion (222 pg/mL; IQR, 167-486) but did not differ between genotypes.", [["LPS", "CHEMICAL", 43, 46], ["IL-8", "GENE_OR_GENE_PRODUCT", 5, 9], ["LPS", "SIMPLE_CHEMICAL", 43, 46], ["IL", "PROTEIN", 5, 7], ["Peak IL", "TEST", 0, 7], ["LPS infusion", "TREATMENT", 43, 55], ["IQR", "TEST", 68, 71]]], ["Subjects homozygous for the A allele had a stronger pro-inflammatory response to LPS in terms of peak TNF and IL-6 levels.", [["LPS", "CHEMICAL", 81, 84], ["Subjects", "ORGANISM", 0, 8], ["A", "GENE_OR_GENE_PRODUCT", 28, 29], ["LPS", "SIMPLE_CHEMICAL", 81, 84], ["TNF", "GENE_OR_GENE_PRODUCT", 102, 105], ["IL-6", "GENE_OR_GENE_PRODUCT", 110, 114], ["A allele", "DNA", 28, 36], ["TNF", "PROTEIN", 102, 105], ["Subjects homozygous", "PROBLEM", 0, 19], ["peak TNF", "TEST", 97, 105], ["IL", "TEST", 110, 112]]], ["In contrast, peak MIP-1 \u03b1 levels were highest in subjects with the GG genotype.", [["MIP-1 \u03b1", "GENE_OR_GENE_PRODUCT", 18, 25], ["MIP", "PROTEIN", 18, 21], ["peak MIP", "TEST", 13, 21], ["the GG genotype", "PROBLEM", 63, 78], ["highest", "OBSERVATION_MODIFIER", 38, 45], ["GG genotype", "OBSERVATION", 67, 78]]], ["Data presented as medians and inter-quartile ranges.MMP-8 Genotypes and Coagulation ActivationAs expected, [13] LPS infusion was associated with a potent activation of the coagulation system as reflected by increases in the plasma concentrations of thrombinanti-thrombin complexes and prothrombin fragments F 1+2 , both peaking after 4 h (54.5 pmol/L [IQR, 28.2-111.8] and 1,130 \u03bcg/L [IQR, 668-1,918], respectively, both p<0.05 vs. time).", [["plasma", "ANATOMY", 224, 230], ["[13] LPS", "CHEMICAL", 107, 115], ["MMP-8", "GENE_OR_GENE_PRODUCT", 52, 57], ["[13] LPS", "SIMPLE_CHEMICAL", 107, 115], ["plasma", "ORGANISM_SUBSTANCE", 224, 230], ["thrombinanti-thrombin complexes", "GENE_OR_GENE_PRODUCT", 249, 280], ["prothrombin fragments F 1+2", "GENE_OR_GENE_PRODUCT", 285, 312], ["MMP", "PROTEIN", 52, 55], ["thrombinanti-thrombin complexes", "PROTEIN", 249, 280], ["MMP", "TEST", 52, 55], ["Coagulation ActivationAs", "TEST", 72, 96], ["LPS infusion", "TREATMENT", 112, 124], ["the coagulation system", "TEST", 168, 190], ["the plasma concentrations", "TEST", 220, 245], ["thrombinanti-thrombin complexes", "PROBLEM", 249, 280], ["prothrombin fragments F", "TEST", 285, 308], ["IQR", "TEST", 352, 355], ["\u03bcg", "TEST", 379, 381], ["IQR", "TEST", 385, 388], ["increases", "OBSERVATION_MODIFIER", 207, 216], ["thrombin complexes", "OBSERVATION", 262, 280]]], ["This LPS-induced coagulant response did not differ between different genotypes.MMP-8 Genotypes and Neutrophil CountsAs expected, neutrophil counts increased about threefold compared to baseline levels (p<0.05 vs. time) after LPS infusion.", [["Neutrophil", "ANATOMY", 99, 109], ["neutrophil", "ANATOMY", 129, 139], ["LPS", "CHEMICAL", 5, 8], ["LPS", "CHEMICAL", 225, 228], ["LPS", "SIMPLE_CHEMICAL", 5, 8], ["MMP-8", "GENE_OR_GENE_PRODUCT", 79, 84], ["Neutrophil", "CELL", 99, 109], ["neutrophil", "CELL", 129, 139], ["LPS", "SIMPLE_CHEMICAL", 225, 228], ["coagulant", "PROTEIN", 17, 26], ["MMP", "PROTEIN", 79, 82], ["neutrophil", "CELL_TYPE", 129, 139], ["This LPS", "TEST", 0, 8], ["induced coagulant response", "PROBLEM", 9, 35], ["MMP", "TEST", 79, 82], ["Genotypes", "TEST", 85, 94], ["Neutrophil CountsAs", "TEST", 99, 118], ["neutrophil counts", "TEST", 129, 146], ["baseline levels", "TEST", 185, 200], ["LPS infusion", "TREATMENT", 225, 237], ["neutrophil counts", "OBSERVATION", 129, 146]]], ["Nadir levels were reached 1.DISCUSSIONData from MMP-8 knockout animals suggest that MMP-8 assists in early PMN recruitment and elimination of chemotactic gradients.", [["PMN", "ANATOMY", 107, 110], ["MMP-8", "GENE_OR_GENE_PRODUCT", 48, 53], ["MMP-8", "GENE_OR_GENE_PRODUCT", 84, 89], ["PMN", "CELL", 107, 110], ["MMP", "PROTEIN", 48, 51], ["MMP-8", "PROTEIN", 84, 89], ["Nadir levels", "TEST", 0, 12], ["MMP", "TEST", 48, 51], ["MMP", "TEST", 84, 87], ["early PMN recruitment", "TREATMENT", 101, 122], ["chemotactic gradients", "TEST", 142, 163], ["chemotactic gradients", "OBSERVATION", 142, 163]]], ["For example, acute lung inflammation (ALI) is less pronounced in MMP-8 wild-type mice compared to knockout mice due to inactivation MIP 1-\u03b1 [4] .", [["lung", "ANATOMY", 19, 23], ["acute lung inflammation", "DISEASE", 13, 36], ["ALI", "DISEASE", 38, 41], ["lung", "ORGAN", 19, 23], ["MMP-8", "GENE_OR_GENE_PRODUCT", 65, 70], ["mice", "ORGANISM", 81, 85], ["mice", "ORGANISM", 107, 111], ["MIP 1-\u03b1", "GENE_OR_GENE_PRODUCT", 132, 139], ["MMP", "PROTEIN", 65, 68], ["MIP 1", "PROTEIN", 132, 137], ["mice", "SPECIES", 81, 85], ["mice", "SPECIES", 107, 111], ["mice", "SPECIES", 107, 111], ["acute lung inflammation", "PROBLEM", 13, 36], ["MMP", "TEST", 65, 68], ["inactivation", "PROBLEM", 119, 131], ["MIP", "TEST", 132, 135], ["acute", "OBSERVATION_MODIFIER", 13, 18], ["lung", "ANATOMY", 19, 23], ["inflammation", "OBSERVATION", 24, 36], ["ALI", "OBSERVATION", 38, 41], ["less", "OBSERVATION_MODIFIER", 46, 50], ["pronounced", "OBSERVATION_MODIFIER", 51, 61]]], ["Compared to knockout animals, MMP-8 wild-type (WT) mice had higher levels of PMN membrane bound MMP, which is likely to be the key bioactive form of the enzyme.", [["PMN membrane", "ANATOMY", 77, 89], ["MMP-8", "GENE_OR_GENE_PRODUCT", 30, 35], ["wild-type (WT) mice", "ORGANISM", 36, 55], ["PMN membrane", "CELLULAR_COMPONENT", 77, 89], ["MMP", "GENE_OR_GENE_PRODUCT", 96, 99], ["MMP", "PROTEIN", 30, 33], ["MMP", "PROTEIN", 96, 99], ["enzyme", "PROTEIN", 153, 159], ["mice", "SPECIES", 51, 55], ["mice", "SPECIES", 51, 55], ["knockout animals", "TEST", 12, 28], ["MMP", "TEST", 30, 33], ["PMN membrane bound MMP", "PROBLEM", 77, 99], ["the enzyme", "TEST", 149, 159]]], ["In turn, MMP-8 inactivated MIP 1-\u03b1, and genetically deleting MIP 1-\u03b1 in MMP-8 knockout mice decreased the increased lung inflammation and mortality, thus emphasizing a possible role for a \"MMP-8/MIP-1\u03b1 axis\" in acute inflammation.DISCUSSIONOur understanding of MMP-8 in human inflammation and infection is less clear, in part due to the fact that we cannot selectively silence the MMP-8 gene.", [["lung", "ANATOMY", 116, 120], ["lung inflammation", "DISEASE", 116, 133], ["inflammation", "DISEASE", 217, 229], ["inflammation", "DISEASE", 276, 288], ["infection", "DISEASE", 293, 302], ["MMP-8", "GENE_OR_GENE_PRODUCT", 9, 14], ["MIP 1-\u03b1", "GENE_OR_GENE_PRODUCT", 27, 34], ["MIP 1-\u03b1", "GENE_OR_GENE_PRODUCT", 61, 68], ["MMP-8", "GENE_OR_GENE_PRODUCT", 72, 77], ["mice", "ORGANISM", 87, 91], ["lung", "ORGAN", 116, 120], ["MMP-8", "GENE_OR_GENE_PRODUCT", 189, 194], ["MIP-1\u03b1", "GENE_OR_GENE_PRODUCT", 195, 201], ["MMP-8", "GENE_OR_GENE_PRODUCT", 261, 266], ["human", "ORGANISM", 270, 275], ["MMP-8", "GENE_OR_GENE_PRODUCT", 381, 386], ["MMP-8", "PROTEIN", 9, 14], ["MIP 1-\u03b1", "PROTEIN", 27, 34], ["MIP 1-\u03b1", "PROTEIN", 61, 68], ["MMP-8", "PROTEIN", 72, 77], ["MMP-8", "PROTEIN", 189, 194], ["MIP", "PROTEIN", 195, 198], ["MMP-8", "PROTEIN", 261, 266], ["MMP-8 gene", "DNA", 381, 391], ["mice", "SPECIES", 87, 91], ["human", "SPECIES", 270, 275], ["mice", "SPECIES", 87, 91], ["human", "SPECIES", 270, 275], ["MMP", "TEST", 9, 12], ["MIP", "TEST", 27, 30], ["MIP", "TEST", 61, 64], ["MMP", "TEST", 72, 75], ["the increased lung inflammation", "PROBLEM", 102, 133], ["a \"MMP", "TEST", 186, 192], ["MIP", "TEST", 195, 198], ["acute inflammation", "PROBLEM", 211, 229], ["MMP", "TEST", 261, 264], ["human inflammation", "PROBLEM", 270, 288], ["infection", "PROBLEM", 293, 302], ["the MMP", "TEST", 377, 384], ["increased", "OBSERVATION_MODIFIER", 106, 115], ["lung", "ANATOMY", 116, 120], ["inflammation", "OBSERVATION", 121, 133], ["acute", "OBSERVATION_MODIFIER", 211, 216], ["inflammation", "OBSERVATION", 217, 229], ["inflammation", "OBSERVATION", 276, 288], ["infection", "OBSERVATION", 293, 302]]], ["Studies to date have largely reported associations between MMP-8 plasma levels and/or MMP-8 genotypes and clinical outcomes without elaborating the underlying mechanisms.", [["plasma", "ANATOMY", 65, 71], ["MMP-8", "GENE_OR_GENE_PRODUCT", 59, 64], ["plasma", "ORGANISM_SUBSTANCE", 65, 71], ["MMP-8", "GENE_OR_GENE_PRODUCT", 86, 91], ["MMP", "PROTEIN", 59, 62], ["MMP", "PROTEIN", 86, 89], ["MMP", "TEST", 59, 62], ["plasma levels", "TEST", 65, 78], ["MMP", "TEST", 86, 89]]], ["Most of these studies report a similar trend, i.e., higher MMP-8 levels are associated with worse clinical disease.", [["MMP-8", "GENE_OR_GENE_PRODUCT", 59, 64], ["MMP", "PROTEIN", 59, 62], ["these studies", "TEST", 8, 21], ["worse clinical disease", "PROBLEM", 92, 114]]], ["For instance, MMP-8 is not only strongly associated with acute inflammatory states in humans such as ARDS [18] but also states with chronic inflammation and neutrophilia such as cystic fibrosis, rheumatoid arthritis, periodontal, and chronic skin diseases [19] [20] [21] [22] .", [["cystic", "ANATOMY", 178, 184], ["periodontal", "ANATOMY", 217, 228], ["skin", "ANATOMY", 242, 246], ["ARDS", "DISEASE", 101, 105], ["inflammation", "DISEASE", 140, 152], ["neutrophilia", "DISEASE", 157, 169], ["cystic fibrosis", "DISEASE", 178, 193], ["rheumatoid arthritis", "DISEASE", 195, 215], ["skin diseases", "DISEASE", 242, 255], ["MMP-8", "GENE_OR_GENE_PRODUCT", 14, 19], ["humans", "ORGANISM", 86, 92], ["skin", "ORGAN", 242, 246], ["[19] [20] [21] [22]", "SIMPLE_CHEMICAL", 256, 275], ["MMP-8", "PROTEIN", 14, 19], ["humans", "SPECIES", 86, 92], ["humans", "SPECIES", 86, 92], ["MMP", "TEST", 14, 17], ["acute inflammatory states", "PROBLEM", 57, 82], ["ARDS", "PROBLEM", 101, 105], ["chronic inflammation", "PROBLEM", 132, 152], ["neutrophilia", "PROBLEM", 157, 169], ["cystic fibrosis", "PROBLEM", 178, 193], ["rheumatoid arthritis", "PROBLEM", 195, 215], ["periodontal, and chronic skin diseases", "PROBLEM", 217, 255], ["acute", "OBSERVATION_MODIFIER", 57, 62], ["inflammatory", "OBSERVATION", 63, 75], ["chronic", "OBSERVATION_MODIFIER", 132, 139], ["inflammation", "OBSERVATION", 140, 152], ["neutrophilia", "OBSERVATION", 157, 169], ["cystic", "OBSERVATION_MODIFIER", 178, 184], ["fibrosis", "OBSERVATION", 185, 193], ["rheumatoid arthritis", "OBSERVATION", 195, 215], ["periodontal", "ANATOMY", 217, 228], ["chronic", "OBSERVATION_MODIFIER", 234, 241], ["skin", "ANATOMY", 242, 246], ["diseases", "OBSERVATION", 247, 255]]], ["For example, MMP-8 levels correlated well with C-reactive protein (CRP) levels in a study of patients with ARDS [23] .", [["ARDS", "DISEASE", 107, 111], ["MMP-8", "GENE_OR_GENE_PRODUCT", 13, 18], ["C-reactive protein", "GENE_OR_GENE_PRODUCT", 47, 65], ["CRP", "GENE_OR_GENE_PRODUCT", 67, 70], ["patients", "ORGANISM", 93, 101], ["MMP", "PROTEIN", 13, 16], ["C-reactive protein", "PROTEIN", 47, 65], ["CRP", "PROTEIN", 67, 70], ["patients", "SPECIES", 93, 101], ["MMP", "TEST", 13, 16], ["C-reactive protein (CRP) levels", "TEST", 47, 78], ["a study", "TEST", 82, 89], ["ARDS", "PROBLEM", 107, 111], ["ARDS", "OBSERVATION", 107, 111]]], ["Alternatively, several functional MMP-8 single-nucleotide polymorphisms (SNPs) have been linked to clinical outcomes as well.", [["MMP-8", "GENE_OR_GENE_PRODUCT", 34, 39], ["MMP-8 single-nucleotide polymorphisms", "DNA", 34, 71], ["several functional MMP", "TEST", 15, 37], ["single-nucleotide polymorphisms (SNPs)", "TREATMENT", 40, 78]]], ["For instance, our preliminary analysis from the GenIMS study showed that the rs1940475 genotype was associated with 90-day mortality in patients with CAP, and patients homozygous for the A allele had the best outcomes [8] .DISCUSSIONIn this study, we show that subjects with the A allele had higher peak TNF and IL-6 levels after LPS challenge than those homozygous for the G allele, whereas MIP-1 \u03b1 levels were higher in subjects homozygous for the G allele.", [["CAP", "DISEASE", 150, 153], ["LPS", "CHEMICAL", 330, 333], ["rs1940475", "GENE_OR_GENE_PRODUCT", 77, 86], ["patients", "ORGANISM", 136, 144], ["patients", "ORGANISM", 159, 167], ["A", "GENE_OR_GENE_PRODUCT", 187, 188], ["A", "GENE_OR_GENE_PRODUCT", 279, 280], ["TNF", "GENE_OR_GENE_PRODUCT", 304, 307], ["IL-6", "GENE_OR_GENE_PRODUCT", 312, 316], ["LPS", "SIMPLE_CHEMICAL", 330, 333], ["G", "GENE_OR_GENE_PRODUCT", 374, 375], ["MIP-1 \u03b1", "GENE_OR_GENE_PRODUCT", 392, 399], ["G", "GENE_OR_GENE_PRODUCT", 450, 451], ["A allele", "DNA", 187, 195], ["A allele", "DNA", 279, 287], ["TNF", "PROTEIN", 304, 307], ["MIP", "PROTEIN", 392, 395], ["G allele", "DNA", 450, 458], ["patients", "SPECIES", 136, 144], ["patients", "SPECIES", 159, 167], ["our preliminary analysis", "TEST", 14, 38], ["the GenIMS study", "TEST", 44, 60], ["CAP", "PROBLEM", 150, 153], ["this study", "TEST", 236, 246], ["IL", "TEST", 312, 314], ["LPS challenge", "TEST", 330, 343], ["the G allele", "TEST", 370, 382], ["MIP", "TEST", 392, 395], ["levels", "TEST", 400, 406]]], ["In addition, subjects with the A allele also showed a stronger clinical response to LPS infusion in terms of drop in MAP and increase in body temperature.", [["body", "ANATOMY", 137, 141], ["LPS", "CHEMICAL", 84, 87], ["LPS", "SIMPLE_CHEMICAL", 84, 87], ["MAP", "GENE_OR_GENE_PRODUCT", 117, 120], ["body", "ORGANISM_SUBDIVISION", 137, 141], ["A allele", "DNA", 31, 39], ["LPS infusion", "TREATMENT", 84, 96], ["drop in MAP", "PROBLEM", 109, 120], ["increase in body temperature", "PROBLEM", 125, 153], ["increase", "OBSERVATION_MODIFIER", 125, 133], ["body temperature", "OBSERVATION_MODIFIER", 137, 153]]], ["As clinical studies have shown a higher pro-inflammatory response to be associated with poorer survival [24] , our findings of higher peak TNF and IL-6 levels in AA homozygous individuals are not consistent with higher survival rates in our preliminary analysis of AA homozygous individuals with CAP [8] .", [["AA", "CHEMICAL", 265, 267], ["CAP", "DISEASE", 296, 299], ["TNF", "GENE_OR_GENE_PRODUCT", 139, 142], ["IL-6", "GENE_OR_GENE_PRODUCT", 147, 151], ["TNF", "PROTEIN", 139, 142], ["clinical studies", "TEST", 3, 19], ["a higher pro-inflammatory response", "PROBLEM", 31, 65], ["higher peak TNF", "TEST", 127, 142], ["IL", "TEST", 147, 149], ["AA homozygous individuals", "PROBLEM", 162, 187], ["higher survival rates", "PROBLEM", 212, 233], ["AA homozygous individuals", "PROBLEM", 265, 290], ["CAP", "TEST", 296, 299], ["higher", "OBSERVATION_MODIFIER", 127, 133], ["peak TNF", "OBSERVATION", 134, 142], ["not consistent with", "UNCERTAINTY", 192, 211]]], ["Conversely, patients homozygous for the G allele had the highest peak MIP-1 alpha levels.", [["patients", "ORGANISM", 12, 20], ["G", "GENE_OR_GENE_PRODUCT", 40, 41], ["MIP-1 alpha", "GENE_OR_GENE_PRODUCT", 70, 81], ["G allele", "DNA", 40, 48], ["MIP", "PROTEIN", 70, 73], ["patients", "SPECIES", 12, 20], ["the G allele", "TEST", 36, 48], ["the highest peak MIP", "TEST", 53, 73]]], ["MIP-1\u03b1 usually parallels TNF and IL-6 response in a TNF independent way [25] .", [["MIP-1\u03b1", "GENE_OR_GENE_PRODUCT", 0, 6], ["TNF", "GENE_OR_GENE_PRODUCT", 25, 28], ["IL-6", "GENE_OR_GENE_PRODUCT", 33, 37], ["TNF", "GENE_OR_GENE_PRODUCT", 52, 55], ["MIP-1\u03b1", "PROTEIN", 0, 6], ["TNF", "PROTEIN", 25, 28], ["TNF", "PROTEIN", 52, 55], ["MIP", "TEST", 0, 3], ["TNF", "TEST", 25, 28], ["IL", "TEST", 33, 35]]], ["Bronchoalveolar fluid levels of MIP-1 \u03b1 were inversely correlated with lung compliance in a small human cohort of ARDS patients but not associated with outcomes.", [["Bronchoalveolar fluid", "ANATOMY", 0, 21], ["lung", "ANATOMY", 71, 75], ["ARDS", "DISEASE", 114, 118], ["MIP-1 \u03b1", "GENE_OR_GENE_PRODUCT", 32, 39], ["lung", "ORGAN", 71, 75], ["human", "ORGANISM", 98, 103], ["patients", "ORGANISM", 119, 127], ["MIP-1 \u03b1", "PROTEIN", 32, 39], ["human", "SPECIES", 98, 103], ["patients", "SPECIES", 119, 127], ["human", "SPECIES", 98, 103], ["Bronchoalveolar fluid levels", "TEST", 0, 28], ["MIP", "TEST", 32, 35], ["ARDS", "PROBLEM", 114, 118], ["fluid", "OBSERVATION", 16, 21], ["lung", "ANATOMY", 71, 75], ["compliance", "OBSERVATION", 76, 86], ["small", "OBSERVATION_MODIFIER", 92, 97], ["ARDS", "OBSERVATION", 114, 118]]], ["These preliminary findings warrant further study in larger cohorts.", [["further study", "TEST", 35, 48]]], ["Our study has several limitations.", [["Our study", "TEST", 0, 9]]], ["First, although we calculated a sample size of 40 to be sufficient to detect a 40 % difference in peak MIP-1\u03b1 levels between AA and GG genotypes, our study was not adequately powered to assess any differences beyond that; hence, all additional analyses must be viewed as exploratory.", [["AA", "CHEMICAL", 125, 127], ["MIP-1\u03b1", "GENE_OR_GENE_PRODUCT", 103, 109], ["MIP", "PROTEIN", 103, 106], ["a sample size", "TEST", 30, 43], ["peak MIP", "TEST", 98, 106], ["AA and GG genotypes", "PROBLEM", 125, 144], ["our study", "TEST", 146, 155], ["all additional analyses", "TEST", 229, 252]]], ["Second, while our results suggest an association between peak plasma cytokine levels and MMP-8 genotypes and thus a role for MMP-8 in cytokine regulation, we do not have insight how this affects downstream cell trafficking to actual sites of infection.", [["plasma", "ANATOMY", 62, 68], ["cell", "ANATOMY", 206, 210], ["sites", "ANATOMY", 233, 238], ["infection", "DISEASE", 242, 251], ["plasma", "ORGANISM_SUBSTANCE", 62, 68], ["MMP-8", "GENE_OR_GENE_PRODUCT", 89, 94], ["MMP-8", "GENE_OR_GENE_PRODUCT", 125, 130], ["cell", "CELL", 206, 210], ["cytokine", "PROTEIN", 69, 77], ["MMP", "PROTEIN", 89, 92], ["MMP-8", "PROTEIN", 125, 130], ["cytokine", "PROTEIN", 134, 142], ["peak plasma cytokine levels", "TEST", 57, 84], ["MMP", "TEST", 89, 92], ["MMP", "TEST", 125, 128], ["cytokine regulation", "TEST", 134, 153], ["infection", "PROBLEM", 242, 251], ["infection", "OBSERVATION", 242, 251]]], ["Hence, additional studies using alternative compartmental models such as inhaled LPS will be helpful to better understand the role of MMP-8 in ALI and pneumonia.", [["LPS", "CHEMICAL", 81, 84], ["ALI", "DISEASE", 143, 146], ["pneumonia", "DISEASE", 151, 160], ["LPS", "SIMPLE_CHEMICAL", 81, 84], ["MMP-8", "GENE_OR_GENE_PRODUCT", 134, 139], ["MMP-8", "PROTEIN", 134, 139], ["additional studies", "TEST", 7, 25], ["alternative compartmental models", "TREATMENT", 32, 64], ["inhaled LPS", "TREATMENT", 73, 84], ["MMP", "TEST", 134, 137], ["ALI", "PROBLEM", 143, 146], ["pneumonia", "PROBLEM", 151, 160], ["ALI", "ANATOMY", 143, 146], ["pneumonia", "OBSERVATION", 151, 160]]], ["Third, we did not measure MMP-8 levels in our healthy volunteers.", [["MMP-8", "GENE_OR_GENE_PRODUCT", 26, 31], ["volunteers", "ORGANISM", 54, 64], ["MMP-8", "PROTEIN", 26, 31], ["MMP", "TEST", 26, 29]]], ["Fourth, our study was conducted in healthy male volunteers, and thus, our results may not apply to females.", [["volunteers", "ORGANISM", 48, 58], ["our study", "TEST", 8, 17]]], ["Currently, the exact link between MMP-8 genotypes and plasma levels/activity levels is not well understood.", [["plasma", "ANATOMY", 54, 60], ["MMP-8", "GENE_OR_GENE_PRODUCT", 34, 39], ["plasma", "ORGANISM_SUBSTANCE", 54, 60], ["MMP", "PROTEIN", 34, 37], ["MMP", "TEST", 34, 37], ["plasma levels/activity levels", "TEST", 54, 83]]], ["While some studies report a clear doseresponse relationship between MMP-8 genotypes and activity levels, we failed to show a significant association in ex vivo incubation experiments (unpublished data).", [["MMP-8", "GENE_OR_GENE_PRODUCT", 68, 73], ["MMP", "PROTEIN", 68, 71], ["some studies", "TEST", 6, 18], ["MMP", "TEST", 68, 71], ["activity levels", "TEST", 88, 103]]], ["However, our preliminary data suggest that the rs1940475 SNP results in a conformational change of the active site, which makes the enzyme less amenable to activation [9] .", [["SNP", "CHEMICAL", 57, 60], ["rs1940475", "GENE_OR_GENE_PRODUCT", 47, 56], ["rs1940475 SNP", "DNA", 47, 60], ["a conformational change of the active site", "PROBLEM", 72, 114], ["the enzyme", "TEST", 128, 138], ["active site", "OBSERVATION", 103, 114]]], ["This needs to be verified in further studies.DISCUSSIONIn conclusion, subjects homozygous for the ancestral A allele had a stronger pro-inflammatory response to LPS compared to other genotypes, whereas peak MIP-1\u03b1 levels were highest in subjects homozygous for the G allele.", [["LPS", "CHEMICAL", 161, 164], ["A", "GENE_OR_GENE_PRODUCT", 108, 109], ["LPS", "SIMPLE_CHEMICAL", 161, 164], ["MIP-1\u03b1", "GENE_OR_GENE_PRODUCT", 207, 213], ["G", "GENE_OR_GENE_PRODUCT", 265, 266], ["ancestral A allele", "DNA", 98, 116], ["MIP", "PROTEIN", 207, 210], ["G allele", "DNA", 265, 273], ["further studies", "TEST", 29, 44], ["LPS", "TEST", 161, 164], ["other genotypes", "TEST", 177, 192], ["peak MIP", "TEST", 202, 210], ["levels", "TEST", 214, 220]]], ["These findings indicate that the rs1940475 SNP modifies the host response to inflammatory stimuli, which may in part explain previously shown associations with clinical outcomes.", [["SNP", "CHEMICAL", 43, 46], ["rs1940475", "GENE_OR_GENE_PRODUCT", 33, 42], ["rs1940475 SNP", "DNA", 33, 46], ["the rs1940475 SNP", "TREATMENT", 29, 46], ["inflammatory stimuli", "TEST", 77, 97], ["inflammatory stimuli", "OBSERVATION", 77, 97]]]], "d7111b44f2d13b24a11d55c8be2d2bbe6b245eac": [["SummaryBackground In December 2019, pneumonia infected with a novel coronavirus burst in Wuhan, China.", [["pneumonia", "DISEASE", 36, 45], ["coronavirus", "ORGANISM", 68, 79], ["coronavirus", "SPECIES", 68, 79], ["pneumonia", "PROBLEM", 36, 45], ["a novel coronavirus burst", "PROBLEM", 60, 85], ["pneumonia", "OBSERVATION", 36, 45], ["coronavirus burst", "OBSERVATION", 68, 85]]], ["Now the situation is almost controlled in China but is worse outside China.", [["almost", "OBSERVATION_MODIFIER", 21, 27], ["controlled", "OBSERVATION", 28, 38], ["worse", "OBSERVATION_MODIFIER", 55, 60]]], ["We aimed to build a mathematical model to capture the global trend of epidemics outside China.SummaryMethods In this retrospective, outside-China diagnosis number reported from Jan 21 to Feb 28, 2020 was downloaded from WHO website.", [["a mathematical model", "TREATMENT", 18, 38]]], ["We develop a simple regression model on these numbers: !\" ( # + 34) = 0 \u00b7 0515 \u00d7 + 2 \u00b7 075 where Nt is the total diagnosed patient till the ith day, t=1 at Feb 1.SummaryFindings Based on this model, we estimate that there have been about 34 unobserved founder patients at the beginning of spread outside China.", [["patient", "ORGANISM", 123, 130], ["patients", "ORGANISM", 260, 268], ["patient", "SPECIES", 123, 130], ["patients", "SPECIES", 260, 268]]], ["The global trend is approximately exponential, with the rate of 10 folds every 19 days.Research in context Evidence before this studyIn December 2019, pneumonia infected with a novel coronavirus burst in Wuhan, China.", [["pneumonia", "DISEASE", 151, 160], ["coronavirus", "ORGANISM", 183, 194], ["coronavirus", "SPECIES", 183, 194], ["pneumonia", "PROBLEM", 151, 160], ["a novel coronavirus burst", "PROBLEM", 175, 200], ["global", "OBSERVATION_MODIFIER", 4, 10], ["trend", "OBSERVATION_MODIFIER", 11, 16], ["approximately", "OBSERVATION_MODIFIER", 20, 33], ["exponential", "OBSERVATION_MODIFIER", 34, 45], ["pneumonia", "OBSERVATION", 151, 160], ["coronavirus burst", "OBSERVATION", 183, 200]]], ["Now the situation is almost controlled in China but is worse outside China.", [["almost", "OBSERVATION_MODIFIER", 21, 27], ["controlled", "OBSERVATION", 28, 38], ["worse", "OBSERVATION_MODIFIER", 55, 60]]], ["Now there are 4,691 patients across 51 countries and territories outside China.", [["patients", "ORGANISM", 20, 28], ["patients", "SPECIES", 20, 28]]], ["We searched PubMed and the China National Knowledge Infrastructure database for articles published up to Feb 28, 2020, using the keywords \"COVID\", \"novel coronavirus\", \"2019-nCoV\" or \"2019 novel coronavirus\".", [["coronavirus", "DISEASE", 154, 165], ["coronavirus", "DISEASE", 195, 206]]], ["No published work about the global trend of epidemics outside China could be identified.Added value of this studyWe built a simple \"log-plus\" linear model to capture the global trend of epidemics outside China.", [["this study", "TEST", 103, 113], ["global", "OBSERVATION_MODIFIER", 170, 176], ["trend", "OBSERVATION_MODIFIER", 177, 182]]], ["We estimate that there have been about 34 unobserved founder patients at the beginning of spread outside China.", [["patients", "ORGANISM", 61, 69], ["patients", "SPECIES", 61, 69]]], ["The global trend is approximately exponential, with the rate of 10 folds every 19 days.Implications of all the available evidenceWith the limited number of data points and the complexity of the real situation, a straightforward model is expected to work better.", [["global", "OBSERVATION_MODIFIER", 4, 10], ["trend", "OBSERVATION_MODIFIER", 11, 16], ["approximately", "OBSERVATION_MODIFIER", 20, 33], ["exponential", "OBSERVATION_MODIFIER", 34, 45]]], ["Our model suggests that the COVID-19 disease follows an approximate exponential growth model stably at the very beginning.", [["the COVID-19 disease", "PROBLEM", 24, 44]]], ["We predict that the number of confirmed patients outside China will increase ten folds in every 19 days without strong intervention by applying our model.", [["patients", "ORGANISM", 40, 48], ["patients", "SPECIES", 40, 48], ["strong intervention", "TREATMENT", 112, 131]]], ["Powerful actions on public health should be taken to combat this epidemic all over the world.IntroductionIn early December of 2019, pneumonia cases of unknown cause emerged in Wuhan, the capital of Hubei province, China.", [["pneumonia", "DISEASE", 132, 141], ["pneumonia", "PROBLEM", 132, 141], ["pneumonia", "OBSERVATION", 132, 141]]], ["1 A novel coronavirus (now named as COVID-19) was verified and identified as the seventh member of enveloped RNA coronavirus (subgenus sarbecovirus, Orthocoronavirinae subfamily) through high-throughput sequencing.", [["coronavirus", "ORGANISM", 10, 21], ["enveloped RNA coronavirus", "ORGANISM", 99, 124], ["subgenus sarbecovirus", "ORGANISM", 126, 147], ["Orthocoronavirinae", "GENE_OR_GENE_PRODUCT", 149, 167], ["COVID", "PROTEIN", 36, 41], ["enveloped RNA coronavirus", "PROTEIN", 99, 124], ["subgenus sarbecovirus, Orthocoronavirinae subfamily", "PROTEIN", 126, 177], ["coronavirus", "SPECIES", 113, 124], ["A novel coronavirus", "PROBLEM", 2, 21], ["COVID", "TEST", 36, 41], ["enveloped RNA coronavirus", "PROBLEM", 99, 124], ["coronavirus", "OBSERVATION", 10, 21], ["RNA coronavirus", "OBSERVATION", 109, 124]]], ["[2] [3] [4] Human-to-human transmission in hospital and family settings had been accumulating 5-7 and has occurred among close contacts since the middle of December 2019 based on evidence from early transmission dynamics.", [["[2] [3] [4", "SIMPLE_CHEMICAL", 0, 10], ["Human", "ORGANISM", 12, 17], ["human", "ORGANISM", 21, 26], ["Human", "SPECIES", 12, 17], ["human", "SPECIES", 21, 26], ["human", "SPECIES", 21, 26]]], ["8 According to WHO statistics, the accumulating number of diagnosed patients in China was 78,961 in Feb 28, 2020.", [["patients", "ORGANISM", 68, 76], ["patients", "SPECIES", 68, 76], ["accumulating", "OBSERVATION_MODIFIER", 35, 47], ["number", "OBSERVATION_MODIFIER", 48, 54]]], ["9 COVID-19 raised intension not only within China but internationally.", [["COVID", "TEST", 2, 7]]], ["Since the first case of pneumonia caused by COVID-19 was reported from Wuhan, COVID-19 patients had rapidly been diagnosed in other cities of China and the neighboring countries including Thailand, South Korea, Japan, and even to a few Western countries.", [["pneumonia", "DISEASE", 24, 33], ["COVID-19", "CHEMICAL", 44, 52], ["patients", "ORGANISM", 87, 95], ["patients", "SPECIES", 87, 95], ["pneumonia", "PROBLEM", 24, 33], ["COVID", "TEST", 44, 49], ["pneumonia", "OBSERVATION", 24, 33]]], ["10-12 On January13 2020, the Ministry of Public Health of Thailand reported the first imported case of lab-confirmed novel coronavirus (2019-nCoV).", [["coronavirus", "DISEASE", 123, 134], ["coronavirus", "ORGANISM", 123, 134], ["novel coronavirus", "PROBLEM", 117, 134]]], ["The number of confirmed COVID-19 cases had reached 4,691 outside China, 9 and the number is still increasing.", [["COVID", "DISEASE", 24, 29], ["COVID", "TEST", 24, 29], ["increasing", "OBSERVATION_MODIFIER", 98, 108]]], ["A surge in cases of COVID-19 in Italy, Japan and Iran also heightened fears that the world is on the brink of a pandemic.", [["COVID", "TEST", 20, 25], ["a pandemic", "PROBLEM", 110, 120]]], ["14 In Feb 28, WHO increased the assessment of the risk of spread and risk of impact of COVID-19 to very high at the global level.IntroductionRecently, many researchers devoted to more details about the analysis of the spread of epidemic.", [["the assessment", "TEST", 28, 42], ["COVID", "TEST", 87, 92], ["the analysis", "TEST", 198, 210], ["epidemic", "PROBLEM", 228, 236]]], ["14,15 Some paralleled results have shown that the reproductive number R0 estimated of COVID-19 is bigger than that of SARS based on different models.", [["SARS", "DISEASE", 118, 122], ["COVID", "PROTEIN", 86, 91], ["COVID", "TEST", 86, 91], ["SARS", "PROBLEM", 118, 122], ["bigger", "OBSERVATION_MODIFIER", 98, 104]]], ["In this study, we propose a \"log-plus\" model for the situation prediction which only requires daily number of total diagnosis outside China.", [["this study", "TEST", 3, 13], ["a \"log-plus\" model", "TREATMENT", 26, 44]]], ["This model assumes that there were some unobserved founder patients at the beginning of spread outside China and exponential growth later.", [["patients", "ORGANISM", 59, 67], ["patients", "SPECIES", 59, 67]]], ["The prediction is expected to provide practical significance on social application and evidence for enhancing public health interventions to avoid severe outbreaks.DataDaily diagnosis number of countries outside China is download from WHO situation reports (https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situationreports).", [["social application", "TREATMENT", 64, 82], ["enhancing public health interventions", "TREATMENT", 100, 137], ["severe outbreaks", "PROBLEM", 147, 163], ["severe", "OBSERVATION_MODIFIER", 147, 153], ["outbreaks", "OBSERVATION", 154, 163]]], ["The data in this analysis starts from Jan 21 and currently it ends at Feb 28.ModelWe first explored the data by plotting log transformed daily number.", [["The data", "TEST", 0, 8], ["this analysis", "TEST", 12, 25]]], ["We observed a good linear trend recently, but a relatively poor fit at the beginning of spread.", [["a relatively poor fit", "PROBLEM", 46, 67], ["good", "OBSERVATION_MODIFIER", 14, 18], ["linear", "OBSERVATION_MODIFIER", 19, 25], ["relatively", "OBSERVATION_MODIFIER", 48, 58], ["poor fit", "OBSERVATION_MODIFIER", 59, 67]]], ["We therefore consider that there are some unobserved founder patients at the beginning.", [["patients", "ORGANISM", 61, 69], ["patients", "SPECIES", 61, 69]]], ["Based on exploratory data analysis and mathematical intuition we proposed the following model:ModelCC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not peer-reviewed)The copyright holder for this preprint . https://doi.org/10.1101/2020.03.01.20029819 doi: medRxiv preprint where Nt is the number of diagnosed patients outside China according to WHO at the tth day, t=1 at Feb 1; u is the number of unobserved founder patients at the beginning of spread outside China; a and b are simple linear regression parameters.", [["patients", "ORGANISM", 432, 440], ["patients", "ORGANISM", 540, 548], ["patients", "SPECIES", 432, 440], ["patients", "SPECIES", 540, 548], ["exploratory data analysis", "TEST", 9, 34], ["ModelCC", "TEST", 94, 101], ["ND", "PROBLEM", 108, 110], ["The copyright holder", "TREATMENT", 289, 309], ["this preprint", "TREATMENT", 314, 327], ["simple linear regression parameters", "TREATMENT", 603, 638], ["med", "ANATOMY", 204, 207]]], ["We selected the 7 that maximize R 2 and estimate corresponding 7 and 8 using a simple linear regression between t and !\" ( # + 7).Availability of source codeThe source code of model estimation is at: https://github.com/wangyi-fudan/COVID-19_Global_ModelResultsData Table The .", [["model estimation", "TEST", 176, 192]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not peer-reviewed)The copyright holder for this preprintGlobal Trend ModelWe plot !\" ( # + 34) against time to visualize the model fitting ( figure 2) .", [["CC", "CHEMICAL", 0, 2], ["ND", "PROBLEM", 9, 11], ["med", "ANATOMY", 105, 108]]], ["The model R 2 is 0\u00b7991 indicating an excellent model fit.Future Number PredictionCurrently the number of diagnoses at Febuary 28 is 4,691.", [["excellent", "OBSERVATION_MODIFIER", 37, 46], ["model fit", "OBSERVATION", 47, 56]]], ["We predict that the number of diagnoses outside China will expand exponentially with the rate of 10 folds every 19 days without strong intervention.ConclusionBased on this model, we estimated that there have been about 34 unobserved founder patients at the beginning of spread outside China.", [["patients", "ORGANISM", 241, 249], ["patients", "SPECIES", 241, 249], ["strong intervention", "TREATMENT", 128, 147]]], ["Our model suggests that the COVID-19 disease follows an approximate exponential growth model stably at the very beginning.", [["the COVID-19 disease", "PROBLEM", 24, 44]]], ["The situation is dangerous as we expect 10 folds increases of patients every 19 days without strong intervention.", [["patients", "ORGANISM", 62, 70], ["patients", "SPECIES", 62, 70], ["strong intervention", "TREATMENT", 93, 112]]], ["The country scale data is available but is not as complete as total number.", [["The country scale data", "TEST", 0, 22]]], ["Here, we limited this analysis to capture the global trend.DiscussionThis model is a minimal extension of the 'default' exponential growth model with the estimation of 34 unobserved founder patients outside China.", [["patients", "ORGANISM", 190, 198], ["patients", "SPECIES", 190, 198], ["this analysis", "TEST", 17, 30], ["the 'default' exponential growth model", "PROBLEM", 106, 144], ["minimal", "OBSERVATION_MODIFIER", 85, 92]]], ["An almost perfect model fitting (R 2 =0\u00b7991) indicates that the spread of disease does follow our model.DiscussionA simple and straightforward linear model inherits with some advantages: (1) it works on small sample size due to limited observation or somewhat unperfect data.", [["the spread of disease", "PROBLEM", 60, 81], ["small sample size", "PROBLEM", 203, 220], ["spread", "OBSERVATION_MODIFIER", 64, 70], ["disease", "OBSERVATION", 74, 81]]], ["(2) it is relatively robust in complex situations.", [["robust", "OBSERVATION_MODIFIER", 21, 27]]], ["The virus spreading pattern is complex and yet varies across the world.", [["The virus spreading pattern", "PROBLEM", 0, 27], ["virus", "OBSERVATION", 4, 9], ["complex", "OBSERVATION_MODIFIER", 31, 38]]], ["(3) A linear model has nice extrapolation ability comparing to complex models (e.g. Neural network).DiscussionThe existent of 34 unobserved founder patients is not surprising.", [["Neural network", "MULTI-TISSUE_STRUCTURE", 84, 98], ["patients", "ORGANISM", 148, 156], ["patients", "SPECIES", 148, 156], ["nice extrapolation ability", "PROBLEM", 23, 49]]], ["They may have mild symptoms thus did not went to the hospitals.", [["mild symptoms", "PROBLEM", 14, 27], ["mild", "OBSERVATION_MODIFIER", 14, 18], ["symptoms", "OBSERVATION", 19, 27]]]], "PMC7353822": [["The epidemic of coronavirus disease-2019 (COVID-19) is caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) virus.", [["coronavirus disease", "DISEASE", 16, 35], ["COVID-19", "CHEMICAL", 42, 50], ["acute respiratory syndrome-coronavirus", "DISEASE", 76, 114], ["coronavirus", "ORGANISM", 16, 27], ["severe acute respiratory syndrome-coronavirus-2", "ORGANISM", 69, 116], ["SARS-CoV-2) virus", "ORGANISM", 118, 135], ["-coronavirus", "SPECIES", 102, 114], ["CoV-2", "SPECIES", 123, 128], ["coronavirus disease-2019 (COVID-19", "SPECIES", 16, 50], ["severe acute respiratory syndrome-coronavirus", "SPECIES", 69, 114], ["SARS-CoV-2) virus", "SPECIES", 118, 135], ["coronavirus disease", "PROBLEM", 16, 35], ["COVID", "TEST", 42, 47], ["the severe acute respiratory syndrome", "PROBLEM", 65, 102], ["coronavirus", "TEST", 103, 114], ["SARS", "TEST", 118, 122], ["CoV", "TEST", 123, 126], ["virus", "PROBLEM", 130, 135], ["coronavirus disease", "OBSERVATION", 16, 35], ["severe", "OBSERVATION_MODIFIER", 69, 75], ["acute", "OBSERVATION_MODIFIER", 76, 81], ["respiratory syndrome", "OBSERVATION", 82, 102]]], ["Some data describing characteristics and prognosis of patients with COVID-19 and diabetes are now available, for example, for hospitalized patients in the CORONADO study [1].", [["diabetes", "DISEASE", 81, 89], ["patients", "ORGANISM", 54, 62], ["patients", "ORGANISM", 139, 147], ["patients", "SPECIES", 54, 62], ["patients", "SPECIES", 139, 147], ["COVID", "TEST", 68, 73], ["diabetes", "PROBLEM", 81, 89]]], ["Potential links between diabetes and COVID-19 infection were already described [2].", [["diabetes", "DISEASE", 24, 32], ["infection", "DISEASE", 46, 55], ["COVID-19", "GENE_OR_GENE_PRODUCT", 37, 45], ["diabetes", "PROBLEM", 24, 32], ["COVID-19 infection", "PROBLEM", 37, 55], ["diabetes", "OBSERVATION", 24, 32], ["infection", "OBSERVATION", 46, 55]]], ["Indeed, angiotensin-converting enzyme 2 (ACE2) has been identified as the receptor for the coronavirus spike protein [3], and ACE is expressed on pancreatic beta cells [2].", [["pancreatic beta cells", "ANATOMY", 146, 167], ["angiotensin", "CHEMICAL", 8, 19], ["angiotensin-converting enzyme 2", "GENE_OR_GENE_PRODUCT", 8, 39], ["ACE2", "GENE_OR_GENE_PRODUCT", 41, 45], ["coronavirus spike protein [3", "GENE_OR_GENE_PRODUCT", 91, 119], ["ACE", "GENE_OR_GENE_PRODUCT", 126, 129], ["pancreatic beta cells", "CELL", 146, 167], ["angiotensin-converting enzyme 2", "PROTEIN", 8, 39], ["ACE2", "PROTEIN", 41, 45], ["coronavirus spike protein", "PROTEIN", 91, 116], ["ACE", "PROTEIN", 126, 129], ["pancreatic beta cells", "CELL_TYPE", 146, 167], ["angiotensin-converting enzyme", "TEST", 8, 37], ["ACE2", "TEST", 41, 45], ["the coronavirus spike protein", "TEST", 87, 116], ["ACE", "TEST", 126, 129], ["pancreatic beta cells", "TEST", 146, 167], ["pancreatic", "ANATOMY", 146, 156], ["beta cells", "OBSERVATION", 157, 167]]], ["It was suggested that SARS-CoV2 could induce beta cell damage and new onset diabetes [2], but the phenotype of these new cases of diabetes has not been described.", [["beta cell", "ANATOMY", 45, 54], ["SARS", "DISEASE", 22, 26], ["beta cell damage", "DISEASE", 45, 61], ["diabetes", "DISEASE", 76, 84], ["diabetes", "DISEASE", 130, 138], ["SARS-CoV2", "GENE_OR_GENE_PRODUCT", 22, 31], ["beta cell", "CELL", 45, 54], ["SARS-CoV2", "PROBLEM", 22, 31], ["beta cell damage", "PROBLEM", 45, 61], ["new onset diabetes", "PROBLEM", 66, 84], ["diabetes", "PROBLEM", 130, 138], ["beta cell damage", "OBSERVATION", 45, 61], ["new", "OBSERVATION_MODIFIER", 66, 69], ["onset", "OBSERVATION_MODIFIER", 70, 75], ["diabetes", "OBSERVATION", 76, 84], ["new", "OBSERVATION_MODIFIER", 117, 120], ["diabetes", "OBSERVATION", 130, 138]]]], "PMC3367357": [["The StudyWe postulated that these populationwide anti-SARS measures would have effects on other infections spread by the respiratory route.", [["respiratory", "ANATOMY", 121, 132], ["infections", "DISEASE", 96, 106], ["these populationwide anti-SARS measures", "TREATMENT", 28, 67], ["other infections spread", "PROBLEM", 90, 113], ["the respiratory route", "TREATMENT", 117, 138], ["infections", "OBSERVATION", 96, 106]]], ["In this study, we examined whether such measures also affected the incidence of some common acute viral respiratory infections.The StudyThe study period was January 1, 1998, to December 31, 2003.", [["respiratory", "ANATOMY", 104, 115], ["viral respiratory infections", "DISEASE", 98, 126], ["this study", "TEST", 3, 13], ["some common acute viral respiratory infections", "PROBLEM", 80, 126], ["The Study", "TEST", 127, 136], ["common", "OBSERVATION_MODIFIER", 85, 91], ["acute", "OBSERVATION_MODIFIER", 92, 97], ["viral", "OBSERVATION_MODIFIER", 98, 103], ["respiratory infections", "OBSERVATION", 104, 126]]], ["At GVU, all respiratory specimens are routinely cultured using 4 continuous cell lines, Rhesus monkey kidney, Madin-Darby canine kidney, rhabdomyosarcoma, and human laryngeal epithelium, which could support the growth of various viruses including influenza, parainfluenza, respiratory syncytial virus (RSV), and adenovirus.", [["respiratory specimens", "ANATOMY", 12, 33], ["cell lines", "ANATOMY", 76, 86], ["kidney", "ANATOMY", 102, 108], ["kidney", "ANATOMY", 129, 135], ["rhabdomyosarcoma", "ANATOMY", 137, 153], ["laryngeal epithelium", "ANATOMY", 165, 185], ["rhabdomyosarcoma", "DISEASE", 137, 153], ["influenza", "DISEASE", 247, 256], ["parainfluenza", "DISEASE", 258, 271], ["respiratory syncytial virus (RSV)", "DISEASE", 273, 306], ["cell lines", "CELL", 76, 86], ["Rhesus", "ORGANISM", 88, 94], ["monkey", "ORGANISM", 95, 101], ["kidney", "ORGAN", 102, 108], ["Madin-Darby canine kidney", "ORGANISM", 110, 135], ["rhabdomyosarcoma", "CANCER", 137, 153], ["human", "ORGANISM", 159, 164], ["laryngeal epithelium", "TISSUE", 165, 185], ["influenza", "ORGANISM", 247, 256], ["parainfluenza,", "ORGANISM", 258, 272], ["respiratory syncytial virus", "ORGANISM", 273, 300], ["RSV", "ORGANISM", 302, 305], ["adenovirus", "ORGANISM", 312, 322], ["continuous cell lines", "CELL_LINE", 65, 86], ["Rhesus monkey", "SPECIES", 88, 101], ["human", "SPECIES", 159, 164], ["parainfluenza", "SPECIES", 258, 271], ["respiratory syncytial virus", "SPECIES", 273, 300], ["Rhesus monkey", "SPECIES", 88, 101], ["canine", "SPECIES", 122, 128], ["human", "SPECIES", 159, 164], ["respiratory syncytial virus", "SPECIES", 273, 300], ["RSV", "SPECIES", 302, 305], ["adenovirus", "SPECIES", 312, 322], ["all respiratory specimens", "TEST", 8, 33], ["4 continuous cell lines", "TREATMENT", 63, 86], ["Madin", "TREATMENT", 110, 115], ["Darby canine kidney", "TREATMENT", 116, 135], ["rhabdomyosarcoma", "PROBLEM", 137, 153], ["human laryngeal epithelium", "PROBLEM", 159, 185], ["various viruses", "PROBLEM", 221, 236], ["influenza", "PROBLEM", 247, 256], ["parainfluenza", "PROBLEM", 258, 271], ["respiratory syncytial virus (RSV)", "PROBLEM", 273, 306], ["adenovirus", "PROBLEM", 312, 322], ["respiratory", "ANATOMY", 12, 23], ["cell lines", "OBSERVATION", 76, 86], ["kidney", "ANATOMY", 102, 108], ["kidney", "ANATOMY", 129, 135], ["rhabdomyosarcoma", "OBSERVATION", 137, 153], ["laryngeal epithelium", "ANATOMY", 165, 185], ["respiratory syncytial", "ANATOMY", 273, 294]]], ["On detection of specific cytopathic effects, the viruses are identified with standard protocols (7).The StudyFor each month of the study period, we obtained the number of respiratory virus isolates as a proportion of the total number of respiratory specimens processed by GVU.", [["respiratory specimens", "ANATOMY", 237, 258], ["specific cytopathic effects", "PROBLEM", 16, 43], ["the viruses", "PROBLEM", 45, 56], ["The Study", "TEST", 100, 109], ["the study", "TEST", 127, 136], ["respiratory virus isolates", "TREATMENT", 171, 197], ["respiratory specimens", "TEST", 237, 258], ["specific", "OBSERVATION_MODIFIER", 16, 24], ["cytopathic effects", "OBSERVATION", 25, 43], ["viruses", "OBSERVATION", 49, 56], ["respiratory specimens", "OBSERVATION", 237, 258]]], ["We computed the percentage change in the proportion of positive specimens (PPS) for each virus between each month of 2003 and the mean PPS in the same month of the preceding 5 years (1998\u20132002), which served as the reference period.", [["specimens", "ANATOMY", 64, 73], ["the percentage change", "PROBLEM", 12, 33], ["positive specimens", "PROBLEM", 55, 73], ["each virus", "PROBLEM", 84, 94], ["the mean PPS", "TEST", 126, 138], ["percentage", "OBSERVATION_MODIFIER", 16, 26], ["change", "OBSERVATION_MODIFIER", 27, 33]]], ["For comparison purposes, we obtained the monthly number of positive tests for immunoglobulin M (IgM) antibody against hepatitis B core antigen (anti-HBc) and the corresponding total number of tests performed in the study period.", [["hepatitis B", "DISEASE", 118, 129], ["immunoglobulin M", "GENE_OR_GENE_PRODUCT", 78, 94], ["IgM", "GENE_OR_GENE_PRODUCT", 96, 99], ["hepatitis B core antigen", "GENE_OR_GENE_PRODUCT", 118, 142], ["anti-HBc", "GENE_OR_GENE_PRODUCT", 144, 152], ["immunoglobulin M (IgM) antibody", "PROTEIN", 78, 109], ["hepatitis B core antigen", "PROTEIN", 118, 142], ["HBc", "PROTEIN", 149, 152], ["comparison purposes", "TEST", 4, 23], ["positive tests", "TEST", 59, 73], ["immunoglobulin M (IgM) antibody", "TEST", 78, 109], ["hepatitis B core antigen", "TEST", 118, 142], ["anti-HBc", "TEST", 144, 152], ["tests", "TEST", 192, 197]]], ["The percentage change in PPS was calculated as above.", [["The percentage change in PPS", "PROBLEM", 0, 28], ["percentage", "OBSERVATION_MODIFIER", 4, 14], ["change", "OBSERVATION_MODIFIER", 15, 21], ["PPS", "OBSERVATION", 25, 28]]], ["Although a positive IgM anti-HBc test result indicates acute hepatitis B infection or an exacerbation of chronic hepatitis B infection, as we were testing the same catchment of population throughout 1998 to 2003, the proportion of exacerbations of chronic hepatitis B infection is assumed to have remained unchanged during the study period.The StudyThe Table shows the change in PPS in 2003 for the various viruses in comparison with the reference period.", [["hepatitis B infection", "DISEASE", 61, 82], ["chronic hepatitis B infection", "DISEASE", 105, 134], ["chronic hepatitis B infection", "DISEASE", 248, 277], ["IgM", "GENE_OR_GENE_PRODUCT", 20, 23], ["hepatitis B", "ORGANISM", 61, 72], ["hepatitis B", "ORGANISM", 113, 124], ["hepatitis B", "ORGANISM", 256, 267], ["HBc", "PROTEIN", 29, 32], ["hepatitis B", "SPECIES", 61, 72], ["hepatitis B", "SPECIES", 113, 124], ["hepatitis B", "SPECIES", 256, 267], ["a positive IgM anti", "TEST", 9, 28], ["HBc test", "TEST", 29, 37], ["acute hepatitis B infection", "PROBLEM", 55, 82], ["chronic hepatitis B infection", "PROBLEM", 105, 134], ["chronic hepatitis B infection", "PROBLEM", 248, 277], ["The Study", "TEST", 340, 349], ["the change in PPS", "PROBLEM", 365, 382], ["the various viruses", "PROBLEM", 395, 414], ["acute", "OBSERVATION_MODIFIER", 55, 60], ["hepatitis", "OBSERVATION", 61, 70], ["infection", "OBSERVATION", 73, 82], ["exacerbation", "OBSERVATION_MODIFIER", 89, 101], ["chronic", "OBSERVATION_MODIFIER", 105, 112], ["hepatitis", "OBSERVATION", 113, 122], ["infection", "OBSERVATION", 125, 134], ["exacerbations", "OBSERVATION", 231, 244], ["chronic", "OBSERVATION_MODIFIER", 248, 255], ["hepatitis", "OBSERVATION", 256, 265], ["infection", "OBSERVATION", 268, 277], ["unchanged", "OBSERVATION_MODIFIER", 306, 315], ["change", "OBSERVATION_MODIFIER", 369, 375], ["PPS", "OBSERVATION_MODIFIER", 379, 382]]], ["In 2003, the monthly number of respiratory specimens ranged from 665 to 5,432 (mean 1,399), in comparison with a range throughout the years 1998\u20132002 of 757 to 3,162 (mean 1,334.5).", [["respiratory specimens", "ANATOMY", 31, 52], ["respiratory specimens", "TEST", 31, 52]]], ["A surge in the number of specimens was noted during March and April 2003 (5,432 and 3,758, respectively).", [["specimens", "ANATOMY", 25, 34], ["specimens", "CANCER", 25, 34]]], ["During March to July 2003, marked reductions in PPS occurred compared with the reference period for influenza virus, parainfluenza virus, RSV, and adenovirus, particularly in the months of April, May, and June.", [["PPS", "DISEASE", 48, 51], ["influenza virus", "DISEASE", 100, 115], ["parainfluenza virus, RSV, and adenovirus", "DISEASE", 117, 157], ["influenza virus", "ORGANISM", 100, 115], ["parainfluenza virus", "ORGANISM", 117, 136], ["RSV", "ORGANISM", 138, 141], ["adenovirus", "ORGANISM", 147, 157], ["influenza virus", "SPECIES", 100, 115], ["parainfluenza virus", "SPECIES", 117, 136], ["influenza virus", "SPECIES", 100, 115], ["parainfluenza virus", "SPECIES", 117, 136], ["RSV", "SPECIES", 138, 141], ["adenovirus", "SPECIES", 147, 157], ["marked reductions in PPS", "PROBLEM", 27, 51], ["influenza virus", "PROBLEM", 100, 115], ["parainfluenza virus", "PROBLEM", 117, 136], ["RSV", "PROBLEM", 138, 141], ["adenovirus", "TREATMENT", 147, 157], ["marked", "OBSERVATION_MODIFIER", 27, 33], ["reductions", "OBSERVATION_MODIFIER", 34, 44], ["parainfluenza virus", "OBSERVATION", 117, 136]]], ["This reduction corresponded to the period when anti-SARS measures in the community were most rigorous.", [["This reduction", "TREATMENT", 0, 14], ["anti-SARS measures", "TREATMENT", 47, 65]]], ["In contrast, similar changes in PPS were not observed for hepatitis B, which is caused by a bloodborne virus with a different mode of transmission than that of the 4 respiratory viruses (Figure 1).", [["hepatitis B", "DISEASE", 58, 69], ["respiratory viruses", "DISEASE", 166, 185], ["hepatitis B", "ORGANISM", 58, 69], ["hepatitis B", "SPECIES", 58, 69], ["bloodborne virus", "SPECIES", 92, 108], ["similar changes in PPS", "PROBLEM", 13, 35], ["hepatitis B", "PROBLEM", 58, 69], ["a bloodborne virus", "PROBLEM", 90, 108], ["bloodborne virus", "OBSERVATION", 92, 108], ["respiratory", "ANATOMY", 166, 177], ["viruses", "OBSERVATION", 178, 185]]], ["Since August 2003, instead of reductions in PPS, a rebound in isolation rates was observed for the 4 viruses.The StudyThe 2003 SARS outbreak overlapped with the traditional seasonal peak from March to September for RSV in Hong Kong (8).", [["SARS", "DISEASE", 127, 131], ["RSV", "ORGANISM", 215, 218], ["RSV", "SPECIES", 215, 218], ["PPS", "TREATMENT", 44, 47], ["a rebound in isolation rates", "TEST", 49, 77], ["the 4 viruses", "PROBLEM", 95, 108], ["The Study", "TEST", 109, 118], ["RSV", "PROBLEM", 215, 218]]], ["In 2003, the RSV peak season shifted to August\u2013October.", [["RSV", "ORGANISM", 13, 16], ["RSV", "SPECIES", 13, 16]]], ["The accumulation of susceptible infants offset the infection control measures instituted against respiratory infections as well as the normal seasonality; as a result, RSV activity increased in the late months of 2003.", [["respiratory", "ANATOMY", 97, 108], ["infection", "DISEASE", 51, 60], ["respiratory infections", "DISEASE", 97, 119], ["infants", "ORGANISM", 32, 39], ["RSV", "ORGANISM", 168, 171], ["infants", "SPECIES", 32, 39], ["RSV", "SPECIES", 168, 171], ["the infection control measures", "TREATMENT", 47, 77], ["respiratory infections", "PROBLEM", 97, 119], ["RSV activity", "PROBLEM", 168, 180], ["accumulation", "OBSERVATION_MODIFIER", 4, 16], ["susceptible", "OBSERVATION_MODIFIER", 20, 31], ["infants", "OBSERVATION_MODIFIER", 32, 39], ["offset", "OBSERVATION_MODIFIER", 40, 46], ["infection", "OBSERVATION", 51, 60], ["infections", "OBSERVATION", 109, 119], ["normal", "OBSERVATION", 135, 141], ["activity", "OBSERVATION_MODIFIER", 172, 180], ["increased", "OBSERVATION_MODIFIER", 181, 190]]], ["Figure 2 illustrates the usual seasonal variation of the 4 respiratory viruses and their pattern from 1998 to 2003.The StudyDiscerning whether the observed effects in our study were real or apparent is important.", [["the 4 respiratory viruses", "PROBLEM", 53, 78], ["our study", "TEST", 167, 176], ["respiratory viruses", "OBSERVATION", 59, 78]]], ["The surge in specimens during March and April 2003 suggested that physicians were more inclined to order tests for patients with respiratory symptoms at the height of the SARS outbreak.", [["specimens", "ANATOMY", 13, 22], ["respiratory", "ANATOMY", 129, 140], ["respiratory symptoms", "DISEASE", 129, 149], ["SARS", "DISEASE", 171, 175], ["patients", "ORGANISM", 115, 123], ["patients", "SPECIES", 115, 123], ["tests", "TEST", 105, 110], ["respiratory symptoms", "PROBLEM", 129, 149], ["the SARS outbreak", "PROBLEM", 167, 184]]], ["This fact could conceivably dilute PPS for respiratory viruses.", [["respiratory viruses", "DISEASE", 43, 62], ["respiratory viruses", "PROBLEM", 43, 62], ["dilute PPS", "OBSERVATION", 28, 38], ["respiratory viruses", "OBSERVATION", 43, 62]]], ["However, since May 2003, the number of tests has returned to normal levels; however, PPS remained significantly decreased during May to July 2003.", [["tests", "TEST", 39, 44], ["PPS", "TEST", 85, 88], ["significantly", "OBSERVATION_MODIFIER", 98, 111], ["decreased", "OBSERVATION", 112, 121]]], ["Thus, PPS reductions cannot be explained by a dilution effect caused by an increased number of specimens processed.", [["specimens", "ANATOMY", 95, 104], ["PPS reductions", "PROBLEM", 6, 20], ["a dilution effect", "PROBLEM", 44, 61], ["an increased number of specimens", "PROBLEM", 72, 104], ["increased", "OBSERVATION_MODIFIER", 75, 84], ["number", "OBSERVATION_MODIFIER", 85, 91]]], ["Furthermore, after we controlled for the patients' age group differences, PPS for influenza virus remained depressed when compared to PPS in the reference period (data not shown).", [["influenza", "DISEASE", 82, 91], ["depressed", "DISEASE", 107, 116], ["patients", "ORGANISM", 41, 49], ["patients", "SPECIES", 41, 49], ["influenza virus", "SPECIES", 82, 97], ["PPS", "TREATMENT", 74, 77], ["influenza virus", "PROBLEM", 82, 97], ["depressed", "PROBLEM", 107, 116]]], ["The same pattern was true for adenovirus.The StudyPopulation coverage for influenza vaccination in Hong Kong has been <15% throughout the study period (A. Chan, pers. comm.), so vaccination was unlikely to have resulted in reduced influenza circulation in the community.", [["influenza", "DISEASE", 74, 83], ["adenovirus", "ORGANISM", 30, 40], ["adenovirus", "PROBLEM", 30, 40], ["The StudyPopulation coverage", "TREATMENT", 41, 69], ["influenza vaccination", "TREATMENT", 74, 95], ["vaccination", "TREATMENT", 178, 189], ["reduced influenza circulation in the community", "PROBLEM", 223, 269], ["adenovirus", "OBSERVATION", 30, 40], ["reduced", "OBSERVATION_MODIFIER", 223, 230], ["influenza", "OBSERVATION", 231, 240]]], ["The concomitant significant reduction in PPS for all 4 respiratory viruses in the same period argues against 2003's being a milder year for influenza.", [["influenza", "DISEASE", 140, 149], ["The concomitant significant reduction in PPS", "PROBLEM", 0, 44], ["all 4 respiratory viruses", "PROBLEM", 49, 74], ["influenza", "PROBLEM", 140, 149], ["concomitant", "OBSERVATION_MODIFIER", 4, 15], ["significant", "OBSERVATION_MODIFIER", 16, 27], ["reduction", "OBSERVATION_MODIFIER", 28, 37], ["PPS", "OBSERVATION_MODIFIER", 41, 44], ["respiratory viruses", "OBSERVATION", 55, 74]]], ["Temporally, the moderation of PPS reductions since August 2003 (the last SARS case was reported on June 2) supported the hypothesis that the effects of populationwide anti-SARS measures on the incidence of respiratory viruses were real.The StudyWith the recent outbreaks of highly pathogenic avian influenza among poultry in Asian countries, and the associated human infections, pandemic planning for influenza has been undertaken with renewed efforts on a worldwide basis (9).", [["SARS", "DISEASE", 73, 77], ["respiratory viruses", "DISEASE", 206, 225], ["avian influenza", "DISEASE", 292, 307], ["human infections", "DISEASE", 361, 377], ["influenza", "DISEASE", 401, 410], ["avian influenza", "ORGANISM", 292, 307], ["human", "ORGANISM", 361, 366], ["avian influenza", "SPECIES", 292, 307], ["human", "SPECIES", 361, 366], ["human", "SPECIES", 361, 366], ["PPS reductions", "PROBLEM", 30, 44], ["populationwide anti-SARS measures", "TREATMENT", 152, 185], ["respiratory viruses", "PROBLEM", 206, 225], ["the associated human infections", "PROBLEM", 346, 377], ["pandemic planning", "TREATMENT", 379, 396], ["influenza", "PROBLEM", 401, 410], ["PPS", "OBSERVATION_MODIFIER", 30, 33], ["reductions", "OBSERVATION_MODIFIER", 34, 44], ["respiratory viruses", "OBSERVATION", 206, 225], ["infections", "OBSERVATION", 367, 377]]], ["In pandemic preparedness planning, control measures have traditionally focused on the use of antiviral chemotherapy and the expedient development of an effective vaccine.", [["control measures", "TREATMENT", 35, 51], ["antiviral chemotherapy", "TREATMENT", 93, 115], ["an effective vaccine", "TREATMENT", 149, 169]]], ["An effective vaccine would probably become available only during the latter phase of the pandemic.", [["An effective vaccine", "TREATMENT", 0, 20]]], ["Information concerning the effects of increased social distance and communitywide hygiene measures on the incidence of common viral respiratory infections at a population level has been lacking.", [["respiratory", "ANATOMY", 132, 143], ["viral respiratory infections", "DISEASE", 126, 154], ["communitywide hygiene measures", "TREATMENT", 68, 98], ["common viral respiratory infections", "PROBLEM", 119, 154], ["respiratory", "ANATOMY", 132, 143], ["infections", "OBSERVATION", 144, 154]]], ["The SARS outbreak offers a unique opportunity to study the association.", [["SARS", "DISEASE", 4, 8]]], ["Although our study was observational and thus could not establish a causal relationship, it suggests a possible association between population-based hygienic measures and the reduced incidence of influenza and other acute viral respiratory infections.", [["respiratory", "ANATOMY", 228, 239], ["influenza", "DISEASE", 196, 205], ["viral respiratory infections", "DISEASE", 222, 250], ["our study", "TEST", 9, 18], ["hygienic measures", "TREATMENT", 149, 166], ["influenza", "PROBLEM", 196, 205], ["other acute viral respiratory infections", "PROBLEM", 210, 250], ["reduced", "OBSERVATION_MODIFIER", 175, 182], ["influenza", "OBSERVATION", 196, 205], ["acute", "OBSERVATION_MODIFIER", 216, 221], ["viral", "OBSERVATION_MODIFIER", 222, 227], ["respiratory infections", "OBSERVATION", 228, 250]]], ["However, the relative contribution of each of these measures could not be estimated in our study.", [["our study", "TEST", 87, 96], ["could not be", "UNCERTAINTY", 61, 73]]], ["The effective implementation of such measures requires determined and sustained educational efforts from health authorities with collaboration of the public.", [["effective", "OBSERVATION_MODIFIER", 4, 13]]], ["We thus propose that stockpiling personal protective equipment and having public education campaigns on infection control practices should form an integral component in pandemic planning for the emergence of novel influenza virus strains in humans.", [["infection", "DISEASE", 104, 113], ["influenza virus", "DISEASE", 214, 229], ["influenza virus", "ORGANISM", 214, 229], ["humans", "ORGANISM", 241, 247], ["influenza virus", "SPECIES", 214, 229], ["humans", "SPECIES", 241, 247], ["humans", "SPECIES", 241, 247], ["personal protective equipment", "TREATMENT", 33, 62], ["public education campaigns", "TREATMENT", 74, 100], ["infection control practices", "TREATMENT", 104, 131], ["an integral component", "PROBLEM", 144, 165], ["pandemic planning", "TREATMENT", 169, 186], ["novel influenza virus strains", "PROBLEM", 208, 237]]]], "PMC1564062": [["IntroductionBiosensors combine biochemical recognition with signal transduction for the detection of specific molecules.", [["IntroductionBiosensors", "TREATMENT", 0, 22], ["signal transduction", "TREATMENT", 60, 79], ["specific molecules", "PROBLEM", 101, 119]]], ["The recognition component, such as a nucleic acid sequence, an antibody, an enzyme, or other biomolecule, specifically binds to or catalyzes a reaction with the target of interest.", [["nucleic acid", "CHEMICAL", 37, 49], ["nucleic acid sequence", "PROTEIN", 37, 58], ["enzyme", "PROTEIN", 76, 82], ["a nucleic acid sequence", "TEST", 35, 58], ["an antibody", "TEST", 60, 71], ["an enzyme", "TEST", 73, 82], ["a reaction", "PROBLEM", 141, 151], ["component", "OBSERVATION_MODIFIER", 16, 25]]], ["The transducer component transforms this recognition event into a measurable signal.", [["The transducer component", "TREATMENT", 0, 24]]], ["Together, these elements enable the specific detection of targets in complex samples.IntroductionThese analytical tools have been utilized in a variety of industrial applications ranging from clinical diagnostics and environmental monitoring to biothreat detection and forensics.", [["samples", "ANATOMY", 77, 84], ["samples", "CANCER", 77, 84], ["targets in complex samples", "PROBLEM", 58, 84], ["clinical diagnostics", "TEST", 192, 212], ["environmental monitoring", "TEST", 217, 241], ["biothreat detection", "TEST", 245, 264]]], ["Their broad applicability comes from their promise of overcoming the limitations of traditional measurement techniques, which can be expensive, complicated, and slow.IntroductionBiosensors can be categorized by the reactant that they measure after the recognition event.", [["traditional measurement techniques", "TEST", 84, 118], ["IntroductionBiosensors", "TREATMENT", 166, 188]]], ["Specifically, biosensor types include optical (light), bioluminescent (photons), thermal (heat), mass (resonance frequency changes), and electrochemical (electron transfer) [3].", [["thermal (heat)", "PROBLEM", 81, 95], ["mass (resonance frequency changes", "PROBLEM", 97, 130], ["mass", "OBSERVATION", 97, 101]]], ["While each of these types has inherent strengths and weaknesses, optical and electrochemical biosensors have become the most widely used.IntroductionOptical biosensors have been adopted throughout clinical diagnostics and life science research due to their speed and sensitivity compared with other techniques.", [["optical and electrochemical biosensors", "TEST", 65, 103], ["IntroductionOptical biosensors", "TREATMENT", 137, 167]]], ["However, most optical biosensors still require the use of target amplification such that the signal is enhanced to a measurable level.", [["target amplification", "TREATMENT", 58, 78]]], ["Of these amplification methods, real-time PCR has emerged as the most widely adopted and is now considered the gold standard for the detection of nucleic acids from a variety of origins [4].", [["nucleic acids", "CHEMICAL", 146, 159], ["nucleic acids", "SIMPLE_CHEMICAL", 146, 159], ["these amplification methods", "TEST", 3, 30], ["real-time PCR", "TEST", 32, 45], ["nucleic acids", "PROBLEM", 146, 159]]], ["Nevertheless, real-time PCR has several limitations and its avoidance remains a holy grail for the industry.", [["real-time PCR", "TEST", 14, 27]]], ["Of primary importance are its time requirement for sample processing and amplification, false positives from sample or reagent contamination, and high instrumentation and labor costs.IntroductionElectrochemical biosensors promise superior speed and selectivity at a low cost [1], [2], [5].", [["sample", "ANATOMY", 51, 57], ["sample processing", "TEST", 51, 68], ["amplification", "TEST", 73, 86], ["false positives", "PROBLEM", 88, 103], ["reagent contamination", "TEST", 119, 140], ["high instrumentation", "TREATMENT", 146, 166], ["labor costs", "PROBLEM", 171, 182], ["high instrumentation", "OBSERVATION", 146, 166]]], ["Historically, however, electrochemical biosensors lacked sufficient sensitivity for use beyond glucose monitoring and clinical chemistry analysis.", [["glucose", "CHEMICAL", 95, 102], ["glucose", "CHEMICAL", 95, 102], ["glucose", "SIMPLE_CHEMICAL", 95, 102], ["electrochemical biosensors", "TEST", 23, 49], ["glucose monitoring", "TEST", 95, 113], ["clinical chemistry analysis", "TEST", 118, 145]]], ["Recently, however, companies such as GeneFluidics have developed platforms that address this sensitivity question and point to electrochemical biosensors\u2019 widespread use in the near future [11].Overview ::: Novel electrochemical detector arrayThis platform consists of a novel electrochemical detection system embodied in disposable, multi-assay sensor chips and a user-friendly potentiostat reader instrument (Fig. 1A).", [["Novel electrochemical detector array", "TREATMENT", 207, 243], ["multi-assay sensor chips", "TREATMENT", 334, 358]]], ["The reader system can acquire pico ampere current signal from the sensor array chip through a chip mount interface (Fig. 1B).", [["the sensor array chip", "TREATMENT", 62, 83], ["a chip mount interface", "TREATMENT", 92, 114]]], ["Raw samples such as blood or urine can be directly applied onto the sensor chip (Fig. 1C).", [["samples", "ANATOMY", 4, 11], ["blood", "ANATOMY", 20, 25], ["urine", "ANATOMY", 29, 34], ["blood", "ORGANISM_SUBSTANCE", 20, 25], ["urine", "ORGANISM_SUBSTANCE", 29, 34], ["Raw samples", "TEST", 0, 11], ["blood or urine", "TEST", 20, 34]]], ["Unlike previously reported electrochemical DNA sensors that used graphite or carbon electrodes, we use a single layer of gold for all three electrodes, i.e., working, auxiliary, and reference electrodes.", [["graphite", "CHEMICAL", 65, 73], ["graphite", "CHEMICAL", 65, 73], ["carbon", "CHEMICAL", 77, 83], ["DNA", "CELLULAR_COMPONENT", 43, 46], ["graphite", "SIMPLE_CHEMICAL", 65, 73], ["electrochemical DNA sensors", "TREATMENT", 27, 54], ["graphite or carbon electrodes", "TREATMENT", 65, 94], ["a single layer of gold for all three electrodes", "TREATMENT", 103, 150], ["carbon electrodes", "OBSERVATION", 77, 94]]], ["Typically, Ag/AgCl or a saturated calomel electrode (SCE) is used as the reference electrode so that reversible oxidation/reduction occurs at a fixed potential at the reference electrode.", [["Ag", "CHEMICAL", 11, 13], ["AgCl", "CHEMICAL", 14, 18], ["SCE", "CHEMICAL", 53, 56], ["Ag", "CHEMICAL", 11, 13], ["AgCl", "CHEMICAL", 14, 18], ["Ag/AgCl", "SIMPLE_CHEMICAL", 11, 18], ["calomel electrode", "SIMPLE_CHEMICAL", 34, 51], ["SCE", "SIMPLE_CHEMICAL", 53, 56], ["Ag", "PROTEIN", 11, 13], ["Ag/AgCl", "TREATMENT", 11, 18], ["a saturated calomel electrode", "TREATMENT", 22, 51], ["reversible oxidation/reduction", "TREATMENT", 101, 131], ["reversible oxidation", "OBSERVATION", 101, 121], ["reduction", "OBSERVATION_MODIFIER", 122, 131]]], ["In contrast, we use Au as the reference electrode because its properties of malleability and durability simplify fabrication and allow use of extremely thin electrodes.", [["Au", "CHEMICAL", 20, 22], ["Au", "CHEMICAL", 20, 22], ["the reference electrode", "TREATMENT", 26, 49], ["durability simplify fabrication", "TREATMENT", 93, 124], ["extremely thin electrodes", "TREATMENT", 142, 167], ["malleability", "OBSERVATION", 76, 88]]], ["In our particular application, where the reduction of a mediator is monitored, Au can be successfully used as the reference electrode because a low voltage difference is maintained for short periods of time.", [["Au", "CHEMICAL", 79, 81], ["Au", "CHEMICAL", 79, 81], ["Au", "SIMPLE_CHEMICAL", 79, 81], ["a low voltage difference", "PROBLEM", 142, 166], ["low voltage", "OBSERVATION_MODIFIER", 144, 155]]], ["The Au/Au/Au electrode system is characterized by cyclic voltammetry and targets are detected by amperometry.Optical-grade sensor surface ::: Novel electrochemical detector arrayWe have developed a robust and proprietary manufacturing process that enables the direct deposition of gold onto silicon, glass, or plastic.", [["Au", "CHEMICAL", 4, 6], ["Au", "CHEMICAL", 7, 9], ["Au", "CHEMICAL", 10, 12], ["Au", "CHEMICAL", 4, 6], ["Au", "CHEMICAL", 7, 9], ["Au", "CHEMICAL", 10, 12], ["silicon", "CHEMICAL", 291, 298], ["Au/Au", "SIMPLE_CHEMICAL", 4, 9], ["The Au/Au/Au electrode system", "TREATMENT", 0, 29], ["cyclic voltammetry", "TEST", 50, 68], ["Novel electrochemical detector arrayWe", "TREATMENT", 142, 180], ["a robust and proprietary manufacturing process", "PROBLEM", 196, 242], ["the direct deposition of gold onto silicon, glass", "TREATMENT", 256, 305], ["cyclic voltammetry", "OBSERVATION", 50, 68]]], ["It is this process that provides the optical-grade flat sensors upon which extremely uniform, stable, and \u201cpinhole-free\u201d self-assembled monolayers (SAMs, described below), can be constructed.", [["monolayers", "CELL", 136, 146], ["\u201d self-assembled monolayers", "CELL_LINE", 119, 146], ["SAMs", "CELL_LINE", 148, 152], ["the optical-grade flat sensors", "PROBLEM", 33, 63], ["pinhole", "TEST", 107, 114], ["stable", "OBSERVATION_MODIFIER", 94, 100]]], ["This optical-grade smooth surface is essential to manufacture a non-conductive SAM with dense packing density free of deposition defects.", [["smooth surface", "ANATOMY", 19, 33], ["a non-conductive SAM", "PROBLEM", 62, 82], ["dense packing density", "PROBLEM", 88, 109], ["deposition defects", "PROBLEM", 118, 136], ["grade", "OBSERVATION_MODIFIER", 13, 18], ["smooth", "OBSERVATION_MODIFIER", 19, 25], ["surface", "OBSERVATION_MODIFIER", 26, 33], ["dense", "OBSERVATION_MODIFIER", 88, 93], ["packing density", "OBSERVATION", 94, 109], ["free", "OBSERVATION_MODIFIER", 110, 114], ["deposition defects", "OBSERVATION", 118, 136]]], ["SAM integrity is essential because any leakage current due to structural defects would result in high background signal.", [["any leakage", "PROBLEM", 35, 46], ["structural defects", "PROBLEM", 62, 80], ["high background signal", "PROBLEM", 97, 119], ["integrity", "OBSERVATION", 4, 13], ["leakage", "OBSERVATION", 39, 46], ["defects", "OBSERVATION", 73, 80], ["high", "OBSERVATION_MODIFIER", 97, 101]]], ["As shown in Fig. 2, a comparison of the X and Y units with those of the Z-axis over the 20 \u03bcM \u00d7 60 \u03bcm area elucidates the exceptional smoothness of our 50 nm thick gold sensor.Nanoscale surface treatment ::: Novel electrochemical detector arrayThe interface between engineering transducers and biological assays plays an important role in the sensitivity and specificity of a biosensor.", [["surface", "ANATOMY", 186, 193], ["X and Y units", "DNA", 40, 53], ["the X and Y units", "TREATMENT", 36, 53], ["Novel electrochemical detector array", "TREATMENT", 208, 244], ["engineering transducers", "TREATMENT", 266, 289], ["biological assays", "TEST", 294, 311], ["the sensitivity", "TEST", 339, 354], ["a biosensor", "TEST", 374, 385], ["Fig", "OBSERVATION", 12, 15], ["exceptional", "OBSERVATION_MODIFIER", 122, 133], ["smoothness", "OBSERVATION_MODIFIER", 134, 144]]], ["Currently, interfaces consisting of SAMs are of great interest because of their potential applications in electronic surface treatment, protective passivation, adhesion, and nanotechnology [6], [7], [8], [9].", [["surface", "ANATOMY", 117, 124], ["[7]", "SIMPLE_CHEMICAL", 194, 197], ["[8]", "SIMPLE_CHEMICAL", 199, 202], ["[9]", "SIMPLE_CHEMICAL", 204, 207], ["electronic surface treatment", "TREATMENT", 106, 134], ["protective passivation", "TREATMENT", 136, 158]]], ["SAMs of organosulfurs on gold films have been shown to form highly organized and ordered systems, which are suitable for membrane mimetic studies such as molecular recognition, catalysis, and cellular interactions.", [["membrane", "ANATOMY", 121, 129], ["cellular", "ANATOMY", 192, 200], ["organosulfurs", "CHEMICAL", 8, 21], ["organosulfurs", "SIMPLE_CHEMICAL", 8, 21], ["gold films", "SIMPLE_CHEMICAL", 25, 35], ["membrane", "CELLULAR_COMPONENT", 121, 129], ["cellular", "CELL", 192, 200], ["gold films", "TEST", 25, 35], ["membrane mimetic studies", "TEST", 121, 145], ["catalysis", "TREATMENT", 177, 186], ["cellular interactions", "OBSERVATION", 192, 213]]], ["The difference between SAMs and other chemical binding techniques is that SAMs can provide specific and uniform molecular bonding.Nanoscale surface treatment ::: Novel electrochemical detector arraySAMs are widely used to chemically modify surfaces by forming a thin layer of uniform molecules with or without exposed functional terminal groups.", [["surface", "ANATOMY", 140, 147], ["SAMs", "SIMPLE_CHEMICAL", 74, 78], ["The difference between SAMs and other chemical binding techniques", "PROBLEM", 0, 65], ["Novel electrochemical detector arraySAMs", "TREATMENT", 162, 202]]], ["Alkanethiols can tether organic compounds or be terminated with alcohol (ethylene glycol) groups to form SAMs that resist the adsorption of proteins or nucleic acids (so-called \u2018inert surfaces\u2019).", [["Alkanethiols", "CHEMICAL", 0, 12], ["alcohol", "CHEMICAL", 64, 71], ["ethylene glycol", "CHEMICAL", 73, 88], ["nucleic acids", "CHEMICAL", 152, 165], ["Alkanethiols", "CHEMICAL", 0, 12], ["alcohol", "CHEMICAL", 64, 71], ["ethylene glycol", "CHEMICAL", 73, 88], ["Alkanethiols", "SIMPLE_CHEMICAL", 0, 12], ["alcohol", "SIMPLE_CHEMICAL", 64, 71], ["ethylene glycol)", "SIMPLE_CHEMICAL", 73, 89], ["SAMs", "SIMPLE_CHEMICAL", 105, 109], ["nucleic acids", "SIMPLE_CHEMICAL", 152, 165], ["Alkanethiols", "TREATMENT", 0, 12], ["tether organic compounds", "PROBLEM", 17, 41], ["alcohol (ethylene glycol) groups", "TREATMENT", 64, 96], ["nucleic acids", "TREATMENT", 152, 165]]], ["These alkanethiols, when used in mixed SAMs, prevent biomolecular interactions of interest from producing non-specific effects.Nanoscale surface treatment ::: Novel electrochemical detector array", [["surface", "ANATOMY", 137, 144], ["alkanethiols", "CHEMICAL", 6, 18], ["alkanethiols", "CHEMICAL", 6, 18], ["alkanethiols", "SIMPLE_CHEMICAL", 6, 18], ["These alkanethiols", "TREATMENT", 0, 18], ["Novel electrochemical detector array", "TREATMENT", 159, 195]]]], "6974a925827dbe9893dcf9f3c8ac0bc69ae7c756": [["phylogenetic tools have greatly aided our analysis of virus evolution, but these methods struggle to characterize the role of virus populations.", [["phylogenetic tools", "TEST", 0, 18], ["virus evolution", "PROBLEM", 54, 69], ["virus populations", "PROBLEM", 126, 143], ["virus", "OBSERVATION", 54, 59], ["virus", "OBSERVATION", 126, 131]]], ["Missing from many of these considerations has been the major role played by persisting viruses in stable virus evolution and disease emergence.", [["persisting viruses", "PROBLEM", 76, 94], ["disease emergence", "PROBLEM", 125, 142], ["persisting", "OBSERVATION_MODIFIER", 76, 86], ["viruses", "OBSERVATION", 87, 94], ["stable", "OBSERVATION_MODIFIER", 98, 104], ["virus", "OBSERVATION", 105, 110]]], ["In many cases, extreme stability is seen with persisting RNA viruses.", [["extreme stability", "PROBLEM", 15, 32], ["persisting RNA viruses", "PROBLEM", 46, 68], ["extreme", "OBSERVATION_MODIFIER", 15, 22], ["stability", "OBSERVATION", 23, 32], ["RNA viruses", "OBSERVATION", 57, 68]]], ["Indeed, examples are known in which it is the persistently infected host that has better survival.", [["persistently", "OBSERVATION_MODIFIER", 46, 58], ["infected", "OBSERVATION", 59, 67]]], ["We have also recently come to appreciate the vast diversity of phage (DNA viruses) of prokaryotes as a system that evolves by genetic exchanges across vast populations (Chapter 10).", [["DNA", "CELLULAR_COMPONENT", 70, 73]]], ["In the large DNA viruses of aquatic microbes we see surprisingly large, complex and diverse viruses.", [["DNA", "CELLULAR_COMPONENT", 13, 16], ["large, complex and diverse viruses", "PROBLEM", 65, 99], ["large", "OBSERVATION_MODIFIER", 7, 12], ["DNA viruses", "OBSERVATION", 13, 24], ["aquatic microbes", "OBSERVATION", 28, 44], ["large", "OBSERVATION_MODIFIER", 65, 70], ["complex", "OBSERVATION_MODIFIER", 72, 79], ["diverse", "OBSERVATION_MODIFIER", 84, 91], ["viruses", "OBSERVATION", 92, 99]]], ["With both prokaryotic and eukaryotic DNA viruses, recombination is the main engine of virus evolution, and virus host co-evolution is common, although not uniform.", [["DNA", "CELLULAR_COMPONENT", 37, 40], ["eukaryotic DNA viruses", "PROBLEM", 26, 48], ["virus host co-evolution", "PROBLEM", 107, 130], ["prokaryotic", "OBSERVATION_MODIFIER", 10, 21], ["eukaryotic DNA viruses", "OBSERVATION", 26, 48], ["main", "OBSERVATION_MODIFIER", 71, 75], ["virus", "OBSERVATION", 86, 91], ["uniform", "OBSERVATION_MODIFIER", 155, 162]]], ["Viral emergence appears to be an unending phenomenon and we can currently witness a selective sweep by retroviruses that infect and become endogenized in koala bears.INTRODUCTIONOur understanding of virus evolution has reached a threshold in that it now appears to provide a much broader vista regarding its general signifi cance and infl uence on host evolution.", [["retroviruses", "ORGANISM", 103, 115], ["koala", "ORGANISM", 154, 159], ["Viral emergence", "PROBLEM", 0, 15], ["an unending phenomenon", "PROBLEM", 30, 52], ["a selective sweep", "TREATMENT", 82, 99], ["virus evolution", "PROBLEM", 199, 214], ["appears to be", "UNCERTAINTY", 16, 29], ["virus", "OBSERVATION", 199, 204], ["host evolution", "OBSERVATION_MODIFIER", 348, 362]]], ["One has been the realization that viruses often evolve by processes involving the collective action of a consortia, or quasispecies.", [["viruses", "PROBLEM", 34, 41], ["a consortia", "PROBLEM", 103, 114], ["quasispecies", "PROBLEM", 119, 131], ["viruses", "OBSERVATION", 34, 41]]], ["And the resulting adaptability and power of such evolution is unmatched by any other genetic entity.", [["adaptability", "OBSERVATION_MODIFIER", 18, 30]]], ["Much of this volume is dedicated to this issue.", [["this volume", "PROBLEM", 8, 19]]], ["In such consortia, the concept of a \" wild-type \" virus is no longer considered to be the fi ttest type, as the quasispecies itself provides fi tness (see Chapters 3 and 4).", [["a \" wild-type \" virus", "PROBLEM", 34, 55], ["no longer", "UNCERTAINTY", 59, 68]]], ["The quasispecies model resembles population genetics in some ways, but it has led to some signifi cant departures from population genetics, and these departures are very well supported by experiments.", [["some signifi cant departures", "PROBLEM", 85, 113], ["quasispecies", "OBSERVATION", 4, 16], ["population", "OBSERVATION_MODIFIER", 33, 43]]], ["Another development that has recalibrated our view of the overall signifi cance of viruses is information on the scale and diversity of viruses.", [["viruses", "PROBLEM", 83, 90], ["the scale", "TEST", 109, 118], ["viruses", "PROBLEM", 136, 143], ["viruses", "OBSERVATION", 83, 90], ["viruses", "OBSERVATION", 136, 143]]], ["Viruses are present at a previously unappreciated global level and appear to have affected the evolution of all life on Earth.", [["Viruses", "PROBLEM", 0, 7], ["evolution", "OBSERVATION_MODIFIER", 95, 104]]], ["Much of this realization has been brought about by the development of metagenomic methods as applied to various habitats.", [["metagenomic methods", "TREATMENT", 70, 89]]], ["Measurements of major habitats (the oceans, soil, extreme environments) have established that our biological world is predominantly viral, in terms of both numbers and diversity ( Paul et al. , 2002 ; Breitbart et al. , 2003 ; Rohwer, 2005a, 2005b ; Edwards and Rohwer, 2005 ; Comeau et al. , 2006 ) .INTRODUCTIONThese two developments would seem reason enough to consider virus evolution in a new light.", [["virus evolution", "PROBLEM", 373, 388], ["predominantly", "OBSERVATION_MODIFIER", 118, 131], ["viral", "OBSERVATION", 132, 137]]], ["However, there have also been numerous theoretical proposals suggesting viral involvement in some of the very earliest events and major transitions in the evolution of life.", [["viral involvement", "PROBLEM", 72, 89], ["numerous", "OBSERVATION_MODIFIER", 30, 38], ["theoretical proposals", "OBSERVATION", 39, 60], ["suggesting", "UNCERTAINTY", 61, 71], ["viral involvement", "OBSERVATION", 72, 89]]], ["We no longer think of viruses as recent agents that escaped from the host chromosomes as run away replicons.", [["chromosomes", "ANATOMY", 74, 85], ["chromosomes", "CELLULAR_COMPONENT", 74, 85], ["host chromosomes", "DNA", 69, 85], ["viruses", "PROBLEM", 22, 29], ["recent agents", "TREATMENT", 33, 46], ["no longer", "UNCERTAINTY", 3, 12], ["viruses", "OBSERVATION", 22, 29]]], ["Viruses now appear very old to us and they relate to and trace all branches of life.", [["Viruses", "PROBLEM", 0, 7], ["trace", "OBSERVATION_MODIFIER", 57, 62], ["all", "OBSERVATION_MODIFIER", 63, 66], ["branches", "OBSERVATION_MODIFIER", 67, 75]]], ["The last 30 years have been very active regarding virus evolution.", [["virus evolution", "PROBLEM", 50, 65], ["virus", "OBSERVATION", 50, 55]]], ["Major developments in theory, technology, medicine, and the study of human disease with respect to virus evolution have all occurred.", [["human", "ORGANISM", 69, 74], ["human", "SPECIES", 69, 74], ["human", "SPECIES", 69, 74], ["the study", "TEST", 56, 65], ["human disease", "PROBLEM", 69, 82], ["virus evolution", "PROBLEM", 99, 114]]], ["And as we seek to grow and manage various life forms for human use, virus evolution has also had major impact on such efforts.INTRODUCTIONAs a science, virus evolution has benefi tted greatly from traditional evolutionary biology.", [["human", "ORGANISM", 57, 62], ["human", "SPECIES", 57, 62], ["human", "SPECIES", 57, 62]]], ["However, since viruses are molecular genetic parasites that are inscrutable by casual observation, our understanding of virus evolution has been dependent upon measuring sequence variation and sequence diversity in a large number of virus genomes.", [["viruses", "PROBLEM", 15, 22], ["molecular genetic parasites", "PROBLEM", 27, 54], ["casual observation", "TEST", 79, 97], ["virus evolution", "PROBLEM", 120, 135], ["sequence variation", "TEST", 170, 188], ["sequence diversity", "PROBLEM", 193, 211], ["a large number of virus genomes", "PROBLEM", 215, 246], ["genetic parasites", "OBSERVATION", 37, 54], ["virus", "OBSERVATION", 120, 125], ["large", "OBSERVATION_MODIFIER", 217, 222], ["virus genomes", "OBSERVATION", 233, 246]]], ["Because of this, these small genetic parasites have been the last domain of life to yield their secrets of evolution.", [["these small genetic parasites", "PROBLEM", 17, 46], ["small", "OBSERVATION_MODIFIER", 23, 28], ["parasites", "OBSERVATION", 37, 46]]], ["And viruses harbor some clearly distinct evolutionary abilities.", [["distinct", "OBSERVATION_MODIFIER", 32, 40], ["evolutionary abilities", "OBSERVATION", 41, 63]]], ["For one, they are polyphyletic.", [["polyphyletic", "PROBLEM", 18, 30], ["polyphyletic", "OBSERVATION", 18, 30]]], ["All major viral lineages have their own distinct origins.", [["viral lineages", "OBSERVATION", 10, 24], ["distinct", "OBSERVATION_MODIFIER", 40, 48], ["origins", "OBSERVATION_MODIFIER", 49, 56]]], ["Even \" dead \" and defective viruses can participate in such exchanges, which confuses the defi nitions of fi tness.", [["defective viruses", "PROBLEM", 18, 35], ["defective", "OBSERVATION_MODIFIER", 18, 27], ["viruses", "OBSERVATION", 28, 35]]], ["We now know that viruses can evolve by a consortia process and also exchange information by recombination across vast genetic pools to assemble new mosaic combinations of genes.", [["viruses", "PROBLEM", 17, 24], ["a consortia process", "PROBLEM", 39, 58], ["viruses", "OBSERVATION", 17, 24], ["new", "OBSERVATION_MODIFIER", 144, 147], ["mosaic combinations", "OBSERVATION", 148, 167]]], ["We thus no longer think of a specifi c genetic lineage in understanding virus evolution, but instead think of a cloud, matrix, or a population as the basis of virus evolution.", [["matrix", "ANATOMY", 119, 125], ["matrix", "CELLULAR_COMPONENT", 119, 125], ["specifi c genetic lineage", "CELL_LINE", 29, 54], ["a specifi c genetic lineage", "PROBLEM", 27, 54], ["a cloud, matrix", "PROBLEM", 110, 125], ["virus evolution", "PROBLEM", 159, 174], ["no longer", "UNCERTAINTY", 8, 17], ["virus", "OBSERVATION", 159, 164]]], ["Viruses are inherently fuzzy entities that can differ from their relatives in any specifi c feature.", [["Viruses", "PROBLEM", 0, 7], ["inherently fuzzy entities", "PROBLEM", 12, 37]]], ["Yet even with such fuzziness, it is clear that common themes also link them.", [["such fuzziness", "PROBLEM", 14, 28]]], ["Patterns of evolution have become clear.", [["clear", "OBSERVATION", 34, 39]]], ["Diversity and variation are often (but not always) observed.", [["variation", "OBSERVATION_MODIFIER", 14, 23]]], ["Stability and host congruence can also be observed.", [["host congruence", "OBSERVATION", 14, 29], ["can also be observed", "UNCERTAINTY", 30, 50]]], ["Nevertheless, the evolutionary power of viruses has been learned at a human cost.INTRODUCTIONThe application of numerous analytical and phylogenetic tools have provided crucial insights into virus origin and evolution.", [["human", "ORGANISM", 70, 75], ["human", "SPECIES", 70, 75], ["human", "SPECIES", 70, 75], ["viruses", "PROBLEM", 40, 47], ["phylogenetic tools", "TEST", 136, 154], ["power", "OBSERVATION_MODIFIER", 31, 36], ["viruses", "OBSERVATION", 40, 47]]], ["Yet these methods struggle to incorporate the fuzzy nature of viruses and have clear limits, especially regarding quasispecies and high recombination rates.", [["viruses", "PROBLEM", 62, 69], ["quasispecies", "PROBLEM", 114, 126]]], ["Structural biology now also adds tools that extend our vision of virus evolution beyond what can be seen in the genetic sequence.", [["virus evolution", "PROBLEM", 65, 80], ["virus", "OBSERVATION", 65, 70]]], ["For example, common structural motifs from phage to eukaryotic DNA viruses (T4 and herpesvirus) suggest very ancient links in virus evolution that span all domains of life (see below).", [["DNA", "CELLULAR_COMPONENT", 63, 66], ["herpesvirus", "ORGANISM", 83, 94], ["common structural motifs", "PROBLEM", 13, 37], ["eukaryotic DNA viruses (T4 and herpesvirus", "PROBLEM", 52, 94], ["virus", "OBSERVATION", 126, 131]]], ["Nevertheless, our analytical methods are currently lacking as we struggle to understand complex genetic mixtures that provide fi tness, reticulated relationships, polyphyletic origins, and virus-host congruence.", [["polyphyletic origins", "OBSERVATION", 163, 183], ["host congruence", "OBSERVATION", 195, 210]]], ["Virus evolution has, for the most part, been considered to be a specifi c, esoteric part of broader evolutionary biology and has been given limited attention in reference works on evolutionary biology (see Pagel, 2002 ) .", [["Virus", "ORGANISM", 0, 5], ["Virus evolution", "PROBLEM", 0, 15]]], ["Historically, the focus has been on various RNA viruses and some DNA viruses that cause disease in humans and domesticated animals and plants .", [["DNA", "CELLULAR_COMPONENT", 65, 68], ["humans", "ORGANISM", 99, 105], ["humans", "SPECIES", 99, 105], ["humans", "SPECIES", 99, 105], ["various RNA viruses", "PROBLEM", 36, 55], ["some DNA viruses", "PROBLEM", 60, 76], ["disease in humans", "PROBLEM", 88, 105]]], ["How viruses evolve in a more general sense informs us of evolutionary paradigms that have not been previously well understood (especially the evolution of consortia or the dynamics of vast reticulated gene pools).", [["How viruses", "PROBLEM", 0, 11]]], ["This volume now extends these traditional topics of virus evolution to include the vast virology of the prokaryotic world.", [["This volume", "PROBLEM", 0, 11], ["virus evolution", "TREATMENT", 52, 67]]], ["In so doing, it illuminates the global consequences viruses have had on all life forms.INTRODUCTIONPrior to the 1970s we saw some stunning successes in vaccine control for major viral human diseases, such as polio, measles, mumps, infl uenza, and especially smallpox virus.", [["viral human diseases", "DISEASE", 178, 198], ["polio", "DISEASE", 208, 213], ["measles", "DISEASE", 215, 222], ["mumps, infl uenza", "DISEASE", 224, 241], ["human", "ORGANISM", 184, 189], ["infl uenza", "ORGANISM", 231, 241], ["smallpox virus", "ORGANISM", 258, 272], ["human", "SPECIES", 184, 189], ["human", "SPECIES", 184, 189], ["smallpox virus", "SPECIES", 258, 272], ["some stunning successes", "TREATMENT", 125, 148], ["vaccine control", "TREATMENT", 152, 167], ["major viral human diseases", "PROBLEM", 172, 198], ["polio", "PROBLEM", 208, 213], ["measles", "PROBLEM", 215, 222], ["mumps", "PROBLEM", 224, 229], ["infl uenza", "PROBLEM", 231, 241], ["smallpox virus", "PROBLEM", 258, 272], ["viral human diseases", "OBSERVATION", 178, 198]]], ["Due to this historic success, American health agencies and educators considered virus disease as a thing of the past, no longer a serious threat.", [["virus disease", "PROBLEM", 80, 93], ["virus disease", "OBSERVATION", 80, 93]]], ["The era of infectious disease that they represented was now one for the historical record, an unfortunate part of human history, or so we thought.", [["infectious disease", "DISEASE", 11, 29], ["human", "ORGANISM", 114, 119], ["human", "SPECIES", 114, 119], ["human", "SPECIES", 114, 119], ["infectious disease", "PROBLEM", 11, 29], ["infectious", "OBSERVATION", 11, 21]]], ["In what now seems to have been a clear case of hubris and naivety, we have been humbled by the evolutionary power of viruses, which was woefully underappreciated, even by most virologists.", [["viruses", "PROBLEM", 117, 124], ["viruses", "OBSERVATION", 117, 124]]], ["By the end of that decade, the evolution and emergence of HIV-1 permanently changed our views (see Chapters 13 and 14) .", [["HIV-1", "ORGANISM", 58, 63], ["HIV-1", "SPECIES", 58, 63], ["HIV-1", "SPECIES", 58, 63], ["our views", "TEST", 84, 93]]], ["This has also been followed by a seemingly never-ending series of viral threats as newly emerging viral diseases have come to our attention.", [["viral diseases", "DISEASE", 98, 112], ["viral threats", "PROBLEM", 66, 79], ["newly emerging viral diseases", "PROBLEM", 83, 112]]], ["HIV-1 provides the only example of a public health situation that has reversed centuries of progress for extending human health and lifespan.", [["HIV-1", "ORGANISM", 0, 5], ["human", "ORGANISM", 115, 120], ["HIV-1", "SPECIES", 0, 5], ["human", "SPECIES", 115, 120], ["HIV-1", "SPECIES", 0, 5], ["human", "SPECIES", 115, 120]]], ["It now limits human life expectancy in many parts of the world, especially sub-Saharian Africa.", [["human", "ORGANISM", 14, 19], ["human", "SPECIES", 14, 19], ["human", "SPECIES", 14, 19]]], ["We are much less confi dent now about predicting the future of virus evolution and its potential impact on human health.INTRODUCTIONDiseases of domesticated microbiological, plant, and animal species have also experienced the trauma of the consequences of emerging viral diseases along with huge losses.", [["trauma", "DISEASE", 226, 232], ["viral diseases", "DISEASE", 265, 279], ["human", "ORGANISM", 107, 112], ["human", "SPECIES", 107, 112], ["human", "SPECIES", 107, 112], ["virus evolution", "PROBLEM", 63, 78], ["emerging viral diseases", "PROBLEM", 256, 279], ["huge losses", "PROBLEM", 291, 302], ["virus", "OBSERVATION", 63, 68], ["domesticated", "OBSERVATION_MODIFIER", 144, 156], ["microbiological", "OBSERVATION", 157, 172], ["viral diseases", "OBSERVATION", 265, 279], ["huge", "OBSERVATION_MODIFIER", 291, 295], ["losses", "OBSERVATION", 296, 302]]], ["However, the human HIV-1 story may not be a fl uke of virology but may be telling us something basic about human and primate evolution.", [["human", "ORGANISM", 13, 18], ["HIV-1", "ORGANISM", 19, 24], ["human", "ORGANISM", 107, 112], ["primate", "ORGANISM", 117, 124], ["human", "SPECIES", 13, 18], ["HIV-1", "SPECIES", 19, 24], ["human", "SPECIES", 107, 112], ["human HIV-1", "SPECIES", 13, 24], ["human", "SPECIES", 107, 112]]], ["As we sought to understand the origin of this new virus, we have come to appreciate a much broader virus-host story which involves simian immunodefi ciency virus (SIV), foamy viruses, and the speciation of Old World primates.", [["simian immunodefi ciency", "DISEASE", 131, 155], ["foamy viruses", "DISEASE", 169, 182], ["simian immunodefi ciency virus", "ORGANISM", 131, 161], ["SIV", "ORGANISM", 163, 166], ["foamy viruses", "ORGANISM", 169, 182], ["Old World primates", "ORGANISM", 206, 224], ["simian", "SPECIES", 131, 137], ["immunodefi ciency virus", "SPECIES", 138, 161], ["simian immunodefi ciency virus", "SPECIES", 131, 161], ["SIV", "SPECIES", 163, 166], ["Old World primates", "SPECIES", 206, 224], ["this new virus", "PROBLEM", 41, 55], ["simian immunodefi ciency virus", "PROBLEM", 131, 161], ["foamy viruses", "PROBLEM", 169, 182], ["foamy viruses", "OBSERVATION", 169, 182]]], ["We have also come to learn that the genomes of these primates show much evidence of past viral interaction and ongoing endogenous retrovirus colonization.", [["primates", "ORGANISM", 53, 61], ["retrovirus", "ORGANISM", 130, 140], ["past viral interaction", "PROBLEM", 84, 106], ["ongoing endogenous retrovirus colonization", "PROBLEM", 111, 153], ["endogenous retrovirus colonization", "OBSERVATION", 119, 153]]], ["The evolution of retroviral endogenization has taken on a much greater signifi cance in basic evolutionary biology.", [["retroviral", "ORGANISM", 17, 27], ["retroviral endogenization", "PROBLEM", 17, 42], ["retroviral endogenization", "OBSERVATION", 17, 42]]], ["Thus it is with great interest that we now study the ongoing endogenization of retroviruses in the koala bear genome (see below).INTRODUCTIONHistorically, we are compelled to study viruses because they can cause serious disease.", [["retroviruses", "ORGANISM", 79, 91], ["koala", "ORGANISM", 99, 104], ["koala bear genome", "DNA", 99, 116], ["retroviruses", "PROBLEM", 79, 91], ["serious disease", "PROBLEM", 212, 227], ["retroviruses", "OBSERVATION", 79, 91]]], ["New viruses come to our attention also mainly because of disease.", [["New viruses", "PROBLEM", 0, 11], ["disease", "PROBLEM", 57, 64], ["viruses", "OBSERVATION", 4, 11], ["disease", "OBSERVATION", 57, 64]]], ["It is therefore understandable that most evolutionary biologists mainly think of viruses strictly as agents of disease.", [["viruses", "PROBLEM", 81, 88], ["disease", "PROBLEM", 111, 118]]], ["These are the products of run away replicons that provide negative selection to host survival.", [["run away replicons", "TREATMENT", 26, 44]]], ["In this light, the application of predator-prey based mathematical models has seemed most appropriate.", [["the application of predator", "TREATMENT", 15, 42]]], ["With such viral disease, variation has long been observed and was initially used for the generation of most vaccines.", [["viral disease", "DISEASE", 10, 23], ["such viral disease", "PROBLEM", 5, 23], ["most vaccines", "TREATMENT", 103, 116], ["viral disease", "OBSERVATION", 10, 23]]], ["However, this disease-centric view has also occluded another more prevalent virus-host relationship.", [["this disease-centric view", "PROBLEM", 9, 34], ["more prevalent", "OBSERVATION_MODIFIER", 61, 75], ["virus", "OBSERVATION", 76, 81]]], ["For example the emergence of HIV-1 has led us conclude that it likely evolved from various versions of SIV.", [["HIV-1", "ORGANISM", 29, 34], ["SIV", "ORGANISM", 103, 106], ["HIV-1", "SPECIES", 29, 34], ["HIV-1", "SPECIES", 29, 34], ["SIV", "SPECIES", 103, 106]]], ["But SIV is not pathogenic in its native African primate host.", [["SIV", "ORGANISM", 4, 7], ["primate", "ORGANISM", 48, 55], ["SIV", "SPECIES", 4, 7], ["SIV", "PROBLEM", 4, 7], ["SIV", "OBSERVATION", 4, 7], ["not", "UNCERTAINTY", 11, 14], ["pathogenic", "OBSERVATION_MODIFIER", 15, 25]]], ["Nor does it show the genetic diversifi cation of HIV-1 in these native primate hosts.", [["HIV-1", "ORGANISM", 49, 54], ["primate", "ORGANISM", 71, 78], ["HIV-1", "SPECIES", 49, 54], ["HIV-1", "SPECIES", 49, 54], ["HIV", "PROBLEM", 49, 52]]], ["It is a silent, asymptomatic infection.", [["infection", "DISEASE", 29, 38], ["a silent, asymptomatic infection", "PROBLEM", 6, 38], ["silent", "OBSERVATION_MODIFIER", 8, 14], ["asymptomatic", "OBSERVATION_MODIFIER", 16, 28], ["infection", "OBSERVATION", 29, 38]]], ["Genomic and metagenomic analysis now allows us to identify many more silent, asymptomatic viruses that would not have previously been observed.", [["metagenomic analysis", "TEST", 12, 32], ["asymptomatic viruses", "PROBLEM", 77, 97], ["viruses", "OBSERVATION", 90, 97]]], ["We now know of many such viruses that are prevalent in a specifi c host.", [["specifi c host", "ORGANISM", 57, 71], ["many such viruses", "PROBLEM", 15, 32], ["viruses", "OBSERVATION", 25, 32]]], ["Evolutionary biology must escape the confi nes of disease-centric thinking and seek to understand these relationships as well.A Role for Persistence in Viral EvolutionIn the last ten years I have attempted to provide another view concerning virus-host evolution.", [["disease", "PROBLEM", 50, 57], ["virus", "PROBLEM", 241, 246], ["host evolution", "OBSERVATION", 247, 261]]], ["I have argued that viruses often attain evolutionary stability by species-specifi c persistence and that such states apply to all domains of life, including prokaryotes.", [["specifi c", "GENE_OR_GENE_PRODUCT", 74, 83], ["viruses", "PROBLEM", 19, 26]]], ["On an evolutionary time-scale, the majority of viral lineages tend to exist as species-specifi c persistent (aka temperate, latent, and chronic) infections in which individual hosts will be colonized by mostly silent (asymptomatic) viruses for the duration of their life .", [["infections", "DISEASE", 145, 155], ["specifi c", "ORGANISM", 87, 96], ["viral lineages", "PROBLEM", 47, 61], ["persistent (aka temperate", "PROBLEM", 97, 122], ["chronic) infections", "PROBLEM", 136, 155], ["silent (asymptomatic) viruses", "PROBLEM", 210, 239], ["viral lineages", "OBSERVATION", 47, 61], ["persistent", "OBSERVATION_MODIFIER", 97, 107], ["aka temperate", "OBSERVATION_MODIFIER", 109, 122], ["chronic", "OBSERVATION_MODIFIER", 136, 143], ["infections", "OBSERVATION", 145, 155]]], ["Such persistence can have major consequences to the evolution of both virus and host, which also leads us to more directly link virus evolution to broader issues of host evolution.", [["both virus", "PROBLEM", 65, 75], ["virus", "OBSERVATION", 70, 75], ["host evolution", "OBSERVATION", 165, 179]]], ["It is from this perspective that we start to clearly see that viruses indeed belong on the tree of life as major participants ( Villarreal, 2005 ( Villarreal, , 2006 .", [["participants", "SPECIES", 113, 125], ["viruses", "PROBLEM", 62, 69], ["viruses", "OBSERVATION", 62, 69]]], ["Persisting viruses are not simply agents responsible for destruction of life, but are also agents that create genetic novelty on a vast scale that infl uences all life and promotes symbiosis ( Marquez et al. , 2007 ; Ryan, 2007 ; Villarreal, 2007 ) .", [["Persisting viruses", "PROBLEM", 0, 18], ["destruction of life", "PROBLEM", 57, 76], ["viruses", "OBSERVATION", 11, 18], ["symbiosis", "OBSERVATION_MODIFIER", 181, 190]]], ["The persistent lifestyle of such symbiotic virus-host relationships is not simply a less effi cient, acute infection; nor is it simply a \" reservoir \" for acute virus (as epidemiologists are prone to assert).", [["infection", "DISEASE", 107, 116], ["such symbiotic virus", "PROBLEM", 28, 48], ["acute infection", "PROBLEM", 101, 116], ["acute virus", "PROBLEM", 155, 166], ["persistent", "OBSERVATION_MODIFIER", 4, 14], ["lifestyle", "OBSERVATION_MODIFIER", 15, 24], ["symbiotic virus", "OBSERVATION", 33, 48], ["less effi", "OBSERVATION_MODIFIER", 84, 93], ["acute", "OBSERVATION_MODIFIER", 101, 106], ["infection", "OBSERVATION", 107, 116]]], ["Neither can it be attributable to concepts of selfi sh DNA.", [["DNA", "CELLULAR_COMPONENT", 55, 58], ["selfi sh DNA", "DNA", 46, 58], ["selfi sh DNA", "PROBLEM", 46, 58]]], ["Persistence represents a major virus life strategy that is both fundamental and highly adapted.", [["a major virus life strategy", "PROBLEM", 23, 50], ["major", "OBSERVATION_MODIFIER", 25, 30], ["virus", "OBSERVATION", 31, 36]]], ["It has distinct genetic, fi tness, and evolutionary characteristics that require intimate, host (tissue)-specifi c viral strategies and precise gene functions to attain stable maintenance in the presence of immunity and to allow biologically controlled reactivation.", [["tissue", "ANATOMY", 97, 103], ["tissue", "TISSUE", 97, 103], ["viral strategies", "TREATMENT", 115, 131], ["biologically controlled reactivation", "PROBLEM", 229, 265], ["distinct", "OBSERVATION_MODIFIER", 7, 15], ["genetic", "OBSERVATION_MODIFIER", 16, 23], ["fi tness", "OBSERVATION_MODIFIER", 25, 33]]], ["Persistence also must resist displacement by similar viruses and competitors.", [["resist", "OBSERVATION_MODIFIER", 22, 28], ["displacement", "OBSERVATION_MODIFIER", 29, 41], ["viruses", "OBSERVATION", 53, 60]]], ["It is virus-host persistence that provides the thread that allows us to link these polyphyletic viral lineages (and their clouds) with the entire tree of life.", [["these polyphyletic viral lineages", "PROBLEM", 77, 110], ["virus", "OBSERVATION", 6, 11], ["host persistence", "OBSERVATION_MODIFIER", 12, 28], ["viral lineages", "OBSERVATION", 96, 110]]], ["In turn, this link identifi es a much more fundamental role for viruses in the evolution of host, visible from the very earliest to the most recent events in host evolution.", [["viruses", "PROBLEM", 64, 71], ["host evolution", "OBSERVATION", 158, 172]]], ["It is from such species-specifi c persistent states that the large majority of acute diseases evolve and emerge by various mechanisms.A Role for Persistence in Viral EvolutionWe know much about virus replication and disease.", [["such species", "PROBLEM", 11, 23], ["acute diseases", "PROBLEM", 79, 93], ["virus replication", "TREATMENT", 194, 211], ["disease", "PROBLEM", 216, 223], ["persistent", "OBSERVATION_MODIFIER", 34, 44], ["large", "OBSERVATION_MODIFIER", 61, 66], ["majority", "OBSERVATION_MODIFIER", 67, 75], ["acute", "OBSERVATION_MODIFIER", 79, 84], ["diseases", "OBSERVATION", 85, 93]]], ["However, our understanding of the specifi c mechanisms of persistence is generally poor.", [["specifi c", "GENE_OR_GENE_PRODUCT", 34, 43]]], ["Persistence is a generally silent and inscrutable state, it does not lend itself to in vitro or cell culture experimental models.", [["cell", "ANATOMY", 96, 100], ["cell", "CELL", 96, 100], ["a generally silent and inscrutable state", "PROBLEM", 15, 55], ["generally", "OBSERVATION_MODIFIER", 17, 26], ["silent", "OBSERVATION", 27, 33]]], ["We are left with but a few examples from which to attempt to extrapolate the possible existence of general relationships.", [["left", "ANATOMY_MODIFIER", 7, 11]]], ["The study of virus evolution thus struggles to incorporate concepts of persistence.Viruses Mediating InnovationAnother recent and major development in virus evolution is the arrival of various proposals suggesting that viruses have been involved in some major innovation and transition in the evolution of life.", [["The study", "TEST", 0, 9], ["virus evolution", "PROBLEM", 13, 28], ["viruses", "PROBLEM", 219, 226], ["persistence", "OBSERVATION_MODIFIER", 71, 82], ["virus", "OBSERVATION", 151, 156], ["viruses", "OBSERVATION", 219, 226], ["major", "OBSERVATION_MODIFIER", 254, 259], ["innovation", "OBSERVATION", 260, 270]]], ["In all these proposals, however, it is necessary that the virus in question has attained a stable genomic persistence with its host.", [["the virus", "PROBLEM", 54, 63], ["virus", "OBSERVATION", 58, 63], ["stable", "OBSERVATION_MODIFIER", 91, 97], ["genomic", "OBSERVATION_MODIFIER", 98, 105], ["persistence", "OBSERVATION_MODIFIER", 106, 117]]], ["These evolutionary events thus seem to be the products of viral-mediated symbiogenesis of host ( Ryan, 2007 ; Villarreal, 2007 ) .", [["These evolutionary events", "PROBLEM", 0, 25]]], ["Proposals include the possibility that viruses may have originated the DNA replication system of all three cellular domains (archaea, bacteria, eukarya) of life ( Forterre, 1999 ( Forterre, , 2005 ( Forterre, , 2006a ( Forterre, , 2006b Filee et al. , 2003 ; Forterre et al. , 2007 ) .", [["cellular", "ANATOMY", 107, 115], ["DNA", "CELLULAR_COMPONENT", 71, 74], ["cellular", "CELL", 107, 115], ["viruses", "PROBLEM", 39, 46], ["viruses", "OBSERVATION", 39, 46]]], ["The discovery and analysis of the largest DNA virus (1200 ORF mimivirus), a lytic cytoplasmic virus of amebae (a distant relative of phycodnavirus and poxviruses), has also led to proposals that this virus lineage may represent an ancient fourth domain of life ( Raoult et al. , 2004 ; Desjardins et al. , 2005 ; Claverie et al. , 2006 ) .", [["cytoplasmic", "ANATOMY", 82, 93], ["DNA", "CELLULAR_COMPONENT", 42, 45], ["cytoplasmic", "ORGANISM_SUBSTANCE", 82, 93], ["phycodnavirus", "CANCER", 133, 146], ["the largest DNA virus", "PROBLEM", 30, 51], ["a lytic cytoplasmic virus of amebae", "PROBLEM", 74, 109], ["phycodnavirus", "TREATMENT", 133, 146], ["poxviruses", "PROBLEM", 151, 161], ["this virus lineage", "PROBLEM", 195, 213], ["lytic", "OBSERVATION_MODIFIER", 76, 81], ["cytoplasmic virus", "OBSERVATION", 82, 99]]], ["It is interesting that in an initial structural analysis, the large complex replication centers for mimivirus were confused with the host nucleus ( Suzan-Monti et al. , 2007 ) .", [["nucleus", "ANATOMY", 138, 145], ["mimivirus", "GENE_OR_GENE_PRODUCT", 100, 109], ["nucleus", "CELLULAR_COMPONENT", 138, 145], ["an initial structural analysis", "TEST", 26, 56], ["mimivirus", "PROBLEM", 100, 109], ["large", "OBSERVATION_MODIFIER", 62, 67], ["complex", "OBSERVATION_MODIFIER", 68, 75], ["replication", "OBSERVATION", 76, 87]]], ["Thus, it seems relevant that others have proposed that a distant relative of phycodnaviruses and poxviruses may have originated the eukaryotic nucleus ( Villarreal, 1999 ; Villarreal and DeFilippis, 2000 ; Bell, 2001 Bell, , 2006 Takemura, 2001 ) .Viruses Mediating InnovationSuch proposals, although consistent with various observations, however, remain outside of the consensus of most evolutionary biologists.", [["nucleus", "ANATOMY", 143, 150], ["phycodnaviruses", "GENE_OR_GENE_PRODUCT", 77, 92], ["poxviruses", "ORGANISM", 97, 107], ["nucleus", "CELLULAR_COMPONENT", 143, 150], ["a distant relative of phycodnaviruses", "PROBLEM", 55, 92], ["poxviruses", "PROBLEM", 97, 107], ["eukaryotic nucleus", "ANATOMY", 132, 150], ["consistent with", "UNCERTAINTY", 301, 316]]], ["Nevertheless, numerous other observations continue to suggest viral involvement in other major host innovations, such as a viral origin of RAG1/2 of the adaptive immune system ( Dreyfus et al. , 1999 Kapitonov and Jurka, 2005 ; Fugmann et al. , 2006 ) or the role of endogenous retroviruses (ERVs) in the evolution of the placenta ( Villarreal and Villareal, 1997 ; Harris, 1998 ; Blond et al. , 2000 ; Mi et al. , 2000 ; Dupressoir et al. , 2005 ; Caceres and Thomas, 2006 ) .", [["placenta", "ANATOMY", 322, 330], ["RAG1/2", "GENE_OR_GENE_PRODUCT", 139, 145], ["retroviruses", "ORGANISM", 278, 290], ["placenta", "ORGAN", 322, 330], ["RAG1", "PROTEIN", 139, 143], ["viral involvement", "PROBLEM", 62, 79], ["the adaptive immune system", "TREATMENT", 149, 175], ["endogenous retroviruses", "PROBLEM", 267, 290], ["viral", "OBSERVATION", 62, 67], ["endogenous retroviruses", "OBSERVATION", 267, 290], ["placenta", "ANATOMY", 322, 330]]], ["Such possible roles for viruses in host evolution are at odds with accepted views of virus-host relationships, but might be the products of viral symbiogenesis.The Virosphere: a New Evolutionary RealityThe metagenomic viral measurements mentioned above for prokaryotic DNA viruses, along with the increasing realization that viruses and host can co-evolve, has led to various calls that a viral tree of life needs to be considered and developed ( Forterre, 2003 ; Villarreal, 2006 ; Filee et al. , 2006b ) .", [["DNA", "CELLULAR_COMPONENT", 269, 272], ["viruses", "PROBLEM", 24, 31], ["viral symbiogenesis", "PROBLEM", 140, 159], ["The metagenomic viral measurements", "TEST", 202, 236], ["prokaryotic DNA viruses", "PROBLEM", 257, 280], ["viruses", "PROBLEM", 325, 332], ["viral symbiogenesis", "OBSERVATION", 140, 159], ["DNA viruses", "OBSERVATION", 269, 280], ["viruses", "OBSERVATION", 325, 332]]], ["A virosphere clearly exists but its nature and boundaries are not so clear.", [["A virosphere", "TREATMENT", 0, 12], ["clear", "OBSERVATION", 69, 74]]], ["Multiple viral origins, their diversity and numerical dominance in distinct and sometimes harsh environments as well as their presence in host genomes suggest that any viral tree of life will be huge, multidimensional, and connected to the host tree of life.", [["Multiple viral origins", "PROBLEM", 0, 22], ["viral origins", "OBSERVATION", 9, 22], ["diversity", "OBSERVATION_MODIFIER", 30, 39], ["numerical dominance", "OBSERVATION", 44, 63]]], ["As discussed below regarding double-stranded (ds)DNA viruses of prokaryotes, they have all the above characteristics.", [["DNA", "CELLULAR_COMPONENT", 49, 52], ["double-stranded (ds)", "TREATMENT", 29, 49]]], ["Such viruses may represent the big bang of biological novelty.", [["Such viruses", "PROBLEM", 0, 12], ["viruses", "OBSERVATION", 5, 12], ["may represent", "UNCERTAINTY", 13, 26]]], ["With their unmatched capacity to generate diversity they can function as the mass creators of biological novelty as well as destroyers of most species.", [["most species", "PROBLEM", 138, 150]]], ["Surely, such capacity must have had big infl uences on the evolution of life.", [["big infl uences", "PROBLEM", 36, 51]]], ["Symbiosis, simply defi ned, is the stable coexistence of two previously separate lineages of organisms.", [["Symbiosis", "DISEASE", 0, 9], ["stable", "OBSERVATION_MODIFIER", 35, 41], ["organisms", "OBSERVATION", 93, 102]]], ["There can be little doubt that many temperate phage can stably colonize a bacterial cell resulting in a stable descendent from two lineages.", [["cell", "ANATOMY", 84, 88], ["bacterial cell", "CELL", 74, 88], ["many temperate phage", "PROBLEM", 31, 51], ["a bacterial cell", "PROBLEM", 72, 88], ["bacterial cell", "OBSERVATION", 74, 88], ["stable", "OBSERVATION_MODIFIER", 104, 110]]], ["This is clearly symbiotic.", [["symbiotic", "OBSERVATION_MODIFIER", 16, 25]]], ["Endogenous retroviruses can similarly be found to persist in vertebrate genomes and also appear symbiotic.", [["retroviruses", "ORGANISM", 11, 23], ["Endogenous retroviruses", "PROBLEM", 0, 23], ["retroviruses", "OBSERVATION", 11, 23], ["vertebrate genomes", "OBSERVATION", 61, 79], ["symbiotic", "OBSERVATION_MODIFIER", 96, 105]]], ["Yet studies of symbiosis seldom consider a role for virus ( Villarreal, 2007 ) .The Virosphere: a New Evolutionary RealityHow important are viruses in general to evolutionary biology?", [["symbiosis seldom", "PROBLEM", 15, 31], ["virus", "PROBLEM", 52, 57], ["viruses", "OBSERVATION", 140, 147]]], ["That cryptic and defective phage are ubiquitous in the genomes of all prokaryotes is generally considered uninteresting by many in the fi eld of evolutionary biology.", [["cryptic and defective phage", "PROBLEM", 5, 32], ["defective phage", "OBSERVATION", 17, 32]]], ["I suggest that the seemingly applicable concepts of selfi sh DNA effectively derailed any thinking that persisting genetic parasites might have a more germinal role in the evolution of life ( Doolittle and Sapienza, 1980 ; Orgel and Crick, 1980 ).", [["DNA", "CELLULAR_COMPONENT", 61, 64], ["selfi sh DNA", "DNA", 52, 64], ["persisting genetic parasites", "PROBLEM", 104, 132]]], ["Yet as outlined above, virus footprints in major evolutionary transitions are clear and a direct role in such events now seems much more plausible.", [["virus footprints", "PROBLEM", 23, 39], ["virus footprints", "OBSERVATION", 23, 39], ["clear", "OBSERVATION", 78, 83]]], ["We therefore must seek to defi ning the nature of the virosphere and how its evolution relates to the tree of life.EXEMPLARS OF VIRUS EVOLUTIONThis book represents the fi rst integration of the entire fi eld of virus evolution, including both prokaryotic and eukaryotic life forms.", [["virosphere", "CANCER", 54, 64], ["virus evolution", "PROBLEM", 211, 226], ["VIRUS", "OBSERVATION", 128, 133], ["virus", "OBSERVATION", 211, 216], ["eukaryotic life", "OBSERVATION", 259, 274]]], ["These exemplars also tend to refl ect a historic disease focus (i.e., E. coli , fl owering plants, mouse, humans).", [["E. coli", "ORGANISM", 70, 77], ["fl owering plants", "ORGANISM", 80, 97], ["mouse", "ORGANISM", 99, 104], ["humans", "ORGANISM", 106, 112], ["E. coli", "SPECIES", 70, 77], ["mouse", "SPECIES", 99, 104], ["humans", "SPECIES", 106, 112], ["E. coli", "SPECIES", 70, 77], ["mouse", "SPECIES", 99, 104], ["humans", "SPECIES", 106, 112], ["a historic disease focus", "PROBLEM", 38, 62], ["E. coli", "PROBLEM", 70, 77]]], ["It is unfortunate that the silent species-specifi c viruses that tend to exist in stable states with long evolutionary histories seldom provide our examplars.", [["species-specifi c viruses", "ORGANISM", 34, 59], ["the silent species", "PROBLEM", 23, 41], ["specifi c viruses", "PROBLEM", 42, 59], ["stable", "OBSERVATION_MODIFIER", 82, 88]]], ["We understand these infections poorly and lack basic defi nitions concerning fi tness or selective advantages.", [["infections", "DISEASE", 20, 30], ["these infections", "PROBLEM", 14, 30], ["infections", "OBSERVATION", 20, 30]]], ["Only metagenomics tools now seem able to inform us of their presence, but not their biology.Errors at the Start of Life: QuasispeciesSelf-organization and the evolution of RNA molecules as an origin of biological information are discussed in Chapter 1.", [["RNA molecules", "PROTEIN", 172, 185], ["Quasispecies", "PROBLEM", 121, 133], ["RNA molecules", "PROBLEM", 172, 185]]], ["Autocatalytic chemical reactions, such as replication of RNA, presents issues such as how to optimize a rugged fi tness landscape yet allow the study of evolution in vitro with RNA.", [["Autocatalytic chemical reactions", "PROBLEM", 0, 32], ["the study", "TEST", 140, 149], ["chemical reactions", "OBSERVATION", 14, 32]]], ["RNA in vitro reduces genotype-phenotype issues to RNA secondary structure and minimal free energy states.", [["RNA", "RNA", 0, 3], ["phenotype issues", "PROBLEM", 30, 46], ["minimal free energy states", "PROBLEM", 78, 104], ["minimal", "OBSERVATION_MODIFIER", 78, 85], ["free energy states", "OBSERVATION", 86, 104]]], ["These same issues are crucial for the study of RNA viruses, whose sites of secondary structure often defi ne replicator identity.", [["the study", "TEST", 34, 43], ["RNA viruses", "PROBLEM", 47, 58], ["secondary structure", "OBSERVATION", 75, 94], ["replicator identity", "OBSERVATION", 109, 128]]], ["Viruses and viroids with their RNA genomes may be the only extant survivors of this pre-DNA world.", [["viroids", "CANCER", 12, 19], ["Viruses", "PROBLEM", 0, 7], ["viroids", "TREATMENT", 12, 19], ["viroids", "OBSERVATION", 12, 19]]], ["Since it was the consideration of error-prone replication that led to the development of the concept of quasispecies (see Chapter 2), such models have provided a conceptual foundation which led to several basic concepts.", [["error-prone replication", "TREATMENT", 34, 57], ["quasispecies", "PROBLEM", 104, 116], ["quasispecies", "OBSERVATION", 104, 116]]], ["Viruses appear to operate close to the error threshold, thus allowing maximum evolutionary exploration ( Biebricher and Eigen, 2006 ) .", [["Viruses", "PROBLEM", 0, 7], ["maximum evolutionary exploration", "TEST", 70, 102]]], ["Although virologists were initially attracted to quasispecies models, many evolutionary biologists were initially hostile to the application of the quasispecies concept to evolution.", [["virologists", "CANCER", 9, 20], ["quasispecies", "OBSERVATION", 148, 160]]], ["It was thought that the classical mathematical models of population biology, as originally developed by Wright and Fisher, and later applied by Kimura and Maruyama to asexual haploid populations at the mutationselection balance, had already fully developed the needed models and precluded additional need for the quasispecies concept.", [["haploid populations", "CELL", 175, 194], ["asexual haploid populations", "PROBLEM", 167, 194], ["the quasispecies concept", "TREATMENT", 309, 333]]], ["The classical models were thus argued to provide adequate mathematical coverage for viruses, including quasispecies and error threshold ( Wilke, 2005 ) .", [["adequate mathematical coverage", "TREATMENT", 49, 79], ["viruses", "PROBLEM", 84, 91], ["quasispecies", "PROBLEM", 103, 115]]], ["However, these two approaches differ fundamentally with regard to the signifi cance of error-prone replication and it was the quasispecies approach that led to the clear experimental establishment that quasispecies selection, per se , is important for viral pathology and fi tness (see below).Errors at the Start of Life: QuasispeciesThe development of quasispecies theory to virology does indeed demonstrate distinct differences with population genetics.", [["error-prone replication", "TREATMENT", 87, 110], ["viral pathology", "PROBLEM", 252, 267], ["Quasispecies", "PROBLEM", 322, 334], ["error-prone replication", "OBSERVATION", 87, 110], ["quasispecies", "OBSERVATION", 202, 214], ["distinct", "OBSERVATION_MODIFIER", 409, 417]]], ["Various phenomena, such as complementation, cooperation, competition, and even defective mediated extinction ( Domingo et al. , 2001 , Domingo 2006 Grande-Perez et al. , 2005 ) have been observed, all of which fall outside of the parameters of classical population genetics.", [["Various phenomena", "PROBLEM", 0, 17], ["even defective mediated extinction", "PROBLEM", 74, 108], ["phenomena", "OBSERVATION", 8, 17]]], ["Viral fi tness has indeed been shown to be due to interaction within a diverse population, and not to the fi ttest or master type.", [["Viral fi tness", "PROBLEM", 0, 14], ["fi tness", "OBSERVATION", 6, 14]]], ["And with RNA viruses, error threshold has become a central issue ( Biebricher and Eigen, 2005 ) .Errors at the Start of Life: QuasispeciesThe collective experience has thus made clear the value of theory to biology.", [["RNA viruses", "PROBLEM", 9, 20], ["error threshold", "PROBLEM", 22, 37], ["RNA viruses", "OBSERVATION", 9, 20], ["central", "OBSERVATION_MODIFIER", 51, 58]]], ["Although in reality, biology may indeed often be too complex for accurate theoretical predictions, these theories have nevertheless clearly stimulated crucial concepts and experimental evaluation, and biologists should be encouraged by them.", [["experimental evaluation", "TEST", 172, 195]]], ["By providing new ways of thinking, entirely new experimental approaches can be developed.Errors at the Start of Life: QuasispeciesThe existence of error-prone replication and quasispecies also raises the issue of the conservation of information.", [["error-prone replication", "TREATMENT", 147, 170], ["quasispecies", "PROBLEM", 175, 187], ["error-prone replication", "OBSERVATION", 147, 170]]], ["These issues have yet to be resolved.", [["resolved", "OBSERVATION_MODIFIER", 28, 36]]], ["One involved cooperative evolution that results from ligated genomes.", [["ligated genomes", "DNA", 53, 68]]], ["A model was proposed in 2000 by Stadler and Schuster in which they considered the dynamics of replicator networks resulting from higher order reactions involving the templated ligation of smaller genomes ( Stadler et al. , 2000 ) .", [["replicator networks", "TREATMENT", 94, 113], ["the templated ligation of smaller genomes", "TREATMENT", 162, 203], ["ligation", "OBSERVATION", 176, 184], ["smaller", "OBSERVATION_MODIFIER", 188, 195]]], ["Although this was based on concepts such as triple-stranded nucleic acids, this clearly has some elements that also resemble the ligation of recombinational processes for DNA phage (presented below).Errors at the Start of Life: QuasispeciesA most interesting outcome of these models is that, depending on initial replicator concentrations, permanent coexistence of replicators could result in a cooperative network.", [["nucleic acids", "CHEMICAL", 60, 73], ["DNA", "CELLULAR_COMPONENT", 171, 174], ["DNA phage", "DNA", 171, 180], ["triple-stranded nucleic acids", "TREATMENT", 44, 73], ["DNA phage", "PROBLEM", 171, 180], ["Quasispecies", "PROBLEM", 228, 240], ["initial replicator concentrations", "TREATMENT", 305, 338], ["ligation", "OBSERVATION", 129, 137]]], ["Such cooperation is a rare outcome for most models and given the conclusion that early DNA based life was a \" horizontal \" consortium, such models are of special interest.", [["DNA", "CELLULAR_COMPONENT", 87, 90]]], ["Consortia selection directly implies cooperation, but cooperation of selfi sh replicators presents dilemmas.", [["dilemmas", "PROBLEM", 99, 107]]], ["Replicator networks with interaction functions that give highly non-linear dynamics can result in complex mixtures, with behaviors ranging from survival of the fi ttest to also including attainment of globally stable equilibrium tantamount to permanent coexistence.", [["stable", "OBSERVATION", 210, 216]]], ["The fi tness of populations, however, is inherent to current quasispecies concepts in virology.", [["populations", "OBSERVATION", 16, 27]]], ["There may also be other ways to explain the genetic origin of cooperation (such as stable persistence involving addiction strategies).", [["may also be", "UNCERTAINTY", 6, 17]]], ["The stable persistence of a genetic parasite can compel cooperation and promote the conservation of information (see below).FITNESS, CONSORTIA, AND PERSISTENCEThe defi nitions of fi tness with respect to a virus in a natural habitat are far from clear.", [["a genetic parasite", "PROBLEM", 26, 44], ["The defi nitions of fi tness", "TREATMENT", 159, 187], ["a virus", "PROBLEM", 204, 211], ["stable", "OBSERVATION_MODIFIER", 4, 10], ["persistence", "OBSERVATION_MODIFIER", 11, 22], ["CONSORTIA", "OBSERVATION", 133, 142], ["clear", "OBSERVATION", 246, 251]]], ["Although the concept of relative replicative fi tness is often applied to lab experiments of virus growth, we know many situations in which virus replication is not maximized in natural settings and many viruses can exist in relatively non-replicative states for long periods.", [["relative replicative fi tness", "TREATMENT", 24, 53], ["virus growth", "PROBLEM", 93, 105], ["virus replication", "TREATMENT", 140, 157], ["many viruses", "PROBLEM", 199, 211], ["replicative fi", "OBSERVATION", 33, 47], ["viruses", "OBSERVATION", 204, 211]]], ["Even in the context of an acutely replicating virus in a host organism, the concept of fi tness is clearly conditional, as the virus must replicate through various in vivo habitats that can have opposing selection.", [["an acutely replicating virus", "PROBLEM", 23, 51], ["a host organism", "PROBLEM", 55, 70], ["fi tness", "PROBLEM", 87, 95], ["the virus", "PROBLEM", 123, 132], ["virus", "OBSERVATION", 46, 51], ["host organism", "OBSERVATION", 57, 70]]], ["As presented below, in vivo models that study fi tness and viral diversity have clearly indicated that diversity per se is important and fi tness is the result of consortia.", [["study fi tness", "TEST", 40, 54], ["viral diversity", "PROBLEM", 59, 74], ["consortia", "PROBLEM", 163, 172], ["consortia", "OBSERVATION", 163, 172]]], ["In the lab, the viability of a virus is usually measured by the ability to produce plaques.", [["plaques", "ANATOMY", 83, 90], ["plaques", "PATHOLOGICAL_FORMATION", 83, 90], ["a virus", "PROBLEM", 29, 36], ["plaques", "PROBLEM", 83, 90], ["virus", "OBSERVATION", 31, 36], ["plaques", "OBSERVATION", 83, 90]]], ["Here, the defi nition of fi tness seems direct: plaque formation equals fi tness.", [["plaque", "ANATOMY", 48, 54], ["plaque", "PATHOLOGICAL_FORMATION", 48, 54], ["the defi nition of fi tness", "TREATMENT", 6, 33], ["plaque formation", "PROBLEM", 48, 64], ["plaque", "OBSERVATION", 48, 54]]], ["Various highly useful models have thus been defi ned and developed that depend on these plaque assays (see Chapter 4).", [["plaque", "ANATOMY", 88, 94], ["these plaque assays", "PROBLEM", 82, 101], ["plaque", "OBSERVATION", 88, 94]]], ["With this, populations and population growth are defi ned as relative growth of plaque-forming units.", [["plaque", "ANATOMY", 80, 86], ["population growth", "PROBLEM", 27, 44], ["relative growth of plaque", "PROBLEM", 61, 86], ["growth", "OBSERVATION_MODIFIER", 70, 76], ["plaque", "OBSERVATION", 80, 86]]], ["Plaque formation is clearly not equal to fi tness in natural habitats.", [["Plaque", "ANATOMY", 0, 6], ["Plaque", "DISEASE", 0, 6], ["Plaque", "PATHOLOGICAL_FORMATION", 0, 6], ["Plaque formation", "PROBLEM", 0, 16]]], ["There are many examples of highly successful viruses that either plaque poorly or not at all.", [["plaque", "ANATOMY", 65, 71], ["plaque", "PROBLEM", 65, 71], ["highly", "OBSERVATION_MODIFIER", 27, 33], ["successful", "OBSERVATION_MODIFIER", 34, 44], ["viruses", "OBSERVATION", 45, 52], ["plaque", "OBSERVATION", 65, 71]]], ["Consider the roughly 100 types of human papillomavirus (HPV), a simple small circular DNA virus of epithelia; this does not form plaques in any known system (Chapter 18).", [["epithelia", "ANATOMY", 99, 108], ["plaques", "ANATOMY", 129, 136], ["human papillomavirus (HPV)", "DISEASE", 34, 60], ["human", "ORGANISM", 34, 39], ["papillomavirus", "ORGANISM", 40, 54], ["HPV", "ORGANISM", 56, 59], ["DNA", "CELLULAR_COMPONENT", 86, 89], ["epithelia", "TISSUE", 99, 108], ["human", "SPECIES", 34, 39], ["human papillomavirus", "SPECIES", 34, 54], ["HPV", "SPECIES", 56, 59], ["human papillomavirus (HPV", "PROBLEM", 34, 59], ["a simple small circular DNA virus of epithelia", "PROBLEM", 62, 108], ["plaques", "PROBLEM", 129, 136], ["small", "OBSERVATION_MODIFIER", 71, 76], ["circular", "OBSERVATION_MODIFIER", 77, 85], ["DNA virus", "OBSERVATION", 86, 95], ["plaques", "OBSERVATION", 129, 136]]], ["HPV is clearly fi t, well adapted to, and stable in its human host.", [["HPV", "ORGANISM", 0, 3], ["human", "ORGANISM", 56, 61], ["human", "SPECIES", 56, 61], ["HPV", "SPECIES", 0, 3], ["human", "SPECIES", 56, 61], ["stable", "OBSERVATION_MODIFIER", 42, 48]]], ["In addition, HPV evolution is phylogenetically congruent with their primate host, as are most persistent viral infections.FITNESS, CONSORTIA, AND PERSISTENCEWe have yet to understand the definition of fi tness in this situation.", [["viral infections", "DISEASE", 105, 121], ["HPV", "ORGANISM", 13, 16], ["primate", "ORGANISM", 68, 75], ["HPV", "SPECIES", 13, 16], ["HPV evolution", "PROBLEM", 13, 26], ["persistent viral infections", "PROBLEM", 94, 121], ["HPV", "OBSERVATION", 13, 16], ["phylogenetically congruent", "OBSERVATION_MODIFIER", 30, 56], ["persistent", "OBSERVATION_MODIFIER", 94, 104], ["viral", "OBSERVATION_MODIFIER", 105, 110], ["infections", "OBSERVATION", 111, 121]]], ["In some cases, it seems selection for plaque propagation has clearly resulted in loss of highly conserved genes; such as with the plaque-adapted laboratory strains of cytomegalovirus (CMV).", [["plaque", "ANATOMY", 38, 44], ["plaque", "ANATOMY", 130, 136], ["plaque", "DISEASE", 38, 44], ["cytomegalovirus (CMV)", "DISEASE", 167, 188], ["plaque", "PATHOLOGICAL_FORMATION", 38, 44], ["cytomegalovirus", "ORGANISM", 167, 182], ["CMV", "ORGANISM", 184, 187], ["CMV", "SPECIES", 184, 187], ["plaque propagation", "PROBLEM", 38, 56], ["loss of highly conserved genes", "PROBLEM", 81, 111], ["the plaque", "PROBLEM", 126, 136], ["cytomegalovirus", "PROBLEM", 167, 182], ["plaque", "OBSERVATION", 38, 44], ["plaque", "OBSERVATION", 130, 136], ["cytomegalovirus", "OBSERVATION", 167, 182]]], ["The problem posed by viruses with ineffi cient plaque formation is not limited to DNA viruses.", [["plaque", "ANATOMY", 47, 53], ["plaque", "DISEASE", 47, 53], ["cient plaque", "PATHOLOGICAL_FORMATION", 41, 53], ["DNA", "CELLULAR_COMPONENT", 82, 85], ["ineffi cient plaque formation", "PROBLEM", 34, 63], ["DNA viruses", "PROBLEM", 82, 93], ["viruses", "OBSERVATION", 21, 28], ["plaque", "OBSERVATION", 47, 53], ["not limited to", "UNCERTAINTY", 67, 81], ["DNA viruses", "OBSERVATION", 82, 93]]], ["Many persisting RNA viruses also do not plaque well or at all, such as most RNA viruses of plants or many insect picorna-like viruses, such as those found in Drosophila and bees (which also conserve an extra ORF).", [["plaque", "ANATOMY", 40, 46], ["insect picorna-like viruses", "ORGANISM", 106, 133], ["ORF", "DNA", 208, 211], ["Drosophila", "SPECIES", 158, 168], ["Drosophila", "SPECIES", 158, 168], ["Many persisting RNA viruses", "PROBLEM", 0, 27], ["plaque", "PROBLEM", 40, 46], ["many insect picorna", "PROBLEM", 101, 120], ["viruses", "PROBLEM", 126, 133], ["RNA viruses", "OBSERVATION", 16, 27], ["plaque", "OBSERVATION", 40, 46], ["viruses", "OBSERVATION", 126, 133]]], ["Nor do most persistent infections make lots of virus.", [["infections", "DISEASE", 23, 33], ["persistent infections", "PROBLEM", 12, 33], ["lots of virus", "PROBLEM", 39, 52], ["persistent", "OBSERVATION_MODIFIER", 12, 22], ["infections", "OBSERVATION", 23, 33], ["virus", "OBSERVATION", 47, 52]]], ["Low-level persistence, such as hantavirus in rodents, for example, is common ( Hart and Bennett, 1999 ) .FITNESS, CONSORTIA, AND PERSISTENCEClearly, our simplifying assumptions of viral fi tness and population dynamics cannot apply to these stable evolutionary states.", [["hantavirus", "DISEASE", 31, 41], ["Low-level persistence", "PROBLEM", 0, 21], ["hantavirus", "PROBLEM", 31, 41], ["viral fi tness", "PROBLEM", 180, 194], ["population dynamics", "PROBLEM", 199, 218], ["-level", "OBSERVATION_MODIFIER", 3, 9], ["persistence", "OBSERVATION_MODIFIER", 10, 21], ["hantavirus", "OBSERVATION", 31, 41], ["stable", "OBSERVATION", 241, 247]]], ["However, if we limit our defi nition of viral fi tness to relative replication or plaque formation we can perform some clear and quantitative evaluations.Fitness Theory for PersistenceExperimental evaluation forces us to study fi tness by only those defi nitions that we can currently measure.", [["plaque", "ANATOMY", 82, 88], ["plaque", "PATHOLOGICAL_FORMATION", 82, 88], ["viral fi tness", "TREATMENT", 40, 54], ["plaque formation", "PROBLEM", 82, 98], ["quantitative evaluations", "TEST", 129, 153], ["PersistenceExperimental evaluation", "TEST", 173, 207], ["plaque", "OBSERVATION", 82, 88]]], ["As fi tness appears to be a relativistic and transient concept, depending very much on the tissue, time, place, extant adaptive and innate immunity, and competition, it is likely that we can only measure with any accuracy one aspect of fi tness at any one time.", [["tissue", "ANATOMY", 91, 97], ["tissue", "TISSUE", 91, 97]]], ["HIV infection of humans shows evidence of this in that the R5 virus is more fi t for transmission and early disease whereas the X4 virus is fi t later during the AIDS disease phase.", [["HIV infection", "DISEASE", 0, 13], ["AIDS", "DISEASE", 162, 166], ["HIV", "ORGANISM", 0, 3], ["humans", "ORGANISM", 17, 23], ["R5 virus", "ORGANISM", 59, 67], ["X4 virus", "ORGANISM", 128, 136], ["HIV", "SPECIES", 0, 3], ["humans", "SPECIES", 17, 23], ["HIV", "SPECIES", 0, 3], ["humans", "SPECIES", 17, 23], ["R5 virus", "SPECIES", 59, 67], ["X4 virus", "SPECIES", 128, 136], ["HIV infection of humans", "PROBLEM", 0, 23], ["the R5 virus", "PROBLEM", 55, 67], ["early disease", "PROBLEM", 102, 115], ["the X4 virus", "PROBLEM", 124, 136], ["the AIDS disease phase", "PROBLEM", 158, 180], ["infection", "OBSERVATION", 4, 13], ["R5 virus", "OBSERVATION", 59, 67], ["early", "OBSERVATION_MODIFIER", 102, 107], ["disease", "OBSERVATION", 108, 115]]], ["Clearly conditional, time-dependent issues relate to fi tness defi nitions.", [["dependent issues", "PROBLEM", 26, 42]]], ["However, much more problematic is that we have no theory for viral persistence or its fi tness.", [["viral persistence", "PROBLEM", 61, 78]]], ["We lack specifi c or measurable parameters other than the simple maintenance of genetic material.", [["specifi c", "GENE_OR_GENE_PRODUCT", 8, 17]]], ["Yet it seems clear that some distinguishing features of persistence can already be recognized.", [["clear", "OBSERVATION", 13, 18]]], ["For example, the possible participation of viral defectives (normally considered unfi t), which in numerous circumstances can modify or mediate persistence, would need to be included.", [["viral defectives", "PROBLEM", 43, 59], ["viral defectives", "OBSERVATION", 43, 59]]], ["Clearly, a defective role in persistence would also preclude them from being considered as genetic \" junk, \" or selfish elements, since they would then matter in measurable ways to the biological outcome of virus persistent infection.Fitness Theory for PersistencePersistence also requires an extended duration of infection, not simply maximized replication.", [["infection", "DISEASE", 224, 233], ["infection", "DISEASE", 314, 323], ["a defective role", "PROBLEM", 9, 25], ["virus persistent infection", "PROBLEM", 207, 233], ["infection", "PROBLEM", 314, 323], ["defective", "OBSERVATION", 11, 20], ["infection", "OBSERVATION", 224, 233], ["infection", "OBSERVATION", 314, 323]]], ["In fact, persistence generally requires mechanisms to limit the replication of at least the same virus for at least some time.", [["persistence", "OBSERVATION_MODIFIER", 9, 20]]], ["Thus, limited replication must be an essential element for this life strategy.", [["this life strategy", "TREATMENT", 59, 77]]], ["In my judgment, and much like the quasispecies concept, the concept of persistence will eventually be recognized for the fundamental (symbiotic) force it represents in virus evolution.Fitness Theory for PersistenceThe experimental work of Domingo and Holland spans the modern assessment of quasispecies theory that occurred in the 1980s and 1990s.", [["virus", "OBSERVATION", 168, 173]]], ["This current volume is an extension from an earlier book on quasispecies and now encompasses both prokaryotic and eukaryotic viruses .", [["an extension", "PROBLEM", 23, 35], ["quasispecies", "PROBLEM", 60, 72], ["eukaryotic viruses", "OBSERVATION", 114, 132]]], ["Since early experimental phage studies provided the foundations for quasispecies theory ( Eigen et al. , 1988 ) , using mathematical descriptions (differential equations) of mutation rates in T-even phage ( Luria and Delbruck, 1943 ) , this inclusion is appropriate.Fitness Theory for PersistenceInterestingly, a second early paper measuring replication rates by these same authors also noted the problems of viral interference and defectives ( Delbruck, 1945 ) .", [["early experimental phage studies", "TEST", 6, 38], ["mutation rates", "TEST", 174, 188], ["viral interference and defectives", "PROBLEM", 409, 442], ["viral interference", "OBSERVATION", 409, 427]]], ["Other early experiments of phage RNA polymerase ( Batschelet et al. , 1976 ) , especially with RNA phage Q\u03b2 ( Domingo et al. , 1978 ) , helped set the stage for the subsequent experiments of the 1980s and 1990s.", [["phage RNA polymerase", "PROTEIN", 27, 47]]], ["From the test tube to mouse models to the study of human disease, the work of Domingo and colleagues has spanned the entire history of viral quasispecies ( Domingo and Gomez, 2007 ; Chapter 4) .Fitness Theory for PersistenceQuasispecies deals with the products of error-prone replication.", [["human disease", "DISEASE", 51, 64], ["tube", "TISSUE", 14, 18], ["mouse", "ORGANISM", 22, 27], ["human", "ORGANISM", 51, 56], ["mouse", "SPECIES", 22, 27], ["human", "SPECIES", 51, 56], ["mouse", "SPECIES", 22, 27], ["human", "SPECIES", 51, 56], ["the study", "TEST", 38, 47], ["human disease", "PROBLEM", 51, 64], ["viral quasispecies", "PROBLEM", 135, 153], ["PersistenceQuasispecies deals", "TREATMENT", 213, 242], ["error-prone replication", "TREATMENT", 264, 287], ["viral quasispecies", "OBSERVATION", 135, 153]]], ["However, it is worth repeating that products of error-prone replication are not behaving in a simple \" selfish DNA \" capacity and are not devoid of biological relevance and phenotype.", [["DNA", "CELLULAR_COMPONENT", 111, 114], ["error-prone replication", "TREATMENT", 48, 71]]], ["In their complex populations, they create clear and varied affects on viral adaptability, competition, and fi tness.", [["complex", "OBSERVATION_MODIFIER", 9, 16], ["populations", "OBSERVATION", 17, 28], ["clear", "OBSERVATION", 42, 47], ["viral adaptability", "OBSERVATION", 70, 88]]], ["Since quasispecies necessarily involve defective and mutant virus, it is easy (and common) to think of these entities simply as genetic junk ( Villarreal, 2005 ( Villarreal, , 2006 .", [["mutant virus", "ORGANISM", 53, 65], ["quasispecies", "PROBLEM", 6, 18], ["defective and mutant virus", "PROBLEM", 39, 65], ["mutant virus", "OBSERVATION", 53, 65]]], ["Defective and even lethal or interfering variation in viral genomes can contribute to adaptability.", [["viral genomes", "DNA", 54, 67], ["Defective and even lethal", "PROBLEM", 0, 25], ["interfering variation in viral genomes", "PROBLEM", 29, 67], ["lethal", "OBSERVATION_MODIFIER", 19, 25], ["interfering", "OBSERVATION", 29, 40], ["viral genomes", "OBSERVATION", 54, 67]]], ["Thus, viruses can clearly adapt as a cloud with a mutant spectra.", [["viruses", "PROBLEM", 6, 13], ["viruses", "OBSERVATION", 6, 13]]], ["In addition, unending competition and exclusion, consistent with the Red Queen hypothesis, has also been observed ( Clarke et al. , 1994 ) .Fitness Theory for PersistenceThe poliovirus-mouse model (see below) in particular has provided a solid experimental system for evaluating the adaptive consequence of quasispecies.", [["mouse", "ORGANISM", 185, 190], ["mouse", "SPECIES", 185, 190], ["mouse", "SPECIES", 185, 190], ["the Red Queen hypothesis", "PROBLEM", 65, 89], ["The poliovirus-mouse model", "TEST", 170, 196], ["quasispecies", "PROBLEM", 307, 319], ["consistent with", "UNCERTAINTY", 49, 64], ["poliovirus", "OBSERVATION", 174, 184], ["quasispecies", "OBSERVATION", 307, 319]]], ["It is thus ironic that these same experiments have also made clear that the original simplifying assumptions of the quasispecies ordinary differential as presented by Eigen are violated by the resulting quasispecies.", [["the resulting quasispecies", "PROBLEM", 189, 215], ["quasispecies", "OBSERVATION", 203, 215]]], ["These products of error-prone replication do indeed strongly interact with each other in both positive and negative ways and such interactions contribute signifi cantly to the observed fi tness of the population.Fitness Theory for PersistenceErrors and interaction are important for fi tness.", [["error-prone replication", "TREATMENT", 18, 41], ["error-prone replication", "OBSERVATION", 18, 41]]], ["For example, defectives have been reported to mediate extermination of a competing wild-type virus ( Grande-Perez et al. , 2005 ).Fitness Theory for PersistenceComplementation has also been observed ( Garcia-Arriaza et al. , 2004 ) , as has trans -dominant inhibition ( Crowder and Kirkegaard, 2005 ) .", [["wild-type virus", "ORGANISM", 83, 98], ["defectives", "PROBLEM", 13, 23], ["PersistenceComplementation", "PROBLEM", 149, 175]]], ["Consider, for example, the fi tness of a defective or mutant outside of its role in a quasispecies.", [["a defective", "PROBLEM", 39, 50], ["defective", "OBSERVATION", 41, 50], ["quasispecies", "OBSERVATION", 86, 98]]], ["Such a consideration ignores the very nature of a quasispecies yet it is an issue that has often been posed and experimentally evaluated.", [["a quasispecies", "PROBLEM", 48, 62], ["quasispecies", "OBSERVATION", 50, 62]]], ["We should refrain from thinking of viruses simply as fi t or non-fi t individual types since they clearly exist in populations that provide population-based adaptability.Fitness Theory for PersistenceThe selection of viral consortia or population raises some fundamental issues for evolutionary biology.", [["viruses", "PROBLEM", 35, 42], ["viral consortia", "PROBLEM", 217, 232], ["viral consortia", "OBSERVATION", 217, 232]]], ["This is essentially group selection in which a population, not the fi ttest individual, is selected.", [["essentially", "OBSERVATION_MODIFIER", 8, 19], ["group selection", "OBSERVATION", 20, 35]]], ["This view makes cooperation or interaction of individual genomes a signifi cant component of selection, which is not commonly thought to be a general or accepted process in evolution.", [["process", "OBSERVATION", 162, 169]]], ["Yet population selection is no longer a contestable issue in RNA virus evolution (see below).", [["RNA virus evolution", "PROBLEM", 61, 80], ["population", "OBSERVATION", 4, 14], ["no longer", "UNCERTAINTY", 28, 37], ["RNA virus", "OBSERVATION", 61, 70]]], ["I expect that many classical evolutionary biologists might interpret this as evidence that viruses really are an oddity in this feature and are not representative of broader processes of evolutionary biology.", [["viruses", "PROBLEM", 91, 98], ["viruses", "OBSERVATION", 91, 98]]], ["Furthermore, viral-based group selection may not be limited to quasispecies-based evolution.", [["viral-based group selection", "PROBLEM", 13, 40], ["quasispecies", "PROBLEM", 63, 75], ["viral", "OBSERVATION", 13, 18], ["quasispecies", "OBSERVATION", 63, 75]]], ["As presented below, persistent viral infections may also provide population-based selective advantage (see below for the P1 and mouse hepatitis virus (MHV) persistence exemplars; Villarreal, 2006 Villarreal, , 2007 .Fitness Theory for PersistenceSince viruses are ancient, numerically dominant, and the most diverse biological entities on Earth, no life form can escape exposure to them.", [["viral infections", "DISEASE", 31, 47], ["mouse hepatitis virus", "DISEASE", 128, 149], ["mouse hepatitis virus", "ORGANISM", 128, 149], ["mouse", "SPECIES", 128, 133], ["hepatitis virus", "SPECIES", 134, 149], ["mouse hepatitis virus", "SPECIES", 128, 149], ["MHV", "SPECIES", 151, 154], ["persistent viral infections", "PROBLEM", 20, 47], ["the P1 and mouse hepatitis virus", "PROBLEM", 117, 149], ["PersistenceSince viruses", "PROBLEM", 235, 259], ["persistent", "OBSERVATION_MODIFIER", 20, 30], ["viral", "OBSERVATION_MODIFIER", 31, 36], ["infections", "OBSERVATION", 37, 47]]], ["Thus we should expect that the viral footprints (including defectives) that we now fi nd in all genomes have likely played an active role in their evolution; a role, I would argue, that is fundamental, dynamic, and unending.", [["the viral footprints", "PROBLEM", 27, 47], ["active", "OBSERVATION_MODIFIER", 126, 132]]], ["We can start to attain a global perspective and appreciation for their ability to assemble genetic function from enormous, complex mixtures of genomes, and select gene sets needed to solve multivariant, temporally dynamic evolutionary problems.", [["temporally dynamic evolutionary problems", "PROBLEM", 203, 243]]], ["We can then seek evidence for the role of viral elements in fundamental host innovation and be open to evaluating the occurrence of viral entities from a constructive perspective and not instinctively dismiss such observations as due to coincidence, \" junk, \" or selfi sh DNA.Fitness Theory for PersistenceThe advantage of such a perspective is that it will promote the specifi c experimental evaluations that can better assess any constructive role genetic parasites might have played in host evolution.", [["DNA", "CELLULAR_COMPONENT", 272, 275], ["viral elements", "DNA", 42, 56], ["selfi sh DNA", "DNA", 263, 275], ["viral elements", "PROBLEM", 42, 56], ["viral entities", "PROBLEM", 132, 146], ["selfi sh DNA", "PROBLEM", 263, 275], ["experimental evaluations", "TEST", 380, 404], ["any constructive role genetic parasites", "PROBLEM", 428, 467], ["viral elements", "OBSERVATION", 42, 56], ["viral", "OBSERVATION", 132, 137]]], ["For example, there is much reason to think ERVs have played an active role in human evolution (for references see Ryan, 2007 ) .", [["human", "ORGANISM", 78, 83], ["ERVs", "DNA", 43, 47], ["human", "SPECIES", 78, 83], ["human", "SPECIES", 78, 83], ["active", "OBSERVATION_MODIFIER", 63, 69]]], ["The quasispecies concept has provided the foundation for us to understand virus evolution and informed us of the evolutionary power viruses possess.", [["quasispecies", "OBSERVATION", 4, 16]]], ["If that power also links to host evolution, then the tree of life becomes enriched by virus, much larger and more dynamic.The Poliovirus-Mouse Exemplar: \" Quasispecies per se Rather than the Selection of Individual Adaptive Mutations Correlates with Enhanced Pathogenesis \"The recent experimental studies from Andino and colleagues using poliovirus in the mouse model should, in my judgment, provide the keystone exemplar regarding the in vivo fi tness of quasispecies (see Chapters 6 and 7; Vignuzzi et al. , 2006 ) .", [["Mouse", "ORGANISM", 137, 142], ["poliovirus", "ORGANISM", 338, 348], ["mouse", "ORGANISM", 356, 361], ["Mouse", "SPECIES", 137, 142], ["mouse", "SPECIES", 356, 361], ["mouse", "SPECIES", 356, 361], ["virus", "PROBLEM", 86, 91], ["Quasispecies", "PROBLEM", 155, 167], ["Individual Adaptive Mutations", "PROBLEM", 204, 233], ["experimental studies", "TEST", 284, 304], ["poliovirus", "TREATMENT", 338, 348], ["quasispecies", "PROBLEM", 456, 468], ["host evolution", "OBSERVATION_MODIFIER", 28, 42], ["tree", "OBSERVATION_MODIFIER", 53, 57], ["larger", "OBSERVATION_MODIFIER", 98, 104], ["more dynamic", "OBSERVATION_MODIFIER", 109, 121], ["Poliovirus", "OBSERVATION", 126, 136]]], ["These studies make clear the importance of quasispecies and error-prone replication.", [["These studies", "TEST", 0, 13], ["quasispecies", "PROBLEM", 43, 55], ["error-prone replication", "TREATMENT", 60, 83]]], ["Such detailed in vivo experiments were made possible by a long and detailed history of poliovirus studies that has identifi ed the nature of RNA polymerase fi delity as well as developed mouse models for the study of pathogenesis.", [["mouse", "ORGANISM", 187, 192], ["RNA polymerase fi delity", "PROTEIN", 141, 165], ["mouse", "SPECIES", 187, 192], ["mouse", "SPECIES", 187, 192], ["poliovirus studies", "TEST", 87, 105], ["RNA polymerase fi delity", "PROBLEM", 141, 165], ["the study", "TEST", 204, 213], ["pathogenesis", "PROBLEM", 217, 229]]], ["Few other virus-host systems could have provided such potential for high resolution.", [["Few other virus-host systems", "PROBLEM", 0, 28], ["virus", "OBSERVATION", 10, 15], ["host systems", "OBSERVATION", 16, 28]]], ["These results also provide the experimental observations that distinguish quasispecies-based evolution from the classical Fisher-based population genetics.", [["the experimental observations", "TEST", 27, 56], ["quasispecies", "PROBLEM", 74, 86]]], ["The general importance of this story for understanding virus evolution thus deserves special emphasis.", [["understanding virus evolution", "PROBLEM", 41, 70]]], ["The very origins of modern animal virology stem from poliovirus studies with the need to develop in vitro cell culture technology in order to grow and evaluate poliovirus and generate variants.", [["cell", "ANATOMY", 106, 110], ["cell", "CELL", 106, 110], ["poliovirus", "SPECIES", 53, 63], ["poliovirus", "SPECIES", 160, 170], ["modern animal virology stem", "PROBLEM", 20, 47], ["poliovirus studies", "TEST", 53, 71], ["vitro cell culture technology", "TEST", 100, 129], ["poliovirus", "PROBLEM", 160, 170]]], ["The live poliovirus vaccine is of special interest with regards to virus evolution and adaptability.", [["live poliovirus", "ORGANISM", 4, 19], ["The live poliovirus vaccine", "TREATMENT", 0, 27]]], ["The \" live \" oral Sabin vaccine can be considered to have been a miracle of the practical approach to virology developed in the 1950s ( Horaud, 1993 ) in that it was used well before our understanding of the relevant evolutionary theory.", [["oral", "ANATOMY", 13, 17], ["oral", "ORGANISM_SUBDIVISION", 13, 17], ["Sabin", "ORGANISM", 18, 23], ["The \" live", "TREATMENT", 0, 10], ["oral Sabin vaccine", "TREATMENT", 13, 31]]], ["The Sabin vaccine strain was the result of rodentadapted virus and differs from the neurovirulent Mahoney strain by 56 point mutations (in the consensus sequence), although only a small number of these mutations were needed for neurovirulence ( Christodoulou et al. , 1990 ) .", [["Sabin", "ORGANISM", 4, 9], ["rodentadapted virus", "ORGANISM", 43, 62], ["Mahoney strain", "ORGANISM", 98, 112], ["consensus sequence", "DNA", 143, 161], ["rodentadapted virus", "SPECIES", 43, 62], ["The Sabin vaccine strain", "TREATMENT", 0, 24], ["rodentadapted virus", "PROBLEM", 43, 62], ["the neurovirulent Mahoney strain", "PROBLEM", 80, 112], ["these mutations", "PROBLEM", 196, 211], ["neurovirulence", "PROBLEM", 228, 242], ["small", "OBSERVATION_MODIFIER", 180, 185]]], ["One of the important neurovirulent mutations was within the RNA polymerase gene ( Tardy-Panit et al. , 1993 ) .", [["RNA polymerase gene", "DNA", 60, 79], ["the important neurovirulent mutations", "PROBLEM", 7, 44], ["neurovirulent mutations", "OBSERVATION", 21, 44]]], ["In time it became apparent that 3Dpol mutants could affect replication fi delity.", [["3Dpol", "GENE_OR_GENE_PRODUCT", 32, 37], ["3Dpol mutants", "PROTEIN", 32, 45]]], ["One poliovirus point mutant, 3DG64S, was shown to have enhanced highfi delity replication and that selective pressure could be designed to increase fi delity in RNA polymerase ( Pfeiffer and Kirkegaard, 2005 ) .The Poliovirus-Mouse Exemplar: \" Quasispecies per se Rather than the Selection of Individual Adaptive Mutations Correlates with Enhanced Pathogenesis \"Another major development was the molecular identifi cation of the poliovirus receptor and the subsequent creation of transgenic mice expressing this receptor, making them susceptible to poliovirus infection.", [["poliovirus infection", "DISEASE", 549, 569], ["Mouse", "ORGANISM", 226, 231], ["mice", "ORGANISM", 491, 495], ["poliovirus", "ORGANISM", 549, 559], ["3DG64S", "PROTEIN", 29, 35], ["RNA polymerase", "PROTEIN", 161, 175], ["poliovirus receptor", "PROTEIN", 429, 448], ["Mouse", "SPECIES", 226, 231], ["mice", "SPECIES", 491, 495], ["mice", "SPECIES", 491, 495], ["poliovirus", "SPECIES", 549, 559], ["enhanced highfi delity replication", "PROBLEM", 55, 89], ["selective pressure", "TREATMENT", 99, 117], ["increase fi delity in RNA polymerase", "PROBLEM", 139, 175], ["Quasispecies", "PROBLEM", 244, 256], ["Individual Adaptive Mutations", "PROBLEM", 293, 322], ["Enhanced Pathogenesis", "PROBLEM", 339, 360], ["the poliovirus receptor", "TREATMENT", 425, 448], ["transgenic mice", "TREATMENT", 480, 495], ["this receptor", "TREATMENT", 507, 520], ["poliovirus infection", "PROBLEM", 549, 569], ["Poliovirus", "OBSERVATION", 215, 225], ["poliovirus infection", "OBSERVATION", 549, 569]]], ["One of these transgenic lines allowed mouse brain infections with neurovirulent versions of poliovirus , and has provided a very useful animal model that allowed the evaluation of viral fi tness in the context of in vivo pathogenesis.", [["brain", "ANATOMY", 44, 49], ["brain infections", "DISEASE", 44, 60], ["transgenic lines", "CELL", 13, 29], ["mouse", "ORGANISM", 38, 43], ["brain", "ORGAN", 44, 49], ["poliovirus", "ORGANISM", 92, 102], ["transgenic lines", "CELL_LINE", 13, 29], ["mouse", "SPECIES", 38, 43], ["mouse", "SPECIES", 38, 43], ["poliovirus", "SPECIES", 92, 102], ["these transgenic lines", "TREATMENT", 7, 29], ["mouse brain infections", "PROBLEM", 38, 60], ["poliovirus", "PROBLEM", 92, 102], ["the evaluation", "TEST", 162, 176], ["viral fi tness", "PROBLEM", 180, 194], ["transgenic lines", "OBSERVATION", 13, 29], ["brain", "ANATOMY", 44, 49], ["infections", "OBSERVATION", 50, 60]]], ["Although 3DG64S replicates well in culture (with lowered error rate), it was less pathogenic in this mouse model and competed poorly with 3D wild-type virus.", [["mouse", "ORGANISM", 101, 106], ["3D wild-type virus", "ORGANISM", 138, 156], ["3DG64S", "DNA", 9, 15], ["mouse", "SPECIES", 101, 106], ["mouse", "SPECIES", 101, 106], ["culture", "TEST", 35, 42], ["3D wild-type virus", "PROBLEM", 138, 156]]], ["It seemed that the decreased viral diversity was less able to generate the variation needed to get past bottlenecks due to multiple selective differences presented in vivo in tissues in the host, such as brain infection ( Pfeiffer and Kirkegaard, 2006 ).", [["tissues", "ANATOMY", 175, 182], ["brain", "ANATOMY", 204, 209], ["brain infection", "DISEASE", 204, 219], ["tissues", "TISSUE", 175, 182], ["brain", "ORGAN", 204, 209], ["the decreased viral diversity", "PROBLEM", 15, 44], ["multiple selective differences", "PROBLEM", 123, 153], ["brain infection", "PROBLEM", 204, 219], ["decreased", "OBSERVATION_MODIFIER", 19, 28], ["viral diversity", "OBSERVATION", 29, 44], ["multiple", "OBSERVATION_MODIFIER", 123, 131], ["selective", "OBSERVATION", 132, 141], ["brain", "ANATOMY", 204, 209], ["infection", "OBSERVATION", 210, 219]]], ["This experimental system also makes clear the greater complexity of fi tness in vivo relative to that typically measured in culture.The Poliovirus-Mouse Exemplar: \" Quasispecies per se Rather than the Selection of Individual Adaptive Mutations Correlates with Enhanced Pathogenesis \"Thus it seems that in vivo there may not be one fi tness but several that cannot be distinguished or individually measured.", [["Mouse", "ORGANISM", 147, 152], ["Mouse", "SPECIES", 147, 152], ["culture", "TEST", 124, 131], ["Quasispecies", "PROBLEM", 165, 177], ["Individual Adaptive Mutations", "PROBLEM", 214, 243], ["greater", "OBSERVATION_MODIFIER", 46, 53], ["Poliovirus", "OBSERVATION", 136, 146], ["may not be", "UNCERTAINTY", 316, 326]]], ["It is likely that various in vivo barriers require distinct fi tness solutions that tend to create bottlenecks and that the diversity per se is essential to get past such bottlenecks.", [["distinct fi tness solutions", "TREATMENT", 51, 78], ["is likely", "UNCERTAINTY", 3, 12]]], ["A population, not a clone or a consensus, appeared more fi t as higher titer infections of 3DG64S also failed to be pathogenic.", [["infections", "DISEASE", 77, 87], ["clone", "CELL", 20, 25], ["3DG64S", "GENE_OR_GENE_PRODUCT", 91, 97], ["3DG64S", "PROTEIN", 91, 97], ["a clone", "PROBLEM", 18, 25], ["higher titer infections of 3DG64S", "PROBLEM", 64, 97], ["pathogenic", "PROBLEM", 116, 126], ["population", "OBSERVATION", 2, 12]]], ["Thus, higher levels of a consensus virus are not equivalent to higher diversity.The Poliovirus-Mouse Exemplar: \" Quasispecies per se Rather than the Selection of Individual Adaptive Mutations Correlates with Enhanced Pathogenesis \"The relationship between RNA polymerase structure, error rates, and ribavirin action is discussed by Cameron in Chapter 6 and has been the subject of numerous studies ( Crotty et al. , 2001 ; Vignuzzi et al. , 2005 ) .", [["ribavirin", "CHEMICAL", 299, 308], ["ribavirin", "CHEMICAL", 299, 308], ["Mouse", "ORGANISM", 95, 100], ["ribavirin", "SIMPLE_CHEMICAL", 299, 308], ["RNA polymerase", "PROTEIN", 256, 270], ["Mouse", "SPECIES", 95, 100], ["a consensus virus", "PROBLEM", 23, 40], ["Quasispecies", "PROBLEM", 113, 125], ["Individual Adaptive Mutations", "PROBLEM", 162, 191], ["Enhanced Pathogenesis", "PROBLEM", 208, 229], ["RNA polymerase structure", "PROBLEM", 256, 280], ["error rates", "TEST", 282, 293], ["ribavirin action", "TREATMENT", 299, 315], ["numerous studies", "TEST", 381, 397], ["Poliovirus", "OBSERVATION", 84, 94]]], ["Knowledge of the structure and catalytic mechanism of RNA polymerase function has allowed a greatly enhanced level of detail to be considered into what affects error rate (see Castro et al. , 2007 ; Korneeva and Cameron, 2007 ; Marcotte et al. , 2007 ) .", [["RNA polymerase", "PROTEIN", 54, 68], ["RNA polymerase function", "PROBLEM", 54, 77]]], ["This has provided insight into the likely action of ribavarin on product fi delity ( Harki et al. , 2002 ) .", [["ribavarin", "CHEMICAL", 52, 61], ["ribavarin", "CHEMICAL", 52, 61], ["ribavarin", "SIMPLE_CHEMICAL", 52, 61], ["ribavarin", "TREATMENT", 52, 61]]], ["Thus, it appeared that even a mutant of RNA polymerase with increased fi delity could still generate elevated diversity by various methods.", [["RNA polymerase", "PROTEIN", 40, 54], ["a mutant of RNA polymerase", "PROBLEM", 28, 54], ["increased fi delity", "PROBLEM", 60, 79], ["elevated diversity", "PROBLEM", 101, 119], ["elevated", "OBSERVATION_MODIFIER", 101, 109], ["diversity", "OBSERVATION_MODIFIER", 110, 119]]], ["Such control of fi delity allowed for the design of control experiments in which the same consensus virus genome could be forced to generate either less or more diverse progeny populations.", [["progeny populations", "CELL", 169, 188], ["consensus virus genome", "DNA", 90, 112], ["control experiments", "TREATMENT", 52, 71], ["the same consensus virus genome", "PROBLEM", 81, 112]]], ["In no other virus-host system have we attained such detailed insight into issues of error rate as those that were put to such excellent use in the poliovirus-mouse system.The Poliovirus-Mouse Exemplar: \" Quasispecies per se Rather than the Selection of Individual Adaptive Mutations Correlates with Enhanced Pathogenesis \"How generally important is this poliovirus in vivo quasispecies result?", [["poliovirus", "ORGANISM", 147, 157], ["mouse", "ORGANISM", 158, 163], ["Mouse", "ORGANISM", 186, 191], ["poliovirus", "ORGANISM", 354, 364], ["mouse", "SPECIES", 158, 163], ["Mouse", "SPECIES", 186, 191], ["mouse", "SPECIES", 158, 163], ["poliovirus", "SPECIES", 354, 364], ["Quasispecies", "PROBLEM", 204, 216], ["Individual Adaptive Mutations", "PROBLEM", 253, 282], ["this poliovirus", "PROBLEM", 349, 364], ["no", "UNCERTAINTY", 3, 5], ["virus", "OBSERVATION", 12, 17], ["Poliovirus", "OBSERVATION", 175, 185]]], ["Although the poliovirus-mouse system provides us with a fi rm experimental result, it seems likely that the generality of this relationship will be questioned by evolutionary biologists for several reasons.", [["poliovirus-mouse", "ORGANISM", 13, 29], ["mouse", "SPECIES", 24, 29], ["mouse", "SPECIES", 24, 29], ["seems likely", "UNCERTAINTY", 86, 98]]], ["Is there any evidence that this result with poliovirus indeed represents a general virus-host evolutionary relationship in natural settings?", [["poliovirus", "SPECIES", 44, 54], ["poliovirus", "PROBLEM", 44, 54], ["a general virus", "PROBLEM", 73, 88]]], ["As presented in Chapters 13-15, retroviruses and also human hepatitis virus C clearly exist as quasispecies populations that affect disease outcome.", [["hepatitis virus", "DISEASE", 60, 75], ["retroviruses", "ORGANISM", 32, 44], ["human hepatitis virus C", "ORGANISM", 54, 77], ["human", "SPECIES", 54, 59], ["hepatitis virus", "SPECIES", 60, 75], ["human hepatitis virus", "SPECIES", 54, 75], ["retroviruses", "TREATMENT", 32, 44], ["human hepatitis virus C", "PROBLEM", 54, 77], ["quasispecies populations", "PROBLEM", 95, 119], ["disease outcome", "PROBLEM", 132, 147]]], ["In the case of the retroviruses, viral populations show diversity that far exceeds that seen for other RNA viruses.", [["retroviruses", "ORGANISM", 19, 31], ["the retroviruses", "PROBLEM", 15, 31], ["viral populations", "PROBLEM", 33, 50], ["other RNA viruses", "PROBLEM", 97, 114], ["retroviruses", "OBSERVATION", 19, 31]]], ["In both HIV-1 and HCV there is clear circumstantial evidence for the importance of quasispecies for in vivo disease outcome, drug resistance, and fi tness.", [["HIV-1 and HCV", "DISEASE", 8, 21], ["HIV-1", "ORGANISM", 8, 13], ["HCV", "ORGANISM", 18, 21], ["HIV-1", "SPECIES", 8, 13], ["HIV-1", "SPECIES", 8, 13], ["HCV", "SPECIES", 18, 21], ["HCV", "PROBLEM", 18, 21], ["quasispecies", "PROBLEM", 83, 95], ["drug resistance", "PROBLEM", 125, 140], ["HIV", "OBSERVATION", 8, 11], ["clear circumstantial evidence for", "UNCERTAINTY", 31, 64]]], ["In addition, with HCV, CNS infection may sometimes result, and such brain infections appear to be mediated by distinct quasispecies ( Forton et al. , 2004 ; Forton et al. , 2006 ) , reminiscent of the polio virus mouse model.", [["CNS", "ANATOMY", 23, 26], ["brain", "ANATOMY", 68, 73], ["infection", "DISEASE", 27, 36], ["brain infections", "DISEASE", 68, 84], ["HCV", "ORGANISM", 18, 21], ["CNS", "ANATOMICAL_SYSTEM", 23, 26], ["brain", "ORGAN", 68, 73], ["polio virus", "ORGANISM", 201, 212], ["mouse", "ORGANISM", 213, 218], ["polio virus", "SPECIES", 201, 212], ["mouse", "SPECIES", 213, 218], ["HCV", "SPECIES", 18, 21], ["polio virus mouse", "SPECIES", 201, 218], ["HCV", "PROBLEM", 18, 21], ["CNS infection", "PROBLEM", 23, 36], ["such brain infections", "PROBLEM", 63, 84], ["the polio virus mouse model", "TREATMENT", 197, 224], ["HCV", "OBSERVATION", 18, 21], ["CNS", "ANATOMY", 23, 26], ["infection", "OBSERVATION", 27, 36], ["brain", "ANATOMY", 68, 73], ["infections", "OBSERVATION", 74, 84], ["distinct", "OBSERVATION_MODIFIER", 110, 118], ["quasispecies", "OBSERVATION", 119, 131], ["polio virus", "OBSERVATION", 201, 212]]], ["Quasispecies memory, as mentioned above, also seems to be an important issue with regard to failure of antiretroviral therapy ( Kijak et al. , 2002 ) and it appears that pol gene mutations could also be involved in this ( Carobene et al. , 2004 ) .", [["pol", "GENE_OR_GENE_PRODUCT", 170, 173], ["Quasispecies memory", "PROBLEM", 0, 19], ["antiretroviral therapy", "TREATMENT", 103, 125], ["pol gene mutations", "PROBLEM", 170, 188]]], ["Measurements of HIV quasispecies in individual patients indicates that multiple evolutionary patterns can be found in typical individual patients ( Casado et al. , 2001 ) , thus mixtures of HIV exist in patients ( Bello et al. , 2004 ( Bello et al. , , 2005 .", [["HIV", "ORGANISM", 16, 19], ["patients", "ORGANISM", 47, 55], ["patients", "ORGANISM", 137, 145], ["HIV", "ORGANISM", 190, 193], ["patients", "ORGANISM", 203, 211], ["HIV", "SPECIES", 16, 19], ["patients", "SPECIES", 47, 55], ["patients", "SPECIES", 137, 145], ["HIV", "SPECIES", 190, 193], ["patients", "SPECIES", 203, 211], ["HIV", "SPECIES", 16, 19], ["HIV", "SPECIES", 190, 193], ["HIV quasispecies", "PROBLEM", 16, 32], ["HIV exist", "PROBLEM", 190, 199], ["HIV quasispecies", "OBSERVATION", 16, 32]]], ["And HIV-1 recombination is clearly contributing to diversity ( Kijak and McCutchan, 2005 ) .", [["HIV-1", "ORGANISM", 4, 9], ["HIV-1", "SPECIES", 4, 9], ["HIV-1", "SPECIES", 4, 9], ["HIV", "PROBLEM", 4, 7]]], ["Thus, with both HIV-1 and HCV, their capacity to cause human disease is clearly associated with quasispecies compositions that affect fi tness in complex ways.", [["HIV-1", "ORGANISM", 16, 21], ["HCV", "ORGANISM", 26, 29], ["human", "ORGANISM", 55, 60], ["HIV-1", "SPECIES", 16, 21], ["human", "SPECIES", 55, 60], ["HIV-1", "SPECIES", 16, 21], ["HCV", "SPECIES", 26, 29], ["human", "SPECIES", 55, 60], ["HCV", "PROBLEM", 26, 29], ["human disease", "PROBLEM", 55, 68], ["quasispecies compositions", "PROBLEM", 96, 121], ["disease", "OBSERVATION", 61, 68]]], ["The poliovirus mouse system therefore appears to refl ect quasispecies issues as observed in natural virus-host situations.The Poliovirus-Mouse Exemplar: \" Quasispecies per se Rather than the Selection of Individual Adaptive Mutations Correlates with Enhanced Pathogenesis \"Consideration of retrovirus-host evolution introduces another large issue in evolution: genomic viruses.", [["poliovirus", "ORGANISM", 4, 14], ["mouse", "ORGANISM", 15, 20], ["Mouse", "ORGANISM", 138, 143], ["retrovirus", "ORGANISM", 291, 301], ["mouse", "SPECIES", 15, 20], ["Mouse", "SPECIES", 138, 143], ["mouse", "SPECIES", 15, 20], ["The poliovirus mouse system", "TREATMENT", 0, 27], ["ect quasispecies issues", "PROBLEM", 54, 77], ["Quasispecies", "PROBLEM", 156, 168], ["Individual Adaptive Mutations", "PROBLEM", 205, 234], ["retrovirus", "PROBLEM", 291, 301], ["genomic viruses", "PROBLEM", 362, 377], ["poliovirus mouse", "OBSERVATION", 4, 20], ["appears to", "UNCERTAINTY", 38, 48], ["natural virus", "OBSERVATION", 93, 106], ["Poliovirus", "OBSERVATION", 127, 137], ["large", "OBSERVATION_MODIFIER", 336, 341], ["genomic viruses", "OBSERVATION", 362, 377]]], ["Unlike poliovirus and most RNA viruses, retroviruses (e.g. non-lentivirus) have colonized the genomes of animal species in large numbers and represent a large fraction of these genomes.", [["retroviruses", "ORGANISM", 40, 52], ["poliovirus", "PROBLEM", 7, 17], ["most RNA viruses", "PROBLEM", 22, 38], ["retroviruses", "PROBLEM", 40, 52], ["animal species", "PROBLEM", 105, 119], ["poliovirus", "OBSERVATION", 7, 17], ["most", "OBSERVATION_MODIFIER", 22, 26], ["RNA viruses", "OBSERVATION", 27, 38], ["animal species", "OBSERVATION", 105, 119], ["large", "OBSERVATION_MODIFIER", 123, 128], ["numbers", "OBSERVATION_MODIFIER", 129, 136], ["large", "OBSERVATION_MODIFIER", 153, 158], ["fraction", "OBSERVATION", 159, 167], ["these genomes", "OBSERVATION", 171, 184]]], ["Genomic retroviruses are present in vast numbers, most of which are defective and mutant copies.", [["retroviruses", "ORGANISM", 8, 20], ["Genomic retroviruses", "PROBLEM", 0, 20], ["mutant copies", "PROBLEM", 82, 95], ["retroviruses", "OBSERVATION", 8, 20], ["defective", "OBSERVATION", 68, 77]]], ["In this genomic colonization they resemble the dsDNA viruses of prokaryotes (discussed below) that also colonize all prokaryotes although at a much lower numbers.", [["this genomic colonization", "PROBLEM", 3, 28], ["the dsDNA viruses of prokaryotes", "PROBLEM", 43, 75], ["genomic colonization", "OBSERVATION", 8, 28]]], ["The human genome has fewer than 26 000 genes, but appears to have 500 000 retroviral-related LTR elements.", [["LTR", "ANATOMY", 93, 96], ["human", "ORGANISM", 4, 9], ["LTR", "CELLULAR_COMPONENT", 93, 96], ["human genome", "DNA", 4, 16], ["LTR elements", "DNA", 93, 105], ["human", "SPECIES", 4, 9], ["human", "SPECIES", 4, 9], ["The human genome", "TEST", 0, 16], ["retroviral", "OBSERVATION", 74, 84], ["LTR elements", "OBSERVATION", 93, 105]]], ["Some of these elements are intact and conserved (human ERVs (HERVs)) and this genomic population has some clear characteristics of a viral quasispecies.", [["human", "ORGANISM", 49, 54], ["ERVs", "GENE_OR_GENE_PRODUCT", 55, 59], ["HERVs", "GENE_OR_GENE_PRODUCT", 61, 66], ["human ERVs", "DNA", 49, 59], ["HERVs", "DNA", 61, 66], ["human", "SPECIES", 49, 54], ["human", "SPECIES", 49, 54], ["this genomic population", "PROBLEM", 73, 96], ["a viral quasispecies", "PROBLEM", 131, 151], ["intact", "OBSERVATION", 27, 33], ["clear characteristics", "OBSERVATION_MODIFIER", 106, 127], ["viral quasispecies", "OBSERVATION", 133, 151]]], ["Such large amounts of genetic material have previously been dismissed simply as selfi sh or junk DNA of no fi tness consequences to the host.", [["DNA", "CELLULAR_COMPONENT", 97, 100], ["Such large amounts of genetic material", "PROBLEM", 0, 38], ["large", "OBSERVATION_MODIFIER", 5, 10], ["amounts", "OBSERVATION_MODIFIER", 11, 18], ["genetic material", "OBSERVATION", 22, 38]]], ["However, given the importance of quasispecies mutant genomes for viral fi tness and persistence, we might need to re-evaluate this dismissal.", [["quasispecies mutant genomes", "DNA", 33, 60], ["quasispecies mutant genomes", "PROBLEM", 33, 60], ["viral fi tness", "PROBLEM", 65, 79]]], ["Retroviruses are clearly part of the human ancestry thus we should seek to understand, not dismiss their role in human evolution.Evolution of High FidelityIn contrast to the story above in which polio infection of mouse brain was dependent on the quasispecies resulting from lowered fi delity replication, a different relationship has been proposed for the nidoviruses.", [["brain", "ANATOMY", 220, 225], ["infection", "DISEASE", 201, 210], ["Retroviruses", "ORGANISM", 0, 12], ["human", "ORGANISM", 37, 42], ["human", "ORGANISM", 113, 118], ["polio", "ORGANISM", 195, 200], ["mouse", "ORGANISM", 214, 219], ["brain", "ORGAN", 220, 225], ["nidoviruses", "GENE_OR_GENE_PRODUCT", 357, 368], ["human", "SPECIES", 37, 42], ["human", "SPECIES", 113, 118], ["mouse", "SPECIES", 214, 219], ["human", "SPECIES", 37, 42], ["human", "SPECIES", 113, 118], ["mouse", "SPECIES", 214, 219], ["High Fidelity", "PROBLEM", 142, 155], ["polio infection of mouse brain", "PROBLEM", 195, 225], ["the quasispecies", "PROBLEM", 243, 259], ["lowered fi delity replication", "PROBLEM", 275, 304], ["the nidoviruses", "PROBLEM", 353, 368], ["High Fidelity", "OBSERVATION", 142, 155], ["infection", "OBSERVATION", 201, 210], ["brain", "ANATOMY", 220, 225]]], ["These are also positive single-stranded polycistronic RNA viruses ( Gorbalenya et al. , 2006 ) .", [["positive single-stranded polycistronic RNA viruses", "PROBLEM", 15, 65], ["positive", "OBSERVATION_MODIFIER", 15, 23], ["stranded", "OBSERVATION_MODIFIER", 31, 39], ["polycistronic RNA viruses", "OBSERVATION", 40, 65]]], ["This group of virus includes the coronaviruses (e.g. mouse hepatitis virus and SARS-associated coronavirus), which are the largest RNA viruses known (26-32 kb).", [["hepatitis virus", "DISEASE", 59, 74], ["SARS", "DISEASE", 79, 83], ["coronaviruses", "ORGANISM", 33, 46], ["mouse hepatitis virus", "ORGANISM", 53, 74], ["SARS-associated coronavirus", "ORGANISM", 79, 106], ["mouse", "SPECIES", 53, 58], ["hepatitis virus", "SPECIES", 59, 74], ["coronavirus", "SPECIES", 95, 106], ["mouse hepatitis virus", "SPECIES", 53, 74], ["SARS-associated coronavirus", "SPECIES", 79, 106], ["virus", "PROBLEM", 14, 19], ["the coronaviruses", "PROBLEM", 29, 46], ["mouse hepatitis virus", "PROBLEM", 53, 74], ["SARS", "PROBLEM", 79, 83], ["coronavirus", "PROBLEM", 95, 106], ["virus", "OBSERVATION", 14, 19], ["largest", "OBSERVATION_MODIFIER", 123, 130], ["RNA viruses", "OBSERVATION", 131, 142]]], ["It has been proposed that such large genomes have required the adaptation of a high-fi delity RNA polymerase in order to increase the error threshold and accommodate large RNA genomes.", [["high-fi delity RNA polymerase", "PROTEIN", 79, 108], ["RNA genomes", "DNA", 172, 183], ["a high-fi delity RNA polymerase", "TREATMENT", 77, 108], ["large RNA genomes", "PROBLEM", 166, 183], ["large", "OBSERVATION_MODIFIER", 31, 36], ["genomes", "OBSERVATION", 37, 44], ["large", "OBSERVATION_MODIFIER", 166, 171], ["RNA genomes", "OBSERVATION", 172, 183]]], ["Based on the phylogenetics of this polymerase and other RNA-processing enzymes, this group of viruses appears to be monophyletic and it is thought that the acquisition of a high-fi delity RNA replicase was central to the origin of this lineage.", [["RNA-processing enzymes", "PROTEIN", 56, 78], ["this polymerase", "TEST", 30, 45], ["processing enzymes", "TEST", 60, 78], ["viruses", "PROBLEM", 94, 101], ["monophyletic", "PROBLEM", 116, 128], ["a high-fi delity RNA replicase", "TREATMENT", 171, 201], ["viruses", "OBSERVATION", 94, 101], ["monophyletic", "OBSERVATION", 116, 128], ["origin", "ANATOMY_MODIFIER", 221, 227]]], ["This type of replicase is unique to RNA viruses.", [["RNA viruses", "PROBLEM", 36, 47], ["RNA viruses", "OBSERVATION", 36, 47]]], ["The monophyletic view stems from an analysis of a small set of conserved genes.", [["conserved genes", "DNA", 63, 78], ["an analysis", "TEST", 33, 44], ["small", "OBSERVATION_MODIFIER", 50, 55]]], ["Overall, however, these larger genomes have many other genes that show no similarities to related viruses.", [["larger", "OBSERVATION_MODIFIER", 24, 30], ["no", "UNCERTAINTY", 71, 73], ["viruses", "OBSERVATION", 98, 105]]], ["The origins and evolution of these more diverse and numerous genes cannot be currently traced.Evolution of High FidelityThis is an inherent problem in the analysis of virus evolution: a small selected set of hallmark genes with some similarity are assumed to trace an apparently linear (tree-based) viral lineage whereas the larger number of genes are not included and cannot be traced.", [["hallmark genes", "DNA", 208, 222], ["viral lineage", "CELL_TYPE", 299, 312], ["High Fidelity", "PROBLEM", 107, 120], ["an inherent problem", "PROBLEM", 128, 147], ["a small selected set of hallmark genes", "PROBLEM", 184, 222], ["trace an apparently linear (tree-based) viral lineage", "PROBLEM", 259, 312], ["origins", "ANATOMY_MODIFIER", 4, 11], ["more", "OBSERVATION_MODIFIER", 35, 39], ["diverse", "OBSERVATION_MODIFIER", 40, 47], ["numerous", "OBSERVATION_MODIFIER", 52, 60], ["genes", "OBSERVATION", 61, 66], ["High Fidelity", "OBSERVATION", 107, 120], ["inherent", "OBSERVATION_MODIFIER", 131, 139], ["problem", "OBSERVATION", 140, 147], ["small", "OBSERVATION_MODIFIER", 186, 191], ["hallmark genes", "OBSERVATION", 208, 222], ["trace", "OBSERVATION_MODIFIER", 259, 264], ["linear", "OBSERVATION_MODIFIER", 279, 285], ["tree", "OBSERVATION_MODIFIER", 287, 291], ["viral lineage", "OBSERVATION", 299, 312], ["larger", "OBSERVATION_MODIFIER", 325, 331], ["number", "OBSERVATION_MODIFIER", 332, 338]]], ["If most of RNA virus evolution is indeed mediated by a mixed cloud of genomes, any role for mutant mixtures thus becomes obscure.", [["RNA virus evolution", "PROBLEM", 11, 30], ["a mixed cloud of genomes", "PROBLEM", 53, 77], ["mutant mixtures", "PROBLEM", 92, 107], ["mixed", "OBSERVATION_MODIFIER", 55, 60], ["cloud", "OBSERVATION", 61, 66]]], ["How might we explain the increased fi delity and genome size of the nidoviruses?", [["the increased fi delity", "PROBLEM", 21, 44], ["the nidoviruses", "PROBLEM", 64, 79], ["increased", "OBSERVATION_MODIFIER", 25, 34], ["size", "OBSERVATION_MODIFIER", 56, 60]]], ["Was there some change in viral adaptation in which quasispecies and generation of mixtures was no longer as important for adaptation?", [["some change in viral adaptation", "PROBLEM", 10, 41], ["generation of mixtures", "TREATMENT", 68, 90], ["some", "OBSERVATION_MODIFIER", 10, 14], ["change", "OBSERVATION_MODIFIER", 15, 21], ["viral adaptation", "OBSERVATION", 25, 41]]], ["Did the need and selection for a larger genome override the use of error to generate adaptability as seen in poliovirus and HIV-1?", [["poliovirus", "ORGANISM", 109, 119], ["HIV-1", "ORGANISM", 124, 129], ["HIV", "SPECIES", 124, 127], ["poliovirus", "SPECIES", 109, 119], ["HIV-1", "SPECIES", 124, 129], ["selection", "TREATMENT", 17, 26], ["poliovirus", "PROBLEM", 109, 119], ["HIV", "PROBLEM", 124, 127]]], ["If so, what selective pressures might have changed this seemingly basic feature?", [["selective pressures", "TEST", 12, 31]]], ["What do we know about the natural biology of these viruses, which might provide some insight into this?Evolution of High FidelityUnfortunately, the natural distribution and gene functions of the nidoviruses are generally poorly understood.", [["nidoviruses", "GENE_OR_GENE_PRODUCT", 195, 206], ["these viruses", "PROBLEM", 45, 58], ["High Fidelity", "PROBLEM", 116, 129], ["viruses", "OBSERVATION", 51, 58], ["High Fidelity", "OBSERVATION", 116, 129], ["natural", "OBSERVATION_MODIFIER", 148, 155], ["distribution", "OBSERVATION_MODIFIER", 156, 168]]], ["In terms of coronaviruses, numerous mammal and avian species can be infected and the virus will cause acute disease.", [["coronaviruses", "ORGANISM", 12, 25], ["avian", "ORGANISM", 47, 52], ["coronaviruses", "PROBLEM", 12, 25], ["numerous mammal and avian species", "PROBLEM", 27, 60], ["the virus", "PROBLEM", 81, 90], ["acute disease", "PROBLEM", 102, 115], ["coronaviruses", "OBSERVATION", 12, 25], ["numerous", "OBSERVATION_MODIFIER", 27, 35], ["mammal", "OBSERVATION_MODIFIER", 36, 42], ["avian species", "OBSERVATION", 47, 60], ["acute", "OBSERVATION_MODIFIER", 102, 107], ["disease", "OBSERVATION", 108, 115]]], ["In several of these acute infections, the virus involved seems to have recently been adapted to the new host from other, often unknown sources.", [["infections", "DISEASE", 26, 36], ["these acute infections", "PROBLEM", 14, 36], ["the virus", "PROBLEM", 38, 47], ["acute", "OBSERVATION_MODIFIER", 20, 25], ["infections", "OBSERVATION", 26, 36]]], ["With the recent emergence of the SARS virus and human infections, however, much greater attention has been focussed on trying to understand the origin and evolution of this virus.", [["SARS virus", "DISEASE", 33, 43], ["human infections", "DISEASE", 48, 64], ["SARS virus", "ORGANISM", 33, 43], ["human", "ORGANISM", 48, 53], ["human", "SPECIES", 48, 53], ["SARS virus", "SPECIES", 33, 43], ["human", "SPECIES", 48, 53], ["the SARS virus", "PROBLEM", 29, 43], ["human infections", "PROBLEM", 48, 64], ["this virus", "PROBLEM", 168, 178], ["infections", "OBSERVATION", 54, 64]]], ["It has recently become clear that there indeed appears to exist an evolutionary stable source of this virus from which adaptation to humans was possible.Evolution of High FidelityVarious bat species have been found to support persistent asymptomatic infections by specifi c versions of SARS viruses ( Tang et al. , 2006 ; Vijaykrishna et al. , 2007 ) .", [["infections", "DISEASE", 250, 260], ["SARS", "DISEASE", 286, 290], ["humans", "ORGANISM", 133, 139], ["bat", "ORGANISM", 187, 190], ["SARS viruses", "ORGANISM", 286, 298], ["humans", "SPECIES", 133, 139], ["humans", "SPECIES", 133, 139], ["SARS viruses", "SPECIES", 286, 298], ["this virus", "PROBLEM", 97, 107], ["High Fidelity", "PROBLEM", 166, 179], ["Various bat species", "PROBLEM", 179, 198], ["persistent asymptomatic infections", "PROBLEM", 226, 260], ["SARS viruses", "PROBLEM", 286, 298], ["clear", "OBSERVATION", 23, 28], ["stable", "OBSERVATION_MODIFIER", 80, 86], ["High Fidelity", "OBSERVATION", 166, 179], ["persistent", "OBSERVATION_MODIFIER", 226, 236], ["asymptomatic", "OBSERVATION_MODIFIER", 237, 249], ["infections", "OBSERVATION", 250, 260]]], ["These studies also indicate that there appear to be three different and independent groups of SARS viruses in bats.", [["SARS", "DISEASE", 94, 98], ["SARS viruses", "ORGANISM", 94, 106], ["bats", "ORGANISM", 110, 114], ["SARS viruses", "SPECIES", 94, 106], ["These studies", "TEST", 0, 13], ["SARS viruses", "PROBLEM", 94, 106], ["SARS viruses", "OBSERVATION", 94, 106]]], ["In fact six novel coronaviruses were isolated from six different bat species showing an astonishing diversity in bats.", [["coronaviruses", "ORGANISM", 18, 31], ["novel coronaviruses", "PROBLEM", 12, 31], ["coronaviruses", "OBSERVATION", 18, 31], ["astonishing diversity", "OBSERVATION", 88, 109]]], ["Furthermore, phylogenetic analysis indicates that all bat coronaviruses appear to have descended from a common ancestor.", [["bat coronaviruses", "ORGANISM", 54, 71], ["bat coronaviruses", "SPECIES", 54, 71], ["phylogenetic analysis", "TEST", 13, 34], ["all bat coronaviruses", "PROBLEM", 50, 71]]], ["Only one of these bat groups includes SARS and SARS-like coronaviruses that adapted to acute human infections.", [["SARS", "DISEASE", 38, 42], ["SARS-like coronaviruses", "DISEASE", 47, 70], ["acute human infections", "DISEASE", 87, 109], ["SARS-like coronaviruses", "ORGANISM", 47, 70], ["human", "ORGANISM", 93, 98], ["human", "SPECIES", 93, 98], ["human", "SPECIES", 93, 98], ["SARS", "PROBLEM", 38, 42], ["SARS", "PROBLEM", 47, 51], ["coronaviruses", "PROBLEM", 57, 70], ["acute human infections", "PROBLEM", 87, 109], ["SARS", "OBSERVATION", 38, 42], ["infections", "OBSERVATION", 99, 109]]], ["Thus, a prevalent and speciesspecifi c persistence of SARS viruses is found in particular geographical populations.", [["SARS viruses", "DISEASE", 54, 66], ["SARS viruses", "ORGANISM", 54, 66], ["SARS viruses", "SPECIES", 54, 66], ["SARS viruses", "PROBLEM", 54, 66], ["SARS viruses", "OBSERVATION", 54, 66]]], ["Could the adaptation to a host-specifi c persistence-based basal life strategy provide some explanations for the evolution of the higher fi delity RNA replicase of these coronaviruses?", [["specifi c", "GENE_OR_GENE_PRODUCT", 31, 40], ["coronaviruses", "ORGANISM", 170, 183], ["basal life strategy", "TREATMENT", 59, 78], ["these coronaviruses", "PROBLEM", 164, 183], ["coronaviruses", "OBSERVATION", 170, 183]]], ["As I have argued, persistent viral infection represents the majority of evolutionary stable viral lineages ( Villarreal, 2006 ) .", [["viral infection", "DISEASE", 29, 44], ["persistent viral infection", "PROBLEM", 18, 44], ["evolutionary stable viral lineages", "PROBLEM", 72, 106], ["persistent", "OBSERVATION_MODIFIER", 18, 28], ["viral", "OBSERVATION_MODIFIER", 29, 34], ["infection", "OBSERVATION", 35, 44], ["stable", "OBSERVATION_MODIFIER", 85, 91], ["viral lineages", "OBSERVATION", 92, 106]]], ["However, we have almost no knowledge regarding how these bat SARS viruses persist and escape elimination by innate and adaptive immunity and what, if any, role the high-fi delity replicase (or other genes) have in this life strategy.MHV-Mouse Exemplar (A Case for Persistence and Virus Addiction)Although we cannot yet evaluate natural SARS virus persistence in native bat hosts, another coronavirus may be more informative regarding the effects of persistence on host populations.", [["SARS", "DISEASE", 61, 65], ["bat SARS viruses", "ORGANISM", 57, 73], ["MHV", "ORGANISM", 233, 236], ["Mouse", "ORGANISM", 237, 242], ["SARS virus", "ORGANISM", 336, 346], ["bat hosts", "ORGANISM", 369, 378], ["coronavirus", "ORGANISM", 388, 399], ["host populations", "CELL", 464, 480], ["high-fi delity replicase", "DNA", 164, 188], ["Mouse", "SPECIES", 237, 242], ["MHV", "SPECIES", 233, 236], ["Mouse", "SPECIES", 237, 242], ["SARS virus", "SPECIES", 336, 346], ["these bat SARS viruses", "PROBLEM", 51, 73], ["natural SARS virus", "PROBLEM", 328, 346], ["another coronavirus", "PROBLEM", 380, 399]]], ["Mouse hepatitis virus (MHV) may provide our best exemplar of virus-host relationships and show how the concept of virus addiction relates to population persistence.", [["Mouse hepatitis virus", "DISEASE", 0, 21], ["Mouse hepatitis virus", "ORGANISM", 0, 21], ["MHV", "ORGANISM", 23, 26], ["Mouse hepatitis virus", "SPECIES", 0, 21], ["Mouse hepatitis virus", "SPECIES", 0, 21], ["MHV", "SPECIES", 23, 26], ["Mouse hepatitis virus", "PROBLEM", 0, 21], ["virus addiction", "PROBLEM", 114, 129], ["virus", "OBSERVATION", 114, 119]]], ["MHV is the best-studied coronavirus.", [["MHV", "ORGANISM", 0, 3], ["coronavirus", "ORGANISM", 24, 35], ["MHV", "SPECIES", 0, 3], ["MHV", "PROBLEM", 0, 3], ["coronavirus", "PROBLEM", 24, 35]]], ["As a natural and prevalent virus of rodents, MHV is our best natural model of persistent RNA virus-host relationships for any mammal.", [["MHV", "ORGANISM", 45, 48], ["MHV", "SPECIES", 45, 48], ["a natural and prevalent virus of rodents", "PROBLEM", 3, 43], ["MHV", "TREATMENT", 45, 48], ["persistent RNA virus", "PROBLEM", 78, 98], ["persistent", "OBSERVATION_MODIFIER", 78, 88], ["RNA virus", "OBSERVATION", 89, 98]]], ["In general, rodents are the most studied non-domestic mammals with regard to natural virus distribution.MHV-Mouse Exemplar (A Case for Persistence and Virus Addiction)Overall, we know that wild-caught rodents seldom show signs of acute virus infection ( Kashuba et al. , 2005 ) .", [["acute virus infection", "DISEASE", 230, 251], ["rodents", "ORGANISM", 12, 19], ["MHV", "ORGANISM", 104, 107], ["Mouse", "ORGANISM", 108, 113], ["rodents", "ORGANISM", 201, 208], ["Mouse", "SPECIES", 108, 113], ["MHV", "SPECIES", 104, 107], ["Mouse", "SPECIES", 108, 113], ["acute virus infection", "PROBLEM", 230, 251], ["natural virus", "OBSERVATION", 77, 90], ["acute", "OBSERVATION_MODIFIER", 230, 235], ["virus", "OBSERVATION", 236, 241]]], ["However, asymptomatic virus persistence is ubiquitous in wild rodents ( Descoteaux et al. , 1977 ; Gannon and Carthew, 1980 ; Schoondermark-van de Ven et al. , 2006 ) , including voles ( Descoteaux and Mihok, 1986 ) .", [["asymptomatic virus persistence", "PROBLEM", 9, 39], ["asymptomatic", "OBSERVATION_MODIFIER", 9, 21], ["virus", "OBSERVATION", 22, 27]]], ["Some fi eld studies have evaluated broader patterns of virus persistence in mice ( Singleton et al. , 1993 ; Becker et al. , 2007 ) which indicated that wild house mice are highly colonized with MHV (80-100% prevalence).", [["mice", "ORGANISM", 76, 80], ["mice", "ORGANISM", 164, 168], ["MHV", "ORGANISM", 195, 198], ["mice", "SPECIES", 76, 80], ["mice", "SPECIES", 164, 168], ["mice", "SPECIES", 76, 80], ["mice", "SPECIES", 164, 168], ["MHV", "SPECIES", 195, 198], ["Some fi eld studies", "TEST", 0, 19], ["virus persistence", "PROBLEM", 55, 72], ["virus", "OBSERVATION", 55, 60]]], ["In addition to MHV, mouse cytomegalovirus, mouse parvovirus, mouse thymic virus, and mouse adenovirus are also prevalent.", [["MHV", "ORGANISM", 15, 18], ["mouse", "ORGANISM", 20, 25], ["cytomegalovirus", "ORGANISM", 26, 41], ["mouse parvovirus", "ORGANISM", 43, 59], ["mouse thymic virus", "ORGANISM", 61, 79], ["mouse", "ORGANISM", 85, 90], ["adenovirus", "ORGANISM", 91, 101], ["mouse", "SPECIES", 20, 25], ["mouse", "SPECIES", 43, 48], ["parvovirus", "SPECIES", 49, 59], ["mouse", "SPECIES", 61, 66], ["mouse", "SPECIES", 85, 90], ["MHV", "SPECIES", 15, 18], ["mouse cytomegalovirus", "SPECIES", 20, 41], ["mouse parvovirus", "SPECIES", 43, 59], ["mouse thymic virus", "SPECIES", 61, 79], ["mouse", "SPECIES", 85, 90], ["MHV", "TREATMENT", 15, 18], ["mouse cytomegalovirus", "PROBLEM", 20, 41], ["mouse parvovirus", "PROBLEM", 43, 59], ["mouse thymic virus", "PROBLEM", 61, 79], ["mouse adenovirus", "PROBLEM", 85, 101], ["MHV", "ANATOMY", 15, 18], ["mouse cytomegalovirus", "OBSERVATION", 20, 41], ["mouse parvovirus", "OBSERVATION", 43, 59], ["mouse thymic virus", "OBSERVATION", 61, 79], ["mouse adenovirus", "OBSERVATION", 85, 101]]], ["Other well-studied mouse viruses, such as lymphocytic choriomeningitis virus (LCMV) and polyomavirus (PyV), were at low natural prevalence.", [["lymphocytic choriomeningitis virus (LCMV) and polyomavirus", "DISEASE", 42, 100], ["mouse", "ORGANISM", 19, 24], ["lymphocytic choriomeningitis virus", "ORGANISM", 42, 76], ["LCMV", "ORGANISM", 78, 82], ["polyomavirus", "ORGANISM", 88, 100], ["PyV", "CANCER", 102, 105], ["mouse", "SPECIES", 19, 24], ["lymphocytic choriomeningitis virus", "SPECIES", 42, 76], ["mouse", "SPECIES", 19, 24], ["lymphocytic choriomeningitis virus", "SPECIES", 42, 76], ["LCMV", "SPECIES", 78, 82], ["PyV", "SPECIES", 102, 105], ["Other well-studied mouse viruses", "PROBLEM", 0, 32], ["lymphocytic choriomeningitis virus", "PROBLEM", 42, 76], ["polyomavirus", "PROBLEM", 88, 100], ["viruses", "OBSERVATION", 25, 32], ["lymphocytic choriomeningitis", "OBSERVATION", 42, 70]]], ["Interestingly, some non-native house mice that have colonized isolated islands may lack MHV ( Moro et al. , 1999 ) , although most other isolated island populations retain MHV ( Moro et al. , 2003 ) .MHV-Mouse Exemplar (A Case for Persistence and Virus Addiction)Other small mammals have yet to show any viral disease whatsoever (hedgehogs, chinchillas, prairie dogs, gerbils, sugar gliders) ( Kashuba et al. , 2005 ) .", [["sugar", "CHEMICAL", 377, 382], ["mice", "ORGANISM", 37, 41], ["MHV", "ORGANISM", 88, 91], ["MHV", "ORGANISM", 172, 175], ["MHV", "ORGANISM", 200, 203], ["Mouse", "ORGANISM", 204, 209], ["chinchillas", "ORGANISM_SUBDIVISION", 341, 352], ["prairie dogs", "ORGANISM", 354, 366], ["gerbils", "ORGANISM_SUBDIVISION", 368, 375], ["mice", "SPECIES", 37, 41], ["Mouse", "SPECIES", 204, 209], ["dogs", "SPECIES", 362, 366], ["mice", "SPECIES", 37, 41], ["MHV", "SPECIES", 88, 91], ["MHV", "SPECIES", 172, 175], ["MHV", "SPECIES", 200, 203], ["Mouse", "SPECIES", 204, 209], ["any viral disease", "PROBLEM", 300, 317], ["MHV", "OBSERVATION_MODIFIER", 172, 175], ["viral", "OBSERVATION", 304, 309]]], ["Thus, asymptomatic persistent viral infection is clearly the norm in rodents.", [["viral infection", "DISEASE", 30, 45], ["asymptomatic persistent viral infection", "PROBLEM", 6, 45], ["asymptomatic", "OBSERVATION_MODIFIER", 6, 18], ["persistent", "OBSERVATION_MODIFIER", 19, 29], ["viral", "OBSERVATION_MODIFIER", 30, 35], ["infection", "OBSERVATION", 36, 45]]], ["Yet, in spite of this usual asymptomatic viral persistence, historically, some zoonotic viral disease outbreaks have occasionally been documented in natural populations.", [["zoonotic viral disease", "DISEASE", 79, 101], ["this usual asymptomatic viral persistence", "PROBLEM", 17, 58], ["some zoonotic viral disease outbreaks", "PROBLEM", 74, 111], ["viral persistence", "OBSERVATION", 41, 58], ["zoonotic", "OBSERVATION_MODIFIER", 79, 87], ["viral disease", "OBSERVATION", 88, 101]]], ["One such early outbreak was an epizootic diarrhea that occurred in infant mice ( Adams and Kraft, 1963 ) .", [["diarrhea", "DISEASE", 41, 49], ["mice", "ORGANISM", 74, 78], ["infant", "SPECIES", 67, 73], ["mice", "SPECIES", 74, 78], ["mice", "SPECIES", 74, 78], ["an epizootic diarrhea", "PROBLEM", 28, 49], ["early", "OBSERVATION_MODIFIER", 9, 14], ["outbreak", "OBSERVATION_MODIFIER", 15, 23], ["epizootic", "OBSERVATION_MODIFIER", 31, 40], ["diarrhea", "OBSERVATION", 41, 49]]], ["Later, it was established that one such infection was due to mouse hepatitis virus ( Carthew, 1977 ; Ishida et al. , 1978 ) .", [["infection", "DISEASE", 40, 49], ["mouse hepatitis virus", "DISEASE", 61, 82], ["mouse", "ORGANISM", 61, 66], ["hepatitis virus", "ORGANISM", 67, 82], ["mouse", "SPECIES", 61, 66], ["hepatitis virus", "SPECIES", 67, 82], ["mouse hepatitis virus", "SPECIES", 61, 82], ["one such infection", "PROBLEM", 31, 49], ["mouse hepatitis virus", "PROBLEM", 61, 82], ["infection", "OBSERVATION", 40, 49]]], ["In spite of this disease outbreak, with MHV, it has since become clear that asymptomatic persistent infections are the norm and are highly stable.", [["infections", "DISEASE", 100, 110], ["MHV", "SPECIES", 40, 43], ["this disease outbreak", "PROBLEM", 12, 33], ["MHV", "TREATMENT", 40, 43], ["asymptomatic persistent infections", "PROBLEM", 76, 110], ["disease", "OBSERVATION", 17, 24], ["asymptomatic", "OBSERVATION_MODIFIER", 76, 88], ["persistent", "OBSERVATION_MODIFIER", 89, 99], ["infections", "OBSERVATION", 100, 110], ["highly", "OBSERVATION_MODIFIER", 132, 138], ["stable", "OBSERVATION_MODIFIER", 139, 145]]], ["Yet MHV disease outbreaks, especially in virus-free mouse facilities, are also common and severe.", [["MHV disease", "DISEASE", 4, 15], ["mouse", "ORGANISM", 52, 57], ["mouse", "SPECIES", 52, 57], ["MHV", "SPECIES", 4, 7], ["mouse", "SPECIES", 52, 57], ["MHV disease outbreaks", "PROBLEM", 4, 25], ["MHV", "OBSERVATION_MODIFIER", 4, 7], ["disease", "OBSERVATION", 8, 15], ["severe", "OBSERVATION_MODIFIER", 90, 96]]], ["How does MHV attain such stable and prevalent persistence in natural population yet retain the ability to cause disease in naive populations?", [["MHV", "ORGANISM", 9, 12], ["naive populations", "CELL_TYPE", 123, 140], ["MHV", "SPECIES", 9, 12], ["disease in naive populations", "PROBLEM", 112, 140], ["stable", "OBSERVATION_MODIFIER", 25, 31]]], ["What maintains the MHV fi tness of natural persistence?MHV-Mouse Exemplar (A Case for Persistence and Virus Addiction)It is well known that once MHV is established in a mouse or rat colony it can be very diffi cult to eliminate ( Gannon and Carthew, 1980 ; Lussier and Descoteaux, 1986 ) , clearly indicating that stability is rapidly attained and likely genetically programmed by the virus.", [["colony", "ANATOMY", 182, 188], ["MHV", "ORGANISM", 55, 58], ["Mouse", "ORGANISM", 59, 64], ["MHV", "ORGANISM", 145, 148], ["mouse", "ORGANISM", 169, 174], ["rat", "ORGANISM", 178, 181], ["Mouse", "SPECIES", 59, 64], ["mouse", "SPECIES", 169, 174], ["rat", "SPECIES", 178, 181], ["MHV", "SPECIES", 55, 58], ["Mouse", "SPECIES", 59, 64], ["MHV", "SPECIES", 145, 148], ["mouse", "SPECIES", 169, 174], ["rat", "SPECIES", 178, 181], ["the virus", "PROBLEM", 381, 390], ["MHV", "OBSERVATION", 19, 22], ["natural persistence", "OBSERVATION", 35, 54], ["stability", "OBSERVATION", 314, 323]]], ["I propose that these stable evolutionary states of viral persistence are due to a strategy we can call virus addiction ( Villarreal, 2005 ) and that MHV can provide the exemplar of such a state.", [["MHV", "ORGANISM", 149, 152], ["MHV", "SPECIES", 149, 152], ["viral persistence", "PROBLEM", 51, 68], ["MHV", "TREATMENT", 149, 152], ["stable", "OBSERVATION_MODIFIER", 21, 27], ["viral persistence", "OBSERVATION", 51, 68]]], ["With MHV, only persistently infected mice colonies are protected from the disease that is otherwise caused by the virus.", [["colonies", "ANATOMY", 42, 50], ["MHV", "ORGANISM", 5, 8], ["mice", "ORGANISM", 37, 41], ["mice", "SPECIES", 37, 41], ["MHV", "SPECIES", 5, 8], ["mice", "SPECIES", 37, 41], ["MHV", "TREATMENT", 5, 8], ["persistently infected mice colonies", "PROBLEM", 15, 50], ["the disease", "PROBLEM", 70, 81], ["the virus", "PROBLEM", 110, 119], ["MHV", "ANATOMY", 5, 8], ["persistently", "OBSERVATION_MODIFIER", 15, 27], ["infected", "OBSERVATION_MODIFIER", 28, 36], ["mice colonies", "OBSERVATION", 37, 50], ["disease", "OBSERVATION", 74, 81], ["virus", "OBSERVATION", 114, 119]]], ["In wild asymptomatic mice, MHV is found mostly as an enteric infection.", [["enteric infection", "DISEASE", 53, 70], ["mice", "ORGANISM", 21, 25], ["MHV", "ORGANISM", 27, 30], ["mice", "SPECIES", 21, 25], ["mice", "SPECIES", 21, 25], ["MHV", "SPECIES", 27, 30], ["MHV", "PROBLEM", 27, 30], ["an enteric infection", "PROBLEM", 50, 70], ["enteric", "OBSERVATION_MODIFIER", 53, 60], ["infection", "OBSERVATION", 61, 70]]], ["The CNS demyelinated disease that MHV can induce is most observed in newborn pups ( Homberger, 1997 ; Nash et al. , 2001 ) and once in the brain, MHV can persist in CNS with recurring disease ( Marten et al. , 2001 ) .", [["CNS", "ANATOMY", 4, 7], ["brain", "ANATOMY", 139, 144], ["CNS", "ANATOMY", 165, 168], ["CNS", "ANATOMICAL_SYSTEM", 4, 7], ["MHV", "ORGANISM", 34, 37], ["pups", "ORGANISM_SUBDIVISION", 77, 81], ["brain", "ORGAN", 139, 144], ["MHV", "ORGANISM", 146, 149], ["CNS", "ANATOMICAL_SYSTEM", 165, 168], ["MHV", "SPECIES", 34, 37], ["MHV", "SPECIES", 146, 149], ["The CNS demyelinated disease", "PROBLEM", 0, 28], ["recurring disease", "PROBLEM", 174, 191], ["CNS", "ANATOMY", 4, 7], ["demyelinated", "OBSERVATION", 8, 20], ["brain", "ANATOMY", 139, 144], ["MHV", "ANATOMY", 146, 149], ["CNS", "ANATOMY", 165, 168]]], ["This recurring CNS disease is also associated with quasispecies (in the S gene) and recombination ( Rowe et al. , 1998 ) .", [["CNS", "ANATOMY", 15, 18], ["CNS", "ANATOMICAL_SYSTEM", 15, 18], ["S gene", "DNA", 72, 78], ["This recurring CNS disease", "PROBLEM", 0, 26], ["quasispecies", "PROBLEM", 51, 63], ["CNS", "ANATOMY", 15, 18], ["disease", "OBSERVATION", 19, 26], ["quasispecies", "OBSERVATION", 51, 63]]], ["The most serious CNS disease is in S-gene variant of MHV-4 (JHM), thus as with the poliomouse model, pathogenic fi tness with MHV is also associated with quasispecies.MHV-Mouse Exemplar (A Case for Persistence and Virus Addiction)Such MHV disease is the bane of all mouse colonies ( Knobler et al. , 1982 ) .", [["CNS", "ANATOMY", 17, 20], ["colonies", "ANATOMY", 272, 280], ["MHV disease", "DISEASE", 235, 246], ["CNS", "ANATOMICAL_SYSTEM", 17, 20], ["MHV-4", "ORGANISM", 53, 58], ["JHM", "CANCER", 60, 63], ["MHV", "ORGANISM", 126, 129], ["MHV", "ORGANISM", 167, 170], ["Mouse", "ORGANISM", 171, 176], ["mouse", "ORGANISM", 266, 271], ["Mouse", "SPECIES", 171, 176], ["mouse", "SPECIES", 266, 271], ["MHV", "SPECIES", 126, 129], ["MHV", "SPECIES", 167, 170], ["Mouse", "SPECIES", 171, 176], ["MHV", "SPECIES", 235, 238], ["mouse", "SPECIES", 266, 271], ["The most serious CNS disease", "PROBLEM", 0, 28], ["the poliomouse model", "PROBLEM", 79, 99], ["pathogenic fi tness", "PROBLEM", 101, 120], ["MHV", "PROBLEM", 126, 129], ["quasispecies", "PROBLEM", 154, 166], ["Such MHV disease", "PROBLEM", 230, 246], ["all mouse colonies", "PROBLEM", 262, 280], ["most", "OBSERVATION_MODIFIER", 4, 8], ["serious", "OBSERVATION_MODIFIER", 9, 16], ["CNS", "ANATOMY", 17, 20], ["disease", "OBSERVATION", 21, 28], ["MHV", "ANATOMY", 53, 56], ["pathogenic fi tness", "OBSERVATION", 101, 120], ["MHV", "OBSERVATION", 126, 129]]], ["However, once MHV persistence is attained, the problem to a mouse facility is not due to acute disease, but because immunological measurements are signifi cantly affected by MHV persistence.", [["mouse", "ORGANISM", 60, 65], ["MHV", "ORGANISM", 174, 177], ["mouse", "SPECIES", 60, 65], ["MHV", "SPECIES", 14, 17], ["mouse", "SPECIES", 60, 65], ["MHV", "SPECIES", 174, 177], ["acute disease", "PROBLEM", 89, 102], ["immunological measurements", "TEST", 116, 142], ["not due to", "UNCERTAINTY", 78, 88], ["acute", "OBSERVATION_MODIFIER", 89, 94], ["disease", "OBSERVATION", 95, 102], ["MHV", "OBSERVATION_MODIFIER", 174, 177], ["persistence", "OBSERVATION_MODIFIER", 178, 189]]], ["Thus MHV alters mouse molecular identity regarding immunological (T-cell) reactions ( Wilberz et al. , 1991 ) .", [["T-cell", "ANATOMY", 66, 72], ["MHV", "ORGANISM", 5, 8], ["mouse", "ORGANISM", 16, 21], ["T-cell", "CELL", 66, 72], ["mouse", "SPECIES", 16, 21], ["MHV", "SPECIES", 5, 8], ["mouse", "SPECIES", 16, 21], ["immunological (T-cell) reactions", "PROBLEM", 51, 83]]], ["To establish stable asymptomatic persistence, however, MHV needs to infect newborns ( Weir et al. , 1987 ) , in which acute disease is prevented due to maternal passive immune antibody transfer ( Gustafsson et al. , 1996 ) .", [["acute disease", "DISEASE", 118, 131], ["MHV", "ORGANISM", 55, 58], ["newborns", "ORGANISM", 75, 83], ["MHV", "SPECIES", 55, 58], ["acute disease", "PROBLEM", 118, 131], ["maternal passive immune antibody transfer", "TREATMENT", 152, 193], ["stable", "OBSERVATION_MODIFIER", 13, 19], ["asymptomatic", "OBSERVATION_MODIFIER", 20, 32], ["persistence", "OBSERVATION", 33, 44], ["acute", "OBSERVATION_MODIFIER", 118, 123], ["disease", "OBSERVATION", 124, 131]]], ["Being born to immune mothers thus protects against CNS disease and promotes enteric (not brain) virus colonization.", [["CNS", "ANATOMY", 51, 54], ["brain", "ANATOMY", 89, 94], ["CNS disease", "DISEASE", 51, 62], ["CNS", "ANATOMICAL_SYSTEM", 51, 54], ["brain", "ORGAN", 89, 94], ["CNS disease", "PROBLEM", 51, 62], ["promotes enteric (not brain) virus colonization", "PROBLEM", 67, 114]]], ["In addition, it appears that persistence also promotes cross-species transfer ( Baric et al. , 1999 ) .MHV-Mouse Exemplar (A Case for Persistence and Virus Addiction)MHV persistence may involve genome stability and result in a distinct evolutionary dynamic.", [["MHV", "ORGANISM", 103, 106], ["Mouse", "ORGANISM", 107, 112], ["MHV", "ORGANISM", 166, 169], ["Mouse", "SPECIES", 107, 112], ["MHV", "SPECIES", 103, 106], ["MHV", "SPECIES", 166, 169], ["genome stability", "OBSERVATION", 194, 210]]], ["Asymptomatic persisting infections in a Lewis rat, for example, showed no variation in MHV S gene sequence, and no quasispecies as seen in brain infections ( Stuhler et al. , 1997 ) .", [["brain", "ANATOMY", 139, 144], ["infections", "DISEASE", 24, 34], ["brain infections", "DISEASE", 139, 155], ["rat", "ORGANISM", 46, 49], ["MHV S", "GENE_OR_GENE_PRODUCT", 87, 92], ["brain", "ORGAN", 139, 144], ["MHV S gene sequence", "DNA", 87, 106], ["rat", "SPECIES", 46, 49], ["MHV", "SPECIES", 87, 90], ["Asymptomatic persisting infections", "PROBLEM", 0, 34], ["variation", "PROBLEM", 74, 83], ["MHV S gene sequence", "TEST", 87, 106], ["quasispecies", "PROBLEM", 115, 127], ["brain infections", "PROBLEM", 139, 155], ["persisting", "OBSERVATION_MODIFIER", 13, 23], ["infections", "OBSERVATION", 24, 34], ["no", "UNCERTAINTY", 112, 114], ["quasispecies", "OBSERVATION", 115, 127], ["brain", "ANATOMY", 139, 144], ["infections", "OBSERVATION", 145, 155]]], ["The need to establish stable persistence could then be providing a strong selection for increased genome complexity and stability and might better explain the selection for the enhanced RNA polymerase fi delity in nidoviruses.", [["nidoviruses", "PATHOLOGICAL_FORMATION", 214, 225], ["RNA polymerase fi delity", "PROTEIN", 186, 210], ["increased genome complexity", "PROBLEM", 88, 115], ["the enhanced RNA polymerase fi delity in nidoviruses", "PROBLEM", 173, 225], ["stability", "OBSERVATION_MODIFIER", 120, 129]]], ["Evolutionary biologists often consider what might differentiate one group from another very similar group in a way that leads to two isolated and distinct populations.MHV-Mouse Exemplar (A Case for Persistence and Virus Addiction)Consider two hypothetical adjacent hay stacks harboring two Mus musculus colonies, one of which is persistently infected with MHV the other which is not.", [["colonies", "ANATOMY", 303, 311], ["MHV", "ORGANISM", 167, 170], ["Mouse", "ORGANISM", 171, 176], ["Mus musculus", "ORGANISM", 290, 302], ["MHV", "ORGANISM", 356, 359], ["Mouse", "SPECIES", 171, 176], ["Mus musculus", "SPECIES", 290, 302], ["MHV", "SPECIES", 167, 170], ["Mouse", "SPECIES", 171, 176], ["Mus musculus", "SPECIES", 290, 302], ["MHV", "SPECIES", 356, 359], ["two hypothetical adjacent hay stacks harboring two Mus musculus colonies", "PROBLEM", 239, 311], ["musculus colonies", "OBSERVATION", 294, 311], ["persistently", "OBSERVATION_MODIFIER", 329, 341], ["infected", "OBSERVATION", 342, 350]]], ["What is the fi tness consequence to the colony harboring MHV relative to its uninfected neighbor?", [["colony", "ANATOMY", 40, 46], ["MHV", "ORGANISM", 57, 60], ["MHV", "SPECIES", 57, 60], ["the colony harboring MHV", "PROBLEM", 36, 60]]], ["Our experience with MHV in mouse breeding colony provides a clear answer.", [["colony", "ANATOMY", 42, 48], ["MHV", "ORGANISM", 20, 23], ["mouse", "ORGANISM", 27, 32], ["mouse", "SPECIES", 27, 32], ["MHV", "SPECIES", 20, 23], ["mouse", "SPECIES", 27, 32]]], ["The colony that is persistently infected with MHV will have a distinct advantage over its neighbor as MHV introduced into this uninfected colony will have severe effects on the offspring.", [["colony", "ANATOMY", 4, 10], ["colony", "ANATOMY", 138, 144], ["MHV", "ORGANISM", 46, 49], ["MHV", "ORGANISM", 102, 105], ["MHV", "SPECIES", 46, 49], ["MHV", "SPECIES", 102, 105], ["MHV", "TREATMENT", 102, 105], ["this uninfected colony", "PROBLEM", 122, 144], ["colony", "OBSERVATION", 4, 10], ["persistently", "OBSERVATION_MODIFIER", 19, 31], ["infected", "OBSERVATION", 32, 40], ["distinct", "OBSERVATION_MODIFIER", 62, 70], ["advantage", "OBSERVATION_MODIFIER", 71, 80], ["severe", "OBSERVATION_MODIFIER", 155, 161]]], ["Eventually, we can expect only the MHV-harboring colony will prevail in both hay stacks.", [["colony", "ANATOMY", 49, 55], ["MHV", "ORGANISM", 35, 38], ["harboring colony", "PROBLEM", 39, 55]]], ["Only mice harboring persistent MHV are protected against the potential pathogenic consequence of acute MHV (or related virus) infection.", [["acute MHV (or related virus) infection", "DISEASE", 97, 135], ["mice", "ORGANISM", 5, 9], ["MHV", "ORGANISM", 31, 34], ["acute MHV", "ORGANISM", 97, 106], ["mice", "SPECIES", 5, 9], ["mice", "SPECIES", 5, 9], ["MHV", "SPECIES", 31, 34], ["MHV", "SPECIES", 103, 106], ["mice harboring persistent MHV", "PROBLEM", 5, 34], ["acute MHV", "PROBLEM", 97, 106], ["related virus) infection", "PROBLEM", 111, 135], ["persistent", "OBSERVATION_MODIFIER", 20, 30], ["MHV", "OBSERVATION", 31, 34], ["acute", "OBSERVATION_MODIFIER", 97, 102], ["MHV", "OBSERVATION", 103, 106], ["infection", "OBSERVATION", 126, 135]]], ["The population is addicted to the virus.MHV-Mouse Exemplar (A Case for Persistence and Virus Addiction)Such a state, however, is clearly affecting colonies (or groups) of host, not individuals.", [["colonies", "ANATOMY", 147, 155], ["MHV", "ORGANISM", 40, 43], ["Mouse", "ORGANISM", 44, 49], ["Mouse", "SPECIES", 44, 49], ["MHV", "SPECIES", 40, 43], ["Mouse", "SPECIES", 44, 49], ["the virus", "PROBLEM", 30, 39]]], ["An individual either quickly succumbs to the virus infection or, if infected, transmits it to others in the colony.", [["colony", "ANATOMY", 108, 114], ["infection", "DISEASE", 51, 60], ["the virus infection", "PROBLEM", 41, 60], ["infected", "PROBLEM", 68, 76], ["virus", "OBSERVATION_MODIFIER", 45, 50], ["infection", "OBSERVATION", 51, 60], ["colony", "ANATOMY", 108, 114]]], ["A colony is thus under selection by MHV.", [["colony", "ANATOMY", 2, 8], ["MHV", "ORGANISM", 36, 39], ["MHV", "SPECIES", 36, 39], ["colony", "OBSERVATION", 2, 8]]], ["To generalize this state, we expect that the persistence of SARS in specifi c bat populations would be expected to also affect the fi tness of the corresponding specifi c bat populations.", [["SARS", "DISEASE", 60, 64], ["specifi c bat", "ORGANISM", 68, 81], ["specifi c bat populations", "CELL_LINE", 161, 186], ["SARS", "PROBLEM", 60, 64]]], ["Persistence is a more demanding phenotype than acute replication.", [["a more demanding phenotype", "PROBLEM", 15, 41], ["acute replication", "PROBLEM", 47, 64], ["more demanding", "OBSERVATION_MODIFIER", 17, 31], ["acute", "OBSERVATION_MODIFIER", 47, 52], ["replication", "OBSERVATION", 53, 64]]], ["It requires greater gene complexity to counter host immunity and also to promote self-regulation.", [["greater", "OBSERVATION_MODIFIER", 12, 19]]], ["Thus the enhanced fi delity of RNA replication is selected in order to conserve this greater genetic complexity and stability.MHV-Mouse Exemplar (A Case for Persistence and Virus Addiction)We know that the high-fi delity RNA replication system (including RNA pol, helicase, endoribonuclease, and other activities) is also present in an ancient nidovirus relative of coronaviruses, such as fi sh-isolated white bream virus (26 kb RNA).", [["MHV", "ORGANISM", 126, 129], ["Mouse", "ORGANISM", 130, 135], ["RNA pol", "GENE_OR_GENE_PRODUCT", 255, 262], ["endoribonuclease", "GENE_OR_GENE_PRODUCT", 274, 290], ["coronaviruses", "ORGANISM", 366, 379], ["fi sh-isolated white bream virus", "ORGANISM", 389, 421], ["RNA pol", "PROTEIN", 255, 262], ["helicase", "PROTEIN", 264, 272], ["endoribonuclease", "PROTEIN", 274, 290], ["26 kb RNA", "RNA", 423, 432], ["Mouse", "SPECIES", 130, 135], ["bream virus", "SPECIES", 410, 421], ["MHV", "SPECIES", 126, 129], ["Mouse", "SPECIES", 130, 135], ["white bream virus", "SPECIES", 404, 421], ["RNA replication", "TREATMENT", 31, 46], ["the high-fi delity RNA replication system", "PROBLEM", 202, 243], ["RNA pol", "TREATMENT", 255, 262], ["helicase, endoribonuclease", "TREATMENT", 264, 290], ["coronaviruses", "PROBLEM", 366, 379], ["fi sh-isolated white bream virus", "PROBLEM", 389, 421], ["RNA replication", "OBSERVATION", 31, 46], ["stability", "OBSERVATION_MODIFIER", 116, 125], ["coronaviruses", "OBSERVATION", 366, 379]]], ["I suggest there will also likely be species-specifi c persistent infections with this virus that require this enhanced replication fi delity and maintain this virus in its natural habitat.", [["infections", "DISEASE", 65, 75], ["specifi c", "ORGANISM", 44, 53], ["species", "PROBLEM", 36, 43], ["persistent infections", "PROBLEM", 54, 75], ["this virus", "PROBLEM", 81, 91], ["this enhanced replication fi delity", "TREATMENT", 105, 140], ["this virus", "PROBLEM", 154, 164], ["persistent", "OBSERVATION_MODIFIER", 54, 64], ["infections", "OBSERVATION", 65, 75]]], ["Thus, I suggest, an ancient persistent life strategy could more easily explain the monophyletic character of the nidovirus virus lineage.", [["nidovirus virus", "ORGANISM", 113, 128], ["nidovirus virus lineage", "CELL_TYPE", 113, 136], ["an ancient persistent life strategy", "TREATMENT", 17, 52], ["the nidovirus virus lineage", "PROBLEM", 109, 136]]], ["It is particularly interesting that one of these unique and conserved replication proteins (ADP ribose-1-monophosphate) is dispensable for culture growth ( Putics et al. , 2005 ) .", [["ADP ribose-1-monophosphate", "CHEMICAL", 92, 118], ["ADP ribose-1-monophosphate", "CHEMICAL", 92, 118], ["ADP ribose-1-monophosphate", "GENE_OR_GENE_PRODUCT", 92, 118], ["replication proteins", "PROTEIN", 70, 90], ["ADP ribose", "TEST", 92, 102], ["culture growth", "TEST", 139, 153]]], ["I suggest it will not be dispensable for persistence.HIV-1The HIV-1 pandemic is an unfi nished story.HIV-1HIV-1 represents a real-time biological event in human evolution that confi rms for us the importance of quasispecies and retroviruses to human biology.", [["HIV-1 pandemic", "DISEASE", 62, 76], ["HIV-1", "ORGANISM", 53, 58], ["HIV-1", "ORGANISM", 62, 67], ["HIV-1HIV-1", "ORGANISM", 101, 111], ["human", "ORGANISM", 155, 160], ["retroviruses", "ORGANISM", 228, 240], ["human", "ORGANISM", 244, 249], ["HIV-1", "SPECIES", 53, 58], ["HIV-1 pandemic", "SPECIES", 62, 76], ["HIV-1HIV", "SPECIES", 101, 109], ["human", "SPECIES", 155, 160], ["human", "SPECIES", 244, 249], ["HIV-1", "SPECIES", 53, 58], ["HIV-1", "SPECIES", 62, 67], ["HIV-1HIV-1", "SPECIES", 101, 111], ["human", "SPECIES", 155, 160], ["human", "SPECIES", 244, 249], ["HIV", "PROBLEM", 53, 56], ["HIV", "PROBLEM", 101, 104], ["quasispecies", "PROBLEM", 211, 223]]], ["However, even though its human toll is huge, modern medicine and culture has responded rapidly enough to limit the impact of HIV-1 to the point at which it will not likely be the cause of a selective evolutionary sweep that could have altered human genetic makeup (in contrast to the koala bear endogenization presented below).", [["human", "ORGANISM", 25, 30], ["HIV-1", "ORGANISM", 125, 130], ["human", "ORGANISM", 243, 248], ["human", "SPECIES", 25, 30], ["HIV-1", "SPECIES", 125, 130], ["human", "SPECIES", 243, 248], ["human", "SPECIES", 25, 30], ["HIV-1", "SPECIES", 125, 130], ["human", "SPECIES", 243, 248], ["modern medicine", "TREATMENT", 45, 60], ["culture", "TEST", 65, 72], ["a selective evolutionary sweep", "PROBLEM", 188, 218]]], ["As described earlier, its amazing adaptability via quasispecies along with extensive recombination contribute directly to HIV-1 ' s diversity and makes it the most dynamic genetic entity ever studied.", [["HIV-1", "ORGANISM", 122, 127], ["HIV", "SPECIES", 122, 125], ["HIV-1", "SPECIES", 122, 127], ["quasispecies", "PROBLEM", 51, 63], ["extensive recombination", "TREATMENT", 75, 98]]], ["Many studies track the dominant HIV population and fail to examine minority populations.", [["HIV", "SPECIES", 32, 35], ["Many studies", "TEST", 0, 12]]], ["Yet it is precisely these minority populations, which evolve independently of the majority population, that can determine drug resistance phenotype and biological outcome ( Charpentier et al. , 2004 ; Briones et al. , 2006 ; Morand-Joubert et al. , 2006 ) .", [["drug resistance phenotype", "PROBLEM", 122, 147], ["minority", "OBSERVATION_MODIFIER", 26, 34], ["populations", "OBSERVATION", 35, 46]]], ["Clearly, the specifi c makeup of a complex HIV population matters.", [["HIV", "SPECIES", 43, 46], ["a complex HIV population matters", "PROBLEM", 33, 65], ["complex", "OBSERVATION_MODIFIER", 35, 42], ["HIV", "OBSERVATION", 43, 46]]], ["Furthermore, HIV defectives and variants can also have major consequences.", [["HIV defectives", "DISEASE", 13, 27], ["HIV", "ORGANISM", 13, 16], ["HIV", "SPECIES", 13, 16], ["HIV", "SPECIES", 13, 16], ["HIV defectives and variants", "PROBLEM", 13, 40]]], ["In some cases, long-term non-progressors of HIV-1 have shown mixed populations and unusual polymorphism in the early phase of HIV infection, sometimes contributing to long-term non-progression (LTNP) ( Alexander et al. , 2000 ) .", [["HIV infection", "DISEASE", 126, 139], ["HIV-1", "ORGANISM", 44, 49], ["HIV", "ORGANISM", 126, 129], ["HIV-1", "SPECIES", 44, 49], ["HIV", "SPECIES", 126, 129], ["HIV-1", "SPECIES", 44, 49], ["HIV", "SPECIES", 126, 129], ["HIV", "PROBLEM", 44, 47], ["mixed populations", "PROBLEM", 61, 78], ["unusual polymorphism", "PROBLEM", 83, 103], ["HIV infection", "PROBLEM", 126, 139], ["unusual polymorphism", "OBSERVATION_MODIFIER", 83, 103], ["early phase", "OBSERVATION_MODIFIER", 111, 122], ["infection", "OBSERVATION", 130, 139], ["long-term", "OBSERVATION_MODIFIER", 167, 176]]], ["One population of LTNPs was reported to have been colonized by an HIV variant that showed low virus replication and slow or arrested evolution ( Bello et al. , 2005 ) .", [["LTNPs", "CANCER", 18, 23], ["HIV", "SPECIES", 66, 69], ["HIV", "SPECIES", 66, 69], ["LTNPs", "PROBLEM", 18, 23], ["an HIV variant", "PROBLEM", 63, 77], ["low virus replication", "PROBLEM", 90, 111], ["slow or arrested evolution", "PROBLEM", 116, 142], ["population", "OBSERVATION", 4, 14], ["colonized", "OBSERVATION", 50, 59], ["low virus", "OBSERVATION", 90, 99]]], ["In another case, a stable non-progressor was colonized by a replication incompetent version of HIV-1 ( Wang et al. , 2003 ) .", [["HIV-1", "ORGANISM", 95, 100], ["HIV", "SPECIES", 95, 98], ["HIV-1", "SPECIES", 95, 100], ["stable", "OBSERVATION_MODIFIER", 19, 25]]], ["Some of these non-progressors also appear to resist super-infection .", [["infection", "DISEASE", 58, 67], ["infection", "PROBLEM", 58, 67], ["non-progressors", "OBSERVATION", 14, 29], ["infection", "OBSERVATION", 58, 67]]], ["It seems clear that at least in these exceptional situations, non-majority HIVs are crucial to the outcome.HIV-1There is also reason to think that other retroviruses have had a major infl uence on recent primate and human evolution, such as apathogenic persisting foamy virus in primates ( Switzer et al. , 2005 ; Murray and Linial, 2006 ) .", [["HIVs", "CANCER", 75, 79], ["HIV-1There", "ORGANISM", 107, 117], ["retroviruses", "ORGANISM", 153, 165], ["human", "ORGANISM", 216, 221], ["foamy virus", "ORGANISM", 264, 275], ["primates", "ORGANISM", 279, 287], ["HIV", "SPECIES", 107, 110], ["human", "SPECIES", 216, 221], ["HIV", "SPECIES", 107, 110], ["human", "SPECIES", 216, 221], ["foamy virus", "SPECIES", 264, 275], ["HIV", "PROBLEM", 107, 110], ["other retroviruses", "PROBLEM", 147, 165], ["apathogenic persisting foamy virus", "PROBLEM", 241, 275], ["clear", "OBSERVATION", 9, 14], ["foamy virus", "OBSERVATION", 264, 275]]], ["Human antiretroviral genes seem to have undergone recent adaptations, such as APOBEC3, which can interfere with exogenous retroviruses (such as MLV and SIV) and underwent an expansion in the hominid lineage ( Esnault et al. , 2005 ) .", [["Human", "ORGANISM", 0, 5], ["APOBEC3", "GENE_OR_GENE_PRODUCT", 78, 85], ["retroviruses", "ORGANISM", 122, 134], ["MLV", "GENE_OR_GENE_PRODUCT", 144, 147], ["SIV", "ORGANISM", 152, 155], ["Human antiretroviral genes", "DNA", 0, 26], ["APOBEC3", "PROTEIN", 78, 85], ["hominid lineage", "CELL_TYPE", 191, 206], ["Human", "SPECIES", 0, 5], ["Human", "SPECIES", 0, 5], ["SIV", "SPECIES", 152, 155], ["Human antiretroviral genes", "TREATMENT", 0, 26], ["APOBEC3", "PROBLEM", 78, 85], ["exogenous retroviruses", "PROBLEM", 112, 134], ["expansion", "OBSERVATION_MODIFIER", 174, 183]]], ["It thus seems clear that human and primate evolution has been signifi cantly affected by earlier, prevalent primate retroviruses.HCVAnother important human-virus quasispecies story that has long been recognized is with hepatitis C virus (HCV), (see Chapter 15; Domingo and Gomez, 2007 ) .", [["hepatitis C", "DISEASE", 219, 230], ["human", "ORGANISM", 25, 30], ["primate", "ORGANISM", 35, 42], ["retroviruses", "ORGANISM", 116, 128], ["human-virus", "ORGANISM", 150, 161], ["hepatitis C virus", "ORGANISM", 219, 236], ["HCV", "ORGANISM", 238, 241], ["human", "SPECIES", 25, 30], ["human", "SPECIES", 150, 155], ["-virus", "SPECIES", 155, 161], ["hepatitis C virus", "SPECIES", 219, 236], ["human", "SPECIES", 25, 30], ["human-virus", "SPECIES", 150, 161], ["hepatitis C virus", "SPECIES", 219, 236], ["HCV", "SPECIES", 238, 241], ["hepatitis C virus", "PROBLEM", 219, 236], ["clear", "OBSERVATION", 14, 19], ["retroviruses", "OBSERVATION", 116, 128]]], ["HCV seems to have adapted to humans in the recent past, possibly from asymptomatic enteric primate viruses currently found in Africa ( Smith et al. , 1997 ) .", [["enteric primate viruses", "DISEASE", 83, 106], ["HCV", "ORGANISM", 0, 3], ["humans", "ORGANISM", 29, 35], ["enteric primate viruses", "ORGANISM", 83, 106], ["humans", "SPECIES", 29, 35], ["HCV", "SPECIES", 0, 3], ["humans", "SPECIES", 29, 35], ["HCV", "PROBLEM", 0, 3], ["asymptomatic enteric primate viruses", "PROBLEM", 70, 106], ["enteric primate viruses", "OBSERVATION", 83, 106]]], ["As HCV remains an infection predominantly transmitted by blood, it does not appear to have fully adapted to the tissues of and transmission within its human host.", [["blood", "ANATOMY", 57, 62], ["tissues", "ANATOMY", 112, 119], ["infection", "DISEASE", 18, 27], ["HCV", "ORGANISM", 3, 6], ["blood", "ORGANISM_SUBSTANCE", 57, 62], ["tissues", "TISSUE", 112, 119], ["human", "ORGANISM", 151, 156], ["human", "SPECIES", 151, 156], ["HCV", "SPECIES", 3, 6], ["human", "SPECIES", 151, 156], ["HCV", "PROBLEM", 3, 6], ["an infection", "PROBLEM", 15, 27], ["HCV", "OBSERVATION", 3, 6], ["infection", "OBSERVATION", 18, 27]]], ["However, like HIV-1, HCV has long been recognized to generate quasispecies in chronically infected people ( Martell et al. , 1992 ) and it soon became apparent that the viral quasispecies are affected by and affects the outcome of antiviral therapy Hohne et al. , 1994 ; Kurosaki et al. , 1994 ; Okamoto and Mishiro, 1994 ) .HCVThus, successful antiviral therapy is directly correlated with an initial dramatic reduction in genetic diversity.", [["chronically infected", "DISEASE", 78, 98], ["HCVThus", "CHEMICAL", 325, 332], ["HIV-1", "ORGANISM", 14, 19], ["HCV", "ORGANISM", 21, 24], ["people", "ORGANISM", 99, 105], ["HIV-1", "SPECIES", 14, 19], ["people", "SPECIES", 99, 105], ["HIV-1", "SPECIES", 14, 19], ["HCV", "SPECIES", 21, 24], ["HCV", "PROBLEM", 21, 24], ["the viral quasispecies", "PROBLEM", 165, 187], ["antiviral therapy", "TREATMENT", 231, 248], ["HCVThus", "PROBLEM", 325, 332], ["successful antiviral therapy", "TREATMENT", 334, 362], ["an initial dramatic reduction", "TREATMENT", 391, 420], ["chronically", "OBSERVATION_MODIFIER", 78, 89], ["infected", "OBSERVATION", 90, 98], ["viral quasispecies", "OBSERVATION", 169, 187], ["antiviral therapy", "OBSERVATION", 345, 362], ["dramatic", "OBSERVATION_MODIFIER", 402, 410], ["reduction", "OBSERVATION_MODIFIER", 411, 420], ["genetic diversity", "OBSERVATION", 424, 441]]], ["Unfortunately, it has become clear that only a minority of HCV-infected individuals will respond favorably to a combination of interferon and ribivarin.", [["HCV-infected", "DISEASE", 59, 71], ["interferon", "CHEMICAL", 127, 137], ["ribivarin", "CHEMICAL", 142, 151], ["ribivarin", "CHEMICAL", 142, 151], ["HCV", "ORGANISM", 59, 62], ["individuals", "ORGANISM", 72, 83], ["interferon", "GENE_OR_GENE_PRODUCT", 127, 137], ["ribivarin", "SIMPLE_CHEMICAL", 142, 151], ["interferon", "PROTEIN", 127, 137], ["HCV", "SPECIES", 59, 62], ["HCV", "PROBLEM", 59, 62], ["infected individuals", "PROBLEM", 63, 83], ["interferon", "TREATMENT", 127, 137], ["ribivarin", "TREATMENT", 142, 151], ["clear", "OBSERVATION", 29, 34], ["HCV", "OBSERVATION", 59, 62], ["infected", "OBSERVATION", 63, 71]]], ["Thus it seems to be diversity per se and the resulting structure of an HCV quasispecies that has a direct consequence to human health.", [["HCV", "ORGANISM", 71, 74], ["human", "ORGANISM", 121, 126], ["human", "SPECIES", 121, 126], ["HCV", "SPECIES", 71, 74], ["human", "SPECIES", 121, 126], ["an HCV quasispecies", "PROBLEM", 68, 87], ["seems to be", "UNCERTAINTY", 8, 19], ["diversity", "OBSERVATION", 20, 29], ["HCV", "OBSERVATION", 71, 74]]], ["However, since HCV is less well-adapted to humans compared with HIV-1, it does not pose the same threat to potentially provoke an evolutionary event in human evolution.VSVVSV is a negative-stranded RNA virus that has been a very important experimental model and has provided many laboratory measurements regarding quasispecies theory (see Chapter 4).", [["VSVVSV", "CHEMICAL", 168, 174], ["HCV", "ORGANISM", 15, 18], ["humans", "ORGANISM", 43, 49], ["HIV-1", "ORGANISM", 64, 69], ["human", "ORGANISM", 152, 157], ["VSVVSV", "GENE_OR_GENE_PRODUCT", 168, 174], ["VSVVSV", "DNA", 168, 174], ["humans", "SPECIES", 43, 49], ["HIV-1", "SPECIES", 64, 69], ["human", "SPECIES", 152, 157], ["HCV", "SPECIES", 15, 18], ["humans", "SPECIES", 43, 49], ["HIV-1", "SPECIES", 64, 69], ["human", "SPECIES", 152, 157], ["VSVVSV", "SPECIES", 168, 174], ["HCV", "PROBLEM", 15, 18], ["VSVVSV", "TEST", 168, 174], ["stranded RNA virus", "PROBLEM", 189, 207], ["negative", "OBSERVATION", 180, 188], ["stranded RNA virus", "OBSERVATION", 189, 207]]], ["Using VSV, evidence supporting the Red Queen hypothesis, involving unending adaptation to greater competition and Mueller ' s ratchet has been presented ( Clarke et al. , 1994 ; Novella et al. , 1995 ; Elena et al. , 1996 ) .", [["VSV", "ORGANISM", 6, 9], ["VSV", "SPECIES", 6, 9], ["VSV", "TREATMENT", 6, 9], ["the Red Queen hypothesis", "PROBLEM", 31, 55], ["Mueller ' s ratchet", "TREATMENT", 114, 133]]], ["When VSV was evaluated as an arbovirus, requiring adaptation to alternating and opposing fi tness of insect and mammalian host, it was also apparent that minority quasispecies populations were responsible for maintaining the apparently antagonistic phenotypes ( Novella et al. , 1999 ) .", [["VSV", "ORGANISM", 5, 8], ["VSV", "SPECIES", 5, 8], ["an arbovirus", "PROBLEM", 26, 38], ["minority quasispecies populations", "PROBLEM", 154, 187]]], ["Thus here too, the consortia character of a quasispecies is clear.", [["quasispecies", "OBSERVATION", 44, 56], ["clear", "OBSERVATION", 60, 65]]], ["Yet in natural settings several very different virus-host relationships can be seen with rhabdoviruses.VSVA distant relative of VSV (VHSV) is also known to be responsible for mass die-off of commercially important fi sh ( Marty et al. , 2003 ) .", [["VSV", "ORGANISM", 128, 131], ["VHSV", "ORGANISM", 133, 137], ["VHSV", "SPECIES", 133, 137], ["VSV", "SPECIES", 128, 131], ["VHSV", "SPECIES", 133, 137], ["rhabdoviruses", "PROBLEM", 89, 102], ["mass die", "PROBLEM", 175, 183], ["rhabdoviruses", "OBSERVATION", 89, 102], ["VSV", "OBSERVATION", 128, 131]]], ["This virus infects many teleost species and has shown 100% mortality in many experiments (i.e. with i.p. inoculation).", [["This virus infects many teleost species", "PROBLEM", 0, 39]]], ["In natural outbreaks, however, it has also shown surprising genetic stability ( Einer-Jensen et al. , 2006 ) .", [["natural", "OBSERVATION_MODIFIER", 3, 10], ["outbreaks", "OBSERVATION", 11, 20], ["stability", "OBSERVATION_MODIFIER", 68, 77]]], ["Clearly error-prone rhabdovirus replication must be kept in check by purifying selection in this situation.", [["error-prone rhabdovirus replication", "TREATMENT", 8, 43], ["rhabdovirus replication", "OBSERVATION", 20, 43]]], ["In contrast, another rhabdovirus, sigma virus of Drosophila , is associated with no mortality but is a vertically transmitted persisting virus in specifi c Drosophila populations ( Fleuriet, 1996 ) .", [["rhabdovirus", "GENE_OR_GENE_PRODUCT", 21, 32], ["sigma virus", "ORGANISM", 34, 45], ["Drosophila", "ORGANISM", 49, 59], ["Drosophila", "SPECIES", 49, 59], ["Drosophila", "SPECIES", 156, 166], ["Drosophila", "SPECIES", 49, 59], ["another rhabdovirus", "PROBLEM", 13, 32], ["sigma virus of Drosophila", "PROBLEM", 34, 59], ["mortality", "PROBLEM", 84, 93], ["a vertically transmitted persisting virus in specifi c Drosophila populations", "PROBLEM", 101, 178], ["rhabdovirus", "OBSERVATION", 21, 32], ["sigma virus", "OBSERVATION", 34, 45], ["no", "UNCERTAINTY", 81, 83], ["mortality", "OBSERVATION", 84, 93], ["vertically", "OBSERVATION_MODIFIER", 103, 113], ["persisting", "OBSERVATION_MODIFIER", 126, 136], ["virus", "OBSERVATION", 137, 142], ["Drosophila populations", "OBSERVATION", 156, 178]]], ["Yet in some recent population measurements, sigma virus infected Drosophila are expanding for unknown reasons ( Fleuriet, 1994 ) .", [["sigma virus", "ORGANISM", 44, 55], ["Drosophila", "ORGANISM", 65, 75], ["Drosophila", "SPECIES", 65, 75], ["Drosophila", "SPECIES", 65, 75], ["sigma virus infected Drosophila", "PROBLEM", 44, 75], ["population", "OBSERVATION", 19, 29], ["sigma virus", "OBSERVATION", 44, 55], ["infected Drosophila", "OBSERVATION", 56, 75]]], ["Clearly this particular virus-host persistent relationship has some undefi ned selective advantage that operates beyond the lab-based concepts as measured above.", [["host persistent", "OBSERVATION_MODIFIER", 30, 45]]], ["Other rhabdoviruses also have peculiar host-specifi c relationships, such as bats that tend to support many persistent infections ( Badrane and Tordo, 2001 ; Li et al. , 2005 ) , or birds that seem to be free of almost all rhabdoviruses.", [["infections", "DISEASE", 119, 129], ["rhabdoviruses", "GENE_OR_GENE_PRODUCT", 6, 19], ["Other rhabdoviruses", "PROBLEM", 0, 19], ["many persistent infections", "PROBLEM", 103, 129], ["rhabdoviruses", "OBSERVATION", 6, 19], ["persistent", "OBSERVATION_MODIFIER", 108, 118], ["infections", "OBSERVATION", 119, 129], ["rhabdoviruses", "OBSERVATION", 223, 236]]], ["Clearly, although VSV lab results have been highly informative, we still have much to learn regarding natural settings that affect rhabdovirus adaptation and evolution.VSVAnother major paradigm for the high rates of negative-strand virus evolution is found with infl uenza virus.", [["VSV", "ORGANISM", 18, 21], ["infl uenza virus", "ORGANISM", 262, 278], ["VSV", "SPECIES", 18, 21], ["infl uenza virus", "SPECIES", 262, 278], ["VSV lab", "TEST", 18, 25], ["natural settings", "TREATMENT", 102, 118], ["the high rates", "TEST", 198, 212], ["strand virus evolution", "PROBLEM", 225, 247], ["infl uenza virus", "PROBLEM", 262, 278], ["rhabdovirus", "OBSERVATION", 131, 142], ["strand virus", "OBSERVATION", 225, 237]]], ["Due to its history and potential for initiating great human epidemics, it has long held the special interest of evolutionary virologists (see Chapter 5; Nelson and Holmes, 2007 ) .", [["human", "ORGANISM", 54, 59], ["human", "SPECIES", 54, 59], ["human", "SPECIES", 54, 59], ["great human epidemics", "PROBLEM", 48, 69]]], ["However, this research has not much emphasized the quasispecies character of infl uenza virus evolution.", [["infl uenza virus", "ORGANISM", 77, 93], ["infl uenza virus", "SPECIES", 77, 93], ["infl uenza virus evolution", "PROBLEM", 77, 103], ["quasispecies", "OBSERVATION", 51, 63], ["infl uenza virus", "OBSERVATION", 77, 93]]], ["Instead, it concentrates on the evolution of the master template or clades of template for the purposes of vaccine development ( Webster and Govorkova, 2006 ) .", [["master template", "DNA", 49, 64], ["the master template", "TREATMENT", 45, 64], ["vaccine development", "TREATMENT", 107, 126]]], ["The views stemming from this type of evolution have lent themselves well to master template-based phylogenetic analysis and have dominated how many researchers think of virus-host evolution.", [["The views", "TEST", 0, 9], ["master template", "TEST", 76, 91], ["phylogenetic analysis", "TEST", 98, 119], ["virus", "PROBLEM", 169, 174], ["virus", "OBSERVATION", 169, 174], ["host evolution", "OBSERVATION", 175, 189]]], ["Thus it is curious, given the above emphasis, that the quasispecies character of infl uenza populations often seems of low relevance to issues of acute disease and vaccination, other then to provide a source of diversity.", [["infl uenza populations", "CELL", 81, 103], ["infl uenza populations", "PROBLEM", 81, 103], ["acute disease", "PROBLEM", 146, 159], ["vaccination", "TREATMENT", 164, 175], ["acute", "OBSERVATION_MODIFIER", 146, 151], ["disease", "OBSERVATION", 152, 159]]], ["In some situations, viral competitive interference may contribute to drift variation and displacement in antigenic epitopes ( Levin et al. , 2004 ).", [["antigenic epitopes", "PROTEIN", 105, 123], ["viral competitive interference", "PROBLEM", 20, 50], ["drift variation", "PROBLEM", 69, 84], ["displacement in antigenic epitopes", "PROBLEM", 89, 123], ["Levin et al", "TREATMENT", 126, 137]]], ["Yet outcomes of individual human and bird infections do not seem much affected by specifi c quasispecies structures, as we saw with HIV-1 and HCV.VSVWith infl uenza, we are mainly concerned with epidemic human disease.", [["infections", "DISEASE", 42, 52], ["human disease", "DISEASE", 204, 217], ["human", "ORGANISM", 27, 32], ["HIV-1", "ORGANISM", 132, 137], ["HCV", "ORGANISM", 142, 145], ["human", "ORGANISM", 204, 209], ["human", "SPECIES", 27, 32], ["HIV-1", "SPECIES", 132, 137], ["human", "SPECIES", 204, 209], ["human", "SPECIES", 27, 32], ["HIV-1", "SPECIES", 132, 137], ["HCV", "SPECIES", 142, 145], ["VSVWith infl uenza", "SPECIES", 146, 164], ["human", "SPECIES", 204, 209], ["individual human and bird infections", "PROBLEM", 16, 52], ["HIV", "PROBLEM", 132, 135], ["HCV", "PROBLEM", 142, 145], ["epidemic human disease", "PROBLEM", 195, 217]]], ["However, by shear numbers of infections and deaths worldwide, it must be admitted that infl uenza virus is really a virus that affects mostly birds.", [["infections", "DISEASE", 29, 39], ["deaths", "DISEASE", 44, 50], ["infl uenza virus", "ORGANISM", 87, 103], ["infl uenza virus", "SPECIES", 87, 103], ["infections", "PROBLEM", 29, 39], ["infl uenza virus", "PROBLEM", 87, 103], ["a virus", "PROBLEM", 114, 121], ["infections", "OBSERVATION", 29, 39]]], ["For example, during the 2005 outbreak in China, only 251 humans died whereas 230 million domestic birds died ( Smith et al. , 2006 ) .", [["humans", "ORGANISM", 57, 63], ["birds", "ORGANISM", 98, 103], ["humans", "SPECIES", 57, 63], ["humans", "SPECIES", 57, 63]]], ["Although our concern on the large potential for human disease is understandable, these numbers should inform us of a more basic virushost biology.", [["human", "ORGANISM", 48, 53], ["virushost", "CANCER", 128, 137], ["human", "SPECIES", 48, 53], ["human", "SPECIES", 48, 53], ["human disease", "PROBLEM", 48, 61], ["large", "OBSERVATION_MODIFIER", 28, 33], ["disease", "OBSERVATION", 54, 61]]], ["In this case, infl uenza shows a high affi nity for various birds; migratory water birds in particular can have high prevalence ( Wallensten et al. , 2006 ) .", [["infl uenza", "ORGANISM", 14, 24], ["infl uenza", "TEST", 14, 24]]], ["Some waterfowl, such as wild mallard ducks, have been called the stealth (asymptomatic) carriers of infl uenza H5N1 and free grazing ducks seem to introduce virus into domestic bird populations ( Gilbert et al. , 2006 ) .", [["mallard ducks", "ORGANISM", 29, 42], ["infl uenza H5N1", "ORGANISM", 100, 115], ["ducks", "ORGANISM", 133, 138], ["mallard ducks", "SPECIES", 29, 42], ["uenza H5N1", "SPECIES", 105, 115], ["ducks", "SPECIES", 133, 138], ["mallard ducks", "SPECIES", 29, 42], ["infl uenza H5N1", "SPECIES", 100, 115], ["infl uenza H5N1", "TREATMENT", 100, 115], ["waterfowl", "OBSERVATION", 5, 14]]], ["But these wild waterfowl, shorebirds, and gulls that are a natural host for avian infl uenza also seem to show a much slower rate of evolution ( Spackman et al. , 2005 ) .", [["avian", "ORGANISM", 76, 81], ["infl uenza", "ORGANISM", 82, 92], ["avian infl uenza", "SPECIES", 76, 92]]], ["In contrast, the much higher rate of evolution as seen in chickens and turkeys indicates that these hosts should not be considered as natural reservoirs ( Suarez, 2000 ) .", [["chickens", "ORGANISM", 58, 66], ["chickens", "SPECIES", 58, 66], ["turkeys", "SPECIES", 71, 78], ["chickens", "SPECIES", 58, 66], ["turkeys", "SPECIES", 71, 78]]], ["In waterfowl, infl uenza infections show several distinctions, such as virus co-infection or virus interference ( Sharp et al. , 1997 ) as well as phylogenetically distinguishable waterfowl dendograms, including specifi c M lineages ( Makarova et al. , 1998 ; Widjaja et al. , 2004 ) .", [["infections", "DISEASE", 25, 35], ["co-infection", "DISEASE", 77, 89], ["infl uenza", "ORGANISM", 14, 24], ["specifi c M lineages", "CELL_LINE", 212, 232], ["infl uenza infections", "PROBLEM", 14, 35], ["several distinctions", "PROBLEM", 41, 61], ["virus co-infection", "PROBLEM", 71, 89], ["virus interference", "PROBLEM", 93, 111], ["several", "OBSERVATION_MODIFIER", 41, 48]]], ["The diverse and stable avian pool of infl uenza virus appears to be ancestral to the infl uenza viruses that infected human populations.The GoodThe phylogenetic methods that have been adapted from evolutionary biology have been tremendously helpful and have allowed us to trace the seemingly untraceable, virus evolution (see Chapter 5).", [["avian", "ORGANISM", 23, 28], ["infl uenza virus", "ORGANISM", 37, 53], ["infl uenza viruses", "ORGANISM", 85, 103], ["human", "ORGANISM", 118, 123], ["human", "SPECIES", 118, 123], ["infl uenza virus", "SPECIES", 37, 53], ["human", "SPECIES", 118, 123], ["infl uenza virus", "PROBLEM", 37, 53], ["The phylogenetic methods", "TEST", 144, 168], ["diverse", "OBSERVATION_MODIFIER", 4, 11], ["stable", "OBSERVATION_MODIFIER", 16, 22], ["infected", "OBSERVATION", 109, 117], ["Good", "OBSERVATION_MODIFIER", 140, 144]]], ["Thus, we have often been able to make informed judgments concerning broader patterns of virus evolution and this has become the major tool for the current study of virus evolution, such as infl uenza virus ( Nelson and Holmes, 2007 ) .", [["infl uenza virus", "ORGANISM", 189, 205], ["uenza virus", "SPECIES", 194, 205], ["infl uenza virus", "SPECIES", 189, 205], ["virus evolution", "PROBLEM", 88, 103], ["the current study", "TEST", 143, 160], ["virus evolution", "PROBLEM", 164, 179], ["virus", "OBSERVATION", 88, 93]]], ["Infl uenza A, for example can be seen to show extended periods of stasis followed by periods of rapid adaptation that necessitates adaptations in vaccine strategy ( Wolf et al. , 2006 ) .", [["stasis", "DISEASE", 66, 72], ["stasis", "PROBLEM", 66, 72], ["rapid adaptation", "PROBLEM", 96, 112], ["adaptations in vaccine strategy", "TREATMENT", 131, 162], ["stasis", "OBSERVATION", 66, 72]]], ["However, the evolutionary variation between seemingly similar viruses can be surprisingly large (see above VSV section).", [["VSV", "ORGANISM", 107, 110], ["variation", "OBSERVATION_MODIFIER", 26, 35], ["similar", "OBSERVATION_MODIFIER", 54, 61], ["viruses", "OBSERVATION", 62, 69], ["large", "OBSERVATION_MODIFIER", 90, 95]]], ["For example, the very different phylogenetic behaviors between infl uenza A and measles virus, both acute human respiratory infections due to membrane-bound negative-stranded RNA viruses, are striking.", [["respiratory", "ANATOMY", 112, 123], ["membrane", "ANATOMY", 142, 150], ["measles virus", "DISEASE", 80, 93], ["respiratory infections", "DISEASE", 112, 134], ["infl uenza A", "ORGANISM", 63, 75], ["measles virus", "ORGANISM", 80, 93], ["human", "ORGANISM", 106, 111], ["membrane", "CELLULAR_COMPONENT", 142, 150], ["measles virus", "SPECIES", 80, 93], ["human", "SPECIES", 106, 111], ["infl uenza A", "SPECIES", 63, 75], ["measles virus", "SPECIES", 80, 93], ["human", "SPECIES", 106, 111], ["the very different phylogenetic behaviors", "PROBLEM", 13, 54], ["measles virus", "PROBLEM", 80, 93], ["both acute human respiratory infections", "PROBLEM", 95, 134], ["membrane-bound", "TEST", 142, 156], ["stranded RNA viruses", "PROBLEM", 166, 186], ["very", "OBSERVATION_MODIFIER", 17, 21], ["different", "OBSERVATION_MODIFIER", 22, 31], ["phylogenetic behaviors", "OBSERVATION", 32, 54], ["acute", "OBSERVATION_MODIFIER", 100, 105], ["respiratory infections", "OBSERVATION", 112, 134], ["negative", "OBSERVATION", 157, 165], ["stranded RNA viruses", "OBSERVATION", 166, 186]]], ["The reasons for the maintained genetic stability of measles virus remain poorly understood, but may well involve more complex fi tness associated with systemic infections.", [["measles virus", "DISEASE", 52, 65], ["systemic infections", "DISEASE", 151, 170], ["measles virus", "ORGANISM", 52, 65], ["measles virus", "SPECIES", 52, 65], ["measles virus", "PROBLEM", 52, 65], ["systemic infections", "PROBLEM", 151, 170], ["systemic", "OBSERVATION_MODIFIER", 151, 159], ["infections", "OBSERVATION", 160, 170]]], ["Phylogenetic methods can also be highly informative regarding the likely origins of viral lineages and possible sources of emergence.", [["Phylogenetic methods", "PROBLEM", 0, 20], ["viral lineages", "PROBLEM", 84, 98], ["emergence", "PROBLEM", 123, 132], ["viral lineages", "OBSERVATION", 84, 98]]], ["For example, the studies of dengue virus by Holmes and colleagues suggest that this virus fi rst entered its human host about 1000 years ago, and that sylvatic (African jungle) asymptomatic infection of primates may have provided the origin of this virus that later became a human pathogen ( Holmes and Twiddy, 2003 ; Holmes, 2006 ) .", [["dengue", "DISEASE", 28, 34], ["infection", "DISEASE", 190, 199], ["dengue virus", "ORGANISM", 28, 40], ["virus fi rst", "ORGANISM", 84, 96], ["human", "ORGANISM", 109, 114], ["primates", "ORGANISM", 203, 211], ["human", "ORGANISM", 275, 280], ["human", "SPECIES", 109, 114], ["human", "SPECIES", 275, 280], ["dengue virus", "SPECIES", 28, 40], ["human", "SPECIES", 109, 114], ["human", "SPECIES", 275, 280], ["the studies", "TEST", 13, 24], ["dengue virus", "PROBLEM", 28, 40], ["this virus fi rst", "PROBLEM", 79, 96], ["sylvatic (African jungle) asymptomatic infection", "PROBLEM", 151, 199], ["this virus", "PROBLEM", 244, 254], ["sylvatic", "OBSERVATION_MODIFIER", 151, 159], ["infection", "OBSERVATION", 190, 199]]], ["Such insight provides valuable clues concerning the likely selective pressures that may lead to the emergence of dengue virus.", [["dengue", "DISEASE", 113, 119], ["dengue virus", "ORGANISM", 113, 125], ["dengue virus", "SPECIES", 113, 125], ["selective pressures", "PROBLEM", 59, 78], ["dengue virus", "PROBLEM", 113, 125]]], ["Phylogenetic methods are also highly informative regarding classifi cation and taxonomy relationships and have allowed us to understand viral relationships across broad species defi nitions ( Zanotto et al. , 1996 ) .The BadHowever, phylogenetic approaches necessarily assume the master template is the fi ttest type and that mutations or variants in the RNA populations are a source of genetic load that are deleterious and limiting to virus adaptation ( Pybus et al. , 2007 ) .", [["cation", "SIMPLE_CHEMICAL", 68, 74], ["master template", "DNA", 280, 295], ["mutations or variants in the RNA populations", "PROBLEM", 326, 370], ["genetic load", "PROBLEM", 387, 399]]], ["Such variation is mostly due to \" unfi t \" mutations, which indicates that a viral cloud is mostly and unfi t consortia.", [["a viral cloud", "PROBLEM", 75, 88], ["viral cloud", "OBSERVATION", 77, 88]]], ["It would seem that such conclusions go against the concept of quasispecies as being fi t per se as described above.", [["quasispecies", "PROBLEM", 62, 74]]], ["In this consideration we see a major weakness of extant phylogenetic methods.", [["a major weakness of extant phylogenetic methods", "PROBLEM", 29, 76], ["major", "OBSERVATION_MODIFIER", 31, 36], ["weakness", "OBSERVATION", 37, 45]]], ["Nor were they designed to follow the evolution of systems with high rates of recombination between numerous parental templates.", [["numerous parental templates", "TREATMENT", 99, 126]]], ["We currently lack the analytical tools for such a population analysis.", [["a population analysis", "TEST", 48, 69]]], ["Without such tools, however, it seems we can only evaluate those parameters we can defi ne and will remain confused by those we cannot.", [["confused", "PROBLEM", 107, 115]]], ["Evolution of a consortia thus provides a new directions for theoretical and laboratory research.", [["consortia", "OBSERVATION", 15, 24]]], ["We should seek to investigate the mixture, not just its average.PlantsAnother major virus-host system that has been highly studied is the viruses of agricultural plants.", [["host system", "OBSERVATION", 90, 101], ["viruses", "OBSERVATION_MODIFIER", 138, 145], ["agricultural plants", "OBSERVATION", 149, 168]]], ["Our understanding of plant viruses has also been highly infl uenced by disease associated with agricultural domestic species, thus natural virus-plant relationships are much less understood, although some recent fi eld studies are starting to change this situation (see Chapter 12).", [["plant viruses", "PROBLEM", 21, 34], ["disease", "PROBLEM", 71, 78], ["agricultural domestic species", "PROBLEM", 95, 124], ["plant viruses", "OBSERVATION", 21, 34], ["domestic species", "OBSERVATION", 108, 124]]], ["We currently have a rather uneven understanding of broader virus-host relationships and evolution in plants.", [["virus", "OBSERVATION", 59, 64]]], ["For example, viruses of the more ancient ferns, if they exist, are essentially unknown.PlantsThe prevalence and diversity of positivestranded RNA viruses in plants is striking.", [["positivestranded RNA viruses", "PROBLEM", 125, 153], ["viruses", "OBSERVATION", 13, 20], ["diversity", "OBSERVATION_MODIFIER", 112, 121], ["RNA viruses", "OBSERVATION", 142, 153]]], ["In addition, we are starting to appreciate that virus-virus interactions are also frequently involved, although this issue remains poorly studied.", [["virus-virus", "ORGANISM", 48, 59], ["virus", "PROBLEM", 48, 53]]], ["One well-studied family of plant virus are the tobamoviruses of angiosperms (see Chapter 11; Gibbs, 1999 ) .", [["plant virus", "ORGANISM", 27, 38], ["plant virus", "PROBLEM", 27, 38]]], ["Progenitors of this virus family appear to also be found in algae and fungi consistent with a very long evolutionary history.", [["algae", "ANATOMY", 60, 65], ["algae", "CELL", 60, 65]]], ["Both high transmission between host and virus-host congruence are observed with these viruses.", [["these viruses", "PROBLEM", 80, 93], ["high", "OBSERVATION_MODIFIER", 5, 9], ["host congruence", "OBSERVATION", 46, 61], ["viruses", "OBSERVATION", 86, 93]]], ["Virus-virus interactions also seem to be important.", [["Virus-virus", "ORGANISM", 0, 11], ["Virus-virus", "SPECIES", 0, 11], ["Virus-virus", "SPECIES", 0, 11], ["Virus", "PROBLEM", 0, 5], ["virus interactions", "PROBLEM", 6, 24], ["virus", "OBSERVATION", 6, 11]]], ["For example, tobacco mosaic virus (TMV) and tomato golden mosaic virus (TMGV) appear to have shown interactions in Australia which have apparently led to the extinction of TMV, but the retention of TMGV with no increase in genetic diversity ( Fraile et al. , 1997 ) .PlantsPlant viruses have also been seen as quasispecies in some but not all settings (see Chapter 12; Roossinck, 2003 ; Roossinck and Schneider, 2006 ) .", [["tobacco mosaic virus", "ORGANISM", 13, 33], ["TMV", "ORGANISM", 35, 38], ["tomato golden mosaic virus", "ORGANISM", 44, 70], ["TMGV", "ORGANISM", 72, 76], ["TMV", "ORGANISM", 172, 175], ["TMGV", "GENE_OR_GENE_PRODUCT", 198, 202], ["tobacco mosaic virus", "SPECIES", 13, 33], ["tomato golden mosaic virus", "SPECIES", 44, 70], ["tobacco mosaic virus", "SPECIES", 13, 33], ["TMV", "SPECIES", 35, 38], ["tomato golden mosaic virus", "SPECIES", 44, 70], ["TMGV", "SPECIES", 72, 76], ["TMV", "SPECIES", 172, 175], ["tobacco mosaic virus (TMV)", "PROBLEM", 13, 39], ["tomato golden mosaic virus", "PROBLEM", 44, 70], ["the extinction of TMV", "PROBLEM", 154, 175], ["the retention of TMGV", "TREATMENT", 181, 202], ["Plant viruses", "PROBLEM", 273, 286], ["tobacco mosaic virus", "OBSERVATION", 13, 33], ["mosaic virus", "OBSERVATION", 58, 70], ["no", "UNCERTAINTY", 208, 210], ["increase", "OBSERVATION_MODIFIER", 211, 219], ["viruses", "OBSERVATION", 279, 286]]], ["Besides the interactions expected for typical viral quasispecies, plants often show evidence of more extensive mixed virus infections.", [["infections", "DISEASE", 123, 133], ["typical viral quasispecies", "PROBLEM", 38, 64], ["more extensive mixed virus infections", "PROBLEM", 96, 133], ["viral quasispecies", "OBSERVATION", 46, 64], ["extensive", "OBSERVATION_MODIFIER", 101, 110], ["mixed virus infections", "OBSERVATION", 111, 133]]], ["There are, for instance, many examples of satellite viruses that must necessarily interact with other RNA viruses of plants.", [["satellite viruses", "ORGANISM", 42, 59], ["satellite viruses", "PROBLEM", 42, 59], ["satellite viruses", "OBSERVATION", 42, 59]]], ["It is also clear that the subviral elements of even a single viral lineage can greatly affect the virus-host relationship.", [["subviral elements", "DNA", 26, 43], ["a single viral lineage", "PROBLEM", 52, 74], ["clear", "OBSERVATION", 11, 16], ["subviral elements", "OBSERVATION", 26, 43]]], ["Such subviral elements (DIs) have been observed to both reduce and intensify disease, and also interact with satellite viruses ( Qiu and Scholthof, 2001 ) , thus virus-virus interactions are clearly crucial in many situations ( Simon et al. , 2004 ) and viral interactions and synergism appear to have led to signifi cant events in plant virus emergence ( Fargette et al. , 2006 ) .PlantsVirus-virus interactions are not limited to plant RNA viruses.", [["virus-virus", "ORGANISM", 162, 173], ["plant virus", "ORGANISM", 332, 343], ["PlantsVirus-virus", "ORGANISM", 382, 399], ["subviral elements", "DNA", 5, 22], ["DIs", "DNA", 24, 27], ["PlantsVirus-virus", "SPECIES", 382, 399], ["intensify disease", "PROBLEM", 67, 84], ["virus-virus interactions", "PROBLEM", 162, 186], ["viral interactions", "PROBLEM", 254, 272], ["synergism", "PROBLEM", 277, 286], ["signifi cant events", "PROBLEM", 309, 328], ["PlantsVirus", "TEST", 382, 393], ["plant RNA viruses", "PROBLEM", 432, 449], ["subviral elements", "OBSERVATION", 5, 22], ["virus", "OBSERVATION", 394, 399], ["RNA viruses", "OBSERVATION", 438, 449]]], ["The ssDNA plant geminiviruses also display complex interactions with satellites as well as high diversity in fi eld isolates of East Africa ( Ndunguru et al. , 2005 ) .", [["ssDNA", "CELLULAR_COMPONENT", 4, 9], ["The ssDNA plant geminiviruses", "TREATMENT", 0, 29], ["plant geminiviruses", "OBSERVATION", 10, 29], ["complex", "OBSERVATION_MODIFIER", 43, 50]]], ["Thus, plant viruses seem particularly prone to interactions.", [["plant viruses", "TREATMENT", 6, 19], ["viruses", "OBSERVATION", 12, 19]]], ["More recently, virus-mediated symbiosis with respect to host survival has been reported ( Roossinck, 2005 ) (discussed below).PlantsPhylogenetic methods also struggle to address the occurrence of high rates of recombination in viral lineages.", [["viral lineages", "CELL_TYPE", 227, 241], ["virus-mediated symbiosis", "PROBLEM", 15, 39], ["high rates of recombination in viral lineages", "PROBLEM", 196, 241], ["symbiosis", "OBSERVATION", 30, 39], ["viral lineages", "OBSERVATION", 227, 241]]], ["Such a situation complicates the analysis, creating hardto-defi ne, reticulated trees, although these limitations can be partially overcome by using sliding windows for the analysis.", [["the analysis", "TEST", 29, 41], ["creating hardto-defi ne, reticulated trees", "PROBLEM", 43, 85], ["sliding windows", "TREATMENT", 149, 164], ["the analysis", "TEST", 169, 181], ["reticulated trees", "OBSERVATION", 68, 85]]], ["Such approaches have allowed surveys of recombination in some viral lineages, such as with the plant potyviruses ( Chare and Holmes, 2006 ) .", [["some viral lineages", "PROBLEM", 57, 76], ["viral lineages", "OBSERVATION", 62, 76]]], ["However, the rampant recombination and quasispecies generation of HIV-1 makes a quantitative assessment of the virus population problematic.", [["HIV-1", "ORGANISM", 66, 71], ["HIV-1", "SPECIES", 66, 71], ["HIV-1", "SPECIES", 66, 71], ["the rampant recombination", "PROBLEM", 9, 34], ["HIV", "PROBLEM", 66, 69], ["a quantitative assessment", "TEST", 78, 103], ["the virus population problematic", "PROBLEM", 107, 139]]], ["One proposed solution is to use a composition vector method ( Gao and Qi, 2007 ) .", [["a composition vector method", "TREATMENT", 32, 59]]], ["The issue of measuring recombination and tracing evolution in large populations is especially a problem that applies to the DNA viruses (phage) of prokaryotes (see below).Prokaryotic DNA Viruses, Mosaic Swarms, the Origin of DNA-BasedCells.Prokaryotic DNA Viruses, Mosaic Swarms, the Origin of DNA-BasedOur perception regarding the overall importance of DNA viruses of prokaryotes to the evolution of life on Earth has undergone a major shift in recent years.", [["DNA", "CELLULAR_COMPONENT", 124, 127], ["DNA", "CELLULAR_COMPONENT", 183, 186], ["DNA", "CELLULAR_COMPONENT", 225, 228], ["DNA", "CELLULAR_COMPONENT", 252, 255], ["DNA", "CELLULAR_COMPONENT", 294, 297], ["DNA", "CELLULAR_COMPONENT", 354, 357], ["Origin of DNA-BasedCells", "DNA", 215, 239], ["measuring recombination", "PROBLEM", 13, 36], ["large populations", "PROBLEM", 62, 79], ["the DNA viruses", "PROBLEM", 120, 135], ["Prokaryotic DNA Viruses", "PROBLEM", 171, 194], ["Mosaic Swarms", "PROBLEM", 196, 209], ["Prokaryotic DNA Viruses", "PROBLEM", 240, 263], ["Mosaic Swarms", "PROBLEM", 265, 278], ["DNA viruses", "PROBLEM", 354, 365], ["large", "OBSERVATION_MODIFIER", 62, 67], ["populations", "OBSERVATION", 68, 79], ["DNA Viruses", "OBSERVATION", 183, 194], ["Mosaic Swarms", "OBSERVATION", 196, 209], ["DNA Viruses", "OBSERVATION", 252, 263], ["Mosaic Swarms", "OBSERVATION", 265, 278]]], ["The main realization is that DNA phage are the numerically dominant genetic entity in most habitats on Earth (mentioned above).", [["DNA", "CELLULAR_COMPONENT", 29, 32], ["DNA phage", "PROBLEM", 29, 38], ["main", "OBSERVATION_MODIFIER", 4, 8], ["DNA phage", "OBSERVATION", 29, 38], ["numerically", "OBSERVATION_MODIFIER", 47, 58], ["dominant", "OBSERVATION_MODIFIER", 59, 67], ["genetic entity", "OBSERVATION", 68, 82], ["most habitats", "OBSERVATION_MODIFIER", 86, 99]]], ["In addition, as discussed in Chapter 10, it is now clear that some of these viruses are surprisingly complex and that essentially the entire pool of dsDNA viruses of prokaryotes may be exchanging DNA via recombination at high rates.", [["dsDNA viruses", "ORGANISM", 149, 162], ["DNA", "CELLULAR_COMPONENT", 196, 199], ["these viruses", "PROBLEM", 70, 83], ["viruses", "OBSERVATION", 76, 83], ["dsDNA viruses", "OBSERVATION", 149, 162]]], ["Historically, the evolution of the DNA viruses of prokaryotes has seldom been considered in the broader context of virus evolution or evolutionary biology.", [["DNA", "CELLULAR_COMPONENT", 35, 38], ["the DNA viruses of prokaryotes", "PROBLEM", 31, 61], ["virus", "OBSERVATION", 115, 120]]], ["Although it has long been realized that there are many basic similarities between viruses of bacteria and eukaryotes ( Luria et al. , 1959 ) , not until structural studies solved the capsid genes of prokaryotic and eukaryotic viruses did the evolutionary relationships between these viruses become clear.", [["capsid genes", "DNA", 183, 195], ["viruses of bacteria", "PROBLEM", 82, 101], ["structural studies", "TEST", 153, 171], ["prokaryotic and eukaryotic viruses", "PROBLEM", 199, 233], ["eukaryotic viruses", "OBSERVATION", 215, 233], ["viruses", "OBSERVATION", 283, 290], ["clear", "OBSERVATION", 298, 303]]], ["In addition, there have been a number of striking proposals that suggest that DNA viruses of prokaryotes may be involved in the origin of several major systems used by cells and that viruses appear to be involved in several major transitions during host evolution.", [["cells", "ANATOMY", 168, 173], ["DNA", "CELLULAR_COMPONENT", 78, 81], ["cells", "CELL", 168, 173], ["DNA viruses of prokaryotes", "PROBLEM", 78, 104], ["viruses", "PROBLEM", 183, 190]]], ["Thus we now consider the possibility that these DNA phage were fundamental to the origin and evolution of life on Earth.The Big Bang of Phage and Cellular DNAIt now seems likely that some large DNA viruses infecting eubacteria, archaea, and eukaryotes share some common evolutionary histories.", [["DNA", "CELLULAR_COMPONENT", 48, 51], ["DNA", "CELLULAR_COMPONENT", 194, 197], ["these DNA phage", "PROBLEM", 42, 57], ["The Big Bang of Phage", "TREATMENT", 120, 141], ["some large DNA viruses infecting eubacteria", "PROBLEM", 183, 226], ["seems likely", "UNCERTAINTY", 165, 177], ["large", "OBSERVATION_MODIFIER", 188, 193], ["DNA viruses", "OBSERVATION", 194, 205], ["infecting eubacteria", "OBSERVATION", 206, 226]]], ["It also seems clear that such viruses can link all three domains of life.", [["such viruses", "PROBLEM", 25, 37], ["clear", "OBSERVATION", 14, 19], ["viruses", "OBSERVATION", 30, 37]]], ["This realization was not apparent based on phylogenetic sequence conservation, which is absent.", [["phylogenetic sequence conservation", "TEST", 43, 77], ["not apparent", "UNCERTAINTY", 21, 33], ["absent", "OBSERVATION_MODIFIER", 88, 94]]], ["It stems from the structure and assembly of virion capsids in which T4 phage, halophage, and the herpesviruses all show clear similarity as well as similarity in replication strategies.", [["T4", "GENE_OR_GENE_PRODUCT", 68, 70], ["halophage", "CANCER", 78, 87], ["virion capsids", "TREATMENT", 44, 58], ["T4 phage", "TREATMENT", 68, 76], ["halophage", "TREATMENT", 78, 87], ["the herpesviruses", "PROBLEM", 93, 110], ["replication strategies", "TREATMENT", 162, 184], ["virion capsids", "OBSERVATION", 44, 58]]], ["In addition, phage PRD1 and adenoviruses show similar broad structural and strategic conservation.", [["PRD1", "GENE_OR_GENE_PRODUCT", 19, 23], ["adenoviruses", "ORGANISM", 28, 40], ["phage PRD1", "PROTEIN", 13, 23], ["phage PRD1", "TREATMENT", 13, 23], ["adenoviruses", "TREATMENT", 28, 40], ["strategic conservation", "OBSERVATION", 75, 97]]], ["Some biochemical (DNA pol family) and genetic similarities (gene order, gene programming) are also apparent, which taken together supports the common origins of these viruses ( Hendrix, 1999 ( Hendrix, , 2002 Hendrix et al. , 1999 Hendrix et al. , , 2003 .", [["DNA", "CELLULAR_COMPONENT", 18, 21], ["pol", "GENE_OR_GENE_PRODUCT", 22, 25], ["DNA pol family", "PROTEIN", 18, 32], ["viruses", "OBSERVATION", 167, 174]]], ["T4-like viruses in particular seem to represent a major source of global genetic diversity.", [["T4-like viruses", "ORGANISM", 0, 15], ["T4-like viruses", "PROBLEM", 0, 15], ["global genetic diversity", "PROBLEM", 66, 90], ["viruses", "OBSERVATION", 8, 15], ["global", "OBSERVATION_MODIFIER", 66, 72], ["genetic diversity", "OBSERVATION", 73, 90]]], ["This giant genetic pool represents a huge potential to affect life ( Filee et al. , 2005 ) and the viral genetic creativity represented by this pool would also be vast ( Nolan et al. , 2006 ) .", [["the viral genetic creativity", "PROBLEM", 95, 123]]], ["Since T4-like phage that infect cyanobacteria also encode virus-specifi c type II photosynthetic core genes, viruses appear able to create the most complex of genes as well ( Clokie et al. , 2006 ; Sullivan et al. , 2006 ) .The Big Bang of Phage and Cellular DNAAs presented in Chapter 10, phage are now thought to evolve by distinct and highly mosaic \" horizontal \" processes of rampant recombination ( Hendrix, 2002 ( Hendrix, , 2003 .", [["T4", "GENE_OR_GENE_PRODUCT", 6, 8], ["virus-specifi c", "ORGANISM", 58, 73], ["type II photosynthetic core", "GENE_OR_GENE_PRODUCT", 74, 101], ["T4", "PROTEIN", 6, 8], ["virus-specifi c type II photosynthetic core genes", "DNA", 58, 107], ["virus-specifi", "SPECIES", 58, 71], ["T4", "TEST", 6, 8], ["infect cyanobacteria", "PROBLEM", 25, 45], ["encode virus", "PROBLEM", 51, 63], ["type II photosynthetic core genes", "PROBLEM", 74, 107], ["viruses", "PROBLEM", 109, 116], ["Cellular DNAAs", "OBSERVATION", 250, 264]]], ["Large DNA phage appear to be ancient, present before the split of the three main branches of cellular life: bacteria, archaea, and eukarya ( Benson et al. , 2004 ) .", [["cellular", "ANATOMY", 93, 101], ["DNA", "CELLULAR_COMPONENT", 6, 9], ["cellular", "CELL", 93, 101], ["Large DNA phage", "PROBLEM", 0, 15], ["bacteria", "PROBLEM", 108, 116], ["archaea", "PROBLEM", 118, 125], ["DNA phage", "OBSERVATION", 6, 15], ["branches", "ANATOMY_MODIFIER", 81, 89], ["cellular life", "OBSERVATION", 93, 106], ["bacteria", "OBSERVATION", 108, 116]]], ["LUCA, the Last Universal Common Ancestor, would represent the putative cell ancestor prior to this split.", [["cell", "ANATOMY", 71, 75], ["cell", "CELL", 71, 75], ["Last Universal Common Ancestor", "DNA", 10, 40], ["putative cell ancestor", "OBSERVATION", 62, 84]]], ["However, phyogenetic analysis of common or conserved genes of LUCA identifi es only about 325 or fewer genes in extant cellular genomes ( Mushegian, 1999 ; Koonin et al. , 2001 ; Mirkin et al. , 2003 ) .", [["cellular genomes", "ANATOMY", 119, 135], ["LUCA", "GENE_OR_GENE_PRODUCT", 62, 66], ["cellular", "CELL", 119, 127], ["LUCA", "DNA", 62, 66], ["325 or fewer genes", "DNA", 90, 108], ["LUCA identifi", "SPECIES", 62, 75], ["phyogenetic analysis", "TEST", 9, 29], ["cellular genomes", "OBSERVATION", 119, 135]]], ["Ironically, the genes needed for DNA replication are not part of this conserved set, calling into question the nature of the fi rst DNA-based cell.", [["cell", "ANATOMY", 142, 146], ["DNA", "CELLULAR_COMPONENT", 33, 36], ["DNA", "CELLULAR_COMPONENT", 132, 135], ["cell", "CELL", 142, 146], ["fi rst DNA", "DNA", 125, 135], ["DNA replication", "TREATMENT", 33, 48]]], ["Large-scale \" horizontal \" transfer seems to have clearly prevailed early in the evolution of DNA-based cellular life and it has recently been asserted that LUCA existed in a highly horizontal \" consortia \" of cooperative genes that developed the common genetic code ( Vetsigian et al. , 2006 ) .The Big Bang of Phage and Cellular DNASince the DNA replication proteins in the extant three domains of life have distinct compositions, it has been proposed by Forterre that DNA viruses and retroviruses were directly involved in the invention of the three extant cellular DNA replication systems .", [["cellular", "ANATOMY", 104, 112], ["cellular", "ANATOMY", 560, 568], ["DNA", "CELLULAR_COMPONENT", 94, 97], ["cellular", "CELL", 104, 112], ["LUCA", "GENE_OR_GENE_PRODUCT", 157, 161], ["DNA", "CELLULAR_COMPONENT", 344, 347], ["DNA", "CELLULAR_COMPONENT", 471, 474], ["retroviruses", "ORGANISM", 487, 499], ["cellular", "CELL", 560, 568], ["DNA", "CELLULAR_COMPONENT", 569, 572], ["LUCA", "PROTEIN", 157, 161], ["cooperative genes", "DNA", 210, 227], ["Cellular DNASince the DNA replication proteins", "PROTEIN", 322, 368], ["The Big Bang of Phage", "TREATMENT", 296, 317], ["Cellular DNASince the DNA replication proteins", "TREATMENT", 322, 368], ["DNA viruses", "PROBLEM", 471, 482], ["retroviruses", "TREATMENT", 487, 499], ["-scale", "OBSERVATION_MODIFIER", 5, 11], ["distinct", "OBSERVATION_MODIFIER", 410, 418], ["compositions", "OBSERVATION_MODIFIER", 419, 431], ["cellular DNA", "OBSERVATION", 560, 572], ["replication systems", "OBSERVATION", 573, 592]]], ["According to this view, early cellular life was completely entangled with viral (phage) lineages; hence cells must have evolved from an ancestral \" virus \" -mediated population not a single genetic lineage.", [["cellular", "ANATOMY", 30, 38], ["cells", "ANATOMY", 104, 109], ["cellular", "CELL", 30, 38], ["cells", "CELL", 104, 109], ["viral (phage) lineages", "PROBLEM", 74, 96], ["an ancestral \" virus \"", "PROBLEM", 133, 155]]], ["Thus the evolution of early life would have clear similarity to the quasispecies (consortia) state of genetic information as seen in RNA viruses above.", [["the quasispecies", "PROBLEM", 64, 80]]], ["Thus the huge creative and adaptive potential of virus would have been directly involved in the very earliest evolution of life.", [["virus", "PROBLEM", 49, 54]]], ["But, these theories are as viable as any other and deserve serious consideration.The Big Bang of Phage and Cellular DNAIn spite of this seemingly unending mosaic exchange in dsDNA phage, some phage isolates show surprisingly stable genetic makeup.", [["The Big Bang of Phage", "TREATMENT", 81, 102], ["mosaic exchange in dsDNA phage", "TREATMENT", 155, 185], ["some phage isolates", "TEST", 187, 206], ["stable", "OBSERVATION_MODIFIER", 225, 231]]], ["We now accept that T4-related phage are an important source of the larger global phage genetic diversity and that most such viral genes are novel ( Filee et al. , 2006b ; Nolan et al. , 2006 ).", [["T4", "GENE_OR_GENE_PRODUCT", 19, 21], ["T4", "PROTEIN", 19, 21], ["viral genes", "DNA", 124, 135], ["T4-related phage", "PROBLEM", 19, 35], ["the larger global phage genetic diversity", "PROBLEM", 63, 104], ["larger", "OBSERVATION_MODIFIER", 67, 73], ["global", "OBSERVATION_MODIFIER", 74, 80], ["phage genetic diversity", "OBSERVATION", 81, 104]]], ["Yet even with T4-like viruses, there can be clear barriers to horizontal gene transfer which promote the evolution of stable viral lineages ( Filee et al. , 2006a ) .", [["T4", "GENE_OR_GENE_PRODUCT", 14, 16], ["T4-like viruses", "PROBLEM", 14, 29], ["horizontal gene transfer", "TREATMENT", 62, 86], ["viruses", "OBSERVATION", 22, 29], ["stable", "OBSERVATION_MODIFIER", 118, 124], ["viral lineages", "OBSERVATION", 125, 139]]], ["In T4-type phage, 24 similar core genes could be seen in all genomes, which seem to be inherited in gene blocks that preclude recombination.", [["T4-type phage", "DNA", 3, 16]]], ["However, these blocks were not seen in the broader T-even and pseudo T-even genomes.", [["T-even and pseudo T-even genomes", "DNA", 51, 83]]], ["Other phage also show surprising genetic stability when repeatedly isolated from similar habitats, such as soil phages of Burkholderia ( Summer et al. , 2006 ) and Bam35 ( Saren et al. , 2005 ) as well as some hot spring isolates ( Khayat et al. , 2005 ) .", [["surprising genetic stability", "PROBLEM", 22, 50]]], ["This Bam35 capsid also identifi es another structural motif mentioned above that is broadly conserved in evolution and shows clear similarity to that capsids found in PRD1 and PBCV-1 (discussed below).", [["Bam35", "GENE_OR_GENE_PRODUCT", 5, 10], ["PRD1", "GENE_OR_GENE_PRODUCT", 167, 171], ["PBCV-1", "GENE_OR_GENE_PRODUCT", 176, 182], ["Bam35 capsid", "PROTEIN", 5, 17], ["PRD1", "PROTEIN", 167, 171], ["PBCV", "PROTEIN", 176, 180], ["PBCV-1", "SPECIES", 176, 182], ["This Bam35 capsid", "TREATMENT", 0, 17], ["PBCV", "TEST", 176, 180]]], ["SH1 also has a clear PRD1related capsid, membrane, and genome; thus this halophilic euryarchaeon virus, although showing no sequence similarity to PRD1 or any other bacterial phage, is clearly structurally related ( Bamford et al. , 2005a ) .The Big Bang of Phage and Cellular DNAIt is interesting that overall the viruses of hyperthermophilic Crenarchaeota generally show no sequence relationship to phage of bacteria.", [["membrane", "ANATOMY", 41, 49], ["SH1", "CHEMICAL", 0, 3], ["SH1", "GENE_OR_GENE_PRODUCT", 0, 3], ["membrane", "CELLULAR_COMPONENT", 41, 49], ["genome", "CELLULAR_COMPONENT", 55, 61], ["euryarchaeon virus", "ORGANISM", 84, 102], ["PRD1", "GENE_OR_GENE_PRODUCT", 147, 151], ["SH1", "PROTEIN", 0, 3], ["PRD1related capsid", "PROTEIN", 21, 39], ["PRD1", "PROTEIN", 147, 151], ["this halophilic euryarchaeon virus", "PROBLEM", 68, 102], ["any other bacterial phage", "PROBLEM", 155, 180], ["The Big Bang of Phage", "TREATMENT", 242, 263], ["hyperthermophilic Crenarchaeota", "PROBLEM", 326, 357], ["bacteria", "PROBLEM", 410, 418], ["clear", "OBSERVATION_MODIFIER", 15, 20], ["PRD1related capsid", "OBSERVATION", 21, 39], ["membrane", "OBSERVATION_MODIFIER", 41, 49], ["Big", "OBSERVATION_MODIFIER", 246, 249], ["Cellular DNAIt", "OBSERVATION", 268, 282], ["hyperthermophilic Crenarchaeota", "OBSERVATION", 326, 357]]], ["In addition, the use of the term phage for these viruses can also be questioned as most establish non-lytic chronic infections.", [["chronic infections", "DISEASE", 108, 126], ["the term phage", "TREATMENT", 24, 38], ["these viruses", "PROBLEM", 43, 56], ["non-lytic chronic infections", "PROBLEM", 98, 126], ["chronic", "OBSERVATION_MODIFIER", 108, 115], ["infections", "OBSERVATION", 116, 126]]], ["Many of these Crenarchaeota viruses have unique morphologies not found in any other domain of life ( Prangishvili et al. , 2006a ( Prangishvili et al. , , 2006b Ortmann et al. , 2006 ) .", [["Crenarchaeota viruses", "ORGANISM", 14, 35], ["these Crenarchaeota viruses", "PROBLEM", 8, 35], ["Crenarchaeota viruses", "OBSERVATION", 14, 35]]], ["Some, however, have clear structural and genetic similarity to specifi c phage (i.e. T4).GENOMIC STABILITY: PERSISTENCE AND TEMPERATE LIFESTYLEConsiderations of phage evolution and rampant recombination (especially with T4 and T-even phage) often emphasize the viral lytic lifestyle and host death.", [["death", "DISEASE", 292, 297], ["specifi c phage", "GENE_OR_GENE_PRODUCT", 63, 78], ["phage evolution", "PROBLEM", 161, 176], ["rampant recombination", "PROBLEM", 181, 202], ["T4 and T-even phage", "TREATMENT", 220, 239], ["host death", "PROBLEM", 287, 297], ["STABILITY", "OBSERVATION_MODIFIER", 97, 106], ["PERSISTENCE", "OBSERVATION_MODIFIER", 108, 119]]], ["In fact this lytic relationship was argued by many early phage researchers to be the fundamental and only character of phage-host relationships in general.", [["lytic", "OBSERVATION_MODIFIER", 13, 18]]], ["We now know, however, that persisting (temperate) phage are also common, some of which have no independent lytic phase.", [["persisting (temperate) phage", "PROBLEM", 27, 55], ["no", "UNCERTAINTY", 92, 94], ["independent", "OBSERVATION_MODIFIER", 95, 106], ["lytic", "OBSERVATION_MODIFIER", 107, 112], ["phase", "OBSERVATION_MODIFIER", 113, 118]]], ["The fundamental model of phage persistence by unique integration into host chromosomes (temperate lysogeny) marks a major development in our understanding of molecular virology and virus-host relationships which was fi rst clarifi ed by Campbell in 1962 (see Campbell, 2007 .", [["chromosomes", "ANATOMY", 75, 86], ["host chromosomes", "DNA", 70, 86], ["phage persistence", "OBSERVATION_MODIFIER", 25, 42]]], ["All free-living prokaryotes show the presence of colonized phage in their genomes.", [["free", "OBSERVATION_MODIFIER", 4, 8], ["colonized phage", "OBSERVATION", 49, 64]]], ["Both complete and defective genomes of dsDNA viruses have been observed in the sequenced DNA of all free living prokaryotic genomes ( Gelfand and Koonin, 1997 ) (exceptions are some intracellular parasites and plastids).", [["intracellular", "ANATOMY", 182, 195], ["plastids", "ANATOMY", 210, 218], ["dsDNA viruses", "ORGANISM", 39, 52], ["DNA", "CELLULAR_COMPONENT", 89, 92], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 182, 195], ["plastids", "CELLULAR_COMPONENT", 210, 218], ["prokaryotic genomes", "DNA", 112, 131], ["dsDNA viruses", "PROBLEM", 39, 52], ["some intracellular parasites", "PROBLEM", 177, 205], ["defective genomes", "OBSERVATION", 18, 35], ["dsDNA viruses", "OBSERVATION", 39, 52]]], ["Thus, the massive genetic diversity and novelty of phage evolution as presented above has a direct conduit into the genetic composition of all prokaryotes via lysogeny.GENOMIC STABILITY: PERSISTENCE AND TEMPERATE LIFESTYLEThe fi tness and evolutionary consequences of such colonization to the evolution of the host and its virus should be considerable but is in need of theoretical development.", [["the massive genetic diversity", "PROBLEM", 6, 35], ["novelty of phage evolution", "PROBLEM", 40, 66], ["a direct conduit", "TREATMENT", 90, 106], ["such colonization", "PROBLEM", 268, 285], ["its virus", "PROBLEM", 319, 328], ["massive", "OBSERVATION_MODIFIER", 10, 17], ["genetic", "OBSERVATION_MODIFIER", 18, 25], ["diversity", "OBSERVATION_MODIFIER", 26, 35], ["lysogeny", "OBSERVATION", 159, 167], ["STABILITY", "OBSERVATION_MODIFIER", 176, 185]]], ["Fitness of temperate phage, however, is more complicated then that of a lytic virus and, like fi tness of persistence discussed above, cannot be simply described by relative replication or effi cient virion production.", [["temperate phage", "PROBLEM", 11, 26], ["a lytic virus", "PROBLEM", 70, 83], ["temperate phage", "OBSERVATION_MODIFIER", 11, 26], ["lytic", "OBSERVATION_MODIFIER", 72, 77], ["virus", "OBSERVATION", 78, 83]]], ["Here too, successful phage colonization must inherently limit the replication of the same virus.", [["successful phage colonization", "TREATMENT", 10, 39], ["the same virus", "PROBLEM", 81, 95]]], ["Thus, a temperate lifestyle also requires an autoinhibitory capacity.", [["an autoinhibitory capacity", "PROBLEM", 42, 68]]], ["This generally involves an immunity gene set that not only limits self-replication but can also affect replication of other temperate and lytic viruses, i.e. lambda (even as a defective) precludes T4 and other T-even phage.", [["T4", "GENE_OR_GENE_PRODUCT", 197, 199], ["immunity gene set", "DNA", 27, 44], ["other temperate and lytic viruses", "PROBLEM", 118, 151]]], ["Uncolonized hosts are thus susceptible to lysis by highly prevalent acute tailed phage.", [["Uncolonized hosts", "PROBLEM", 0, 17], ["lysis", "TREATMENT", 42, 47]]], ["Host fi tness is thus strongly affected by a temperate phage due to its ability to preclude and survive other competing phage.", [["a temperate phage", "TREATMENT", 43, 60]]], ["I suggest this situation is similar to the MHV-mouse exemplar above, in that virus-colonized hosts are in a state of \" virus addiction \" in which persistence is needed to provide protection from the same or similar virus ( Villarreal, 2005 ( Villarreal, , 2006 .GENOMIC STABILITY: PERSISTENCE AND TEMPERATE LIFESTYLEIt is well established that most natural populations of bacteria have specifi c patterns of phage colonization, hence the utility of phage typing for strain identifi cation.", [["mouse", "ORGANISM", 47, 52], ["hosts", "ORGANISM", 93, 98], ["specifi c", "GENE_OR_GENE_PRODUCT", 386, 395], ["cation", "SIMPLE_CHEMICAL", 482, 488], ["mouse", "SPECIES", 47, 52], ["mouse", "SPECIES", 47, 52], ["bacteria", "PROBLEM", 372, 380], ["phage colonization", "PROBLEM", 408, 426], ["phage typing", "TEST", 449, 461], ["STABILITY", "OBSERVATION_MODIFIER", 270, 279], ["PERSISTENCE", "OBSERVATION_MODIFIER", 281, 292], ["phage colonization", "OBSERVATION_MODIFIER", 408, 426]]], ["From this, we can infer that virus-virus competition is a prevalent and major issue regarding the prokaryotic fi tness resulting from a symbiotic temperate phage-host combination.", [["virus-virus", "ORGANISM", 29, 40], ["virus-virus", "SPECIES", 29, 40], ["the prokaryotic fi tness", "PROBLEM", 94, 118], ["a symbiotic temperate phage", "TREATMENT", 134, 161]]], ["In addition, such virus-host symbiosis can also affect competition with other bacteria.", [["such virus-host symbiosis", "PROBLEM", 13, 38], ["other bacteria", "PROBLEM", 72, 86]]], ["This would be very much like the virus addiction concept outlined above for the MHV examplar.GENOMIC STABILITY: PERSISTENCE AND TEMPERATE LIFESTYLEThe original observation of a lysogenic process and coining of this term occurred in the 1920s when two pure cultures of bacteria were grown together.", [["MHV", "ORGANISM", 80, 83], ["MHV", "SPECIES", 80, 83], ["a lysogenic process", "PROBLEM", 175, 194], ["bacteria", "PROBLEM", 268, 276], ["virus", "OBSERVATION", 33, 38], ["MHV", "ANATOMY", 80, 83], ["STABILITY", "OBSERVATION_MODIFIER", 101, 110], ["lysogenic", "OBSERVATION", 177, 186]]], ["It was observed that in some combinations, one strain would lyse the other strain (was lysogenic).", [["the other strain", "PROBLEM", 65, 81]]], ["Later, it became clear that such lysis was mediated by reactivation of temperate phage present in the lysogenic strain, but absent from the non-lysogenic susceptible strain.", [["strain", "ANATOMY", 112, 118], ["such lysis", "PROBLEM", 28, 38], ["temperate phage", "TREATMENT", 71, 86], ["the lysogenic strain", "PROBLEM", 98, 118], ["the non-lysogenic susceptible strain", "PROBLEM", 136, 172], ["lysis", "OBSERVATION", 33, 38], ["temperate phage", "OBSERVATION_MODIFIER", 71, 86], ["lysogenic strain", "OBSERVATION", 102, 118], ["susceptible strain", "OBSERVATION", 154, 172]]], ["In this relationship, we see another example of group selection operating on bacterial populations harboring a persistent virus.", [["bacterial populations", "PROBLEM", 77, 98], ["a persistent virus", "PROBLEM", 109, 127], ["persistent", "OBSERVATION_MODIFIER", 111, 121], ["virus", "OBSERVATION", 122, 127]]], ["Thus, what host is fi t depends very much on the prevalent viruses it will encounter as well as the viruses that colonize it.", [["the viruses", "PROBLEM", 96, 107]]], ["Bacterial populations that are colonized by the same or similar phage express the appropriate immunity functions and are protected from lysis by the same or similar phage.GENOMIC STABILITY: PERSISTENCE AND TEMPERATE LIFESTYLESuch a situation has signifi cant implication for the evolution of immunity and group identity for cells.", [["cells", "ANATOMY", 324, 329], ["Bacterial populations", "CELL", 0, 21], ["cells", "CELL", 324, 329], ["Bacterial populations", "PROBLEM", 0, 21], ["lysis", "TREATMENT", 136, 141], ["populations", "OBSERVATION", 10, 21], ["STABILITY", "OBSERVATION_MODIFIER", 179, 188], ["PERSISTENCE", "OBSERVATION_MODIFIER", 190, 201]]], ["Host stability becomes a major fi tness issue for a persistent virus life strategy.", [["a persistent virus life strategy", "TREATMENT", 50, 82], ["stability", "OBSERVATION_MODIFIER", 5, 14]]], ["It is generally thought that a temperate virus attains a stable colonization of its host by simply integrating into and become one with the host genome.", [["host genome", "DNA", 140, 151], ["a temperate virus", "PROBLEM", 29, 46], ["temperate", "OBSERVATION_MODIFIER", 31, 40], ["virus", "OBSERVATION", 41, 46], ["stable", "OBSERVATION_MODIFIER", 57, 63], ["colonization", "OBSERVATION", 64, 76], ["host genome", "OBSERVATION", 140, 151]]], ["However, there are also clear examples of stable phage persistence that does not integrate and uses other strategies to attain host stability (similar to eukaryotic DNA viruses; see below for the P1 phage exemplar of this).", [["DNA", "CELLULAR_COMPONENT", 165, 168], ["other strategies", "TREATMENT", 100, 116], ["host stability", "PROBLEM", 127, 141], ["eukaryotic DNA viruses", "PROBLEM", 154, 176], ["clear", "OBSERVATION", 24, 29], ["stable", "OBSERVATION_MODIFIER", 42, 48], ["phage", "OBSERVATION", 49, 54]]], ["Like a temperate phage, a host that is colonized by episomal persisting viruses has also been much affected in its evolutionary potential.EPISOMAL STABILITY: THE P1 EXEMPLAR OF PERSISTENCEIt is clear that phage can have complex effects on host populations, but these phage themselves often exist in complex and mixed states that can be diffi cult to unravel ( Harcombe and Bull, 2005 ) .", [["a temperate phage", "PROBLEM", 5, 22], ["episomal persisting viruses", "PROBLEM", 52, 79], ["host populations", "TREATMENT", 239, 255], ["temperate phage", "OBSERVATION_MODIFIER", 7, 22], ["persisting", "OBSERVATION_MODIFIER", 61, 71], ["viruses", "OBSERVATION", 72, 79], ["STABILITY", "OBSERVATION_MODIFIER", 147, 156], ["clear", "OBSERVATION", 194, 199]]], ["It has been known for some time that the presence of otherwise silent phage can greatly affect the growth of other virus and susceptibility of host.", [["otherwise silent phage", "PROBLEM", 53, 75], ["other virus", "PROBLEM", 109, 120]]], ["One such silent and common phage that has long been studied is P1.", [["P1", "DNA", 63, 65], ["One such silent and common phage", "PROBLEM", 0, 32], ["silent", "OBSERVATION", 9, 15], ["common phage", "OBSERVATION_MODIFIER", 20, 32]]], ["P1 was initially discovered due to its effect on T4 and lambda.", [["T4", "SIMPLE_CHEMICAL", 49, 51], ["P1", "DNA", 0, 2], ["P1", "PROBLEM", 0, 2], ["its effect on T4 and lambda", "PROBLEM", 35, 62]]], ["However, P1 has been a very interesting model, not because it causes disease or offers potential therapy against bacterial pathogens, but simply because it persists effi ciently as an episome and competes effectively with many other phage ( Yarmolinsky, 2004 ) .", [["disease", "PROBLEM", 69, 76], ["potential therapy", "TREATMENT", 87, 104], ["bacterial pathogens", "PROBLEM", 113, 132], ["pathogens", "OBSERVATION", 123, 132], ["episome", "OBSERVATION", 184, 191]]], ["Since it does so without integrating, P1 provides us with one of the only well-studied models that can inform us regarding the molecular strategies and details of how stability in non-genomic persistence is attained.EPISOMAL STABILITY: THE P1 EXEMPLAR OF PERSISTENCECuriously, a main strategy by which P1 attains this stability was inapparent and not suspected after several decades of study.", [["P1", "DNA", 38, 40], ["study", "TEST", 386, 391], ["STABILITY", "OBSERVATION_MODIFIER", 225, 234], ["main", "OBSERVATION_MODIFIER", 279, 283], ["not suspected", "UNCERTAINTY", 347, 360]]], ["It became apparent only after replication mutations were made that induced self-destruction and uncovered the existence of what came to be called \" addiction modules \" ( Lehnherr et al. , 1993 ) .", [["replication mutations", "PROBLEM", 30, 51], ["self-destruction", "PROBLEM", 75, 91]]], ["P1 encodes several gene pairs (toxins/ antitoxins, such as the PhD/DOC pair) that protect bacteria harboring P1, but kill daughter bacteria that have lost the P1 genome ( Gazit and Sauer, 1999 ) .", [["DOC", "CHEMICAL", 67, 70], ["antitoxins", "GENE_OR_GENE_PRODUCT", 39, 49], ["PhD", "GENE_OR_GENE_PRODUCT", 63, 66], ["DOC", "GENE_OR_GENE_PRODUCT", 67, 70], ["P1", "DNA", 0, 2], ["antitoxins", "DNA", 39, 49], ["PhD", "DNA", 63, 66], ["DOC pair", "DNA", 67, 75], ["P1", "DNA", 109, 111], ["P1 genome", "DNA", 159, 168], ["several gene pairs (toxins", "PROBLEM", 11, 37], ["antitoxins", "TREATMENT", 39, 49], ["the PhD/DOC pair", "TREATMENT", 59, 75], ["bacteria harboring P1", "PROBLEM", 90, 111]]], ["This strategy compels colonized E. coli to maintain P1 or die (DOC, death on curing).", [["DOC", "CHEMICAL", 63, 66], ["death", "DISEASE", 68, 73], ["DOC", "CHEMICAL", 63, 66], ["E. coli", "ORGANISM", 32, 39], ["E. coli", "SPECIES", 32, 39], ["E. coli", "SPECIES", 32, 39]]], ["However, these very same addiction systems are also involved in protecting a P1-colonized colony from T4 and lambda infection and will also induce self-destruction when cells are infected by those viruses, protecting the colony (population).", [["colony", "ANATOMY", 90, 96], ["cells", "ANATOMY", 169, 174], ["colony", "ANATOMY", 221, 227], ["infection", "DISEASE", 116, 125], ["T4", "SIMPLE_CHEMICAL", 102, 104], ["cells", "CELL", 169, 174], ["a P1-colonized colony", "PROBLEM", 75, 96], ["T4 and lambda infection", "PROBLEM", 102, 125], ["self-destruction when cells", "PROBLEM", 147, 174], ["lambda", "OBSERVATION_MODIFIER", 109, 115], ["infection", "OBSERVATION", 116, 125]]], ["P1 also provides an exquisite level of molecular self-identifi cation in that it will recognize a single second copy of its own genome ( Yarmolinsky, 2000 ) .EPISOMAL STABILITY: THE P1 EXEMPLAR OF PERSISTENCEWhat then is the fi tness and evolutionary consequence to E. coli harboring P1?", [["cation", "SIMPLE_CHEMICAL", 63, 69], ["E. coli", "ORGANISM", 266, 273], ["P1", "DNA", 0, 2], ["P1", "DNA", 284, 286], ["E. coli", "SPECIES", 266, 273], ["E. coli", "SPECIES", 266, 273], ["the fi tness", "PROBLEM", 221, 233], ["E. coli harboring P1", "PROBLEM", 266, 286], ["STABILITY", "OBSERVATION_MODIFIER", 167, 176], ["coli harboring", "OBSERVATION", 269, 283]]], ["Clearly it is major, but mostly host fi tness is affected relative to other viruses.", [["major", "OBSERVATION_MODIFIER", 14, 19], ["viruses", "OBSERVATION", 76, 83]]], ["Accordingly, when contemplating the amazing complexity of the P1 immunity and how it evolved, Yarmolinsky posed the question; \" Could the byzantine complexity of the controls at ImmI be the outcome, not of successive host-parasite accommodations, but of competition among related phages? \"", [["ImmI", "GENE_OR_GENE_PRODUCT", 178, 182]]], ["If we answer yes to this question, then we would also conclude that virus-virus interactions and competition in general are major forces in the adaptability and evolution of persisting phage and surviving colonized host.", [["virus-virus", "ORGANISM", 68, 79], ["virus-virus interactions", "PROBLEM", 68, 92], ["persisting phage", "PROBLEM", 174, 190]]], ["In this light, viral persistence takes on a major role in virus and host evolution.", [["viral persistence", "PROBLEM", 15, 32], ["viral persistence", "OBSERVATION", 15, 32], ["virus", "OBSERVATION", 58, 63], ["host evolution", "OBSERVATION", 68, 82]]], ["The P1 exemplar has thus provided us the concept of viral addiction that also promotes host group selection.PROKARYOTES AND THEIR VIRUSES AS ONE EVOLUTIONARY POOLHistorically, we are biased to think of viruses (and phage) as agents that simply kill their host.", [["viral addiction", "DISEASE", 52, 67], ["viral addiction", "PROBLEM", 52, 67], ["viruses", "PROBLEM", 202, 209], ["viral addiction", "OBSERVATION", 52, 67], ["VIRUSES", "OBSERVATION", 130, 137]]], ["Some have proposed that the prokaryotic global biomass is phage partitioned into those populations that live and those that die due to viral lysis.", [["the prokaryotic global biomass", "PROBLEM", 24, 54], ["viral lysis", "TREATMENT", 135, 146], ["prokaryotic", "OBSERVATION_MODIFIER", 28, 39], ["global", "OBSERVATION_MODIFIER", 40, 46], ["biomass", "OBSERVATION", 47, 54], ["viral lysis", "OBSERVATION", 135, 146]]], ["From such a perspective, viral novelity would seen of little relevance to host evolution.", [["viral novelity", "PROBLEM", 25, 39], ["host evolution", "OBSERVATION_MODIFIER", 74, 88]]], ["Metagenomic projects as noted above, have sequenced nearly 2 million phage genomes and report that most of these phage genes are unique, not in the database, and likely not derived from host ( Edwards and Rohwer, 2005 ) .", [["phage genomes", "DNA", 69, 82], ["phage genes", "DNA", 113, 124]]], ["The protein repertoire of sequenced phage indicates that 80% of conserved phage genes are specifi c to phage and show an evolutionary independence from genes of host .", [["specifi c", "GENE_OR_GENE_PRODUCT", 90, 99], ["conserved phage genes", "DNA", 64, 85], ["sequenced phage", "TEST", 26, 41]]], ["This identifi es a massive genetic novelty from virus, which is especially apparent in large DNA phage.", [["DNA", "CELLULAR_COMPONENT", 93, 96], ["a massive genetic novelty from virus", "PROBLEM", 17, 53], ["large DNA phage", "PROBLEM", 87, 102], ["massive", "OBSERVATION_MODIFIER", 19, 26], ["large", "OBSERVATION_MODIFIER", 87, 92], ["DNA phage", "OBSERVATION", 93, 102]]], ["As just discussed above, however, those hosts that live are also products of phage selection, and persisting temperate phage play a major role in this.", [["phage selection", "TREATMENT", 77, 92]]], ["Such phage colonization allows this massive phage novelty to fi nd its way into host genomes, which allows viral complex gene sets to be applied to novel problems of host adaptation.", [["viral complex gene sets", "DNA", 107, 130], ["Such phage colonization", "PROBLEM", 0, 23], ["this massive phage novelty", "TREATMENT", 31, 57], ["viral complex gene sets", "TREATMENT", 107, 130]]], ["Host novelty can thus be introduced by phage ( Comeau and Krisch, 2005 ) .PROKARYOTES AND THEIR VIRUSES AS ONE EVOLUTIONARY POOLThat persistence is a major life strategy of phage is confi rmed by the large numbers of genes associated with persistence (i.e. integrases, immunity) observed in metagenomic screens.", [["metagenomic screens", "TEST", 291, 310], ["VIRUSES", "OBSERVATION", 96, 103], ["large", "OBSERVATION_MODIFIER", 200, 205]]], ["There is also much practical experience that supports the crucial role of prophage in host evolution.", [["prophage", "OBSERVATION", 74, 82], ["host evolution", "OBSERVATION", 86, 100]]], ["One particularly well-studied system that has been studied for over 50 years is the ongoing evaluation of phage evolution as observed in the dairy industry ( Canchaya et al. , 2003 Brussow et al. , 2004 ) .", [["the ongoing evaluation", "TEST", 80, 102], ["phage evolution", "PROBLEM", 106, 121]]], ["The temperate phage analysis of these bacteria follows a long tradition of lambda and E. coli studies ( Campbell et al. , 1992 ; Canchaya et al. , 2003 Canchaya et al. , , 2004 .", [["E. coli", "ORGANISM", 86, 93], ["E. coli", "SPECIES", 86, 93], ["E. coli", "SPECIES", 86, 93], ["The temperate phage analysis", "TEST", 0, 28], ["these bacteria", "PROBLEM", 32, 46], ["E. coli studies", "TEST", 86, 101]]], ["These studies have led Brussow to conclude that much of the more recent dairy bacteria evolution can be considered to have resulted from the action of temperate phage.PROKARYOTES AND THEIR VIRUSES AS ONE EVOLUTIONARY POOLA similar view applies to E. coli and cyanobacteria.", [["E. coli", "ORGANISM", 247, 254], ["E. coli", "SPECIES", 247, 254], ["E. coli", "SPECIES", 247, 254], ["These studies", "TEST", 0, 13], ["the more recent dairy bacteria", "PROBLEM", 56, 86], ["temperate phage", "TREATMENT", 151, 166], ["E. coli", "PROBLEM", 247, 254], ["cyanobacteria", "PROBLEM", 259, 272], ["VIRUSES", "OBSERVATION", 189, 196], ["E. coli", "OBSERVATION", 247, 254]]], ["In addition, the ECOR collection of 72 sequenced E. coli genomes of medical interest shows that they differ from each other mainly due to patterns of genetic colonization, mostly by prophage, but they also show the presence tRNA-adjacent defective prophage and plasmid elements that differentiate these strains ( Hurtado and Rodriguez-Valera, 1999 ; Mazel et al. , 2000 ; Nilsson et al. , 2004 ) .", [["E. coli", "ORGANISM", 49, 56], ["ECOR", "DNA", 17, 21], ["tRNA-adjacent defective prophage", "DNA", 224, 256], ["plasmid elements", "DNA", 261, 277], ["E. coli", "SPECIES", 49, 56], ["E. coli", "SPECIES", 49, 56], ["the ECOR collection", "TEST", 13, 32], ["genetic colonization", "PROBLEM", 150, 170], ["adjacent defective prophage", "PROBLEM", 229, 256], ["plasmid elements", "PROBLEM", 261, 277], ["these strains", "PROBLEM", 297, 310], ["Hurtado", "TEST", 313, 320], ["genetic colonization", "OBSERVATION", 150, 170], ["defective prophage", "OBSERVATION", 238, 256]]], ["Cyanobacteria ( Prochlorococcus ) is major model for the study of the origin of the type II (plant-like) photosynthetic system.", [["Cyanobacteria", "CHEMICAL", 0, 13], ["Prochlorococcus", "CHEMICAL", 16, 31], ["Cyanobacteria ( Prochlorococcus )", "PROBLEM", 0, 33], ["the study", "TEST", 53, 62], ["the type II (plant-like) photosynthetic system", "PROBLEM", 80, 126], ["origin", "ANATOMY_MODIFIER", 70, 76]]], ["Since such genes show much evidence of recent and massive horizontal movement, it seem quite likely that prophage are mediators of such transfers, especially as these phage encode their own version of these photosynthetic genes ( Lindell et al. , 2004 ; Sullivan et al. , 2006 ) .PROKARYOTES AND THEIR VIRUSES AS ONE EVOLUTIONARY POOLVery similar Prochlorococcus strains exist in distinct oceanic populations in various habitats known as ecotypes.", [["photosynthetic genes", "DNA", 207, 227], ["recent and massive horizontal movement", "PROBLEM", 39, 77], ["similar Prochlorococcus strains", "PROBLEM", 339, 370], ["massive", "OBSERVATION_MODIFIER", 50, 57], ["horizontal movement", "OBSERVATION", 58, 77], ["seem quite likely", "UNCERTAINTY", 82, 99], ["VIRUSES", "OBSERVATION", 302, 309], ["Prochlorococcus strains", "OBSERVATION", 347, 370], ["distinct", "OBSERVATION_MODIFIER", 380, 388], ["oceanic populations", "OBSERVATION", 389, 408]]], ["Some think that such ecotypes represent the initial type of genetic variation that leads to speciation.", [["genetic variation", "OBSERVATION", 60, 77]]], ["The sequencing of six ecotypes has shown that they are 99% similar to one another, but the genetic variation that distinguishes them is mostly due to patterns of prophage colonization (called phage islands) ( Bouman et al. , 2006 ; Coleman et al. , 2006 ) .PROKARYOTES AND THEIR VIRUSES AS ONE EVOLUTIONARY POOLThus in all these prokaryotic models, persisting viruses play a fundamental role in host evolution and host genetic novelty is mostly phage derived.", [["prophage colonization", "PROBLEM", 162, 183], ["persisting viruses", "PROBLEM", 349, 367], ["VIRUSES", "OBSERVATION", 279, 286], ["prokaryotic models", "OBSERVATION", 329, 347], ["persisting", "OBSERVATION_MODIFIER", 349, 359], ["viruses", "OBSERVATION", 360, 367]]], ["Such observations have led some to propose that \" war is peace \" regarding virus-host evolution ( Comeau and Krisch, 2005 ) .", [["virus", "PROBLEM", 75, 80]]], ["Massive and complex innovation by phage appears to be a major force in the prokaryotic world.PROKARYOTES AND THEIR VIRUSES AS ONE EVOLUTIONARY POOLProkaryotes are the most adaptable of all cells.", [["cells", "ANATOMY", 189, 194], ["cells", "CELL", 189, 194], ["Massive and complex innovation", "PROBLEM", 0, 30], ["complex", "OBSERVATION_MODIFIER", 12, 19], ["innovation", "OBSERVATION", 20, 30], ["VIRUSES", "OBSERVATION", 115, 122], ["all cells", "OBSERVATION", 185, 194]]], ["If we can accept the above conclusion concerning the role for viruses in the evolution of prokaryotes, we must then ask why such a successful evolutionary strategy was not apparently maintained in eukaryotes?", [["viruses", "PROBLEM", 62, 69]]], ["In eukaryotes we see little evidence that largescale integration by DNA viruses is an important evolutionary process (although the story with retroviruses is different).", [["DNA", "CELLULAR_COMPONENT", 68, 71], ["retroviruses", "ORGANISM", 142, 154], ["largescale integration", "PROBLEM", 42, 64], ["DNA viruses", "PROBLEM", 68, 79]]], ["Nevertheless, as noted at the start of this section, we do see good evidence that links the evolution of large DNA viruses of prokaryotes to the large DNA viruses of eukaryotes.DNA QuasispeciesIn case we were becoming comfortable with the apparently clear distinctions between RNA and DNA virus evolution as outlined above (quasispecies vs. domain recombination respectively), the evolution of the parvoviruses informs us that DNA viruses can also evolve by a quasispecies process.", [["DNA", "CELLULAR_COMPONENT", 111, 114], ["DNA", "CELLULAR_COMPONENT", 151, 154], ["DNA", "CELLULAR_COMPONENT", 177, 180], ["DNA", "CELLULAR_COMPONENT", 285, 288], ["DNA", "CELLULAR_COMPONENT", 427, 430], ["large DNA viruses", "PROBLEM", 105, 122], ["DNA Quasispecies", "PROBLEM", 177, 193], ["clear distinctions between RNA", "PROBLEM", 250, 280], ["DNA virus evolution", "PROBLEM", 285, 304], ["quasispecies", "PROBLEM", 324, 336], ["the parvoviruses", "PROBLEM", 394, 410], ["DNA viruses", "PROBLEM", 427, 438], ["a quasispecies process", "PROBLEM", 458, 480], ["large", "OBSERVATION_MODIFIER", 105, 110], ["DNA viruses", "OBSERVATION", 111, 122], ["large", "OBSERVATION_MODIFIER", 145, 150], ["DNA viruses", "OBSERVATION", 151, 162], ["Quasispecies", "OBSERVATION", 181, 193], ["parvoviruses", "OBSERVATION", 398, 410], ["quasispecies", "OBSERVATION", 460, 472]]], ["Parvovirus evolution (see Chapter 17) can show a sharp contrast to the evolutionary pattern displayed by other small dsDNA viruses above (HPV, Py).", [["Parvovirus", "ORGANISM", 0, 10], ["Parvovirus evolution", "PROBLEM", 0, 20], ["other small dsDNA viruses", "PROBLEM", 105, 130], ["small", "OBSERVATION_MODIFIER", 111, 116], ["dsDNA viruses", "OBSERVATION", 117, 130]]], ["With the emergence of an acute pandemic in domestic dogs and cats (as well as other wild carnivore species), we see what is essentially evolution driven by single point mutations, mostly affecting the capsid genes and host cell receptor binding.", [["cell", "ANATOMY", 223, 227], ["dogs", "ORGANISM", 52, 56], ["cats", "ORGANISM", 61, 65], ["host cell receptor", "GENE_OR_GENE_PRODUCT", 218, 236], ["capsid genes", "DNA", 201, 213], ["dogs", "SPECIES", 52, 56], ["cats", "SPECIES", 61, 65], ["an acute pandemic in domestic dogs and cats", "PROBLEM", 22, 65], ["single point mutations", "PROBLEM", 156, 178], ["acute", "OBSERVATION_MODIFIER", 25, 30], ["pandemic", "OBSERVATION", 31, 39], ["capsid genes", "OBSERVATION", 201, 213], ["host cell", "OBSERVATION", 218, 227], ["receptor binding", "OBSERVATION", 228, 244]]], ["This system provides us with one of the better studied examples of the evolutionary dynamics of an emergent viral disease.", [["viral disease", "DISEASE", 108, 121], ["an emergent viral disease", "PROBLEM", 96, 121], ["viral disease", "OBSERVATION", 108, 121]]], ["In addition, in vivo mouse studies with minute virus of mouse (MVM) now make it clear that parvoviruses can behave much like RNA viruses, generating quasispecies of diverse progeny that allow a high adaptability for the generation of fi tness and disease in vivo ( Lopez-Bueno et al. , 2006 ) .", [["mouse", "ORGANISM", 21, 26], ["mouse", "ORGANISM", 56, 61], ["MVM", "ORGANISM", 63, 66], ["parvoviruses", "ORGANISM", 91, 103], ["mouse", "SPECIES", 21, 26], ["mouse", "SPECIES", 56, 61], ["mouse", "SPECIES", 21, 26], ["mouse", "SPECIES", 56, 61], ["vivo mouse studies", "TEST", 16, 34], ["parvoviruses", "PROBLEM", 91, 103], ["RNA viruses", "PROBLEM", 125, 136], ["fi tness", "PROBLEM", 234, 242], ["disease", "PROBLEM", 247, 254]]], ["This story is very reminiscent of the study of poliovirus in mice mentioned above.", [["poliovirus", "ORGANISM", 47, 57], ["mice", "ORGANISM", 61, 65], ["mice", "SPECIES", 61, 65], ["poliovirus", "SPECIES", 47, 57], ["mice", "SPECIES", 61, 65], ["the study", "TEST", 34, 43], ["poliovirus", "PROBLEM", 47, 57], ["poliovirus", "OBSERVATION", 47, 57]]], ["Human studies with B19 parvovirus are also consistent with high mutation rates ( Parsyan et al. , 2007 ; Shackelton and Holmes, 2006 ) .The Phycodnavirus ExemplarAlthough not specifi cally addressed in this volume, the viruses of eukaryotic unicellular green algae are of special interest from the perspective of DNA virus evolution.", [["B19 parvovirus", "DISEASE", 19, 33], ["Human", "ORGANISM", 0, 5], ["B19 parvovirus", "ORGANISM", 19, 33], ["green algae", "ORGANISM", 253, 264], ["DNA", "CELLULAR_COMPONENT", 313, 316], ["Human", "SPECIES", 0, 5], ["B19 parvovirus", "SPECIES", 19, 33], ["B19 parvovirus", "SPECIES", 19, 33], ["Human studies", "TEST", 0, 13], ["B19 parvovirus", "PROBLEM", 19, 33], ["high mutation rates", "PROBLEM", 59, 78], ["DNA virus evolution", "PROBLEM", 313, 332], ["consistent with", "UNCERTAINTY", 43, 58], ["high mutation", "OBSERVATION", 59, 72], ["eukaryotic unicellular", "OBSERVATION", 230, 252], ["green algae", "OBSERVATION", 253, 264], ["DNA virus", "OBSERVATION", 313, 322]]], ["These large, complex dsDNA membrane-containing icosahedral viruses are abundant in some water habitats ( Van Etten, 2003 ; Ghedin and Claverie, 2005 ) .", [["membrane", "ANATOMY", 27, 35], ["dsDNA", "CELLULAR_COMPONENT", 21, 26], ["membrane", "CELLULAR_COMPONENT", 27, 35], ["These large, complex dsDNA membrane", "PROBLEM", 0, 35], ["icosahedral viruses", "PROBLEM", 47, 66], ["large", "OBSERVATION_MODIFIER", 6, 11], ["complex", "OBSERVATION_MODIFIER", 13, 20], ["dsDNA membrane", "OBSERVATION", 21, 35], ["icosahedral viruses", "OBSERVATION", 47, 66], ["abundant", "OBSERVATION_MODIFIER", 71, 79]]], ["The reason they deserve special attention is that they clearly have many features that are characteristic of both prokaryotic and eukaryotic viruses.", [["both prokaryotic and eukaryotic viruses", "PROBLEM", 109, 148], ["eukaryotic viruses", "OBSERVATION", 130, 148]]], ["They resemble prokaryotic viruses in that their life cycle is clearly phagelike, such as external virion attachment, injection of DNA and no pinocytosis.", [["virion", "ANATOMY", 98, 104], ["DNA", "CELLULAR_COMPONENT", 130, 133], ["prokaryotic viruses", "PROBLEM", 14, 33], ["external virion attachment", "TREATMENT", 89, 115], ["DNA", "PROBLEM", 130, 133], ["pinocytosis", "PROBLEM", 141, 152], ["prokaryotic viruses", "OBSERVATION", 14, 33], ["no", "UNCERTAINTY", 138, 140], ["pinocytosis", "OBSERVATION", 141, 152]]], ["In addition, they also encode many phage-like genes, such as restriction-modifi cation enzymes and homing endonucleases ( Filee et al. , 2006c ) .", [["phage-like genes", "DNA", 35, 51], ["restriction-modifi cation enzymes", "PROTEIN", 61, 94], ["homing endonucleases", "PROTEIN", 99, 119], ["homing endonucleases", "TREATMENT", 99, 119]]], ["They also resemble eukaryotic viruses in that they have eukaryotic DNA replication proteins (DNA polymerase beta and PCNA; Chen and Suttle, 1996 ; Nagasaki et al. , 2005 ; Villarreal and DeFilippis, 2000 ) as well as many genes associated with eukaryotic signal transduction ( Van Etten et al. , 2002 ) .", [["DNA", "CELLULAR_COMPONENT", 67, 70], ["DNA polymerase beta", "GENE_OR_GENE_PRODUCT", 93, 112], ["PCNA", "GENE_OR_GENE_PRODUCT", 117, 121], ["eukaryotic DNA replication proteins", "PROTEIN", 56, 91], ["DNA polymerase beta", "PROTEIN", 93, 112], ["PCNA", "PROTEIN", 117, 121], ["eukaryotic viruses", "PROBLEM", 19, 37], ["eukaryotic DNA replication proteins", "TREATMENT", 56, 91], ["DeFilippis", "TREATMENT", 187, 197], ["eukaryotic viruses", "OBSERVATION", 19, 37]]], ["Thus they represent a clear link between prokaryotic and eukaryotic DNA viruses.", [["DNA", "CELLULAR_COMPONENT", 68, 71], ["prokaryotic and eukaryotic DNA viruses", "PROBLEM", 41, 79], ["clear", "OBSERVATION", 22, 27], ["eukaryotic DNA viruses", "OBSERVATION", 57, 79]]], ["For example, the DNA polymerase of paramecium bursaria chlorella virus (PBCV-1) is the most conserved gene and most closely resembles that found in human herpesvirus and is distantly related to the similar family DNA pol encoded by T4.", [["DNA", "CELLULAR_COMPONENT", 17, 20], ["paramecium bursaria chlorella virus", "ORGANISM", 35, 70], ["PBCV-1", "GENE_OR_GENE_PRODUCT", 72, 78], ["human", "ORGANISM", 148, 153], ["herpesvirus", "ORGANISM", 154, 165], ["DNA", "CELLULAR_COMPONENT", 213, 216], ["T4", "GENE_OR_GENE_PRODUCT", 232, 234], ["DNA polymerase", "PROTEIN", 17, 31], ["DNA pol", "DNA", 213, 220], ["T4", "PROTEIN", 232, 234], ["paramecium bursaria chlorella virus", "SPECIES", 35, 70], ["human", "SPECIES", 148, 153], ["paramecium bursaria chlorella virus (PBCV-1", "SPECIES", 35, 78], ["human herpesvirus", "SPECIES", 148, 165], ["the DNA polymerase", "TEST", 13, 31], ["paramecium bursaria chlorella virus", "PROBLEM", 35, 70], ["PBCV", "TEST", 72, 76], ["human herpesvirus", "PROBLEM", 148, 165], ["chlorella virus", "OBSERVATION", 55, 70], ["human herpesvirus", "OBSERVATION", 148, 165]]], ["This polymerase is distinct from that of the poxviruses or PRD1/adenoviruses (associated with protein-primed DNA replication).", [["poxviruses", "ORGANISM", 45, 55], ["PRD1", "GENE_OR_GENE_PRODUCT", 59, 63], ["adenoviruses", "ORGANISM", 64, 76], ["DNA", "CELLULAR_COMPONENT", 109, 112], ["PRD1", "PROTEIN", 59, 63], ["This polymerase", "TEST", 0, 15], ["the poxviruses", "PROBLEM", 41, 55], ["PRD1/adenoviruses", "TREATMENT", 59, 76], ["protein-primed DNA replication", "TREATMENT", 94, 124], ["distinct", "OBSERVATION_MODIFIER", 19, 27], ["poxviruses", "OBSERVATION", 45, 55]]], ["However, numerous other genes of the phycodnaviruses are similar to some genes found in the mimiviruses (giant DNA virus of ameba), including the presence of conserved intenes in the DNA pol gene ( Ogata et al. , 2005 ) .The Phycodnavirus ExemplarIn view of this it is most curious that in structural similarity, polydnavirus capsids clearly resemble PRD1 capsid ( Khayat et al. , 2005 ; Nandhagopal et al. , 2002 ) .", [["phycodnaviruses", "GENE_OR_GENE_PRODUCT", 37, 52], ["mimiviruses", "GENE_OR_GENE_PRODUCT", 92, 103], ["giant DNA virus", "ORGANISM", 105, 120], ["ameba", "GENE_OR_GENE_PRODUCT", 124, 129], ["intenes", "GENE_OR_GENE_PRODUCT", 168, 175], ["DNA", "CELLULAR_COMPONENT", 183, 186], ["pol", "GENE_OR_GENE_PRODUCT", 187, 190], ["polydnavirus capsids", "ORGANISM", 313, 333], ["PRD1", "GENE_OR_GENE_PRODUCT", 351, 355], ["phycodnaviruses", "DNA", 37, 52], ["conserved intenes", "DNA", 158, 175], ["DNA pol gene", "DNA", 183, 195], ["PRD1 capsid", "PROTEIN", 351, 362], ["the phycodnaviruses", "PROBLEM", 33, 52], ["giant DNA virus of ameba", "PROBLEM", 105, 129], ["polydnavirus capsids", "PROBLEM", 313, 333]]], ["PRD1 contains the double-barrel trimer capsid structure that was fi rst observed in adenovirus (for references see Saren et al. , 2005 ) .", [["PRD1", "GENE_OR_GENE_PRODUCT", 0, 4], ["adenovirus", "ORGANISM", 84, 94], ["PRD1", "PROTEIN", 0, 4], ["double-barrel trimer capsid structure", "PROTEIN", 18, 55], ["PRD1", "TREATMENT", 0, 4], ["the double-barrel trimer capsid structure", "TREATMENT", 14, 55], ["adenovirus", "PROBLEM", 84, 94], ["double", "OBSERVATION_MODIFIER", 18, 24], ["barrel trimer", "OBSERVATION_MODIFIER", 25, 38], ["capsid structure", "OBSERVATION", 39, 55]]], ["Adenovirus also closely resembles PRD1 in DNA replication strategy (i.e. linear DNA with covalently closed ends ( Benson et al. , 2004 ; Khayat et al. , 2005 ) .", [["Adenovirus", "ORGANISM", 0, 10], ["PRD1", "GENE_OR_GENE_PRODUCT", 34, 38], ["DNA", "CELLULAR_COMPONENT", 42, 45], ["DNA", "CELLULAR_COMPONENT", 80, 83], ["PRD1", "PROTEIN", 34, 38], ["linear DNA", "DNA", 73, 83], ["Adenovirus", "SPECIES", 0, 10], ["Adenovirus", "TREATMENT", 0, 10], ["DNA replication strategy", "TREATMENT", 42, 66], ["covalently closed ends", "TREATMENT", 89, 111]]], ["The lineage of adenovirus-like DNA viruses, however, is thought to be distinct from that herpes and poxviruses and its DNA polymerase is clearly distinct from polyndavirus.", [["herpes", "DISEASE", 89, 95], ["adenovirus", "ORGANISM", 15, 25], ["DNA", "CELLULAR_COMPONENT", 31, 34], ["herpes", "ORGANISM", 89, 95], ["poxviruses", "ORGANISM", 100, 110], ["DNA", "CELLULAR_COMPONENT", 119, 122], ["polyndavirus", "GENE_OR_GENE_PRODUCT", 159, 171], ["DNA polymerase", "PROTEIN", 119, 133], ["adenovirus", "PROBLEM", 15, 25], ["DNA viruses", "PROBLEM", 31, 42], ["herpes", "PROBLEM", 89, 95], ["poxviruses", "PROBLEM", 100, 110], ["its DNA polymerase", "TEST", 115, 133], ["polyndavirus", "PROBLEM", 159, 171], ["lineage", "OBSERVATION_MODIFIER", 4, 11], ["adenovirus", "OBSERVATION", 15, 25], ["DNA viruses", "OBSERVATION", 31, 42], ["thought to be", "UNCERTAINTY", 56, 69], ["herpes", "OBSERVATION", 89, 95], ["distinct", "OBSERVATION_MODIFIER", 145, 153]]], ["It is clear that related elements of all these viruses can be found in phycodnaviruses.", [["phycodnaviruses", "CANCER", 71, 86], ["all these viruses", "PROBLEM", 37, 54], ["clear", "OBSERVATION", 6, 11], ["viruses", "OBSERVATION", 47, 54]]], ["Overall, the phycodnaviruses, like phage, also appear to be creating genes in large numbers and they encode many genes unrelated to their host.", [["phycodnaviruses", "GENE_OR_GENE_PRODUCT", 13, 28], ["phycodnaviruses", "DNA", 13, 28], ["large", "OBSERVATION_MODIFIER", 78, 83]]], ["What then is the evolutionary relationship that links all of these seemingly distinct viruses?The Phycodnavirus ExemplarAs outlined above, the pattern of evolution of dsDNA phage involves lots of exchange by recombination from a vast gene pool.", [["Phycodnavirus ExemplarAs", "DNA", 98, 122], ["dsDNA phage", "DNA", 167, 178], ["dsDNA phage", "TREATMENT", 167, 178], ["distinct", "OBSERVATION_MODIFIER", 77, 85], ["viruses", "OBSERVATION", 86, 93], ["dsDNA phage", "OBSERVATION", 167, 178]]], ["This pool resembles a cloud from which various mosaic subelements and substrategies are assembled to allow viral gene acquisition and novelty ( Blum et al. , 2001 ; Benson et al. , 2004 ) .", [["a cloud", "PROBLEM", 20, 27], ["viral gene acquisition", "TEST", 107, 129], ["cloud", "OBSERVATION_MODIFIER", 22, 27], ["mosaic subelements", "OBSERVATION", 47, 65]]], ["Does such a distributed pattern of evolution and gene novelty also apply to the phycodnaviruses?The Phycodnavirus ExemplarRecently, another distinct phycodnavirus has been sequenced: coccolithovirus (EhV-86) ( Allen et al. , 2006a ( Allen et al. , , 2006b conserves only 24 core genes in common with PBCV-1 and is unique to the phycodnaviruses in that it has acquired six DNAdep RNA polymerase subunit genes, which are absent in all other phycodnaviruses.The Phycodnavirus ExemplarAs RNA polymerase is considered a core viral gene function, it is clear that phycodnaviruses can alter some very basic molecular functions during their evolution.", [["phycodnaviruses", "DISEASE", 80, 95], ["phycodnavirus", "CANCER", 149, 162], ["PBCV-1", "GENE_OR_GENE_PRODUCT", 300, 306], ["phycodnaviruses", "CANCER", 439, 454], ["Phycodnavirus ExemplarAs", "GENE_OR_GENE_PRODUCT", 459, 483], ["phycodnaviruses", "GENE_OR_GENE_PRODUCT", 558, 573], ["PBCV-1", "DNA", 300, 306], ["DNAdep RNA polymerase subunit genes", "DNA", 372, 407], ["Phycodnavirus ExemplarAs RNA polymerase", "PROTEIN", 459, 498], ["coccolithovirus", "TEST", 183, 198], ["EhV", "TEST", 200, 203], ["acquired six DNAdep RNA polymerase subunit genes", "PROBLEM", 359, 407], ["The Phycodnavirus ExemplarAs RNA polymerase", "TEST", 455, 498], ["a core viral gene function", "PROBLEM", 513, 539]]], ["Oceanic phycodnaviruses are thought to have large infl uence on the free-living populations of eukaryotic algae, such as the termination of algal blooms reported for Emilian Huxley virus ( Martinez et al. , 2007 ; Schroeder et al. , 2003 ) .", [["algal blooms", "DISEASE", 140, 152], ["Emilian Huxley virus", "ORGANISM", 166, 186], ["Emilian Huxley virus", "SPECIES", 166, 186], ["Oceanic phycodnaviruses", "PROBLEM", 0, 23], ["large infl uence", "PROBLEM", 44, 60], ["eukaryotic algae", "PROBLEM", 95, 111], ["algal blooms", "PROBLEM", 140, 152], ["Emilian Huxley virus", "PROBLEM", 166, 186], ["large", "OBSERVATION_MODIFIER", 44, 49], ["infl", "OBSERVATION", 50, 54], ["eukaryotic algae", "OBSERVATION", 95, 111], ["algal blooms", "OBSERVATION", 140, 152]]], ["However, not all phycodnaviruses are lytic.", [["phycodnaviruses", "CANCER", 17, 32], ["lytic", "PROBLEM", 37, 42], ["lytic", "OBSERVATION", 37, 42]]], ["Another lineage of phycodnaviruses is represented by two viruses of fi lamentous brown algae, EsV-1 and FirrV-1 ( Delaroque et al. , 2003 ) .", [["phycodnaviruses", "GENE_OR_GENE_PRODUCT", 19, 34], ["lamentous brown algae", "ORGANISM", 71, 92], ["EsV-1", "GENE_OR_GENE_PRODUCT", 94, 99], ["FirrV-1", "GENE_OR_GENE_PRODUCT", 104, 111], ["EsV", "TEST", 94, 97], ["FirrV", "TEST", 104, 109], ["lineage", "OBSERVATION_MODIFIER", 8, 15], ["phycodnaviruses", "OBSERVATION", 19, 34], ["two", "OBSERVATION_MODIFIER", 53, 56], ["viruses", "OBSERVATION", 57, 64], ["lamentous", "OBSERVATION_MODIFIER", 71, 80], ["brown algae", "OBSERVATION", 81, 92]]], ["Unlike the lytic phycodnaviruses noted above, these two viruses are \" temperate phage \" like.", [["the lytic phycodnaviruses", "PROBLEM", 7, 32], ["these two viruses", "PROBLEM", 46, 63], ["lytic", "OBSERVATION_MODIFIER", 11, 16], ["viruses", "OBSERVATION", 56, 63]]], ["That is they exist as silent viruses whose DNA is integrated into the germlines of their host.", [["germlines", "ANATOMY", 70, 79], ["DNA", "CELLULAR_COMPONENT", 43, 46], ["silent viruses whose DNA", "PROBLEM", 22, 46], ["viruses", "OBSERVATION", 29, 36]]], ["In this, they are unique to all known eukaryotic DNA viruses; host chromosome integration is a normal part of their persistent life strategy.", [["chromosome", "ANATOMY", 67, 77], ["DNA", "CELLULAR_COMPONENT", 49, 52], ["chromosome", "CELLULAR_COMPONENT", 67, 77], ["all known eukaryotic DNA viruses", "PROBLEM", 28, 60], ["host chromosome integration", "PROBLEM", 62, 89], ["eukaryotic DNA viruses", "OBSERVATION", 38, 60], ["persistent", "OBSERVATION_MODIFIER", 116, 126]]], ["EsV-1 has a 335 593-bp genome and encodes 231 likely genes ( Delaroque et al. , 2001 ) .", [["EsV-1", "GENE_OR_GENE_PRODUCT", 0, 5], ["EsV-1", "DNA", 0, 5], ["335 593-bp genome", "DNA", 12, 29], ["231 likely genes", "DNA", 42, 58], ["EsV", "TEST", 0, 3], ["bp genome", "TEST", 20, 29]]], ["These genes are mostly unique and only 28 are clearly related to PBCV-1 genes.", [["PBCV-1", "GENE_OR_GENE_PRODUCT", 65, 71], ["PBCV-1 genes", "DNA", 65, 77], ["PBCV-1", "SPECIES", 65, 71], ["PBCV", "TEST", 65, 69]]], ["The gene differences include many replication genes and their gene order is completely different.", [["replication genes", "DNA", 34, 51], ["The gene differences", "PROBLEM", 0, 20], ["replication genes", "OBSERVATION", 34, 51]]], ["Like the temperate phage-host evolutionary relationship outlined above, it would be most interesting to understand how the integration of these large DNA viruses has affected host evolution.The Phycodnavirus ExemplarThus, the phycodnaviruses appear to represent a basal but diverse viral lineage that has both acute and persistent lifestyle and have some clear relationships to most large eukaryotic DNA viruses and many phage.A Comment on the Proposed Monophylogeny of Nucleo-Cytoplasmic Large DNA Viruses (NCLDVs)The phycodnavirus exemplar above should leave us with several impressions regarding the nature and evolution of these large and ubiquitous DNA viruses of algae, an early eukaryotic host.", [["DNA", "CELLULAR_COMPONENT", 150, 153], ["DNA", "CELLULAR_COMPONENT", 400, 403], ["DNA", "CELLULAR_COMPONENT", 495, 498], ["DNA", "CELLULAR_COMPONENT", 654, 657], ["algae", "CELL", 669, 674], ["these large DNA viruses", "PROBLEM", 138, 161], ["a basal but diverse viral lineage", "PROBLEM", 262, 295], ["large eukaryotic DNA viruses", "PROBLEM", 383, 411], ["Nucleo", "TEST", 470, 476], ["Cytoplasmic Large DNA Viruses", "PROBLEM", 477, 506], ["these large and ubiquitous DNA viruses of algae", "PROBLEM", 627, 674], ["large", "OBSERVATION_MODIFIER", 144, 149], ["DNA viruses", "OBSERVATION", 150, 161], ["appear to represent", "UNCERTAINTY", 242, 261], ["basal", "ANATOMY_MODIFIER", 264, 269], ["diverse", "OBSERVATION_MODIFIER", 274, 281], ["viral lineage", "OBSERVATION", 282, 295], ["both", "OBSERVATION_MODIFIER", 305, 309], ["acute", "OBSERVATION_MODIFIER", 310, 315], ["persistent", "OBSERVATION_MODIFIER", 320, 330], ["lifestyle", "OBSERVATION", 331, 340], ["most large", "OBSERVATION_MODIFIER", 378, 388], ["eukaryotic DNA viruses", "OBSERVATION", 389, 411], ["Large", "OBSERVATION_MODIFIER", 489, 494], ["DNA Viruses", "OBSERVATION", 495, 506], ["large", "OBSERVATION_MODIFIER", 633, 638], ["DNA viruses", "OBSERVATION", 654, 665], ["eukaryotic host", "OBSERVATION", 685, 700]]], ["They show clear linkages by structure and function to both phage and various eukaryotic DNA viruses.", [["DNA", "CELLULAR_COMPONENT", 88, 91], ["clear", "OBSERVATION", 10, 15], ["DNA viruses", "OBSERVATION", 88, 99]]], ["They also show major variation and novelty in their own genetic composition, including their core genes.", [["core genes", "DNA", 93, 103], ["major", "OBSERVATION_MODIFIER", 15, 20], ["variation", "OBSERVATION_MODIFIER", 21, 30]]], ["In addition, they show clear relationships to distinct and seemingly separate viral lineages (adenoviruses, herpesviruses, poxviruses, iridoviruses).", [["adenoviruses", "ORGANISM", 94, 106], ["herpesviruses", "ORGANISM", 108, 121], ["iridoviruses", "CANCER", 135, 147], ["seemingly separate viral lineages (adenoviruses", "PROBLEM", 59, 106], ["herpesviruses", "PROBLEM", 108, 121], ["poxviruses", "PROBLEM", 123, 133], ["clear", "OBSERVATION", 23, 28], ["viral lineages", "OBSERVATION", 78, 92]]], ["The picture we are left with is that they seem to resemble phage evolution in that they appear to have evolved from a diverse pool that has exchanged many basic viral features and created many new genes.", [["a diverse pool", "PROBLEM", 116, 130], ["many basic viral features", "PROBLEM", 150, 175], ["left", "ANATOMY_MODIFIER", 19, 23], ["many", "OBSERVATION_MODIFIER", 188, 192], ["new", "OBSERVATION_MODIFIER", 193, 196]]], ["This view, however, contrasts sharply with the work of Iyer et al. (2001 Iyer et al. ( , 2006 .", [["This view", "TEST", 0, 9]]], ["By considering the small number of conserved genes in four families of eukaryotic DNA viruses (poxviruses, asfarviruses, iridoviruses, phycodnaviruses), they suggest that these viruses are monophyletic, evolving from a common nucleo-cytoplasmic large DNA virus (NCLDV) with an icosahedral capsid.A Comment on the Proposed Monophylogeny of Nucleo-Cytoplasmic Large DNA Viruses (NCLDVs)Given the above information, I fi nd this view unhelpful and possibly confusing.", [["cytoplasmic", "ANATOMY", 233, 244], ["DNA", "CELLULAR_COMPONENT", 82, 85], ["asfarviruses", "GENE_OR_GENE_PRODUCT", 107, 119], ["iridoviruses", "GENE_OR_GENE_PRODUCT", 121, 133], ["phycodnaviruses", "GENE_OR_GENE_PRODUCT", 135, 150], ["cytoplasmic", "ORGANISM_SUBSTANCE", 233, 244], ["DNA", "CELLULAR_COMPONENT", 251, 254], ["DNA", "CELLULAR_COMPONENT", 364, 367], ["conserved genes", "DNA", 35, 50], ["eukaryotic DNA viruses", "PROBLEM", 71, 93], ["poxviruses", "TREATMENT", 95, 105], ["asfarviruses", "TREATMENT", 107, 119], ["iridoviruses", "TREATMENT", 121, 133], ["phycodnaviruses", "TREATMENT", 135, 150], ["these viruses", "PROBLEM", 171, 184], ["monophyletic", "PROBLEM", 189, 201], ["a common nucleo-cytoplasmic large DNA virus", "PROBLEM", 217, 260], ["an icosahedral capsid", "PROBLEM", 274, 295], ["Nucleo", "TEST", 339, 345], ["Cytoplasmic Large DNA Viruses", "PROBLEM", 346, 375], ["small", "OBSERVATION_MODIFIER", 19, 24], ["eukaryotic DNA viruses", "OBSERVATION", 71, 93], ["viruses", "OBSERVATION", 177, 184], ["large", "OBSERVATION_MODIFIER", 245, 250], ["DNA virus", "OBSERVATION", 251, 260], ["icosahedral capsid", "OBSERVATION", 277, 295], ["Large", "OBSERVATION_MODIFIER", 358, 363], ["DNA Viruses", "OBSERVATION", 364, 375]]], ["It has numerous problems.", [["numerous problems", "PROBLEM", 7, 24], ["numerous", "OBSERVATION_MODIFIER", 7, 15], ["problems", "OBSERVATION", 16, 24]]], ["The main problem is that it fails to acknowledge the clear link between prokaryotic and eukaryotic viruses.", [["prokaryotic and eukaryotic viruses", "PROBLEM", 72, 106], ["main", "OBSERVATION_MODIFIER", 4, 8], ["problem", "OBSERVATION", 9, 16], ["eukaryotic viruses", "OBSERVATION", 88, 106]]], ["Furthermore, by focussing on a small set of related genes, it represents a traditional perspective as found in evolutionary biology that assumes a common (fi ttest) linear lineage, not a cloud, cooperative, or mosaic pool as the main source of novelty resulting in the matrix pattern of virus evolution.", [["matrix", "CELLULAR_COMPONENT", 269, 275], ["virus evolution", "PROBLEM", 287, 302], ["virus", "OBSERVATION", 287, 292]]], ["The virosphere is clearly not disconnected from itself, but it is also clearly not a linear or tree-like evolutionary system as suggested above.", [["clearly not", "UNCERTAINTY", 18, 29], ["disconnected", "OBSERVATION", 30, 42], ["tree", "OBSERVATION", 95, 99]]], ["We must learn to think of virus evolution in its own terms; fuzzy, mixed, reticulated, and cloud-like.HERPESVIRUS; MOSTLY PERSISTING AND CO-SPECIATIONAs mentioned in the phage section, there have been various publications that suggest a deep evolutionary relationship between the herpesviruses and dsDNA viruses of prokaryotes ( Rice et al. , 2004 ; Khayat et al. , 2005 ; Duda et al. , 2006 ; Akita et al. , 2007 ) .", [["herpesviruses", "ORGANISM", 280, 293], ["dsDNA viruses", "ORGANISM", 298, 311], ["virus evolution", "PROBLEM", 26, 41], ["fuzzy", "PROBLEM", 60, 65], ["HERPESVIRUS", "PROBLEM", 102, 113], ["various publications", "PROBLEM", 201, 221], ["the herpesviruses", "PROBLEM", 276, 293], ["mixed", "OBSERVATION_MODIFIER", 67, 72], ["reticulated", "OBSERVATION_MODIFIER", 74, 85], ["cloud", "OBSERVATION_MODIFIER", 91, 96], ["MOSTLY", "OBSERVATION_MODIFIER", 115, 121], ["PERSISTING", "OBSERVATION_MODIFIER", 122, 132], ["deep", "ANATOMY_MODIFIER", 237, 241], ["herpesviruses", "OBSERVATION", 280, 293]]], ["Although herpes-like viruses are found in invertebrates (such as ostreid herpesvirus 1 (OsHV-1)) in both lytic and asymptomatic states ( Barbosa-Solomieu et al. , 2005 ) , our interest in their evolution has been mainly focussed on the vertebrate herpesviruses.", [["herpes-like viruses", "DISEASE", 9, 28], ["herpes-like viruses", "ORGANISM", 9, 28], ["ostreid herpesvirus 1", "ORGANISM", 65, 86], ["OsHV-1", "ORGANISM", 88, 94], ["herpesviruses", "ORGANISM", 247, 260], ["ostreid herpesvirus 1", "SPECIES", 65, 86], ["ostreid herpesvirus 1 (OsHV-1", "SPECIES", 65, 94], ["herpes", "PROBLEM", 9, 15], ["like viruses", "PROBLEM", 16, 28], ["ostreid herpesvirus", "TEST", 65, 84], ["OsHV", "TEST", 88, 92], ["viruses", "OBSERVATION", 21, 28], ["lytic", "OBSERVATION_MODIFIER", 105, 110]]], ["Vertebrate herpesvirus do tend to show clear sequence conservation that suggests broad patterns of evolution.", [["Vertebrate herpesvirus", "ORGANISM", 0, 22], ["Vertebrate herpesvirus", "SPECIES", 0, 22], ["Vertebrate herpesvirus", "PROBLEM", 0, 22], ["broad", "OBSERVATION_MODIFIER", 81, 86]]], ["One interesting feature of this evolution is the apparent link between the biology of the virus and its evolution.", [["the virus", "PROBLEM", 86, 95], ["virus", "OBSERVATION", 90, 95]]], ["A common, but not universal pattern is that of virus and host co-evolution ( McGeoch et al. , 2000 ( McGeoch et al. , , 2006 McGeoch and Gatherer, 2005 ) .", [["virus", "PROBLEM", 47, 52]]], ["This trend has maintained several biological characteristics, such as highly species host-and tissue-specifi c persistence (i.e. neuronal and lymphoid persistence).HERPESVIRUS; MOSTLY PERSISTING AND CO-SPECIATIONThe discovery of HHV-8 has further stimulated studies of herpesvirus evolution in that HHV-8 appears to have undergone much recombination with herpesviruses of related primate lineages ( McGeoch and Davison, 1999 ) .", [["tissue", "ANATOMY", 94, 100], ["neuronal", "ANATOMY", 129, 137], ["lymphoid", "ANATOMY", 142, 150], ["HHV-8", "CHEMICAL", 229, 234], ["tissue", "TISSUE", 94, 100], ["specifi c", "GENE_OR_GENE_PRODUCT", 101, 110], ["neuronal", "CELL", 129, 137], ["lymphoid", "CELL", 142, 150], ["HHV-8", "ORGANISM", 229, 234], ["herpesvirus", "ORGANISM", 269, 280], ["HHV-8", "ORGANISM", 299, 304], ["primate", "ORGANISM", 380, 387], ["HHV-8", "DNA", 229, 234], ["HHV-8", "SPECIES", 229, 234], ["HHV-8", "SPECIES", 299, 304], ["HERPESVIRUS", "PROBLEM", 164, 175], ["HHV", "PROBLEM", 229, 232], ["herpesvirus evolution", "PROBLEM", 269, 290], ["several", "OBSERVATION_MODIFIER", 26, 33], ["biological characteristics", "OBSERVATION_MODIFIER", 34, 60], ["lymphoid persistence", "OBSERVATION", 142, 162]]], ["Thus recombination seems prevalent in herpesviruses.", [["herpesviruses", "ORGANISM", 38, 51], ["herpesviruses", "PROBLEM", 38, 51], ["seems prevalent", "UNCERTAINTY", 19, 34]]], ["The apparent link between herpesvirus evolution and recent human evolution, as well as an apparent link to primate retroviral evolution, is fascinating, but of unknown signifi cance ( Kung and Wood, 1994 ; Lacoste et al. , 2000 ) .Herpesvirus Gene AcquisitionThe herpesviruses lineages will often show the presence of lineage-specifi c genes.", [["herpesvirus", "ORGANISM", 26, 37], ["human", "ORGANISM", 59, 64], ["Herpesvirus", "ORGANISM", 231, 242], ["herpesviruses", "ORGANISM", 263, 276], ["specifi c", "GENE_OR_GENE_PRODUCT", 326, 335], ["lineage-specifi c genes", "DNA", 318, 341], ["human", "SPECIES", 59, 64], ["human", "SPECIES", 59, 64], ["The apparent link between herpesvirus evolution", "PROBLEM", 0, 47], ["The herpesviruses lineages", "PROBLEM", 259, 285], ["herpesvirus evolution", "OBSERVATION", 26, 47], ["human evolution", "OBSERVATION_MODIFIER", 59, 74], ["retroviral evolution", "OBSERVATION", 115, 135], ["herpesviruses lineages", "OBSERVATION", 263, 285]]], ["Many of these genes affect innate and adaptive host functions, whereas others affect host metabolism.", [["host", "CELL", 85, 89]]], ["When the source of such genes has been contemplated, in contrast to phage, phycodnaviruses, or baculoviruses ( Herniou et al. , 2001 ) , it is often proposed that most such herpes genes originate from the host.", [["phycodnaviruses", "GENE_OR_GENE_PRODUCT", 75, 90], ["herpes", "ORGANISM", 173, 179], ["herpes genes", "DNA", 173, 185], ["phycodnaviruses", "PROBLEM", 75, 90]]], ["It is well accepted that the three major lineages of herpesviruses descended from a common ancestor in vertebrates ( McGeoch et al. , 2006 ) .", [["herpesviruses", "ORGANISM", 53, 66], ["herpesviruses", "OBSERVATION", 53, 66]]], ["There have been numerous proposals that most new lineage-specifi c herpesvirus genes have originated from host (see Becker and Darai, 2000 ) .", [["specifi c herpesvirus", "ORGANISM", 57, 78], ["specifi c herpesvirus genes", "DNA", 57, 84], ["numerous", "OBSERVATION_MODIFIER", 16, 24]]], ["This includes herpesvirus dUTPase ( Davison and Stow, 2005 ) , and viral chemokines and viral Bcl-2 ( Nicholas et al. , 1998 ) .", [["herpesvirus", "ORGANISM", 14, 25], ["dUTPase", "GENE_OR_GENE_PRODUCT", 26, 33], ["Bcl-2", "GENE_OR_GENE_PRODUCT", 94, 99], ["herpesvirus dUTPase", "PROTEIN", 14, 33], ["viral chemokines", "PROTEIN", 67, 83], ["viral Bcl-2", "PROTEIN", 88, 99], ["herpesvirus dUTPase ( Davison", "TREATMENT", 14, 43], ["viral chemokines", "TEST", 67, 83], ["viral Bcl", "TEST", 88, 97], ["herpesvirus dUTPase", "OBSERVATION", 14, 33], ["viral Bcl", "OBSERVATION", 88, 97]]], ["In my evaluation of such claims, however, it seems clear that the possibility that there was an ancient viral source of such genes was not considered and cannot now be dismissed.Herpesvirus Gene AcquisitionWe currently believe that ancient herpesvirus ancestors can be traced to tailed phage ( Hendrix, 1999 ; Bamford, 2003 ; Baker et al. , 2005 ; Duda et al. , 2006 ; McGeoch et al. , 2006 ) .", [["Herpesvirus", "ORGANISM", 178, 189], ["herpesvirus", "ORGANISM", 240, 251], ["my evaluation", "TEST", 3, 16], ["an ancient viral source of such genes", "PROBLEM", 93, 130], ["ancient herpesvirus ancestors", "PROBLEM", 232, 261]]], ["Other phage lineages also appear to trace to eukaryotic viruses ( Bamford et al. , 2005b ) .", [["Other phage lineages", "PROBLEM", 0, 20], ["viruses", "OBSERVATION", 56, 63]]], ["Within the herpesviruses, the same T-16 icosahedral structure, as well as invertable DNA regions are also present in the very distant but much more recognizable oceanic ostreid herpesvirus 1 .Herpesvirus Gene AcquisitionGiven the highly diverse and mosaic nature of large DNA virus evolution in prokaryotes and lower eukaryotes described above, it seem quite possible that many other viral genes might also trace far back in virus evolution.", [["herpesviruses", "ORGANISM", 11, 24], ["DNA", "CELLULAR_COMPONENT", 85, 88], ["ostreid herpesvirus 1", "ORGANISM", 169, 190], ["Herpesvirus", "ORGANISM", 192, 203], ["DNA", "CELLULAR_COMPONENT", 272, 275], ["T-16 icosahedral structure", "DNA", 35, 61], ["invertable DNA regions", "DNA", 74, 96], ["viral genes", "DNA", 384, 395], ["invertable DNA regions", "PROBLEM", 74, 96], ["large DNA virus evolution", "PROBLEM", 266, 291], ["many other viral genes", "PROBLEM", 373, 395], ["herpesviruses", "OBSERVATION_MODIFIER", 11, 24], ["16 icosahedral", "OBSERVATION_MODIFIER", 37, 51], ["very", "OBSERVATION_MODIFIER", 121, 125], ["distant", "OBSERVATION_MODIFIER", 126, 133], ["oceanic", "OBSERVATION_MODIFIER", 161, 168], ["ostreid herpesvirus", "OBSERVATION", 169, 188], ["diverse", "OBSERVATION_MODIFIER", 237, 244], ["large", "OBSERVATION_MODIFIER", 266, 271], ["DNA virus", "OBSERVATION", 272, 281], ["lower eukaryotes", "OBSERVATION_MODIFIER", 311, 327], ["seem quite possible", "UNCERTAINTY", 348, 367], ["viral genes", "OBSERVATION", 384, 395], ["virus", "OBSERVATION", 425, 430]]], ["Consider the example of dUTPase in avian and mammalian herpesvirus ( Davison and Stow, 2005 ; McGeehan et al. , 2001 ) .", [["dUTPase", "GENE_OR_GENE_PRODUCT", 24, 31], ["avian", "ORGANISM", 35, 40], ["mammalian herpesvirus", "ORGANISM", 45, 66], ["dUTPase", "PROTEIN", 24, 31], ["dUTPase", "PROBLEM", 24, 31]]], ["The current view requires very complicated gene rearrangements to account for the viral source of this gene from its host.", [["very complicated gene rearrangements", "PROBLEM", 26, 62]]], ["Yet we know that diverse dUTPases are found in many ancient viral lineages.", [["dUTPases", "GENE_OR_GENE_PRODUCT", 25, 33], ["dUTPases", "PROTEIN", 25, 33], ["diverse dUTPases", "PROBLEM", 17, 33], ["viral lineages", "OBSERVATION", 60, 74]]], ["For example, the ERVs present in all vertebrate genomes also conserve dUT-Pase ( Jern et al. , 2005 ) , as do exogenous retroviruses (i.e. lentiviruses) ( McIntosh and Haynes, 1996 ) .", [["dUT-Pase", "GENE_OR_GENE_PRODUCT", 70, 78], ["retroviruses", "ORGANISM", 120, 132], ["lentiviruses", "ORGANISM", 139, 151], ["ERVs", "DNA", 17, 21], ["dUT", "DNA", 70, 73], ["exogenous retroviruses", "PROBLEM", 110, 132], ["ERVs", "OBSERVATION", 17, 21], ["retroviruses", "OBSERVATION", 120, 132]]], ["In fact, since the herpesviruses genes are especially poor in introns, it would seem likely that any herpesviral gene acquisition would necessarily involve a retrovirus via a cDNA.Herpesvirus Gene AcquisitionThe oceans are especially fi lled with large complex DNA viruses (such as mimivirus and phycodnavirus, plus numerous relatives of OsHV-1) thought to be ancient ancestors of herpesvirus.", [["herpesvirus", "DISEASE", 381, 392], ["herpesviruses", "ORGANISM", 19, 32], ["retrovirus", "ORGANISM", 158, 168], ["Herpesvirus", "ORGANISM", 180, 191], ["DNA", "CELLULAR_COMPONENT", 261, 264], ["phycodnavirus", "CANCER", 296, 309], ["OsHV-1", "GENE_OR_GENE_PRODUCT", 338, 344], ["herpesvirus", "ORGANISM", 381, 392], ["herpesviruses genes", "DNA", 19, 38], ["introns", "DNA", 62, 69], ["herpesviral gene", "DNA", 101, 117], ["cDNA", "DNA", 175, 179], ["the herpesviruses genes", "PROBLEM", 15, 38], ["any herpesviral gene acquisition", "PROBLEM", 97, 129], ["large complex DNA viruses", "PROBLEM", 247, 272], ["mimivirus", "PROBLEM", 282, 291], ["phycodnavirus", "TREATMENT", 296, 309], ["herpesvirus", "PROBLEM", 381, 392], ["oceans", "OBSERVATION", 212, 218], ["large", "OBSERVATION_MODIFIER", 247, 252], ["complex", "OBSERVATION_MODIFIER", 253, 260], ["DNA viruses", "OBSERVATION", 261, 272], ["herpesvirus", "OBSERVATION", 381, 392]]], ["The phycodnavirus (chlorella virus, PBCV-1) provides a clear bridge between phage and eukaryotic DNA viruses.", [["phycodnavirus", "ORGANISM", 4, 17], ["chlorella virus", "ORGANISM", 19, 34], ["PBCV-1", "ORGANISM", 36, 42], ["DNA", "CELLULAR_COMPONENT", 97, 100], ["chlorella virus", "SPECIES", 19, 34], ["chlorella virus", "SPECIES", 19, 34], ["The phycodnavirus (chlorella virus", "TREATMENT", 0, 34], ["PBCV", "TEST", 36, 40], ["a clear bridge between phage", "TREATMENT", 53, 81], ["eukaryotic DNA viruses", "TREATMENT", 86, 108], ["DNA viruses", "OBSERVATION", 97, 108]]], ["PBCV-1 also encodes a dUTPase that has the highly conserved motif III ( Zhang et al. , 2005 ) .", [["PBCV-1", "GENE_OR_GENE_PRODUCT", 0, 6], ["dUTPase", "GENE_OR_GENE_PRODUCT", 22, 29], ["PBCV", "PROTEIN", 0, 4], ["dUTPase", "PROTEIN", 22, 29], ["PBCV-1", "SPECIES", 0, 6], ["PBCV", "TEST", 0, 4]]], ["Many phage are also known to encode dUTPases of diverse types, such as B. subtilis (SPbeta) ( Persson et al. , 2005 ) , and a phage of Thermus thermophilus ( Naryshkina et al. , 2006 ) .", [["dUTPases", "GENE_OR_GENE_PRODUCT", 36, 44], ["B. subtilis", "ORGANISM", 71, 82], ["SPbeta", "GENE_OR_GENE_PRODUCT", 84, 90], ["Thermus thermophilus", "ORGANISM", 135, 155], ["dUTPases", "PROTEIN", 36, 44], ["B. subtilis", "SPECIES", 71, 82], ["Thermus thermophilus", "SPECIES", 135, 155], ["B. subtilis", "SPECIES", 71, 82], ["Thermus thermophilus", "SPECIES", 135, 155], ["diverse types", "OBSERVATION_MODIFIER", 48, 61]]], ["This Thermus phage (phiYS40) is of special note since its dUTPase gene is clearly related to the dUTPases of eukaryotic viruses and has a version that has undergone multiple events of recombination from apparently distinct phage, exactly as expected for mosaic phage genes.Herpesvirus Gene AcquisitionThus, the origin of new herpesvirus genes might not be so different than that seen in other large DNA viruses and a potential ancient source of new genes from these ancestral viruses remains plausible.Herpesvirus Gene AcquisitionSimilar considerations apply to other possible examples of herpesvirus gene capture.", [["Thermus phage", "GENE_OR_GENE_PRODUCT", 5, 18], ["phiYS40", "GENE_OR_GENE_PRODUCT", 20, 27], ["dUTPase", "GENE_OR_GENE_PRODUCT", 58, 65], ["dUTPases", "GENE_OR_GENE_PRODUCT", 97, 105], ["Herpesvirus", "ORGANISM", 273, 284], ["herpesvirus", "ORGANISM", 325, 336], ["DNA", "CELLULAR_COMPONENT", 399, 402], ["Herpesvirus", "ORGANISM", 502, 513], ["herpesvirus", "ORGANISM", 589, 600], ["Thermus phage", "PROTEIN", 5, 18], ["phiYS40", "PROTEIN", 20, 27], ["dUTPase gene", "DNA", 58, 70], ["dUTPases", "DNA", 97, 105], ["mosaic phage genes", "DNA", 254, 272], ["herpesvirus genes", "DNA", 325, 342], ["This Thermus phage", "TREATMENT", 0, 18], ["eukaryotic viruses", "PROBLEM", 109, 127], ["mosaic phage genes", "PROBLEM", 254, 272], ["new herpesvirus genes", "PROBLEM", 321, 342], ["large DNA viruses", "PROBLEM", 393, 410], ["new genes", "PROBLEM", 445, 454], ["these ancestral viruses", "PROBLEM", 460, 483], ["Herpesvirus Gene AcquisitionSimilar considerations", "TREATMENT", 502, 552], ["herpesvirus gene capture", "TREATMENT", 589, 613], ["eukaryotic viruses", "OBSERVATION", 109, 127], ["distinct phage", "OBSERVATION_MODIFIER", 214, 228], ["new", "OBSERVATION_MODIFIER", 321, 324], ["herpesvirus genes", "OBSERVATION", 325, 342], ["large", "OBSERVATION_MODIFIER", 393, 398], ["DNA viruses", "OBSERVATION", 399, 410], ["new", "OBSERVATION_MODIFIER", 445, 448], ["ancestral viruses", "OBSERVATION", 466, 483]]], ["For example, the herpes thymidylate synthase (TS) has also been considered to have originated by host gene capture ).", [["herpes", "GENE_OR_GENE_PRODUCT", 17, 23], ["thymidylate synthase", "GENE_OR_GENE_PRODUCT", 24, 44], ["herpes thymidylate synthase", "PROTEIN", 17, 44], ["TS", "PROTEIN", 46, 48], ["the herpes thymidylate synthase", "TREATMENT", 13, 44]]], ["Yet distinct versions of these genes are also found in different herpesviral lineages, which would necessitate multiple independent \" capture \" events of different version of host TS genes.", [["TS", "GENE_OR_GENE_PRODUCT", 180, 182], ["herpesviral lineages", "CELL_TYPE", 65, 85], ["host TS genes", "DNA", 175, 188], ["different herpesviral lineages", "PROBLEM", 55, 85], ["distinct", "OBSERVATION_MODIFIER", 4, 12], ["herpesviral lineages", "OBSERVATION", 65, 85]]], ["TS genes are present in ancient virus sources.", [["TS", "GENE_OR_GENE_PRODUCT", 0, 2], ["TS genes", "DNA", 0, 8]]], ["For example, Bacillus phage beta 22 encodes TS, which also has a self-splicing intron ( Bechhofer et al. , 1994 ) .", [["Bacillus phage beta 22", "GENE_OR_GENE_PRODUCT", 13, 35], ["TS", "GENE_OR_GENE_PRODUCT", 44, 46], ["Bacillus phage beta 22", "PROTEIN", 13, 35], ["self-splicing intron", "DNA", 65, 85], ["Bacillus phage beta 22", "SPECIES", 13, 35], ["Bacillus phage beta 22 encodes TS", "PROBLEM", 13, 46], ["a self-splicing intron", "TREATMENT", 63, 85]]], ["Also, phage phiKZ has a highly conserved TS ( Mesyanzhinov et al. , 2002 ), yet this virus lacks a DNA polymerase or other replication proteins, clearly indicating that the viral TS genes has a basic viral role.", [["phiKZ", "CHEMICAL", 12, 17], ["phiKZ", "GENE_OR_GENE_PRODUCT", 12, 17], ["DNA", "CELLULAR_COMPONENT", 99, 102], ["TS", "GENE_OR_GENE_PRODUCT", 179, 181], ["phage phiKZ", "PROTEIN", 6, 17], ["DNA polymerase", "PROTEIN", 99, 113], ["replication proteins", "PROTEIN", 123, 143], ["viral TS genes", "DNA", 173, 187], ["this virus", "PROBLEM", 80, 90], ["a DNA polymerase", "PROBLEM", 97, 113], ["other replication proteins", "PROBLEM", 117, 143], ["the viral TS genes", "PROBLEM", 169, 187]]], ["Similarly, the cytokines-like genes (such as IL-10) as found in poxviruses and herpesviruses appear to have originated in at least three independent events prior to the divergence of mammalian eutherian orders.", [["IL-10", "GENE_OR_GENE_PRODUCT", 45, 50], ["poxviruses", "ORGANISM", 64, 74], ["herpesviruses", "ORGANISM", 79, 92], ["cytokines", "PROTEIN", 15, 24], ["IL-10", "DNA", 45, 50], ["the cytokines", "TEST", 11, 24], ["poxviruses", "PROBLEM", 64, 74], ["herpesviruses", "PROBLEM", 79, 92], ["mammalian eutherian orders", "TREATMENT", 183, 209], ["cytokines", "OBSERVATION", 15, 24], ["poxviruses", "OBSERVATION", 64, 74]]], ["Yet it is still presupposed that they are necessarily the products of host gene capture ( Hughes, 2002 ) .Herpesvirus Gene AcquisitionComparative genomics supports the idea that the herpesviruse lineages are originating viral genes.", [["Herpesvirus", "ORGANISM", 106, 117], ["herpesviruse", "GENE_OR_GENE_PRODUCT", 182, 194], ["herpesviruse lineages", "CELL_TYPE", 182, 203], ["viral genes", "DNA", 220, 231], ["the herpesviruse lineages", "PROBLEM", 178, 203], ["viral genes", "OBSERVATION", 220, 231]]], ["A broader phylogenetic analysis of all herpesvirus genomes identifi ed only 17 genes in common to all 30 taxa of herpesvirus .", [["herpesvirus", "DISEASE", 113, 124], ["herpesvirus", "ORGANISM", 39, 50], ["herpesvirus", "ORGANISM", 113, 124], ["herpesvirus genomes", "DNA", 39, 58], ["17 genes", "DNA", 76, 84], ["A broader phylogenetic analysis", "TEST", 0, 31], ["all herpesvirus genomes", "PROBLEM", 35, 58], ["herpesvirus", "PROBLEM", 113, 124]]], ["Thus only 30 genes appear to be in common to all the herpesviruses.", [["herpesviruses", "ORGANISM", 53, 66], ["herpesviruses", "OBSERVATION", 53, 66]]], ["In this analysis, only a few genes of recent origin could be identifi ed as possibly having been transferred between virus and host (e.g. new genes found at tips of phylogenetic dendograms).", [["this analysis", "TEST", 3, 16]]], ["Thus, gene gain in the herpesviruses (as in DNA phage and phycodnavirus) is prevalent but the origination of such genes from the host is not prevalent.", [["herpesviruses", "ORGANISM", 23, 36], ["DNA", "CELLULAR_COMPONENT", 44, 47], ["phycodnavirus", "GENE_OR_GENE_PRODUCT", 58, 71], ["gene gain in the herpesviruses", "PROBLEM", 6, 36], ["DNA phage", "TREATMENT", 44, 53]]], ["I suggest that our tendency to assume that new viral genes are usually \" stolen \" from the host should be revised ( Moreira and Lopez-Garcia, 2005 ).Poxvirus as Mostly Acute , with Frequent Species ShiftsIn contrast to the herpesviruses, the poxviruses evolution tend to have little congruence to host evolution (see Chapter 19 ).", [["herpesviruses", "ORGANISM", 223, 236], ["viral genes", "DNA", 47, 58], ["new viral genes", "PROBLEM", 43, 58], ["Poxvirus", "TREATMENT", 149, 157], ["Frequent Species Shifts", "PROBLEM", 181, 204], ["Acute", "OBSERVATION_MODIFIER", 168, 173], ["herpesviruses", "OBSERVATION", 223, 236], ["host evolution", "OBSERVATION_MODIFIER", 297, 311]]], ["Yet, they too show evidence of ancient linkages to other viruses.", [["ancient linkages to other viruses", "PROBLEM", 31, 64], ["viruses", "OBSERVATION", 57, 64]]], ["The replication of poxvirus DNA is distinct in that it involves a linear genome with inverted ends that have covalently closed \" snapback \" DNA.", [["poxvirus", "ORGANISM", 19, 27], ["DNA", "CELLULAR_COMPONENT", 28, 31], ["DNA", "CELLULAR_COMPONENT", 140, 143], ["poxvirus DNA", "DNA", 19, 31], ["linear genome", "DNA", 66, 79], ["inverted ends", "DNA", 85, 98], ["snapback \" DNA", "DNA", 129, 143], ["poxvirus", "SPECIES", 19, 27], ["poxvirus DNA", "PROBLEM", 19, 31], ["poxvirus DNA", "OBSERVATION", 19, 31], ["distinct", "OBSERVATION_MODIFIER", 35, 43], ["linear genome", "OBSERVATION", 66, 79], ["covalently", "OBSERVATION_MODIFIER", 109, 119], ["closed", "OBSERVATION", 120, 126]]], ["The resulting replication structures involve head-to-tail and tail-to-tail intermediates.", [["head", "ANATOMY", 45, 49], ["tail", "ANATOMY", 62, 66], ["head-to-tail", "PROTEIN", 45, 57], ["replication", "OBSERVATION", 14, 25], ["head", "ANATOMY", 45, 49], ["tail", "ANATOMY_MODIFIER", 53, 57], ["tail", "ANATOMY", 62, 66], ["tail", "ANATOMY_MODIFIER", 70, 74]]], ["This replication strategy is very different from that used by the host (and most other DNA viruses), but is clearly related to that found in other eukaryotic and prokaryotic viruses.", [["DNA", "CELLULAR_COMPONENT", 87, 90], ["prokaryotic viruses", "ORGANISM", 162, 181], ["This replication strategy", "TREATMENT", 0, 25], ["DNA viruses", "PROBLEM", 87, 98], ["prokaryotic viruses", "OBSERVATION", 162, 181]]], ["Similar replication mechanisms are seen in all poxviruses, as well as African swine fever virus and phycodnaviruses (PBCV-1).Poxvirus as Mostly Acute , with Frequent Species ShiftsThis exact replication strategy is also present in archaeal lipothrixviruses (SIRV1 and SIRV2) which has been proposed to be ancestral to phycodnaviruses and poxviruses ( Persson et al. , 2005 ) .", [["swine fever", "DISEASE", 78, 89], ["African swine fever virus", "ORGANISM", 70, 95], ["lipothrixviruses", "GENE_OR_GENE_PRODUCT", 240, 256], ["SIRV1", "GENE_OR_GENE_PRODUCT", 258, 263], ["SIRV2", "GENE_OR_GENE_PRODUCT", 268, 273], ["archaeal lipothrixviruses", "PROTEIN", 231, 256], ["SIRV1", "PROTEIN", 258, 263], ["SIRV2", "PROTEIN", 268, 273], ["swine fever virus", "SPECIES", 78, 95], ["African swine fever virus", "SPECIES", 70, 95], ["PBCV-1", "SPECIES", 117, 123], ["Similar replication mechanisms", "PROBLEM", 0, 30], ["African swine fever virus", "PROBLEM", 70, 95], ["phycodnaviruses", "TREATMENT", 100, 115], ["PBCV", "TEST", 117, 121], ["Poxvirus", "TREATMENT", 125, 133], ["Frequent Species Shifts", "PROBLEM", 157, 180], ["replication", "OBSERVATION", 8, 19], ["all", "OBSERVATION_MODIFIER", 43, 46], ["poxviruses", "OBSERVATION", 47, 57], ["Acute", "OBSERVATION_MODIFIER", 144, 149]]], ["A similar replication strategy is also seen with N15 ( Lobocka et al. , 1996 ) , an unusual phage of E. coli that persists as a linear DNA ( Casjens et al. , 2004 ) .", [["E. coli", "ORGANISM", 101, 108], ["DNA", "CELLULAR_COMPONENT", 135, 138], ["linear DNA", "DNA", 128, 138], ["E. coli", "SPECIES", 101, 108], ["E. coli", "SPECIES", 101, 108], ["E. coli", "PROBLEM", 101, 108], ["a linear DNA", "PROBLEM", 126, 138], ["similar", "OBSERVATION_MODIFIER", 2, 9], ["replication", "OBSERVATION", 10, 21], ["E. coli", "OBSERVATION", 101, 108]]], ["Conservation of such replication similarities clearly suggests ancestral relationships, but no sequence similarity can be seen between these viruses.", [["viruses", "OBSERVATION", 141, 148]]], ["The similarity between poxvirus and PBCV-1 DNA replication deserves some additional comment.", [["poxvirus", "ORGANISM", 23, 31], ["PBCV-1", "GENE_OR_GENE_PRODUCT", 36, 42], ["DNA", "CELLULAR_COMPONENT", 43, 46], ["poxvirus and PBCV-1 DNA", "DNA", 23, 46], ["PBCV-1", "SPECIES", 36, 42], ["poxvirus", "TREATMENT", 23, 31], ["PBCV", "TEST", 36, 40], ["1 DNA replication", "TREATMENT", 41, 58]]], ["PBVC-1 and herpesvirus have very similar DNA polymerase genes, yet differ fundamentally in replication strategy.", [["PBVC-1", "GENE_OR_GENE_PRODUCT", 0, 6], ["herpesvirus", "ORGANISM", 11, 22], ["DNA", "CELLULAR_COMPONENT", 41, 44], ["DNA polymerase genes", "DNA", 41, 61], ["PBVC", "TEST", 0, 4], ["herpesvirus", "PROBLEM", 11, 22], ["very similar DNA polymerase genes", "PROBLEM", 28, 61]]], ["Furthermore, the poxviral DNA polymerase gene is very different from that found in the herpesviruses.", [["poxviral", "GENE_OR_GENE_PRODUCT", 17, 25], ["DNA", "CELLULAR_COMPONENT", 26, 29], ["herpesviruses", "ORGANISM", 87, 100], ["poxviral DNA polymerase gene", "DNA", 17, 45], ["the poxviral DNA polymerase", "TEST", 13, 40], ["very different", "OBSERVATION_MODIFIER", 49, 63], ["herpesviruses", "OBSERVATION", 87, 100]]], ["Yet, the PBCV-1 capsid was clearly similar to that of adenoviruses and PRD1 phage (and iridovirus capsids).", [["PBCV-1", "GENE_OR_GENE_PRODUCT", 9, 15], ["adenoviruses", "ORGANISM", 54, 66], ["PRD1 phage", "GENE_OR_GENE_PRODUCT", 71, 81], ["iridovirus capsids", "ORGANISM", 87, 105], ["PBCV", "PROTEIN", 9, 13], ["PBCV-1", "SPECIES", 9, 15], ["the PBCV", "TEST", 5, 13], ["adenoviruses", "PROBLEM", 54, 66], ["PRD1 phage", "TREATMENT", 71, 81], ["iridovirus capsids", "TREATMENT", 87, 105]]], ["How then do we link poxvirus evolution to other more ancient DNA viruses, such as PBCV-1 which has the same DNA replication mechanism, but distinct replication proteins?", [["DNA", "CELLULAR_COMPONENT", 61, 64], ["PBCV-1", "GENE_OR_GENE_PRODUCT", 82, 88], ["DNA", "CELLULAR_COMPONENT", 108, 111], ["PBCV-1", "DNA", 82, 88], ["replication proteins", "PROTEIN", 148, 168], ["DNA viruses", "PROBLEM", 61, 72], ["PBCV", "TEST", 82, 86]]], ["Such observations might seem confusing, but they are clearly consistent with mosaic, reticulated evolution of DNA viruses.", [["DNA", "CELLULAR_COMPONENT", 110, 113], ["DNA viruses", "PROBLEM", 110, 121], ["reticulated", "OBSERVATION_MODIFIER", 85, 96], ["DNA viruses", "OBSERVATION", 110, 121]]], ["Various distinct phage lineages can link in multiple ways to various distinct eukaryotic DNA viruses.", [["DNA", "CELLULAR_COMPONENT", 89, 92], ["Various distinct phage lineages", "PROBLEM", 0, 31], ["distinct", "OBSERVATION_MODIFIER", 8, 16], ["phage lineages", "OBSERVATION", 17, 31], ["eukaryotic DNA viruses", "OBSERVATION", 78, 100]]], ["The concept of a net or matrix rather than a tree is thus a better way to describe the broad topology of DNA virus evolution.Poxvirus as Mostly Acute , with Frequent Species ShiftsThe issue of gene gain and gene loss is also of central interest to orthopoxvirus evolution.", [["matrix", "CELLULAR_COMPONENT", 24, 30], ["DNA", "CELLULAR_COMPONENT", 105, 108], ["orthopoxvirus", "CANCER", 248, 261], ["DNA virus evolution", "PROBLEM", 105, 124], ["Poxvirus", "TREATMENT", 125, 133], ["Frequent Species Shifts", "PROBLEM", 157, 180], ["gene gain", "PROBLEM", 193, 202], ["gene loss", "PROBLEM", 207, 216], ["DNA virus", "OBSERVATION", 105, 114], ["Acute", "OBSERVATION_MODIFIER", 144, 149]]], ["Typically, we seek to understand poxviruses evolution from the perspective of pathogenesis, such as the origin of human-specifi c smallpox virus.", [["poxviruses", "ORGANISM", 33, 43], ["human-specifi c smallpox virus", "ORGANISM", 114, 144], ["human", "SPECIES", 114, 119], ["-specifi", "SPECIES", 119, 127], ["human-specifi c smallpox virus", "SPECIES", 114, 144], ["pathogenesis", "PROBLEM", 78, 90], ["smallpox virus", "PROBLEM", 130, 144]]], ["With the comparative genomics of several orthopoxviruses now possible, we see curious overall patterns of gene loss in their evolution ( Randall et al. , 2004 ) .", [["several orthopoxviruses", "PROBLEM", 33, 56], ["gene loss", "PROBLEM", 106, 115], ["orthopoxviruses", "OBSERVATION", 41, 56], ["gene loss", "OBSERVATION", 106, 115]]], ["For example, comparing human smallpox to cowpox DNA (a rodent virus that is phylogenetically basal to smallpox), we observe an overall diminution of gene content in smallpox virus.", [["smallpox", "DISEASE", 29, 37], ["smallpox", "DISEASE", 165, 173], ["human", "ORGANISM", 23, 28], ["cowpox", "ORGANISM", 41, 47], ["DNA", "CELLULAR_COMPONENT", 48, 51], ["rodent virus", "ORGANISM", 55, 67], ["smallpox virus", "ORGANISM", 165, 179], ["cowpox DNA", "DNA", 41, 51], ["human", "SPECIES", 23, 28], ["rodent", "SPECIES", 55, 61], ["human", "SPECIES", 23, 28], ["cowpox", "SPECIES", 41, 47], ["smallpox virus", "SPECIES", 165, 179], ["human smallpox", "TREATMENT", 23, 37], ["cowpox DNA", "PROBLEM", 41, 51], ["a rodent virus", "PROBLEM", 53, 67], ["gene content in smallpox virus", "PROBLEM", 149, 179], ["cowpox DNA", "OBSERVATION", 41, 51], ["gene content", "OBSERVATION", 149, 161], ["smallpox virus", "OBSERVATION", 165, 179]]], ["Several poxviruses seem to have also lost genes relative to cowpoxvirus, especially genes that appear to affect immunity ( Hughes and Friedman, 2005 ) .", [["cowpoxvirus", "GENE_OR_GENE_PRODUCT", 60, 71], ["cowpoxvirus", "DNA", 60, 71], ["poxviruses", "OBSERVATION", 8, 18]]], ["I suggest that this evolutionary tendency for gene reduction is associated with a switch from a more demanding species-specifi c persistent life strategy to a less demanding, acute life strategy in a new host.", [["gene reduction", "PROBLEM", 46, 60], ["a more demanding species", "PROBLEM", 94, 118], ["acute life strategy", "TREATMENT", 175, 194]]], ["Cowpox is a naturally persistent infection in rodents (bank voles) ( Feore et al. , 1997 ; Chantrey et al. , 1999 ) , which has been called a natural virus reservoir ( Hazel et al. , 2000 ) .", [["Cowpox", "CHEMICAL", 0, 6], ["infection", "DISEASE", 33, 42], ["bank voles", "SPECIES", 55, 65], ["a naturally persistent infection", "PROBLEM", 10, 42], ["a natural virus reservoir", "TREATMENT", 140, 165], ["naturally", "OBSERVATION_MODIFIER", 12, 21], ["persistent", "OBSERVATION_MODIFIER", 22, 32], ["infection", "OBSERVATION", 33, 42]]], ["Smallpox is a strictly acute and human-specifi c disease.", [["acute and human-specifi c disease", "DISEASE", 23, 56], ["human", "ORGANISM", 33, 38], ["human", "SPECIES", 33, 38], ["human", "SPECIES", 33, 38], ["specifi c disease", "PROBLEM", 39, 56], ["strictly acute", "OBSERVATION_MODIFIER", 14, 28]]], ["Such gene loss in association with lost persistence could be a general situation and might also explain why clinical isolates of human cytomegalovirus isolates show a strong tendency to delete genes with passage in culture ( Davison et al. , 2003 ) .Poxvirus as Mostly Acute , with Frequent Species ShiftsMost orthopoxviruses are not phylogenetically congruent with their vertebrate host.", [["human", "ORGANISM", 129, 134], ["cytomegalovirus", "ORGANISM", 135, 150], ["human", "SPECIES", 129, 134], ["human cytomegalovirus", "SPECIES", 129, 150], ["Such gene loss", "PROBLEM", 0, 14], ["human cytomegalovirus isolates", "TEST", 129, 159], ["a strong tendency to delete genes", "PROBLEM", 165, 198], ["passage in culture", "PROBLEM", 204, 222], ["Poxvirus", "PROBLEM", 250, 258], ["Frequent Species Shifts", "PROBLEM", 282, 305], ["Most orthopoxviruses", "PROBLEM", 305, 325], ["gene loss", "OBSERVATION", 5, 14], ["Mostly", "OBSERVATION_MODIFIER", 262, 268], ["Acute", "OBSERVATION_MODIFIER", 269, 274]]], ["Host switching and acute replication seem to be relatively common but recent occurrences in their evolution ( Babkin and Shchelkunov, 2006 ) .", [["acute replication", "TREATMENT", 19, 36]]], ["The avian poxviruses are not as well studied in this context, but curiously have signifi cantly more complex genomes than the orthopoxviruses ( Jarmin et al. , 2006 ) .", [["avian poxviruses", "ORGANISM", 4, 20], ["The avian poxviruses", "TREATMENT", 0, 20], ["poxviruses", "OBSERVATION", 10, 20]]], ["The entomopoxviruses are even less well understood from both a biological and molecular perspective, although they do conserve 49 genes found in all poxvirus family members ( Gubser et al. , 2004 ) .", [["entomopoxviruses", "GENE_OR_GENE_PRODUCT", 4, 20]]], ["Clearly these poxviruses share some degree of evolutionary history.Poxvirus as Mostly Acute , with Frequent Species ShiftsIt is most curious that entomopoxviruses have even larger, more diverse and complex genomes than the other poxviruses.", [["poxviruses", "ORGANISM", 14, 24], ["entomopoxviruses", "CANCER", 146, 162], ["Poxvirus", "TREATMENT", 67, 75], ["Frequent Species Shifts", "PROBLEM", 99, 122], ["poxviruses", "OBSERVATION", 14, 24], ["Acute", "OBSERVATION_MODIFIER", 86, 91], ["most curious", "OBSERVATION_MODIFIER", 128, 140], ["larger", "OBSERVATION_MODIFIER", 173, 179], ["more diverse", "OBSERVATION_MODIFIER", 181, 193], ["complex", "OBSERVATION_MODIFIER", 198, 205], ["genomes", "OBSERVATION", 206, 213], ["poxviruses", "OBSERVATION", 229, 239]]], ["As insects lack an adaptive immune system (the target of many orthopoxvirus genes), they would seem to present a simpler host for virus adaptation.", [["immune system", "ANATOMICAL_SYSTEM", 28, 41], ["orthopoxvirus", "GENE_OR_GENE_PRODUCT", 62, 75], ["orthopoxvirus genes", "DNA", 62, 81], ["an adaptive immune system", "TREATMENT", 16, 41], ["many orthopoxvirus genes", "TREATMENT", 57, 81], ["virus adaptation", "TREATMENT", 130, 146]]], ["This group appears to be the most basal phylogenetically, but evolutionary relationships between entomopoxvirus and insect evolution have not been studied.", [["entomopoxvirus", "GENE_OR_GENE_PRODUCT", 97, 111]]], ["The enotomopoxviruses are particularly prevalent in grasshopper and locust species, often in unapparent states.", [["enotomopoxviruses", "GENE_OR_GENE_PRODUCT", 4, 21], ["The enotomopoxviruses", "TREATMENT", 0, 21], ["locust species", "PROBLEM", 68, 82], ["locust species", "OBSERVATION", 68, 82]]], ["Interestingly, within these viruses we can fi nd examples of major shifts in core replication genes, such as the family of DNA pol gene that is used (a shift from DNA pol X to DNA pol B in two entomopoxvirus lineages).", [["DNA", "CELLULAR_COMPONENT", 123, 126], ["pol", "GENE_OR_GENE_PRODUCT", 127, 130], ["DNA", "CELLULAR_COMPONENT", 163, 166], ["pol X", "GENE_OR_GENE_PRODUCT", 167, 172], ["DNA", "CELLULAR_COMPONENT", 176, 179], ["pol B", "GENE_OR_GENE_PRODUCT", 180, 185], ["core replication genes", "DNA", 77, 99], ["DNA pol gene", "DNA", 123, 135], ["DNA pol X", "DNA", 163, 172], ["DNA pol B", "DNA", 176, 185], ["entomopoxvirus lineages", "CELL_TYPE", 193, 216], ["DNA pol gene", "TREATMENT", 123, 135], ["DNA pol", "TREATMENT", 163, 170], ["DNA pol B", "TREATMENT", 176, 185]]], ["We can recall that the DNA pol B gene closely resembles that found in phycodnaviruses (and herpesvirus), but is distinct from that in orthopoxvirus ( Zhu, 2003 ) .", [["DNA", "CELLULAR_COMPONENT", 23, 26], ["pol B", "GENE_OR_GENE_PRODUCT", 27, 32], ["phycodnaviruses", "CANCER", 70, 85], ["herpesvirus", "ORGANISM", 91, 102], ["DNA pol B gene", "DNA", 23, 37], ["the DNA pol", "TREATMENT", 19, 30], ["herpesvirus", "PROBLEM", 91, 102]]], ["We also see in the entomopoxviruses some clear links to phage genes, such as T4-like RNA ligase found in all entomopoxviruses ( Ho and Shuman, 2002 ) as well as a lambdalike integrase seen in D1EPV ( Hashimoto and Lawrence, 2005 ) .", [["T4", "GENE_OR_GENE_PRODUCT", 77, 79], ["phage genes", "DNA", 56, 67], ["T4", "DNA", 77, 79], ["RNA ligase", "PROTEIN", 85, 95], ["lambdalike integrase", "PROTEIN", 163, 183], ["T4-like RNA ligase", "PROBLEM", 77, 95], ["a lambdalike integrase", "TREATMENT", 161, 183]]], ["This integrase in D1EPV implies possible integration and persistence, thus it is most signifi cant that D1EPV also shows a clear persistent host infection as well as symbiosis and apparent phylogenetic congruence between virus and host.Poxvirus as Mostly Acute , with Frequent Species ShiftsThis virus is symbiotic in its parasitoid wasp host in that virus is injected into larval host along with the wasp egg (and also along with a second D1RhV rhabdovirus) and virus is needed for successful host parasitization.", [["egg", "ANATOMY", 406, 409], ["infection", "DISEASE", 145, 154], ["D1EPV", "GENE_OR_GENE_PRODUCT", 18, 23], ["D1EPV", "GENE_OR_GENE_PRODUCT", 104, 109], ["egg", "ORGANISM_SUBSTANCE", 406, 409], ["D1RhV", "GENE_OR_GENE_PRODUCT", 440, 445], ["D1EPV", "DNA", 18, 23], ["This integrase in D1EPV", "TREATMENT", 0, 23], ["a clear persistent host infection", "PROBLEM", 121, 154], ["symbiosis", "PROBLEM", 166, 175], ["apparent phylogenetic congruence between virus", "PROBLEM", 180, 226], ["Poxvirus", "PROBLEM", 236, 244], ["Frequent Species Shifts", "PROBLEM", 268, 291], ["This virus", "PROBLEM", 291, 301], ["the wasp egg", "PROBLEM", 397, 409], ["a second D1RhV rhabdovirus", "TREATMENT", 431, 457], ["virus", "PROBLEM", 463, 468], ["successful host parasitization", "TREATMENT", 483, 513], ["implies possible", "UNCERTAINTY", 24, 40], ["clear", "OBSERVATION_MODIFIER", 123, 128], ["persistent", "OBSERVATION_MODIFIER", 129, 139], ["host", "OBSERVATION_MODIFIER", 140, 144], ["infection", "OBSERVATION", 145, 154], ["phylogenetic congruence", "OBSERVATION", 189, 212], ["Acute", "OBSERVATION_MODIFIER", 255, 260], ["parasitization", "OBSERVATION", 499, 513]]], ["This symbiosis is clearly very reminiscent of the genomic polydnaviruses of other parasitoid wasp species.", [["other parasitoid wasp species", "PROBLEM", 76, 105], ["genomic polydnaviruses", "OBSERVATION", 50, 72], ["parasitoid wasp species", "OBSERVATION", 82, 105]]], ["DIEPV is also expressed in the male poison gland.", [["poison gland", "ANATOMY", 36, 48], ["DIEPV", "GENE_OR_GENE_PRODUCT", 0, 5], ["poison gland", "ORGAN", 36, 48], ["DIEPV", "PROTEIN", 0, 5], ["gland", "ANATOMY", 43, 48]]], ["However, it is unknown if DIEPV is integrating into the host DNA.", [["DIEPV", "CHEMICAL", 26, 31], ["DIEPV", "GENE_OR_GENE_PRODUCT", 26, 31], ["DNA", "CELLULAR_COMPONENT", 61, 64], ["DIEPV", "PROTEIN", 26, 31], ["host DNA", "DNA", 56, 64], ["host DNA", "OBSERVATION", 56, 64]]], ["Clearly, D1EPV it is part of a complex virus-virus-host symbiotic interaction.Small DNA VirusesThe overall evolution of orthopoxviruses contrasts sharply with that of the papillomaviruses as presented by Bernard in Chapter 18.", [["D1EPV", "GENE_OR_GENE_PRODUCT", 9, 14], ["DNA", "CELLULAR_COMPONENT", 84, 87], ["papillomaviruses", "ORGANISM", 171, 187], ["D1EPV", "PROTEIN", 9, 14], ["virus-virus", "SPECIES", 39, 50], ["a complex virus", "PROBLEM", 29, 44], ["Small DNA Viruses", "PROBLEM", 78, 95], ["orthopoxviruses contrasts", "PROBLEM", 120, 145], ["DNA Viruses", "OBSERVATION", 84, 95], ["orthopoxviruses", "OBSERVATION", 120, 135], ["papillomaviruses", "OBSERVATION", 171, 187]]], ["Here, highly species-specifi c and tissuespecifi c host infection are the norm and the viral evolution is typically highly congruent with the host (with some exceptions).", [["infection", "DISEASE", 56, 65], ["specifi c", "ORGANISM", 21, 30], ["tissuespecifi c host", "ORGANISM", 35, 55], ["specifi c and tissuespecifi c host infection", "PROBLEM", 21, 65], ["the viral evolution", "PROBLEM", 83, 102], ["host", "OBSERVATION_MODIFIER", 51, 55], ["infection", "OBSERVATION", 56, 65], ["viral", "OBSERVATION", 87, 92]]], ["The resolution between virus and host can be high, in that human racial and geographical populations, for example, can often be differentiated based on the type of HPV they harbor.", [["human", "ORGANISM", 59, 64], ["HPV", "ORGANISM", 164, 167], ["human", "SPECIES", 59, 64], ["human", "SPECIES", 59, 64], ["HPV", "SPECIES", 164, 167], ["The resolution between virus", "PROBLEM", 0, 28], ["resolution", "OBSERVATION_MODIFIER", 4, 14]]], ["Yet here too there is evidence of signifi cant shifts in core gene usage early during papillomavirus evolution.", [["papillomavirus", "ORGANISM", 86, 100], ["signifi cant shifts", "PROBLEM", 34, 53]]], ["In the human and rodent viruses, a highly conserved gene function associated with replication and cell control are the E6 and E7 early genes.", [["cell", "ANATOMY", 98, 102], ["human", "ORGANISM", 7, 12], ["cell", "CELL", 98, 102], ["E6", "GENE_OR_GENE_PRODUCT", 119, 121], ["E7", "GENE_OR_GENE_PRODUCT", 126, 128], ["E6 and E7 early genes", "DNA", 119, 140], ["human", "SPECIES", 7, 12], ["rodent", "SPECIES", 17, 23], ["human", "SPECIES", 7, 12], ["replication and cell control", "TREATMENT", 82, 110], ["viruses", "OBSERVATION", 24, 31]]], ["In particular, the pRB-binding domain of the E7 gene is thought to be central to the biological strategy of the virus.", [["pRB", "GENE_OR_GENE_PRODUCT", 19, 22], ["E7", "GENE_OR_GENE_PRODUCT", 45, 47], ["pRB-binding domain", "PROTEIN", 19, 37], ["E7 gene", "DNA", 45, 52], ["the virus", "PROBLEM", 108, 117], ["thought to be", "UNCERTAINTY", 56, 69], ["virus", "OBSERVATION", 112, 117]]], ["Thus, it is most curious that the papillomaviruses of lagomorphs, such as bovine and reindeer papillomavirus, lack an E7 Rb-binding domain and instead appear to use E5 or E9 genes for this regulatory function ( Narechania et al. , 2004 ) .", [["lagomorphs", "ANATOMY", 54, 64], ["bovine and reindeer papillomavirus", "DISEASE", 74, 108], ["papillomaviruses", "ORGANISM", 34, 50], ["lagomorphs", "CANCER", 54, 64], ["bovine", "ORGANISM", 74, 80], ["reindeer papillomavirus", "ORGANISM", 85, 108], ["E7", "GENE_OR_GENE_PRODUCT", 118, 120], ["Rb", "GENE_OR_GENE_PRODUCT", 121, 123], ["E5", "GENE_OR_GENE_PRODUCT", 165, 167], ["E9", "GENE_OR_GENE_PRODUCT", 171, 173], ["E7 Rb-binding domain", "PROTEIN", 118, 138], ["E5 or E9 genes", "DNA", 165, 179], ["bovine", "SPECIES", 74, 80], ["reindeer papillomavirus", "SPECIES", 85, 108], ["bovine", "SPECIES", 74, 80], ["reindeer papillomavirus", "SPECIES", 85, 108], ["the papillomaviruses of lagomorphs", "PROBLEM", 30, 64], ["bovine and reindeer papillomavirus", "TEST", 74, 108], ["papillomaviruses", "OBSERVATION", 34, 50]]], ["It seems an early but signifi cant and bifurcating shift occurred in the molecular strategy during the virus-host evolution of this group of viruses for unknown reasons.Small DNA VirusesOther small DNA viruses (JCV, BKV, Py) can also show similar high-resolution host congruence ( Shadan and Villarreal, 1995 ) .", [["DNA", "CELLULAR_COMPONENT", 175, 178], ["DNA", "CELLULAR_COMPONENT", 198, 201], ["JCV", "ORGANISM", 211, 214], ["BKV", "ORGANISM", 216, 219], ["signifi cant", "PROBLEM", 22, 34], ["bifurcating shift", "PROBLEM", 39, 56], ["the virus", "PROBLEM", 99, 108], ["viruses", "PROBLEM", 141, 148], ["Small DNA VirusesOther small DNA viruses", "PROBLEM", 169, 209], ["early", "OBSERVATION_MODIFIER", 12, 17], ["bifurcating shift", "OBSERVATION", 39, 56], ["viruses", "OBSERVATION", 141, 148], ["DNA", "OBSERVATION_MODIFIER", 175, 178], ["VirusesOther", "OBSERVATION_MODIFIER", 179, 191], ["small", "OBSERVATION_MODIFIER", 192, 197], ["DNA viruses", "OBSERVATION", 198, 209]]], ["For example, the presence of a middle Tantigen in mouse virus (a third early gene), but its absence from primate viruses ( Gottlieb and Villarreal, 2001 ) , clearly differentiates these viral lineages.", [["Tantigen", "GENE_OR_GENE_PRODUCT", 38, 46], ["mouse", "ORGANISM", 50, 55], ["middle Tantigen", "PROTEIN", 31, 46], ["mouse", "SPECIES", 50, 55], ["mouse virus", "SPECIES", 50, 61], ["a middle Tantigen in mouse virus", "PROBLEM", 29, 61], ["primate viruses", "PROBLEM", 105, 120], ["these viral lineages", "PROBLEM", 180, 200], ["middle", "ANATOMY_MODIFIER", 31, 37], ["mouse virus", "OBSERVATION", 50, 61], ["viruses", "OBSERVATION", 113, 120], ["viral lineages", "OBSERVATION", 186, 200]]], ["Although the origins of these entire small DNA viruses are obscure, and any links to prokaryotic viruses are unknown, it does appear they have tended to retain their overall biological strategy and show a strong tendency for tissue-specifi c (especially kidney) persistence and virus-host congruence.Persistence as Symbiosis, another Foundation for Virus-Host EvolutionSince persistence requires the stable coexistence of a virus and its host, it also fi ts the simple defi nition of symbiosis (the stable living together of two distinct lineages of organisms).", [["tissue", "ANATOMY", 225, 231], ["kidney", "ANATOMY", 254, 260], ["Symbiosis", "DISEASE", 315, 324], ["DNA", "CELLULAR_COMPONENT", 43, 46], ["tissue", "TISSUE", 225, 231], ["specifi c", "GENE_OR_GENE_PRODUCT", 232, 241], ["kidney", "ORGAN", 254, 260], ["Virus", "ORGANISM", 349, 354], ["these entire small DNA viruses", "PROBLEM", 24, 54], ["prokaryotic viruses", "PROBLEM", 85, 104], ["a strong tendency for tissue-specifi c (especially kidney)", "PROBLEM", 203, 261], ["Virus", "PROBLEM", 349, 354], ["a virus", "PROBLEM", 422, 429], ["symbiosis", "PROBLEM", 484, 493], ["origins", "ANATOMY_MODIFIER", 13, 20], ["entire", "OBSERVATION_MODIFIER", 30, 36], ["small", "OBSERVATION_MODIFIER", 37, 42], ["DNA viruses", "OBSERVATION", 43, 54], ["viruses", "OBSERVATION", 97, 104], ["kidney", "ANATOMY", 254, 260], ["virus", "OBSERVATION", 278, 283], ["host congruence", "OBSERVATION", 284, 299], ["Symbiosis", "OBSERVATION", 315, 324], ["stable", "OBSERVATION_MODIFIER", 400, 406], ["symbiosis", "OBSERVATION", 484, 493], ["stable", "OBSERVATION_MODIFIER", 499, 505]]], ["Viral involvement in symbiosis is a foreign idea to many and possibly presents a fundamentally different view of the role viruses may have in host evolution.", [["Viral involvement in symbiosis", "PROBLEM", 0, 30], ["symbiosis", "OBSERVATION", 21, 30], ["viruses", "OBSERVATION", 122, 129], ["host evolution", "OBSERVATION", 142, 156]]], ["A major role for persisting (temperate, cryptic) viruses in the evolution of prokaryotes is no longer a controversial idea.", [["persisting (temperate, cryptic) viruses", "PROBLEM", 17, 56], ["no longer", "UNCERTAINTY", 92, 101]]], ["The MHV-mouse exemplar as presented above has suggested how persistence can directly affect host survival.", [["MHV", "ORGANISM", 4, 7], ["mouse", "ORGANISM", 8, 13], ["mouse", "SPECIES", 8, 13], ["MHV", "SPECIES", 4, 7], ["mouse", "SPECIES", 8, 13], ["The MHV-mouse exemplar", "TREATMENT", 0, 22], ["MHV", "OBSERVATION_MODIFIER", 4, 7]]], ["Can this be considered an example of symbiosis in the accepted sense?Persistence as Symbiosis, another Foundation for Virus-Host EvolutionA crowning achievement in the fi eld of symbiosis has been to explain the origin of plastids (chloroplasts, mitochondria) from symbiotic prokaryotes in eukaryotic cytoplasm ( Margulis and Bermudes, 1985 ) .", [["plastids", "ANATOMY", 222, 230], ["chloroplasts", "ANATOMY", 232, 244], ["mitochondria", "ANATOMY", 246, 258], ["cytoplasm", "ANATOMY", 301, 310], ["Symbiosis", "DISEASE", 84, 93], ["plastids", "CELLULAR_COMPONENT", 222, 230], ["chloroplasts", "CELLULAR_COMPONENT", 232, 244], ["mitochondria", "CELLULAR_COMPONENT", 246, 258], ["cytoplasm", "ORGANISM_SUBSTANCE", 301, 310], ["symbiosis", "PROBLEM", 37, 46], ["Virus", "PROBLEM", 118, 123], ["plastids (chloroplasts, mitochondria", "PROBLEM", 222, 258], ["symbiotic prokaryotes", "PROBLEM", 265, 286], ["symbiosis", "OBSERVATION", 37, 46], ["Symbiosis", "OBSERVATION", 84, 93], ["symbiosis", "OBSERVATION", 178, 187], ["plastids", "OBSERVATION", 222, 230], ["eukaryotic cytoplasm", "OBSERVATION", 290, 310]]], ["This idea involves the high adaptability of prokaryotes to provide innovation but would seem not to involve virus in any way.", [["virus", "PROBLEM", 108, 113], ["high adaptability", "OBSERVATION_MODIFIER", 23, 40]]], ["Yet here too we can fi nd viral footprints that suggest some involvement.", [["viral footprints", "OBSERVATION", 26, 42]]], ["For example, various plastid-specifi c RNA and DNA polymerases clearly resemble polymerases from T3/T7-like phage ( Cermakian et al. , 1996 ; Shutt and Gray, 2006 ) .", [["plastid-specifi c", "GENE_OR_GENE_PRODUCT", 21, 38], ["DNA", "CELLULAR_COMPONENT", 47, 50], ["T3/T7", "ORGANISM", 97, 102], ["plastid", "DNA", 21, 28], ["specifi c RNA", "RNA", 29, 42], ["DNA polymerases", "PROTEIN", 47, 62], ["T7", "DNA", 100, 102], ["various plastid-specifi c RNA", "TREATMENT", 13, 42], ["DNA polymerases", "TEST", 47, 62], ["polymerases", "TEST", 80, 91], ["T3/T7", "TREATMENT", 97, 102], ["T7", "ANATOMY", 100, 102]]], ["Other models of symbiosis also show evidence of a viral role, such as the sexual isolation of Buchnera ( Moran et al. , 2005 ) .Persistence as Symbiosis, another Foundation for Virus-Host EvolutionAnother very popular topic in the fi eld of symbiosis is the symbiotic origin of the photosynthetic sea slug, Elysa chlorotica .", [["Symbiosis", "DISEASE", 143, 152], ["Elysa chlorotica", "ORGANISM", 307, 323], ["Elysa chlorotica", "SPECIES", 307, 323], ["Elysa chlorotica", "SPECIES", 307, 323], ["a viral role", "PROBLEM", 48, 60], ["Virus", "PROBLEM", 177, 182], ["Elysa chlorotica", "TREATMENT", 307, 323], ["symbiosis", "OBSERVATION", 16, 25], ["viral", "OBSERVATION", 50, 55], ["Symbiosis", "OBSERVATION", 143, 152], ["very", "OBSERVATION_MODIFIER", 205, 209], ["popular", "OBSERVATION_MODIFIER", 210, 217], ["symbiosis", "OBSERVATION", 241, 250], ["symbiotic origin", "OBSERVATION_MODIFIER", 258, 274], ["photosynthetic sea slug", "OBSERVATION", 282, 305], ["Elysa chlorotica", "OBSERVATION", 307, 323]]], ["What could be more fascinating than a green sea slug-an animal that can use light for photosynthesis?", [["a green sea slug", "PROBLEM", 36, 52]]], ["E. chlorotica eats photosynthetic eukaryotic algae ( Vaucheria litorea ) and retains the functional chloroplast from algae for months.", [["chloroplast", "ANATOMY", 100, 111], ["E. chlorotica", "ORGANISM", 0, 13], ["Vaucheria litorea", "ORGANISM", 53, 70], ["chloroplast", "CELLULAR_COMPONENT", 100, 111], ["E. chlorotica", "SPECIES", 0, 13], ["Vaucheria litorea", "SPECIES", 53, 70], ["E. chlorotica", "SPECIES", 0, 13], ["Vaucheria litorea", "SPECIES", 53, 70], ["photosynthetic eukaryotic algae", "OBSERVATION", 19, 50]]], ["Here too, however, there lies a viral footprint.", [["a viral footprint", "PROBLEM", 30, 47], ["viral footprint", "OBSERVATION", 32, 47]]], ["This slug harbors an unusual endogenous retrovirus which is expressed in large numbers during sexual reproduction, following which all slugs die via synchronized apoptosis and in which the chloroplasts have accumulated numerous viral particles ( Pierce et al. , 1999 ; Mondy and Pierce, 2003 ) .", [["chloroplasts", "ANATOMY", 189, 201], ["retrovirus", "ORGANISM", 40, 50], ["chloroplasts", "CELLULAR_COMPONENT", 189, 201], ["an unusual endogenous retrovirus", "PROBLEM", 18, 50], ["synchronized apoptosis", "PROBLEM", 149, 171], ["unusual", "OBSERVATION_MODIFIER", 21, 28], ["endogenous retrovirus", "OBSERVATION", 29, 50], ["large", "OBSERVATION_MODIFIER", 73, 78], ["numbers", "OBSERVATION_MODIFIER", 79, 86], ["synchronized apoptosis", "OBSERVATION", 149, 171], ["numerous", "OBSERVATION_MODIFIER", 219, 227], ["viral particles", "OBSERVATION", 228, 243]]], ["Since there is reason to think gene movement from the algae to the slug genome is involved in this symbiosis, the presence of this retrovirus is a strong candidate to also be involved in symbiogenesis.Persistence as Symbiosis, another Foundation for Virus-Host EvolutionClearly we should thus investigate retroviral elements as possible symbiotic participants and not dismiss them beforehand as irrelevant or \" junk DNA \" (as is automatically done in many database screens).Persistence as Symbiosis, another Foundation for Virus-Host EvolutionIf viral persistence is a kind of symbiosis, viruses may also mediate the establishment of other symbiotic relationships ( Villarreal, 2007 ) .", [["Symbiosis", "DISEASE", 216, 225], ["retrovirus", "ORGANISM", 131, 141], ["retroviral", "ORGANISM", 305, 315], ["DNA", "CELLULAR_COMPONENT", 416, 419], ["slug genome", "DNA", 67, 78], ["retroviral elements", "DNA", 305, 324], ["junk DNA", "DNA", 411, 419], ["participants", "SPECIES", 347, 359], ["gene movement", "PROBLEM", 31, 44], ["this retrovirus", "PROBLEM", 126, 141], ["Virus", "PROBLEM", 250, 255], ["retroviral elements", "PROBLEM", 305, 324], ["Virus", "PROBLEM", 523, 528], ["viral persistence", "PROBLEM", 546, 563], ["symbiosis", "PROBLEM", 577, 586], ["viruses", "PROBLEM", 588, 595], ["slug genome", "OBSERVATION", 67, 78], ["retrovirus", "OBSERVATION", 131, 141], ["Symbiosis", "OBSERVATION", 216, 225], ["Symbiosis", "OBSERVATION", 489, 498]]], ["The recent studies by Roossinck and colleagues (see Chapter 12), in which a persisting virus, a plant, and a fungus were all symbiotically involved in altering the thermal tolerance of the plant could be an example of this ( Marquez et al. , 2007 ) .", [["The recent studies", "TEST", 0, 18], ["a persisting virus", "PROBLEM", 74, 92], ["a fungus", "PROBLEM", 107, 115], ["persisting", "OBSERVATION_MODIFIER", 76, 86], ["virus", "OBSERVATION", 87, 92]]], ["Many other virus-host relationships should also be examined for possible symbiosis.", [["symbiosis", "PROBLEM", 73, 82], ["virus", "OBSERVATION", 11, 16]]], ["For example, placental vertebrate evolution has involved various endogenous retroviruses (i.e. HERV-W, HERV-FRD).", [["placental", "ANATOMY", 13, 22], ["placental", "ANATOMICAL_SYSTEM", 13, 22], ["retroviruses", "ORGANISM", 76, 88], ["HERV-W", "GENE_OR_GENE_PRODUCT", 95, 101], ["HERV-FRD", "GENE_OR_GENE_PRODUCT", 103, 111], ["HERV", "DNA", 95, 99], ["HERV", "DNA", 103, 107], ["FRD", "DNA", 108, 111], ["placental vertebrate evolution", "PROBLEM", 13, 43], ["various endogenous retroviruses", "PROBLEM", 57, 88], ["placental vertebrate", "OBSERVATION", 13, 33], ["various", "OBSERVATION_MODIFIER", 57, 64], ["endogenous retroviruses", "OBSERVATION", 65, 88]]], ["Intact HERV genomes, including env ORFs, are important for placental trophoblast fusion (for references see Ryan, 2007 ) .Persistence as Symbiosis, another Foundation for Virus-Host EvolutionSome will dismiss this situation as the quirky usurping of a viral gene for host function which is of little general signifi cance.", [["placental trophoblast", "ANATOMY", 59, 80], ["Symbiosis", "DISEASE", 137, 146], ["HERV", "GENE_OR_GENE_PRODUCT", 7, 11], ["env ORFs", "GENE_OR_GENE_PRODUCT", 31, 39], ["placental trophoblast", "CELL", 59, 80], ["HERV genomes", "DNA", 7, 19], ["env ORFs", "DNA", 31, 39], ["viral gene", "DNA", 252, 262], ["placental trophoblast fusion", "TREATMENT", 59, 87], ["Virus", "PROBLEM", 171, 176], ["a viral gene", "TREATMENT", 250, 262], ["HERV genomes", "OBSERVATION", 7, 19], ["Symbiosis", "OBSERVATION", 137, 146]]], ["The specifi c ERV involved is simply selfi sh and mostly defective genetic material of no general consequence.", [["specifi c ERV", "GENE_OR_GENE_PRODUCT", 4, 17], ["specifi c ERV", "DNA", 4, 17], ["mostly defective genetic material", "PROBLEM", 50, 83], ["general consequence", "PROBLEM", 90, 109]]], ["If so, why is it that in sheep a distinctly different lineage of retrovirus (enJSRV) was also selected to provide a related placental function to a another mammal with signifi cantly different placental reproductive biology?", [["placental", "ANATOMY", 124, 133], ["placental", "ANATOMY", 193, 202], ["sheep", "ORGANISM", 25, 30], ["retrovirus", "ORGANISM", 65, 75], ["enJSRV", "GENE_OR_GENE_PRODUCT", 77, 83], ["placental", "TISSUE", 124, 133], ["placental reproductive", "MULTI-TISSUE_STRUCTURE", 193, 215], ["sheep", "SPECIES", 25, 30], ["sheep", "SPECIES", 25, 30], ["enJSRV", "SPECIES", 77, 83], ["a related placental function", "PROBLEM", 114, 142], ["retrovirus", "OBSERVATION", 65, 75]]], ["It has been experimentally well established the enJSRV env is essential for sheep embryo implantation ( Dunlap et al. , 2006a ( Dunlap et al. , , 2006b . enJSRV is the endogenous version of JSRV, a problematic sheep-specifi c retrovirus that induces lung tumors (responsible for the death of Dolly, the famous fi rst cloned sheep).", [["embryo", "ANATOMY", 82, 88], ["lung tumors", "ANATOMY", 250, 261], ["lung tumors", "DISEASE", 250, 261], ["death", "DISEASE", 283, 288], ["enJSRV", "GENE_OR_GENE_PRODUCT", 48, 54], ["sheep", "ORGANISM", 76, 81], ["embryo", "DEVELOPING_ANATOMICAL_STRUCTURE", 82, 88], ["JSRV", "ORGANISM", 190, 194], ["sheep-specifi c retrovirus", "ORGANISM", 210, 236], ["lung tumors", "CANCER", 250, 261], ["sheep", "ORGANISM", 324, 329], ["enJSRV env", "DNA", 48, 58], ["sheep", "SPECIES", 76, 81], ["sheep", "SPECIES", 210, 215], ["sheep", "SPECIES", 324, 329], ["sheep", "SPECIES", 76, 81], ["JSRV", "SPECIES", 190, 194], ["sheep-specifi c retrovirus", "SPECIES", 210, 236], ["sheep", "SPECIES", 324, 329], ["sheep embryo implantation", "TREATMENT", 76, 101], ["JSRV", "PROBLEM", 190, 194], ["a problematic sheep", "PROBLEM", 196, 215], ["retrovirus", "PROBLEM", 226, 236], ["lung tumors", "PROBLEM", 250, 261], ["lung", "ANATOMY", 250, 254], ["tumors", "OBSERVATION", 255, 261]]], ["The endogenous virus (enJSRV) is present in 20 copies in the sheep genome and all sheep have this virus.", [["enJSRV", "GENE_OR_GENE_PRODUCT", 22, 28], ["sheep", "ORGANISM", 61, 66], ["sheep", "ORGANISM", 82, 87], ["sheep genome", "DNA", 61, 73], ["sheep", "SPECIES", 61, 66], ["sheep", "SPECIES", 82, 87], ["sheep", "SPECIES", 61, 66], ["sheep", "SPECIES", 82, 87], ["The endogenous virus", "PROBLEM", 0, 20], ["this virus", "PROBLEM", 93, 103], ["endogenous", "OBSERVATION_MODIFIER", 4, 14], ["virus", "OBSERVATION", 15, 20]]], ["Sheep genomes also encoded a trans -dominant enJRSV gag that is inhibitory to exogenous JSRV ( Mura et al. , 2004 ; Oliveira et al. , 2006 ; Murcia et al. , 2007 ) .", [["Sheep", "ORGANISM", 0, 5], ["enJRSV", "GENE_OR_GENE_PRODUCT", 45, 51], ["JSRV", "ORGANISM", 88, 92], ["Sheep genomes", "DNA", 0, 13], ["trans -dominant enJRSV gag", "DNA", 29, 55], ["Sheep", "SPECIES", 0, 5], ["JSRV", "SPECIES", 88, 92]]], ["It seems clear that this situation can also be considered from the perspective of viral symbiosis and/or virus addiction in host evolution.", [["viral symbiosis", "PROBLEM", 82, 97], ["virus addiction", "PROBLEM", 105, 120], ["clear", "OBSERVATION", 9, 14], ["viral symbiosis", "OBSERVATION", 82, 97]]], ["We should thus seek to understand why colonization by an ERV population might generally provide a good solution to the evolutionary demands of placental biology.Open Questions Regarding Virus in Human EvolutionThere are many other opportunities to examine the potential role of persistent and symbiotic viruses in the evolution of viruses, animals, primates, and humans.", [["placental", "ANATOMY", 143, 152], ["ERV", "ORGANISM", 57, 60], ["placental", "ANATOMICAL_SYSTEM", 143, 152], ["Virus", "ORGANISM", 186, 191], ["Human", "ORGANISM", 195, 200], ["primates", "ORGANISM", 349, 357], ["humans", "ORGANISM", 363, 369], ["Human", "SPECIES", 195, 200], ["humans", "SPECIES", 363, 369], ["humans", "SPECIES", 363, 369], ["persistent and symbiotic viruses", "PROBLEM", 278, 310], ["viruses", "PROBLEM", 331, 338], ["persistent", "OBSERVATION_MODIFIER", 278, 288], ["symbiotic viruses", "OBSERVATION", 293, 310], ["viruses", "OBSERVATION", 331, 338]]], ["For example, as we seek to understand the origins of the adaptive immune system we should pay attention to viral footprints.", [["the adaptive immune system", "TREATMENT", 53, 79]]], ["We can ask, for example, why the major histocompatibility complex (MHC) locus, the most polymorphic, diverse, and rapidly evolving gene set in our chromosome, is so densely colonized with retroviral elements ( Andersson et al. , 1998 ) .", [["chromosome", "ANATOMY", 147, 157], ["chromosome", "CELLULAR_COMPONENT", 147, 157], ["retroviral", "ORGANISM", 188, 198], ["major histocompatibility complex (MHC) locus", "DNA", 33, 77], ["retroviral elements", "DNA", 188, 207], ["retroviral elements", "TREATMENT", 188, 207], ["most polymorphic", "OBSERVATION_MODIFIER", 83, 99], ["diverse", "OBSERVATION_MODIFIER", 101, 108], ["densely", "OBSERVATION_MODIFIER", 165, 172], ["colonized", "OBSERVATION", 173, 182], ["retroviral elements", "OBSERVATION", 188, 207]]], ["Why is a retrovirus also the basic element of the duplication unit that was thought to have been the progenitor for the expansion of the MHC class I (and II) genes ( Gaudieri et al. , 1997 ; Kulski et al. , 1998 Kulski et al. , , 2005 ?", [["MHC class I", "GENE_OR_GENE_PRODUCT", 137, 148], ["duplication unit", "DNA", 50, 66], ["MHC class I (and II) genes", "DNA", 137, 163], ["retrovirus", "OBSERVATION", 9, 19]]], ["Why do similar HERV element (L and 16) also differentiate between human and chimpanzee MHC I ( Watkins, 1995 ; Kulski et al. , 1999 ) ?", [["human", "ORGANISM", 66, 71], ["HERV element", "DNA", 15, 27], ["human", "SPECIES", 66, 71], ["human", "SPECIES", 66, 71]]], ["What was the role for SIV in the evolution of primate MHC ( Vogel et al. , 1999 ) ?", [["SIV", "ORGANISM", 22, 25], ["primate", "ORGANISM", 46, 53], ["primate MHC", "PROTEIN", 46, 57]]], ["Humans and primates appear to have undergone some signifi cant and relatively recent evolution with regard to their endogenous and exogeneous retroviruses.", [["Humans", "ORGANISM", 0, 6], ["primates", "ORGANISM", 11, 19], ["retroviruses", "ORGANISM", 142, 154], ["Humans", "SPECIES", 0, 6], ["some signifi cant", "PROBLEM", 45, 62], ["their endogenous and exogeneous retroviruses", "PROBLEM", 110, 154], ["exogeneous retroviruses", "OBSERVATION", 131, 154]]], ["Along these lines, APOBEC-like genes are basic component of the adaptive immune response but they are also antiretroviral genes that act on retroviral cDNA and gag ( OhAinle et al. , 2006 ) .", [["lines", "CELL", 12, 17], ["APOBEC", "GENE_OR_GENE_PRODUCT", 19, 25], ["retroviral", "ORGANISM", 140, 150], ["gag", "GENE_OR_GENE_PRODUCT", 160, 163], ["APOBEC-like genes", "DNA", 19, 36], ["antiretroviral genes", "DNA", 107, 127], ["retroviral cDNA", "DNA", 140, 155], ["gag", "DNA", 160, 163], ["APOBEC-like genes", "PROBLEM", 19, 36], ["antiretroviral genes", "TREATMENT", 107, 127], ["retroviral cDNA", "TEST", 140, 155], ["lines", "OBSERVATION", 12, 17], ["adaptive immune response", "OBSERVATION", 64, 88]]], ["The APOBEC3 antiviral system has expanded recently in humans, but not chimpanzees ( Sawyer et al. , 2004 ; OhAinle et al. , 2006 ) .", [["APOBEC3", "GENE_OR_GENE_PRODUCT", 4, 11], ["humans", "ORGANISM", 54, 60], ["chimpanzees", "ORGANISM", 70, 81], ["humans", "SPECIES", 54, 60], ["humans", "SPECIES", 54, 60], ["The APOBEC3 antiviral system", "TREATMENT", 0, 28], ["APOBEC3", "OBSERVATION", 4, 11], ["antiviral system", "OBSERVATION", 12, 28]]], ["All African primates support unapparent foamy viruses (and also SIV co-infection), but not humans ( Murray and Linial, 2006 ) .", [["infection", "DISEASE", 71, 80], ["primates", "ORGANISM", 12, 20], ["foamy viruses", "ORGANISM", 40, 53], ["SIV", "ORGANISM", 64, 67], ["humans", "ORGANISM", 91, 97], ["humans", "SPECIES", 91, 97], ["foamy viruses", "SPECIES", 40, 53], ["SIV", "SPECIES", 64, 67], ["humans", "SPECIES", 91, 97], ["foamy viruses", "PROBLEM", 40, 53], ["SIV co-infection", "PROBLEM", 64, 80], ["foamy viruses", "OBSERVATION", 40, 53], ["infection", "OBSERVATION", 71, 80]]], ["APOBEC3C is active against foamy viruses ( Delebecque et al. , 2006 ) .", [["APOBEC3C", "GENE_OR_GENE_PRODUCT", 0, 8], ["foamy viruses", "ORGANISM", 27, 40], ["APOBEC3C", "PROTEIN", 0, 8], ["foamy viruses", "SPECIES", 27, 40], ["active", "OBSERVATION_MODIFIER", 12, 18]]], ["Old World primates also underwent an expansion of ERVL colonization (a clear relative of foamy virus) ( Sawyer et al. , 2004 ) .", [["primates", "ORGANISM", 10, 18], ["ERVL", "GENE_OR_GENE_PRODUCT", 50, 54], ["foamy virus", "ORGANISM", 89, 100], ["foamy virus", "SPECIES", 89, 100], ["ERVL colonization", "PROBLEM", 50, 67], ["foamy virus", "PROBLEM", 89, 100], ["expansion", "OBSERVATION_MODIFIER", 37, 46], ["ERVL", "OBSERVATION_MODIFIER", 50, 54], ["colonization", "OBSERVATION", 55, 67]]], ["Was this ERVL colonization of relevance to the ancient co-speciation of simian foamy virus and their primate host ( Switzer et al. , 2005 ) ?", [["ERVL", "CANCER", 9, 13], ["simian foamy virus", "ORGANISM", 72, 90], ["simian foamy virus", "SPECIES", 72, 90], ["simian foamy virus", "SPECIES", 72, 90], ["simian foamy virus", "TREATMENT", 72, 90], ["foamy virus", "OBSERVATION", 79, 90]]], ["What exactly was the relevance of HERV endogenization to human survival and adaptations?Open Questions Regarding Virus in Human EvolutionCuriously, human brain (neocortex) specifically expresses many of these more recent ERVs as transcripts ( Nakamura et al. , 2003 ; Yi et al. , 2004 ) .", [["brain", "ANATOMY", 154, 159], ["neocortex", "ANATOMY", 161, 170], ["HERV", "ORGANISM", 34, 38], ["human", "ORGANISM", 57, 62], ["Virus", "ORGANISM", 113, 118], ["Human", "ORGANISM", 122, 127], ["human", "ORGANISM", 148, 153], ["brain", "ORGAN", 154, 159], ["neocortex", "CANCER", 161, 170], ["ERVs", "DNA", 221, 225], ["human", "SPECIES", 57, 62], ["Human", "SPECIES", 122, 127], ["human", "SPECIES", 148, 153], ["human", "SPECIES", 57, 62], ["human", "SPECIES", 148, 153], ["brain", "ANATOMY", 154, 159]]], ["If we consider these situations as possible examples of virus-mediated symbiosis in human evolution, perhaps they may make more sense of the otherwise confusing role or HERVs.REAL-TIME VIRUS-HOST EVOLUTION: KOALA BEAR EXEMPLARAs noted, all primates, but especially humans show much evidence of recent endogenization by retroviruses.", [["human", "ORGANISM", 84, 89], ["HERVs", "GENE_OR_GENE_PRODUCT", 169, 174], ["humans", "ORGANISM", 265, 271], ["retroviruses", "ORGANISM", 319, 331], ["human", "SPECIES", 84, 89], ["humans", "SPECIES", 265, 271], ["human", "SPECIES", 84, 89], ["humans", "SPECIES", 265, 271], ["virus", "PROBLEM", 56, 61], ["recent endogenization by retroviruses", "PROBLEM", 294, 331], ["endogenization", "OBSERVATION", 301, 315], ["retroviruses", "OBSERVATION", 319, 331]]], ["But these events mostly occurred in our extinct ancestors and we do not see ongoing evidence that any HERVs remain active.", [["HERVs", "GENE_OR_GENE_PRODUCT", 102, 107], ["these events", "PROBLEM", 4, 16], ["active", "OBSERVATION", 115, 121]]], ["However, we are currently witnessing a related virus-host evolutionary event of considerable interest.", [["a related virus", "PROBLEM", 37, 52]]], ["Koala bears, native marsupials of Australia, are currently experiencing a major epidemic caused by a leukemiainducing retrovirus.", [["leukemiainducing retrovirus", "ORGANISM", 101, 128], ["a leukemiainducing retrovirus", "PROBLEM", 99, 128], ["native", "OBSERVATION_MODIFIER", 13, 19], ["marsupials", "OBSERVATION_MODIFIER", 20, 30], ["Australia", "OBSERVATION_MODIFIER", 34, 43], ["leukemiainducing retrovirus", "OBSERVATION", 101, 128]]], ["As a consequence, they are undergoing massive endogenization by a gammaretrovirus (MLV-related).", [["MLV", "ORGANISM", 83, 86], ["massive endogenization", "PROBLEM", 38, 60], ["a gammaretrovirus", "PROBLEM", 64, 81], ["massive", "OBSERVATION_MODIFIER", 38, 45], ["endogenization", "OBSERVATION", 46, 60]]], ["This virus is similar to Gibbon ape leukemia virus, but most likely originated from rodent ancestry ( Tarlinton et al. , 2006 ; Fiebig et al. , 2006 ) .", [["Gibbon ape leukemia virus", "DISEASE", 25, 50], ["Gibbon ape leukemia virus", "ORGANISM", 25, 50], ["ape leukemia virus", "SPECIES", 32, 50], ["rodent", "SPECIES", 84, 90], ["Gibbon ape leukemia virus", "SPECIES", 25, 50], ["This virus", "PROBLEM", 0, 10], ["Gibbon ape leukemia virus", "PROBLEM", 25, 50], ["Gibbon ape leukemia virus", "OBSERVATION", 25, 50], ["most likely", "UNCERTAINTY", 56, 67]]], ["The expectation is that extinction awaits those koalas that do not adapt or endogenize the retrovirus successfully ( Stoye, 2006 ) .", [["retrovirus", "ORGANISM", 91, 101], ["retrovirus", "ANATOMY", 91, 101]]], ["This event has the appearances of a retroviral-driven addiction that will result in a genetic variant of koala bear that has acquired a new antiretroviral state.", [["retroviral", "ORGANISM", 36, 46], ["koala", "ORGANISM", 105, 110], ["a retroviral-driven addiction", "PROBLEM", 34, 63], ["a new antiretroviral state", "PROBLEM", 134, 160], ["retroviral", "OBSERVATION", 36, 46], ["new", "OBSERVATION_MODIFIER", 136, 139], ["antiretroviral state", "OBSERVATION", 140, 160]]], ["This seems equivalent to the expansion of human APOBEC3; or perhaps a closer analogy is the endogenization of a suppressive gag as occurred with enJSRV.", [["human", "ORGANISM", 42, 47], ["APOBEC3", "GENE_OR_GENE_PRODUCT", 48, 55], ["gag", "GENE_OR_GENE_PRODUCT", 124, 127], ["human APOBEC3", "PROTEIN", 42, 55], ["suppressive gag", "DNA", 112, 127], ["enJSRV", "PROTEIN", 145, 151], ["human", "SPECIES", 42, 47], ["human", "SPECIES", 42, 47], ["the expansion of human APOBEC3", "PROBLEM", 25, 55], ["a suppressive gag", "PROBLEM", 110, 127], ["expansion", "OBSERVATION_MODIFIER", 29, 38], ["human APOBEC3", "OBSERVATION", 42, 55], ["suppressive", "OBSERVATION_MODIFIER", 112, 123], ["gag", "OBSERVATION", 124, 127]]], ["The surviving koala bears will likely tolerate or be persistently infected with this retrovirus pool.", [["koala", "ORGANISM", 14, 19], ["retrovirus", "ORGANISM", 85, 95], ["this retrovirus pool", "TREATMENT", 80, 100], ["infected", "OBSERVATION", 66, 74]]], ["The genome of the species will have undergone considerable (but unpredictable) genetic perturbations and likely contain a large pool of variant and defective retrovirus.", [["genetic perturbations", "PROBLEM", 79, 100], ["a large pool of variant and defective retrovirus", "PROBLEM", 120, 168], ["large", "OBSERVATION_MODIFIER", 122, 127], ["pool of variant", "OBSERVATION", 128, 143], ["defective retrovirus", "OBSERVATION", 148, 168]]], ["However, in so doing, the descendent koalas will likely present a biological hazard to any koala species that remain virus-free (as in virus addiction).", [["koalas", "CANCER", 37, 43], ["koala", "ORGANISM", 91, 96], ["any koala species", "PROBLEM", 87, 104], ["virus", "PROBLEM", 117, 122]]], ["Currently, one island colony of koalas is suffi ciently isolated to have remained virus-free.", [["colony", "ANATOMY", 22, 28], ["koalas", "ANATOMY", 32, 38], ["koalas", "ORGANISM", 32, 38], ["virus", "PROBLEM", 82, 87], ["island", "OBSERVATION_MODIFIER", 15, 21], ["colony", "OBSERVATION", 22, 28], ["koalas", "OBSERVATION", 32, 38], ["virus", "OBSERVATION", 82, 87], ["free", "OBSERVATION_MODIFIER", 88, 92]]], ["This population will henceforth be under persistent threat from populations of endogenized koalas, now favored by group selection.", [["endogenized koalas", "PROBLEM", 79, 97]]], ["From the very earliest events in evolution of prebiotic replicators to very recent events in human evolution, including the emergence of human-specifi c HIV, we expect viral evolution to show profound effects on the evolution of all life.", [["human", "ORGANISM", 93, 98], ["human-specifi c HIV", "ORGANISM", 137, 156], ["human", "SPECIES", 93, 98], ["human", "SPECIES", 137, 142], ["HIV", "SPECIES", 153, 156], ["human", "SPECIES", 93, 98], ["human-specifi c HIV", "SPECIES", 137, 156], ["prebiotic replicators", "TREATMENT", 46, 67], ["HIV", "PROBLEM", 153, 156], ["profound effects", "PROBLEM", 192, 208]]], ["Unlike accepted host evolution, viruses also employ consortia and mixed populations to evolve, sometimes at unprecedented rates.", [["viruses", "PROBLEM", 32, 39], ["mixed populations", "PROBLEM", 66, 83], ["host evolution", "OBSERVATION", 16, 30]]], ["Thus viruses have informed us of quasispecies, group dynamics, and group selection in evolution.", [["quasispecies", "PROBLEM", 33, 45], ["viruses", "OBSERVATION", 5, 12]]], ["Virus evolution should now be considered as basic science, not just a medical concern.", [["Virus", "ORGANISM", 0, 5], ["Virus evolution", "PROBLEM", 0, 15]]]], "e387ff88edea33558d146489b90cb0be13d3a9a0": [["IPAG Business School Paris, FranceThe Environmental and Resource Economics special issue \"Economics of the Environment in the Shadow of Coronavirus\" comes at a hugely critical time for environmental economists and policy makers alike.", [["Coronavirus", "PROBLEM", 136, 147]]], ["We are in a situation of significant social change, a change that could potentially lay the foundation for mankind's future in the years to come.IPAG Business School Paris, FranceAs part of this special issue, ERE is trialling a novel, experimental form of article, drawing together short, focussed pieces from a wide group of authors addressing the plethora of issues which such a fundamental challenge as the coronavirus pandemic generates.", [["coronavirus", "DISEASE", 411, 422], ["coronavirus", "ORGANISM", 411, 422], ["ERE", "DNA", 210, 213], ["a fundamental challenge", "TREATMENT", 380, 403], ["significant", "OBSERVATION_MODIFIER", 25, 36], ["social", "OBSERVATION", 37, 43]]], ["These provide critical and reflective perspectives on the environmental, socio-economic and policy paths that may be taken in the near and further future-strategies that could lead mankind either on roads to a much more sustainable development, or along paths that could bring about more instability, inequality and further environmental pressures.", [["further environmental pressures", "TEST", 316, 347]]], ["This innovative article combines short, policy-relevant and less technical papers that deal with specific aspects and provide clear recommendations for policy makers and suggestions for future research alike.", [["policy makers", "TREATMENT", 152, 165]]], ["The target audiences are policy makers and companies, but also researchers who want quick yet sufficiently detailed knowledge about particular analyses relating to COVID-19 and issues in environmental economics.", [["COVID", "TEST", 164, 169], ["target", "OBSERVATION_MODIFIER", 4, 10], ["audiences", "OBSERVATION", 11, 20]]], ["We hope that the articles contained within this Perspectives collection provide the necessary information for policy makers to take wise decisions for our future, and for researchers the knowledge to help guide policy makers in their decisions.Pushing the Boundaries on Spaceship EarthHumankind has been very fortunate to have lived through a period of sustained economic growth pretty much since the agricultural revolution, with especially high rates of growth starting from the second half of the twentieth century.", [["the agricultural revolution", "TREATMENT", 397, 424]]], ["Many of us have been fortunate enough to have lived without a war for the past 70 years, which is widely believed to be due to the development of international institutions and a deepening of international trade that led to widespread cooperation and, with it, it brought a new era of global stability.Pushing the Boundaries on Spaceship EarthAt the same time, the rapid increases in humankind's population, from around 2 billion in 1930 to 7.8 billion in 2020, coupled with an increase in real-world GDP by a factor of roughly 40 during the same period, have led mankind to progressively push closer to the boundaries of planet Earth.", [["GDP", "CHEMICAL", 501, 504], ["GDP", "CHEMICAL", 501, 504], ["GDP", "SIMPLE_CHEMICAL", 501, 504], ["new", "OBSERVATION_MODIFIER", 274, 277], ["global stability", "OBSERVATION", 285, 301], ["rapid", "OBSERVATION_MODIFIER", 365, 370], ["increases", "OBSERVATION_MODIFIER", 371, 380], ["increase", "OBSERVATION_MODIFIER", 478, 486], ["planet Earth", "OBSERVATION", 622, 634]]], ["To provide additional food for the surge in population, agricultural land use has increased by 30%; to provide goods and services for the surge in demand, the material footprint of our production increased by an estimated factor of 40; and to provide energy for our lifestyles, our use of non-renewable and polluting resources (coal, oil, gas) increased by a factor of 8.", [["coal", "CHEMICAL", 328, 332], ["oil", "ORGANISM_SUBSTANCE", 334, 337]]], ["This increase in consumption coupled with a similar increase in input use has transformed the face of the planet Earth and has given rise to unwanted side effects and new challenges.Pushing the Boundaries on Spaceship EarthSome of these challenges are well known, such as local and global pollution, problems of waste and certainly climate change.", [["unwanted side effects", "PROBLEM", 141, 162], ["increase", "OBSERVATION_MODIFIER", 5, 13]]], ["Another, often neglected challenge, has been a consistent pressure on biodiversity due to our increase in land use.", [["a consistent pressure on biodiversity", "TREATMENT", 45, 82], ["pressure", "OBSERVATION_MODIFIER", 58, 66], ["increase", "OBSERVATION_MODIFIER", 94, 102]]], ["A mixture of burgeoning population and increasing resource use that carved deeply in nature's pristine areas has led to species conflict manifested not only in the rapid loss of other species, but also in a much ignored yet increasingly visible negative feedback in the form of viral crossovers (Smith et al. 2014 ).", [["burgeoning population", "TREATMENT", 13, 34], ["the rapid loss of other species", "PROBLEM", 160, 191], ["burgeoning", "OBSERVATION_MODIFIER", 13, 23], ["population", "OBSERVATION", 24, 34], ["increasing", "OBSERVATION_MODIFIER", 39, 49]]], ["The linkages between economic development, viral crossovers in the form of communicable diseases and environmental issues in particular have, up to now, seen little attention from environmental economists.A New Global Threat Enters the StageAs we have now seen, it was worryingly neglectful on our part to not consider these feedbacks more seriously.", [["communicable diseases", "DISEASE", 75, 96], ["viral crossovers", "PROBLEM", 43, 59], ["communicable diseases", "PROBLEM", 75, 96], ["environmental issues", "PROBLEM", 101, 121], ["linkages", "OBSERVATION_MODIFIER", 4, 12], ["economic", "OBSERVATION_MODIFIER", 21, 29], ["development", "OBSERVATION_MODIFIER", 30, 41], ["viral crossovers", "OBSERVATION", 43, 59], ["communicable diseases", "OBSERVATION", 75, 96], ["New", "OBSERVATION_MODIFIER", 207, 210], ["Global", "OBSERVATION_MODIFIER", 211, 217], ["Threat", "OBSERVATION", 218, 224], ["Stage", "OBSERVATION_MODIFIER", 236, 241]]], ["The greater interconnectedness via global trade and international migration, air travel for both tourism and business purposes, as well as the ongoing growth of large city hubs, have made it easy for communicable diseases to transcend local spaces and quickly make their appearance in even remote corners of the world.", [["communicable diseases", "PROBLEM", 200, 221], ["greater", "OBSERVATION_MODIFIER", 4, 11], ["interconnectedness", "OBSERVATION_MODIFIER", 12, 30], ["global", "OBSERVATION_MODIFIER", 35, 41], ["trade", "OBSERVATION_MODIFIER", 42, 47], ["migration", "OBSERVATION_MODIFIER", 66, 75], ["large", "OBSERVATION_MODIFIER", 161, 166]]], ["While the Black Death and the Spanish Flu have been among the worst communicable disease outbreaks in recent history, in late 2019 a new virus was detected in Wuhan, China.", [["Death", "DISEASE", 16, 21], ["Flu", "CHEMICAL", 38, 41], ["the Black Death", "PROBLEM", 6, 21], ["a new virus", "PROBLEM", 131, 142], ["new", "OBSERVATION_MODIFIER", 133, 136], ["virus", "OBSERVATION", 137, 142]]], ["Identified as a new member of the coronavirus family and subsequently called COVID-19, within the course of half a year this virus has spread out from the Huanan wet market in Wuhan across the whole world.", [["coronavirus", "ORGANISM", 34, 45], ["coronavirus", "SPECIES", 34, 45], ["this virus", "PROBLEM", 120, 130]]], ["Even inhabitants from otherwise remote places such as villages in Timbuktu, the Korubo and Yanomami tribes of the Amazon, the Navajo Nation of North America and the Arctic Inuit have already tested positive for Due to initial uncertainty surrounding both the impact of COVID-19 and its spread through society, many policy makers quickly decided to shut down interactions among individuals by restricting local, national and international mobility.", [["COVID", "TEST", 269, 274]]], ["These \"lockdowns\" had pervasive impacts on economic activity across the globe, with significant reductions in production, increases in unemployment, falls in international migration, diminished levels of international trade, significant increases in bankruptcy filings and large ripple effects down supply chains.", [["falls", "DISEASE", 149, 154], ["economic activity across the globe", "PROBLEM", 43, 77], ["significant reductions in production", "PROBLEM", 84, 120], ["falls in international migration", "PROBLEM", 149, 181], ["diminished levels of international trade", "PROBLEM", 183, 223], ["significant increases in bankruptcy filings", "PROBLEM", 225, 268], ["large ripple effects down supply chains", "PROBLEM", 273, 312], ["pervasive", "OBSERVATION_MODIFIER", 22, 31], ["impacts", "OBSERVATION_MODIFIER", 32, 39], ["globe", "ANATOMY", 72, 77], ["significant", "OBSERVATION_MODIFIER", 84, 95], ["reductions", "OBSERVATION_MODIFIER", 96, 106], ["increases", "OBSERVATION_MODIFIER", 122, 131], ["diminished", "OBSERVATION_MODIFIER", 183, 193], ["significant", "OBSERVATION_MODIFIER", 225, 236], ["increases", "OBSERVATION_MODIFIER", 237, 246], ["large", "OBSERVATION_MODIFIER", 273, 278], ["ripple", "OBSERVATION_MODIFIER", 279, 285]]], ["Relative impacts between developed and developing countries are still very much developing.", [["impacts", "OBSERVATION_MODIFIER", 9, 16]]], ["Globally, herd immunity is expected to take some time to develop if indeed it ever does.", [["herd", "ORGANISM_SUBDIVISION", 10, 14]]], ["A vaccine that has the potential to be potent and widely available may need at least another 1 or 2 years for development and broad deployment.", [["A vaccine", "TREATMENT", 0, 9], ["broad deployment", "TREATMENT", 126, 142]]], ["While reducing physical contacts to \"flatten the curve\" of disease and death has been the preferred policy to slow down the spread of the were advocating for.", [["death", "DISEASE", 71, 76], ["disease", "PROBLEM", 59, 66], ["death", "PROBLEM", 71, 76], ["disease", "OBSERVATION", 59, 66]]], ["In particular, the arguments forwarded support a strengthened focus on economic recovery that, first and foremost, should not undermine the green transition, while also, if possible, provide measures to advance the green transition.", [["green transition", "OBSERVATION", 215, 231]]], ["The articles then discuss the approaches and potential difficulties that policy makers will be faced with when being confronted with the precise means to implement these green recoveries.Approaches and Difficulties when Designing a Post-COVID-19 Green TransitionAs a first step, due to unprecedented levels of unemployment in places such as the USA and significant contractions to economic growth in most countries of the world, an important consideration is that the focus of the stimuli packages should be the economic recovery, i.e. to predominantly deal with the direct impact of the lockdowns on economic activity.", [["significant contractions", "PROBLEM", 353, 377], ["the stimuli packages", "TREATMENT", 477, 497]]], ["Once the virus is contained and the short-run recoveries are under way, then it is, however, important to quickly integrate longer-term factors into policy making (Borghesi and co-authors).", [["the virus", "PROBLEM", 5, 14], ["virus", "OBSERVATION", 9, 14]]], ["A more specific focus on furthering a green transition should only be placed once a certain level of economic recovery has been achieved.", [["a green transition", "TREATMENT", 36, 54]]], ["This is especially vital as the disruptions to supply chains can have fundamental and unpredictable consequences, as often even companies themselves are not fully aware of their complete supply chains.", [["the disruptions to supply chains", "PROBLEM", 28, 60]]], ["Cazcarro and co-authors estimate some of the impacts of these trade-related supply chains and, for example, show that the European demand changes due to COVID-19 have, in total, larger impacts on the rest of the world than on Europe itself.Approaches and Difficulties when Designing a Post-COVID-19 Green TransitionRequirements for successful green stimuli are that these policies are implemented in a clear and transparent manner (Rickels and Peterson).", [["Cazcarro", "TREATMENT", 0, 8], ["the European demand changes", "PROBLEM", 118, 145], ["COVID", "TEST", 153, 158], ["a Post-COVID-19 Green TransitionRequirements", "TREATMENT", 283, 327], ["successful green stimuli", "TREATMENT", 332, 356], ["larger", "OBSERVATION_MODIFIER", 178, 184], ["impacts", "OBSERVATION_MODIFIER", 185, 192]]], ["In this regard, Ing and Nicolai argue that companies are likely to prefer stimuli packages that are tight to some environmental efforts rather than to new environmental regulations.", [["stimuli packages", "TREATMENT", 74, 90]]], ["Several of the articles in this special issue draw particular attention to the fact that the green stimuli are not enough to successfully further a green transition.", [["the green stimuli", "TEST", 89, 106], ["green transition", "OBSERVATION", 148, 164]]], ["What is also necessary is to couple this with a price on carbon and a restructuring of the subsidies paying attention to both the green and fossil industry (Gawel and Lehmann).", [["carbon", "CHEMICAL", 57, 63], ["carbon", "CHEMICAL", 57, 63], ["carbon", "TREATMENT", 57, 63]]], ["A stronger social contract with a higher degree of citizen involvement will furthermore help gain public support but also strengthen social norms and thus decentralized internalization of externalities.Approaches and Difficulties when Designing a Post-COVID-19 Green TransitionLopez-Feldman and co-authors discuss the policy responses to COVID-19 with a focus on Latin America and argue that, to minimize the likely rebound effect, policies need to be much better coordinated.", [["public support", "TREATMENT", 98, 112], ["a Post-COVID-19 Green TransitionLopez-Feldman", "TREATMENT", 245, 290], ["rebound effect", "PROBLEM", 416, 430]]], ["We have seen that international cooperation quickly breaks down when a crisis looms, so that it would make sense to design international institutions with binding laws and penalties in case of non-compliance.New Implications for ResearchWhat we have seen so far is that COVID-19 has the potential to become a game changer when it comes to combining stimulus packages with the green transition.", [["COVID-19", "CHEMICAL", 270, 278], ["COVID-19", "CHEMICAL", 270, 278], ["a crisis looms", "PROBLEM", 69, 83], ["non-compliance", "PROBLEM", 193, 207], ["green transition", "OBSERVATION", 376, 392]]], ["While the articles contained in this special issue already provide many reasons for policy makers to push for green stimuli, they also clearly point out the difficulties associated with implementing these well.", [["green stimuli", "TEST", 110, 123]]], ["For example, Borghesi and co-authors discuss that during the COVID-19 crisis the Market Stability Reserve helped to stabilize the EU ETS price, but imperfectly.", [["the COVID", "TEST", 57, 66]]], ["On a different topic, Laude explains how the COVID-19 crisis has brought to light both advantages and problems with having local, short supply chains for food, and that there is a substantial lack of research directed towards the impact of crises on the agricultural sector.", [["local, short supply chains", "TREATMENT", 123, 149]]], ["Another example is a more cautionary tale and deals with the COVID-19 cases data.", [["the COVID", "TEST", 57, 66]]], ["Here, Cohen and co-authors show very clearly that researchers must be careful with simply using these data as there are many problems in the data collection processes, which differ across countries and also time.New Implications for ResearchAs a final remark, we would like to observe that this special issue not only comes at a very turbulent time for mankind in general, but it also comes at a special time for environmental economists in particular.", [["these data", "TEST", 96, 106], ["many problems in the data collection processes", "PROBLEM", 120, 166]]], ["The COVID-19 crisis gives the opportunity to invest significant amounts of money towards aiding the green transition, and the widespread public support is there.", [["The COVID", "TEST", 0, 9]]], ["We need to now be able to advise policy makers on efficient, reasonable and relevant policies that they may implement as part of the green stimuli packages.", [["the green stimuli packages", "TREATMENT", 129, 155]]], ["However, these policies also need to be well structured and grounded in good research.", [["good", "OBSERVATION_MODIFIER", 72, 76]]], ["The peer-reviewed articles in this special issue provide suggestions and articles with these features and will thus, hopefully, serve as a first benchmark in this endeavour.IntroductionIn this paper, we use a multisectoral and multiregional model of the world economy to evaluate the short-term effects that the COVID-19 crisis may have on environmental pressures and resource consumption (measured in terms of water, air emissions and materials extraction).", [["the short-term effects", "PROBLEM", 280, 302], ["the COVID", "TEST", 308, 317], ["environmental pressures", "TREATMENT", 340, 363], ["resource consumption", "TEST", 368, 388], ["air emissions", "TREATMENT", 418, 431], ["materials extraction", "TREATMENT", 436, 456]]], ["Specifically, we focus on the relationship between current and forecast changes in demand and mobility patterns in the EU27 + UK for 2020 and its effect on global resources through global supply chains.", [["global supply chains", "TREATMENT", 181, 201], ["supply chains", "OBSERVATION", 188, 201]]], ["This integrated analysis could answer urgent research questions: What are the short-term impacts on emissions and resource consumption of the current and predicted declines in final demand?", [["short-term", "OBSERVATION_MODIFIER", 78, 88]]], ["Do the impacts differ among environmental pressures?", [["environmental pressures", "TEST", 28, 51]]], ["How elastic are environmental responses to demand drops?", [["demand drops", "TREATMENT", 43, 55]]], ["On the basis of these short-term responses, what is the relationship between economic growth and environmental pressure?", [["environmental pressure", "TEST", 97, 119], ["environmental pressure", "OBSERVATION", 97, 119]]], ["Do these effects go beyond European countries through global supply chains?Computations and ResultsIn order to evaluate the short-term effects of changes in aggregated sectoral consumption and demand on environmental pressures, and their diffusion through global supply chains, we develop an environmentally extended multiregional input-output model (see Miller and Blair 2009, or recently Hubacek et al. 2016; Guan et al. 2020 ), using the EXIOBASE 3.7 database (Stadler et al. 2019) .", [["global supply chains", "TREATMENT", 54, 74], ["changes in aggregated sectoral consumption", "PROBLEM", 146, 188], ["environmental pressures", "TEST", 203, 226]]], ["We focus on water consumption (blue and green), mineral extraction and emissions (CO 2eq , SOx, NOx, NH 3 and CO).", [["NOx", "CHEMICAL", 96, 99], ["CO", "CHEMICAL", 82, 84], ["SOx", "CHEMICAL", 91, 94], ["NOx", "CHEMICAL", 96, 99], ["NH 3", "CHEMICAL", 101, 105], ["CO", "CHEMICAL", 110, 112], ["water", "SIMPLE_CHEMICAL", 12, 17], ["SOx", "SIMPLE_CHEMICAL", 91, 94], ["NOx", "SIMPLE_CHEMICAL", 96, 99], ["CO", "SIMPLE_CHEMICAL", 110, 112], ["mineral extraction", "TREATMENT", 48, 66]]], ["1 Sectoral changes in private consumption are estimated based on EC (2020b) and OECD (2020), assuming different sectoral sensitivities to the COVID-19 crisis.", [["EC", "CELL", 65, 67], ["EC", "CELL_TYPE", 65, 67], ["the COVID", "TEST", 138, 147], ["Sectoral", "OBSERVATION_MODIFIER", 2, 10]]], ["Specific details and the complete matching process can be found in online Appendix.", [["Appendix", "ANATOMY", 74, 82]]], ["Our results are as follows: Figure 1 shows the EU27 + UK (light blue bars) and global (dark blue bars) change in different environmental pressures associated with the shock to final demand and household mobility in EU27 + UK, as a consequence of the 2020 COVID-19 lockdown.", [["shock", "DISEASE", 167, 172], ["global (dark blue bars)", "PROBLEM", 79, 102], ["different environmental pressures", "TREATMENT", 113, 146], ["the shock", "PROBLEM", 163, 172], ["dark", "OBSERVATION", 87, 91], ["blue bars", "OBSERVATION", 92, 101], ["environmental pressures", "OBSERVATION", 123, 146]]], ["The expected percentage impacts are much larger in the EU27 + UK, as the simulation of final demand and mobility directly affects these countries, given the high level of intra-EU dependence.", [["intra-EU dependence", "PROBLEM", 171, 190], ["expected", "OBSERVATION_MODIFIER", 4, 12], ["percentage", "OBSERVATION_MODIFIER", 13, 23], ["impacts", "OBSERVATION", 24, 31], ["much", "OBSERVATION_MODIFIER", 36, 40], ["larger", "OBSERVATION_MODIFIER", 41, 47], ["mobility", "OBSERVATION_MODIFIER", 104, 112], ["intra-EU dependence", "OBSERVATION", 171, 190]]], ["However, the European lockdown also impacts foreign resources due to the interlinkages throughout the production chain.", [["foreign resources", "TREATMENT", 44, 61], ["the interlinkages throughout the production chain", "PROBLEM", 69, 118]]], ["In general, the largest decline happens to gas emissions, both in EU27 + UK and worldwide.", [["largest", "OBSERVATION_MODIFIER", 16, 23], ["decline", "OBSERVATION", 24, 31], ["gas emissions", "OBSERVATION", 43, 56]]], ["The average 7.8% fall in the aggregate of the three cited components of European final demand (households, government expenditure and investment, representing a 6.9% fall in total final demand) that globally represents a 1.6% decline, would involve a 0.4% decline in global water consumption and 1.3% in mineral extraction.", [["The average 7.8% fall", "PROBLEM", 0, 21], ["a 6.9% fall", "PROBLEM", 159, 170], ["a 1.6% decline", "PROBLEM", 219, 233], ["global water consumption", "TREATMENT", 267, 291], ["mineral extraction", "TREATMENT", 304, 322], ["average", "OBSERVATION_MODIFIER", 4, 11], ["7.8%", "OBSERVATION_MODIFIER", 12, 16]]], ["The global fall in emissions from the slowdown in economic activity and European mobility restrictions would be around 1.2% (CO 2eq ).", [["CO", "CHEMICAL", 125, 127], ["The global fall in emissions", "PROBLEM", 0, 28], ["European mobility restrictions", "TREATMENT", 72, 102], ["global", "OBSERVATION_MODIFIER", 4, 10], ["fall", "OBSERVATION", 11, 15], ["slowdown", "OBSERVATION_MODIFIER", 38, 46], ["economic", "OBSERVATION_MODIFIER", 50, 58], ["activity", "OBSERVATION_MODIFIER", 59, 67]]], ["Comparing the effect in EU27 + UK with the global impact, the percentage change runs from four times larger in Europe, in the case of water, to 14 times greater for CO 2eq emissions.", [["CO", "CHEMICAL", 165, 167], ["CO 2eq", "SIMPLE_CHEMICAL", 165, 171], ["the percentage change runs", "PROBLEM", 58, 84], ["percentage", "OBSERVATION_MODIFIER", 62, 72], ["change", "OBSERVATION", 73, 79], ["four times", "OBSERVATION_MODIFIER", 90, 100], ["larger", "OBSERVATION_MODIFIER", 101, 107]]], ["We find a drop of more than 5% for mineral extraction and emissions in EU27 + UK.Computations and ResultsEmissions are reduced, and by more than water and minerals.", [["water", "SIMPLE_CHEMICAL", 145, 150], ["mineral extraction", "TREATMENT", 35, 53], ["drop", "OBSERVATION_MODIFIER", 10, 14], ["reduced", "OBSERVATION_MODIFIER", 119, 126]]], ["Also, even when no direct electricity demand change is assumed, given the reduction in sector activity, indirect energy demand diminishes and so do emissions.", [["direct electricity demand change", "PROBLEM", 19, 51], ["the reduction in sector activity", "PROBLEM", 70, 102], ["indirect energy demand diminishes", "PROBLEM", 104, 137]]], ["In line with the results of Le Qu\u00e9r\u00e9 et al. (2020) , our estimates confirm that the reduction of emissions associated with private mobility restrictions would account for 30% 2 of the total fall in emissions in Europe, whereas the reduction linked to air travel reaches 10.5%.", [["the reduction of emissions", "PROBLEM", 80, 106], ["private mobility restrictions", "TREATMENT", 123, 152], ["the total fall", "PROBLEM", 180, 194]]], ["The European lockdown affects the iron and steel industries globally, representing 7% of the global fall in greenhouse emissions.Computations and ResultsSeveral other resources are less dependent on the most-affected sectors.", [["iron", "CHEMICAL", 34, 38], ["iron", "CHEMICAL", 34, 38], ["iron", "SIMPLE_CHEMICAL", 34, 38], ["the global fall in greenhouse emissions", "PROBLEM", 89, 128], ["global", "OBSERVATION_MODIFIER", 93, 99], ["fall", "OBSERVATION", 100, 104], ["greenhouse emissions", "OBSERVATION", 108, 128], ["less dependent", "OBSERVATION_MODIFIER", 181, 195]]], ["The supply chain of food clearly depends on the supply of water.", [["supply", "OBSERVATION_MODIFIER", 4, 10], ["chain", "OBSERVATION_MODIFIER", 11, 16]]], ["It is difficult to estimate the reductions in the HORECA sector based on the available data.", [["the available data", "TEST", 73, 91]]], ["That sector, as well as many others that indirectly require these natural factors throughout their supply chains, exhibits significant reductions in resource use.", [["significant", "OBSERVATION_MODIFIER", 123, 134], ["reductions", "OBSERVATION_MODIFIER", 135, 145]]], ["Our data show that the largest decline in water consumption (both blue and green) is associated with the primary sectors, which, as expected, experience slight negative growth rates around \u2212 0.3%, given the relatively stable and anticyclical nature of food demand.Computations and ResultsAnalysing the changes induced by the different components of final demand, 3 the decrease in household consumption and investment drives environmental impacts to a lesser extent.", [["water", "SIMPLE_CHEMICAL", 42, 47], ["Our data", "TEST", 0, 8], ["the largest decline in water consumption", "PROBLEM", 19, 59], ["slight negative growth rates", "PROBLEM", 153, 181], ["largest", "OBSERVATION_MODIFIER", 23, 30], ["decline", "OBSERVATION_MODIFIER", 31, 38], ["water consumption", "OBSERVATION_MODIFIER", 42, 59], ["slight", "OBSERVATION_MODIFIER", 153, 159], ["negative", "OBSERVATION_MODIFIER", 160, 168], ["growth", "OBSERVATION_MODIFIER", 169, 175], ["rates", "OBSERVATION_MODIFIER", 176, 181], ["stable", "OBSERVATION_MODIFIER", 218, 224], ["food demand", "OBSERVATION", 252, 263], ["decrease", "OBSERVATION_MODIFIER", 369, 377], ["lesser extent", "OBSERVATION_MODIFIER", 452, 465]]], ["Reductions in investment have a larger role in reducing emissions in small countries like Croatia and Malta, and also in Eastern Europe, such as in Hungary, Latvia, and Slovenia.", [["larger", "OBSERVATION_MODIFIER", 32, 38], ["small", "OBSERVATION_MODIFIER", 69, 74]]], ["In the EU27 + UK, household consumption is the most significant element of final demand driving the changes in environmental pressures (with the exception of mineral extraction), explaining 45% of the European greenhouse gas emissions fall.", [["environmental pressures", "TREATMENT", 111, 134], ["mineral extraction", "TREATMENT", 158, 176], ["gas emissions", "OBSERVATION", 221, 234]]], ["As for minerals, their strong dependency on gross capital formation destinations, such as construction, manufacture of machinery and equipment, computer and related activities, explains that the 2.7% fall in investment worldwide (-15.3% in EU27 + UK) triggers a 1.1% drop in their global extraction (\u2212 4.6% in Europe).Computations and ResultsThese changes are distinct by country, with implications for different areas of the world.", [["a 1.1% drop", "PROBLEM", 260, 271], ["their global extraction", "TREATMENT", 275, 298], ["capital formation", "OBSERVATION", 50, 67]]], ["The intra-EU trade is revealed to be highly important, showing that the main changes occur within the EU27 + UK countries (even if the individual shock of a given country is not so significant).", [["shock", "DISEASE", 146, 151], ["main", "OBSERVATION_MODIFIER", 72, 76]]], ["Figure 2 displays the percentage falls in CO 2eq , SO X , NO X and NH 3 emissions by EU27 + UK country.", [["NO", "CHEMICAL", 58, 60], ["CO 2eq", "CHEMICAL", 42, 48], ["SO X", "CHEMICAL", 51, 55], ["NO X", "CHEMICAL", 58, 62], ["NH 3", "CHEMICAL", 67, 71], ["CO 2eq", "SIMPLE_CHEMICAL", 42, 48], ["NO X", "SIMPLE_CHEMICAL", 58, 62], ["the percentage falls", "PROBLEM", 18, 38]]], ["According to the projected changes, the greatest cuts are expected in CO 2eq emissions.Computations and ResultsAlmost a quarter of the estimated reduction in CO 2eq emissions occur in Germany (Figure SI 2) .", [["CO", "CHEMICAL", 70, 72], ["CO", "CHEMICAL", 158, 160], ["CO 2eq", "SIMPLE_CHEMICAL", 70, 76], ["CO 2eq", "SIMPLE_CHEMICAL", 158, 164], ["the estimated reduction", "TREATMENT", 131, 154], ["greatest", "OBSERVATION_MODIFIER", 40, 48]]], ["The reductions in CO 2eq emissions in smaller economies, such as Ireland, Austria, Greece, and Cyprus exhibit the largest percentage falls.", [["CO", "CHEMICAL", 18, 20], ["CO 2eq", "SIMPLE_CHEMICAL", 18, 24], ["The reductions", "PROBLEM", 0, 14], ["reductions", "OBSERVATION_MODIFIER", 4, 14], ["smaller", "OBSERVATION_MODIFIER", 38, 45], ["economies", "OBSERVATION_MODIFIER", 46, 55], ["largest", "OBSERVATION_MODIFIER", 114, 121], ["percentage falls", "OBSERVATION", 122, 138]]], ["Reductions in Mediterranean and Eastern countries are high, mainly in large countries like France, Romania, Portugal, and Spain.Computations and ResultsWe note the potential reduction in NO X emissions as a consequence of the production shutdown in France and Germany (as it occurs with NH 3 emissions), but the largest percentage drops occur in smaller economies, like Austria, Ireland, and Greece.", [["NO", "CHEMICAL", 187, 189], ["NO X", "CHEMICAL", 187, 191], ["NH 3", "CHEMICAL", 287, 291], ["NO X", "SIMPLE_CHEMICAL", 187, 191], ["Mediterranean", "OBSERVATION_MODIFIER", 14, 27], ["high", "OBSERVATION_MODIFIER", 54, 58], ["large", "OBSERVATION_MODIFIER", 70, 75], ["largest", "OBSERVATION_MODIFIER", 312, 319], ["percentage", "OBSERVATION_MODIFIER", 320, 330], ["drops", "OBSERVATION", 331, 336], ["smaller", "OBSERVATION_MODIFIER", 346, 353], ["economies", "OBSERVATION_MODIFIER", 354, 363]]], ["France also shows the highest reductions in SO X emissions, together with Poland and Germany, Ireland and smaller countries.Computations and ResultsOur model also allows us to evaluate how the reduction in the EU27 + UK demand modifies the pressures on environmental resources outside Europe, by considering transmission effects through global supply chains.", [["global supply chains", "TREATMENT", 337, 357], ["highest", "OBSERVATION_MODIFIER", 22, 29], ["reductions", "OBSERVATION_MODIFIER", 30, 40], ["smaller", "OBSERVATION_MODIFIER", 106, 113], ["pressures", "OBSERVATION_MODIFIER", 240, 249], ["supply chains", "OBSERVATION", 344, 357]]], ["The largest percentage reduction in domestic impacts arising from the lockdown and subsequent situations in Europe occurs in non-European developed countries, with smaller effects in developing economies (Fig. 3) .Computations and ResultsWe find considerable indirect declines in mineral extraction (larger than 4%) and gas emissions (between \u2212 0.8 and \u2212 2.1%) in the USA and Japan.", [["mineral", "SIMPLE_CHEMICAL", 280, 287], ["The largest percentage reduction", "PROBLEM", 0, 32], ["domestic impacts", "PROBLEM", 36, 52], ["mineral extraction", "TREATMENT", 280, 298], ["gas emissions", "TEST", 320, 333], ["\u2212", "TEST", 343, 344], ["largest", "OBSERVATION_MODIFIER", 4, 11], ["percentage", "OBSERVATION_MODIFIER", 12, 22], ["reduction", "OBSERVATION_MODIFIER", 23, 32], ["domestic", "OBSERVATION_MODIFIER", 36, 44], ["impacts", "OBSERVATION_MODIFIER", 45, 52], ["smaller", "OBSERVATION_MODIFIER", 164, 171], ["effects", "OBSERVATION_MODIFIER", 172, 179], ["economies", "OBSERVATION_MODIFIER", 194, 203]]], ["In countries such as China, Brazil and India, none of the falls in environmental pressure exceeds 0.6% (with the exception of a 1% fall in mineral extraction in India).", [["falls", "DISEASE", 58, 63], ["the falls", "PROBLEM", 54, 63], ["a 1% fall in mineral extraction", "TREATMENT", 126, 157]]], ["These results support the statements of Baldwin and Mauro (2020) on the existence of a \"supply-chain contagion\" related to the COVID-19 lockdown (in Europe in this study).", [["COVID-19 lockdown", "DNA", 127, 144], ["this study", "TEST", 159, 169]]], ["However, the \"environmental supply-chain contagion\" is modest outside the EU27 + UK.ConclusionsOne of the main implications of our work is that the changes occurring in 2020 in the EU27 + UK are not, in and of themselves, able to sufficiently reduce global environmental pressures.", [["UK", "GENE_OR_GENE_PRODUCT", 188, 190], ["main", "OBSERVATION_MODIFIER", 106, 110], ["environmental pressures", "OBSERVATION", 257, 280]]], ["These changes have entailed reductions in domestic activities, which have also affected other EU partners, given the high level of intra-EU trade.", [["reductions", "OBSERVATION_MODIFIER", 28, 38], ["domestic activities", "OBSERVATION", 42, 61]]], ["Although some of those changes do not have strong impacts on domestic environmental pressures, transport restrictions within the EU have notably reduced CO 2eq emissions and, even more positively, reduced other pollution-induced health damage.", [["CO", "CHEMICAL", 153, 155], ["domestic environmental pressures", "TREATMENT", 61, 93], ["reduced CO 2eq emissions", "PROBLEM", 145, 169], ["health damage", "OBSERVATION", 229, 242]]], ["Changes outside Europe occur due to spillover effects, being relatively more notable for minerals.", [["spillover effects", "PROBLEM", 36, 53], ["spillover", "OBSERVATION", 36, 45]]], ["However, the demand for goods, which ultimately depends on resource use and pressures external to the EU27 + UK, has not fallen so clearly, and the lion's share of the pressures has not been reduced as much as final demand.", [["pressures", "TEST", 76, 85], ["the pressures", "TEST", 164, 177], ["pressures", "OBSERVATION", 168, 177], ["reduced", "OBSERVATION_MODIFIER", 191, 198]]], ["In short, we have shown the importance of intersectoral relationships and multipliers to understand demand changes, which are uncertain along 2020, and which weThe European Green Deal, Sustainability, Carbon Neutrality and COVID-19Anastasios Xepapadeas 4Athens University of Economics and Business and University of BolognaOn 19 December 2019, the European Commission presented The European Green Deal (EGD 2019)-a roadmap for making the EU's economy sustainable by turning climate and environmental challenges into opportunities across all policy areas, and making the transition just and inclusive for all.", [["Carbon", "CHEMICAL", 201, 207], ["Carbon Neutrality", "TEST", 201, 218], ["COVID", "TEST", 223, 228], ["EGD", "TEST", 403, 406], ["the EU's economy", "TREATMENT", 434, 450]]], ["The central objective of the EGD is to attain a climate neutral EU by 2050, which means that the EU will aim to reach net-zero greenhouse gas emissions by that year.", [["the EGD", "TEST", 25, 32], ["central", "OBSERVATION_MODIFIER", 4, 11]]], ["The actions required to reach this target include decarbonizing the energy sector, which accounts for more than 75% of the EU's greenhouse gas emissions; renovating buildings to help reduce energy use which currently accounts for 40% of the EU's energy consumption; supporting industry so it can innovate and become a global leader in the green economy; and promoting cleaner transport, which constitutes an important source of the EU's emissions.", [["renovating buildings", "TREATMENT", 154, 174], ["green economy", "OBSERVATION", 339, 352]]], ["Furthermore, the EGD encompasses the so-called just transition mechanism whose objective is to help reduce the negative impacts on coal mines or steel factories associated with decarbonization.Athens University of Economics and Business and University of BolognaThe roadmap for the EGD includes actions related to climate ambition, clean energy, circular economy, smart mobility, greening the common agricultural policy, preserving and protecting biodiversity, and attaining a toxic-free environment and was planned to commence during the spring of 2020.Athens University of Economics and Business and University of BolognaThe COVID-19 pandemic which appeared in Europe in early 2020, and the containment measures taken in order to control the pandemic and reduce the transmissibility of the virusthe R 0 6 -below 1, have had a profound impact on the economy.", [["coal", "CHEMICAL", 131, 135], ["the EGD", "TEST", 13, 20], ["coal mines", "TREATMENT", 131, 141], ["decarbonization", "TREATMENT", 177, 192], ["the EGD", "TEST", 278, 285], ["The COVID", "TEST", 623, 632], ["the containment measures", "TREATMENT", 689, 713], ["profound", "OBSERVATION_MODIFIER", 828, 836], ["impact", "OBSERVATION", 837, 843]]], ["7 In terms of macroeconomics, the COVID-19 shock on the economy can be regarded as a Keynesian supply shock in a multi-sector economy which triggers shortages in aggregate demand larger than the shocks themselves (Guerrieri et al. 2020) .", [["shock", "DISEASE", 43, 48], ["shock", "DISEASE", 102, 107], ["macroeconomics", "TEST", 14, 28], ["the COVID", "TEST", 30, 39], ["a Keynesian supply shock", "PROBLEM", 83, 107], ["larger", "OBSERVATION_MODIFIER", 179, 185]]], ["Policies to deal with immediate impacts of COVID-19 are aimed at a fast recovery from the recession, so that the policies are designed and implemented in a short-run context.Athens University of Economics and Business and University of BolognaThe question which this note seeks to explore is whether the policies undertaken as a response to COVID-19 could have long-run implications-positive or negative-in terms of sustainability and the objective of carbon neutrality.", [["COVID-19", "CHEMICAL", 43, 51], ["COVID-19", "CHEMICAL", 341, 349], ["carbon", "CHEMICAL", 452, 458], ["COVID", "TEST", 341, 346], ["carbon neutrality", "PROBLEM", 452, 469], ["carbon neutrality", "OBSERVATION", 452, 469]]], ["Comprehensive wealth is the value of the assets 8 of an economy, with the asset base or productive base consisting of reproducible capital, natural capital, human capital and health capital.", [["human", "ORGANISM", 157, 162], ["human", "SPECIES", 157, 162], ["human", "SPECIES", 157, 162], ["productive", "OBSERVATION_MODIFIER", 88, 98], ["base", "ANATOMY_MODIFIER", 99, 103], ["reproducible", "OBSERVATION_MODIFIER", 118, 130], ["capital", "OBSERVATION", 131, 138], ["natural capital", "OBSERVATION", 140, 155]]], ["Social capital can also be included in the productive base.", [["capital", "OBSERVATION", 7, 14], ["base", "ANATOMY_MODIFIER", 54, 58]]], ["Thus, the issue of sustainability can be analysed in terms of non-declining comprehensive wealth or productive base.", [["productive", "OBSERVATION_MODIFIER", 100, 110], ["base", "OBSERVATION_MODIFIER", 111, 115]]], ["9 The implications of the COVID-19 shock on sustainability should therefore be examined in the context of its impacts on the productive base of an economy.", [["shock", "DISEASE", 35, 40], ["the COVID-19 shock on sustainability", "TREATMENT", 22, 58], ["impacts", "OBSERVATION", 110, 117], ["productive", "OBSERVATION_MODIFIER", 125, 135], ["base", "OBSERVATION_MODIFIER", 136, 140], ["economy", "OBSERVATION", 147, 154]]], ["The impact of COVID-19 on the productive base is realized directly through morbidity and mortality and indirectly through the recession that is induced by policies implemented to contain the pandemic and the positive effects of public spending aimed at recovery.", [["COVID-19", "CHEMICAL", 14, 22], ["COVID", "TREATMENT", 14, 19], ["the pandemic", "PROBLEM", 187, 199], ["recession", "OBSERVATION", 126, 135]]], ["6 R 0 is the basic reproduction number which is defined as the average number of secondary infections produced when one infected individual is introduced into a host population where everyone is susceptible.", [["infections", "DISEASE", 91, 101], ["secondary infections", "PROBLEM", 81, 101], ["average", "OBSERVATION_MODIFIER", 63, 70], ["number", "OBSERVATION_MODIFIER", 71, 77], ["secondary", "OBSERVATION_MODIFIER", 81, 90], ["infections", "OBSERVATION", 91, 101]]], ["In a fully susceptible population, an infection can get started if and only if R 0 > 1.", [["infection", "DISEASE", 38, 47], ["an infection", "PROBLEM", 35, 47], ["susceptible", "OBSERVATION_MODIFIER", 11, 22], ["population", "OBSERVATION", 23, 33], ["infection", "OBSERVATION", 38, 47]]], ["If R 0 < 1, a typical infective replaces itself with less than one infective, and the number of infectives tends to zero with the passage of time (e.g. Hethcote 2000) .", [["a typical infective replaces", "PROBLEM", 12, 40], ["one infective", "PROBLEM", 63, 76], ["infectives", "PROBLEM", 96, 106], ["infective", "OBSERVATION", 22, 31], ["infective", "OBSERVATION", 67, 76]]], ["7 See, for example, the World Economic Outlook (IMF, 2020) in which the projection for the percentage change in output in the Euro Area in 2020 is \u2212 7.5% with a rebound to + 4.7% in 2021.", [["the percentage change in output", "PROBLEM", 87, 118], ["a rebound", "TEST", 159, 168], ["output", "OBSERVATION_MODIFIER", 112, 118]]], ["It should be noted, however, that in the current world of deep uncertainty, these predictions could be inaccurate.", [["deep uncertainty", "OBSERVATION", 58, 74]]], ["Greenstone and Nigam (2020) indicate that moderate distancing policies have substantial economic benefits in terms of mortality benefits and avoided hospital Intensive Care Unit costs.", [["moderate", "OBSERVATION_MODIFIER", 42, 50]]], ["Thus, the virus does not destroy reproducible capital per se, but it reduces its utilization through containment policies.", [["the virus", "PROBLEM", 6, 15], ["virus", "OBSERVATION", 10, 15], ["reproducible", "OBSERVATION_MODIFIER", 33, 45], ["capital", "OBSERVATION", 46, 53]]], ["However, the pandemic could affect capital accumulation if the recession slows down investment in reproducible capital.", [["capital accumulation", "PROBLEM", 35, 55], ["the recession", "PROBLEM", 59, 72], ["recession", "OBSERVATION", 63, 72], ["reproducible", "OBSERVATION_MODIFIER", 98, 110], ["capital", "OBSERVATION_MODIFIER", 111, 118]]], ["COVID-19 seems to be beneficial for natural capital, at least in the short run.", [["COVID-19", "CHEMICAL", 0, 8], ["COVID", "TEST", 0, 5]]], ["Coal use fell by 40% at China's six largest power plants between the last quarter of 2019 and March 2020, while in Europe satellite images showed nitrogen dioxide (NO 2 ) emissions fading away over northern Italy, with a similar picture in Spain and the UK (Henriques 2020) .", [["nitrogen dioxide", "CHEMICAL", 146, 162], ["NO", "CHEMICAL", 164, 166], ["nitrogen dioxide", "CHEMICAL", 146, 162], ["NO 2", "CHEMICAL", 164, 168], ["nitrogen dioxide", "SIMPLE_CHEMICAL", 146, 162], ["nitrogen dioxide", "TEST", 146, 162], ["nitrogen dioxide", "OBSERVATION", 146, 162]]], ["According to a recent International Energy Agency (2020) report, global CO 2 emissions are expected to decline during 2020 to 30.6 GtCO 2 , which is 8.3% lower than in 2019 (36.8 GtCO 2 ) (Global Carbon Project 2019).", [["CO 2", "CHEMICAL", 72, 76], ["Carbon", "CHEMICAL", 196, 202], ["global CO 2 emissions", "PROBLEM", 65, 86], ["GtCO", "TEST", 131, 135]]], ["This would be the lowest level since 2010, and six times larger than the previous record reduction of 0.4 Gt in 2009 due to the financial crisis.Athens University of Economics and Business and University of BolognaHowever, the International Energy Agency (2020) report also indicates that if efforts to contain the virus and restart economies are more successful, the decrease in energy demand could be limited to less than 4%.", [["the financial crisis", "PROBLEM", 124, 144], ["the virus", "PROBLEM", 311, 320], ["restart economies", "TREATMENT", 325, 342], ["the decrease in energy demand", "PROBLEM", 364, 393], ["decrease", "OBSERVATION_MODIFIER", 368, 376], ["energy demand", "OBSERVATION", 380, 393]]], ["Since the International Energy Agency's (2020) April report, data show signs of a recovery in carbon emissions.", [["carbon", "CHEMICAL", 94, 100], ["carbon", "SIMPLE_CHEMICAL", 94, 100], ["a recovery in carbon emissions", "PROBLEM", 80, 110], ["carbon emissions", "OBSERVATION", 94, 110]]], ["A very recent reportin June 2020-states that new data show a V-shaped recovery in carbon emissions, with carbon emissions declining from February 2020, reaching a minimum in April and then recovering slowly towards the February levels (Domjan 2020) .Athens University of Economics and Business and University of BolognaRegarding human capital, defined in terms of changes in the work force and education level, the pandemic is having a short-term negative effect on work force, but in the long term it might change educational patterns and the geographical structure of the supply of education if extensive on-line teaching is established.", [["carbon", "CHEMICAL", 82, 88], ["carbon", "CHEMICAL", 105, 111], ["carbon", "SIMPLE_CHEMICAL", 82, 88], ["human", "ORGANISM", 329, 334], ["human", "SPECIES", 329, 334], ["human", "SPECIES", 329, 334], ["carbon emissions", "TREATMENT", 105, 121], ["-line teaching", "TREATMENT", 609, 623], ["carbon emissions", "OBSERVATION", 82, 98], ["short-term negative effect", "OBSERVATION_MODIFIER", 436, 462]]], ["Thus, policies to start up the economy after appropriate containment of the pandemic and return to long-term desired growth paths will be beneficial for productive-based sustainability components such as health, human and social capital and reproducible capital through the increase in its utilization.Athens University of Economics and Business and University of BolognaThe issue of primary interest is the impact of recovery-related policies on natural capital and climate change.", [["human", "ORGANISM", 212, 217], ["human", "SPECIES", 212, 217], ["human", "SPECIES", 212, 217], ["the pandemic", "PROBLEM", 72, 84], ["productive-based sustainability components", "PROBLEM", 153, 195], ["reproducible", "OBSERVATION_MODIFIER", 241, 253], ["capital", "OBSERVATION", 254, 261], ["increase", "OBSERVATION_MODIFIER", 274, 282]]], ["This issue relates to the way in which the EGD might be adjusted during the start-up period and whether the current beneficial impact of the virus-induced recession on emissions signals a long-term impact.Athens University of Economics and Business and University of BolognaRecent results in climate science have established an approximately proportional relationship between the change in the global average surface temperature relative to the preindustrial period (the temperature anomaly) and cumulative CO 2 emissions relative to the same base period (e.g. Matthews et al. 2009 ).", [["surface", "ANATOMY", 409, 416], ["CO 2", "CHEMICAL", 507, 511], ["the EGD", "TEST", 39, 46], ["the virus", "PROBLEM", 137, 146], ["induced recession", "PROBLEM", 147, 164], ["a long-term impact", "PROBLEM", 186, 204], ["the temperature anomaly", "PROBLEM", 467, 490], ["cumulative CO 2 emissions", "PROBLEM", 496, 521], ["long-term impact", "OBSERVATION_MODIFIER", 188, 204], ["change", "OBSERVATION_MODIFIER", 380, 386], ["global", "OBSERVATION_MODIFIER", 394, 400], ["average", "OBSERVATION_MODIFIER", 401, 408], ["surface", "OBSERVATION_MODIFIER", 409, 416]]], ["With cumulative emissions since 1850 being approximately 2400 \u00b1 240 GtCO 2 (Friedlingtein et al. 2019) , the expected reduction of approximately 6.2 GtCO 2 relative to 2019 due to the COVID-related recession 10 will have negligible effects on the temperature anomaly.", [["the COVID-related recession", "PROBLEM", 180, 207], ["the temperature anomaly", "PROBLEM", 243, 266]]], ["Furthermore, if the recovery projections in 2021 are realized, then it is reasonable to expect that the pre-pandemic situation will reemerge with regard to greenhouse gas emissions, unless the pandemic continues in strong recurring waves which make extended and persistent lockdowns necessary.", [["the pre-pandemic situation", "PROBLEM", 100, 126], ["greenhouse gas emissions", "TEST", 156, 180], ["the pandemic", "PROBLEM", 189, 201]]], ["If emissions recover in the short or even medium term, the projected time period for crossing the 1.5 \u00b0C threshold-according to the business-as-usual or alternative emissions paths-will not be affected in a significant way (IPCC 2018) .Athens University of Economics and Business and University of BolognaIn this context, the COVID-19 event is expected to have a negative impact on the global productive base (health, human, social and reproducible capital) and therefore on the global sustainability conditions, while the seemingly beneficial impact on natural capital, and especially climate, will be temporary and a return to pre-pandemic paths is most likely.", [["human", "ORGANISM", 418, 423], ["human", "SPECIES", 418, 423], ["human", "SPECIES", 418, 423], ["emissions", "PROBLEM", 3, 12], ["crossing the 1.5 \u00b0C threshold", "TREATMENT", 85, 114], ["negative", "OBSERVATION", 363, 371], ["global", "OBSERVATION_MODIFIER", 386, 392], ["productive", "OBSERVATION_MODIFIER", 393, 403], ["base", "OBSERVATION_MODIFIER", 404, 408], ["most likely", "UNCERTAINTY", 651, 662]]], ["This means that in the post-pandemic world, risks related to climate change damages, including risks from tipping elements and crossing of climate thresholds, are not expected to change.Athens University of Economics and Business and University of BolognaHow does this picture fit with the European response to COVID-19 in the context of the EGD?", [["COVID-19", "CHEMICAL", 311, 319], ["climate change damages", "PROBLEM", 61, 83], ["tipping elements", "PROBLEM", 106, 122], ["COVID", "TEST", 311, 316], ["the EGD", "TEST", 338, 345]]], ["The EU is currently developing and implementing a number of policies and stimulus packages to address the recession.", [["stimulus packages", "TREATMENT", 73, 90], ["the recession", "PROBLEM", 102, 115], ["recession", "OBSERVATION", 106, 115]]], ["The purpose of this note is not to analyse these measures, but rather to explore induced adjustments to the EGD.Athens University of Economics and Business and University of BolognaIt has been reported that there will be some reprioritization of EDG initiatives as a result of the EU response to the pandemic (Involved in Europe 2020).", [["the EGD", "TEST", 104, 111], ["EDG initiatives", "TREATMENT", 246, 261]]], ["Some of the initiatives such as the renewed sustainable financial strategy, which aims to increase private investment in sustainable projects, or the \"renovation wave\", will remain since they are expected to stimulate economic activity; others such as \"offshore renewable energy\" or \"the biodiversity strategy for 2030\" might be delayed, but initiatives such as the new EU Strategy on Adaptation to Climate Change and the new EU Forest Strategy will be delayed to 2021.Athens University of Economics and Business and University of BolognaIt is clear that the COVID-19 shock and the need to start up the economy will make substantial policy changes necessary.", [["shock", "DISEASE", 568, 573], ["the COVID", "TEST", 555, 564], ["substantial policy changes", "TREATMENT", 621, 647]]], ["Looking at sustainability in terms of natural capital and the environment, it should be clear that any short-run improvement is transient, while looking at sustainability in terms of climate change, it is most likely that there will be no change in the long-term trends.", [["change in the long-term trends", "PROBLEM", 239, 269], ["most likely", "UNCERTAINTY", 205, 216]]], ["What is important is that, after the shock, the start-up will be based on environmentally friendly policies.Athens University of Economics and Business and University of BolognaThus, maintaining initiatives such as the renovation wave, or promoting the pillar of cleaner transport, is important.", [["shock", "DISEASE", 37, 42], ["the shock", "PROBLEM", 33, 42], ["pillar", "OBSERVATION_MODIFIER", 253, 259]]], ["This is because the rationale behind delaying such strategies seems to be that recovery from the recession is expected to be rapid and therefore the delays will be of short duration and no significant time will be lost.Athens University of Economics and Business and University of BolognaHowever, recovery might be impeded or delayed by issues such as new, possibly weaker waves of the pandemic or more technical issues such as fiscal multipliers.", [["the pandemic", "PROBLEM", 382, 394], ["recession", "OBSERVATION", 97, 106]]], ["Fiscal multipliers during a recession when shocks are concentrated in certain sectors are not expected to be operational, with the multiplier for government spending being around one and the multiplier for transfers likely less than one.", [["Fiscal multipliers", "PROBLEM", 0, 18], ["a recession", "PROBLEM", 26, 37]]], ["These factors might result in the delays-initially projected to be of short duration-extending for a much longer period.Athens University of Economics and Business and University of BolognaThe important point here is that the COVID-19 shock will have a negligible effect on the evolution of the temperature anomaly.", [["shock", "DISEASE", 235, 240], ["the COVID-19 shock", "TREATMENT", 222, 240], ["the temperature anomaly", "PROBLEM", 291, 314], ["anomaly", "OBSERVATION", 307, 314]]], ["Thus, if adaptation activities and decarbonization do not proceed rapidly, the risks of a climate shock will not be sufficiently mitigated.", [["shock", "DISEASE", 98, 103], ["decarbonization", "TREATMENT", 35, 50], ["a climate shock", "TREATMENT", 88, 103]]], ["The need for strong action now is exemplified by the fact that the emissions gap in 2030 between current policies and the emissions necessary to keep the temperature anomaly below 1.5 \u00b0C in 2100 is approximately 34-39 GtCO 2 (UNEP 2019).", [["the emissions gap", "TEST", 63, 80], ["the temperature anomaly", "TEST", 150, 173]]], ["11 The COVID impact on emissions in 2020 is expected to reduce the gap by approximately 6 GtCO 2 , which falls very far short of the gap that needs to be closed.Athens University of Economics and Business and University of BolognaThe important aspect of a climate shock is that in addition to the negative impacts on the productive base of the economy-human, health and social capital-it will have a much more serious negative impact on the reproducible capital relative to the pandemic.", [["shock", "DISEASE", 264, 269], ["The COVID impact on emissions", "TREATMENT", 3, 32], ["the gap", "TEST", 63, 70], ["a climate shock", "TREATMENT", 254, 269], ["negative", "OBSERVATION", 297, 305], ["productive", "OBSERVATION_MODIFIER", 321, 331], ["base", "OBSERVATION_MODIFIER", 332, 336]]], ["This is because the climate shock will not just reduce the utilization of this type of capital, it will destroy part of the capital stock, since it will affect infrastructure, equipment, buildings and so on.", [["shock", "DISEASE", 28, 33], ["the climate shock", "PROBLEM", 16, 33], ["capital", "OBSERVATION", 87, 94], ["capital stock", "OBSERVATION", 124, 137]]], ["Recovery in such a case will clearly be slower and more difficult.Athens University of Economics and Business and University of BolognaThis creates a serious argument against delaying adaptation programmes which could provide substantial benefits in the presence of climate shocks.", [["adaptation programmes", "TREATMENT", 184, 205], ["climate shocks", "TREATMENT", 266, 280]]], ["Typical adaptation projects (e.g. early warning systems, water resource and flood-risk management, sustainable agriculture, strengthening the resilience of existing infrastructure making new infrastructure resilient) are characterized by high benefit-cost ratios (Fankhauser 2017; GCA 2019) .", [["flood-risk management", "TREATMENT", 76, 97], ["GCA", "TEST", 281, 284]]], ["12 Under the resource constraints imposed by pandemic containment policies and the deep structural uncertainty characterizing the situation, the prioritization of these adaptation policies could necessitate the use of max-min expected utility criteria in decision making.", [["pandemic containment policies", "TREATMENT", 45, 74], ["deep structural", "OBSERVATION_MODIFIER", 83, 98]]], ["As second-round benefits, adaptation programmes which involve investment could stimulate the economy and provide new jobs.Athens University of Economics and Business and University of BolognaTo summarize, three important points should be taken into account: (i) that the indications thus far suggest that the benefits associated with the reduction of greenhouse gas emissions because of the COVID-19 are transient, which means that the long-term trends associated with climate change are not expected to change, and therefore, mitigation and adaptation strategies should be strongly pursued in the post-COVID-19 era 13 ; (ii) that there is a need for an ambitious and comprehensive European economic recovery plan from the COVID-19 crisis (European Economic and Social Committee 2020b); (iii) that climate-change-related investments, in particular in adaptation, are expected to deliver significant economic benefits.", [["adaptation programmes", "TREATMENT", 26, 47], ["greenhouse gas emissions", "TREATMENT", 351, 375], ["the COVID", "TEST", 387, 396], ["adaptation strategies", "TREATMENT", 542, 563], ["long-term", "OBSERVATION_MODIFIER", 436, 445]]], ["Based on these points, it becomes clear that a green recovery plan with resources directed towards achieving the combined objective of both providing the necessary economic stimuli for recovery and also promoting the transition to a low-carbon economy and adaptation to climate change along with investment in natural capital and increase in comprehensive savings could be a feasible and efficient plan.Athens University of Economics and Business and University of BolognaThe EGD is an important strategy for securing the sustained development of the EU and protecting climate as a global public good.", [["carbon", "CHEMICAL", 237, 243], ["a low-carbon economy", "TREATMENT", 231, 251], ["investment in natural capital", "TREATMENT", 296, 325], ["The EGD", "TEST", 472, 479], ["clear", "OBSERVATION", 34, 39], ["increase", "OBSERVATION_MODIFIER", 330, 338]]], ["At the same time, it is clear that addressing the pandemic requires action now in the form of new policies and changes in priorities.", [["clear", "OBSERVATION", 24, 29]]], ["However, although COVID-19 is of necessity in the spotlight at present as a major global threat, it should not displace action aimed at an equal or greater global threatthat of climate change-under the misconception that the temporary drop in emissions during the pandemic allows us to delay climate change action now.", [["COVID", "TEST", 18, 23], ["the temporary drop", "PROBLEM", 221, 239], ["temporary drop", "OBSERVATION", 225, 239]]], ["A green recovery plan could realistically provide the double dividend of helping the EU economies to recover from the COVID-19 crisis and, at the same time, promote the attainment of a climate-neutral EU.", [["the EU economies", "TREATMENT", 81, 97], ["the COVID", "TEST", 114, 123]]], ["12 According to the GCA (2019) study, adaptation investment of $1.8 trillion in the areas mentioned will provide total net benefits of $7.1 trillion by 2030, with benefit-cost ratios ranging between 5 and 10.", [["cost ratios", "TEST", 171, 182]]], ["13 See, for example, the recent EU European Economic and Social Committee (2020a) opinion about the transition to a low-carbon EU and the financing of adaptation to climate change.Athens University of Economics and Business and University of BolognaInvolved in Europe (2020), LEAKED: Full list of delayed European Green Deal initiatives-euractiv.com.", [["carbon", "CHEMICAL", 120, 126], ["a low-carbon EU", "TREATMENT", 114, 129]]], ["IPCC (2018), Global Warming of 1.5 \u00b0C. An IPCC Special Report on the impacts of global warming of 1.5 \u00b0C above pre-industrial levels and related global greenhouse gas emission pathways, in the context of strengthening the global response to the threat of climate change, sustainable development, and efforts to eradicate poverty.", [["poverty", "DISEASE", 321, 328], ["Global Warming", "TREATMENT", 13, 27], ["global warming", "TREATMENT", 80, 94], ["pre-industrial levels", "TEST", 111, 132], ["global greenhouse gas emission pathways", "PROBLEM", 145, 184], ["global", "OBSERVATION_MODIFIER", 145, 151], ["greenhouse gas", "OBSERVATION", 152, 166]]], ["Masson-Delmotte, V., Zhai, P.IntroductionRebound effect studies have been generally focused on energy use (Sorrell 2007) , although some studies for other natural resources have recently emerged (Freire-Gonz\u00e1lez and Font Vivanco 2017).", [["some studies", "TEST", 132, 144]]], ["Rebound effect occurs when the use of resources is not reduced as expected after a resource efficiency policy or a specific behaviour.", [["Rebound effect", "PROBLEM", 0, 14]]], ["Empirical rebound studies aim at capturing the secondary effects of policies and behaviours in order to obtain more adjusted assessments of policies and actions.", [["Empirical rebound studies", "TEST", 0, 25]]], ["It is well known in the rebound literature that, counterintuitively, resource efficiency may not reduce the use of these resources, but the contrary.", [["these resources", "TREATMENT", 115, 130]]], ["This extreme case is known as backfire, Khazzoom-Brookes postulate, or Jevons' Paradox.", [["Khazzoom", "TREATMENT", 40, 48]]], ["Rebound effects are not usually observed by policy-makers, as it requires different perspectives and approaches coming from social, behavioural and environmental sciences.", [["Rebound effects", "PROBLEM", 0, 15]]], ["Environmental and social sciences show us that human-environment systems are deeply interconnected.", [["human", "ORGANISM", 47, 52], ["human", "SPECIES", 47, 52], ["human", "SPECIES", 47, 52]]], ["This way of thinking has, however, still not fully permeated in mainstream policy decision circles, which are largely rooted in old intellectual paradigms and other short-term interests.Potential Environmental Rebound Effects Post-COVID-19The pandemic has caused many abrupt changes in production and consumption, transport patterns, working conditions, social interaction and many other aspects.", [["Post-COVID-19", "CHEMICAL", 226, 239], ["Post-COVID", "TEST", 226, 236], ["many abrupt changes in production", "PROBLEM", 263, 296], ["short-term", "OBSERVATION_MODIFIER", 165, 175], ["many", "OBSERVATION_MODIFIER", 263, 267], ["abrupt", "OBSERVATION_MODIFIER", 268, 274], ["changes", "OBSERVATION", 275, 282]]], ["Most of these changes have been triggered by the policies implemented to contain the pandemic.", [["the pandemic", "PROBLEM", 81, 93], ["pandemic", "OBSERVATION_MODIFIER", 85, 93]]], ["Overall, they have translated into improvements in most environmental indicators, such as carbon emissions, air quality and biodiversity loss (Saadat et al. 2020) .", [["carbon", "CHEMICAL", 90, 96], ["carbon", "SIMPLE_CHEMICAL", 90, 96], ["carbon emissions", "TEST", 90, 106], ["biodiversity loss", "PROBLEM", 124, 141], ["biodiversity loss", "OBSERVATION", 124, 141]]], ["An important question is, thus, whether COVID-19 will reduce environmental impacts in the future, when economic activity returns to \"normality\" (in terms of pre-COVID conditions).", [["COVID-19", "CHEMICAL", 40, 48], ["COVID", "TEST", 40, 45]]], ["14 Rebound literature shows the importance of considering behavioural and systemic responses to answer this question.Potential Environmental Rebound Effects Post-COVID-19Beyond other considerations, the pandemic has accelerated some already observed trends, like the pace of implementation and use of digital technologies.", [["digital technologies", "TREATMENT", 301, 321]]], ["One of the most remarkable changes are those related to the impulse of information and communications technologies (ICT), due to imposed social distancing rules.", [["most remarkable", "OBSERVATION_MODIFIER", 11, 26]]], ["There already was a tendency towards an increased use of ICT, but its use has been dramatically accelerated due to the pandemic.", [["ICT", "TREATMENT", 57, 60], ["the pandemic", "PROBLEM", 115, 127], ["tendency", "OBSERVATION_MODIFIER", 20, 28], ["increased", "OBSERVATION_MODIFIER", 40, 49]]], ["15 This acceleration can be observed in many areas, such as teleworking, e-commerce, remote social relationships, virtual sightseeing, surveillance technologies, and other online areas and events (cultural, academic, leisure, educational, etc.) .", [["surveillance technologies", "TEST", 135, 160]]], ["For instance, in many countries, nonessential workers have been legally obliged to be confined during the pandemic to stop the contagion of the virus, thus promoting telework.", [["the virus", "PROBLEM", 140, 149]]], ["Despite the potential advantages of teleworking in increasing labour productivity in many industries (Harker Martin and McDonnell 2012) , rigidities in corporate culture and other legal and cultural restraints were hindering and adjourning its consolidation.", [["increasing labour productivity", "PROBLEM", 51, 81], ["corporate culture", "TEST", 152, 169], ["cultural restraints", "TREATMENT", 190, 209], ["its consolidation", "PROBLEM", 240, 257], ["increasing", "OBSERVATION_MODIFIER", 51, 61], ["labour", "OBSERVATION", 62, 68], ["consolidation", "OBSERVATION", 244, 257]]], ["The use of ICT is thought to be environmentally beneficial, largely due to decreased transport, but this premise has been challenged by rebound effect studies.", [["ICT", "TREATMENT", 11, 14], ["decreased transport", "PROBLEM", 75, 94], ["decreased", "OBSERVATION", 75, 84]]], ["Takahashi et al. (2004) calculated the rebound effect of ICT services in a case study on videoconferences and found that rebound can reduce up to 20% of carbon savings.", [["carbon", "CHEMICAL", 153, 159], ["ICT services", "TREATMENT", 57, 69], ["rebound", "PROBLEM", 121, 128], ["carbon savings", "TREATMENT", 153, 167]]], ["Joyce et al. (2019) recently found for Sweden strong environmental rebound effects associated with ICT use, in most cases far above 100% (more resources use than before).", [["ICT use", "TREATMENT", 99, 106], ["rebound", "OBSERVATION", 67, 74]]], ["This backfire effect is strongest for energy use and total material footprint, both close to 200%.Potential Environmental Rebound Effects Post-COVID-19Another change may take place in land use and the housing sector, as initial evidence suggests that attributes such as floor space and outdoor space will have elevated importance (Mikolai et al. 2020) .", [["total material footprint", "TREATMENT", 53, 77]]], ["The potential re-distribution of time and expenditures towards resource-intensive sectors, such as construction, water and energy services, will likely cause material, water and energy rebounds.", [["re-distribution", "OBSERVATION_MODIFIER", 14, 29]]], ["However, the expansion of teleworking can, at the same time, reallocate space and incomes in office rental market.", [["expansion", "OBSERVATION_MODIFIER", 13, 22]]], ["Public transport may also be negatively impacted in the short and mid-term, leading to increased private transport (Honey-Ros\u00e9s et al. 2020), another resource-intensive activity.Potential Environmental Rebound Effects Post-COVID-19Other structural changes may also take place, such as changes in sufficiency measures and broader productivity, leading to macro-economic rebound effects (Lemoine 2017).", [["Post-COVID", "TEST", 218, 228], ["structural changes", "PROBLEM", 237, 255], ["sufficiency measures", "TREATMENT", 296, 316], ["macro-economic rebound effects", "PROBLEM", 354, 384], ["may also be", "UNCERTAINTY", 17, 28], ["negatively", "OBSERVATION_MODIFIER", 29, 39], ["impacted", "OBSERVATION", 40, 48], ["increased", "OBSERVATION_MODIFIER", 87, 96], ["Environmental", "OBSERVATION_MODIFIER", 188, 201], ["Rebound", "OBSERVATION", 202, 209]]], ["The pandemic may increase the social acceptance of sufficiency measures such as working less time, spending more time with family and friends, or connecting with nature.", [["sufficiency measures", "TREATMENT", 51, 71], ["increase", "OBSERVATION_MODIFIER", 17, 25]]], ["These measures have long been proposed to reduce consumption and associated environmental impacts (Hayden and Shandra 2009 ).", [["environmental", "OBSERVATION_MODIFIER", 76, 89], ["impacts", "OBSERVATION_MODIFIER", 90, 97]]], ["These measures have, however, been associated with macro-economic price rebound effects as the decreased demand for some products can lower their price and induce additional demand (Sorrell et al. 2020) .", [["macro-economic price rebound effects", "PROBLEM", 51, 87], ["the decreased demand", "PROBLEM", 91, 111], ["some products", "TREATMENT", 116, 129]]], ["Moreover, the postpandemic society may likely be a more productive one in labour and capital terms.", [["may likely be", "UNCERTAINTY", 35, 48]]], ["For example, teleworking (Harker Martin and MacDonnell 2012) and increased spending in research and development have been associated with productivity growth, which boosts economic growth and resource use.Final RemarksThe COVID-19 pandemic will likely cause a range of changes in society, but their permanence and effect on the environment are unclear, especially if we contemplate the secondary effects of behaviour, measures and policies.", [["productivity growth", "PROBLEM", 138, 157], ["The COVID", "TEST", 218, 227], ["increased", "OBSERVATION_MODIFIER", 65, 74]]], ["A key question is whether they will acquire a certain level of permanence, even modifying the mindsets of agents.", [["the mindsets of agents", "TREATMENT", 90, 112]]], ["Given the high uncertainty around this aspect, its real dimension could only be assessed ex-post.", [["high", "OBSERVATION_MODIFIER", 10, 14], ["uncertainty", "OBSERVATION_MODIFIER", 15, 26]]], ["However, due to confinements, the pandemic has greatly accelerated the expansion and use of general-purpose technologies, like ICT.", [["confinements", "PROBLEM", 16, 28], ["general-purpose technologies", "TREATMENT", 92, 120], ["expansion", "OBSERVATION_MODIFIER", 71, 80]]], ["As this has been a long-observed trend, before the irruption of the virus, they have probably come to stay to a large degree.Final RemarksThe pandemic offers a great potential to improving (and consolidating) environmental conditions.", [["the virus", "PROBLEM", 64, 73], ["consolidating) environmental conditions", "PROBLEM", 194, 233], ["large", "OBSERVATION_MODIFIER", 112, 117], ["degree", "OBSERVATION_MODIFIER", 118, 124]]], ["But beyond what conventional environmental indicators show, additional measures would be needed to counteract hidden rebound effects and, therefore, take full advantage of potential improvements.", [["hidden rebound effects", "PROBLEM", 110, 132]]], ["Recent literature shows that different economic instruments like environmental taxation, resource pricing or setting limits to resource use, can be effective for this purpose.", [["different economic instruments", "TREATMENT", 29, 59], ["environmental taxation", "TREATMENT", 65, 87], ["resource pricing", "TREATMENT", 89, 105]]], ["This is particularly necessary in this case, given the high risk of backfire due to the high expansion of general-purpose technologies observed.MotivationThe global financial and commodity markets are facing economic distortions caused by the coronavirus (COVID-19) pandemic (Fernandes 2020; Irwin 2020).", [["coronavirus", "DISEASE", 243, 254], ["coronavirus", "ORGANISM", 243, 254], ["the high expansion", "PROBLEM", 84, 102], ["facing economic distortions", "PROBLEM", 201, 228], ["the coronavirus", "PROBLEM", 239, 254], ["COVID", "TEST", 256, 261]]], ["COVID-19 acts as a negative shock to overall demand of goods and services, resulting in aggravated shortrun volatility in prices (Albulescu 2020).", [["shock", "DISEASE", 28, 33], ["COVID", "TEST", 0, 5]]], ["Among these products, oil has been dramatically affected due to community lockdown regulations, shutdown of car factories, decline in energy use and increase in unemployment (Reed 2020a; The Associated Press 2020).", [["oil", "ANATOMY", 22, 25], ["oil", "ORGANISM_SUBSTANCE", 22, 25]]], ["However, a decrease in oil consumption may lead to reductions in carbon dioxide emissions (Pe\u00f1a-L\u00e9vano et al. 2019).", [["oil", "ANATOMY", 23, 26], ["carbon dioxide", "CHEMICAL", 65, 79], ["carbon dioxide", "CHEMICAL", 65, 79], ["oil", "ORGANISM_SUBSTANCE", 23, 26], ["carbon dioxide", "SIMPLE_CHEMICAL", 65, 79], ["a decrease in oil consumption", "PROBLEM", 9, 38], ["carbon dioxide emissions", "TREATMENT", 65, 89], ["decrease", "OBSERVATION_MODIFIER", 11, 19], ["oil consumption", "OBSERVATION", 23, 38], ["carbon dioxide", "OBSERVATION", 65, 79]]], ["Data recorded by EPA (2020) during March-April 2020 show an improvement in overall air quality, especially in high-density populated cities (Regan 2020).MotivationAir pollution is considered by many scientists as a negative contributor in the coronavirus situation by worsening the susceptibility of infection.", [["coronavirus", "DISEASE", 243, 254], ["infection", "DISEASE", 300, 309], ["coronavirus", "ORGANISM", 243, 254], ["the coronavirus situation", "PROBLEM", 239, 264], ["infection", "PROBLEM", 300, 309], ["improvement", "OBSERVATION_MODIFIER", 60, 71], ["overall", "OBSERVATION_MODIFIER", 75, 82], ["air quality", "OBSERVATION", 83, 94], ["high", "OBSERVATION_MODIFIER", 110, 114], ["density", "OBSERVATION_MODIFIER", 115, 122], ["infection", "OBSERVATION", 300, 309]]], ["A decline in emissions somehow may help prevent mortality temporarily, especially among more vulnerable individuals with underlying health conditions, such as heart and respiratory diseases (Conticini et al. 2020; Dutheil et al. 2020 ; Mooney 2020; Ogen 2020).", [["heart", "ANATOMY", 159, 164], ["respiratory", "ANATOMY", 169, 180], ["heart and respiratory diseases", "DISEASE", 159, 189], ["heart", "ORGAN", 159, 164], ["A decline in emissions", "PROBLEM", 0, 22], ["underlying health conditions", "PROBLEM", 121, 149], ["heart and respiratory diseases", "PROBLEM", 159, 189], ["heart", "ANATOMY", 159, 164], ["respiratory", "ANATOMY", 169, 180], ["diseases", "OBSERVATION", 181, 189]]], ["Thus, in this short article, we discuss the interaction between fossil fuels, air pollution and health risk under the coronavirus pandemic and the lockdown regulations during the period of March-May 2020.Oil Production, Consumption and Resulting Air Quality During the PandemicThe oil market has been dramatically affected by several exogenous factors during the pandemic period:Oil Production, Consumption and Resulting Air Quality During the Pandemic(1) \"Shelter in place\" mandates aimed at curbing the spread of the coronavirus have decreased people's social mobility and transportation activities.", [["coronavirus pandemic", "DISEASE", 118, 138], ["coronavirus", "DISEASE", 519, 530], ["coronavirus", "ORGANISM", 519, 530], ["people", "SPECIES", 546, 552], ["fossil fuels", "TREATMENT", 64, 76], ["air pollution", "TREATMENT", 78, 91], ["the coronavirus pandemic", "TREATMENT", 114, 138], ["the lockdown regulations", "TREATMENT", 143, 167], ["the coronavirus", "PROBLEM", 515, 530], ["air pollution", "OBSERVATION", 78, 91], ["Air Quality", "OBSERVATION", 246, 257], ["dramatically", "OBSERVATION_MODIFIER", 301, 313], ["Air Quality", "OBSERVATION", 421, 432]]], ["In the USA, the passenger volume dropped 95% from a year ago (compared to April 2019) as estimated by Airlines for America, with an overall reduced accommodation of 12 passengers per carrier (Rappeport and Chokshi 2020); (3) Tourism activity slumped as many governments banned international travel, heightened border and immigration controls and barred the entrance of foreign visitors to decrease risk of infection.", [["infection", "DISEASE", 406, 415], ["the passenger volume", "TEST", 12, 32], ["heightened border", "TREATMENT", 299, 316], ["immigration controls", "TREATMENT", 321, 341], ["infection", "PROBLEM", 406, 415], ["infection", "OBSERVATION", 406, 415]]], ["For regions such as the Caribbean Islands (where tourism is a primary economic staple good), this also represents a significant decline in their gross domestic products (Semple 2020); (4) Unemployment has pervaded among the national economies (Mazzei and Tavernise 2020).", [["a significant decline", "PROBLEM", 114, 135], ["Caribbean", "OBSERVATION_MODIFIER", 24, 33], ["Islands", "OBSERVATION", 34, 41], ["significant", "OBSERVATION_MODIFIER", 116, 127], ["decline", "OBSERVATION", 128, 135]]], ["More than 44 million people have filed for unemployment in the USA in a 12-week period (U.S. Department of Labor 2020).", [["people", "ORGANISM", 21, 27], ["people", "SPECIES", 21, 27]]], ["Worsening unemployment conditions have substantially reduced consumers' purchasing power.", [["Worsening unemployment conditions", "PROBLEM", 0, 33], ["substantially", "OBSERVATION_MODIFIER", 39, 52], ["reduced", "OBSERVATION_MODIFIER", 53, 60]]], ["Among its consequences is an overall decline in car sales (Reuters 2020; The Associated Press 2020); (5) Many industries, restaurants and buildings have been shut down during the lockdown.Oil Production, Consumption and Resulting Air Quality During the PandemicThese closures reduced energy consumption, especially petroleum use, which is a large energy input in the USA and other countries (EIA 2019).Oil Production, Consumption and Resulting Air Quality During the PandemicMeanwhile, global oil supply responded slowly to the decline in demand as refineries cannot abruptly halt production (Caldara et al. 2019; Pe\u00f1a-L\u00e9vano 2018).", [["oil", "ANATOMY", 493, 496], ["petroleum", "SIMPLE_CHEMICAL", 315, 324], ["oil", "ORGANISM_SUBSTANCE", 493, 496], ["the PandemicThese closures", "TREATMENT", 249, 275], ["overall", "OBSERVATION_MODIFIER", 29, 36], ["decline", "OBSERVATION_MODIFIER", 37, 44], ["Air Quality", "OBSERVATION", 230, 241], ["large", "OBSERVATION_MODIFIER", 341, 346], ["energy input", "OBSERVATION", 347, 359], ["Air Quality", "OBSERVATION", 444, 455]]], ["The Russia-Saudi Arabia oil price war in March 2020 worsened the situation by oversupplying the market and consequently dropping oil prices (Irwin 2020; Reed 2020a).", [["oil", "ORGANISM_SUBSTANCE", 129, 132]]], ["In April, the major petroleum exporting countries agreed to decrease the world oil output by 10% during May-July, which is equivalent to 9.7 million barrels a day (Krauss 2020; Reed 2020b).", [["oil", "ANATOMY", 79, 82], ["oil", "ORGANISM_SUBSTANCE", 79, 82], ["major", "OBSERVATION_MODIFIER", 14, 19], ["petroleum", "OBSERVATION_MODIFIER", 20, 29]]], ["Two recent studies published in Geophysical Research Letters validate the realized reduction in nitrogen dioxide (NO 2 ) pollution in several regions.", [["nitrogen dioxide", "CHEMICAL", 96, 112], ["NO", "CHEMICAL", 114, 116], ["nitrogen dioxide", "CHEMICAL", 96, 112], ["NO 2 )", "CHEMICAL", 114, 120], ["nitrogen dioxide", "SIMPLE_CHEMICAL", 96, 112], ["NO 2", "SIMPLE_CHEMICAL", 114, 118], ["Two recent studies", "TEST", 0, 18], ["nitrogen dioxide", "TREATMENT", 96, 112], ["reduction", "OBSERVATION_MODIFIER", 83, 92], ["nitrogen dioxide", "OBSERVATION", 96, 112]]], ["Bauwens et al. (2020) compared NO 2 levels in the atmosphere recorded in January to April 2020 and for the same period in 2019.", [["NO", "CHEMICAL", 31, 33], ["NO 2", "CHEMICAL", 31, 35], ["NO 2", "GENE_OR_GENE_PRODUCT", 31, 35]]], ["Notably, NO 2 , which is produced by emissions from vehicles and industrial operations, can cause serious lung ailments.", [["lung", "ANATOMY", 106, 110], ["NO", "CHEMICAL", 9, 11], ["lung ailments", "DISEASE", 106, 119], ["NO 2", "CHEMICAL", 9, 13], ["NO 2", "GENE_OR_GENE_PRODUCT", 9, 13], ["lung", "ORGAN", 106, 110], ["industrial operations", "TREATMENT", 65, 86], ["serious lung ailments", "PROBLEM", 98, 119], ["NO", "UNCERTAINTY", 9, 11], ["industrial operations", "OBSERVATION", 65, 86], ["serious", "OBSERVATION_MODIFIER", 98, 105], ["lung", "ANATOMY", 106, 110], ["ailments", "OBSERVATION", 111, 119]]], ["Their estimates indicate a significant reduction of 40% in China and 20-38% drop in the USA and western Europe.", [["a significant reduction", "PROBLEM", 25, 48], ["significant", "OBSERVATION_MODIFIER", 27, 38], ["reduction", "OBSERVATION_MODIFIER", 39, 48]]], ["Shi and Brasseur (2020) estimate a 60% reduction in NO 2 pollution in Northern China in January and February 2020.", [["NO", "CHEMICAL", 52, 54], ["NO 2", "CHEMICAL", 52, 56], ["NO 2", "SIMPLE_CHEMICAL", 52, 56], ["a 60% reduction", "TREATMENT", 33, 48]]], ["In the same period, they also found a 35% reduction in particulate matter pollution (particles smaller than 2.5 \u00b5m).", [["a 35% reduction in particulate matter pollution", "PROBLEM", 36, 83], ["reduction", "OBSERVATION_MODIFIER", 42, 51], ["particulate matter", "OBSERVATION", 55, 73], ["smaller", "OBSERVATION_MODIFIER", 95, 102]]], ["While such cleaner air conditions may persist only temporarily, these trends indicate that the desired environmental gains are feasible and realizable if stringent emission regulations, perhaps mirroring to some extent the pandemic's enforced limits on social mobility and industrial activities, are enforced in the future.Air Quality and Health RiskSeveral studies relate ambient air quality to mortality and morbidity conditions caused by COVID-19.", [["COVID-19", "CHEMICAL", 441, 449], ["such cleaner air conditions", "PROBLEM", 6, 33], ["stringent emission regulations", "PROBLEM", 154, 184], ["Health RiskSeveral studies", "TEST", 339, 365], ["ambient air quality", "PROBLEM", 373, 392], ["morbidity conditions", "PROBLEM", 410, 430], ["COVID", "TEST", 441, 446]]], ["This contention echoes an earlier correlation applied to the SARS virus outbreak in China in the early 2000s.", [["SARS", "DISEASE", 61, 65], ["SARS virus", "SPECIES", 61, 71], ["the SARS virus outbreak", "PROBLEM", 57, 80]]], ["Researchers from UCLA's School of Public Health analysed air pollution levels and SARS fatality rates among Chinese residents.", [["SARS", "DISEASE", 82, 86]]], ["Their results indicate that SARS patients' probability of dying would be doubled among residents in areas with high air pollution indexes (Cui et al. 2003) .", [["SARS", "DISEASE", 28, 32], ["patients", "ORGANISM", 33, 41], ["patients", "SPECIES", 33, 41], ["high air pollution indexes", "PROBLEM", 111, 137], ["high", "OBSERVATION_MODIFIER", 111, 115], ["air pollution", "OBSERVATION", 116, 129]]], ["As applied to the current pandemic, the Center for Disease Control and Prevention (CDC) explains that COVID-19 causes a respiratory illness with a heightened risk among people who are 65 years and older as well as those with certain underlying health conditions.", [["respiratory", "ANATOMY", 120, 131], ["COVID-19", "CHEMICAL", 102, 110], ["respiratory illness", "DISEASE", 120, 139], ["people", "ORGANISM", 169, 175], ["people", "SPECIES", 169, 175], ["COVID-19", "SPECIES", 102, 110], ["Disease Control", "TREATMENT", 51, 66], ["a respiratory illness", "PROBLEM", 118, 139], ["respiratory illness", "OBSERVATION", 120, 139]]], ["Latest CDC statistics on the pandemic's severity and fatality indicate that persons with heart ailment, diabetes and chronic respiratory diseases could be at a higher risk of being severely infected by the virus (Vogel 2020).", [["heart", "ANATOMY", 89, 94], ["respiratory", "ANATOMY", 125, 136], ["heart ailment", "DISEASE", 89, 102], ["diabetes", "DISEASE", 104, 112], ["chronic respiratory diseases", "DISEASE", 117, 145], ["persons", "ORGANISM", 76, 83], ["heart", "ORGAN", 89, 94], ["persons", "SPECIES", 76, 83], ["heart ailment", "PROBLEM", 89, 102], ["diabetes", "PROBLEM", 104, 112], ["chronic respiratory diseases", "PROBLEM", 117, 145], ["severely infected", "PROBLEM", 181, 198], ["heart", "ANATOMY", 89, 94], ["ailment", "OBSERVATION", 95, 102], ["chronic", "OBSERVATION_MODIFIER", 117, 124], ["respiratory diseases", "OBSERVATION", 125, 145], ["infected", "OBSERVATION", 190, 198]]], ["Wu et al. (2020) further clarify that pre-existing health conditions identified as relatively more susceptible to contracting COVID-19 are similar to those normally affected by air pollution in the USA.", [["COVID-19", "CHEMICAL", 126, 134], ["pre-existing health conditions", "PROBLEM", 38, 68], ["contracting COVID", "TEST", 114, 131], ["air pollution", "OBSERVATION", 177, 190]]], ["Their study estimates that an increase of 1 g m \u22123 in long-term exposure to particular matter (PM 2.5 ) increases the coronavirus mortality rate by 8%.", [["coronavirus", "DISEASE", 118, 129], ["coronavirus", "ORGANISM", 118, 129], ["Their study", "TEST", 0, 11], ["the coronavirus mortality rate", "TEST", 114, 144], ["increase", "OBSERVATION_MODIFIER", 30, 38], ["long-term", "OBSERVATION_MODIFIER", 54, 63]]], ["Isaifan (2020) presents corroborating evidence indicating that 75% of COVID-19-related deaths were cases with pre-existing illnesses, with majority of the victims over 80 years of age.", [["Isaifan", "CHEMICAL", 0, 7], ["COVID-19", "CHEMICAL", 70, 78], ["deaths", "DISEASE", 87, 93], ["COVID-19", "ORGANISM", 70, 78], ["COVID", "TEST", 70, 75], ["pre-existing illnesses", "PROBLEM", 110, 132]]], ["Conticini et al. (2020) , however, warn that even young and healthy individuals could also be at risk as prolonged exposure to dangerous air pollutants causing chronic respiratory issues could be an additional co-factor that helps increase their vulnerability to being infected by the virus.Air Quality and Health RiskOgen (2020) establishes that exposure to NO 2 may be an important instigator of COVID-19 fatalities according to his research involving four European Union countries.", [["respiratory", "ANATOMY", 168, 179], ["NO", "CHEMICAL", 359, 361], ["fatalities", "DISEASE", 407, 417], ["NO 2", "CHEMICAL", 359, 363], ["NO 2", "GENE_OR_GENE_PRODUCT", 359, 363], ["dangerous air pollutants", "PROBLEM", 127, 151], ["chronic respiratory issues", "PROBLEM", 160, 186], ["an additional co-factor", "PROBLEM", 196, 219], ["the virus", "PROBLEM", 281, 290]]], ["These findings are supported by the findings of a study published by the Italian Society of Environmental Medicine (Setti et al. 2020) on virus infections in Northern Italy associated with air pollutants tagged as carriers and boosters.Air Quality and Health RiskPoor air quality has been cited as an aggravating factor in virus transmission.", [["infections", "DISEASE", 144, 154], ["a study", "TEST", 48, 55], ["virus infections", "PROBLEM", 138, 154], ["air pollutants", "PROBLEM", 189, 203], ["an aggravating factor in virus transmission", "PROBLEM", 298, 341], ["air pollutants", "OBSERVATION", 189, 203]]], ["Using data from 55 Italian province capitals, Coccia (2020) notes an accelerated transmission dynamics of COVID-19 leading to his conclusion that the spread of this virus can be considered more as following an \"air pollution-to-human transmission\" mechanism instead of an interpersonal transmission mode.", [["human", "ORGANISM", 228, 233], ["human", "SPECIES", 228, 233], ["human", "SPECIES", 228, 233], ["COVID", "TEST", 106, 111], ["this virus", "PROBLEM", 160, 170], ["an \"air pollution", "TREATMENT", 207, 224]]], ["Moreover, Fattorini and Regoli (2020) analyse long-term air quality data in Northern Italy and suggest that chronic exposure to a contaminated atmosphere may have created conducive conditions for the spread of the virus.Air Quality and Health RiskSeveral studies relate the time frame of exposure to toxic air pollutants to mortality and morbidity conditions.", [["chronic exposure", "PROBLEM", 108, 124], ["a contaminated atmosphere", "TREATMENT", 128, 153], ["the virus", "PROBLEM", 210, 219], ["Health RiskSeveral studies", "TEST", 236, 262], ["toxic air pollutants", "PROBLEM", 300, 320], ["morbidity conditions", "PROBLEM", 338, 358], ["chronic", "OBSERVATION_MODIFIER", 108, 115]]], ["Lim et al. (2019) establish a significant association between longterm ozone (O 3 ) exposure and elevated mortality risk of certain respiratory diseases.", [["respiratory", "ANATOMY", 132, 143], ["ozone", "CHEMICAL", 71, 76], ["O 3 )", "CHEMICAL", 78, 83], ["respiratory diseases", "DISEASE", 132, 152], ["ozone", "CHEMICAL", 71, 76], ["O 3", "CHEMICAL", 78, 81], ["ozone", "SIMPLE_CHEMICAL", 71, 76], ["elevated mortality risk", "PROBLEM", 97, 120], ["certain respiratory diseases", "PROBLEM", 124, 152], ["significant", "OBSERVATION_MODIFIER", 30, 41], ["respiratory diseases", "OBSERVATION", 132, 152]]], ["Given limited data on the current pandemic, Hoang and Jones (2020) present emerging evidence on the severity of COVID-19 infection attributed to persistent air pollution conditions, thus suggesting that longer exposure to a polluted atmosphere could aggravate virus infection.", [["COVID-19", "CHEMICAL", 112, 120], ["infection", "DISEASE", 121, 130], ["infection", "DISEASE", 266, 275], ["COVID-19", "ORGANISM", 112, 120], ["COVID-19", "SPECIES", 112, 120], ["COVID-19 infection", "PROBLEM", 112, 130], ["persistent air pollution conditions", "PROBLEM", 145, 180], ["a polluted atmosphere", "TREATMENT", 222, 243], ["aggravate virus infection", "PROBLEM", 250, 275], ["persistent", "OBSERVATION_MODIFIER", 145, 155], ["air pollution", "OBSERVATION", 156, 169]]], ["Zhu et al. (2020) , however, provide concrete evidence suggesting that even short-term exposure to air pollution could increase probability of virus infection.", [["infection", "DISEASE", 149, 158], ["short-term exposure", "PROBLEM", 76, 95], ["air pollution", "PROBLEM", 99, 112], ["virus infection", "PROBLEM", 143, 158], ["virus infection", "OBSERVATION", 143, 158]]], ["Their study analysed daily confirmed cases in 120 cities in China recorded from 23 January 2020 to 29 February 2020 and found significant relationships between the levels of certain air pollutants and the number of newly identified COVID-19-infected cases.", [["COVID-19-infected", "DISEASE", 232, 249], ["COVID-19", "GENE_OR_GENE_PRODUCT", 232, 240], ["Their study", "TEST", 0, 11], ["certain air pollutants", "PROBLEM", 174, 196], ["COVID", "TEST", 232, 237], ["air pollutants", "OBSERVATION", 182, 196]]], ["Specifically, their results indicate that a 10-\u03bcg/m 3 increase in the air pollutants' levels was associated with about 1.76% to 6.94% increases in daily new COVID-19 cases.Air Quality and Health RiskConversely, the health benefits of cleaner air resulting from reduced emissions from fossil fuel during the pandemic's lockdown period deserve attention.", [["the air pollutants' levels", "PROBLEM", 66, 92], ["new COVID", "TEST", 153, 162], ["cleaner air", "PROBLEM", 234, 245], ["reduced emissions", "PROBLEM", 261, 278], ["air pollutants", "OBSERVATION", 70, 84], ["fossil fuel", "OBSERVATION", 284, 295]]], ["Several studies recognize that improved air quality during the pandemic temporarily mitigated health risks associated with respiratory illnesses.", [["respiratory", "ANATOMY", 123, 134], ["respiratory illnesses", "DISEASE", 123, 144], ["Several studies", "TEST", 0, 15], ["respiratory illnesses", "PROBLEM", 123, 144], ["improved", "OBSERVATION_MODIFIER", 31, 39], ["air quality", "OBSERVATION", 40, 51], ["respiratory illnesses", "OBSERVATION", 123, 144]]], ["Cole et al. (2020) employed a two-step analytical approach using machine learning techniques and the Augmented Synthetic Control Method to estimate possible reductions in death rates in certain regions in China and for the whole country that may be attributed to actual reductions in NO 2 concentrations during the lockdown period.", [["death", "DISEASE", 171, 176], ["NO", "CHEMICAL", 284, 286], ["NO 2", "CHEMICAL", 284, 288], ["NO 2", "SIMPLE_CHEMICAL", 284, 288], ["a two-step analytical approach", "TREATMENT", 28, 58], ["machine learning techniques", "TREATMENT", 65, 92], ["the Augmented Synthetic Control Method", "TREATMENT", 97, 135], ["death rates", "PROBLEM", 171, 182]]], ["Isaifan (2020) analyse air quality conditions prior to and during the lockdown period.", [["Isaifan", "CHEMICAL", 0, 7]]], ["His results indicate that lives may have been saved due to diminished ambient pollution levels, although eluding possible virus infection still is not necessarily guaranteed.", [["infection", "DISEASE", 128, 137], ["diminished ambient pollution levels", "PROBLEM", 59, 94], ["virus infection", "PROBLEM", 122, 137], ["possible", "UNCERTAINTY", 113, 121], ["virus", "OBSERVATION_MODIFIER", 122, 127], ["infection", "OBSERVATION", 128, 137], ["not necessarily", "UNCERTAINTY", 147, 162]]], ["This contention is corroborated by another China-based study conducted by Dutheil et al. (2020) .", [["based study", "TEST", 49, 60]]], ["These studies' assertions imply that air quality improvements realized even in such a shorter period of time (spanning less than half of a year) already could have some health benefit potentials, especially in relation to respiratory ailments.Air Quality and Health RiskThe health benefits of the current pandemic's notable environmental gain in air quality, however, will be optimized only if such favourable conditions are sustained over the longer term.", [["respiratory", "ANATOMY", 222, 233], ["respiratory ailments", "DISEASE", 222, 242], ["These studies", "TEST", 0, 13], ["air quality improvements", "PROBLEM", 37, 61], ["respiratory ailments", "PROBLEM", 222, 242], ["such favourable conditions", "PROBLEM", 394, 420], ["air quality", "OBSERVATION", 37, 48], ["respiratory ailments", "OBSERVATION", 222, 242]]], ["A brief respite from a usual contaminated atmosphere does not ensure an effective permanent eradication of chronic health conditions.", [["a usual contaminated atmosphere", "TREATMENT", 21, 52], ["chronic health conditions", "PROBLEM", 107, 132], ["chronic", "OBSERVATION_MODIFIER", 107, 114]]], ["A general economic slowdown overtly reflected in, among others, reduced consumer demand, spiralling unemployment figures and significant drop in oil consumption causes heightened fears of an imminent economic recession.", [["oil", "ANATOMY", 145, 148], ["oil", "ORGANISM_SUBSTANCE", 145, 148], ["A general economic slowdown", "PROBLEM", 0, 27], ["spiralling unemployment figures", "PROBLEM", 89, 120], ["significant drop in oil consumption", "PROBLEM", 125, 160], ["an imminent economic recession", "PROBLEM", 188, 218], ["significant", "OBSERVATION_MODIFIER", 125, 136], ["drop", "OBSERVATION_MODIFIER", 137, 141], ["oil consumption", "OBSERVATION", 145, 160], ["economic recession", "OBSERVATION", 200, 218]]], ["Unexpectedly, it took a serious pandemic to realize such feat.Final RemarksThis article traces the interplay of reduced oil consumption with economic issues as well as environmental consequences under pandemic conditions.", [["oil", "ANATOMY", 120, 123], ["oil", "ORGANISM_SUBSTANCE", 120, 123], ["economic issues", "PROBLEM", 141, 156], ["reduced", "OBSERVATION_MODIFIER", 112, 119], ["oil consumption", "OBSERVATION", 120, 135]]], ["The more imperative issues now lie on the severity of a looming recession and the global economy's resiliency in transcending the difficult challenges it may bring.", [["a looming recession", "PROBLEM", 54, 73]]], ["However, proponents of a cleaner world can always draw some inspiration from recent successes in air quality control, especially with the assurance that cleaner air is not necessarily a lofty goal.", [["a cleaner", "TREATMENT", 23, 32], ["air quality control", "TREATMENT", 97, 116], ["air quality", "OBSERVATION", 97, 108]]], ["The challenge in the future lies in achieving such environmental benefit without the need to sacrifice the economic health of the global community.", [["The challenge", "TREATMENT", 0, 13]]], ["On February 25, 2020, the Brazilian Ministry of Health confirmed that a 61-year-old man was positive for SARS-CoV-2: COVID-19 had arrived to Latin America.", [["SARS", "DISEASE", 105, 109], ["man", "ORGANISM", 84, 87], ["SARS-CoV-2", "ORGANISM", 105, 115], ["man", "SPECIES", 84, 87], ["SARS-CoV", "SPECIES", 105, 113], ["SARS", "PROBLEM", 105, 109]]], ["Furthermore, so far there have been more than 120,000 deaths in the region and the trends show that the first wave of the pandemic is far from over (ibid.).ReferencesThere is of course no suitable time for a pandemic to arrive, but these are especially complicated times for Latin America.", [["deaths", "DISEASE", 54, 60], ["the pandemic", "PROBLEM", 118, 130], ["pandemic", "OBSERVATION", 122, 130]]], ["The region is in the midst of a difficult economic situation accompanied by rising social discontent (ECLAC 2020; OECD 2020).", [["a difficult economic situation", "PROBLEM", 30, 60], ["rising", "OBSERVATION_MODIFIER", 76, 82], ["social discontent", "OBSERVATION", 83, 100]]], ["Moreover, it is characterized by high rates of informality, health systems with limited and unequal capacity, and most of the countries have high levels of debt (OECD 2020).", [["high rates of informality", "PROBLEM", 33, 58], ["limited and unequal capacity", "PROBLEM", 80, 108], ["high", "OBSERVATION_MODIFIER", 33, 37]]], ["Under these circumstances, COVID-19 is having major short-run socio-economic effects with possible serious long-run consequences, including several potential implications for the environment and the management of natural resources.Air PollutionRestrictions of free movement and circulation within and across urban areas of Latin America have reduced economic activity as well as the use of motorized vehicles.", [["COVID", "TEST", 27, 32], ["serious long-run consequences", "PROBLEM", 99, 128], ["natural resources", "TREATMENT", 213, 230], ["free movement", "OBSERVATION", 260, 273], ["circulation", "OBSERVATION_MODIFIER", 278, 289], ["reduced", "OBSERVATION_MODIFIER", 342, 349], ["economic activity", "OBSERVATION", 350, 367]]], ["As a result, many Latin American megacities have experienced a short-run decrease in air pollution.", [["a short-run decrease in air pollution", "PROBLEM", 61, 98], ["air pollution", "OBSERVATION", 85, 98]]], ["Concentrations of NO 2 have decreased considerably in cities all over the region compared to the levels observed prior to the lockdown measures (IADB 2020).", [["NO", "CHEMICAL", 18, 20], ["NO 2", "CHEMICAL", 18, 22], ["NO 2", "GENE_OR_GENE_PRODUCT", 18, 22], ["the lockdown measures", "TREATMENT", 122, 143], ["NO", "UNCERTAINTY", 18, 20], ["decreased", "OBSERVATION_MODIFIER", 28, 37], ["considerably", "OBSERVATION_MODIFIER", 38, 50], ["cities", "OBSERVATION_MODIFIER", 54, 60]]], ["Levels of PM 10 , PM 2.5 and CO have decreased in Bogota, Buenos Aires and Quito (Bogota's District Secretary of Environment, personal communication, 3 June 2020; Roa 2020; Rocha 2020).Air PollutionNevertheless, the pandemia has not had the same effect on air quality in all the major cities in the region.", [["pandemia", "DISEASE", 216, 224], ["CO", "CHEMICAL", 29, 31], ["Levels", "TEST", 0, 6], ["CO", "TEST", 29, 31], ["Air Pollution", "PROBLEM", 185, 198], ["decreased", "OBSERVATION_MODIFIER", 37, 46], ["air quality", "OBSERVATION", 256, 267], ["major", "OBSERVATION_MODIFIER", 279, 284], ["cities", "OBSERVATION_MODIFIER", 285, 291], ["region", "ANATOMY_MODIFIER", 299, 305]]], ["In Mexico City, the reductions in SO 2 , PM 2.5 and PM 10 concentrations have been modest, and there has been no reduction in ozone.", [["ozone", "CHEMICAL", 126, 131], ["ozone", "CHEMICAL", 126, 131], ["SO 2", "GENE_OR_GENE_PRODUCT", 34, 38], ["ozone", "SIMPLE_CHEMICAL", 126, 131], ["reduction in ozone", "PROBLEM", 113, 131], ["reductions", "OBSERVATION_MODIFIER", 20, 30], ["modest", "OBSERVATION_MODIFIER", 83, 89], ["no", "UNCERTAINTY", 110, 112], ["reduction", "OBSERVATION_MODIFIER", 113, 122], ["ozone", "OBSERVATION", 126, 131]]], ["16 In Rio de Janeiro, ozone concentrations have increased (Dantas et al. 2020) .", [["ozone", "CHEMICAL", 22, 27], ["ozone", "CHEMICAL", 22, 27], ["ozone", "SIMPLE_CHEMICAL", 22, 27], ["increased", "OBSERVATION_MODIFIER", 48, 57]]], ["Furthermore, as the virus and its negative consequences spread across rural areas and make its way through the southernmost part of the region, outdoor and indoor pollution might actually increase.", [["the virus", "PROBLEM", 16, 25], ["increase", "OBSERVATION_MODIFIER", 188, 196]]], ["Meanwhile, as winter hits central and southern Chile, urban households might increase their use of firewood for heating given that, due to the lockdowns, they have to spend more time inside dwellings (Encinas et al. 2020) .", [["heating", "TREATMENT", 112, 119]]], ["This rise in air pollution could arguably increase the risks associated with COVID-19.DeforestationIt is too soon to do a formal evaluation of the effects of the pandemic on deforestation and land use change in the region.", [["COVID-19", "CHEMICAL", 77, 85], ["air pollution", "PROBLEM", 13, 26], ["COVID", "TEST", 77, 82], ["a formal evaluation", "TEST", 120, 139], ["the pandemic", "PROBLEM", 158, 170], ["deforestation", "TREATMENT", 174, 187], ["rise", "OBSERVATION_MODIFIER", 5, 9], ["air pollution", "OBSERVATION", 13, 26]]], ["Nevertheless, the available information suggests that COVID-19 is likely to have negative effects on forest cover across the region.", [["COVID-19", "DNA", 54, 62], ["COVID", "TEST", 54, 59]]], ["Early deforestation warnings from Peru show that, although deforestation decreased between March 15 and April 15, since then it has increased surpassing the levels observed during the same period in 2018.", [["deforestation", "OBSERVATION", 6, 19], ["increased", "OBSERVATION_MODIFIER", 132, 141]]], ["17 According to data from the Brazilian National Institute for Space Research (INPE), the first quarter of 2020 already evidenced a rise of 50% in deforested hectares compared to last year's figures.", [["rise", "OBSERVATION_MODIFIER", 132, 136]]], ["Although at this point it cannot be claimed that the pandemic caused the observed increase in deforestation, it certainly does not seem to have provided incentives to halt it.DeforestationIn Colombia, contrary to other countries in the Amazon region, the trend in 2019 showed a reduction in deforestation compared to 2018.", [["the pandemic", "PROBLEM", 49, 61], ["DeforestationIn Colombia", "PROBLEM", 175, 199], ["a reduction in deforestation", "PROBLEM", 276, 304], ["increase", "OBSERVATION_MODIFIER", 82, 90], ["deforestation", "OBSERVATION", 94, 107], ["reduction", "OBSERVATION_MODIFIER", 278, 287]]], ["However, 2020 started with an increasing tendency and the quarantine seems to have worsened the situation (FCDS 2020).", [["an increasing tendency", "PROBLEM", 27, 49], ["increasing", "OBSERVATION_MODIFIER", 30, 40], ["tendency", "OBSERVATION", 41, 49]]], ["The absence of environmental monitoring during the pandemic seems to have encouraged illegal armed groups and regional mafias to take advantage of the situation, exacerbating deforestation with the possible intensification of illegal activities from which these actors derive income, such as illegal mining, land grabbing and illicit crops (BBC 2020).DeforestationAccording to the Pan American Health Organization, in 18 May 2020 there were already 20,000 COVID-19-confirmed cases in the Amazon basin (Mart\u00edn 2020).", [["environmental monitoring", "TEST", 15, 39], ["exacerbating deforestation", "PROBLEM", 162, 188], ["COVID", "TEST", 456, 461]]], ["The impact of the pandemic in forest-based indigenous communities is an important source of concern.", [["pandemic", "OBSERVATION_MODIFIER", 18, 26]]], ["The spread of the virus in these communities could imply a tragedy that, in addition to the human losses, could affect the traditional knowledge, having negative impacts on the governance of natural resources in the region.", [["human", "ORGANISM", 92, 97], ["human", "SPECIES", 92, 97], ["human", "SPECIES", 92, 97], ["the virus", "PROBLEM", 14, 23], ["the human losses", "PROBLEM", 88, 104], ["natural resources", "TREATMENT", 191, 208], ["spread", "OBSERVATION_MODIFIER", 4, 10], ["virus", "OBSERVATION", 18, 23], ["human losses", "OBSERVATION", 92, 104], ["region", "ANATOMY_MODIFIER", 216, 222]]], ["This could lead to even more deforestation processes in the future.Other Impacts on the Environment and Natural ResourcesCOVID-19 has caused a disruption in the national and international trade of nature-based goods and services.", [["disruption", "OBSERVATION", 143, 153]]], ["In countries like Costa Rica, where the touristic industry is intertwined with nature, the shock to the sector could have negative effects for biodiversity and forests.", [["shock", "DISEASE", 91, 96]]], ["Without income from tourism, and given that as a slow recovery process is anticipated, the incentives to protect forests are expected to decrease in the short and medium run.", [["a slow recovery process", "PROBLEM", 47, 70]]], ["Fishing and aquaculture are other industries that have been negatively affected.", [["aquaculture", "OBSERVATION", 12, 23]]], ["Information for the case of the Chilean salmon aquaculture industry suggests that there has been a reduction in demand from international markets (Ch\u00e1vez et al. 2020) .", [["Chilean salmon", "SPECIES", 32, 46], ["reduction", "OBSERVATION_MODIFIER", 99, 108]]], ["The effect of the shock is being transmitted through the value chain, affecting processing plants and farming facilities.Potential Effects on Environmental Policies and RegulationsThe economic crisis can end up having long-run negative consequences for the environment if, as a result, regulations and environmental policies are relaxed or if institutions are weakened.", [["shock", "DISEASE", 18, 23], ["the shock", "PROBLEM", 14, 23], ["Environmental Policies", "TREATMENT", 142, 164], ["The economic crisis", "PROBLEM", 180, 199], ["shock", "OBSERVATION", 18, 23], ["economic", "OBSERVATION_MODIFIER", 184, 192], ["crisis", "OBSERVATION", 193, 199]]], ["Although at this point there is no evidence of any country in the region purposefully relaxing environmental regulations to promote growth, it is certainly a possibility.", [["no evidence of", "UNCERTAINTY", 32, 46], ["certainly a possibility", "UNCERTAINTY", 146, 169]]], ["Even if countries have a relatively strong environmental legal framework, without a budget to monitor and enforce the regulations, this framework is worthless.Potential Effects on Environmental Policies and RegulationsCountries in the region will very likely incur fiscal deficits and increase their debts in order to fight the crisis.", [["Environmental Policies", "TREATMENT", 180, 202], ["fiscal deficits", "PROBLEM", 265, 280], ["the crisis", "PROBLEM", 324, 334]]], ["In the meantime, it seems that the short-run legitimate demands to recover employment levels and improve the health systems might very well push aside the necessary investments to successfully tackle climate change and biodiversity loss.", [["biodiversity loss", "DISEASE", 219, 236], ["the short-run legitimate demands", "PROBLEM", 31, 63], ["biodiversity loss", "PROBLEM", 219, 236], ["biodiversity loss", "OBSERVATION", 219, 236]]], ["If this indeed happens, it could be the most serious effect of the COVID-19 pandemic in both environmental and social terms.Discussion and Research AgendaThe economic projections suggest that the region will experience a crisis whose magnitude has no precedent in modern history (ECLAC 2020).", [["a crisis", "PROBLEM", 219, 227]]], ["The social unrest manifested recently in the social mobilizations in the region, should make clear that the apparent trade-off between economic, social and environmental objectives is the result of a false dichotomy between shortand long-run objectives.", [["a false dichotomy", "PROBLEM", 198, 215], ["social unrest", "OBSERVATION", 4, 17]]], ["If environmental objectives are put aside, as has so often happened with social objectives, the economy might recover in the short run but at a very high price.Discussion and Research AgendaThe lockdown measures seem to be having a temporal positive effect on reducing urban pollution in some Latin American cities.", [["The lockdown measures", "TREATMENT", 190, 211], ["a temporal positive effect", "PROBLEM", 230, 256], ["reducing urban pollution", "TREATMENT", 260, 284], ["temporal", "OBSERVATION_MODIFIER", 232, 240], ["positive", "OBSERVATION_MODIFIER", 241, 249], ["effect", "OBSERVATION_MODIFIER", 250, 256]]], ["This is an opportunity to rethink the urban environmental policies while trying to recover from an unprecedented social crisis.", [["social crisis", "OBSERVATION", 113, 126]]], ["At the same time, the observed increase in deforestation reopens political and academic debates about the role of national parks, indigenous reserves and other protection categories in a context of deteriorated livelihoods, illegal economies and a lack of state presence.Discussion and Research AgendaLatin American countries could see this moment as an opportunity to improve regional cooperation in order to design and implement coordinated policy responses not only to the economic crisis but also to the challenges of mitigation and adaptation to climate change.", [["increase", "OBSERVATION_MODIFIER", 31, 39], ["deforestation", "OBSERVATION", 43, 56]]], ["Furthermore, countries should coordinate efforts to increase monitoring and presence in the region to effectively reduce deforestation.Discussion and Research AgendaWe have presented an account of some of the most evident environmental effects that the COVID-19 pandemic is having in Latin America at this point.", [["COVID-19", "ORGANISM", 253, 261], ["increase monitoring", "TEST", 52, 71]]], ["There are many potential paths for future research; here, we mention just a few.Discussion and Research AgendaThe consequences of the interactions between poor air quality and COVID-19 on human health are clearly worth studying.", [["COVID-19", "CHEMICAL", 176, 184], ["human", "ORGANISM", 188, 193], ["human", "SPECIES", 188, 193], ["human", "SPECIES", 188, 193], ["poor air quality", "PROBLEM", 155, 171], ["COVID", "TEST", 176, 181]]], ["This is particularly relevant for the Latin American context, characterized by health systems with very limited capacity and high numbers of population without formal employment.", [["very limited capacity", "PROBLEM", 99, 120]]], ["Results from studies in this area could help us provide better guides to set environmental quality goals, as well as to implement policy interventions that can reduce pollution in the region's context of income inequality and spatial segregation.Discussion and Research AgendaThe short-run environmental effects of COVID-19 show early warnings of an increase in the pressure on forest and other ecosystems across Latin America.", [["COVID-19", "CHEMICAL", 315, 323], ["studies", "TEST", 13, 20], ["policy interventions", "TREATMENT", 130, 150], ["spatial segregation", "PROBLEM", 226, 245], ["COVID", "TEST", 315, 320], ["an increase", "PROBLEM", 347, 358], ["the pressure on forest", "TREATMENT", 362, 384], ["spatial segregation", "OBSERVATION", 226, 245], ["increase", "OBSERVATION_MODIFIER", 350, 358], ["pressure", "OBSERVATION_MODIFIER", 366, 374]]], ["Understanding the impacts of the pandemic on terrestrial and marine ecosystems, as well as on livelihood opportunities for local communities, has the potential to contribute to the design of policies which can improve management and conservation.Discussion and Research AgendaThe pandemic is opening new research questions regarding the impacts of global shocks on natural resource-based industries that participate in international markets.", [["new", "OBSERVATION_MODIFIER", 300, 303]]], ["Furthermore, the paths that different countries take to get out of the economic crisis might have profound impacts on international trade.", [["the economic crisis", "PROBLEM", 67, 86], ["profound", "OBSERVATION_MODIFIER", 98, 106], ["impacts", "OBSERVATION_MODIFIER", 107, 114]]], ["If, for example, the world transitions to more reliance upon local production, or if emissions-related tariffs are imposed, large exporters of commodities in the region will be highly affected.", [["large", "OBSERVATION_MODIFIER", 124, 129]]], ["In any case, Latin American countries are highly vulnerable to the effects of climate change and some of these effects (e.g. migration) could result in future health crises.", [["climate change", "TREATMENT", 78, 92], ["future health crises", "PROBLEM", 152, 172]]], ["A better understanding of the ways in which individuals might adapt to a changing climate, as well as of the barriers that they face to adopt adaptation measures, will be a valuable tool for the design of adaptation policies that prevent future health crises in the region and elsewhere.Discussion and Research AgendaThe distributional and gender-differentiated impacts of the pandemic, and the related environmental policy responses, is another area that deserves attention, especially because early evidence shows that the more vulnerable segments of the population in the region are the ones that are being hit hardest.", [["adaptation measures", "TREATMENT", 142, 161], ["adaptation policies", "TREATMENT", 205, 224], ["the pandemic", "PROBLEM", 373, 385], ["distributional", "OBSERVATION_MODIFIER", 321, 335], ["differentiated", "OBSERVATION_MODIFIER", 347, 361], ["impacts", "OBSERVATION_MODIFIER", 362, 369], ["more", "OBSERVATION_MODIFIER", 525, 529], ["vulnerable", "OBSERVATION_MODIFIER", 530, 540], ["segments", "OBSERVATION_MODIFIER", 541, 549], ["population", "OBSERVATION_MODIFIER", 557, 567], ["region", "ANATOMY_MODIFIER", 575, 581]]], ["Finally, as has been recently pointed out by , the experience of the pandemic might lead to changes in behaviour and personal choices.", [["the pandemic", "PROBLEM", 65, 77]]], ["An even more important issue to consider is what would these changes imply for the design of behaviour-based policy instruments aiming to change consumption and production patterns, as well as transport and land use decisions in Latin America.ReferencesBBC (2020) The place where nature isn\u00b4t healing. https ://www.bbc.com/reel/video / p08bd wfc/the-forgo tten-peopl e-of-the-globa l-pande mic Accessed 7 June 2020 BBC News (2020) Coronavirus en Ecuador: las multitudinarias protestas por las dr\u00e1sticas medidas econ\u00f3micas y recortes de Len\u00edn Moreno. https ://www.bbc.com/mundo / notic ias-ameri ca-latin a-52814 371 Accessed 7 June 2020 Ch\u00e1vez C, Salazar C, Simon J (2020) Efectos socioecon\u00f3micos y respuestas p\u00fablicoprivadas de corto plazo ante la crisis del Covid-19 en el sector salmonicultor, Una fotograf\u00eda de la experiencia internacional.", [["corto plazo ante la crisis del Covid-19 en el sector salmonicultor", "SPECIES", 729, 795], ["based policy instruments", "TREATMENT", 103, 127], ["ReferencesBBC", "TEST", 243, 256], ["n\u00b4t healing", "PROBLEM", 289, 300], ["tten", "TEST", 356, 360], ["Efectos", "TEST", 673, 680], ["socioecon\u00f3micos", "TEST", 681, 696], ["p\u00fablicoprivadas", "TEST", 710, 725], ["Covid", "TEST", 760, 765], ["n\u00b4t", "OBSERVATION_MODIFIER", 289, 292], ["healing", "OBSERVATION", 293, 300]]], ["Interdisciplinary Center for Aquaculture Research-INCAR, FONDAP-ANID, Center, Chile. https ://www.incar .cl/wp-conte nt/ uploa ds/2020/06/PB6.pdf Accessed 12 June 2020 Dantas G, Siciliano B, Fran\u00e7a B. B, da Silva C. M, Arbilla G (2020) The impact of COVID-19 partial lockdown on the air quality of the city of Rio de Janeiro, Brazil.", [["2020/06", "DNA", 130, 137], ["PB6", "DNA", 138, 141], ["COVID", "TREATMENT", 250, 255]]], ["ECLAC (2020) Report on the economic impact of coronavirus disease (COVID-19) on Latin America and the Caribbean: study prepared by the ECLAC, Santiago, 38 p Encinas F, Truffello R, Urquiza A, Vald\u00e9s M (2020) Covid-19, pobreza energ\u00e9tica y contaminaci\u00f3n: redefiniendo la vulnerabilidad en el centro-sur de Chile.", [["coronavirus disease", "DISEASE", 46, 65], ["coronavirus", "ORGANISM", 46, 57], ["coronavirus disease", "PROBLEM", 46, 65], ["COVID", "TEST", 67, 72], ["Covid", "TEST", 208, 213], ["coronavirus disease", "OBSERVATION", 46, 65]]], ["Centro de Investigaci\u00f3n e Informaci\u00f3n Period\u00edstica. https ://ciper chile .cl/2020/05/15/covid -19pobre za-energ etica -y-conta minac ion-redefi nien do-la-vulne rabil idad-en-el-centr o-surde-chile /.", [["https ://ciper chile .cl/2020/05/15/covid -19pobre za-energ etica -y-conta minac ion-redefi nien do-la-vulne rabil idad-en-el-centr o-surde-chile", "SPECIES", 52, 197], ["covid", "TEST", 88, 93], ["za-energ", "TEST", 103, 111], ["etica", "TEST", 112, 117], ["conta", "TEST", 121, 126], ["minac", "TEST", 127, 132], ["la", "TEST", 152, 154], ["vulne", "TEST", 155, 160], ["idad", "TEST", 167, 171]]], ["Cifras deforestaci\u00f3n en el bioma Amaz\u00f3nico, Enero-Abril 2020.https :// fcds.org.co/site/wp-conte nt/uploa ds/2020/06/defor estac ion_2020.pdf Accessed 10 June 2020 Greenpeace Brasil (2020).", [["https :// fcds.org.co/site/wp-conte nt/uploa ds/2020/06/defor estac ion_2020.pdf", "SPECIES", 61, 141], ["Cifras", "TREATMENT", 0, 6]]], ["Desmatamento em terras ind\u00edgenas aumenta 59% em 2020. https ://www.green peace .org/brasi l/press /desma tamen to-em-terra s-indig enas-aumen ta-59-duran te-a-pande mia-da-covid -19/ Accessed 8 June 2020 Helm D (2020) .", [["brasi l", "ORGANISM", 84, 91], ["desma", "ORGANISM", 99, 104], ["tamen", "ORGANISM", 105, 110], ["https ://www.green peace .org/brasi l/press /desma tamen to-em-terra s-indig enas-aumen ta-59-duran te-a-pande mia-da-covid -19/ Accessed 8 June 2020 Helm D", "SPECIES", 54, 210]]], ["Contributing to a global effort.", [["global effort", "OBSERVATION", 18, 31]]], ["Roa S (2020) Medidas para enfrentar al Covid-19 mejoran calidad del aire en dos ciudades ecuatorianas.", [["Medidas para enfrentar al Covid-19 mejoran calidad", "TREATMENT", 13, 63]]], ["Infobae. https ://www.infob ae.com/socie dad/2020/03/27/por-lacuare ntena -la-conta minac ion-del-aire-bajo-a-la-mitad -en-la-ciuda d-de-bueno s-aires / Accessed 10 June 2020 Resource exporters are now facing new urgent economic policy challenges due to COVID-19.", [["https ://www.infob ae.com/socie dad/2020/03/27/por-lacuare ntena -la-conta minac ion-del-aire-bajo-a-la-mitad", "SPECIES", 9, 118], ["lacuare", "TEST", 60, 67], ["ntena", "TEST", 68, 73], ["new urgent economic policy challenges", "TREATMENT", 209, 246], ["COVID", "TEST", 254, 259], ["aire", "OBSERVATION", 98, 102]]], ["These challenges are aggravated due to their dependence on finite commodities with volatile prices and demand.", [["volatile prices", "TREATMENT", 83, 98], ["volatile prices", "OBSERVATION", 83, 98]]], ["In response to the pandemic, resource exporters (such as Botswana and Saudi Arabia) announced cuts in expenditures along with large fiscal (tax relief) and consumption-focused macroeconomic stimulus packages.", [["large fiscal (tax relief", "TREATMENT", 126, 150], ["macroeconomic stimulus packages", "TREATMENT", 176, 207], ["large", "OBSERVATION_MODIFIER", 126, 131]]], ["Critically, the novel issues raised by the coronavirus pandemic bring new trade-offs of energy policy between shortterm gains and long-term sustainability, creating an urgent need for critical, quantitative, policy-focused research in the resource exporters-energy policy nexus.ReferencesA few novel issues emerged in resource exporters during the pandemic that give rise to short-term economic challenges.", [["coronavirus", "DISEASE", 43, 54], ["coronavirus", "ORGANISM", 43, 54], ["the novel issues", "PROBLEM", 12, 28], ["long-term sustainability", "PROBLEM", 130, 154], ["short-term economic challenges", "PROBLEM", 375, 405]]], ["First, price shocks of unprecedented magnitude for commodities (Deutsche Bank 2020; World Bank 2020), from coffee (Hernandez et al. 2020) to hydrocarbons (IEA 2020b), causing a large drop in energy investment (IEA 2020a).", [["hydrocarbons", "CHEMICAL", 141, 153], ["hydrocarbons", "CHEMICAL", 141, 153], ["a large drop in energy investment", "PROBLEM", 175, 208], ["large", "OBSERVATION_MODIFIER", 177, 182], ["drop", "OBSERVATION", 183, 187], ["energy investment", "OBSERVATION", 191, 208]]], ["For oil, prices dropped initially due to travel bans and economic activities hiatus, and further with oil price wars following the collapse of OPEC + agreement.", [["oil", "ANATOMY", 4, 7], ["oil", "ORGANISM_SUBSTANCE", 4, 7], ["oil", "ORGANISM_SUBSTANCE", 102, 105], ["prices", "TREATMENT", 9, 15], ["economic activities hiatus", "PROBLEM", 57, 83], ["collapse", "OBSERVATION", 131, 139]]], ["By April 2020, with oversupply, the rise of stockpiles, and the saturation of available oil storage, oil prices reached the lowest level in more than 20 years, and West Texas Intermediate (WTI) reached negative levels for the first time.", [["oil", "ANATOMY", 88, 91], ["oil", "ANATOMY", 101, 104], ["oil", "ORGANISM_SUBSTANCE", 88, 91], ["oil", "ORGANISM_SUBSTANCE", 101, 104], ["the rise of stockpiles", "PROBLEM", 32, 54], ["available oil storage", "TREATMENT", 78, 99], ["oil prices", "TREATMENT", 101, 111]]], ["Prices have subsequently partially recovered but are expected to remain low with continuous fears of new COVID-19 waves and uncertain demand.", [["new COVID", "TREATMENT", 101, 110]]], ["Second, unprecedented economic contraction, because the pandemic-triggered decline in economic activity was significantly exacerbated by declines in export revenue.", [["the pandemic-triggered decline", "PROBLEM", 52, 82], ["unprecedented", "OBSERVATION_MODIFIER", 8, 21], ["economic contraction", "OBSERVATION", 22, 42]]], ["Third, unprecedented fiscal pressure, resulting from costs of fiscal and economic stimulus packages plus a simultaneous rise in domestic expenses (especially healthcare and unemployment benefits) and sharp declines in resource export revenue.", [["economic stimulus packages", "TREATMENT", 73, 99], ["sharp declines", "PROBLEM", 200, 214], ["unprecedented", "OBSERVATION_MODIFIER", 7, 20], ["fiscal pressure", "OBSERVATION", 21, 36], ["simultaneous", "OBSERVATION_MODIFIER", 107, 119], ["rise", "OBSERVATION_MODIFIER", 120, 124], ["domestic expenses", "OBSERVATION", 128, 145]]], ["Fourth, record and continuous withdrawals from SWFs to fund post-pandemic recovery along with reallocation of funds and increased government debt (examples in Arabian Business 2020; Holter and Bloomberg 2020).", [["continuous withdrawals", "PROBLEM", 19, 41], ["fund post-pandemic recovery", "TREATMENT", 55, 82]]], ["Fifth, in oil-exporting Gulf states, the unusual stay of millions of citizens and guest workers in the upcoming scorching summer in lieu of usual tourism travel or home-country visits, pressuring existing energy capacity.ReferencesCritically, in oil exporters, these novel issues and policy responses to them further expose existing economic fragilities and challenges, threatening long-term economic and environmental sustainability.", [["oil", "ORGANISM_SUBSTANCE", 246, 249]]], ["For distorted oil economies in urgent need for economic diversification, said diversification and reverse Dutch disease are impeded by their existing high distortions in labour, fiscal, industrial and energy markets (Shehabi 2020) .", [["distorted oil economies", "PROBLEM", 4, 27], ["economic diversification", "TREATMENT", 47, 71], ["reverse Dutch disease", "PROBLEM", 98, 119], ["high distortions in labour", "PROBLEM", 150, 176], ["oil economies", "OBSERVATION", 14, 27], ["high distortions", "OBSERVATION", 150, 166]]], ["Oil exporters suffer from economic inefficiencies resulting from pervasive oligopolies (Shehabi 2017) and market failure in long-run contracts for exploration and development of natural resources (Ruta and Venables 2012).", [["oligopolies", "DISEASE", 75, 86], ["economic inefficiencies", "PROBLEM", 26, 49], ["pervasive oligopolies", "PROBLEM", 65, 86], ["market failure", "PROBLEM", 106, 120], ["exploration", "TEST", 147, 158], ["economic inefficiencies", "OBSERVATION", 26, 49], ["failure", "OBSERVATION", 113, 120]]], ["Fossil fuels are the primary source of energy in most oil exporters.", [["oil", "ANATOMY", 54, 57], ["oil", "ORGANISM_SUBSTANCE", 54, 57]]], ["In developing oil exporters, the dominant political economy undergirding policy making is a welfare rentier state, in which maintaining a political equilibrium is central.", [["oil", "ORGANISM_SUBSTANCE", 14, 17], ["oil exporters", "OBSERVATION", 14, 27], ["dominant", "OBSERVATION_MODIFIER", 33, 41], ["political", "OBSERVATION_MODIFIER", 42, 51], ["central", "OBSERVATION_MODIFIER", 163, 170]]], ["Balancing spending-saving decisions for sustainable resource rents management depends on the sustainability of windfall expectations (Gelb and Grassmann 2010).", [["sustainable resource rents management", "TREATMENT", 40, 77]]], ["Yet the novel issues create new trade-offs of post-pandemic energy policy: achieving short-term gains will be at the expense of longterm gains in resource economies.", [["the novel issues", "PROBLEM", 4, 20], ["new", "OBSERVATION_MODIFIER", 28, 31]]], ["Thus, it is critical for fast policy-focused research to address the resource exporters-energy policy nexus, especially in the following two areas.Trade-offs between energy transition and economic recovery.Although investments in renewables have been more resilient than in fossil fuels, and while we have seen an increased share of global energy spending on clean energy technologies in 2020 (IEA 2020a), the reality in hydrocarbon-exporting developing states is different.", [["hydrocarbon", "CHEMICAL", 421, 432], ["hydrocarbon", "SIMPLE_CHEMICAL", 421, 432], ["economic recovery", "TREATMENT", 188, 205], ["different", "OBSERVATION_MODIFIER", 464, 473]]], ["Global oil market supply and demand dynamics have raised their opportunity cost for transitioning away from fossil fuels and for investing in green technology.", [["oil", "ANATOMY", 7, 10], ["oil", "OBSERVATION_MODIFIER", 7, 10]]], ["Accordingly, post-pandemic economic stimuli might achieve short-term recovery but harm long-term energy transition.", [["post-pandemic economic stimuli", "TREATMENT", 13, 43], ["harm long-term energy transition", "PROBLEM", 82, 114]]], ["First, the rise in opportunity costs of energy transition will facilitate the reallocation of funds away from renewables projects towards post-pandemic economic stimuli (similar to \"green tape\" cuts in Australia and Canada).", [["rise", "OBSERVATION_MODIFIER", 11, 15]]], ["Second, recovering lost investments in energy transition projects is unlikely because the resource rents that fund them are likely to continue to be low in the future, given low resource prices and demand pressures of climate change mitigation.", [["low resource prices", "TREATMENT", 174, 193], ["demand pressures", "TREATMENT", 198, 214], ["climate change mitigation", "TREATMENT", 218, 243]]], ["Third, continuous withdrawals of diminishing SWFs will entail limited resources for future energy transition projects.", [["diminishing SWFs", "PROBLEM", 33, 49], ["future energy transition projects", "TREATMENT", 84, 117]]], ["This is especially so as recovering SWFs' withdrawals is unlikely in the light of expected low resource export revenue and the collapse in financial and commodity markets accompanying the unprecedented global recession.", [["recovering SWFs' withdrawals", "PROBLEM", 25, 53], ["the collapse in financial and commodity markets", "PROBLEM", 123, 170], ["the unprecedented global recession", "PROBLEM", 184, 218], ["collapse", "OBSERVATION", 127, 135], ["unprecedented", "OBSERVATION_MODIFIER", 188, 201], ["global recession", "OBSERVATION", 202, 218]]], ["19 Finally, economic stimuli expand consumption and welfare redistributive measures, which increase greenhouse gas (GHG) emissions ) and exacerbate existing distortions that have been shown to prevent economic and energy diversification (Shehabi 2020) .Trade-offs between energy transition and economic recovery.New research should investigate the design and implementation of new economic solutions that have at their forefront long-term energy transition goals along with short-term economic recovery.", [["welfare redistributive measures", "TREATMENT", 52, 83], ["existing distortions", "PROBLEM", 148, 168], ["economic recovery", "TREATMENT", 294, 311], ["new economic solutions", "TREATMENT", 377, 399]]], ["A policy solution to target consumers is technological advancements (both private and public funded) in energy efficiency coupled with economic incentives to rationalize energy consumption.", [["A policy solution", "TREATMENT", 0, 17], ["technological advancements", "TREATMENT", 41, 67]]], ["This policy combination can achieve energy transition goals despite expected delays in renewables and without requiring large multiyear investments.", [["large multiyear investments", "TREATMENT", 120, 147]]], ["It is especially important in Gulf oil states where skyrocketing cooling and desalination needs in the summer will be met using fossil fuels (renewables contribute less than 1% of power generation).", [["skyrocketing cooling", "TREATMENT", 52, 72], ["fossil fuels", "TREATMENT", 128, 140]]], ["A policy suggestion at the sectoral level is investing in clean energy technologies to decarbonize the energy sector itself, namely through carbon capture and storage as well as hydrogen.", [["hydrogen", "CHEMICAL", 178, 186], ["carbon", "CHEMICAL", 140, 146], ["hydrogen", "CHEMICAL", 178, 186], ["hydrogen", "SIMPLE_CHEMICAL", 178, 186], ["carbon capture", "TREATMENT", 140, 154]]], ["Beyond short-term economic and environmental benefits, these investments can keep oil exporters relevant in a future with a diminishing role of hydrocarbons and collapsing commodity prices.", [["hydrocarbons", "CHEMICAL", 144, 156], ["hydrocarbons", "SIMPLE_CHEMICAL", 144, 156]]], ["The final policy suggestion is microeconomic and energy policy reform that can moderate effects of export price declines on the economy without the need for additional cuts in renewables investments or further withdrawals from SWFs.", [["SWFs", "DISEASE", 227, 231], ["additional cuts in renewables investments", "TREATMENT", 157, 198], ["further withdrawals from SWFs", "PROBLEM", 202, 231]]], ["Examples include microeconomic reforms of labour and human capital to increase long-term productive capacity and oligopoly regulation in non-tradables and energy sectors which can increase efficiency and welfare gains that translate economywide (Shehabi 2020) .", [["human", "ORGANISM", 53, 58], ["oligopoly", "SIMPLE_CHEMICAL", 113, 122], ["human", "SPECIES", 53, 58], ["human", "SPECIES", 53, 58], ["long-term productive capacity", "PROBLEM", 79, 108], ["increase", "OBSERVATION_MODIFIER", 70, 78], ["long-term productive capacity", "OBSERVATION_MODIFIER", 79, 108]]], ["Consequently, resource rents could be salvaged for SWFs resources or investments necessary for future development.Negative long-term effects of energy and carbon pricing policy on the environment.In the light of the aforementioned novel issues in resource exporters, the postpandemic energy policy and economic stimulus packages are likely to have negative long-term effects on the environment.", [["carbon", "CHEMICAL", 155, 161], ["carbon", "SIMPLE_CHEMICAL", 155, 161], ["resource rents", "TREATMENT", 14, 28], ["SWFs resources", "TREATMENT", 51, 65], ["carbon pricing policy", "TREATMENT", 155, 176], ["the postpandemic energy policy", "TREATMENT", 267, 297], ["economic stimulus packages", "TREATMENT", 302, 328], ["long-term effects", "OBSERVATION_MODIFIER", 123, 140], ["long-term effects", "OBSERVATION_MODIFIER", 357, 374]]], ["First, while lockdown measures that minimized transportation and human activity reduced short-term emissions, they also increased power demand which in resource exporters is met mostly through fossil fuels, especially as international demand and prices remain low.", [["human", "ORGANISM", 65, 70], ["human", "SPECIES", 65, 70], ["human", "SPECIES", 65, 70]]], ["Second, short-term improvements will be negated upon the resumption of human activity, absent changes in energy policy regimes.", [["human", "ORGANISM", 71, 76], ["human", "SPECIES", 71, 76], ["human", "SPECIES", 71, 76], ["energy policy regimes", "TREATMENT", 105, 126], ["short-term", "OBSERVATION_MODIFIER", 8, 18]]], ["Third, there will be limited resources in the future to dedicate towards environmental regulation and GHG emissions reduction.", [["GHG emissions reduction", "TREATMENT", 102, 125]]], ["Fourth, GHG emissions will increase due to consumption-focused economic stimulus packages and expanded use of fossil fuels to meet rising energy demand.", [["economic stimulus packages", "TREATMENT", 63, 89], ["fossil fuels", "TREATMENT", 110, 122], ["rising energy demand", "PROBLEM", 131, 151], ["GHG emissions", "OBSERVATION", 8, 21]]], ["This is particularly problematic because even prior to the advent of the pandemic, resource exporters were among the highest energy consumers and carbon emitters globally.", [["carbon", "CHEMICAL", 146, 152], ["carbon emitters", "TREATMENT", 146, 161]]], ["Indeed, the ten highest per capita carbon emitters are all resource exporters, with emissions ranging from 49 tonnes (t) per capita (Qatar) to 16.7 t per capita (Kazakhstan), more than 3.5 times the global average of 4.8 t per capita (Ritchie and Roser 2017) .", [["carbon", "CHEMICAL", 35, 41]]], ["Finally, and most importantly, the implementation of policy instruments-namely energy subsidy reform and carbon taxes-to achieve resource exporters' Intended Nationally Determined Contributions (INDCs), is rendered significantly more difficult post-pandemic.", [["carbon", "CHEMICAL", 105, 111], ["policy instruments", "TREATMENT", 53, 71], ["carbon taxes", "TREATMENT", 105, 117]]], ["It is a consequence of the magnitude of novel economic contraction and fiscal pressures in welfare-based states.", [["fiscal pressures", "TEST", 71, 87], ["economic contraction", "OBSERVATION", 46, 66], ["fiscal pressures", "OBSERVATION", 71, 87]]], ["These additional political constraints exacerbate environmental laws' enforcement, for which there already was a widespread failure in resource exporters (UNEP 2019).Negative long-term effects of energy and carbon pricing policy on the environment.Therefore, new research must quantify effects of proposed economic stimuli and of rising use of fossil fuels on resource exporters' environment and economy and accordingly evaluate and design new alternative policies that can achieve short-term recovery and national climate target goals.", [["carbon", "CHEMICAL", 207, 213], ["carbon", "SIMPLE_CHEMICAL", 207, 213], ["a widespread failure", "PROBLEM", 111, 131], ["carbon pricing policy", "TREATMENT", 207, 228], ["widespread", "OBSERVATION_MODIFIER", 113, 123], ["failure", "OBSERVATION", 124, 131], ["long-term effects", "OBSERVATION_MODIFIER", 175, 192]]], ["First, reducing emissions in ways other than the politically difficult tax instruments, mainly through enhancing energy efficiency that reduces emissions at a given consumption level coupled with economic incentives that reduce energy consumption.", [["enhancing energy efficiency", "PROBLEM", 103, 130], ["economic incentives", "TREATMENT", 196, 215], ["enhancing", "OBSERVATION_MODIFIER", 103, 112], ["energy efficiency", "OBSERVATION", 113, 130]]], ["Second, implementing carbon tax instruments in ways that do not harm the most vulnerable of populations and reduce resource exporters' fiscal distortions, thus achieving a \"double dividend\".", [["carbon", "CHEMICAL", 21, 27], ["carbon tax instruments", "TREATMENT", 21, 43], ["carbon tax", "OBSERVATION", 21, 31], ["fiscal distortions", "OBSERVATION", 135, 153]]], ["Third, in the light of the novel issues, a key policy solution is adopting \"green welfare expansion\": including green options in the typical post-pandemic welfare packages at lower governmental budgetary requirements.", [["the novel issues", "PROBLEM", 23, 39], ["a key policy solution", "TREATMENT", 41, 62], ["lower", "ANATOMY_MODIFIER", 175, 180], ["governmental budgetary", "OBSERVATION", 181, 203]]], ["Examples include expanding subsidies for green technologies (such as solar panels, public transportation or electric cars), as well as excluding from subsidies non-essential high-carbon-emitting products for households above a certain income level.", [["carbon", "CHEMICAL", 179, 185], ["green technologies", "PROBLEM", 41, 59], ["solar panels", "TEST", 69, 81], ["non-essential high-carbon-emitting products", "TREATMENT", 160, 203]]], ["Fourth, increasing the political viability of green recovery packages (such as clean physical infrastructure and natural capital investments), including engaging the private sector in initiatives that are typically public-led-such as climate finance, renewables expansion and resource mobilization.", [["green recovery packages", "TREATMENT", 46, 69], ["resource mobilization", "TREATMENT", 276, 297], ["increasing", "OBSERVATION_MODIFIER", 8, 18], ["political", "OBSERVATION_MODIFIER", 23, 32], ["viability", "OBSERVATION_MODIFIER", 33, 42], ["green recovery", "OBSERVATION", 46, 60]]], ["This policy is critical because, although green recovery packages may boost economic growth while helping climate change , they are politically contentious in resource exporters where they compete with welfare distribution.Negative long-term effects of energy and carbon pricing policy on the environment.Critically, applicable to the aforesaid two research areas, the pandemic offers resource exporters an opportunity to engage in a comprehensive reform agenda that addresses short-term pandemic effects while advancing long-term energy transition, economic and resource sustainability.", [["carbon", "CHEMICAL", 264, 270], ["carbon", "SIMPLE_CHEMICAL", 264, 270], ["green recovery packages", "TREATMENT", 42, 65], ["economic growth", "PROBLEM", 76, 91], ["carbon pricing policy", "TREATMENT", 264, 285], ["short-term pandemic effects", "PROBLEM", 477, 504], ["advancing long-term energy transition", "TREATMENT", 511, 548], ["long-term effects", "OBSERVATION_MODIFIER", 232, 249]]], ["Properly coordinated policy reforms offer an avenue to address inefficiencies and underlying structural distortions in a way to realize mutual gains and multiple policy objectives at the lowest cost.Negative long-term effects of energy and carbon pricing policy on the environment.In designing these reforms and addressing the two areas above, the most suitable research methods are economy-wide general equilibrium models that can quantify effects of shocks and policy solutions in a \"second-best\" environment.", [["carbon", "CHEMICAL", 240, 246], ["carbon", "SIMPLE_CHEMICAL", 240, 246], ["underlying structural distortions", "PROBLEM", 82, 115], ["carbon pricing policy", "TREATMENT", 240, 261], ["policy solutions", "TREATMENT", 463, 479], ["long-term effects", "OBSERVATION_MODIFIER", 208, 225]]], ["This feature is necessary given the large existing economic distortions in resource economies.", [["the large existing economic distortions", "PROBLEM", 32, 71], ["resource economies", "TREATMENT", 75, 93], ["large", "OBSERVATION_MODIFIER", 36, 41], ["economic distortions", "OBSERVATION", 51, 71], ["resource economies", "OBSERVATION", 75, 93]]], ["These models represent economic linkages and agents and include a wide range of policies (energy, carbon, fiscal, labour or industrial).", [["carbon", "CHEMICAL", 98, 104], ["agents", "TREATMENT", 45, 51], ["economic linkages", "OBSERVATION", 23, 40]]], ["This research will be critical for filling gaps in the literature on long-term economic and resource sustainability in resource exporters.IntroductionThe current global greenhouse gas (GHG) emissions trajectory indicates that the world is likely to experience catastrophic consequences due to climate change, unless swift action is taken towards funding green solutions and the defunding of fossil fuel activities ( Given the ambition of the European Union to become a net zero-carbon economy by 2050 and the numerous calls to avoid the bailout and stimulus packages towards fossil fuel companies , we examine whether the features of the European Central Bank's (ECB) \u20ac1350 billion Pandemic Emergency Purchase Programme (PEPP) encourages the resilience of the incumbent fossil fuel sector, or whether it promotes the growth of the emerging low-carbon energy sector during the COVID-19 pandemic and beyond.IntroductionWe draw on a novel dataset of corporate bonds issued in the European energy sector between 1 January 2020 and 19 June 2020 in combination with the European Central Bank's (ECB) purchases under the Pandemic Emergency Purchase Programme in response to COVID-19.", [["GHG", "CHEMICAL", 185, 188], ["carbon", "CHEMICAL", 844, 850], ["filling gaps", "PROBLEM", 35, 47], ["catastrophic consequences", "PROBLEM", 260, 285], ["green solutions", "TREATMENT", 354, 369], ["fossil fuel activities", "PROBLEM", 391, 413], ["a net zero-carbon economy", "TREATMENT", 467, 492], ["the bailout and stimulus packages", "TREATMENT", 533, 566], ["the COVID", "TEST", 872, 881], ["COVID", "TEST", 1167, 1172]]], ["We show that the likelihood of an energy company bond to be bought as part of the ECB's programme increases with the GHG intensity of the bond issuing firm.", [["ECB", "PROTEIN", 82, 85], ["the ECB", "TEST", 78, 85], ["firm", "OBSERVATION", 151, 155]]], ["We also find weaker evidence that the ECB's PEPP portfolio during the pandemic is likely to become tilted towards companies with anti-climate lobbying activities and companies with less transparent GHG emissions disclosure in the event of increased Euro-denominated bond issuances in the following months, or re-denominations of non-Euro bonds already issued by European energy companies. kainen et al. 2017 ).", [["non-Euro", "CHEMICAL", 329, 337], ["the ECB", "TEST", 34, 41], ["non-Euro bonds", "PROBLEM", 329, 343], ["GHG emissions", "OBSERVATION", 198, 211], ["denominated bond", "OBSERVATION", 254, 270]]], ["That does not mean, however, that the aim of central banks to remain sector neutral is achievable in practice, as the implementation of ECB's post-2008 quantitative easing shows that assets purchased by central banks to stimulate overall economic growth are benefitting more from the policy than assets which are not purchased by the bank (Haldane et al. 2016; Matikainen et al. 2017) .", [["ECB", "TEST", 136, 139]]], ["This is particularly important in the low-carbon economy context, as the fossil fuel energy sector is largely financed through bonds and syndicated bank loans (Cojoianu et al. 2019) , whereas much of the emerging clean technology companies are financed through private equity, equity issuances and asset financing (Cojoianu et al. 2020; Gaddy et al. 2017) .Many central banks remain of the view that central bank interventions should be marketneutral and not discriminate between sectors in the low-carbon energy transition (MatiGiven that the ECB has chosen to enact its asset purchasing program post-2008 crisis predominantly through bonds, this has been shown to favour the incumbent fossil fuel industry (Battiston and Monasterolo 2019; Matikainen et al. 2017) , as 62% of ECB's corporate bond purchases (out of a total of \u20ac82 billion) are in GHG intensive sectorsthough they make up only 18% of the Eurozone area economy and produce 59% of GHG emissions.Many central banks remain of the view that central bank interventions should be marketneutral and not discriminate between sectors in the low-carbon energy transition (MatiThe criteria for the corporate bonds bought under the PEPP are that: (i) the company must be incorporated in the Eurozone and its bond issuance denominated in Euro, (ii) the firm cannot be a financial corporation (or a credit institution supervised by the ECB), (iii) it cannot be a public entity, (iv) the bond issuance has to be endorsed by one positive credit rating by an external credit assessment institution accepted within the Eurosystem credit assessment framework and (v) they have a maximum maturity of up to 31 years and a minimum maturity of 6 months.Data and MethodologyIn order to understand whether the ECB's bond buying activity during the COVID-19 pandemic has been tilted towards less transparent, more fossil fuel intensive as well as anticlimate lobbying European energy companies, we undertake the following steps.", [["Eurozone", "CHEMICAL", 1244, 1252], ["carbon", "CHEMICAL", 42, 48], ["carbon", "CHEMICAL", 499, 505], ["carbon", "CHEMICAL", 1101, 1107], ["central bank interventions", "TREATMENT", 400, 426], ["central bank interventions", "TREATMENT", 1002, 1028], ["an external credit assessment", "TEST", 1504, 1533], ["the COVID", "TEST", 1784, 1793], ["central banks", "OBSERVATION", 362, 375], ["carbon energy", "OBSERVATION", 499, 512], ["GHG emissions", "OBSERVATION", 945, 958], ["central banks", "OBSERVATION", 964, 977], ["firm", "OBSERVATION", 1305, 1309]]], ["These span the following energy subsectors as classified by Bloomberg Industry Classification System (BICS): power generation, renewable energy, integrated oil and gas companies, oil and gas exploration and production, oil and gas services and utilities.", [["oil", "ORGANISM_SUBSTANCE", 179, 182], ["oil", "ORGANISM_SUBSTANCE", 219, 222], ["gas companies", "TREATMENT", 164, 177], ["gas exploration", "TEST", 187, 202]]], ["Our resulting dataset with complete data across all variables of interest is comprised of a cross-section of 68 bonds issued across several currencies, and 52 Eurodenominated bonds.Data and MethodologyOur dependent variable quantifies the likelihood that the bond of a European energy company is bought by the ECB during the first 5 months of 2020 and coded as 1 if it has been bought by the ECB, and 0 if it has not.", [["Eurodenominated bonds", "OBSERVATION", 159, 180]]], ["The full model specification is the following, where \u03b5 i is the stochastic error:Results and DiscussionWe show that after controlling for the revenue of the issuer, the bond amount raised and the rate of the coupon, the ECB is statistically significantly more likely to buy the bonds of more GHG intensive European energy companies (Models 1-4, Table 1 ).", [["Models", "TEST", 333, 339]]], ["On average, a one standard deviation increase in the GHG intensity of an energy company results in a 147% increase in the likelihood that its bonds are bought by the ECB (\u03b2 = 0.907, p < 0.01, odds ratio: 2.47, Model 3).Results and DiscussionWhen we consider only Euro-denominated bonds (Models 2 and 3), which are directly under the remit of the ECB, GHG disclosure completeness and pro-climate lobbying are statistically insignificant, yet negative, which suggests that the ECB may be likely to tilt its portfolio towards companies with poorer GHG emission disclosures and less responsible climate lobbying activities.", [["a one standard deviation increase", "PROBLEM", 12, 45], ["the ECB", "TEST", 162, 169], ["odds ratio", "TEST", 192, 202], ["GHG disclosure completeness", "TEST", 351, 378], ["increase", "OBSERVATION_MODIFIER", 37, 45], ["GHG", "OBSERVATION_MODIFIER", 53, 56], ["intensity", "OBSERVATION_MODIFIER", 57, 66], ["increase", "OBSERVATION_MODIFIER", 106, 114]]], ["Subsequently, we include the bonds issued by European energy companies in denominations other than Euro, to account for potential sample selection bias due to the choice of energy companies to abstain from issuing Euro-denominated bonds as they may have received discouraging signals from the ECB.", [["ECB", "PROTEIN", 293, 296]]], ["In other words, analysing the bond issuance of European energy companies in all currencies considers signals that the ECB may have given to the energy companies prior to issuance, while analysing only Euro-denominated bonds only considers the observable decision of the ECB to purchase the bonds of specific energy companies post-issuance.", [["ECB", "PROTEIN", 270, 273]]], ["When we do so (Model 4), it emerges that considering the entire universe of bonds issued by European energy companies, the ECB's portfolio is tilted not only to those energy companies that are more GHG intensive, but also to companies which are less transparent on their GHG Performance as well as those companies who are more likely to oppose progressive climate action.", [["progressive climate action", "PROBLEM", 344, 370]]], ["Inspecting the economic relevance of the GHG intensity variable in Model 3, we find GHG intensity to have the largest marginal effects.", [["the GHG intensity", "TEST", 37, 54], ["largest", "OBSERVATION_MODIFIER", 110, 117], ["marginal effects", "OBSERVATION", 118, 134]]], ["In conclusion, the importance of GHG intensity is underlined by its marginal economic effects and its statistical relevance, as it explains more variation in the dependent variable on its own than all other variables taken together.", [["GHG intensity", "OBSERVATION", 33, 46], ["dependent", "OBSERVATION_MODIFIER", 162, 171], ["variable", "OBSERVATION_MODIFIER", 172, 180]]], ["We also conduct further robustness tests controlling for ECB Bond i = 0 + 1 * Pro-Climate Lobbying Activities Score i + 2 * GHG Emissions Intensity i + 3 * GHG Reporting Completeness i + 4 * Borrower Revenue i + 5 * Bond Issuance Amount i + 6 * Bond Coupon Rate i + i . bond maturity, bond rating and interactions of key variables and find our results to remain statistically significant.", [["further robustness tests", "TEST", 16, 40], ["ECB Bond i", "TEST", 57, 67], ["Lobbying Activities Score i", "TEST", 90, 117], ["GHG Emissions", "TEST", 124, 137], ["Completeness", "TEST", 170, 182], ["Bond Issuance Amount i", "TEST", 216, 238], ["bond maturity", "PROBLEM", 270, 283], ["bond rating", "TEST", 285, 296]]], ["21 In conclusion, drawing on a novel dataset of corporate bonds issued in the European energy sector since January 2020 and the database of ECB's purchases under the PEPP in response to COVID-19, we find evidence that the likelihood for a bond to be bought by the ECB increases with the GHG intensity of the bond issuing firm.", [["ECB", "PROTEIN", 264, 267], ["the PEPP", "TEST", 162, 170], ["COVID", "TEST", 186, 191], ["firm", "OBSERVATION", 321, 325]]], ["We also find weaker evidence that the ECB's PEPP portfolio during the pandemic is likely to become tilted towards companies with anti-climate lobbying activities and companies with less transparent GHG emissions disclosure.Results and DiscussionOur findings imply that, at later stages of the COVID-19 recovery, an in-depth analysis may be necessary to understand if, and if yes, why the ECB fuelled the climate crisis.", [["the ECB", "TEST", 34, 41], ["an in-depth analysis", "TEST", 312, 332], ["GHG emissions", "OBSERVATION", 198, 211]]], ["Even if one accepts that fossil fuel companies were eligible for PEPP, then our preliminary evidence still raises the significant question, why the ECB was more likely to directly finance those fossil fuel firms that are likely more harmful to the planet (i.e. have a higher GHG intensity)?Karaoli & A. Dimitriou St., 18534 Piraeus GreeceThe coronavirus COVID-19 pandemic is the defining global health crisis of our time, causing over half a million deaths to date (1 July 2020).", [["coronavirus COVID-19 pandemic", "DISEASE", 342, 371], ["deaths", "DISEASE", 450, 456], ["coronavirus COVID-19", "ORGANISM", 342, 362], ["coronavirus", "SPECIES", 342, 353], ["coronavirus COVID-19", "SPECIES", 342, 362], ["PEPP", "TREATMENT", 65, 69], ["The coronavirus COVID", "TEST", 338, 359], ["coronavirus", "OBSERVATION_MODIFIER", 342, 353], ["global", "OBSERVATION_MODIFIER", 388, 394], ["health crisis", "OBSERVATION", 395, 408]]], ["23 But COVID-19 is much more than a health crisis, it has tremendous socioeconomic impact, the scale of which is still hard to assess.", [["COVID", "TEST", 7, 12], ["tremendous", "OBSERVATION_MODIFIER", 58, 68]]], ["Social isolation measures to \"flatten the curve of the pandemic\" buy time to increase capacity in the healthcare sector but inevitably deepen the macroeconomic recession.Karaoli & A. Dimitriou St., 18534 Piraeus GreeceThe World Bank 24 expect the global economy contract by 5.2% in 2020, approximately three times the size of the 2008-2009 Great Financial Crisis (GFC) and far more widespread.", [["Social isolation measures", "TREATMENT", 0, 25], ["the macroeconomic recession", "PROBLEM", 142, 169], ["GFC", "TEST", 364, 367], ["macroeconomic recession", "OBSERVATION", 146, 169], ["size", "OBSERVATION_MODIFIER", 318, 322], ["widespread", "OBSERVATION_MODIFIER", 382, 392]]], ["Emerging Markets and Developing Economies (EMDEs) have been severely hit by massive capital outflows, reducing debt servicing abilities (especially for dollardenominated debt) and generating long-term challenges; \"With more than 90% of EMDEs expected to experience contractions in per capita incomes this year, many millions are likely to fall back into poverty\" (World Bank 2020).Karaoli & A. Dimitriou St., 18534 Piraeus GreeceThe economic consequences of the adverse coronavirus shock are: (i) an elevation of uncertainty, which increases precautionary savings, thus reducing consumption and also curtails the appetite for productive investments; (ii) a rise in unemployment, part of which is likely to be permanent; (iii) a decline in the volume of international trade and disruptions in global supply chains; (iv) falls in commodity prices (especially the price of oil), making current account financing of traditional commodity exports challenging; (v) a sharp increase in the required risk premia for holding risky assets.", [["coronavirus shock", "DISEASE", 470, 487], ["oil", "ORGANISM_SUBSTANCE", 870, 873], ["massive capital outflows", "PROBLEM", 76, 100], ["contractions", "PROBLEM", 265, 277], ["the adverse coronavirus shock", "PROBLEM", 458, 487], ["an elevation of uncertainty", "PROBLEM", 497, 524], ["a decline", "PROBLEM", 726, 735], ["disruptions in global supply chains", "PROBLEM", 777, 812], ["a sharp increase", "PROBLEM", 959, 975], ["Economies", "OBSERVATION", 32, 41], ["severely", "OBSERVATION_MODIFIER", 60, 68], ["hit", "OBSERVATION", 69, 72], ["massive", "OBSERVATION_MODIFIER", 76, 83], ["capital outflows", "OBSERVATION", 84, 100], ["adverse", "OBSERVATION_MODIFIER", 462, 469], ["coronavirus shock", "OBSERVATION", 470, 487], ["elevation", "OBSERVATION", 500, 509], ["likely to be", "UNCERTAINTY", 696, 708], ["permanent", "OBSERVATION", 709, 718], ["sharp", "OBSERVATION_MODIFIER", 961, 966], ["increase", "OBSERVATION_MODIFIER", 967, 975]]], ["This initially resulted in a plunge in prices of risky assets (e.g. stocks or high-yield bonds) and a sharp increase in financial volatility.", [["high-yield bonds", "PROBLEM", 78, 94], ["a sharp increase in financial volatility", "PROBLEM", 100, 140], ["sharp", "OBSERVATION_MODIFIER", 102, 107], ["increase", "OBSERVATION_MODIFIER", 108, 116], ["financial volatility", "OBSERVATION", 120, 140]]], ["However, Central Bank interventions (especially by the Federal Reserve of the United States of America-US FED) have seen recoveries from March 2020.Karaoli & A. Dimitriou St., 18534 Piraeus GreeceExtraordinary macroeconomic policy response, on both the fiscal and monetary fronts, has slowed the rates of economic decline.", [["Central Bank interventions", "TREATMENT", 9, 35], ["economic decline", "PROBLEM", 305, 321], ["Central Bank", "OBSERVATION", 9, 21], ["macroeconomic policy", "OBSERVATION", 210, 230], ["slowed", "OBSERVATION_MODIFIER", 285, 291], ["economic decline", "OBSERVATION", 305, 321]]], ["In many countries, fiscal measures have replaced a proportion of lost incomes and mitigated default risk, loan guarantees have helped keep businesses afloat, and liquidity provision by central banks have kept the financial system functional.", [["fiscal measures", "TREATMENT", 19, 34]]], ["Fiscal authorities in European and the USA took measures that can be classified within three broad categories: immediate fiscal measures and direct transfers to households; tax deferrals and liquidity measures; and loan guarantees.", [["immediate fiscal measures", "TREATMENT", 111, 136], ["tax deferrals", "TREATMENT", 173, 186], ["liquidity measures", "TREATMENT", 191, 209]]], ["The scale of intervention is truly unprecedented reaching almost 50% of 2019 GDP in Germany and 15% of GDP in the USA.Karaoli & A. Dimitriou St., 18534 Piraeus GreeceOn the monetary front, the FED cut interest rates to zero, announced unlimited purchases of treasuries and mortgage backed securities and started buying corporate debt.", [["GDP", "CHEMICAL", 77, 80], ["GDP", "CHEMICAL", 103, 106], ["intervention", "TREATMENT", 13, 25]]], ["Moreover, the FED opened debt swap lines with 14 foreign central banks to provide dollar liquidity to the international financial system.", [["debt swap lines", "TREATMENT", 25, 40], ["14 foreign central banks", "TREATMENT", 46, 70]]], ["Moreover, the EU's Recovery Plan 26 (proposed 27 May 2020) mobilizes investments through a recovery instrument of \u20ac750bn for the period 2021-2024 and a reinforced a long-term budget of \u20ac1.1 trillion for the period 2021-2027.Karaoli & A. Dimitriou St., 18534 Piraeus GreeceDespite these unprecedented measures, the course of the pandemic and its developing economic impact remains uncertain.", [["a long-term budget", "TREATMENT", 163, 181], ["the pandemic", "PROBLEM", 324, 336]]], ["How can long-term economic dislocation be avoided?Karaoli & A. Dimitriou St., 18534 Piraeus GreeceA first priority should be to ensure that the work force remains employed.", [["dislocation", "DISEASE", 27, 38], ["long-term economic dislocation", "PROBLEM", 8, 38], ["dislocation", "OBSERVATION", 27, 38]]], ["Second, governments should channel financial support to public and private institutions that support vulnerable citizen groups.", [["channel financial support", "TREATMENT", 27, 52]]], ["Third, Small Medium Enterprises (SMEs) should be safeguarded against bankruptcy.", [["Small", "OBSERVATION_MODIFIER", 7, 12], ["Medium", "OBSERVATION_MODIFIER", 13, 19], ["Enterprises", "OBSERVATION", 20, 31]]], ["(The need for taxpayer money to support large nonfinancial corporations is much less obvious.)", [["taxpayer money", "TREATMENT", 14, 28]]], ["Fifth, fiscal packages, comparable to the loss of GDP, will have to be financed by national debt.", [["GDP", "CHEMICAL", 50, 53], ["GDP", "SIMPLE_CHEMICAL", 50, 53], ["the loss of GDP", "PROBLEM", 38, 53], ["fiscal packages", "OBSERVATION", 7, 22]]], ["While this should be structured to avoid another debt crisis, finance should be directed to investments with positive social, economic and environmentally sustainable profiles, as discussed in the following.The Way Forward to a Climate-Neutral, Resilient and Sustainable FutureThere is widespread scientific speculation that economic growth has pushed humanity into new ecological niches wherein humans and animals exchange novel, infectious viruses of which COVID-19 is just the latest in a considerable list of examples.", [["humans", "ORGANISM", 396, 402], ["humans", "SPECIES", 396, 402], ["humans", "SPECIES", 396, 402], ["another debt crisis", "PROBLEM", 41, 60], ["infectious viruses", "PROBLEM", 431, 449], ["infectious", "OBSERVATION_MODIFIER", 431, 441]]], ["Furthermore, the Intergovernmental Panel on Climate Change (IPCC) has warned that global warming will likely accelerate the emergence of new viruses.", [["the Intergovernmental Panel", "TEST", 13, 40], ["global warming", "TREATMENT", 82, 96], ["new viruses", "PROBLEM", 137, 148], ["new", "OBSERVATION_MODIFIER", 137, 140], ["viruses", "OBSERVATION", 141, 148]]], ["27 Overall, climate change has the potential to end up killing more people than COVID-19, although this is obtusely referred to as an \"increased frequency and severity of natural disasters\".", [["people", "ORGANISM", 68, 74], ["people", "SPECIES", 68, 74], ["COVID", "TEST", 80, 85]]], ["Such language, the delayed, cumulative nature of the threat and the necessity of coordinated international response, all mitigate against the urgent action that is required.", [["the urgent action", "TREATMENT", 138, 155]]], ["That said, there are aspects of the climate change crisis which are less challenging than the COVID-19 pandemic.", [["the climate change crisis", "PROBLEM", 32, 57], ["the COVID", "TEST", 90, 99], ["pandemic", "PROBLEM", 103, 111], ["climate change", "OBSERVATION", 36, 50], ["less", "OBSERVATION_MODIFIER", 68, 72]]], ["As Sterner (2020) notes, the climate crisis requires policy changes that are less disruptive, economically, socially and culturally, than the measures being taken right now to tackle COVID-19.", [["the climate crisis", "PROBLEM", 25, 43], ["COVID", "TEST", 183, 188]]], ["On the contrary, we need a transition to a low-carbon economy that supports public and private investments in renewables, energy efficient and circular, technologies and infrastructure.", [["carbon", "CHEMICAL", 47, 53], ["a low-carbon economy", "TREATMENT", 41, 61]]], ["These technologies exist (wind, solar, etc.) and are becoming consistently cheaper than fossil fuels, while energy storage installations are increasing exponentially.The Way Forward to a Climate-Neutral, Resilient and Sustainable FutureThere is growing evidence that green stimulus policies have advantages over traditional fiscal stimulus and that climate-positive policies also offer superior economic characteristics.", [["green stimulus policies", "TREATMENT", 267, 290], ["traditional fiscal stimulus", "TEST", 312, 339], ["increasing", "OBSERVATION_MODIFIER", 141, 151], ["exponentially", "OBSERVATION_MODIFIER", 152, 165], ["green stimulus", "OBSERVATION", 267, 281]]], ["For example, Hepburn et al. 2020 run a global survey to assess stimulatory fiscal recovery policies implemented in response to GFC.", [["GFC", "CANCER", 127, 130], ["a global survey", "TEST", 37, 52], ["stimulatory fiscal recovery policies", "TREATMENT", 63, 99]]], ["The economists from 53 countries were asked to ascertain their perspectives on COVID-19 fiscal recovery packages according to: \"speed of implementation\", \"long-run economic multiplier\", \"climate impact potential\" and \"overall desirability\" according to social, political and personal factors.", [["COVID-19 fiscal recovery packages", "TREATMENT", 79, 112]]], ["The responses indicate that green stimulus policies deliver higher multiples due to reduced long-term energy costs and flow-on effects to the wider economy.Seizing the Day: A Green Recovery from the COVID-19 Pandemic\"Relaunching the economy does not mean going back to the status quo before the crisis but bouncing forward.", [["green stimulus policies", "TREATMENT", 28, 51], ["reduced long-term energy costs", "PROBLEM", 84, 114], ["the COVID", "TEST", 195, 204], ["the crisis", "PROBLEM", 291, 301], ["green stimulus", "OBSERVATION", 28, 42], ["reduced", "OBSERVATION_MODIFIER", 84, 91], ["long-term energy", "OBSERVATION_MODIFIER", 92, 108]]], ["We must repair the short-term damage from the COVID-19 crisis in a 27 Intergovernmental Panel on Climate Change, 2018. way that also invests in our long-term future\".", [["repair", "TREATMENT", 8, 14], ["the short-term damage", "PROBLEM", 15, 36], ["the COVID", "TEST", 42, 51], ["short-term damage", "OBSERVATION_MODIFIER", 19, 36]]], ["28 This code explains the strategy of the EU Recovery Plan based on three axis: the European Green Deal, adaptation to the digital age, and a fair and inclusive recovery for all.Seizing the Day: A Green Recovery from the COVID-19 PandemicWe must start investing in what makes our socio-economic system resilient to crisis.", [["the COVID", "TREATMENT", 217, 226]]], ["The European Green Deal (EGD) announced December 2019 is the new growth strategy of the European Union and is based on four principles: (a) climate neutrality by 2050, (b) protection of human life and biodiversity by cutting pollution, (c) world leadership in clean technology, (d) leave no one behind.", [["human", "ORGANISM", 186, 191], ["human", "SPECIES", 186, 191], ["human", "SPECIES", 186, 191], ["EGD", "TEST", 25, 28], ["human life", "TREATMENT", 186, 196]]], ["The EGD Just Transition Mechanism will help mobilize at least \u20ac100 billion over the period 2021-2027 in the most affected regions.", [["The EGD", "TREATMENT", 0, 7]]], ["The proposed European Climate Law 29 aims to turn the EGD's political commitment of 2050 climate neutrality, into a legal obligation.", [["the EGD", "TEST", 50, 57]]], ["Unfortunately, the proposed law does not include an ambitious goal with regards 2030 emissions, nor does it address the legislative interventions required to achieve climate neutrality by 2050.", [["the legislative interventions", "TREATMENT", 116, 145]]], ["31 Together with the EGD, the Sustainable Development Goals (SDGs) and the Paris Agreement call for deep transformations.", [["the EGD", "TEST", 17, 24], ["deep transformations", "PROBLEM", 100, 120]]], ["While significant progress is being made on some goals, no country is currently on track towards achieving all SDGs.", [["SDGs", "CANCER", 111, 115]]], ["32 Sachs et al. (2019) identify the major interventions needed to achieve each SDG and group them in six SDG Transformations, which operationalize the SDGs at government level and can prove instrumental for EGD implementation.", [["EGD implementation", "TREATMENT", 207, 225]]], ["33 The success of the join implementation of the SDGs, the EGD and the EU Recovery Plan will depend on the EU's capacity to engage with its citizens in codesigning the pathways that will allow them to reach the 2050 vision, hence the introduction of the European Commission Climate Pact.", [["the SDGs", "TREATMENT", 45, 53], ["the EGD", "TEST", 55, 62]]], ["34 28 https ://ec.europ a.eu/info/live-work-trave l-eu/healt h/coron aviru s-respo nse/recov ery-plan-europ e_en.", [["34 28 https ://ec.europ a.eu/info/live-work-trave l-eu/healt h/coron aviru s-respo nse/recov ery-plan-europ", "SPECIES", 0, 107]]], ["Moreover, the law does not consider (a) the well-documented heterogeneity in area-specific climate vulnerability among MS, (b) an EU wide carbon tax and (c) strengthening the European ETS.", [["MS", "DISEASE", 119, 121], ["carbon", "CHEMICAL", 138, 144], ["an EU wide carbon tax", "TREATMENT", 127, 148], ["carbon tax", "OBSERVATION", 138, 148]]], ["32 Sachs et al. (2020) : The Sustainable Development Goals and Covid-19.", [["Covid", "TEST", 63, 68]]], ["34 https ://ec.europ a.eu/clima /polic ies/eu-clima te-actio n/pact_en.ConclusionsRecent generations, including the present, have experienced at least three global crises: the financial crisis 2007-2008, the ongoing COVID-19 pandemic and the developing climate crisis.", [["34 https ://ec.europ a.eu/clima /polic ies/eu-clima te-actio n/pact_en", "SPECIES", 0, 70], ["ConclusionsRecent generations", "PROBLEM", 71, 100], ["the ongoing COVID", "TEST", 204, 221], ["pandemic", "PROBLEM", 225, 233], ["the developing climate crisis", "PROBLEM", 238, 267], ["global", "OBSERVATION_MODIFIER", 157, 163], ["crises", "OBSERVATION", 164, 170], ["climate crisis", "OBSERVATION", 253, 267]]], ["We can use the integration of scientific, economic and socio-political knowledge to design policies which not only address the immediate impacts of the COVID-19 pandemic, but mitigate the existential threats of future pandemics and the ongoing and unfolding disasters of climate change, biodiversity loss and planetary boundary exceedance.", [["biodiversity loss", "PROBLEM", 287, 304], ["planetary boundary exceedance", "TREATMENT", 309, 338], ["biodiversity loss", "OBSERVATION", 287, 304], ["planetary boundary", "OBSERVATION", 309, 327]]], ["We need big thinking and big changes.", [["big thinking and big changes", "PROBLEM", 8, 36]]], ["Now is the time, in addition to directing funds to the control of the epidemic and relevant biomedical research, as well as investing in border security, safe travel and safe trade, now is the time for financial institutions and governments to embrace EU taxonomy for sustainable investments (2020) 35 to phase out fossil fuels by deploying existing renewable energy technologies, eliminate fossil fuel subsidies and redirect them to green and smart climate mitigation and adaptation infrastructural projects, invest in circular and low-carbon economies, shift from industrial to regenerative agriculture and invest in food security, promote European supply chains, reduce transportation needs and exploit the limits of the digital revolution, while ensuring secure Information and Communication Technology networks.ConclusionsA decisive march along this sustainable pathway will enhance economic and environmental resilience, create jobs, and improve health and well-being.", [["carbon", "CHEMICAL", 537, 543], ["renewable energy technologies", "TREATMENT", 350, 379], ["circular and low-carbon economies", "TREATMENT", 520, 553], ["European supply chains", "TREATMENT", 642, 664], ["carbon economies", "OBSERVATION", 537, 553]]], ["The transition should be inclusive and \"leave no one behind\", hence the need of transforming citizens into codesigners and co-owners of the sustainability transition pathways.Wilfried Rickels and Sonja PetersonKiel Institute for the World Economy, Kiellinie 66, 24150 Kiel, Germany. wilfried.rickels@ifw-kiel.deCommitting to rigid shutdown measures to contain the spreading of the corona virus has been undertaken on the tacit assumption that these measures will be temporary and can be loosened when the COVID-19 infection rates decrease and discontinued altogether once vaccines are available.", [["infection", "DISEASE", 514, 523], ["rigid shutdown measures", "TREATMENT", 325, 348], ["the corona virus", "PROBLEM", 377, 393], ["the COVID", "TEST", 501, 510], ["infection rates", "PROBLEM", 514, 529], ["vaccines", "TREATMENT", 572, 580], ["rigid shutdown", "OBSERVATION", 325, 339], ["corona virus", "ANATOMY", 381, 393]]], ["Mitigating climate change and achieving ambitious temperature targets as set out in the Paris Agreement require a long-term structural change taking us away from our current carbon-intensive economy to a zero-carbon and then net-negative carbon economy.", [["zero-carbon", "CHEMICAL", 204, 215], ["carbon", "CHEMICAL", 174, 180], ["zero-carbon", "CHEMICAL", 204, 215], ["carbon", "CHEMICAL", 238, 244], ["zero-carbon", "SIMPLE_CHEMICAL", 204, 215], ["Mitigating climate change", "PROBLEM", 0, 25], ["a long-term structural change", "TREATMENT", 112, 141], ["carbon economy", "OBSERVATION", 238, 252]]], ["As current research holds out little hope that a \"perfect\" vaccine in the form of solar climate engineering will be available in the future, the measures and efforts required must translate into a permanent, ongoing form of commitment.", [["a \"perfect\" vaccine", "TREATMENT", 47, 66], ["solar climate engineering", "TREATMENT", 82, 107]]], ["While progressive climate change and the spread of the coronavirus operate on very different timescales, impatience about the duration of corona lockdown has indicated once more a fundamental problem for (long-term) environmental concerns.", [["coronavirus", "ORGANISM", 55, 66], ["progressive climate change", "PROBLEM", 6, 32], ["the coronavirus", "PROBLEM", 51, 66], ["corona lockdown", "TREATMENT", 138, 153], ["progressive", "OBSERVATION_MODIFIER", 6, 17], ["climate", "OBSERVATION", 18, 25], ["coronavirus", "OBSERVATION", 55, 66]]], ["Clearly, the economic and social costs associated with the emergence of the virus and the shutdown are significant , OECD 2020 .", [["the virus", "PROBLEM", 72, 81], ["significant", "OBSERVATION_MODIFIER", 103, 114]]], ["But any serious cost-benefit analysis would need to take into account not only the fact that different degrees of lockdown are available but also that the overall cost is affected by the expectations of agents regarding possible future re-lockdowns due to insufficient containment of the virus.", [["any serious cost-benefit analysis", "PROBLEM", 4, 37], ["agents", "TREATMENT", 203, 209], ["future re-lockdowns", "TREATMENT", 229, 248], ["the virus", "PROBLEM", 284, 293], ["virus", "OBSERVATION", 288, 293]]], ["Seen thus, it is anything but clear at which point in time the actual cost of lockdown would have exceeded the economic cost of the virus spreading in an unmitigated (or insufficiently mitigated) way.rickels@ifw-kiel.deDuring the course of lockdown measures, voices calling for a \"green\" recovery stimulus package centring around low-carbon investments in the aftermath of the corona crisis have make themselves heard.", [["carbon", "CHEMICAL", 334, 340], ["the virus", "PROBLEM", 128, 137], ["lockdown measures", "TREATMENT", 240, 257], ["low-carbon investments", "TREATMENT", 330, 352], ["the corona crisis", "PROBLEM", 373, 390], ["corona crisis", "OBSERVATION", 377, 390]]], ["Such well-meant counsels as the statement issued by the German National Academy of Sciences Leopoldina (2020) are useful in reminding us that recovery from the corona crisis should not come at the expense of neglecting other objectives and that climate policy should not be backburnered, as was the case after the financial crisis in 2009.", [["the corona crisis", "PROBLEM", 156, 173]]], ["Otherwise, they are of little practical value.rickels@ifw-kiel.deThe second approach has involved rather detailed proposals calling either for a \"greening\" of recovery by foregrounding measures to support renewable energies, public transport, energy efficiency, etc. or for a \"blackening\" of recovery by postponing and/or abandoning climate measures and environmental regulations.", [["abandoning climate measures", "TREATMENT", 322, 349]]], ["For example, representatives of the aviation industry try to prevent the harmonization of carbon prices on fuels with respect to kerosene and argue against the introduction of kerosene taxes.", [["kerosene", "CHEMICAL", 129, 137], ["carbon", "CHEMICAL", 90, 96], ["kerosene", "CHEMICAL", 129, 137], ["kerosene", "CHEMICAL", 176, 184], ["kerosene", "SIMPLE_CHEMICAL", 129, 137], ["carbon prices", "TREATMENT", 90, 103], ["kerosene", "TREATMENT", 129, 137], ["kerosene taxes", "TREATMENT", 176, 190]]], ["On the other hand, in its comprehensive list of (recovery) demands, the NGO German Environment Action (2020) urges for example for the abandonment of blue hydrogen projects (though not explaining why this is likely to stimulate economic recovery).", [["blue hydrogen", "CHEMICAL", 150, 163], ["hydrogen", "CHEMICAL", 155, 163], ["blue hydrogen", "SIMPLE_CHEMICAL", 150, 163], ["blue hydrogen projects", "TREATMENT", 150, 172]]], ["36 Clearly, there is no point in discussing nonsensical ideas of this kind.", [["no point", "UNCERTAINTY", 21, 29]]], ["But some of these proposals also make sensible suggestions like adjusting the German cap on renewable energy installations or abandoning the EU average fleet-consumption regulation because the former contradicts German renewable energy targets and the latter is an inefficient instrument for regulating vehicle emissions.", [["renewable energy installations", "TREATMENT", 92, 122]]], ["While specific processes and regulation timelines for regulations may need to be adjusted in the context of the corona crisis, sensible measures of this kind should be discussed and decided upon in the regular political process.", [["the corona crisis", "PROBLEM", 108, 125], ["corona crisis", "OBSERVATION", 112, 125]]], ["Confining potential stimulus and recovery measures to their proper purpose does not mean imposing a ban on meaningful (climate or environmental) policies that are not associated with the corona crisis.rickels@ifw-kiel.deThe third and most sensible perspective replaces specific proposals with (sustainability) assessment guidelines like those suggested by the World Bank (2020).", [["recovery measures", "TREATMENT", 33, 50]]], ["The World Bank has suggested that potential measures up for consideration as part of a recovery strategy need to be assessed against both, short-and long-term criteria, an example for the former being the expected economic multiplier associated with certain measures.", [["certain measures", "TREATMENT", 250, 266]]], ["However, privatesector spending like this should not imply any unintended adverse effects on essential long-term structural change that might arise from such things as (temporarily) adjusted risk preferences.", [["long-term structural", "OBSERVATION_MODIFIER", 103, 123]]], ["Once postponed or stimulated demand and investment take place during the recovery process, carbon-price signals are vital in providing technology-neutral incentives for low-CO 2 purchasing and production decisions.rickels@ifw-kiel.deOverloading stimulus or recovery packages with too many (emission-related) conditions performs poorly against the short-term criteria with respect to a timely recovery.", [["carbon", "CHEMICAL", 91, 97], ["CO 2", "CHEMICAL", 173, 177], ["recovery packages", "TREATMENT", 257, 274]]], ["Even worse, the inclusion in recovery packages of various detailed suggestions from the various interest groups usually results in a non-transparent, rent-seeking, and political bargaining process in which it remains unclear whether (sensible) individual emissionrelated decisions are being prioritized at the expense of a more challenging long-term climate policy.", [["worse", "OBSERVATION_MODIFIER", 5, 10]]], ["Accordingly, accounting for the long-term criteria requires that existing or planned climate policies providing incentives for emission reductions and technological innovation should remain in place and not be postponed, let alone weakened.", [["emission reductions", "TREATMENT", 127, 146], ["technological innovation", "TREATMENT", 151, 175]]], ["Otherwise, uncertain (short-term) recovery impulses most likely come at the cost of less efficient emission-reduction paths in the long term.IntroductionThe coronavirus pandemic is having a serious impact on the economy.", [["coronavirus pandemic", "DISEASE", 157, 177], ["coronavirus", "ORGANISM", 157, 168], ["reduction", "OBSERVATION_MODIFIER", 108, 117], ["paths", "OBSERVATION_MODIFIER", 118, 123], ["long term", "OBSERVATION_MODIFIER", 131, 140], ["coronavirus pandemic", "OBSERVATION", 157, 177], ["serious", "OBSERVATION_MODIFIER", 190, 197]]], ["Eurostat estimates that seasonally adjusted GDP decreased by 3.5% in the EU during the first quarter of 2020, compared with the previous quarter.", [["GDP", "CHEMICAL", 44, 47], ["GDP", "CHEMICAL", 44, 47], ["GDP", "SIMPLE_CHEMICAL", 44, 47], ["Eurostat estimates", "TEST", 0, 18]]], ["In certain sectors, the COVID-19 crisis has led to the temporary or even permanent closure of sites, a collapse in demand and an increase in production costs linked to the fight against the spread of the virus.", [["sites", "ANATOMY", 94, 99], ["the COVID", "TEST", 20, 29], ["the temporary", "TREATMENT", 51, 64], ["permanent closure of sites", "TREATMENT", 73, 99], ["a collapse in demand", "PROBLEM", 101, 121], ["an increase in production costs", "PROBLEM", 126, 157], ["the virus", "PROBLEM", 200, 209], ["permanent", "OBSERVATION_MODIFIER", 73, 82], ["closure", "OBSERVATION", 83, 90], ["sites", "OBSERVATION_MODIFIER", 94, 99], ["collapse", "OBSERVATION", 103, 111], ["demand", "OBSERVATION_MODIFIER", 115, 121], ["increase", "OBSERVATION_MODIFIER", 129, 137], ["virus", "OBSERVATION", 204, 209]]], ["This decline in activity can trigger bankruptcies, which result in unemployment and the destruction of physical and human capital, leading in turn to a loss of specific knowledge and skills and to market concentration and the partial relocation of production activities.", [["bankruptcies", "DISEASE", 37, 49], ["human", "ORGANISM", 116, 121], ["human", "SPECIES", 116, 121], ["human", "SPECIES", 116, 121], ["the destruction of physical and human capital", "PROBLEM", 84, 129], ["partial", "OBSERVATION_MODIFIER", 226, 233]]], ["From an environmental point of view, bankruptcies and relocation may generate higher emissions by increasing production in more polluting sites abroad and by increasing the transportation of goods.", [["bankruptcies", "TREATMENT", 37, 49], ["increasing production", "PROBLEM", 98, 119], ["increasing", "OBSERVATION_MODIFIER", 98, 108], ["production", "OBSERVATION_MODIFIER", 109, 119]]], ["In addition, the decline in economic activity may have a negative effect on research and development spending, which is crucial for future growth and the development of more environmentally friendly technologies.IntroductionMany measures have been put in place to limit the economic effects of the COVID-19 crisis.", [["the decline in economic activity", "PROBLEM", 13, 45], ["the COVID", "TEST", 294, 303], ["decline", "OBSERVATION_MODIFIER", 17, 24], ["negative effect", "OBSERVATION_MODIFIER", 57, 72]]], ["At the European Union level, a number of measures such as direct subsidies, selective tax benefits, advance payments, state guarantees for loans and subsidized public loans to companies have been implemented.", [["selective tax benefits", "TREATMENT", 76, 98], ["advance payments", "TREATMENT", 100, 116]]], ["In addition, many large companies are being bailed out and there is a debate on whether conditions should be attached to this state aid.", [["many", "OBSERVATION_MODIFIER", 13, 17], ["large", "OBSERVATION_MODIFIER", 18, 23], ["companies", "OBSERVATION", 24, 33]]], ["On 8 May 2020, the EU confirmed that large companies receiving emergency cash during the COVID-19 crisis will not be obliged to devote funds to \"greening\" their operations.", [["emergency cash", "TREATMENT", 63, 77], ["the COVID", "TREATMENT", 85, 94], ["large", "OBSERVATION_MODIFIER", 37, 42]]], ["Rescued firms will only have to report on their use of the aid and in some cases the aid could be attached to conditions such as a ban on dividends and management bonus payments.", [["management bonus payments", "TREATMENT", 152, 177]]], ["For instance, the EG3 think tank proposes making the rescue of airlines conditional on the use of less polluting fuels and tying aid to car manufacturers to the development of electric vehicles.", [["less polluting fuels", "TREATMENT", 98, 118]]], ["We focus on the rescue plans for companies rather than on recovery plans or the European Green Deal, which was launched before the COVID-19 crisis.", [["the COVID", "TEST", 127, 136]]], ["We also discuss the merits of tying bailouts to environmental efforts compared with implementing more stringent environmental policies (presuming that companies will be bailed out in any case).Acceptability of Environmental PoliciesSince environmental efforts can lead to higher product prices and lower profits, two dimensions of acceptability must be taken into account: acceptability from the point of view of companies and social acceptability.Acceptability of Environmental PoliciesAcceptability of environmental policies by companies is a necessary condition for their implementation.", [["tying bailouts", "TREATMENT", 30, 44]]], ["In the midst of the current crisis, many polluting industries are lobbying to weaken and delay environmental regulations.", [["polluting industries", "OBSERVATION", 41, 61]]], ["40 For instance, the Environmental Protection Agency issued a sweeping suspension of its enforcement of environmental laws, allowing companies to breach environmental standards during the coronavirus outbreak.", [["coronavirus", "DISEASE", 188, 199], ["coronavirus", "ORGANISM", 188, 199], ["the coronavirus outbreak", "PROBLEM", 184, 208]]], ["In Indonesia, the trade ministry revoked rules requiring basic certification that wood exports were legally produced, in response to lobbying from the furniture and logging industries.", [["basic certification", "TREATMENT", 57, 76]]], ["41 Lobbyists may also encourage legislators to compensate companies for losses related to environmental regulation.", [["losses", "PROBLEM", 72, 78]]], ["42 The implementation of rescue plans, by providing aid and guarantees, could be a tool to make environmental efforts more acceptable for firms.Acceptability of Environmental PoliciesAcceptability by society is also central.", [["rescue plans", "TREATMENT", 25, 37], ["central", "OBSERVATION_MODIFIER", 216, 223]]], ["In France, the \"red caps\" and \"yellow vests\" movements illustrate the difficulty of implementing such policies.", [["the \"red caps\"", "PROBLEM", 11, 25], ["\"yellow vests\" movements", "PROBLEM", 30, 54]]], ["Both of these movements led to the cancellation and delay of environmental policies (eco-tax applied to heavy vehicles and carbon tax, respectively).", [["carbon", "CHEMICAL", 123, 129], ["tax", "PROTEIN", 89, 92], ["carbon tax", "PROTEIN", 123, 133], ["the cancellation", "TEST", 31, 47], ["environmental policies", "TREATMENT", 61, 83], ["eco-tax", "TREATMENT", 85, 92], ["carbon tax", "TREATMENT", 123, 133]]], ["The COVID-19 crisis may affect societies' support for more ambitious environmental policies.", [["The COVID", "TEST", 0, 9]]], ["First, it appears that there is a confirmation bias, as countries and NGOs that had already committed to fight against global warming want to intensify efforts, while countries that were already recalcitrant are calling for a decrease in efforts in the light of the economic crisis.", [["a decrease in efforts", "PROBLEM", 224, 245], ["the economic crisis", "PROBLEM", 262, 281], ["economic crisis", "OBSERVATION", 266, 281]]], ["43 Second, the COVID-19 crisis makes the risk of disaster more salient and vivid and may therefore increase the demand for stronger environmental protection.", [["the COVID", "TEST", 11, 20]]], ["As explained by Sunstein (2006) , if a particular risk is cognitively \"available\" then people will have an increased fear of the risk in question.", [["people", "ORGANISM", 87, 93], ["people", "SPECIES", 87, 93]]], ["Finally, the crisis has revealed that populations will accept drastic measures (lockdown, wearing face masks) and a rapid change in social norms (social-distancing, for instance), which shows the ease with which individuals could adapt to more ambitious environmental policies.", [["the crisis", "PROBLEM", 9, 19], ["drastic measures", "TREATMENT", 62, 78], ["face masks", "TREATMENT", 98, 108], ["a rapid change", "PROBLEM", 114, 128]]], ["42 Burkey and Durden (1998) and Joskow and Schmalensee (1998) have detailed how firms can influence the regulator's decisions in the context of pollution rights markets, while Bovenberg and Goulder (2001) , Hepburn et al. (2013) and Nicola\u00ef (2019) have shown that few permits are sufficient to neutralize the losses in profits and make the implementation of pollution permits acceptable.", [["Nicola\u00ef", "TREATMENT", 233, 240]]], ["For instance, in France, Renault's bailout requires it to increase the share of electric vehicles, while the 7 billion euro Air France bailout imposes the use of at least 2% of alternative jet fuel by 2025, a target of 50% emissions cuts by 2030, and a 50% decrease in domestic flights by 2024, especially those that compete with high-speed trains.", [["Renault's bailout", "TREATMENT", 25, 42], ["alternative jet fuel", "TREATMENT", 177, 197]]], ["Conditional bailouts allow the regulator to individualize the standards applied to a particular firm, making it possible to set the most appropriate instrument and the optimal level of severity for each firm.", [["the regulator", "TREATMENT", 27, 40], ["firm", "OBSERVATION", 203, 207]]], ["When making its decisions, the regulator should consider the possibility of a rebound effect as explained by Saunders (1992) .", [["a rebound effect", "PROBLEM", 76, 92]]], ["If the firm commits to finance research and development in green technology in exchange for being bailed out, it will be hard for the government to determine whether the state aid was actually allocated to research.", [["firm", "OBSERVATION_MODIFIER", 7, 11]]], ["For example, since the results of research are uncertain, a lack of innovation may be explained either by the firm's characteristics (anti-selection problem) or by the misallocation of public funds (moral hazard problem).The Design and Monitoring of Environmental ConditionsFinally, the regulator should take into account competition, since firms receiving bailouts usually have market power.", [["moral hazard problem", "PROBLEM", 199, 219], ["firm", "OBSERVATION", 110, 114]]], ["A government will mainly intervene to save a firm if its bankruptcy would have a significant effect on the economy.", [["significant", "OBSERVATION_MODIFIER", 81, 92]]], ["A firm with a competitive advantage, for example with cleaner technology, may have an interest in advocating more ambitious environmental efforts for itself but also for its competitors in order to increase its market share by preventing the entry or inducing the exit of such competitors.", [["cleaner technology", "TREATMENT", 54, 72], ["firm", "OBSERVATION", 2, 6]]], ["45 The effectiveness of conditions will therefore depend on the type of commitment, competition in the market, and the demand elasticity of the final good.The Design and Monitoring of Environmental ConditionsAnother question relates to the duration of the contract.", [["the demand elasticity", "TEST", 115, 136]]], ["For example, the use of cleaner but more expensive inputs is an easily reversible strategy, while a shift in production, for example from internal combustion vehicles to electric vehicles, is a more expensive choice to change.", [["cleaner", "TREATMENT", 24, 31], ["an easily reversible strategy", "PROBLEM", 61, 90], ["reversible", "OBSERVATION_MODIFIER", 71, 81], ["strategy", "OBSERVATION", 82, 90]]], ["In addition, research and development efforts produce long-term effects with the creation of innovations and possible technological spillovers.", [["long-term effects", "PROBLEM", 54, 71], ["the creation of innovations", "TREATMENT", 77, 104], ["technological spillovers", "PROBLEM", 118, 142], ["long-term effects", "OBSERVATION_MODIFIER", 54, 71]]], ["The duration must therefore be individualized in function of the company's characteristics.The Design and Monitoring of Environmental ConditionsIt should also be noted that conditional aid can lead to windfall gains.", [["windfall gains", "PROBLEM", 201, 215]]], ["Some companies had already planned emission reductions and changes in strategy.", [["emission reductions", "TREATMENT", 35, 54], ["changes in strategy", "TREATMENT", 59, 78]]], ["47 One possibility for alleviating control costs is to publicly announce the commitments, which facilitates the monitoring of companies' commitments by society (e.g. by journalists, politicians and non-governmental organizations).", [["alleviating control costs", "PROBLEM", 23, 48], ["possibility for", "UNCERTAINTY", 7, 22]]], ["This also gives the firm a further incentive to respect the agreement in order to maintain its reputation and to retain its customer base (Heyes et al. (2018) and Heyes and Kapur (2012) ).The Design and Monitoring of Environmental ConditionsWe now focus on the sanctions to be applied in the event of non-compliance with the commitments.", [["the sanctions", "TREATMENT", 257, 270]]], ["Various penalties could be considered, such as financial penalties, a ban on applying for the attribution of public contracts and the state's participation in the company.", [["could be considered", "UNCERTAINTY", 18, 37]]], ["Increasing the stringency of environmental policy involves determining new levels for existing instruments, which generates costs, but there will be no additional monitoring costs.", [["existing instruments", "TREATMENT", 86, 106], ["stringency", "OBSERVATION_MODIFIER", 15, 25], ["environmental policy", "OBSERVATION", 29, 49]]], ["Moreover, opting for a more stringent environmental policy means that market-based instruments can be employed, which is not feasible in the first strategy.", [["market-based instruments", "TREATMENT", 70, 94]]], ["48 Environmental economists agree that these instruments are more effective than command-and-control instruments since they have the potential to generate revenue and allow for a double dividend, provide incentives to invest in clean technology and require less information to be designed.", [["these instruments", "TREATMENT", 39, 56], ["a double dividend", "TREATMENT", 177, 194]]], ["Nevertheless, making aid conditional on environmental efforts makes it possible to individualize the regulatory instruments for each firm, which is not possible in the context of marketbased instruments.", [["marketbased instruments", "TREATMENT", 179, 202], ["firm", "OBSERVATION", 133, 137], ["not possible", "UNCERTAINTY", 148, 160]]], ["The positive effect of the instrumental individualization induced by conditionality only materializes if the existing environmental policy is based on commandand-control instruments.", [["positive effect", "OBSERVATION_MODIFIER", 4, 19]]], ["With market-based instruments, individualization is not required to achieve an efficient outcome, whereas it is necessary in the case of command-and-control instruments.Increasing the Stringency of Environmental PoliciesCompanies' negotiation power is an additional argument for increasing the severity of environmental policies rather than conditioning bailouts on environmental efforts.", [["instruments", "OBSERVATION", 18, 29], ["Stringency", "OBSERVATION_MODIFIER", 184, 194]]], ["Furthermore, making environmental policy more stringent will affect all companies and not only those receiving bailouts, which increases the attractiveness of this strategy.", [["this strategy", "TREATMENT", 159, 172]]], ["Since they apply to a larger number of companies, these more restrictive policies will have a greater effect on the environment.ConclusionTo conclude, this note analyses the advantages and disadvantages of making bailouts conditional on environmental efforts.", [["greater effect", "OBSERVATION_MODIFIER", 94, 108]]], ["However, it is costly, requires a large amount of information, and is less efficient than increasing the stringency of existing environmental policies.", [["large", "OBSERVATION_MODIFIER", 34, 39], ["amount", "OBSERVATION_MODIFIER", 40, 46]]], ["For instance, a recent survey by IPSOS 49 shows that three out of four people in 16 major countries expect their government to make protection of the environment a priority when planning a recovery from the coronavirus pandemic, although there is considerable heterogeneity across countries.", [["coronavirus", "DISEASE", 207, 218], ["people", "ORGANISM", 71, 77], ["coronavirus", "ORGANISM", 207, 218], ["people", "SPECIES", 71, 77], ["a recent survey", "TEST", 14, 29], ["IPSOS", "TEST", 33, 38], ["the coronavirus pandemic", "PROBLEM", 203, 227], ["coronavirus", "OBSERVATION", 207, 218], ["considerable", "OBSERVATION_MODIFIER", 247, 259], ["heterogeneity", "OBSERVATION", 260, 273]]], ["The EU Green Deal objectives should be maintained but concrete policies may have to be adjusted to this new reality.Climate and Energy Policies After COVID-19A major energy transition is under way, shaped by political will to tackle climate change.", [["COVID-19A", "CHEMICAL", 150, 159]]], ["50 The immediate recession following the COVID-19 crisis drastically reduced energy consumption and greenhouse gas emissions (Le Qu\u00e9r\u00e9 et al. 2020) .", [["The immediate recession", "TREATMENT", 3, 26], ["the COVID", "TEST", 37, 46], ["greenhouse gas emissions", "TEST", 100, 124], ["immediate", "OBSERVATION_MODIFIER", 7, 16], ["recession", "OBSERVATION", 17, 26]]], ["The sudden decline in greenhouse gas emissions is the opposite of what a meaningful response to climate change should be, in terms of both quality of life and economic efficiency.", [["The sudden decline in greenhouse gas emissions", "PROBLEM", 0, 46], ["economic efficiency", "PROBLEM", 159, 178], ["sudden", "OBSERVATION_MODIFIER", 4, 10], ["decline", "OBSERVATION_MODIFIER", 11, 18], ["greenhouse", "OBSERVATION", 22, 32], ["gas emissions", "OBSERVATION", 33, 46], ["economic efficiency", "OBSERVATION", 159, 178]]], ["The challenge is to structurally decouple economic growth from emissions, not to have them both going down.Climate and Energy Policies After COVID-19The lockdown may have some lasting effect in changing some of our habits ), e.g. a generalized familiarity with telework.", [["COVID", "TEST", 141, 146]]], ["One can also expect a more general reflection on whether all business and leisure travel, not least by air, is necessary.", [["air", "OBSERVATION", 103, 106]]], ["For this reason, it is important to integrate a climate check into the stimulus packages that governments and European institutions are currently designing.", [["the stimulus packages", "TREATMENT", 67, 88], ["European institutions", "TREATMENT", 110, 131]]], ["51 The current health crisis and the likely economic downturn could be seen as an unsolicited-and much regrettableopportunity towards a carbon-neutral future Koundouri 2020) .", [["carbon", "CHEMICAL", 136, 142]]], ["The agreements reached in the context of the Eurogroup, 52 the latest turn in the European budgetary discussions, as well as the statements by the Commission President all point into this promising direction.Climate and Energy Policies After COVID-19The EU Green Deal has confirmed the EU Emissions Trading System (ETS) as a key element and the price of EU allowances serves as a key indicator worldwide.", [["COVID", "TEST", 242, 247]]], ["As could and should be expected, carbon prices have fallen during the lockdown reflecting reduced demand for allowances in line with the drop in power and industrial production.", [["carbon", "CHEMICAL", 33, 39], ["carbon prices", "TREATMENT", 33, 46], ["reduced demand", "PROBLEM", 90, 104], ["allowances in line", "TREATMENT", 109, 127], ["industrial production", "OBSERVATION", 155, 176]]], ["This temporary drop from the \u20ac25 to a \u20ac15-20 range, 53 acts as an important automatic stabilizer for businesses in distress.", [["This temporary drop", "PROBLEM", 0, 19], ["distress", "PROBLEM", 115, 123], ["temporary", "OBSERVATION_MODIFIER", 5, 14], ["drop", "OBSERVATION_MODIFIER", 15, 19]]], ["A repetition of the experience of a sharp fall in the 50 See on this issue the important draft report prepared by the European Parliament Committee on the Environment, Public Health and Food Safety (European Parliament, 2020).", [["a sharp fall", "PROBLEM", 34, 46]]], ["51 https ://lifed icetp rojec t.eui.eu/2020/04/08/covid -19-clima te-polic y-and-carbo n-marke ts/.", [["51 https ://lifed icetp rojec t.eui.eu/2020/04/08/covid -19", "SPECIES", 0, 59], ["covid", "TEST", 50, 55]]], ["52 https ://www.consi lium.europ a.eu/en/press /press -relea ses/2020/04/09/repor t-on-the-compr ehens iveecono mic-polic y-respo nse-to-the-covid -19-pande mic/-point 21: \"Work is ongoing on a broader Roadmap and an Action Plan to support the recovery of the European economy through high quality job creation and reforms to strengthen resilience and competitiveness, in line with a sustainable growth strategy\".", [["52 https ://www.consi lium.europ a.eu/en/press /press -relea ses/2020/04/09/repor", "SPECIES", 0, 81]]], ["53 https ://ember -clima te.org/carbo n-price -viewe r/. price of EU ETS allowances after the 2008 recession and a long period of very lowcarbon price levels should be avoided.", [["very lowcarbon price levels", "TREATMENT", 130, 157]]], ["There are two reasons to believe that this could happen: (i) the EU ETS now has a Market Stability Reserve (MSR) operating in the short-medium term and (ii) long-term market expectations could be shaped by the 2050 carbon neutrality objective.Climate and Energy Policies After COVID-19The MSR started to operate last year and absorbs a potential oversupply in the market in the short and medium term.", [["carbon", "CHEMICAL", 215, 221], ["MSR", "PROTEIN", 289, 292], ["COVID", "TEST", 277, 282]]], ["If the allowances market is \"long\" beyond a threshold set in legislation (833 million tons, which is approximately 50% of ETS emissions in 2018), the MSR intervenes by withdrawing allowances equal to a percentage (24% up to 2023, 12% thereafter) of the excess.", [["MSR", "PROTEIN", 150, 153], ["the excess", "PROBLEM", 249, 259]]], ["At the end of 2018, the allowance market was 1.65 billion tons \"long\" and, therefore, the supply of allowances for the period 1 September 2019 to 31 August 2020 has been reduced by 397 million tons (these allowances are placed in the MSR).", [["MSR", "PROTEIN", 234, 237]]], ["Some question whether the MSR, with its delayed adjustment mechanism, will be sufficient to avoid a sharp fall in the allowance price (cf. Flachsland et al. 2020) .", [["MSR", "PROTEIN", 26, 29], ["the MSR", "PROBLEM", 22, 29], ["a sharp fall", "PROBLEM", 98, 110]]], ["In fact, any reduction in the supply of allowances through the MSR for the period September 2020-August 2021 will still be based on the excess supply of allowances in 2019, i.e. before the current crisis started.", [["MSR", "PROTEIN", 63, 66], ["reduction", "OBSERVATION_MODIFIER", 13, 22]]], ["In case the MSR is unable to absorb the surplus, the EU Commission should propose changes in the planned review of the ETS in 2021.Climate and Energy Policies After COVID-19Long-term expectations might overtake this short-term risk.", [["MSR", "PROTEIN", 12, 15], ["COVID-19Long-term expectations", "TREATMENT", 165, 195]]], ["Today, the ETS sectors face a mandatory emission reduction of 43% by 2030 compared to 2005, and revised targets will likely increase that obligation by at least another 10 or 15%.", [["a mandatory emission reduction", "TREATMENT", 28, 58]]], ["Such a reduction in the supply of allowances would likely push their prices up, or at least reduce the extent of their decline, in the face of lower demand due to the economic downturn.", [["a reduction", "TREATMENT", 5, 16], ["their decline", "PROBLEM", 113, 126], ["lower demand", "PROBLEM", 143, 155], ["the economic downturn", "PROBLEM", 163, 184], ["reduction", "OBSERVATION_MODIFIER", 7, 16], ["extent", "OBSERVATION_MODIFIER", 103, 109], ["decline", "OBSERVATION", 119, 126]]], ["Therefore, carbon market participants as well as those developing innovative clean technologies and products of the future are likely to expect significantly higher carbon prices in the future.", [["carbon", "CHEMICAL", 11, 17], ["carbon", "CHEMICAL", 165, 171], ["participants", "SPECIES", 25, 37], ["innovative clean technologies", "TREATMENT", 66, 95], ["higher carbon prices", "TREATMENT", 158, 178], ["carbon prices", "OBSERVATION", 165, 178]]], ["This raises the question about a possible loss of competitiveness in Europe's traditional industries vis-\u00e0-vis competitors located in countries where no similar burden is imposed.", [["loss of competitiveness", "PROBLEM", 42, 65], ["similar burden", "PROBLEM", 153, 167], ["no", "UNCERTAINTY", 150, 152], ["similar", "OBSERVATION_MODIFIER", 153, 160], ["burden", "OBSERVATION", 161, 167]]], ["Some proposed a border adjustment, which would imply both a levy on imports and possibly a rebate on exports.", [["a border adjustment", "TREATMENT", 14, 33]]], ["Therefore, it is of crucial importance to realize that a WTO-compatible border adjustment mechanism will take some time before it can be implemented.", [["a WTO-compatible border adjustment mechanism", "TREATMENT", 55, 99]]], ["Meanwhile, at least equal attention needs to go to domestic policy reinforcement, such as support for innovation and a less rigid interpretation of the state aid rules.Climate and Energy Policies After COVID-19Governments and European institutions are currently developing a major investment stimulus package.", [["domestic policy reinforcement", "TREATMENT", 51, 80], ["innovation", "TREATMENT", 102, 112], ["COVID-19Governments", "TREATMENT", 202, 221], ["European institutions", "TREATMENT", 226, 247], ["a major investment stimulus package", "TREATMENT", 273, 308]]], ["The Commission's impact assessments on climate and energy policy serve as useful guidance on where a major surge in investments is needed.", [["climate and energy policy", "TREATMENT", 39, 64]]], ["We know that the energy transition requires more investments in renewable energy, digitised grid infrastructure and energy storage.", [["the energy transition", "PROBLEM", 13, 34]]], ["The significantly reduced electricity demand of today indicates that much more attention should go towards managing flexibility in real time instead of increasing baseload capacity.", [["increasing baseload capacity", "PROBLEM", 152, 180], ["significantly", "OBSERVATION_MODIFIER", 4, 17], ["reduced", "OBSERVATION_MODIFIER", 18, 25], ["electricity", "OBSERVATION", 26, 37]]], ["In transport, electrification is on its way, but investment in charging facilities, traffic management, clean public transport and long-distance rail needs to be ramped up.", [["traffic management", "TREATMENT", 84, 102], ["long-distance rail", "TREATMENT", 131, 149]]], ["In industry, not least in power generation and carbon intensive industrial sectors, major efforts are being undertaken to develop new technologies based on hydrogen and carbon capture, use and storage, for example.", [["carbon", "CHEMICAL", 47, 53], ["hydrogen", "CHEMICAL", 156, 164], ["carbon", "CHEMICAL", 169, 175], ["hydrogen", "SIMPLE_CHEMICAL", 156, 164], ["carbon", "SIMPLE_CHEMICAL", 169, 175], ["carbon intensive industrial sectors", "TREATMENT", 47, 82], ["hydrogen and carbon capture", "TREATMENT", 156, 183]]], ["Such investments can create the jobs we need in the post-COVID-19 era and allow to realise the EU Green Deal objectives at the same time.Climate and Energy Policies After COVID-19Apart from carbon prices and investment support schemes, it remains of equal importance to maintain a consistent energy price signal throughout the economy.", [["COVID-19Apart", "CHEMICAL", 171, 184], ["carbon", "CHEMICAL", 190, 196], ["carbon prices", "TREATMENT", 190, 203], ["investment support schemes", "TREATMENT", 208, 234]]], ["However, the recent fall in the prices of fossil fuels is upsetting the incentives that should support a transition towards sustainability.", [["the recent fall", "PROBLEM", 9, 24], ["fall", "OBSERVATION", 20, 24]]], ["A reference criterion for economic decisions has been lost and the consequence may be a paralysis, or even a \"comeback\" of fossil fuels, mothballing or abandonment of investment in renewables.", [["paralysis", "DISEASE", 88, 97], ["a paralysis", "PROBLEM", 86, 97], ["paralysis", "OBSERVATION", 88, 97], ["fossil fuels", "OBSERVATION", 123, 135]]], ["Consequently, the business case of the green transition may appear to be weakened in the near term, but a clear policy response may be politically more acceptable because of the price drop in fossil fuels.", [["weakened", "OBSERVATION", 73, 81], ["fossil fuels", "OBSERVATION", 192, 204]]], ["This offers a major opportunity to remove the all too generous exemptions, such as on maritime and aviation fuels, or by adding a CO2 element to the harmonized minimum tax rates.", [["CO2", "CHEMICAL", 130, 133], ["CO2", "SIMPLE_CHEMICAL", 130, 133], ["tax", "PROTEIN", 168, 171], ["a CO2 element", "TREATMENT", 128, 141]]], ["In such a manner, prices of fossil fuels could be stabilized at the pre-COVID levels via temporary taxes, whose revenue could help finance the various income-support policies adopted and/ or an acceleration of investment projects for sustainability.", [["fossil fuels", "PROBLEM", 28, 40], ["temporary taxes", "TREATMENT", 89, 104]]], ["In this way the EU should better prepare for a long period of low oil and gas prices and seize the opportunities these can offer.", [["oil", "ANATOMY", 66, 69], ["oil", "ORGANISM_SUBSTANCE", 66, 69], ["low oil and gas prices", "TREATMENT", 62, 84]]], ["Public measures to combat the COVID-19 pandemic have led to a severe economic crisis.", [["Public measures", "TREATMENT", 0, 15], ["the COVID", "TEST", 26, 35], ["a severe economic crisis", "PROBLEM", 60, 84], ["severe", "OBSERVATION_MODIFIER", 62, 68], ["economic", "OBSERVATION_MODIFIER", 69, 77], ["crisis", "OBSERVATION", 78, 84]]], ["In order to cope with this crisis, comprehensive government aid is being requested.", [["this crisis", "PROBLEM", 22, 33]]], ["Accordingly, governments across the world have pledged billions of Euros for extensive recovery programs.", [["extensive recovery programs", "TREATMENT", 77, 104]]], ["One of the main questions debated in this context at the moment is how \"green\" these recovery programs should be ).The Coronavirus Crisis as a Moment for Interest GroupsThe expectation of huge amounts of public money being distributed at short notice brings interest groups of every shade to the scene-preferably with old wish lists on hand.", [["hand", "ANATOMY", 336, 340], ["hand", "ORGANISM_SUBDIVISION", 336, 340], ["The Coronavirus Crisis", "PROBLEM", 115, 137], ["main", "OBSERVATION_MODIFIER", 11, 15], ["Coronavirus Crisis", "OBSERVATION", 119, 137], ["huge", "OBSERVATION_MODIFIER", 188, 192], ["amounts", "OBSERVATION_MODIFIER", 193, 200]]], ["On the one hand, climate change mitigation is put under pressure as being an \"extra burden\" for industries.", [["climate change mitigation", "TREATMENT", 17, 42]]], ["For example, European car manufacturers have called for postponing the upcoming tightening of EU emission standards for car fleets (Topham and Harvey 2020) .", [["car fleets", "TREATMENT", 120, 130]]], ["On the other hand, many recommend spending the public money mainly on measures that also help mitigating climate change-among them Frans Timmermans, Executive Vice-President of the European Commission (Schulz 2020), or Fatih Birol, head of the International Energy Agency (Birol 2020) .The Coronavirus Crisis as a Moment for Interest GroupsThere is one thing that must not be overlooked in this politico-economic competition: public funds are still short and must be used reasonably.", [["head", "ORGAN", 232, 236], ["The Coronavirus Crisis", "PROBLEM", 286, 308], ["head", "ANATOMY", 232, 236], ["Coronavirus Crisis", "OBSERVATION", 290, 308]]], ["Otherwise ill-designed (green) subsidies can quickly turn into a part of the problem instead of being the solution.", [["ill", "OBSERVATION", 10, 13]]], ["Empirical analyses have shown very mixed results regarding both the economic and the environmental stimulus effects of these measures (Grigolon et al. 2016; Li et al. 2013; Mian and Sufi 2012) .", [["Empirical analyses", "TEST", 0, 18]]], ["At the beginning of every discussion about (green) recovery programmes, it is therefore important to develop transparent and sensible criteria based on which public aid should be allocated.Recovery Programmes Must be Climate-ProofAfter the initial bail-out programmes, public recovery programmes to stabilize the economy are now debated politically.", [["public recovery programmes", "TREATMENT", 269, 295]]], ["Certainly, this generates an unprecedented window of opportunity for structural transformation.", [["structural transformation", "PROBLEM", 69, 94], ["structural transformation", "OBSERVATION", 69, 94]]], ["Consequently, the currently available political degrees of freedom should be used to promote the transition of society towards sustainability.", [["political degrees of freedom", "TREATMENT", 38, 66]]], ["Subsidies to branches like tourism, aviation and agriculture-which are particularly hit by the crisis and are lagging behind in terms of sustainability-should be paid conditional on meeting minimum environmental standards.", [["the crisis", "PROBLEM", 91, 101], ["branches", "ANATOMY_MODIFIER", 13, 21], ["tourism", "OBSERVATION_MODIFIER", 27, 34]]], ["A recovery program cannot only be about re-establishing the status quo ante by assigning large public funds, possibly creating new barriers for sustainability transitions.", [["large", "OBSERVATION_MODIFIER", 89, 94], ["new", "OBSERVATION_MODIFIER", 127, 130]]], ["In this respect, it makes sense to implement recovery programs that are in line with the objective of mitigating climate change-as called for by many at the moment.", [["recovery programs", "TREATMENT", 45, 62]]], ["However, such green recovery programmes must not be arbitrary.Broadband Green Subsidy Programmes are Not the SolutionGreen recovery programmes must go beyond green subsidies.", [["the SolutionGreen recovery programmes", "TREATMENT", 105, 142]]], ["First of all, it is also important to reduce unnecessary barriers for green investments, for example by revising legal constraints to the expansion of renewable energies like solar photovoltaics of wind power.", [["unnecessary barriers", "TREATMENT", 45, 65], ["green investments", "TREATMENT", 70, 87], ["solar photovoltaics", "TREATMENT", 175, 194]]], ["Moreover, any green recovery program can only effectively and efficiently spur decarbonization if it combines with a carbon price and the abolition of environmentally harmful subsidies.", [["carbon", "CHEMICAL", 117, 123], ["a carbon price", "TREATMENT", 115, 129]]], ["The direction of recovery must be crystal clear.", [["crystal", "OBSERVATION_MODIFIER", 34, 41], ["clear", "OBSERVATION", 42, 47]]], ["Otherwise green subsidies risk being ineffective and costly approaches to mitigating climate change (Kalkuhl et al. 2013; Palmer and Burtraw 2005) , while imposing additional burdens on public budgets and reducing political degrees of freedom in the future.", [["public budgets", "TREATMENT", 186, 200]]], ["For subsidies to be economically justified, they need to meet clear criteria.Green Stimuli Must Help Stabilize the EconomyFor green recovery programs to succeed in the competition for public funds with other important policy fields (such as health or digitalization), they must help stabilize the economy.", [["green recovery programs", "TREATMENT", 126, 149]]], ["Moreover, policy makers need to be aware that some of the currently observed economic problems might even resolve without any government aid.", [["economic problems", "PROBLEM", 77, 94]]], ["It can expected, for example, that global supply chains will resume and that people will catch up on purchasing durable goods like cars, at least partly.", [["people", "ORGANISM", 77, 83], ["people", "SPECIES", 77, 83]]], ["It is exactly (the maintenance of) environmental regulation that may help steer this consumption towards more sustainable modes.Green Stimuli Must Help Stabilize the EconomyGovernment interventions must take effect where permanent disruptions are looming.", [["environmental regulation", "TREATMENT", 35, 59], ["Green Stimuli", "TREATMENT", 128, 141], ["the EconomyGovernment interventions", "TREATMENT", 162, 197], ["permanent disruptions", "PROBLEM", 221, 242]]], ["In contrast, attempts to lower prices for goods and services-e.g. for cars (VAT reduction, purchase premiums) or electricity (reduction of energy levies)-are rather inappropriate means to stabilize the economy.", [["cars (VAT reduction", "TREATMENT", 70, 89]]], ["Furthermore, it is unclear whether and to what extent such discounts will be passed through to final consumers by market prices (Peltzman 2000) .Green Stimuli Must be Checked for Mitigation Potential and MaturityGreen recovery programs should focus on government interventions that would also have been economically reasonable without the COVID-19 crisis-for example, to correct market failures next to the CO 2 externality (Bennear and Stavins 2005; Fischer and Newell 2008; Lehmann 2012)-and that have the highest priority for climate policy.", [["CO 2", "CHEMICAL", 407, 411], ["Green Stimuli", "TREATMENT", 145, 158], ["Green recovery programs", "TREATMENT", 212, 235], ["government interventions", "TREATMENT", 252, 276], ["the COVID", "TEST", 335, 344]]], ["This sector is severely lagging behind in terms of climate change mitigation, and economic rationales for public expenditures exist at least partly (Briggs et al. 2015; Low and Astle 2009 ).", [["severely lagging", "PROBLEM", 15, 31], ["climate change mitigation", "TREATMENT", 51, 76], ["public expenditures", "PROBLEM", 106, 125], ["severely", "OBSERVATION_MODIFIER", 15, 23], ["lagging", "OBSERVATION_MODIFIER", 24, 31]]], ["Those measures that can be implemented quickly, should now be launched-for instance to electrify the transport sector or to strengthen public transport.Polluters Should Contribute to Funding Green Recovery Programmes(Green) recovery programmes must not only address the expenditure side.", [["Green) recovery programmes", "TREATMENT", 217, 243]]], ["A currently still disregarded issue is the question how the required billions of Euro could be raised.", [["Euro", "TREATMENT", 81, 85]]], ["Public expenditures for a green recovery program should at least partly be funded by polluters by implementing a carbon price and abandoning ecological harmful subsidies.", [["carbon", "CHEMICAL", 113, 119], ["a green recovery program", "TREATMENT", 24, 48], ["a carbon price", "TREATMENT", 111, 125]]], ["Such policies internalizing environmental costs would not be an extra sacrifice-but rather part of the solution both for revenue problems and for the redirection towards sustainability (for a review of the double-dividend hypothesis, see Goulder 2013).Conclusion: Combine Economic Stabilization, Mitigation of Climate Change and Revenue RaisingThe coronavirus crisis has opened up a window of opportunity for transformation.", [["coronavirus", "DISEASE", 348, 359], ["coronavirus", "ORGANISM", 348, 359], ["coronavirus", "SPECIES", 348, 359], ["an extra sacrifice", "TREATMENT", 61, 79], ["Combine Economic Stabilization", "TREATMENT", 264, 294], ["Climate Change", "TREATMENT", 310, 324], ["The coronavirus crisis", "PROBLEM", 344, 366], ["transformation", "PROBLEM", 409, 423], ["coronavirus crisis", "OBSERVATION", 348, 366]]], ["Green recovery programs must not be reduced to a mere competition for green subsidies.", [["Green recovery programs", "TREATMENT", 0, 23]]], ["Abandoning barriers to green investments and imposing a carbon price are equally important.", [["carbon", "CHEMICAL", 56, 62], ["green investments", "TREATMENT", 23, 40], ["a carbon price", "TREATMENT", 54, 68]]], ["Moreover, smart green recovery programs may contribute to raising revenues for the additionally necessary public expenditures.1) IntroductionThe world is currently facing the largest pandemic since Spanish flu in 1918.", [["smart green recovery programs", "TREATMENT", 10, 39]]], ["This has led to a lockdown policy on an unprecedented scale and measures of social distancing that are expected to continue.", [["a lockdown policy", "TREATMENT", 16, 33], ["an unprecedented scale", "TREATMENT", 37, 59]]], ["Populations have seen their food consumption habits be severely modified (e.g. closure of restaurants and markets).", [["severely modified", "PROBLEM", 55, 72]]], ["Food production has also been disturbed, most notably by the reduction in the available workforce, whether domestic (due to the lockdown, illness or childcare) or foreign (temporary closure of borders).", [["illness", "DISEASE", 138, 145], ["foreign (temporary closure of borders", "TREATMENT", 163, 200]]], ["The issues at stakes are numerous, including deglobalization and environmental impacts, in both the long and short terms .", [["numerous", "OBSERVATION_MODIFIER", 25, 33]]], ["The pandemic will lead to unprecedented uncertainties in food supply chains.1) IntroductionIn addition to the health crisis, a dramatic drop in worldwide GDP is anticipatedapproximately 3%-with a partial catch-up in 2021, according to the International Monetary Fund (IMF 2020).", [["GDP", "CHEMICAL", 154, 157], ["GDP", "SIMPLE_CHEMICAL", 154, 157], ["a dramatic drop in worldwide GDP", "PROBLEM", 125, 157], ["dramatic", "OBSERVATION_MODIFIER", 127, 135], ["drop", "OBSERVATION_MODIFIER", 136, 140]]], ["The reduction in income will soon impact food consumption.", [["reduction", "OBSERVATION_MODIFIER", 4, 13]]], ["Some authors are already pointing to an increase in social inequalities.", [["increase", "OBSERVATION_MODIFIER", 40, 48]]], ["The most fragile populations could slide into severe food insecurity, including in developed countries, as shown by Deaton and Deaton (2020) for Canada and Power et al. (2020) for the UK.", [["food insecurity", "DISEASE", 53, 68], ["The most fragile populations", "PROBLEM", 0, 28], ["severe food insecurity", "PROBLEM", 46, 68], ["most fragile", "OBSERVATION_MODIFIER", 4, 16], ["populations", "OBSERVATION", 17, 28], ["severe", "OBSERVATION_MODIFIER", 46, 52], ["food insecurity", "OBSERVATION", 53, 68]]], ["However, the FAO is rather reassuring about the total volume of food (cereal) at the global level.", [["cereal", "ORGANISM_SUBDIVISION", 70, 76]]], ["This does not necessarily mean that this decline is effective regardless of the type of agricultural production.", [["agricultural production", "PROBLEM", 88, 111], ["agricultural production", "OBSERVATION", 88, 111]]], ["In particular, fruits and vegetables could become more expensive.1) IntroductionAgriculture is by nature a risky activity, and the adoption of eco-environmental practices can only increase this risk.", [["fruits", "ANATOMY", 15, 21], ["vegetables", "ANATOMY", 26, 36], ["fruits", "ORGANISM_SUBDIVISION", 15, 21], ["vegetables", "ORGANISM_SUBDIVISION", 26, 36], ["eco-environmental practices", "TREATMENT", 143, 170], ["fruits", "OBSERVATION", 15, 21]]], ["As a consequence, organic farmers, for instance, could be particularly affected by the combination of health and economic crises.", [["economic crises", "PROBLEM", 113, 128]]], ["The cost of organic production is therefore structurally higher, which could pose a problem in the event of an income shock.", [["shock", "DISEASE", 118, 123], ["organic production", "PROBLEM", 12, 30], ["an income shock", "PROBLEM", 108, 123], ["organic production", "OBSERVATION", 12, 30], ["higher", "OBSERVATION_MODIFIER", 57, 63], ["shock", "OBSERVATION", 118, 123]]], ["To add value to their production, many small farmers combine organic farming with short food supply chains.", [["small", "OBSERVATION_MODIFIER", 39, 44]]], ["This makes it possible to regain a more comfortable margin than that allowed by mass distribution.", [["mass", "OBSERVATION", 80, 84]]], ["While supermarkets were stormed with shoppers at the beginning of the crisis, some short channels were closed, such as markets and restaurants, to preserve social distancing.1) IntroductionThis article therefore considers the consequences of COVID-19 for sustainable agricultural practices, particularly for farmers who have chosen organic farming in short supply chains.", [["COVID-19", "CHEMICAL", 242, 250], ["COVID", "TEST", 242, 247], ["sustainable agricultural practices", "TREATMENT", 255, 289]]], ["To do so, we use the multi-level perspective (Geels 2002) approach to conceptualize socio-economic transitions.2) The Multi-level Perspective: An Analytical Framework for Sustainable Transition of the Agri-food RegimeThe multi-level perspective (MLP) approach analyses transitions as mutation processes from one socio-technical regime to another under the pressure of macrolevel forces and the emergence of market niches that could provide the basis for a new regime (Geels 2002) .", [["the Agri-food Regime", "TREATMENT", 197, 217], ["mutation processes", "PROBLEM", 284, 302], ["the pressure of macrolevel forces", "TREATMENT", 352, 385], ["a new regime", "TREATMENT", 454, 466]]], ["We show here why local food supply chains are perceived by some farmers-especially the smallest-as a way to enhance the economic value of eco-friendly agricultural practices, such as organic farming.2) The Multi-level Perspective: An Analytical Framework for Sustainable Transition of the Agri-food RegimeIn France, the current dominant socio-technical regime based on conventional agriculture emerged gradually in the 1950s.", [["the Agri-food RegimeIn", "TREATMENT", 285, 307]]], ["Conventional agriculture diffuses slowly at first because of the high investment costs.", [["Conventional agriculture diffuses", "PROBLEM", 0, 33], ["the high investment costs", "PROBLEM", 61, 86]]], ["However, the French state and farmers' unions support it as a means of increasing production and improving living and working conditions.", [["increasing production", "PROBLEM", 71, 92]]], ["Farmers are then inclined to take on more debt and become dependent on their suppliers (phytosanitary products, seeds, tools, etc.), the food industry and supermarkets.", [["phytosanitary products", "TREATMENT", 88, 110], ["dependent", "OBSERVATION_MODIFIER", 58, 67]]], ["As a result, this modernization of agriculture has been controversial from the outset, at least with regard to farmer autonomy and the country's food sovereignty (Levidow et al. 2014 ).2) The Multi-level Perspective: An Analytical Framework for Sustainable Transition of the Agri-food RegimeThe early development of organic farming in France began in the 1980s due to the effects of three negative effects of conventional agriculture, namely pollution, soil impoverishment and the lack of autonomy mentioned above.", [["the Agri-food Regime", "TREATMENT", 271, 291], ["conventional agriculture", "TREATMENT", 409, 433], ["early", "OBSERVATION_MODIFIER", 295, 300], ["organic farming", "OBSERVATION", 316, 331]]], ["The organic label has become a marketing argument that is profitable for large farms, since they achieve significant scale effects on these standardized products.", [["these standardized products", "TREATMENT", 134, 161]]], ["Large scale organic farming is therefore less demanding and, by its nature, allows to benefit from the effects of scale.", [["Large scale organic farming", "PROBLEM", 0, 27], ["scale", "OBSERVATION_MODIFIER", 6, 11], ["organic farming", "OBSERVATION", 12, 27], ["less demanding", "OBSERVATION_MODIFIER", 41, 55]]], ["This is new competition for small farmers struggling to differentiate themselves.", [["small farmers struggling", "PROBLEM", 28, 52], ["new", "OBSERVATION_MODIFIER", 8, 11], ["small", "OBSERVATION_MODIFIER", 28, 33]]], ["The organic label itself does not allow farmers to free themselves from the pressures upstream and downstream in the production chain.2) The Multi-level Perspective: An Analytical Framework for Sustainable Transition of the Agri-food RegimeTo differentiate themselves from large organic farms, some farmers are starting to sell in open-air markets again.", [["the pressures upstream", "TEST", 72, 94], ["the Agri-food RegimeTo", "TREATMENT", 220, 242], ["large organic farms", "PROBLEM", 273, 292], ["pressures", "OBSERVATION_MODIFIER", 76, 85], ["downstream", "OBSERVATION_MODIFIER", 99, 109], ["production", "OBSERVATION_MODIFIER", 117, 127], ["chain", "OBSERVATION_MODIFIER", 128, 133], ["large", "OBSERVATION_MODIFIER", 273, 278], ["organic farms", "OBSERVATION", 279, 292], ["air markets", "OBSERVATION", 336, 347]]], ["A new initiative is gradually emerging: collective farmers' shops.", [["new", "OBSERVATION_MODIFIER", 2, 5]]], ["These initiatives began, for example, in the south of France in the mid-1980s and represent a more important restructuring of the farmers' market.3) Looking Ahead and Lessons from the PandemicIn the medium term, the drop in income could increase the consumption of basic necessities (Giffen goods) to the detriment of organic products.", [["organic products", "TREATMENT", 318, 334], ["more important", "OBSERVATION_MODIFIER", 94, 108], ["restructuring", "OBSERVATION_MODIFIER", 109, 122]]], ["Everything will depend on the elasticity of the demand for these products.", [["these products", "TREATMENT", 59, 73]]], ["Until now, organic products have been extremely popular.", [["organic products", "TREATMENT", 11, 27]]], ["It is possible that \"industrial organic\" will take market share from a \"more artisanal organic\" if consumers still want to consume organic products but cannot afford to spend a large part of their budget on them.3) Looking Ahead and Lessons from the PandemicFarmers in short supply chains often have several distribution channels simultaneously, especially market gardening farmers.", [["organic products", "TREATMENT", 131, 147], ["several", "OBSERVATION_MODIFIER", 300, 307], ["distribution channels", "OBSERVATION", 308, 329]]], ["Thus, the closure of farmers' markets and restaurants can be compensated for by farm shops, community-supported agriculture (CSA), fixed point or home delivery, or collective farmers' shops.3) Looking Ahead and Lessons from the PandemicRegarding hygiene measures, farmers are faced with two main types of strategies: receiving customers in the original locations or digitizing the process, including the more marginal case of automatic food dispensers (e.g. for eggs).", [["the closure of farmers' markets", "TREATMENT", 6, 37], ["home delivery", "TREATMENT", 146, 159], ["the PandemicRegarding hygiene measures", "TREATMENT", 224, 262], ["closure", "OBSERVATION", 10, 17]]], ["However, conserving this method makes it possible to maintain the relational proximity between farmers and consumers.", [["this method", "TREATMENT", 20, 31]]], ["Initially, this relational proximity is one of the main arguments in favour of short supply chains, as it is supposed to allow better traceability of products and to fight against social isolation (especially of the elderly).3) Looking Ahead and Lessons from the PandemicThe other strategy, therefore, is to limit direct contact between human beings by means of computer tools.", [["human", "ORGANISM", 337, 342], ["human", "SPECIES", 337, 342], ["human", "SPECIES", 337, 342], ["short supply chains", "TREATMENT", 79, 98], ["social isolation", "TREATMENT", 180, 196], ["one", "OBSERVATION_MODIFIER", 40, 43], ["main", "OBSERVATION_MODIFIER", 51, 55], ["arguments", "OBSERVATION", 56, 65]]], ["Internet platforms already existed before the crisis and are expected to develop.", [["Internet platforms", "TEST", 0, 18], ["the crisis", "PROBLEM", 42, 52]]], ["The pandemic has accelerated this process, and some regions have launched their own platforms.", [["pandemic", "OBSERVATION", 4, 12]]], ["Others fled from supermarkets, considering that the products were handled by a large number of people and that there was too much traffic.", [["people", "ORGANISM", 95, 101], ["people", "SPECIES", 95, 101]]], ["It is difficult to predict whether these changes in behaviour will have a long-term impact.3) Looking Ahead and Lessons from the PandemicIn addition, the pandemic has raised concerns about the reliability of international distribution channels.", [["a long-term impact", "PROBLEM", 72, 90], ["long-term impact", "OBSERVATION_MODIFIER", 74, 90]]], ["It is therefore possible that some policies may be sensitive to the has been growing at a very fast pace (see an indicative list of references in supplementary material 1).", [["therefore possible", "UNCERTAINTY", 6, 24]]], ["However, little attention has been paid to the reliability of this type of epidemiological data to make statistical inferences.3) Looking Ahead and Lessons from the PandemicOur initial aim was to produce a detailed statistical analysis of the relationship between weather conditions and the spread of COVID-19.", [["epidemiological data", "TEST", 75, 95], ["COVID", "TEST", 301, 306]]], ["This question has attracted significant attention from the media (e.g. Ravilious 2020; Clive Cookson 2020) and the research community (e.g. Araujo and Naimi 2020; Carleton et al. 2020 ; see a wider list in supplementary material 1) due to the possibility that summer weather might slow the spread of the virus.", [["the virus", "PROBLEM", 300, 309], ["significant", "OBSERVATION_MODIFIER", 28, 39]]], ["After going through all the steps of such an analysis, we reached the unexpected conclusion that the limitations of the available COVID-19 data are so severe that we would not be able to make any reliable statistical inference.", [["an analysis", "TEST", 42, 53]]], ["The elements discussed in this paper are also likely to be applicable to other epidemiological datasets obtained with insufficient testing and monitoring, either during exceptional epidemics or seasonal outbreaks.3) Looking Ahead and Lessons from the PandemicSeveral challenges could undermine any causal statistical analysis of the influence of a potential determinant, such as the weather, on the spread of COVID-19.", [["insufficient testing", "TEST", 118, 138], ["monitoring", "TEST", 143, 153], ["seasonal outbreaks", "PROBLEM", 194, 212], ["the PandemicSeveral challenges", "TREATMENT", 247, 277], ["COVID", "TEST", 409, 414]]], ["To start, confounding variables are likely to pose a significant problem: many factors (e.g. changes in policy or social interactions) are simultaneously influencing how the disease spreads.3) Looking Ahead and Lessons from the PandemicIn addition, significant challenges come from the limitations of the COVID-19 case count data itself.", [["a significant problem", "PROBLEM", 51, 72], ["the disease spreads", "PROBLEM", 170, 189], ["the COVID", "TEST", 301, 310]]], ["Firstly, testing capacity has been a major issue in most countries.", [["testing capacity", "TEST", 9, 25]]], ["By 30 April 2020, highincome countries had significantly increased their testing capacity, but testing remained critically infrequent in most low-and middle-income countries.", [["testing", "TEST", 95, 102], ["critically infrequent", "PROBLEM", 112, 133]]], ["55 Figure 1 , panel a, illustrates the effect that insufficient testing capacity has on the number of confirmed cases.", [["insufficient testing capacity", "PROBLEM", 51, 80]]], ["It distinguishes between three phases of limited (I), intermediate (II) and widespread (III) testing.", [["widespread (III) testing", "PROBLEM", 76, 100]]], ["In Phases I and II, there is a risk that the number of confirmed cases depends more on the number of tests available than on the actual number of people who have COVID-19, questioning the validity of any analysis relying too heavily on these data.3) Looking Ahead and Lessons from the PandemicMoreover, there have been numerous concerns regarding the accuracy of the COVID-19 tests performed so far (Ai et al. 2020; Apostolopoulos and Tzani 2020; Hu 2020; Hall et al. 2020) .", [["people", "ORGANISM", 146, 152], ["people", "SPECIES", 146, 152], ["COVID", "TEST", 162, 167], ["any analysis", "TEST", 200, 212], ["these data", "TEST", 236, 246], ["the COVID-19 tests", "TEST", 363, 381], ["numerous", "OBSERVATION_MODIFIER", 319, 327]]], ["False-negative results would imply that the number of confirmed COVID-19 cases is underestimated.", [["COVID", "DISEASE", 64, 69], ["COVID", "TEST", 64, 69], ["negative", "OBSERVATION", 6, 14]]], ["False-positive results would imply that people who do not have COVID-19 are included in the number of confirmed COVID-19 cases.", [["people", "ORGANISM", 40, 46], ["people", "SPECIES", 40, 46], ["COVID", "TEST", 63, 68], ["COVID", "TEST", 112, 117]]], ["Concerns regarding test accuracy create an additional problem of measurement that might affect statistical analyses.3) Looking Ahead and Lessons from the PandemicThe two above-mentioned challenges are inherent in all current datasets of COVID-19 confirmed case count and mortality.", [["test accuracy", "TEST", 19, 32], ["COVID", "TEST", 237, 242], ["case count", "TEST", 256, 266]]], ["In addition, specific datasets may have imperfect geographical or time coverage.3) Looking Ahead and Lessons from the PandemicTo look at the impact of the weather on the spread of COVID-19, we initially used a well-established approach, similar to the ones used previously to look at the impact of the weather on other diseases (e.g. Deschenes and Enrico 2009; Gasparrini et al. 2015 ) (see details in supplementary material 2).", [["a well-established approach", "TREATMENT", 208, 235], ["other diseases", "PROBLEM", 313, 327]]], ["However, the fundamental measurement issues associated with the COVID-19 case count data cannot be corrected by statistical techniques, as we outline in the following.3) Looking Ahead and Lessons from the PandemicThe main problem is that the weather could be influencing the number of tests carried out and the segment of the population tested.", [["the fundamental measurement issues", "PROBLEM", 9, 43], ["the COVID", "TEST", 60, 69], ["case count data", "TEST", 73, 88], ["tests", "TEST", 285, 290], ["main", "OBSERVATION_MODIFIER", 217, 221]]], ["For example, other respiratory diseases are often similar to COVID-19 in their symptoms (e.g. WHO 2020) and are more common during cold weather (e.g. Deschenes and Enrico 2009; Gasparrini et al. 2015) , which could influence the number of tests performed on people displaying symptoms of respiratory infection.", [["respiratory", "ANATOMY", 19, 30], ["respiratory", "ANATOMY", 288, 299], ["respiratory diseases", "DISEASE", 19, 39], ["respiratory infection", "DISEASE", 288, 309], ["people", "ORGANISM", 258, 264], ["people", "SPECIES", 258, 264], ["other respiratory diseases", "PROBLEM", 13, 39], ["COVID", "TEST", 61, 66], ["their symptoms", "PROBLEM", 73, 87], ["tests", "TEST", 239, 244], ["symptoms", "PROBLEM", 276, 284], ["respiratory infection", "PROBLEM", 288, 309], ["respiratory diseases", "OBSERVATION", 19, 39], ["respiratory", "ANATOMY", 288, 299], ["infection", "OBSERVATION", 300, 309]]], ["Therefore, even if the model correctly identified the impact of the weather on COVID-19 case counts, it cannot distinguish between the impact of the weather on the spread of the disease and its impact on testing.", [["COVID", "TEST", 79, 84], ["the disease", "PROBLEM", 174, 185], ["testing", "TEST", 204, 211], ["disease", "OBSERVATION", 178, 185]]], ["Table 1 provides a non-exhaustive list of elements that could undermine any analysis of the impact of the weather on the spread of COVID-19 using data on confirmed cases.", [["COVID", "TEST", 131, 136]]], ["The evidence suggests that the weather may correlate with the number of tests conducted and who gets tested.", [["tests", "TEST", 72, 77]]], ["We have not been able to find any specific COVID-19-related evidence that the weather could impact test accuracy (e.g. the weather affecting the nasopharyngeal or oropharyngeal swabs used in the PCR analysis), even though this could be possible.3) Looking Ahead and Lessons from the PandemicOther points of concern include: the fact that there may be indirect effects of weather conditions on other factors that could have an impact on the spread of COVID-19 (such as social interactions or air pollution); the heterogeneity of impacts across populations and subgroups within a population; and the fact that some people may have travelled and therefore been infected in a different place from where the cases are reported.", [["nasopharyngeal", "ANATOMY", 145, 159], ["oropharyngeal swabs", "ANATOMY", 163, 182], ["nasopharyngeal", "CANCER", 145, 159], ["oropharyngeal swabs", "MULTI-TISSUE_STRUCTURE", 163, 182], ["people", "ORGANISM", 613, 619], ["people", "SPECIES", 613, 619], ["test accuracy", "TEST", 99, 112], ["the nasopharyngeal or oropharyngeal swabs", "PROBLEM", 141, 182], ["the PCR analysis", "TEST", 191, 207], ["COVID", "TEST", 450, 455], ["nasopharyngeal", "ANATOMY", 145, 159], ["impacts", "OBSERVATION_MODIFIER", 528, 535], ["infected", "OBSERVATION", 658, 666]]], ["We ran our model (as detailed in supplementary material 2) and provide results and robustness checks in supplementary material 3.", [["robustness checks", "TEST", 83, 100]]], ["Figure 2 , panel a, provides an illustration of how we could have obtained a negative correlation even if temperature had no impact or a positive impact on the spread of COVID-19 in our sample.", [["COVID-19", "CHEMICAL", 170, 178], ["a positive impact", "PROBLEM", 135, 152], ["COVID", "TEST", 170, 175]]], ["The total number of estimated cases is given by the size of the circles as a function of temperature (x-axis).", [["total", "OBSERVATION_MODIFIER", 4, 9], ["number", "OBSERVATION_MODIFIER", 10, 16], ["size", "OBSERVATION_MODIFIER", 52, 56]]], ["The circles in green correspond to the effects we are interested in-those that explain the influence of temperature on the spread of COVID-19.", [["COVID", "TEST", 133, 138], ["circles", "OBSERVATION_MODIFIER", 4, 11]]], ["If temperature has no effect on the spread of COVID-19, then the green circles should be the same size at low and high temperatures.", [["COVID-19", "CHEMICAL", 46, 54], ["COVID", "TEST", 46, 51], ["the green circles", "TREATMENT", 61, 78], ["no", "UNCERTAINTY", 19, 21], ["effect", "OBSERVATION_MODIFIER", 22, 28], ["green circles", "OBSERVATION", 65, 78], ["size", "OBSERVATION_MODIFIER", 98, 102], ["high temperatures", "OBSERVATION_MODIFIER", 114, 131]]], ["The pink circles represent the possible effect of temperature on testing (as reported in Table 1 ) under the illustrative assumption that high temperatures reduce testing frequency.", [["temperature on testing", "TEST", 50, 72], ["high temperatures reduce testing frequency", "PROBLEM", 138, 180], ["pink circles", "OBSERVATION", 4, 16], ["possible effect", "OBSERVATION_MODIFIER", 31, 46]]], ["In this case, the overall result is a negative correlation between temperature and confirmed COVID-19 cases, even if temperature has no effect on the spread of the disease.", [["temperature", "TEST", 67, 78], ["COVID", "TEST", 93, 98], ["temperature", "TEST", 117, 128], ["the disease", "PROBLEM", 160, 171], ["disease", "OBSERVATION", 164, 171]]], ["In practice, we naturally do not know the direction of the bias caused by the effect of temperature on testing when using standard statistical methods.", [["temperature on testing", "TEST", 88, 110]]], ["There is also no way for us to evaluate the contribution of each of these effects (green Table 1 Non-exhaustive list of reasons why weather conditions could affect the number of COVID-19 tests carried out and who gets tested Potential reason Potential implication Unrelated respiratory diseases are weather sensitive (e.g. Deschenes and Enrico 2009; Gasparrini et al. 2015) and can be confused with COVID-19 (e.g. Ai et al. 2020; Chen et al. 2020) More patients with symptoms of unrelated respiratory diseases could be tested during cold weather The prevalence of other weather-sensitive respiratory diseases might make false-positive results more likely, especially if only radiographic imaging is used, since it is possible to confuse these diseases for COVID-19 (e.g. Ai et al. 2020; Chen et al. 2020) The incidence of other pathologies (e.g. cardiovascular diseases) is influenced by the weather (e.g. Deschenes and Enrico 2009; Gasparrini et al. 2015) Hospital capacity and the workload of medical staff and testing structures are affected by weather conditions, with potential implications on the number of tests conducted At-risk individuals suffering from unrelated conditions are more likely to be tested for COVID-19, even if they only have mild symptoms for COVID-19 People may be more inclined to seek medical attention depending on the weather (e.g. Norris et al. 2014) Due to weather conditions, people may or may not decide to seek medical attention, affecting the number of patients going to the hospital with COVID-19, and the workload of medical staff or pink) in our estimate.", [["respiratory", "ANATOMY", 489, 500], ["respiratory", "ANATOMY", 588, 599], ["cardiovascular", "ANATOMY", 846, 860], ["respiratory diseases", "DISEASE", 274, 294], ["respiratory diseases", "DISEASE", 489, 509], ["respiratory diseases", "DISEASE", 588, 608], ["cardiovascular diseases", "DISEASE", 846, 869], ["COVID-19", "CHEMICAL", 399, 407], ["patients", "ORGANISM", 453, 461], ["people", "ORGANISM", 1410, 1416], ["patients", "ORGANISM", 1490, 1498], ["patients", "SPECIES", 453, 461], ["People", "SPECIES", 1278, 1284], ["people", "SPECIES", 1410, 1416], ["patients", "SPECIES", 1490, 1498], ["COVID", "TEST", 178, 183], ["Unrelated respiratory diseases", "PROBLEM", 264, 294], ["COVID", "TEST", 399, 404], ["symptoms", "PROBLEM", 467, 475], ["unrelated respiratory diseases", "PROBLEM", 479, 509], ["sensitive respiratory diseases", "PROBLEM", 578, 608], ["radiographic imaging", "TEST", 675, 695], ["these diseases", "PROBLEM", 737, 751], ["COVID", "TEST", 756, 761], ["other pathologies (e.g. cardiovascular diseases", "PROBLEM", 822, 869], ["Hospital capacity", "TEST", 957, 974], ["tests", "TEST", 1113, 1118], ["unrelated conditions", "PROBLEM", 1164, 1184], ["COVID", "TEST", 1218, 1223], ["mild symptoms", "PROBLEM", 1251, 1264], ["COVID", "TEST", 1269, 1274], ["respiratory", "ANATOMY", 489, 500], ["diseases", "OBSERVATION", 501, 509], ["respiratory diseases", "OBSERVATION", 588, 608], ["pathologies", "OBSERVATION", 828, 839]]], ["We arrive at the final size of the circles and cannot be sure if the association that we are interested in is either negative, null or positive.", [["null or positive", "PROBLEM", 127, 143], ["size", "OBSERVATION_MODIFIER", 23, 27]]], ["Figure 2 , panel b, focuses on the risk that effects could be different across different samples.", [["samples", "ANATOMY", 89, 96]]], ["The circles in blue capture other underlying factors that are influenced by temperature (such as acclimatization or the level of social interactions in the population), as well as other socioeconomic factors (such as the demographic characteristics of a population).", [["circles", "OBSERVATION_MODIFIER", 4, 11], ["blue capture", "OBSERVATION", 15, 27]]], ["These factors could be radically different in different regions but may also evolve over time (e.g. between winter and summer seasons).3) Looking Ahead and Lessons from the PandemicThere are strong reasons to be concerned with the scenario illustrated in Figure 2 , panel b.", [["could be", "UNCERTAINTY", 14, 22], ["radically", "OBSERVATION_MODIFIER", 23, 32], ["different", "OBSERVATION_MODIFIER", 33, 42], ["may also evolve", "UNCERTAINTY", 68, 83]]], ["In our sample, for example, we only have data from the start of the pandemic until end of April 2020; some countries (e.g. China) may be over-represented in the dataset; and the average daily temperature is relatively low at 10.5 \u00b0C. Furthermore, many countries have implemented a stringent containment policy during the period covered by the sample.", [["the average daily temperature", "TEST", 174, 203], ["a stringent containment policy", "TREATMENT", 279, 309]]], ["Containment policies may have heightened (or lowered) the sensitivity of the spread of the disease to the weather because social interactions are limited.", [["the disease", "PROBLEM", 87, 98]]], ["We are not able to observe howEffect of the weather in another sampleFor example, SARS-CoV-2 is more infec\u019fous; the weather affects people's immune systems; People-to-people transmission is higher.Effect of the weather in another sampleFor example, changes in the number of people with respiratory diseases other than COVID-19, affec\u019fng the number of tests performed.Effect of the weather in another sampleFor example, social interac\u019fons evolve; or samples are for different countries.TemperatureExample 2 Temperature (a) Es\u019fmates are likely to be biased because the weather influences data collec\u019fon (b) Es\u019fmates could vary between samples Fig. 2 Effects potentially captured by our estimate.", [["respiratory", "ANATOMY", 286, 297], ["SARS", "DISEASE", 82, 86], ["respiratory diseases", "DISEASE", 286, 306], ["COVID-19", "CHEMICAL", 318, 326], ["SARS-CoV-2", "ORGANISM", 82, 92], ["people", "ORGANISM", 132, 138], ["People", "ORGANISM", 157, 163], ["people", "ORGANISM", 167, 173], ["people", "ORGANISM", 274, 280], ["people", "SPECIES", 132, 138], ["People", "SPECIES", 157, 163], ["people", "SPECIES", 167, 173], ["people", "SPECIES", 274, 280], ["SARS-CoV", "SPECIES", 82, 90], ["SARS", "TEST", 82, 86], ["respiratory diseases", "PROBLEM", 286, 306], ["COVID", "TEST", 318, 323], ["tests", "TEST", 351, 356], ["TemperatureExample", "TEST", 485, 503], ["higher", "OBSERVATION_MODIFIER", 190, 196], ["number", "OBSERVATION_MODIFIER", 264, 270], ["respiratory diseases", "OBSERVATION", 286, 306]]], ["The size of the circles represents the estimated number of cases at different temperatures.", [["size", "OBSERVATION_MODIFIER", 4, 8], ["circles", "OBSERVATION_MODIFIER", 16, 23], ["estimated", "OBSERVATION_MODIFIER", 39, 48], ["number", "OBSERVATION_MODIFIER", 49, 55], ["different", "OBSERVATION_MODIFIER", 68, 77], ["temperatures", "OBSERVATION_MODIFIER", 78, 90]]], ["(Color figure online) the impact of the weather on COVID-19 might change at different gradients of social interaction.", [["COVID-19", "CHEMICAL", 51, 59], ["COVID", "TREATMENT", 51, 56]]], ["Finally, our estimate is based on small, observed changes in temperatures, and not on radical increases or reductions in temperatures.", [["small, observed changes in temperatures", "PROBLEM", 34, 73], ["radical increases", "TREATMENT", 86, 103], ["reductions in temperatures", "PROBLEM", 107, 133], ["small", "OBSERVATION_MODIFIER", 34, 39], ["reductions", "OBSERVATION_MODIFIER", 107, 117]]], ["The spread of COVID-19 may respond differently to large variations in temperature, e.g. by 5 \u00b0C or 10 \u00b0C across seasons, making seasonal predictions even more unreliable.TemperatureStrong precautions need to be taken before using COVID-19 case count datasets for inference.", [["COVID-19", "CHEMICAL", 14, 22], ["COVID-19", "DNA", 14, 22], ["COVID", "TEST", 14, 19], ["large variations in temperature", "PROBLEM", 50, 81], ["TemperatureStrong precautions", "TREATMENT", 170, 199], ["COVID", "TEST", 230, 235], ["large", "OBSERVATION_MODIFIER", 50, 55], ["variations", "OBSERVATION_MODIFIER", 56, 66]]], ["The results of our model using existing COVID-19 data would seemingly imply a negative association between temperature and confirmed COVID-19 cases.", [["COVID", "DNA", 40, 45], ["existing COVID", "TEST", 31, 45], ["temperature", "TEST", 107, 118], ["COVID", "TEST", 133, 138], ["negative", "OBSERVATION", 78, 86]]], ["Any projection of COVID-19 cases with such estimates could conclude that, during the upcoming months of June to September 2020, Southern Hemisphere countries would be exposed to higher risks of COVID-19 spread and Northern Hemisphere countries to lower risks.", [["COVID", "TEST", 18, 23], ["COVID", "TEST", 194, 199]]], ["56 These types of unsubstantiated results could be used as a misinformed justification for an early relaxation of effective social distancing measures in the Northern Hemisphere.TemperatureThese findings have equally strong implications for statistical analyses focusing on other questions that rely on COVID-19 confirmed case count and/or mortality count data.", [["Temperature", "TEST", 178, 189], ["statistical analyses", "TEST", 241, 261], ["COVID", "TEST", 303, 308], ["case count", "TEST", 322, 332], ["mortality count data", "TEST", 340, 360], ["early", "OBSERVATION_MODIFIER", 94, 99], ["relaxation", "OBSERVATION_MODIFIER", 100, 110], ["effective", "OBSERVATION_MODIFIER", 114, 123], ["social", "OBSERVATION_MODIFIER", 124, 130], ["distancing", "OBSERVATION", 131, 141], ["Northern Hemisphere", "ANATOMY", 158, 177]]], ["Even though the exact nature of the effects may change, such studies are also at risk of capturing the effect that their parameters of interest have on tests and test results.", [["such studies", "TEST", 56, 68], ["tests", "TEST", 152, 157], ["test results", "TEST", 162, 174]]], ["For example, studies interested in the effect of containment policies may have to consider that these policies substantially affect testing because they change the awareness of the disease in the population, political demands for more testing or the risk of contracting other respiratory diseases.", [["respiratory", "ANATOMY", 276, 287], ["respiratory diseases", "DISEASE", 276, 296], ["studies", "TEST", 13, 20], ["containment policies", "TREATMENT", 49, 69], ["the disease", "PROBLEM", 177, 188], ["more testing", "TEST", 230, 242], ["contracting other respiratory diseases", "PROBLEM", 258, 296], ["respiratory diseases", "OBSERVATION", 276, 296]]], ["Other studies may also produce estimates that are very specific to the current circumstances in the development of the pandemic and are, therefore, not suitable to use for forecasts of what could happen in the coming months.TemperatureIn the medium term, more reliable data need to be gathered, for example through experimental studies that randomly test a sample of the population for COVID-19.", [["Other studies", "TEST", 0, 13], ["experimental studies", "TEST", 315, 335], ["COVID", "TEST", 386, 391], ["pandemic", "OBSERVATION", 119, 127], ["medium term", "OBSERVATION_MODIFIER", 242, 253]]], ["In the short term, we are in a situation of fundamental uncertainty about how different factors affect or are affected by the widespread societal changes we see with the COVID-19 pandemic.", [["the COVID", "TEST", 166, 175], ["pandemic", "PROBLEM", 179, 187], ["short term", "OBSERVATION_MODIFIER", 7, 17]]], ["Therefore, scientists, policy makers, journalists and the general public need to be very cautious when discussing how the spread of COVID-19 correlates with the weather or any other factor.TemperatureIn the long term, this paper suggests that more attention should be given to how epidemiological data is recorded and used during exceptional epidemics and seasonal outbreaks, since insufficient testing and monitoring can undermine essential statistical analyses.", [["COVID-19", "CHEMICAL", 132, 140], ["seasonal outbreaks", "PROBLEM", 356, 374], ["insufficient testing", "TEST", 382, 402], ["long term", "OBSERVATION_MODIFIER", 207, 216]]], ["This article calls for the complementary use of different methods for data collection, such as random testing in samples of the population.", [["different methods", "TREATMENT", 48, 65], ["data collection", "TEST", 70, 85], ["random testing", "TEST", 95, 109]]]], "PMC7335234": [["MAIN TEXTFrom the first cases reported in China in December 2019, a form of severe acute respiratory distress syndrome due to SARS-CoV-2, a new human-infecting beta-coronavirus, became a global health threat.MAIN TEXTItaly was the first western country affected by virus diffusion where the two first clusters of this new coronavirus disease (COVID-19) were identified in two neighbouring northern regions, Lombardy and Veneto.", [["respiratory", "ANATOMY", 89, 100], ["respiratory distress syndrome", "DISEASE", 89, 118], ["SARS", "DISEASE", 126, 130], ["human-infecting beta-coronavirus", "DISEASE", 144, 176], ["coronavirus disease", "DISEASE", 322, 341], ["SARS-CoV-2", "ORGANISM", 126, 136], ["human", "ORGANISM", 144, 149], ["coronavirus", "ORGANISM", 322, 333], ["human", "SPECIES", 144, 149], ["coronavirus", "SPECIES", 322, 333], ["SARS-CoV-2", "SPECIES", 126, 136], ["human", "SPECIES", 144, 149], ["severe acute respiratory distress syndrome", "PROBLEM", 76, 118], ["SARS", "PROBLEM", 126, 130], ["virus diffusion", "PROBLEM", 265, 280], ["this new coronavirus disease", "PROBLEM", 313, 341], ["COVID", "TEST", 343, 348], ["severe", "OBSERVATION_MODIFIER", 76, 82], ["acute", "OBSERVATION_MODIFIER", 83, 88], ["respiratory distress", "OBSERVATION", 89, 109], ["virus", "OBSERVATION", 265, 270], ["new", "OBSERVATION_MODIFIER", 318, 321], ["coronavirus disease", "OBSERVATION", 322, 341]]], ["To date June 2nd, with the effect of a three-month-long lockdown, the number of new daily COVID-19 cases is no longer increasing, and its prevalence settles around 4 cases per 1000 inhabitants, mostly in northern Italy.", [["new daily COVID", "TREATMENT", 80, 95], ["no longer", "UNCERTAINTY", 108, 117]]], ["[Istituto superiore di sanit\u00e0 (ISS) 2020]MAIN TEXTNotably, the clinical spectrum of COVID-19 is broad, and it appears to have a severe course mostly in people over 60 years of age and those with pre-existing risk conditions.", [["people", "ORGANISM", 152, 158], ["people", "SPECIES", 152, 158], ["COVID", "TEST", 84, 89], ["pre-existing risk conditions", "PROBLEM", 195, 223], ["severe", "OBSERVATION_MODIFIER", 128, 134], ["course", "OBSERVATION_MODIFIER", 135, 141]]], ["[Onder, 2020]MAIN TEXTIt is not yet fully established if pwMS are at increased risk of developing severe complications of COVID-19 even if positive initial data about it are coming.", [["COVID-19", "CHEMICAL", 122, 130], ["pwMS", "CANCER", 57, 61], ["MAIN TEXTIt", "TREATMENT", 13, 24], ["pwMS", "PROBLEM", 57, 61], ["developing severe complications", "PROBLEM", 87, 118], ["COVID", "TEST", 122, 127], ["severe", "OBSERVATION_MODIFIER", 98, 104], ["complications", "OBSERVATION", 105, 118]]], ["[Sormani, 2020]MAIN TEXTThe present aims to report the frequency of COVID-19 in pwMS from the Veneto region, as well as report the level of immunosuppression determined by the ongoing treatment and informing on the outcome.MAIN TEXTWe have systematically collected data on the presence of symptoms compatible with COVID-19 in pwMS living in the Veneto region both by email-specific inhouse questionnaire sent to patients followed at Veneto MS regional Centre of Verona and, partially, by self-reported new information.", [["pwMS", "CANCER", 80, 84], ["pwMS", "CANCER", 326, 330], ["patients", "ORGANISM", 412, 420], ["COVID-19", "DNA", 68, 76], ["patients", "SPECIES", 412, 420], ["COVID", "TEST", 68, 73], ["immunosuppression", "TREATMENT", 140, 157], ["the ongoing treatment", "TREATMENT", 172, 193], ["systematically collected data", "TEST", 240, 269], ["symptoms", "PROBLEM", 289, 297], ["COVID", "TEST", 314, 319]]], ["By implementing a daily phone-interview system, it was possible to monitor their clinical evolution.MAIN TEXTCOVID-19 was suspected in the presence of fever (temperature > 37.5\u00b0C) plus at least one other compatible symptom.", [["fever", "DISEASE", 151, 156], ["MAIN TEXTCOVID", "TEST", 100, 114], ["fever", "PROBLEM", 151, 156], ["temperature", "TEST", 158, 169], ["compatible symptom", "PROBLEM", 204, 222], ["fever", "OBSERVATION", 151, 156], ["symptom", "OBSERVATION", 215, 222]]], ["Confirmed COVID-19 was defined by a positive rt-PCR for SARS-CoV-2 on a nasopharyngeal swab.", [["nasopharyngeal swab", "ANATOMY", 72, 91], ["SARS-CoV-2", "GENE_OR_GENE_PRODUCT", 56, 66], ["nasopharyngeal swab", "MULTI-TISSUE_STRUCTURE", 72, 91], ["COVID-19", "DNA", 10, 18], ["SARS-CoV", "SPECIES", 56, 64], ["COVID", "TEST", 10, 15], ["a positive rt-PCR", "PROBLEM", 34, 51], ["SARS", "PROBLEM", 56, 60], ["CoV", "TEST", 61, 64], ["a nasopharyngeal swab", "TREATMENT", 70, 91], ["nasopharyngeal", "ANATOMY", 72, 86], ["swab", "OBSERVATION", 87, 91]]], ["The temporary suspension of DMT was suggested in presence of COVID-19 symptoms.", [["DMT", "CHEMICAL", 28, 31], ["DMT", "CHEMICAL", 28, 31], ["DMT", "SIMPLE_CHEMICAL", 28, 31], ["The temporary suspension of DMT", "TREATMENT", 0, 31], ["COVID-19 symptoms", "PROBLEM", 61, 78], ["temporary", "OBSERVATION_MODIFIER", 4, 13], ["suspension", "OBSERVATION_MODIFIER", 14, 24], ["DMT", "OBSERVATION", 28, 31]]], ["[Giovannoni et al., 2020]MAIN TEXTFor each patient the latest blood chemistry findings (at most within six months) were retrieved from the medical records: the total number of lymphocytes, T- and B-cells were reported.", [["blood", "ANATOMY", 62, 67], ["lymphocytes", "ANATOMY", 176, 187], ["T- and B-cells", "ANATOMY", 189, 203], ["patient", "ORGANISM", 43, 50], ["blood", "ORGANISM_SUBSTANCE", 62, 67], ["lymphocytes", "CELL", 176, 187], ["T-", "CELL", 189, 191], ["B-cells", "CELL", 196, 203], ["lymphocytes", "CELL_TYPE", 176, 187], ["T- and B-cells", "CELL_TYPE", 189, 203], ["patient", "SPECIES", 43, 50], ["the latest blood chemistry findings", "TEST", 51, 86], ["lymphocytes", "TEST", 176, 187], ["T", "TEST", 189, 190], ["lymphocytes", "ANATOMY", 176, 187]]], ["A patient was considered immunosuppressed if the total number of lymphocytes was <1000/\u03bcL, or T-cells were <800/\u03bcL and/or B-cells <100/\u03bcL.MAIN TEXTAmong 1034 pwMS [765 females (F) and 269 males (M)], 29 (2.8%; 15F/14M) have a confirmed- or possible COVID-19.", [["lymphocytes", "ANATOMY", 65, 76], ["T-cells", "ANATOMY", 94, 101], ["B-cells", "ANATOMY", 122, 129], ["patient", "ORGANISM", 2, 9], ["lymphocytes", "CELL", 65, 76], ["T-cells", "CELL", 94, 101], ["B-cells", "CELL", 122, 129], ["lymphocytes", "CELL_TYPE", 65, 76], ["T-cells", "CELL_TYPE", 94, 101], ["B-cells", "CELL_TYPE", 122, 129], ["COVID-19", "DNA", 249, 257], ["patient", "SPECIES", 2, 9], ["immunosuppressed", "PROBLEM", 25, 41], ["lymphocytes", "TEST", 65, 76], ["T-cells", "TEST", 94, 101], ["B-cells", "TEST", 122, 129], ["COVID", "TEST", 249, 254]]], ["None of these had demonstrated signs of MS activity within previous six months.", [["MS", "DISEASE", 40, 42], ["MS activity", "PROBLEM", 40, 51]]], ["Among these, 11 (1%; 4F/7M) were confirmed COVID-19, while 18 (1.8%; 11F/7M) showed symptoms highly suggestive of COVID-19 but were not established by rt-PCR (possible COVID-19).", [["COVID", "TEST", 43, 48], ["symptoms", "PROBLEM", 84, 92], ["COVID", "TEST", 114, 119], ["PCR", "TEST", 154, 157], ["COVID", "TEST", 168, 173]]], ["At the time of the current analysis, amongst the 5 million inhabitants of the Veneto region, 19.162 (0.4%) cases of COVID-19 were diagnosed.", [["the current analysis", "TEST", 15, 35], ["COVID", "TEST", 116, 121]]], ["[Portale Regione del Veneto Azienda Zero Emergenza Coronavirus SARS-CoV-2/COVID-19 2020]MAIN TEXTIn the confirmed COVID-19 pwMS, the mean [SD] age was 49 [Giovannoni et al., 2020] years (range 43-55 years) with an apparent higher incidence in males (7/269M, 2.6%) than females (4/765F, 0.5%; p<0.001).MAIN TEXTThese results were confirmed even if the possible COVID-19 cases were considered: 5.2% M (14/269) and 1.9% F (15/765; p<0.001).", [["COVID-19 pwMS", "DNA", 114, 127], ["Veneto Azienda Zero Emergenza Coronavirus SARS-CoV-2/COVID-19", "SPECIES", 21, 82], ["Portale Regione", "TEST", 1, 16], ["Azienda", "TEST", 28, 35], ["Zero", "TEST", 36, 40], ["Coronavirus SARS", "TEST", 51, 67], ["CoV", "TEST", 68, 71], ["COVID", "TEST", 74, 79], ["COVID", "TEST", 114, 119], ["COVID", "TEST", 360, 365], ["higher", "OBSERVATION_MODIFIER", 223, 229]]], ["Immunosuppression was present in 11/29 (38%; 5 confirmed- and 6 possible cases) pwMS.MAIN TEXTHospitalization was required only in 2 male confirmed cases (18%; 2/11), because of high fever and dyspnoea due to pneumonia (chest radiography of both patients showed typical ground-glass opacities; swab test was performed).", [["chest", "ANATOMY", 220, 225], ["pwMS", "DISEASE", 80, 84], ["fever", "DISEASE", 183, 188], ["dyspnoea", "DISEASE", 193, 201], ["pneumonia", "DISEASE", 209, 218], ["chest", "ORGANISM_SUBDIVISION", 220, 225], ["patients", "ORGANISM", 246, 254], ["patients", "SPECIES", 246, 254], ["Immunosuppression", "TREATMENT", 0, 17], ["high fever", "PROBLEM", 178, 188], ["dyspnoea", "PROBLEM", 193, 201], ["pneumonia", "PROBLEM", 209, 218], ["chest radiography", "TEST", 220, 237], ["typical ground-glass opacities", "PROBLEM", 262, 292], ["swab test", "TEST", 294, 303], ["high", "OBSERVATION_MODIFIER", 178, 182], ["fever", "OBSERVATION", 183, 188], ["pneumonia", "OBSERVATION", 209, 218], ["chest", "ANATOMY", 220, 225], ["glass opacities", "OBSERVATION", 277, 292]]], ["These patients were on fingolimod and dimethyl fumarate (total lymphocytes at hospital admission, respectively, 610/\u03bcL and 1420/\u03bcL).", [["lymphocytes", "ANATOMY", 63, 74], ["fingolimod", "CHEMICAL", 23, 33], ["dimethyl fumarate", "CHEMICAL", 38, 55], ["fingolimod", "CHEMICAL", 23, 33], ["dimethyl fumarate", "CHEMICAL", 38, 55], ["patients", "ORGANISM", 6, 14], ["fingolimod", "SIMPLE_CHEMICAL", 23, 33], ["dimethyl fumarate", "SIMPLE_CHEMICAL", 38, 55], ["lymphocytes", "CELL", 63, 74], ["patients", "SPECIES", 6, 14], ["fingolimod and dimethyl fumarate", "TREATMENT", 23, 55]]], ["They did not need intensive care given the stability of vital parameters during hospitalization and were discharged respectively 6- and 8-days later, after treatment with lopinavir/ritonavir or hydroxychloroquine.", [["lopinavir/ritonavir", "CHEMICAL", 171, 190], ["hydroxychloroquine", "CHEMICAL", 194, 212], ["lopinavir", "CHEMICAL", 171, 180], ["ritonavir", "CHEMICAL", 181, 190], ["hydroxychloroquine", "CHEMICAL", 194, 212], ["lopinavir", "SIMPLE_CHEMICAL", 171, 180], ["ritonavir", "SIMPLE_CHEMICAL", 181, 190], ["hydroxychloroquine", "SIMPLE_CHEMICAL", 194, 212], ["intensive care", "TREATMENT", 18, 32], ["treatment", "TREATMENT", 156, 165], ["lopinavir", "TREATMENT", 171, 180], ["ritonavir", "TREATMENT", 181, 190], ["hydroxychloroquine", "TREATMENT", 194, 212]]], ["Their home-isolation continued without complication.MAIN TEXTFor all other 27 patients of which 10 were immunosuppressed (mean lymphocyte count of 815 \u00b1 134 cell/\u03bcL), it was enough to take symptomatic drugs staying at home with an average duration of symptoms of 13 days (range 8-26 days).MAIN TEXTAlthough no statistical analysis can be performed because of the small number of confirmed COVID-19 in our cohort to accurately compare our data with those of the general population of the Veneto region (based only on confirmed cases), we observed a slightly lower, although not considerably different, prevalence of people who needed hospitalization or ICU admission: in the overall regional population, hospitalization has been requested in 30% (5545 people) of confirmed COVID-19 (vs 18% in our cohort, expected number of hospitalization 3) and ICU admission in 13% of them (vs 0% in our cohort, expected number of ICU admission 1) [Portale Regione del Veneto Azienda Zero Emergenza Coronavirus SARS-CoV-2/COVID-19 2020].", [["lymphocyte", "ANATOMY", 127, 137], ["cell", "ANATOMY", 157, 161], ["patients", "ORGANISM", 78, 86], ["lymphocyte", "CELL", 127, 137], ["people", "ORGANISM", 615, 621], ["people", "ORGANISM", 751, 757], ["patients", "SPECIES", 78, 86], ["people", "SPECIES", 615, 621], ["people", "SPECIES", 751, 757], ["Azienda Zero Emergenza Coronavirus SARS-CoV-2/COVID-19 2020", "SPECIES", 961, 1020], ["complication", "PROBLEM", 39, 51], ["mean lymphocyte count", "TEST", 122, 143], ["cell/\u03bcL", "TEST", 157, 164], ["symptomatic drugs", "TREATMENT", 189, 206], ["symptoms", "PROBLEM", 251, 259], ["statistical analysis", "TEST", 310, 330], ["COVID", "TEST", 389, 394], ["a slightly lower", "PROBLEM", 546, 562], ["COVID", "TEST", 772, 777], ["Portale Regione del Veneto Azienda", "TREATMENT", 934, 968], ["Coronavirus SARS", "TEST", 984, 1000], ["CoV", "TEST", 1001, 1004], ["small", "OBSERVATION_MODIFIER", 363, 368], ["slightly", "OBSERVATION_MODIFIER", 548, 556], ["lower", "OBSERVATION_MODIFIER", 557, 562]]], ["Overall no deaths were reported in our patients.MAIN TEXTDespite derived from a small sample size, the frequency measure of COVID-19 in pwMS living in the Veneto region seems to be 2.5 times higher (1%; considering the confirmed cases of our cohort) than that reported in the inhabitants of the Veneto region (0.4%), leading to some interesting questions that need future investigations to be elucidated: are the pwMS more susceptible to SARS-CoV-2 infection or, simply, assuming that the individual risk of pwMS to develop COVID-19 who are not severely immunosuppressed (5/11 confirmed COVID-19 pwMS were moderately immunosuppressed with an average lymphocyte count of 640 \u00b1 130 cell/\u03bcL) makes this similar to that of the general population?", [["lymphocyte", "ANATOMY", 650, 660], ["cell", "ANATOMY", 680, 684], ["deaths", "DISEASE", 11, 17], ["SARS-CoV-2 infection", "DISEASE", 438, 458], ["patients", "ORGANISM", 39, 47], ["COVID-19", "GENE_OR_GENE_PRODUCT", 124, 132], ["pwMS", "CANCER", 136, 140], ["SARS-CoV-2", "ORGANISM", 438, 448], ["lymphocyte", "CELL", 650, 660], ["COVID-19", "DNA", 124, 132], ["patients", "SPECIES", 39, 47], ["SARS-CoV", "SPECIES", 438, 446], ["deaths", "PROBLEM", 11, 17], ["a small sample size", "PROBLEM", 78, 97], ["COVID", "TEST", 124, 129], ["future investigations", "TEST", 365, 386], ["the pwMS", "PROBLEM", 409, 417], ["SARS", "PROBLEM", 438, 442], ["CoV-2 infection", "PROBLEM", 443, 458], ["pwMS", "PROBLEM", 508, 512], ["COVID", "TEST", 524, 529], ["severely immunosuppressed", "PROBLEM", 545, 570], ["COVID", "TEST", 587, 592], ["pwMS", "TEST", 596, 600], ["moderately immunosuppressed", "PROBLEM", 606, 633], ["an average lymphocyte count", "TEST", 639, 666], ["cell/\u03bcL", "TEST", 680, 687], ["small", "OBSERVATION_MODIFIER", 80, 85], ["sample", "OBSERVATION_MODIFIER", 86, 92], ["size", "OBSERVATION_MODIFIER", 93, 97], ["Veneto", "ANATOMY", 155, 161], ["Veneto", "ANATOMY", 295, 301], ["infection", "OBSERVATION", 449, 458]]], ["[Berger, 2020]MAIN TEXTTherefore, considering this last point and the fact that everything we know on the state of infection comes only from laboratory-confirmed cases, further MS-population based studies, eventually using serological analysis, to be a potential good way to address the theory that currently we are underestimating the infection prevalence in the general population [Flaxman et al., 2020].", [["infection", "DISEASE", 115, 124], ["infection", "DISEASE", 336, 345], ["infection", "PROBLEM", 115, 124], ["further MS", "TEST", 169, 179], ["population based studies", "TEST", 180, 204], ["serological analysis", "TEST", 223, 243], ["the infection prevalence", "PROBLEM", 332, 356], ["infection", "OBSERVATION", 115, 124], ["infection", "OBSERVATION", 336, 345]]], ["In support of this, just consider that if we take into account 1% of confirmed + 1.8% of possible COVID-19, the prevalence of the infection is 2.8% in our cohort (7-times higher than that generally reported).", [["infection", "DISEASE", 130, 139], ["COVID", "TEST", 98, 103], ["the infection", "PROBLEM", 126, 139], ["infection", "OBSERVATION", 130, 139]]], ["[Portale Regione del Veneto Azienda Zero Emergenza Coronavirus SARS-CoV-2/COVID-19 2020]MAIN TEXTWe not observed a specific DMT exposure which appears to be associated with a higher risk to experience COVID-19 or its complication even in presence in some cases of immunosuppression.", [["DMT", "CHEMICAL", 124, 127], ["DMT", "CHEMICAL", 124, 127], ["COVID-19", "CHEMICAL", 201, 209], ["Portale Regione del Veneto Azienda", "TREATMENT", 1, 35], ["COVID", "TEST", 201, 206], ["its complication", "PROBLEM", 213, 229], ["immunosuppression", "TREATMENT", 264, 281], ["immunosuppression", "OBSERVATION", 264, 281]]], ["However, we would also like to highlight the caution with which these finding must be read since the small sample size does not let an appropriate assessment of the DMT-related SARS-CoV-2 risk infection.", [["DMT", "CHEMICAL", 165, 168], ["SARS", "DISEASE", 177, 181], ["infection", "DISEASE", 193, 202], ["SARS-CoV-2", "ORGANISM", 177, 187], ["the small sample size", "PROBLEM", 97, 118], ["the DMT", "PROBLEM", 161, 168], ["SARS", "PROBLEM", 177, 181], ["CoV-2 risk infection", "PROBLEM", 182, 202], ["small", "OBSERVATION_MODIFIER", 101, 106], ["infection", "OBSERVATION", 193, 202]]], ["Future studies on larger cohorts could identify DMTs at modify the risk of COVID- 19 and perhaps associated with a favourable course even if in the presence of immunosuppression, thus emphasising the hypothesis, also recently illustrated by Novi et al.", [["Future studies", "TEST", 0, 14], ["DMTs", "TREATMENT", 48, 52], ["COVID", "TEST", 75, 80], ["immunosuppression", "TREATMENT", 160, 177], ["immunosuppression", "OBSERVATION", 160, 177]]], ["[Novi G Mikulska M Briano F Toscanini F Tazza F Uccelli et al., 2020], that immunosuppressant could be protective (certainly not in all clinical scenarios) against the acute respiratory distress syndrome [Chen et al., 2020].", [["respiratory", "ANATOMY", 174, 185], ["respiratory distress syndrome", "DISEASE", 174, 203], ["immunosuppressant", "TREATMENT", 76, 93], ["the acute respiratory distress syndrome", "PROBLEM", 164, 203], ["acute", "OBSERVATION_MODIFIER", 168, 173], ["respiratory distress", "OBSERVATION", 174, 194]]], ["It is also possible that the younger age and the low disability physical status (median EDSS 2.5) might have contributed to mitigating the COVID-19 course in our cohort.,", [["low disability", "DISEASE", 49, 63], ["the low disability physical status", "PROBLEM", 45, 79], ["also possible", "UNCERTAINTY", 6, 19]]]], "85ece9f1023725b3ec39debf92766abf64adb03f": [["IntroductionThe multi-country epidemic of severe acute respiratory syndrome (SARS) Table 1 , Fig. 1 ).", [["acute respiratory syndrome", "DISEASE", 49, 75], ["SARS", "DISEASE", 77, 81], ["severe acute respiratory syndrome", "PROBLEM", 42, 75], ["severe", "OBSERVATION_MODIFIER", 42, 48], ["acute", "OBSERVATION_MODIFIER", 49, 54], ["respiratory syndrome", "OBSERVATION", 55, 75]]], ["During the early stages of most outbreaks, the majority of infections occurred in health care settings and many health care workers were infected.", [["infections", "DISEASE", 59, 69], ["infections", "PROBLEM", 59, 69], ["most outbreaks", "OBSERVATION_MODIFIER", 27, 41], ["infections", "OBSERVATION", 59, 69]]], ["This resulted in a crisis in health care systems in severely affected countries and areas.", [["a crisis in health care systems", "PROBLEM", 17, 48], ["crisis", "OBSERVATION", 19, 25]]], ["There was also a huge economic impact in many countries.", [["huge", "OBSERVATION_MODIFIER", 17, 21], ["economic", "OBSERVATION_MODIFIER", 22, 30], ["impact", "OBSERVATION", 31, 37]]], ["The SARS outbreaks highlighted the lack of preparedness for emerging diseases in most countries.", [["SARS", "DISEASE", 4, 8], ["The SARS outbreaks", "PROBLEM", 0, 18], ["emerging diseases", "PROBLEM", 60, 77]]], ["Public health systems, and in particular surveillance and response systems, are still not fully able to detect and contain outbreaks at an early stage.", [["response systems", "TEST", 58, 74]]], ["Patterns of transmission during the SARS outbreaks showed that infection control practices in health care settings are not optimal in many countries.", [["SARS", "DISEASE", 36, 40], ["infection", "DISEASE", 63, 72], ["the SARS outbreaks", "PROBLEM", 32, 50], ["infection control practices", "TREATMENT", 63, 90], ["infection", "OBSERVATION", 63, 72]]], ["SARS also demonstrated the critical role of rapid and transparent information exchange between countries in containing disease outbreaks.Early EventsResponse of the World Health Organization (WHO) to SARS began in early February, when anecdotal information about an outbreak of severe pneumonia in Guangdong was received from several sources.", [["SARS", "DISEASE", 0, 4], ["SARS", "DISEASE", 200, 204], ["pneumonia", "DISEASE", 285, 294], ["disease outbreaks", "PROBLEM", 119, 136], ["severe pneumonia", "PROBLEM", 278, 294], ["disease", "OBSERVATION", 119, 126], ["severe", "OBSERVATION_MODIFIER", 278, 284], ["pneumonia", "OBSERVATION", 285, 294]]], ["The level of international concern increased after confirmation of influenza A (H5N1) infection in a family in Hong Kong on 19 February (2) .", [["influenza A (H5N1) infection", "DISEASE", 67, 95], ["influenza A (H5N1)", "ORGANISM", 67, 85], ["influenza A (H5N1", "SPECIES", 67, 84], ["influenza A (H5N1)", "SPECIES", 67, 85], ["influenza A (H5N1) infection", "PROBLEM", 67, 95]]], ["The family had travelled to Fujian province China before the onset of illness.", [["illness", "DISEASE", 70, 77], ["illness", "PROBLEM", 70, 77]]], ["The first WHO team arrived in Beijing on 23 February, but no further information was provided until 5 March and the government approval for on-site investigation in Guangdong was not obtained until 2 April, and WHO teams started their work in Guangdong on 3 April.Early EventsOn 28 February, the WHO office in Viet Nam informed the Regional Office of a case of typical pneumonia in Hanoi.", [["pneumonia", "DISEASE", 369, 378], ["typical pneumonia", "PROBLEM", 361, 378], ["typical", "OBSERVATION_MODIFIER", 361, 368], ["pneumonia", "OBSERVATION", 369, 378]]], ["By 5 March, there had been an outbreak of respiratory illness among health care workers in the hospital where the index patient was hospitalized.", [["respiratory", "ANATOMY", 42, 53], ["respiratory illness", "DISEASE", 42, 61], ["patient", "ORGANISM", 120, 127], ["patient", "SPECIES", 120, 127]]], ["The crisis of the hospital outbreak escalated everyday and more than 20 health care staff developed the illness by 8 March.", [["illness", "DISEASE", 104, 111], ["crisis", "OBSERVATION_MODIFIER", 4, 10]]], ["On 11 March, the Hong Kong Government officially notified WHO of an outbreak of respiratory illness among health care workers.", [["respiratory", "ANATOMY", 80, 91], ["respiratory illness", "DISEASE", 80, 99]]], ["By 14 March, it was confirmed that the disease had spread to Singapore and Toronto, Canada.WHO ResponsesAs an immediate response to the multi-country outbreaks, a SARS outbreak response and preparedness team was established in the regional office in Manila.", [["SARS", "DISEASE", 163, 167], ["the disease", "PROBLEM", 35, 46], ["disease", "OBSERVATION", 39, 46], ["Manila", "ANATOMY", 250, 256]]], ["The main objectives were to:WHO Responses1.", [["main", "OBSERVATION_MODIFIER", 4, 8]]], ["Provide guidance and assistance to enable vulnerable countries to prepare for the possible arrival of the virus; and 4.", [["the virus", "PROBLEM", 102, 111]]], ["At the early stage of the outbreaks, the causative agent was still unknown.", [["the causative agent", "PROBLEM", 37, 56], ["early stage", "OBSERVATION_MODIFIER", 7, 18]]], ["To identify the causative agent of SARS and the development of diagnostic tests, WHO set up a laboratory network on 17 March.", [["SARS", "DISEASE", 35, 39], ["SARS", "PROBLEM", 35, 39], ["diagnostic tests", "TEST", 63, 79]]], ["Initially 11 laboratories in 9 countries participated in this collaborative multi-center research project on SARS diagnosis.", [["SARS", "DISEASE", 109, 113]]], ["The network had identified SARS coronavirus as a causative agent by 16 April 2003.", [["SARS coronavirus", "DISEASE", 27, 43], ["SARS coronavirus", "SPECIES", 27, 43], ["SARS coronavirus", "PROBLEM", 27, 43], ["SARS coronavirus", "OBSERVATION", 27, 43]]], ["Similar global networks were also established to discuss technical issues such as epidemiology, clinical management, public health measures and infection control.WHO ResponsesWHO teams of epidemiologists and infection control experts were immediately sent to China, Hong Kong (China), the Philippines, Singapore, Viet Nam and other countries to provide support and guidance for outbreak response.", [["infection", "DISEASE", 144, 153], ["infection", "DISEASE", 208, 217], ["clinical management", "TREATMENT", 96, 115], ["public health measures", "TREATMENT", 117, 139], ["infection control", "TREATMENT", 144, 161]]], ["Logistical support and supplies were sent to countries for response and preparedness activities, supported by the Government of Japan.", [["Logistical support", "TREATMENT", 0, 18]]], ["WHO worked closely with countries to ensure that enhanced surveillance was put in place to enable early detection of cases and contact tracing for a timely and appropriate response.", [["contact tracing", "TEST", 127, 142]]], ["Guidelines on enhanced surveillance, hospital and community infection control, international travel, laboratory procedures and public awareness were drawn up.WHO ResponsesPublic awareness was improved by establishing close contact with national media focal points and regularly updating the WHO websites.Global ContainmentFollowing intensive work by both governments and WHO, the SARS outbreaks in affected countries were progressively brought under control.", [["infection", "DISEASE", 60, 69], ["SARS", "DISEASE", 380, 384], ["enhanced surveillance", "TEST", 14, 35], ["community infection control", "TREATMENT", 50, 77], ["laboratory procedures", "TEST", 101, 122], ["public awareness", "TEST", 127, 143], ["the SARS outbreaks", "PROBLEM", 376, 394], ["Containment", "OBSERVATION_MODIFIER", 311, 322]]], ["The last WHO travel advisory (to Beijing, China) was lifted on 24 June and the last area to be listed by WHO as having recent local transmission (Taiwan, China) was removed from the list on 5 July (4).Global ContainmentThe SARS outbreaks in various parts of the world were contained due to strong government commitments, unprecedented collaboration among scientists and laboratories, epidemiologists, clinicians and public health experts; and the hard work, dedication and courage of the clinical and public health staff in affected countries, some of whom gave their lives in the battle against SARS.Lessons LearnedSARS affected many countries in different parts of the world.", [["SARS", "DISEASE", 223, 227], ["SARS", "DISEASE", 596, 600], ["Containment", "OBSERVATION_MODIFIER", 208, 219], ["SARS", "OBSERVATION_MODIFIER", 223, 227]]], ["The global nature of the SARS epidemic vividly demonstrated the critical importance of a rapid exchange of information on public health events of international concern.", [["SARS", "DISEASE", 25, 29], ["the SARS epidemic", "PROBLEM", 21, 38], ["global", "OBSERVATION_MODIFIER", 4, 10]]], ["When WHO issued a global alert on 12 March, practically nothing was known about this new disease.", [["this new disease", "PROBLEM", 80, 96]]], ["The causative agent had not been identified, and it was not even known if the disease was caused by virus or bacteria.", [["the disease", "PROBLEM", 74, 85], ["virus", "PROBLEM", 100, 105], ["bacteria", "PROBLEM", 109, 117], ["disease", "OBSERVATION", 78, 85]]], ["Identification of the causative agent is a first step to develop diagnostic tools.", [["the causative agent", "PROBLEM", 18, 37]]], ["No diagnostic tools were available at that stage.", [["diagnostic tools", "TEST", 3, 19]]], ["Epidemiology of the disease such as mode of transmission, incubation period, infectious period and susceptible age group was also largely unknown except some information from Hanoi and Hong Kong.", [["the disease", "PROBLEM", 16, 27], ["disease", "OBSERVATION", 20, 27]]], ["Such epidemiological information was critical to establish effective control and containment strategies.", [["containment strategies", "TREATMENT", 81, 103]]], ["Clinical information such as clinical course, complications, case fatality rate and effective treatment was limited.", [["complications", "PROBLEM", 46, 59], ["effective treatment", "TREATMENT", 84, 103]]], ["Clinicians were forced to treat patients with a little knowledge about the disease.", [["patients", "ORGANISM", 32, 40], ["patients", "SPECIES", 32, 40], ["the disease", "PROBLEM", 71, 82], ["disease", "OBSERVATION", 75, 82]]], ["The disease was already spreading many countries while government officials, public health experts, laboratory scientists and clinicians in many countries were trying to find better ways to deal with this new disease.", [["The disease", "PROBLEM", 0, 11], ["this new disease", "PROBLEM", 200, 216], ["disease", "OBSERVATION", 4, 11]]], ["In fact, most of the effective containment strategies including surveillance with appropriate clinical case definitions, contract tracing, quarantine and isolation, and infection control measures in hospitals had already been established by mid March in Guangdong.", [["infection", "DISEASE", 169, 178], ["surveillance", "TEST", 64, 76], ["contract tracing", "TEST", 121, 137], ["quarantine", "TREATMENT", 139, 149], ["isolation", "TREATMENT", 154, 163], ["infection control measures", "TREATMENT", 169, 195]]], ["The delay in sharing critical information with WHO and the international community hindered work to understand the nature of the disease and its causative agent and to formulate the best strategy for containment.Way ForwardIn the era of globalisation with huge international travel and trade, communicable diseases can be transmitted from country to country more rapidly and easily than ever.", [["communicable diseases", "DISEASE", 293, 314], ["the disease", "PROBLEM", 125, 136], ["huge", "OBSERVATION_MODIFIER", 256, 260]]], ["International collaboration, particularly quick and transparent information exchange, is essential to prevent the cross-border spread of diseases.", [["diseases", "PROBLEM", 137, 145], ["diseases", "OBSERVATION", 137, 145]]], ["WHO has the International Health Regulations (IHR) as an international legal framework to deal with communicable disease threats.", [["communicable disease threats", "PROBLEM", 100, 128]]], ["However, the current IHR were established in 1969 and have a narrow focus and a number of limitations (5) .", [["the current IHR", "TEST", 9, 24], ["narrow", "OBSERVATION_MODIFIER", 61, 67], ["focus", "OBSERVATION", 68, 73]]], ["For example, notification is dependent on member states making voluntary notification to WHO of only three diseases, cholera, yellow fever and plague.", [["cholera", "DISEASE", 117, 124], ["yellow fever", "DISEASE", 126, 138], ["plague", "DISEASE", 143, 149], ["three diseases", "PROBLEM", 101, 115], ["cholera", "PROBLEM", 117, 124], ["yellow fever", "PROBLEM", 126, 138], ["plague", "PROBLEM", 143, 149]]], ["Therefore the regulations cannot deal with newly emerging diseases such as SARS, and WHO cannot take any actions without notification from member states.", [["SARS", "DISEASE", 75, 79], ["newly emerging diseases", "PROBLEM", 43, 66], ["SARS", "PROBLEM", 75, 79]]], ["The draft of new IHR has already been developed and discussed at the Intergovernmental Working Group in November 2004 (6).", [["new IHR", "PROBLEM", 13, 20], ["new", "OBSERVATION_MODIFIER", 13, 16], ["IHR", "OBSERVATION", 17, 20]]], ["Each member state should also have minimum core capacities such as adequate early warning surveillance systems to detect and report all public health emergencies of international concern.", [["minimum core capacities", "PROBLEM", 35, 58]]]], "564a3bbd035d9730cf4a71f5299fd92c83deaecc": [["IntroductionMolecules containing various Michael acceptor scaffolds are common in pharmaceuticals, agrochemicals and natural products and have attracted considerable attention from organic chemists and medicinal chemists.", [["IntroductionMolecules", "TREATMENT", 0, 21], ["various Michael acceptor scaffolds", "TREATMENT", 33, 67], ["natural products", "TREATMENT", 117, 133], ["acceptor scaffolds", "OBSERVATION", 49, 67]]], ["1 Michael acceptors have been found to have various different biological activities, such as antibacterial, anticancer and antiviral activities.", [["anticancer", "ANATOMY", 108, 118], ["Michael acceptors", "SIMPLE_CHEMICAL", 2, 19], ["anticancer", "CANCER", 108, 118], ["antibacterial, anticancer", "TREATMENT", 93, 118], ["antiviral activities", "TREATMENT", 123, 143]]], ["2 For example, the crystal structure of HCoV-NL63 M Pro complexed with a Michael acceptor inhibitor was obtained, providing insight into the rational development of wide spectrum antiviral therapeutics to treat infections caused by human coronaviruses.", [["HCoV-NL63 M Pro", "CHEMICAL", 40, 55], ["infections", "DISEASE", 211, 221], ["Pro", "CHEMICAL", 52, 55], ["HCoV-NL63 M Pro", "SIMPLE_CHEMICAL", 40, 55], ["Michael acceptor", "SIMPLE_CHEMICAL", 73, 89], ["human", "ORGANISM", 232, 237], ["HCoV", "PROTEIN", 40, 44], ["human", "SPECIES", 232, 237], ["human coronaviruses", "SPECIES", 232, 251], ["HCoV", "TEST", 40, 44], ["a Michael acceptor inhibitor", "TREATMENT", 71, 99], ["wide spectrum antiviral therapeutics", "TREATMENT", 165, 201], ["infections", "PROBLEM", 211, 221], ["human coronaviruses", "PROBLEM", 232, 251], ["crystal", "OBSERVATION_MODIFIER", 19, 26]]], ["3 Two Michael acceptors used as cysteine protease inhibitors, K-777 (CRA-3316) and rupintrivir (AG7088), and developed to treat Chagas disease and as an antirhinoviral agent, respectively, are already in clinical trials.", [["K-777", "CHEMICAL", 62, 67], ["CRA-3316", "CHEMICAL", 69, 77], ["rupintrivir", "CHEMICAL", 83, 94], ["AG7088", "CHEMICAL", 96, 102], ["Chagas disease", "DISEASE", 128, 142], ["cysteine", "CHEMICAL", 32, 40], ["K-777", "CHEMICAL", 62, 67], ["CRA-3316", "CHEMICAL", 69, 77], ["rupintrivir", "CHEMICAL", 83, 94], ["AG7088", "CHEMICAL", 96, 102], ["cysteine protease inhibitors", "SIMPLE_CHEMICAL", 32, 60], ["K-777", "SIMPLE_CHEMICAL", 62, 67], ["CRA-3316", "SIMPLE_CHEMICAL", 69, 77], ["rupintrivir", "SIMPLE_CHEMICAL", 83, 94], ["AG7088", "SIMPLE_CHEMICAL", 96, 102], ["Two Michael acceptors", "TREATMENT", 2, 23], ["cysteine protease inhibitors", "TREATMENT", 32, 60], ["K", "TEST", 62, 63], ["CRA", "TEST", 69, 72], ["rupintrivir", "TEST", 83, 94], ["Chagas disease", "PROBLEM", 128, 142], ["an antirhinoviral agent", "TREATMENT", 150, 173], ["Chagas disease", "OBSERVATION", 128, 142]]], ["4 On the other hand, as basic building blocks Michael acceptors have been extensively employed in the area of organic chemistry, such as in multicomponent cascade or Domino reactions, 5 transition-metal catalyzed reactions, 6 enantioselective organocatalysis 7 and complex natural product synthesis.", [["transition-metal", "CHEMICAL", 186, 202], ["Michael acceptors", "SIMPLE_CHEMICAL", 46, 63], ["basic building blocks Michael acceptors", "TREATMENT", 24, 63], ["organic chemistry", "TEST", 110, 127], ["multicomponent cascade", "PROBLEM", 140, 162], ["Domino reactions", "PROBLEM", 166, 182], ["metal catalyzed reactions", "TREATMENT", 197, 222], ["6 enantioselective organocatalysis", "TREATMENT", 224, 258], ["complex natural product synthesis", "TREATMENT", 265, 298], ["product synthesis", "OBSERVATION", 281, 298]]], ["8 In the textbook of graduate students, dimethyl sulfoxide (DMSO) is described as a high-boiling, protic and low-toxicity solvent, and a widely used oxidant 9 in several named reactions, such as the Swern oxidation 10 and Pftizner-Moffatt oxidation.", [["dimethyl sulfoxide", "CHEMICAL", 40, 58], ["DMSO", "CHEMICAL", 60, 64], ["toxicity", "DISEASE", 113, 121], ["dimethyl sulfoxide", "CHEMICAL", 40, 58], ["DMSO", "CHEMICAL", 60, 64], ["dimethyl sulfoxide", "SIMPLE_CHEMICAL", 40, 58], ["DMSO", "SIMPLE_CHEMICAL", 60, 64], ["Pftizner-Moffatt", "SIMPLE_CHEMICAL", 222, 238], ["dimethyl sulfoxide (DMSO", "TREATMENT", 40, 64], ["low-toxicity solvent", "TREATMENT", 109, 129], ["the Swern oxidation", "TREATMENT", 195, 214], ["Pftizner", "TREATMENT", 222, 230], ["Moffatt oxidation", "TREATMENT", 231, 248], ["low-toxicity", "OBSERVATION_MODIFIER", 109, 121]]], ["11 In the past few decades, the nature of DMSO has been further exploited as a reagent that can act as an oxygen source, a carbon source and a sulfur source.", [["DMSO", "CHEMICAL", 42, 46], ["oxygen", "CHEMICAL", 106, 112], ["sulfur", "CHEMICAL", 143, 149], ["DMSO", "CHEMICAL", 42, 46], ["oxygen", "CHEMICAL", 106, 112], ["carbon", "CHEMICAL", 123, 129], ["sulfur", "CHEMICAL", 143, 149], ["DMSO", "SIMPLE_CHEMICAL", 42, 46], ["oxygen", "SIMPLE_CHEMICAL", 106, 112], ["sulfur", "SIMPLE_CHEMICAL", 143, 149], ["DMSO", "TREATMENT", 42, 46], ["a reagent", "TREATMENT", 77, 86], ["an oxygen source", "PROBLEM", 103, 119]]], ["12 However, the reaction scope of DMSO is still limited and needs to be expanded.", [["DMSO", "CHEMICAL", 34, 38], ["DMSO", "CHEMICAL", 34, 38], ["DMSO", "SIMPLE_CHEMICAL", 34, 38], ["the reaction scope of DMSO", "PROBLEM", 12, 38]]], ["To date, a cascade reaction with DMSO as both a solvent and one-carbon source for the preparation of Michael acceptors has not been reported.IntroductionHerein, we report a Lewis acid-promoted cascade reaction for the synthesis of a,b-unsaturated amides.", [["DMSO", "CHEMICAL", 33, 37], ["DMSO", "CHEMICAL", 33, 37], ["carbon", "CHEMICAL", 64, 70], ["Lewis acid-", "CHEMICAL", 173, 184], [",b-unsaturated amides", "CHEMICAL", 232, 253], ["DMSO", "SIMPLE_CHEMICAL", 33, 37], ["Michael acceptors", "SIMPLE_CHEMICAL", 101, 118], [",b-unsaturated amides", "SIMPLE_CHEMICAL", 232, 253], ["a cascade reaction", "PROBLEM", 9, 27], ["DMSO", "TREATMENT", 33, 37], ["a solvent", "TREATMENT", 46, 55], ["Michael acceptors", "TREATMENT", 101, 118], ["a Lewis acid-promoted cascade reaction", "TREATMENT", 171, 209], ["a,b-unsaturated amides", "TREATMENT", 231, 253]]], ["The proper choice of base in the reaction results in the production of dimeric compounds.", [["the reaction", "PROBLEM", 29, 41], ["dimeric compounds", "PROBLEM", 71, 88], ["base", "ANATOMY_MODIFIER", 21, 25]]], ["The Pummerer rearrangement with DMSO as a methylene source is believed to be an initial step for the reaction based on mechanistic studies.Results and discussionWe are focused on C(sp 3 )\u00c0H bond functionalization reactions.", [["DMSO", "CHEMICAL", 32, 36], ["methylene", "CHEMICAL", 42, 51], ["DMSO", "CHEMICAL", 32, 36], ["methylene", "CHEMICAL", 42, 51], ["C(sp 3 )\u00c0H", "CHEMICAL", 179, 189], ["DMSO", "SIMPLE_CHEMICAL", 32, 36], ["methylene", "SIMPLE_CHEMICAL", 42, 51], ["C(sp 3 )\u00c0H", "SIMPLE_CHEMICAL", 179, 189], ["DMSO", "TREATMENT", 32, 36], ["a methylene source", "TREATMENT", 40, 58], ["the reaction", "PROBLEM", 97, 109], ["mechanistic studies", "TEST", 119, 138], ["\u00c0H bond functionalization reactions", "TREATMENT", 187, 222]]], ["13 In this project, the C(sp 3 )\u00c0H bond functionalization in amide substrate 1a was tested under the following reaction conditions: CoCl 2 (1.5 equiv), KOAc (2.0 equiv) and AgOAc (2.0 equiv) dissolved in DMSO (2.0 mL) in a microwave and heated at 150 C for 2 h.", [["amide substrate 1a", "CHEMICAL", 61, 79], ["CoCl 2", "CHEMICAL", 132, 138], ["KOAc", "CHEMICAL", 152, 156], ["AgOAc", "CHEMICAL", 173, 178], ["DMSO", "CHEMICAL", 204, 208], ["C", "CHEMICAL", 24, 25], ["\u00c0H", "CHEMICAL", 32, 34], ["amide", "CHEMICAL", 61, 66], ["CoCl 2", "CHEMICAL", 132, 138], ["KOAc", "CHEMICAL", 152, 156], ["AgOAc", "CHEMICAL", 173, 178], ["DMSO", "CHEMICAL", 204, 208], ["C(sp 3 )\u00c0H", "SIMPLE_CHEMICAL", 24, 34], ["amide substrate 1a", "SIMPLE_CHEMICAL", 61, 79], ["CoCl 2", "SIMPLE_CHEMICAL", 132, 138], ["KOAc", "SIMPLE_CHEMICAL", 152, 156], ["AgOAc", "SIMPLE_CHEMICAL", 173, 178], ["DMSO", "SIMPLE_CHEMICAL", 204, 208], ["the C(sp 3 )\u00c0H bond functionalization in amide substrate 1a", "TREATMENT", 20, 79], ["CoCl", "TEST", 132, 136], ["KOAc", "TEST", 152, 156], ["AgOAc", "TEST", 173, 178], ["DMSO", "TREATMENT", 204, 208]]], ["To our delight, functionalization at the benzylic position occurred as expected, affording a, b-unsaturated carboxylamide 2a in a 23% yield ( Table 1 , entry 1).", [["carboxylamide", "CHEMICAL", 108, 121], ["carboxylamide", "CHEMICAL", 108, 121], ["b-unsaturated carboxylamide 2a", "SIMPLE_CHEMICAL", 94, 124], ["benzylic position", "OBSERVATION", 41, 58]]], ["Control experiments showed that this reaction proceeded with similar results in the absence of AgOAc, while the reaction did not occur without KOAc (Table 1 , entries 2e4).", [["AgOAc", "CHEMICAL", 95, 100], ["AgOAc", "CHEMICAL", 95, 100], ["KOAc", "CHEMICAL", 143, 147], ["AgOAc", "SIMPLE_CHEMICAL", 95, 100], ["this reaction", "PROBLEM", 32, 45], ["the reaction", "PROBLEM", 108, 120]]], ["Then, various Lewis acids were screened in this reaction ( Table 1 , entries 5e9).", [["Lewis acids", "CHEMICAL", 14, 25], ["Lewis acids", "SIMPLE_CHEMICAL", 14, 25], ["various Lewis acids", "TREATMENT", 6, 25]]], ["When one equivalent of PbCl 2 was used as the Lewis acid, the yield of product 2a increased to 55% along with some amount of sulfide product 3a (Table 1 , entry 9).", [["PbCl 2", "CHEMICAL", 23, 29], ["sulfide", "CHEMICAL", 125, 132], ["PbCl 2", "CHEMICAL", 23, 29], ["Lewis acid", "CHEMICAL", 46, 56], ["sulfide", "CHEMICAL", 125, 132], ["PbCl 2", "SIMPLE_CHEMICAL", 23, 29], ["Lewis acid", "SIMPLE_CHEMICAL", 46, 56], ["sulfide", "SIMPLE_CHEMICAL", 125, 132], ["PbCl 2", "TREATMENT", 23, 29], ["the Lewis acid", "TREATMENT", 42, 56], ["sulfide product", "TREATMENT", 125, 140]]], ["The effect of the base on the reaction was screened with various bases.", [["the reaction", "PROBLEM", 26, 38], ["base", "ANATOMY_MODIFIER", 18, 22]]], ["The results of this screening indicated that potassium acetate and sodium acetate are the most favorable bases for this reaction ( Table 1 , entries 9e11 and details in supporting information).", [["potassium acetate", "CHEMICAL", 45, 62], ["sodium acetate", "CHEMICAL", 67, 81], ["potassium acetate", "CHEMICAL", 45, 62], ["sodium acetate", "CHEMICAL", 67, 81], ["potassium acetate", "SIMPLE_CHEMICAL", 45, 62], ["sodium acetate", "SIMPLE_CHEMICAL", 67, 81], ["this screening", "TEST", 15, 29], ["potassium acetate", "TREATMENT", 45, 62], ["sodium acetate", "TREATMENT", 67, 81], ["this reaction", "PROBLEM", 115, 128]]], ["When the reaction was carried out in air or under O 2 atmosphere, the yield of product decreased (Table 1 , entries 12e13).", [["O 2", "CHEMICAL", 50, 53], ["the reaction", "PROBLEM", 5, 17], ["decreased", "OBSERVATION_MODIFIER", 87, 96]]], ["This indicated that the oxidizing reagents hindered the reaction from proceeding.", [["the oxidizing reagents", "TREATMENT", 20, 42], ["the reaction", "PROBLEM", 52, 64]]], ["The effect of temperature on the reaction was subsequently investigated, which showed that temperatures either above 160 C or below 150 C were not suitable for this reaction ( Table 1 , entries 14e17).", [["temperatures", "TEST", 91, 103], ["this reaction", "PROBLEM", 160, 173]]], ["Finally, optimized reaction conditions of PbCl 2 (1.5 equiv) and KOAc (1.5 equiv) in DMSO at 156 C in a sealed tube under N 2 for 13 h gave the product 2a in 77% yield and 3a in 12% yields, respectively (Table 1 , entry 17).", [["PbCl 2", "CHEMICAL", 42, 48], ["KOAc", "CHEMICAL", 65, 69], ["DMSO", "CHEMICAL", 85, 89], ["PbCl 2", "CHEMICAL", 42, 48], ["KOAc", "CHEMICAL", 65, 69], ["DMSO", "CHEMICAL", 85, 89], ["PbCl 2", "SIMPLE_CHEMICAL", 42, 48], ["KOAc", "SIMPLE_CHEMICAL", 65, 69], ["DMSO", "SIMPLE_CHEMICAL", 85, 89], ["PbCl", "TEST", 42, 46], ["KOAc", "TEST", 65, 69], ["DMSO", "TREATMENT", 85, 89], ["a sealed tube", "TREATMENT", 102, 115], ["tube", "OBSERVATION", 111, 115]]], ["Interestingly, when Ac 2 O was used instead of PbCl 2 , sulfide product 3a was obtained in 50% yield (Table 1 , entry 18).", [["Ac 2 O", "CHEMICAL", 20, 26], ["PbCl 2 , sulfide", "CHEMICAL", 47, 63], ["Ac 2 O", "CHEMICAL", 20, 26], ["PbCl 2", "CHEMICAL", 47, 53], ["sulfide", "CHEMICAL", 56, 63], ["Ac 2 O", "SIMPLE_CHEMICAL", 20, 26], ["PbCl 2", "SIMPLE_CHEMICAL", 47, 53], ["sulfide", "SIMPLE_CHEMICAL", 56, 63], ["PbCl", "TREATMENT", 47, 51]]], ["The combination of Ac 2 O/AcOH, or Ac 2 O/ TsOH, or TFAA/TFA in DMSO, commonly used in the Pummerer rearrangement reaction, did not afford any product.Results and discussionThe coexistence of products 2a and 3a throughout the process of optimizing the reaction conditions stimulated us to investigate the mechanism of this reaction.", [["Ac 2 O/AcOH", "CHEMICAL", 19, 30], ["Ac 2 O", "CHEMICAL", 35, 41], ["TsOH", "CHEMICAL", 43, 47], ["TFAA", "CHEMICAL", 52, 56], ["TFA", "CHEMICAL", 57, 60], ["DMSO", "CHEMICAL", 64, 68], ["Ac 2 O", "CHEMICAL", 19, 25], ["AcOH", "CHEMICAL", 26, 30], ["Ac 2 O", "CHEMICAL", 35, 41], ["TsOH", "CHEMICAL", 43, 47], ["TFAA", "CHEMICAL", 52, 56], ["TFA", "CHEMICAL", 57, 60], ["DMSO", "CHEMICAL", 64, 68], ["Ac 2 O/AcOH", "SIMPLE_CHEMICAL", 19, 30], ["Ac 2 O/ TsOH", "SIMPLE_CHEMICAL", 35, 47], ["TFAA", "SIMPLE_CHEMICAL", 52, 56], ["TFA", "SIMPLE_CHEMICAL", 57, 60], ["DMSO", "SIMPLE_CHEMICAL", 64, 68], ["the reaction conditions", "PROBLEM", 248, 271], ["this reaction", "PROBLEM", 318, 331]]], ["Several experiments concerning the study of the mechanism were conducted (eqs.", [["the study", "TEST", 31, 40]]], ["Isolated sulfide 3a was subjected to the standard reaction conditions, affording product 2a in 75% yield with 22% recovery of 3a (eq.", [["sulfide 3a", "CHEMICAL", 9, 19], ["sulfide", "CHEMICAL", 9, 16], ["sulfide 3a", "SIMPLE_CHEMICAL", 9, 19], ["Isolated sulfide 3a", "PROBLEM", 0, 19], ["sulfide 3a", "OBSERVATION", 9, 19]]], ["These results indicated that there is an equilibrium between 2a and 3a in the reaction mixture.", [["an equilibrium between 2a and 3a", "PROBLEM", 38, 70], ["the reaction mixture", "TREATMENT", 74, 94], ["equilibrium", "OBSERVATION", 41, 52], ["reaction mixture", "OBSERVATION", 78, 94]]], ["When the reaction was carried out in DMSO-d 6 , it provided the corresponding deuterated products (d 2 -2a and d 5 -3a) in 73% and 9% yields, respectively, which provided precise evidence for the methylene group originating from the solvent dimethylsulfoxide (eq.", [["DMSO", "CHEMICAL", 37, 41], ["d 2 -2a and d 5 -3a", "CHEMICAL", 99, 118], ["methylene", "CHEMICAL", 196, 205], ["dimethylsulfoxide", "CHEMICAL", 241, 258], ["DMSO", "CHEMICAL", 37, 41], ["methylene", "CHEMICAL", 196, 205], ["dimethylsulfoxide", "CHEMICAL", 241, 258], ["DMSO-d 6", "SIMPLE_CHEMICAL", 37, 45], ["d 2 -2a", "SIMPLE_CHEMICAL", 99, 106], ["d 5 -3a", "SIMPLE_CHEMICAL", 111, 118], ["methylene", "SIMPLE_CHEMICAL", 196, 205], ["dimethylsulfoxide", "SIMPLE_CHEMICAL", 241, 258], ["the methylene group", "TREATMENT", 192, 211], ["the solvent dimethylsulfoxide", "TREATMENT", 229, 258]]], ["When six equivalents of TMPO was added to a reaction run under the reaction conditions, 53% of 2a and 5% of 3a were still obtained, which suggested that this reaction probably did not involve any radical species (eq.", [["TMPO", "CHEMICAL", 24, 28], ["TMPO", "CHEMICAL", 24, 28], ["TMPO", "SIMPLE_CHEMICAL", 24, 28], ["TMPO", "TREATMENT", 24, 28], ["a reaction", "PROBLEM", 42, 52], ["this reaction", "PROBLEM", 153, 166], ["any radical species", "PROBLEM", 192, 211], ["radical species", "OBSERVATION", 196, 211]]], ["Moreover, two control experiments showed that both Lewis acid PbCl 2 and KOAc are necessary for the reaction to occur (see the supporting information).Results and discussionBased on these preliminary results and some leading references on the Pummerer rearrangement 14 reaction, a rational mechanism for this reaction is proposed in Scheme 1.", [["PbCl", "CHEMICAL", 62, 66], ["KOAc", "CHEMICAL", 73, 77], ["Lewis acid PbCl 2", "CHEMICAL", 51, 68], ["KOAc", "CHEMICAL", 73, 77], ["KOAc", "SIMPLE_CHEMICAL", 73, 77], ["two control experiments", "TEST", 10, 33], ["Lewis acid PbCl", "TEST", 51, 66], ["the reaction", "PROBLEM", 96, 108], ["this reaction", "PROBLEM", 304, 317]]], ["A sulfur-substituted carbocation is obtained through promotion by both the Lewis acid (PbCl 2 ) and base (KOAc), and it then reacts with a carbon nucleophile to afford a-substituted sulfide 3a.", [["sulfur", "CHEMICAL", 2, 8], ["PbCl 2", "CHEMICAL", 87, 93], ["KOAc", "CHEMICAL", 106, 110], ["a-substituted sulfide", "CHEMICAL", 168, 189], ["sulfur", "CHEMICAL", 2, 8], ["Lewis acid", "CHEMICAL", 75, 85], ["PbCl 2 )", "CHEMICAL", 87, 95], ["KOAc", "CHEMICAL", 106, 110], ["carbon", "CHEMICAL", 139, 145], ["a-substituted sulfide", "CHEMICAL", 168, 189], ["sulfur-substituted carbocation", "SIMPLE_CHEMICAL", 2, 32], ["Lewis acid", "SIMPLE_CHEMICAL", 75, 85], ["PbCl 2 )", "SIMPLE_CHEMICAL", 87, 95], ["KOAc", "SIMPLE_CHEMICAL", 106, 110], ["carbon nucleophile", "SIMPLE_CHEMICAL", 139, 157], ["a-substituted sulfide 3", "SIMPLE_CHEMICAL", 168, 191], ["A sulfur-substituted carbocation", "TREATMENT", 0, 32], ["the Lewis acid (PbCl", "TREATMENT", 71, 91], ["a carbon nucleophile", "TREATMENT", 137, 157], ["a-substituted sulfide", "TREATMENT", 168, 189]]], ["There is an equilibrium between 3a and 2a in the reaction mixture.", [["an equilibrium between 3a", "PROBLEM", 9, 34], ["the reaction mixture", "TREATMENT", 45, 65], ["equilibrium", "OBSERVATION", 12, 23], ["reaction mixture", "OBSERVATION", 49, 65]]], ["Michael acceptor Table 1 Optimization of reaction conditions. a,bEntryLewis acid Base Additive (equiv)Entryproduct 2a is afforded by an elimination reaction of 3a affected by the base (KOAc).", [["EntryLewis acid", "CHEMICAL", 65, 80], ["bEntryLewis acid", "SIMPLE_CHEMICAL", 64, 80], ["reaction conditions", "PROBLEM", 41, 60], ["a,bEntryLewis acid Base Additive (equiv)Entryproduct 2a", "TREATMENT", 62, 117], ["an elimination reaction", "TEST", 133, 156], ["base", "ANATOMY_MODIFIER", 179, 183]]], ["Furthermore, another Michael addition reaction proceeds with 2a through the attack of a carbon nucleophile to afford 4a.EntryWith the optimized conditions in hand, we next explored the effect on the reaction of substitution on the phenyl ring.", [["carbon", "CHEMICAL", 88, 94], ["phenyl", "CHEMICAL", 231, 237], ["carbon nucleophile", "SIMPLE_CHEMICAL", 88, 106], ["phenyl ring", "SIMPLE_CHEMICAL", 231, 242], ["a carbon nucleophile", "TREATMENT", 86, 106], ["substitution on the phenyl ring", "TREATMENT", 211, 242], ["phenyl ring", "OBSERVATION", 231, 242]]], ["Generally, electron-donating groups on the phenyl ring under our standard conditions led to good to excellent combined yields of products 2a-o and 3a-o (Table 2) .", [["phenyl", "CHEMICAL", 43, 49], ["phenyl", "CHEMICAL", 43, 49], ["electron", "SIMPLE_CHEMICAL", 11, 19], ["phenyl ring", "SIMPLE_CHEMICAL", 43, 54], ["the phenyl ring", "TREATMENT", 39, 54]]], ["This reaction tolerated mono-, di-or even tri-substituted patterns on the phenyl ring.", [["phenyl", "CHEMICAL", 74, 80], ["mono-, di-or", "SIMPLE_CHEMICAL", 24, 36], ["phenyl ring", "SIMPLE_CHEMICAL", 74, 85], ["This reaction", "PROBLEM", 0, 13], ["di", "PROBLEM", 31, 33], ["the phenyl ring", "TREATMENT", 70, 85], ["phenyl ring", "OBSERVATION", 74, 85]]], ["Interestingly, a substrate with a heterocycle instead of a phenyl ring, such as thiofuran, afforded the corresponding product (2o) in a synthetically useful yield (Table 2) .", [["thiofuran", "CHEMICAL", 80, 89], ["phenyl", "CHEMICAL", 59, 65], ["thiofuran", "CHEMICAL", 80, 89], ["phenyl ring", "SIMPLE_CHEMICAL", 59, 70], ["thiofuran", "SIMPLE_CHEMICAL", 80, 89], ["2o", "SIMPLE_CHEMICAL", 127, 129], ["a heterocycle", "TREATMENT", 32, 45], ["a phenyl ring", "TREATMENT", 57, 70], ["phenyl ring", "OBSERVATION", 59, 70]]], ["When substrates with electron-withdrawing groups on the phenyl rings were subjected to the standard reaction conditions, they gave low yields of the corresponding products.", [["phenyl", "CHEMICAL", 56, 62], ["electron", "SIMPLE_CHEMICAL", 21, 29], ["phenyl rings", "SIMPLE_CHEMICAL", 56, 68], ["the phenyl rings", "TREATMENT", 52, 68]]], ["After an exploration of the types and amounts of bases, it was found that decreasing the amount of KOAc to 0.6 equivalent led to good yields of 2p-x and 3p-x with the concomitant production of dimeric compounds 4p-v ( Table 3 ).", [["KOAc", "CHEMICAL", 99, 103], ["KOAc", "CHEMICAL", 99, 103], ["KOAc", "SIMPLE_CHEMICAL", 99, 103], ["2p-x", "SIMPLE_CHEMICAL", 144, 148], ["3p-x", "SIMPLE_CHEMICAL", 153, 157], ["an exploration", "TEST", 6, 20], ["KOAc", "TEST", 99, 103], ["dimeric compounds", "PROBLEM", 193, 210], ["exploration", "OBSERVATION", 9, 20], ["amounts", "OBSERVATION_MODIFIER", 38, 45], ["bases", "ANATOMY_MODIFIER", 49, 54], ["decreasing", "OBSERVATION_MODIFIER", 74, 84], ["amount", "OBSERVATION_MODIFIER", 89, 95]]], ["The reaction tolerated many electron-withdrawing groups on the phenyl rings, such as F, Cl, Br, I, OCF 3 and SCF 3 .EntryThe substrate scope with different phenyl amine groups was subsequently investigated (Table 4 ).", [["phenyl amine", "CHEMICAL", 156, 168], ["phenyl", "CHEMICAL", 63, 69], ["F", "CHEMICAL", 85, 86], ["Cl", "CHEMICAL", 88, 90], ["Br", "CHEMICAL", 92, 94], ["I", "CHEMICAL", 96, 97], ["OCF 3", "CHEMICAL", 99, 104], ["phenyl amine", "CHEMICAL", 156, 168], ["phenyl rings", "SIMPLE_CHEMICAL", 63, 75], ["F, Cl", "SIMPLE_CHEMICAL", 85, 90], ["phenyl amine", "SIMPLE_CHEMICAL", 156, 168], ["The reaction", "PROBLEM", 0, 12], ["the phenyl rings", "TREATMENT", 59, 75], ["The substrate scope", "TREATMENT", 121, 140], ["different phenyl amine groups", "TREATMENT", 146, 175]]], ["In general, electronwithdrawing groups on the phenyl amine rings promoted the reaction, probably due to the easy formation of a carbon anion at the benzylic position of these substrates in the reaction mixture.", [["phenyl amine", "CHEMICAL", 46, 58], ["carbon anion", "CHEMICAL", 128, 140], ["phenyl amine", "CHEMICAL", 46, 58], ["carbon", "CHEMICAL", 128, 134], ["phenyl amine rings", "SIMPLE_CHEMICAL", 46, 64], ["carbon anion", "SIMPLE_CHEMICAL", 128, 140], ["the phenyl amine rings", "TREATMENT", 42, 64], ["the reaction", "PROBLEM", 74, 86], ["a carbon anion", "TREATMENT", 126, 140], ["the reaction mixture", "TREATMENT", 189, 209], ["probably due to", "UNCERTAINTY", 88, 103], ["reaction mixture", "OBSERVATION", 193, 209]]], ["In the case of substrates bearing alkylamines being used as the amide component, the reaction did not work at all.EntryAfter an extensive screening of many different bases, KHCO 3 was identified to be the optimal one for producing a set of dimeric products (4a, 4l-m, 4o-x) in synthetically useful yields, probably because the mild basicity of KHCO 3 modulates the equilibrium between the intermediates, such as the sulfur-substituted carbocation, carbon nucleophile, a-substituted sulfide 3a and Michael acceptor 2a, all of which exist in the reaction mixture, to directly push the reaction forward to the formation of dimeric compounds (Table 5) .", [["alkylamines", "CHEMICAL", 34, 45], ["KHCO", "CHEMICAL", 173, 177], ["4a, 4l-m, 4o-x", "CHEMICAL", 258, 272], ["KHCO", "CHEMICAL", 344, 348], ["sulfur", "CHEMICAL", 416, 422], ["carbon nucleophile", "CHEMICAL", 448, 466], ["sulfide", "CHEMICAL", 482, 489], ["alkylamines", "CHEMICAL", 34, 45], ["amide", "CHEMICAL", 64, 69], ["KHCO 3", "CHEMICAL", 173, 179], ["KHCO 3", "CHEMICAL", 344, 350], ["sulfur", "CHEMICAL", 416, 422], ["carbon", "CHEMICAL", 448, 454], ["a-substituted sulfide", "CHEMICAL", 468, 489], ["alkylamines", "SIMPLE_CHEMICAL", 34, 45], ["4l-m", "SIMPLE_CHEMICAL", 262, 266], ["4o-x", "SIMPLE_CHEMICAL", 268, 272], ["KHCO 3", "SIMPLE_CHEMICAL", 344, 350], ["sulfur-substituted carbocation", "SIMPLE_CHEMICAL", 416, 446], ["carbon nucleophile", "SIMPLE_CHEMICAL", 448, 466], ["a-substituted sulfide 3a", "SIMPLE_CHEMICAL", 468, 492], ["Michael acceptor 2a", "SIMPLE_CHEMICAL", 497, 516], ["substrates bearing alkylamines", "TREATMENT", 15, 45], ["the amide component", "PROBLEM", 60, 79], ["the reaction", "PROBLEM", 81, 93], ["an extensive screening", "TEST", 125, 147], ["the mild basicity of KHCO", "PROBLEM", 323, 348], ["the sulfur-substituted carbocation", "TREATMENT", 412, 446], ["carbon nucleophile", "TREATMENT", 448, 466], ["a-substituted sulfide 3a and Michael acceptor 2a", "TREATMENT", 468, 516], ["bearing alkylamines", "OBSERVATION", 26, 45], ["mild", "OBSERVATION_MODIFIER", 327, 331], ["basicity", "OBSERVATION", 332, 340], ["dimeric compounds", "OBSERVATION", 620, 637]]], ["Unfortunately, in the case of substrates with electron-donating groups on the phenyl ring, the reaction was unable to afford any of the corresponding dimeric products, regardless of the kind of base used.ConclusionIn conclusion, we have studied a Lewis acid-promoted cascade reaction with dimethyl sulfoxide as a methylene source for the synthesis of a,b-unsaturated amides.", [["dimethyl sulfoxide", "CHEMICAL", 289, 307], ["methylene", "CHEMICAL", 313, 322], ["phenyl", "CHEMICAL", 78, 84], ["Lewis acid-", "CHEMICAL", 247, 258], ["dimethyl sulfoxide", "CHEMICAL", 289, 307], ["methylene", "CHEMICAL", 313, 322], [",b-unsaturated amides", "CHEMICAL", 352, 373], ["electron", "SIMPLE_CHEMICAL", 46, 54], ["phenyl ring", "SIMPLE_CHEMICAL", 78, 89], ["dimethyl sulfoxide", "SIMPLE_CHEMICAL", 289, 307], ["methylene", "SIMPLE_CHEMICAL", 313, 322], [",b-unsaturated amides", "SIMPLE_CHEMICAL", 352, 373], ["electron-donating groups", "TREATMENT", 46, 70], ["the phenyl ring", "TREATMENT", 74, 89], ["the reaction", "PROBLEM", 91, 103], ["a Lewis acid-promoted cascade reaction", "TREATMENT", 245, 283], ["dimethyl sulfoxide", "TREATMENT", 289, 307], ["a methylene source", "TREATMENT", 311, 329], ["a,b-unsaturated amides", "TREATMENT", 351, 373]]], ["The reaction proceeds with a wide substrate scope under mild conditions and with inexpensive reagents.", [["The reaction", "PROBLEM", 0, 12], ["a wide substrate scope", "TREATMENT", 27, 49], ["mild conditions", "PROBLEM", 56, 71], ["inexpensive reagents", "TREATMENT", 81, 101], ["mild", "OBSERVATION_MODIFIER", 56, 60]]], ["The identity of both the Lewis acid and base were found to be critical for this reaction to proceed well.", [["Lewis acid", "CHEMICAL", 25, 35], ["Lewis acid", "SIMPLE_CHEMICAL", 25, 35], ["this reaction", "PROBLEM", 75, 88]]], ["Extensive studies provide insight into a possible mechanism, leading to the belief that the Pummerer rearrangement with dimethyl sulfoxide as a methylene source is an initial step.General techniquesAll melting points are uncorrected.", [["dimethyl sulfoxide", "CHEMICAL", 120, 138], ["methylene", "CHEMICAL", 144, 153], ["dimethyl sulfoxide", "CHEMICAL", 120, 138], ["methylene", "CHEMICAL", 144, 153], ["Pummerer", "SIMPLE_CHEMICAL", 92, 100], ["dimethyl sulfoxide", "SIMPLE_CHEMICAL", 120, 138], ["methylene", "SIMPLE_CHEMICAL", 144, 153], ["Extensive studies", "TEST", 0, 17], ["dimethyl sulfoxide", "TREATMENT", 120, 138], ["a methylene source", "TREATMENT", 142, 160]]], ["Preparative chromatographic separations were performed on silica gel (300e400 mesh).", [["silica gel", "CHEMICAL", 58, 68], ["silica gel", "CHEMICAL", 58, 68], ["silica", "SIMPLE_CHEMICAL", 58, 64], ["Preparative chromatographic separations", "TREATMENT", 0, 39], ["silica gel", "TREATMENT", 58, 68]]], ["Reactions were followed by TLC analysis using silica plates with a fluorescent indicator (254 nm) and visualized with a UV lamp.", [["silica", "CHEMICAL", 46, 52], ["silica", "CHEMICAL", 46, 52], ["TLC analysis", "TEST", 27, 39], ["silica plates", "TREATMENT", 46, 59], ["a UV lamp", "TREATMENT", 118, 127]]], ["1 H and 13 C NMR spectra were recorded in Fourier transform mode at the field strength specified on a 400, or 600 MHz spectrometer.", [["1 H", "CHEMICAL", 0, 3], ["C", "CHEMICAL", 11, 12], ["NMR spectra", "TEST", 13, 24], ["MHz spectrometer", "TEST", 114, 130]]], ["Spectra were obtained on CDCl 3 solution in 5 mm diameter tubes, and chemical shifts in ppm (part per million) are quoted relative to the residual signals of chloroform (d H 7.26 ppm, or d C 77.00 ppm) .", [["chloroform", "CHEMICAL", 158, 168], ["CDCl 3", "CHEMICAL", 25, 31], ["chloroform", "CHEMICAL", 158, 168], ["H", "CHEMICAL", 172, 173], ["chloroform", "SIMPLE_CHEMICAL", 158, 168], ["CDCl 3 solution in 5 mm diameter tubes", "TREATMENT", 25, 63], ["chemical shifts in ppm", "TREATMENT", 69, 91], ["chemical shifts", "OBSERVATION", 69, 84]]], ["J values are given in hertz.", [["J values", "TEST", 0, 8]]], ["IR spectra were measured for samples as Table 2 Substrate scope with the electron-donating groups on the phenyl ring. a KBr pellets in a FT-IR spectrophotometer.", [["phenyl", "CHEMICAL", 105, 111], ["phenyl ring", "SIMPLE_CHEMICAL", 105, 116], ["IR spectra", "TEST", 0, 10], ["the electron", "TREATMENT", 69, 81], ["the phenyl ring", "TREATMENT", 101, 116], ["a KBr pellets", "TREATMENT", 118, 131], ["a FT-IR spectrophotometer", "TREATMENT", 135, 160], ["phenyl ring", "OBSERVATION", 105, 116]]], ["High resolution mass spectra (HRMS) were measured at 70 eV using a double focusing magnetic sector mass analyzer with an EI source or ESI source.", [["High resolution mass spectra", "PROBLEM", 0, 28], ["a double focusing magnetic sector mass analyzer", "PROBLEM", 65, 112], ["mass", "OBSERVATION", 16, 20]]], ["2-Phenyl-N-[2-(trifluoromethoxy) phenyl]acetamides (1a-1x, 1aa- Table 3 Substrate scope with the electron-withdrawing groups on the phenyl ring. a Table 4 The effect on the reaction of substituents on the phenyl amine ring. a 1ae and 1ba-1bc) were prepared according to the literature procedure.", [["2-Phenyl-N-[2-(trifluoromethoxy) phenyl]acetamides", "CHEMICAL", 0, 50], ["phenyl amine", "CHEMICAL", 205, 217], ["2-Phenyl-N-[2-(trifluoromethoxy) phenyl]acetamides", "CHEMICAL", 0, 50], ["phenyl", "CHEMICAL", 132, 138], ["phenyl amine", "CHEMICAL", 205, 217], ["2-Phenyl-N-[2-(trifluoromethoxy) phenyl]acetamides", "SIMPLE_CHEMICAL", 0, 50], ["electron", "SIMPLE_CHEMICAL", 97, 105], ["phenyl ring", "SIMPLE_CHEMICAL", 132, 143], ["phenyl amine ring", "SIMPLE_CHEMICAL", 205, 222], ["1ba-1bc", "SIMPLE_CHEMICAL", 234, 241], ["1ba", "PROTEIN", 234, 237], ["1bc", "DNA", 238, 241], ["Phenyl", "TREATMENT", 2, 8], ["[2-(trifluoromethoxy) phenyl]acetamides", "TREATMENT", 11, 50], ["the electron", "TREATMENT", 93, 105], ["the phenyl ring", "TREATMENT", 128, 143], ["the reaction of substituents", "PROBLEM", 169, 197], ["the phenyl amine ring", "TREATMENT", 201, 222], ["the literature procedure", "TREATMENT", 270, 294]]], ["13a Among them, substrates 1aa, 15 1ad 16 and 1ae 17 were known.General procedure for the preparation of 2-phenyl-N-[2-(trifluoromethoxy) phenyl]Acetamides (1a-1x, 1ab, 1ac and 1ba-1bc).", [["2-phenyl-N-[2-(trifluoromethoxy) phenyl]", "CHEMICAL", 105, 145], ["Acetamides", "CHEMICAL", 145, 155], ["2-phenyl-N-[2-(trifluoromethoxy) phenyl]", "CHEMICAL", 105, 145], ["Acetamides", "CHEMICAL", 145, 155], ["2-phenyl-N-[2-(trifluoromethoxy) phenyl]", "SIMPLE_CHEMICAL", 105, 145], ["Acetamides", "SIMPLE_CHEMICAL", 145, 155], ["1ba-1bc", "SIMPLE_CHEMICAL", 177, 184], ["General procedure", "TREATMENT", 64, 81], ["the preparation", "TREATMENT", 86, 101], ["phenyl-N-[2-(trifluoromethoxy) phenyl", "TREATMENT", 107, 144], ["Acetamides", "TREATMENT", 145, 155]]], ["To a solution of 2phenylacetic acid (7.0 mmol), 2-(trifluoromethoxy)aniline (7.7 mmol) in anhydrous CH 2 Cl 2 (25 mL) were added EDCI (1.745 g, 9.1 mmol) and DMAP (256.6 mg, 2.1 mmol).", [["2phenylacetic acid", "CHEMICAL", 17, 35], ["2-(trifluoromethoxy)aniline", "CHEMICAL", 48, 75], ["anhydrous CH 2 Cl", "CHEMICAL", 90, 107], ["EDCI", "CHEMICAL", 129, 133], ["DMAP", "CHEMICAL", 158, 162], ["2phenylacetic acid", "CHEMICAL", 17, 35], ["2-(trifluoromethoxy)aniline", "CHEMICAL", 48, 75], ["anhydrous CH 2 Cl 2", "CHEMICAL", 90, 109], ["EDCI", "CHEMICAL", 129, 133], ["DMAP", "CHEMICAL", 158, 162], ["2phenylacetic acid", "SIMPLE_CHEMICAL", 17, 35], ["2-(trifluoromethoxy)aniline", "SIMPLE_CHEMICAL", 48, 75], ["anhydrous CH 2 Cl 2", "SIMPLE_CHEMICAL", 90, 109], ["EDCI", "SIMPLE_CHEMICAL", 129, 133], ["DMAP", "SIMPLE_CHEMICAL", 158, 162], ["a solution of 2phenylacetic acid", "TREATMENT", 3, 35], ["(trifluoromethoxy)aniline", "TREATMENT", 50, 75], ["anhydrous CH", "TREATMENT", 90, 102], ["EDCI", "TREATMENT", 129, 133], ["DMAP", "TREATMENT", 158, 162]]], ["The reaction mixture was stirred at room temperature overnight, diluted with HCl (1 M) aqueous solution, and extracted with CH 2 Cl 2 (3 \u00c2 25 mL).", [["HCl", "CHEMICAL", 77, 80], ["CH 2 Cl", "CHEMICAL", 124, 131], ["HCl", "CHEMICAL", 77, 80], ["CH 2 Cl 2", "CHEMICAL", 124, 133], ["HCl", "SIMPLE_CHEMICAL", 77, 80], ["The reaction mixture", "PROBLEM", 0, 20], ["HCl", "TREATMENT", 77, 80], ["aqueous solution", "TREATMENT", 87, 103]]], ["The combined organic phase was washed with saturated NaHCO 3 aqueous solution and brine, dried over anhydrous Na 2 SO 4 168.9, 160.4, 137.9, 135.2, 130.6, 127.5, 124.2, 121.7, 121.4, 120.5 (d, , 120.2 (q, JC-F \u00bc 257.9 Hz), 115.", [["Na", "CHEMICAL", 110, 112], ["NaHCO 3", "CHEMICAL", 53, 60], ["Na 2 SO", "CHEMICAL", 110, 117], ["saturated NaHCO", "TREATMENT", 43, 58], ["anhydrous Na", "TEST", 100, 112], ["JC", "TEST", 205, 207], ["Hz", "TEST", 218, 220]]], ["1, 113.5, 100.0, 55.2, 45.1; 19F NMR (376 MHz, CDCl3) 8, 133.5, 130.7, 129.5, 127.5, 127.3, 124.0, 121.3, 120.5, 120 8, 161.7, 137.9, 135.8, 130.6, 127.6, 124.2, 121.3, 120.5, 120.3 3441, 3403, 3263, 1665 3441, 3403, 3263, , 1608 3441, 3403, 3263, , 1596 3441, 3403, 3263, , 1536 3441, 3403, 3263, , 1457 3441, 3403, 3263, , 1318 3441, 3403, 3263, , 1299 3441, 3403, 3263, , 1267 3441, 3403, 3263, , 1212 3441, 3403, 3263, , 1190 3441, 3403, 3263, , 1158 Hz), 137.9, 130.4, 127.6, 126.5 3289, 1661, 1608, 1593, 1537, 1509, 1460, 1424, 1329, 1295, 1256, 1187, 1172, 1150, 1128 .", [["CDCl3", "CHEMICAL", 47, 52], ["NMR", "TEST", 33, 36], ["MHz", "TEST", 42, 45], ["CDCl3", "TEST", 47, 52], ["Hz", "TEST", 455, 457]]], ["9, 133.9, 133.4, 131.7, 130.5, 129.6, 128.3, 127.5, 125.0, 124.2, 121.5, 120.3, 120.28 4, 138.0, 134.0, 132.2, 130.8, 130.3, 129.4, 127.5, 124.4, 121.5, 120.4, 120.3 168.2, 138.0, 136.0, 132.5, 131.0, 130.7, 130.3, 128.0, 127.5, 124.4, 123.3, 121.6, 120.5, 120.3General procedure for the preparation of 2-phenyl-N-[2-(trifluoromethoxy) phenyl]Hz), 121.5, 120.5, 116.6 (d, J C-F \u00bc 21.", [["2-phenyl-N-[2-(trifluoromethoxy) phenyl", "CHEMICAL", 303, 342], ["2-phenyl-N-[2-(trifluoromethoxy) phenyl]Hz", "CHEMICAL", 303, 345], ["2-phenyl-N-[2-(trifluoromethoxy) phenyl]Hz", "SIMPLE_CHEMICAL", 303, 345], ["General procedure", "TREATMENT", 262, 279], ["phenyl", "TREATMENT", 305, 311], ["J C-F \u00bc", "TEST", 372, 379]]], ["N-(2-(difluoromethoxy)phenyl)-2-(3-(trifluoromethoxy) phenyl)acetamide (1x) 168.0, 149.7, 140.0, 136.2, 130.6, 129.8, 127.9, 126.3, 124.4, 122.1, 121.3, 120.4 3, 137.6, 137.4, 131.3, 129.9, 129.4, 128.9, 124.4, 119.7, 44.4, 21 3298, 1670, 1598, 1530, 1499, 1442, 1410, 1343, 1307, 1298, 1254, 1188.", [["N-(2-(difluoromethoxy)phenyl)-2-(3-(trifluoromethoxy) phenyl)acetamide", "CHEMICAL", 0, 70], ["N-(2-(difluoromethoxy)phenyl)-2-(3-(trifluoromethoxy) phenyl)acetamide", "CHEMICAL", 0, 70], ["N-(2-(difluoromethoxy)phenyl)-2-(3-(trifluoromethoxy) phenyl)acetamide", "SIMPLE_CHEMICAL", 0, 70], ["(difluoromethoxy)phenyl)", "TREATMENT", 5, 29], ["(trifluoromethoxy) phenyl)acetamide", "TREATMENT", 35, 70]]], ["General procedure for the synthesis of a,b-unsaturatal amide compounds 2 and sulfide compounds 3General procedure for the preparation of 2-phenyl-N-[2-(trifluoromethoxy) phenyl]A mixture of substrate 1 (0.1 mmol), PbCl 2 (41.7 mg, 0.15 mmol) and KOAc (14.7 mg, 0.15 mmol) or (5.9 mg, 0.06 mmol) in DMSO (2.0 mL) was put into a 15 mL seal tube.", [["unsaturatal amide compounds 2 and sulfide", "CHEMICAL", 43, 84], ["2-phenyl-N-[2-(trifluoromethoxy) phenyl]", "CHEMICAL", 137, 177], ["PbCl 2", "CHEMICAL", 214, 220], ["KOAc", "CHEMICAL", 246, 250], ["DMSO", "CHEMICAL", 298, 302], ["amide", "CHEMICAL", 55, 60], ["sulfide", "CHEMICAL", 77, 84], ["2-phenyl-N-[2-(trifluoromethoxy) phenyl]", "CHEMICAL", 137, 177], ["PbCl 2", "CHEMICAL", 214, 220], ["KOAc", "CHEMICAL", 246, 250], ["DMSO", "CHEMICAL", 298, 302], [",b-unsaturatal amide compounds 2", "SIMPLE_CHEMICAL", 40, 72], ["sulfide", "SIMPLE_CHEMICAL", 77, 84], ["2-phenyl-N-[2-(trifluoromethoxy) phenyl]", "SIMPLE_CHEMICAL", 137, 177], ["PbCl 2", "SIMPLE_CHEMICAL", 214, 220], ["KOAc", "SIMPLE_CHEMICAL", 246, 250], ["DMSO", "SIMPLE_CHEMICAL", 298, 302], ["General procedure", "TREATMENT", 0, 17], ["the synthesis", "TREATMENT", 22, 35], ["a,b-unsaturatal amide compounds", "TREATMENT", 39, 70], ["3General procedure", "TREATMENT", 95, 113], ["the preparation", "TREATMENT", 118, 133], ["phenyl-N-[2-(trifluoromethoxy) phenyl", "TREATMENT", 139, 176], ["A mixture of substrate", "TREATMENT", 177, 199], ["PbCl", "TEST", 214, 218], ["KOAc", "TEST", 246, 250], ["DMSO", "TREATMENT", 298, 302], ["a 15 mL seal tube", "TREATMENT", 325, 342], ["tube", "OBSERVATION", 338, 342]]], ["The air in the seal tube was exchanged with N 2 .", [["seal tube", "TISSUE", 15, 24], ["The air in the seal tube", "TREATMENT", 0, 24], ["air", "OBSERVATION", 4, 7], ["seal tube", "OBSERVATION", 15, 24]]], ["The reaction mixture was stirred at 156 C for 13 h under N 2 , then cooled down to room temperature, diluted with H 2 O, and extracted with EtOAc (3 \u00c2 5 mL).", [["H 2 O", "CHEMICAL", 114, 119], ["H 2 O", "CHEMICAL", 114, 119], ["EtOAc", "CHEMICAL", 140, 145], ["H 2 O", "SIMPLE_CHEMICAL", 114, 119], ["EtOAc", "SIMPLE_CHEMICAL", 140, 145], ["The reaction mixture", "PROBLEM", 0, 20], ["EtOAc", "TREATMENT", 140, 145]]], ["The combined organic phase was washed with brine and dried over anhydrous Na 2 SO 4 , and concentrated under vacuum.", [["Na", "CHEMICAL", 74, 76], ["Na 2 SO 4", "CHEMICAL", 74, 83], ["Na 2 SO 4", "SIMPLE_CHEMICAL", 74, 83], ["The combined organic phase", "PROBLEM", 0, 26], ["brine", "TREATMENT", 43, 48], ["organic phase", "OBSERVATION", 13, 26], ["vacuum", "OBSERVATION", 109, 115]]], ["The residue was purified by preparative TLC plate (petroleum ether: ethyl acetate \u00bc 10: 1 as eluent) to get the product 2 and 3.General procedure for the preparation of 2-phenyl-N-[2-(trifluoromethoxy) phenyl]2-Phenyl-N-(2-(trifluoromethoxy)phenyl)acrylamide (2a) 136.", [["petroleum ether", "CHEMICAL", 51, 66], ["ethyl acetate", "CHEMICAL", 68, 81], ["2-phenyl-N-[2-(trifluoromethoxy) phenyl]2-Phenyl-N-(2-(trifluoromethoxy)phenyl)acrylamide (2a) 136", "CHEMICAL", 169, 267], ["petroleum ether", "CHEMICAL", 51, 66], ["ethyl acetate", "CHEMICAL", 68, 81], ["2-phenyl-N-[2-(trifluoromethoxy) phenyl]2-Phenyl-N-(2-(trifluoromethoxy)phenyl)acrylamide", "CHEMICAL", 169, 258], ["petroleum ether", "SIMPLE_CHEMICAL", 51, 66], ["ethyl acetate", "SIMPLE_CHEMICAL", 68, 81], ["2-phenyl-N-[2-(trifluoromethoxy) phenyl]2-Phenyl-N-(2-(trifluoromethoxy)phenyl)acrylamide (2a) 136", "SIMPLE_CHEMICAL", 169, 267], ["The residue", "PROBLEM", 0, 11], ["preparative TLC plate", "TREATMENT", 28, 49], ["ethyl acetate \u00bc", "TREATMENT", 68, 83], ["General procedure", "TREATMENT", 128, 145], ["the preparation", "TREATMENT", 150, 165], ["phenyl-N-[2-(trifluoromethoxy) phenyl]", "TREATMENT", 171, 209], ["Phenyl-N-(2-(trifluoromethoxy)phenyl)acrylamide", "TREATMENT", 211, 258]]], ["3, 130.5, 128.9, 128.8, 128.3, 127.5, 124.7, 124.3, 121.5, 1202-(m-Tolyl)-N-(2-(trifluoromethoxy)phenyl)acrylamide (2b), 3-(Methylthio)-2-(m-tolyl)-N-(2-(trifluoromethoxy)phenyl) propanamide (3b).", [["124.7, 124.3, 121.5, 1202-(m-Tolyl)-N-(2-(trifluoromethoxy)phenyl)acrylamide", "CHEMICAL", 38, 114], ["3-(Methylthio)-2-(m-tolyl)-N-(2-(trifluoromethoxy)phenyl) propanamide", "CHEMICAL", 121, 190], ["3, 130.5, 128.9, 128.8, 128.3, 127.5, 124.7, 124.3, 121.5, 1202-(m-Tolyl)-N-(2-(trifluoromethoxy)phenyl)acrylamide", "CHEMICAL", 0, 114], ["3-(Methylthio)-2-(m-tolyl)-N-(2-(trifluoromethoxy)phenyl) propanamide", "CHEMICAL", 121, 190], ["1202-(m-Tolyl)-N-(2-(trifluoromethoxy)phenyl)acrylamide (2b), 3-(Methylthio)-2-(m-tolyl)-N-(2-(trifluoromethoxy)phenyl) propanamide (3b", "SIMPLE_CHEMICAL", 59, 194], ["N-(2-(trifluoromethoxy)phenyl)acrylamide", "TREATMENT", 74, 114], ["(Methylthio)", "TREATMENT", 123, 135], ["m-tolyl)", "TREATMENT", 139, 147], ["(trifluoromethoxy)phenyl) propanamide", "TREATMENT", 153, 190]]], ["Data of 2b: Brown oil; 1 d 170.6, 138.2, 134.5, 130.5, 130.0, 128.7, 127.9, 127.5, 124.2, 121.5, 120.4, 120.3 (q, 54.2, 36.8, 21.1, 16.3; 19 3409, 1660, 1609, 1529, 1455, 1253,1216, 1186.", [["Brown oil", "TEST", 12, 21]]], ["2-(4-Isopropylphenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide (2e) and 2-(4 eIsopropylphenyl)-3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide (3e).", [["2-(4-Isopropylphenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide", "CHEMICAL", 0, 63], ["2-(4 eIsopropylphenyl)-3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide", "CHEMICAL", 73, 152], ["2-(4-Isopropylphenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide", "CHEMICAL", 0, 63], ["2-(4 eIsopropylphenyl)-3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide", "CHEMICAL", 73, 152], ["2-(4-Isopropylphenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide (2e)", "SIMPLE_CHEMICAL", 0, 68], ["2-(4 eIsopropylphenyl)-3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide", "SIMPLE_CHEMICAL", 73, 152], ["Isopropylphenyl)", "TREATMENT", 5, 21], ["(trifluoromethoxy)phenyl) acrylamide (2e)", "TREATMENT", 27, 68], ["methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide", "TREATMENT", 99, 152]]], ["19 164.6, 152.1, 144.4, 138.1 (d, J \u00bc 1.2 Hz), 133.4, 130.7, 128.2, 127.6, 126.0, 124.5, 124.2, 121.4, 120.3 (d, 170.6, 151.3, 137.9, 134.4, 130.5, 127.7, 127.5, 126.3, 124.2, 121.5, 120.4, 120 .2 (q, J C-F \u00bc 257.8 Hz), 54.2, 36.8, 34.6, 31.2, 16.4; 19 3426, 1686, 1617, 1528, 1257, 1217, 1178.", [["J", "TEST", 34, 35], ["Hz", "TEST", 42, 44], ["J C", "TEST", 201, 204], ["Hz", "TEST", 215, 217]]], ["2-(4-Butoxyphenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide (2g) and 2-(4-Butoxyphenyl)-3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide (3g).", [["2-(4-Butoxyphenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide", "CHEMICAL", 0, 60], ["2-(4-Butoxyphenyl)-3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide", "CHEMICAL", 70, 145], ["2-(4-Butoxyphenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide", "CHEMICAL", 0, 60], ["2-(4-Butoxyphenyl)-3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide", "CHEMICAL", 70, 145], ["2-(4-Butoxyphenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide (2g)", "SIMPLE_CHEMICAL", 0, 65], ["2-(4-Butoxyphenyl)-3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide", "SIMPLE_CHEMICAL", 70, 145], ["Butoxyphenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide", "TREATMENT", 5, 60], ["methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide", "TREATMENT", 92, 145]]], ["Data of 2g: White solid; mp 64e66 C; 1 H NMR (400 MHz, CDCl 3 ) d 8.54 (d, J \u00bc 8.1 Hz, 1H) , 7.89 (s, 1H), 7.38e7.28 (m, 3H), 7.21 (d, J \u00bc 8.1 Hz, 1H) , 7.13e7.05 (m, 1H), 6.95 (d, J \u00bc 8.5 Hz, 2H) , 6.32 (s, 1H), 5.69 (s, 1H), 4.00 (t, J \u00bc 6.5 Hz, 2H), 1.85e1.73 (m, 2H), 1.57e1.45 (m, 2H) , 0.99 (t, J \u00bc 7.", [["H", "CHEMICAL", 39, 40], ["1H", "CHEMICAL", 87, 89], ["1H", "CHEMICAL", 102, 104], ["1H", "CHEMICAL", 147, 149], ["1H", "CHEMICAL", 167, 169], ["2H", "CHEMICAL", 193, 195], ["1H", "CHEMICAL", 208, 210], ["1H", "CHEMICAL", 222, 224], ["2H", "CHEMICAL", 248, 250], ["White solid", "TEST", 12, 23], ["mp", "TEST", 25, 27], ["NMR", "TEST", 41, 44], ["MHz", "TEST", 50, 53], ["CDCl", "TEST", 55, 59], ["d", "TEST", 64, 65], ["J", "TEST", 75, 76], ["Hz", "TEST", 83, 85], ["3H", "TEST", 121, 123], ["d", "TEST", 132, 133], ["J", "TEST", 135, 136], ["Hz", "TEST", 143, 145], ["1H", "TEST", 147, 149], ["1H", "TEST", 167, 169], ["d", "TEST", 178, 179], ["J", "TEST", 181, 182], ["Hz", "TEST", 189, 191], ["2H", "TEST", 193, 195], ["s", "TEST", 205, 206], ["1H", "TEST", 208, 210], ["s", "TEST", 219, 220], ["1H", "TEST", 222, 224], ["t", "TEST", 233, 234], ["J", "TEST", 236, 237], ["Hz", "TEST", 244, 246], ["2H", "TEST", 248, 250], ["2H", "TEST", 267, 269], ["t", "TEST", 298, 299]]], ["4 Hz, 3H ); 13 C NMR (100 MHz, CDCl 3 ) d 165.", [["3H", "CHEMICAL", 6, 8], ["13 C", "CHEMICAL", 12, 16], ["NMR", "TEST", 17, 20], ["CDCl", "TEST", 31, 35]]], ["1, 159.7, 144.2, 138.2 (d, J \u00bc 1.3 Hz), 130.7, 129.6, 128.3, 127.6, 124.3, 123.5, 121.6, 120.4 (d, J \u00bc 1.0 Hz) , 120.3 (q, J C-F \u00bc 257.8 Hz), 115.0, 67.8, 31.2, 19.2, 13.8; 19 8, 159.1, 137.9, 130.5, 129.1, 128.9, 127.5, 124.2, 121.5, 120.4, 120.3 (q, 115.2, 67.7, 53.8, 37.0, 31.2, 19.2, 16.3, 13.8; 19 (d, J \u00bc 1.3 Hz), 130.9, 130.6, 129.90, 129.87, 127.7, 124.4, 124.1, 123.8, 121.", [["Hz", "TEST", 35, 37], ["J", "TEST", 99, 100], ["Hz", "TEST", 107, 109], ["J C", "TEST", 123, 126], ["Hz", "TEST", 137, 139], ["J", "TEST", 308, 309], ["Hz", "TEST", 316, 318]]], ["6, 120.4 and 7.7 Hz, 1H), 2.12 (s, 3H); 13 C NMR (100 MHz, CDCl 3 ) d 170.", [["1H", "CHEMICAL", 21, 23], ["C", "CHEMICAL", 43, 44], ["Hz", "TEST", 17, 19], ["NMR", "TEST", 45, 48], ["MHz", "TEST", 54, 57], ["CDCl", "TEST", 59, 63]]], ["4, 158.6, 157.5, 156.6, 132.1, 130.4, 129.8, 129.4, 127.6, 124.3, 123.7, 121.7, 120.5, 120.4 (q, 119.3, 119.2, 54.0, 37.1, 16.4; 19 F NMR 164.6, 144.3, 141.9, 140.3, 138.2 (d, J \u00bc 1.4 Hz), 135.1, 130.6, 128.9, 128.8, 127.74, 127.69, 127.6, 127.1, 124.5, 124.4, 121.6, 120.4 4, 117.7, 117.5, 54.3, 36.9, 16.4; 19 F NMR (376 MHz, CDCl 3 ) d \u00c057.86; HRMS (EI) Calcd for C 23 H 20 F 3 NO 2 S [M \u00fe ]: 431.1167 found 431.1154; IR (KBr) n(cm \u00c01 ): 3406, 1673, 1608, 1529, 1255, 1217, 1180.", [["NO", "CHEMICAL", 381, 383], ["NO", "CHEMICAL", 381, 383], ["NMR", "TEST", 134, 137], ["Hz", "TEST", 184, 186], ["NMR", "TEST", 314, 317], ["MHz", "TEST", 323, 326], ["CDCl", "TEST", 328, 332], ["d", "TEST", 337, 338], ["HRMS", "TEST", 347, 351], ["EI", "TEST", 353, 355], ["Calcd", "TEST", 357, 362], ["C", "TEST", 367, 368], ["IR", "TEST", 421, 423], ["KBr", "TEST", 425, 428]]], ["2-(3,5-Dimethylphenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide (2j) and 2- (3,5- 164.6, 144.7, 138.8, 138.1 (d, J \u00bc 1.5 Hz), 136.3, 130.7, 130.5, 127.6, 126.2, 124.7, 124.2, 121.6, 120.4 (d, J \u00bc 8.2 Hz, 1H), 7.54 (s, 1H), 7.29e7.22 (m, 1H), 7.20e7.13 (m, 1H) , 7.10e7.02 (m, 1H), 6.97 (d, J \u00bc 6.7 Hz, 3H), 3.75 (t, J \u00bc 7.4 Hz, 1H), 3.42 (dd, J \u00bc 13.2 and 6.9 Hz, 1H), 2.98 (dd, J \u00bc 13.2 and 8.0 Hz, 1H) , 2.32 (s, 6H), 2.12 (s, 3H); 13 C NMR (150 MHz, CDCl 3 ) d 170.", [["2-(3,5-Dimethylphenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide", "CHEMICAL", 0, 64], ["2-(3,5-Dimethylphenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide", "CHEMICAL", 0, 64], ["1H", "CHEMICAL", 205, 207], ["1H", "CHEMICAL", 219, 221], ["1H", "CHEMICAL", 238, 240], ["1H", "CHEMICAL", 257, 259], ["1H", "CHEMICAL", 277, 279], ["3H", "CHEMICAL", 303, 305], ["1H", "CHEMICAL", 329, 331], ["1H", "CHEMICAL", 365, 367], ["1H", "CHEMICAL", 401, 403], ["13 C", "CHEMICAL", 435, 439], ["2-(3,5-Dimethylphenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide", "SIMPLE_CHEMICAL", 0, 64], ["2- (3,5- 164.6", "SIMPLE_CHEMICAL", 74, 88], ["Dimethylphenyl", "TEST", 7, 21], ["J", "TEST", 193, 194], ["Hz", "TEST", 201, 203], ["J", "TEST", 291, 292], ["Hz", "TEST", 299, 301], ["3H", "TEST", 303, 305], ["t", "TEST", 314, 315], ["J", "TEST", 317, 318], ["Hz", "TEST", 325, 327], ["1H", "TEST", 329, 331], ["dd", "TEST", 340, 342], ["J", "TEST", 344, 345], ["Hz", "TEST", 361, 363], ["1H", "TEST", 365, 367], ["dd", "TEST", 376, 378], ["J \u00bc", "TEST", 380, 383], ["Hz", "TEST", 397, 399], ["1H", "TEST", 401, 403], ["s", "TEST", 413, 414], ["6H", "TEST", 416, 418], ["s", "TEST", 427, 428], ["3H", "TEST", 430, 432], ["NMR", "TEST", 440, 443], ["MHz", "TEST", 449, 452], ["CDCl", "TEST", 454, 458], ["d", "TEST", 463, 464]]], ["5, 139.1, 137.9, 137.3, 130.5, 130.0, 127.5, 125.7, 124.2, 121.5, 120.4, 120.3 (q, 54.4, 36.6, 21.2, 16.3; 19 161.2, 144.4, 138.3, 138.1 (d, J \u00bc 1.3 Hz), 130.6, 127.6, 125.1, 124.3, 121.6, 120.4 (d, J \u00bc 1.1 Hz) , 120.3 (q, J C-F \u00bc 258.0 Hz), 106.", [["J", "TEST", 141, 142], ["Hz", "TEST", 149, 151], ["J", "TEST", 199, 200], ["Hz", "TEST", 207, 209], ["J C", "TEST", 223, 226], ["Hz", "TEST", 237, 239]]], ["5, 100.7, 55.4; 19 F NMR (376 MHz (d, J \u00bc 8.1 Hz, 1H), 7.60 (s, 1H), 7.29e7.23 (m, 1H), 7.21e7.15 (m, 1H), 7.10e7.01 (m, 1H), 6.55e6.47 (m, 2H), 6.47e7.39 (m, 1H) , 3.79 (s, 6H), 3.75 (t, J \u00bc 7.4 Hz, 1H), 3.40 (dd, J \u00bc 13.3 and 6.9 Hz, 1H), 2.97 (dd, J \u00bc 13.3 and 7.9 Hz, 1H) , 2.12 (s, 3H); 13 C NMR (100 MHz, CDCl 3 ) d 170.0, 161.5, 142.9, 139.8, 130.5, 127.5, 124.2, 121.6, 120.45, 120.38 (q, 106.1, 99.9, 55.3, 54.9, 36.5, 16.4; 19 F NMR (376 MHz, CDCl 3 ) 5 Hz), 148.3 (d, J \u00bc 10.6 Hz), 143.4 (d, J \u00bc 15.7 Hz), 138.2 (d, J \u00bc 1.5 Hz), 130.5, 129.0 (d, J \u00bc 6.5 Hz), 127.7, 124.5, 124.4 (d, J \u00bc 3.6 Hz), 123.8, 121.6, 120.4 (d, J \u00bc 1.2 Hz) 147.6 (d, J C-F \u00bc 18.9 Hz), 138.1, 130.4 (d, 130.3, 127.6, 124.4, 124.0 (d, 121.7, 120.5, 120.3 (q, 115.7 (d, 113.9 (d, 56.3, 53.7, 37.0, 16.4; 19 3435, 1632, 1522, 1259, 1219, 1177.", [["1H", "CHEMICAL", 50, 52], ["1H", "CHEMICAL", 64, 66], ["1H", "CHEMICAL", 83, 85], ["1H", "CHEMICAL", 102, 104], ["1H", "CHEMICAL", 121, 123], ["1H", "CHEMICAL", 159, 161], ["1H", "CHEMICAL", 200, 202], ["1H", "CHEMICAL", 236, 238], ["1H", "CHEMICAL", 272, 274], ["C", "CHEMICAL", 295, 296], ["NMR", "TEST", 21, 24], ["MHz", "TEST", 30, 33], ["J", "TEST", 38, 39], ["Hz", "TEST", 46, 48], ["e", "TEST", 111, 112], ["1H", "TEST", 121, 123], ["1H", "TEST", 159, 161], ["s", "TEST", 171, 172], ["6H", "TEST", 174, 176], ["t", "TEST", 185, 186], ["J", "TEST", 188, 189], ["Hz", "TEST", 196, 198], ["1H", "TEST", 200, 202], ["dd", "TEST", 211, 213], ["J \u00bc", "TEST", 215, 218], ["Hz", "TEST", 232, 234], ["1H", "TEST", 236, 238], ["dd", "TEST", 247, 249], ["J \u00bc", "TEST", 251, 254], ["Hz", "TEST", 268, 270], ["1H", "TEST", 272, 274], ["s", "TEST", 284, 285], ["3H", "TEST", 287, 289], ["NMR", "TEST", 297, 300], ["MHz", "TEST", 306, 309], ["CDCl", "TEST", 311, 315], ["d", "TEST", 320, 321], ["NMR", "TEST", 439, 442], ["MHz", "TEST", 448, 451], ["CDCl", "TEST", 453, 457], ["Hz", "TEST", 464, 466], ["d", "TEST", 476, 477], ["J", "TEST", 479, 480], ["Hz", "TEST", 488, 490], ["d", "TEST", 500, 501], ["J", "TEST", 503, 504], ["Hz", "TEST", 512, 514], ["J", "TEST", 527, 528], ["Hz", "TEST", 535, 537], ["J", "TEST", 557, 558], ["Hz", "TEST", 565, 567], ["J", "TEST", 594, 595], ["Hz", "TEST", 602, 604], ["J", "TEST", 631, 632], ["Hz", "TEST", 639, 641], ["d", "TEST", 650, 651], ["J C", "TEST", 653, 656], ["Hz", "TEST", 666, 668]]], ["N-(2-(Trifluoromethoxy)phenyl)-2- (3,4,5-trimethoxyphenyl) acrylamide (2m) and 3-(Methylthio)-N-(2-(trifluoromethoxy) phenyl)-2- (3,4,5-trimethoxyphenyl) propanamide (3m).", [["N-(2-(Trifluoromethoxy)phenyl)-2- (3,4,5-trimethoxyphenyl) acrylamide", "CHEMICAL", 0, 69], ["3-(Methylthio)-N-(2-(trifluoromethoxy) phenyl)-2- (3,4,5-trimethoxyphenyl) propanamide", "CHEMICAL", 79, 165], ["N-(2-(Trifluoromethoxy)phenyl)-2- (3,4,5-trimethoxyphenyl) acrylamide", "CHEMICAL", 0, 69], ["3-(Methylthio)-N-(2-(trifluoromethoxy) phenyl)-2- (3,4,5-trimethoxyphenyl) propanamide", "CHEMICAL", 79, 165], ["N-(2-(Trifluoromethoxy)phenyl)-2- (3,4,5-trimethoxyphenyl) acrylamide (2m)", "SIMPLE_CHEMICAL", 0, 74], ["3-(Methylthio)-N-(2-(trifluoromethoxy) phenyl)-2- (3,4,5-trimethoxyphenyl) propanamide", "SIMPLE_CHEMICAL", 79, 165], ["(Trifluoromethoxy)phenyl)", "TREATMENT", 5, 30], ["trimethoxyphenyl) acrylamide", "TREATMENT", 41, 69], ["Methylthio)-N-(2-(trifluoromethoxy) phenyl)", "TREATMENT", 82, 125], ["trimethoxyphenyl) propanamide", "TREATMENT", 136, 165]]], ["Data of 2m: White solid; mp 62e63 C; 1 H NMR (400 MHz, CDCl 3 ) d 8.55 (d, J \u00bc 8.0 Hz, 1H), 7.92 (s, 1H), 7.35e7.27 (m, 1H), 7.24e7.15 (m, 1H), 7.14e7.05 (m, 1H) , 6.61 (s, 2H), 6.42 (s, 1H), 5.72 (d, J \u00bc 0.7 Hz, 1H) , 3 .87 (s, 9H); 13 C NMR (100 MHz, CDCl 3 ) d 164.", [["H", "CHEMICAL", 39, 40], ["1H", "CHEMICAL", 87, 89], ["1H", "CHEMICAL", 101, 103], ["1H", "CHEMICAL", 120, 122], ["1H", "CHEMICAL", 139, 141], ["1H", "CHEMICAL", 158, 160], ["2H", "CHEMICAL", 173, 175], ["1H", "CHEMICAL", 187, 189], ["1H", "CHEMICAL", 213, 215], ["13 C", "CHEMICAL", 234, 238], ["White solid", "TEST", 12, 23], ["mp", "TEST", 25, 27], ["NMR", "TEST", 41, 44], ["MHz", "TEST", 50, 53], ["CDCl", "TEST", 55, 59], ["d", "TEST", 64, 65], ["J", "TEST", 75, 76], ["Hz", "TEST", 83, 85], ["s", "TEST", 184, 185], ["1H", "TEST", 187, 189], ["d", "TEST", 198, 199], ["J", "TEST", 201, 202], ["\u00bc", "TEST", 203, 204], ["Hz", "TEST", 209, 211], ["1H", "TEST", 213, 215], ["s", "TEST", 226, 227], ["NMR", "TEST", 239, 242], ["MHz", "TEST", 248, 251], ["CDCl", "TEST", 253, 257], ["d", "TEST", 262, 263]]], ["3, 153.6, 144.5, 138.6, 138.0 (d, J \u00bc 1.1 Hz), 131.8, 130.6, 127.7, 124.7, 124.3, 121.4, 120.4, 120.3 (q, 105.6, 60.8, 56.1; 19 3, 138.0, 135.0, 133.5, 133.0, 130.4, 129.3, 127.9, 127.7, 127.5, 127.4, 126.6, 126.4, 125.2, 124.3, 121.7, 120.4, 120 .2 (q, J C-F \u00bc 258.", [["Hz", "TEST", 42, 44], ["J C", "TEST", 254, 257]]], ["3 164.7, 139.5, 138.2 (d, J \u00bc 1.4 Hz), 136.7, 130.5, 127.6, 127.04, 126.99, 124.6, 124.4, 123.0, 121.7, 120.38 162.9, 143.9, 138.0 (d, J \u00bc 1.5 Hz), 137.5, 133.3, 131.4, 130.65, 130.59, 128.1, 127.6, 127.3, 124.2, 123.7, 121.3, 120.3 (d, J \u00bc 1.0 Hz) , 120.2 (q, J C-F \u00bc 258.0 Hz); 19 4, 138.0, 137.1, 133.2, 130.4, 129.5, 128.7, 128.4, 127.5, 124.7, 124.3, 121.7, 120.4 2-(4-Chlorophenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide (2q) and 2-(4-Chlorophenyl)-3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide (3q).", [["120.4 2-(4-Chlorophenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide", "CHEMICAL", 363, 429], ["2-(4-Chlorophenyl)-3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide", "CHEMICAL", 439, 514], ["2-(4-Chlorophenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide", "CHEMICAL", 369, 429], ["2-(4-Chlorophenyl)-3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide", "CHEMICAL", 439, 514], ["120.4 2-(4-Chlorophenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide (2q)", "SIMPLE_CHEMICAL", 363, 434], ["2-(4-Chlorophenyl)-3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide", "SIMPLE_CHEMICAL", 439, 514], ["Hz", "TEST", 34, 36], ["J", "TEST", 135, 136], ["Hz", "TEST", 143, 145], ["J", "TEST", 237, 238], ["Hz", "TEST", 245, 247], ["J C", "TEST", 261, 264], ["Hz", "TEST", 275, 277], ["Chlorophenyl", "TEST", 374, 386], ["(trifluoromethoxy)phenyl) acrylamide", "TREATMENT", 393, 429], ["(trifluoromethoxy)phenyl)propanamide", "TREATMENT", 478, 514]]], ["Data of 2q: White solid; mp 88e89 C; 1 H NMR (400 MHz, CDCl 3 ) d 8.51 (d, J \u00bc 8.1 Hz, 1H) , 7.77 (s, 1H), 7.45e7.36 (m, 4H), 7.35e7.28 (m, 1H), 7.25e7.19 (m, 1H), 7.15e7.08 (m, 1H), 6.35 (s, 1H), 5.77 (s, 1H); 13 C NMR (100 MHz, CDCl 3 ) d 164.", [["H", "CHEMICAL", 39, 40], ["1H", "CHEMICAL", 87, 89], ["1H", "CHEMICAL", 102, 104], ["1H", "CHEMICAL", 140, 142], ["1H", "CHEMICAL", 159, 161], ["1H", "CHEMICAL", 178, 180], ["1H", "CHEMICAL", 192, 194], ["1H", "CHEMICAL", 206, 208], ["13 C", "CHEMICAL", 211, 215], ["White solid", "TEST", 12, 23], ["mp", "TEST", 25, 27], ["NMR", "TEST", 41, 44], ["MHz", "TEST", 50, 53], ["CDCl", "TEST", 55, 59], ["d", "TEST", 64, 65], ["J", "TEST", 75, 76], ["Hz", "TEST", 83, 85], ["1H", "TEST", 159, 161], ["e", "TEST", 168, 169], ["1H", "TEST", 192, 194], ["s", "TEST", 203, 204], ["1H", "TEST", 206, 208], ["NMR", "TEST", 216, 219], ["MHz", "TEST", 225, 228], ["CDCl", "TEST", 230, 234], ["d", "TEST", 239, 240]]], ["4, 143.7, 138.2 (d, J \u00bc 1.4 Hz), 135.1, 134.7, 130.4, 129.6, 129.2, 127.6, 124.6, 124.5, 121.7, 120.4 (s, 3H); 13 C NMR (150 MHz, CDCl 3 ) d 169.", [["13 C", "CHEMICAL", 111, 115], ["J", "TEST", 20, 21], ["Hz", "TEST", 28, 30], ["NMR", "TEST", 116, 119], ["MHz", "TEST", 125, 128], ["CDCl", "TEST", 130, 134]]], ["8, 138.1, 136.1, 134.2, 129.4, 129.3, 129.0, 127.6, 124.5, 121.7, 120 .6 (q, J C-F \u00bc 256.9 Hz), 120.", [["J C", "TEST", 77, 80], ["Hz", "TEST", 91, 93]]], ["2-(4-Bromophenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide (2r) and 2-(4-Bromophenyl) -3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide (3r).", [["2-(4-Bromophenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide", "CHEMICAL", 0, 59], ["2r", "CHEMICAL", 61, 63], ["2-(4-Bromophenyl) -3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide", "CHEMICAL", 69, 144], ["2-(4-Bromophenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide", "CHEMICAL", 0, 59], ["2r", "CHEMICAL", 61, 63], ["2-(4-Bromophenyl) -3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide", "CHEMICAL", 69, 144], ["3r", "CHEMICAL", 146, 148], ["2-(4-Bromophenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide (2r)", "SIMPLE_CHEMICAL", 0, 64], ["2-(4-Bromophenyl) -3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide", "SIMPLE_CHEMICAL", 69, 144], ["3r", "SIMPLE_CHEMICAL", 146, 148], ["Bromophenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide", "TREATMENT", 5, 59], ["Bromophenyl)", "TREATMENT", 74, 86], ["methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide", "TREATMENT", 91, 144]]], ["Data of 2r: White solid; mp 90e91 C; 1 H NMR (400 MHz, CDCl 3 ) d 8.50 (d, J \u00bc 8.1 Hz, 1H) , 7.76 (s, 1H), 7.58 (d, J \u00bc 8.3 Hz, 2H) , 7.37e7.28 (m, 3H), 7.22 (d, J \u00bc 8.2 Hz, 1H) , 7.16e7.08 (m, 1H), 6.36 (s, 1H), 5.78 (s, 1H); 13 C NMR (100 MHz, CDCl 3 ) d 164.", [["H", "CHEMICAL", 39, 40], ["1H", "CHEMICAL", 87, 89], ["1H", "CHEMICAL", 102, 104], ["2H", "CHEMICAL", 128, 130], ["1H", "CHEMICAL", 174, 176], ["1H", "CHEMICAL", 194, 196], ["1H", "CHEMICAL", 208, 210], ["1H", "CHEMICAL", 222, 224], ["13 C", "CHEMICAL", 227, 231], ["White solid", "TEST", 12, 23], ["mp", "TEST", 25, 27], ["NMR", "TEST", 41, 44], ["MHz", "TEST", 50, 53], ["CDCl", "TEST", 55, 59], ["d", "TEST", 64, 65], ["J", "TEST", 75, 76], ["Hz", "TEST", 83, 85], ["1H", "TEST", 102, 104], ["d", "TEST", 113, 114], ["J", "TEST", 116, 117], ["Hz", "TEST", 124, 126], ["3H", "TEST", 148, 150], ["d", "TEST", 159, 160], ["J", "TEST", 162, 163], ["Hz", "TEST", 170, 172], ["1H", "TEST", 174, 176], ["1H", "TEST", 194, 196], ["s", "TEST", 205, 206], ["1H", "TEST", 208, 210], ["s", "TEST", 219, 220], ["1H", "TEST", 222, 224], ["NMR", "TEST", 232, 235], ["MHz", "TEST", 241, 244], ["CDCl", "TEST", 246, 250], ["d", "TEST", 255, 256]]], ["3, 143.8, 138.2 (d, J \u00bc 1.1 Hz), 135.1, 132.2, 130.4, 129.9, 127.7, 124.6, 124.5, 123.3, 121.7, 120.5 (d, 8, 138.2, 136.7, 132.1, 130.1, 129.5, 129.2, 127.4, 124.5, 122.0, 120.4, 120.22-(4-(Tert-butyl)phenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide (2f) and 2-(4-(Tert-butyl)phenyl)-3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide (3f).", [["120.22-(4-(Tert-butyl)phenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide", "CHEMICAL", 179, 250], ["2-(4-(Tert-butyl)phenyl)-3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide", "CHEMICAL", 260, 341], ["120.22-(4-(Tert-butyl)phenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide", "CHEMICAL", 179, 250], ["2-(4-(Tert-butyl)phenyl)-3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide", "CHEMICAL", 260, 341], ["120.22-(4-(Tert-butyl)phenyl)-N-(2-(trifluoromethoxy)phenyl) acrylamide (2f)", "SIMPLE_CHEMICAL", 179, 255], ["2-(4-(Tert-butyl)phenyl)-3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide", "SIMPLE_CHEMICAL", 260, 341], ["J", "TEST", 20, 21], ["Hz", "TEST", 28, 30], ["Tert", "TEST", 190, 194], ["phenyl", "TEST", 201, 207], ["(trifluoromethoxy)phenyl) acrylamide", "TREATMENT", 214, 250], ["Tert-butyl)phenyl)", "TREATMENT", 266, 284], ["(trifluoromethoxy)phenyl)propanamide (3f", "TREATMENT", 305, 345]]], ["Data of 2f:(d, J \u00bc 1.0 Hz), 120.3 (q, J C-F \u00bc 257.72-(4-Iodophenyl)-N-(2-(trifluoromethoxy)phenyl)acrylamide (2s) and 2-(4-Iodophenyl)-3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide (3s).", [["257.72-(4-Iodophenyl)-N-(2-(trifluoromethoxy)phenyl)acrylamide", "CHEMICAL", 46, 108], ["2-(4-Iodophenyl)-3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide", "CHEMICAL", 118, 191], ["C-F \u00bc 257.72-(4-Iodophenyl)-N-(2-(trifluoromethoxy)phenyl)acrylamide", "CHEMICAL", 40, 108], ["2-(4-Iodophenyl)-3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide", "CHEMICAL", 118, 191], ["C-F \u00bc 257.72-(4-Iodophenyl)-N-(2-(trifluoromethoxy)phenyl)acrylamide (2s)", "SIMPLE_CHEMICAL", 40, 113], ["2-(4-Iodophenyl)-3-(methylthio)-N-(2-(trifluoromethoxy)phenyl)propanamide", "SIMPLE_CHEMICAL", 118, 191], ["J C", "TEST", 38, 41], ["\u00bc", "TEST", 44, 45], ["Iodophenyl", "TEST", 56, 66], ["trifluoromethoxy", "TEST", 74, 90], ["phenyl", "TEST", 91, 97], ["acrylamide", "TEST", 98, 108], ["(trifluoromethoxy)phenyl)propanamide", "TREATMENT", 155, 191]]], ["Data of 2s: White solid; mp 95e97 C; 1 H NMR (400 MHz, CDCl 3 ) d 8.50 (d, J \u00bc 8.1 Hz, 1H) , 7.97e7.67 (m, 3H), 7.35e7.28 (m, 1H), 7.25e7.20 (m, 1H), 7.18 (d, J \u00bc 8.3 Hz, 2H) , 7.15e7.09 (m, 1H), 6.35 (s, 1H), 5.77 (s, 1H); 13 C NMR (100 MHz, CDCl 3 ) d 164.2, 143.9, 138.3 (d, J \u00bc 1.3 Hz), 138.1, 135.7, 130.4, 130.0, 127.7, 124.6, 124.4, 121.7, 120.5 (d, J \u00bc 1.", [["H", "CHEMICAL", 39, 40], ["1H", "CHEMICAL", 87, 89], ["1H", "CHEMICAL", 126, 128], ["1H", "CHEMICAL", 145, 147], ["2H", "CHEMICAL", 171, 173], ["1H", "CHEMICAL", 191, 193], ["1H", "CHEMICAL", 205, 207], ["1H", "CHEMICAL", 219, 221], ["13 C", "CHEMICAL", 224, 228], ["White solid", "TEST", 12, 23], ["mp", "TEST", 25, 27], ["NMR", "TEST", 41, 44], ["MHz", "TEST", 50, 53], ["CDCl", "TEST", 55, 59], ["d", "TEST", 64, 65], ["J", "TEST", 75, 76], ["Hz", "TEST", 83, 85], ["1H", "TEST", 126, 128], ["1H", "TEST", 145, 147], ["d", "TEST", 156, 157], ["J", "TEST", 159, 160], ["Hz", "TEST", 167, 169], ["2H", "TEST", 171, 173], ["1H", "TEST", 191, 193], ["s", "TEST", 202, 203], ["1H", "TEST", 205, 207], ["s", "TEST", 216, 217], ["1H", "TEST", 219, 221], ["NMR", "TEST", 229, 232], ["MHz", "TEST", 238, 241], ["CDCl", "TEST", 243, 247], ["d", "TEST", 252, 253], ["d", "TEST", 275, 276], ["J", "TEST", 278, 279], ["Hz", "TEST", 286, 288]]], ["2-Phenyl-N-(2-(trifluoromethyl)phenyl)acrylamide (2aa) and 3-(Methylthio)-2-phenyl-N-(2-(trifluoromethyl)phenyl) propanamide (3aa).", [["2-Phenyl-N-(2-(trifluoromethyl)phenyl)acrylamide", "CHEMICAL", 0, 48], ["3-(Methylthio)-2-phenyl-N-(2-(trifluoromethyl)phenyl) propanamide", "CHEMICAL", 59, 124], ["2-Phenyl-N-(2-(trifluoromethyl)phenyl)acrylamide", "CHEMICAL", 0, 48], ["3-(Methylthio)-2-phenyl-N-(2-(trifluoromethyl)phenyl) propanamide", "CHEMICAL", 59, 124], ["2-Phenyl-N-(2-(trifluoromethyl)phenyl)acrylamide (2aa)", "SIMPLE_CHEMICAL", 0, 54], ["3-(Methylthio)-2-phenyl-N-(2-(trifluoromethyl)phenyl) propanamide", "SIMPLE_CHEMICAL", 59, 124], ["Phenyl-N-(2-(trifluoromethyl)phenyl)acrylamide (2aa) and 3-(Methylthio)", "TREATMENT", 2, 73], ["phenyl-N-(2-(trifluoromethyl)phenyl) propanamide", "TREATMENT", 76, 124]]]]}